Psyllid ID: psy11194
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 316 | 2.2.26 [Sep-21-2011] | |||||||
| Q9D411 | 328 | Testis-specific serine/th | yes | N/A | 0.889 | 0.856 | 0.474 | 3e-73 | |
| Q9BXA7 | 367 | Testis-specific serine/th | yes | N/A | 0.857 | 0.738 | 0.482 | 3e-71 | |
| Q3SZW1 | 367 | Testis-specific serine/th | no | N/A | 0.870 | 0.749 | 0.475 | 8e-71 | |
| Q61241 | 365 | Testis-specific serine/th | no | N/A | 0.886 | 0.767 | 0.467 | 2e-70 | |
| Q96PF2 | 358 | Testis-specific serine/th | no | N/A | 0.892 | 0.787 | 0.453 | 3e-69 | |
| O54863 | 358 | Testis-specific serine/th | no | N/A | 0.857 | 0.756 | 0.469 | 3e-69 | |
| Q6SA08 | 328 | Testis-specific serine/th | no | N/A | 0.860 | 0.829 | 0.471 | 3e-69 | |
| Q9D2E1 | 268 | Testis-specific serine/th | no | N/A | 0.819 | 0.966 | 0.449 | 6e-66 | |
| Q96PN8 | 268 | Testis-specific serine/th | no | N/A | 0.819 | 0.966 | 0.430 | 1e-63 | |
| Q9BXA6 | 273 | Testis-specific serine/th | no | N/A | 0.816 | 0.945 | 0.441 | 3e-60 |
| >sp|Q9D411|TSSK4_MOUSE Testis-specific serine/threonine-protein kinase 4 OS=Mus musculus GN=Tssk4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 275 bits (703), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 139/293 (47%), Positives = 188/293 (64%), Gaps = 12/293 (4%)
Query: 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV 76
+V+E +GY VGKIIG GSY TV A T+ VA+KI+SK +A DYL KFLPREI+V+
Sbjct: 18 SVMEEYGYEVGKIIGHGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 77
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
K L+H LI F QAIETT RVYII+E A+ G + + I+ G E A +WF Q+ +
Sbjct: 78 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACAETLAGKWFSQMALGIA 137
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR---------AHMRCRSNAADNSLSET 187
Y H +G+VHRD+K ENLLLD N+K+SDFGFA+ + R + + LS+T
Sbjct: 138 YLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSSQPVHSSPSYRQMNSLSHLSQT 197
Query: 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF 247
+CGS+AYA PEIL G+PY P LSD WSMGV+L+ +V RLPFDD+++ +LL++ Q +VTF
Sbjct: 198 YCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNLKKLLRETQKEVTF 257
Query: 248 PKQPEVSTECKELISNILSPVQTRPRLKTIAEDRWL---KPKPKSRGVDKAEA 297
P +S ECK LI +L R + + D W+ +P+ S + EA
Sbjct: 258 PANLTISQECKNLILQLLRQSTKRATILDVLRDPWMLKFQPEQPSNEIRLLEA 310
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9BXA7|TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (685), Expect = 3e-71, Method: Compositional matrix adjust.
Identities = 135/280 (48%), Positives = 197/280 (70%), Gaps = 9/280 (3%)
Query: 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV 75
VL+ GY +G +G GSYA VK A S R +VAIKI+ + +AP D+L+KFLPREIE+
Sbjct: 4 AAVLKRRGYLLGINLGEGSYAKVKSAYSERLKFNVAIKIIDRKKAPADFLEKFLPREIEI 63
Query: 76 VKGLKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEA 134
+ L H ++I+ + ET+H +VYI+ME A G L ++I+ +G + E AR+ F QL A
Sbjct: 64 LAMLNHCSIIKTYEIFETSHGKVYIVMELAVQGDLLELIKTRGALHEDEARKKFHQLSLA 123
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC-RSNAADNSLSETFCGSYA 193
++YCH+ VVHRD+KC+NLLLD D+NIKLSDF F++ RC R ++ +LS+TFCGS A
Sbjct: 124 IKYCHDLDVVHRDLKCDNLLLDKDFNIKLSDFSFSK---RCLRDDSGRMALSKTFCGSPA 180
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK-QVQNKVTFPKQPE 252
YA+PE+LQGIPY P + DIWS+GV+L+ MV G +P+DDS++ ++L+ Q +++V FP+
Sbjct: 181 YAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKH 240
Query: 253 VSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKPKSRG 291
++ ECK+LI ++L P V R + I W+ +PK+RG
Sbjct: 241 LTGECKDLIYHMLQPDVNRRLHIDEILSHCWM--QPKARG 278
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus GN=TSSK1B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 267 bits (682), Expect = 8e-71, Method: Compositional matrix adjust.
Identities = 135/284 (47%), Positives = 196/284 (69%), Gaps = 9/284 (3%)
Query: 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV 75
VL+ GY +G +G GSYA VK A S R +VA+KI+ + +AP D+L+KFLPREIE+
Sbjct: 4 AAVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEI 63
Query: 76 VKGLKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEA 134
+ L H ++I+ + ET+ +VYI+ME G L + I+ +G + E AR+ F QL A
Sbjct: 64 LAMLNHRSIIKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSA 123
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC-RSNAADNSLSETFCGSYA 193
++YCH+ VVHRD+KCENLLLD D+NIKLSDFGF++ RC R ++ +LS+TFCGS A
Sbjct: 124 IKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSK---RCLRDDSGRLTLSKTFCGSAA 180
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK-QVQNKVTFPKQPE 252
YA+PE+LQGIPY P + DIWS+GV+L+ MV G +P+DDS++ ++L+ Q +++V FP+
Sbjct: 181 YAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKH 240
Query: 253 VSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKPKSRGVDKA 295
++ ECK+LI +L P V R + I W+ +PK+RG+ A
Sbjct: 241 LTGECKDLIYRMLQPDVTRRLHIDEILSHCWV--QPKARGLSSA 282
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q61241|TSSK1_MOUSE Testis-specific serine/threonine-protein kinase 1 OS=Mus musculus GN=Tssk1b PE=1 SV=2 | Back alignment and function description |
|---|
Score = 266 bits (680), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 135/289 (46%), Positives = 195/289 (67%), Gaps = 9/289 (3%)
Query: 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV 75
VL+ GY +G +G GSYA VK A S R +VA+KI+ + +AP D+L+KFLPREIE+
Sbjct: 4 AAVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPSDFLEKFLPREIEI 63
Query: 76 VKGLKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEA 134
+ L H ++++ + ET+ +VYI+ME G L + I+ +G + E AR+ F QL A
Sbjct: 64 LAMLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSA 123
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC-RSNAADNSLSETFCGSYA 193
++YCH+ VVHRD+KCENLLLD D+NIKLSDFGF++ RC R ++ LS+TFCGS A
Sbjct: 124 IKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSK---RCLRDDSGRLILSKTFCGSAA 180
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK-QVQNKVTFPKQPE 252
YA+PE+LQGIPY P + DIWS+GV+L+ MV G +P+DDS++ ++L+ Q +++V FP+
Sbjct: 181 YAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKH 240
Query: 253 VSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKPK--SRGVDKAEAE 298
++ ECK+LI +L P V R + I W++PK + S G E E
Sbjct: 241 LTGECKDLIYRMLQPDVNRRLHIDEILNHCWVQPKARGLSSGAINKEGE 289
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PF2|TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 136/300 (45%), Positives = 196/300 (65%), Gaps = 18/300 (6%)
Query: 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV 75
TVL GY VG +G GSYA VK A S R +VA+KI+ + + P D++++FLPRE+++
Sbjct: 4 ATVLRKKGYIVGINLGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDI 63
Query: 76 VKGLKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEA 134
+ + H ++I+ + ET+ R+YIIME G L + I+ QG + E AR+ F QL A
Sbjct: 64 LATVNHGSIIKTYEIFETSDGRIYIIMELGVQGDLLEFIKCQGALHEDVARKMFRQLSSA 123
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC-RSNAADNSLSETFCGSYA 193
++YCH+ +VHRD+KCENLLLD D+NIKLSDFGF++ RC R + LS+TFCGS A
Sbjct: 124 VKYCHDLDIVHRDLKCENLLLDKDFNIKLSDFGFSK---RCLRDSNGRIILSKTFCGSAA 180
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK-QVQNKVTFPKQPE 252
YA+PE+LQ IPY P + DIWS+GV+L+ MV G +P+DDS + ++L+ Q +++V FP+
Sbjct: 181 YAAPEVLQSIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIRKMLRIQKEHRVDFPRSKN 240
Query: 253 VSTECKELISNILSP-VQTRPRLKTIAEDRWLK-PKPKS----------RGVDKAEAELD 300
++ ECK+LI +L P V R + I WL+ PKPK+ G +AE +LD
Sbjct: 241 LTCECKDLIYRMLQPDVSQRLHIDEILSHSWLQPPKPKATSSASFKREGEGKYRAECKLD 300
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates TSKS at 'Ser-288' and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O54863|TSSK2_MOUSE Testis-specific serine/threonine-protein kinase 2 OS=Mus musculus GN=Tssk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 131/279 (46%), Positives = 189/279 (67%), Gaps = 8/279 (2%)
Query: 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV 75
VL GY VG +G GSYA VK A S R +VA+KI+ + + P D++++FLPRE+++
Sbjct: 4 AAVLRKKGYIVGINLGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDI 63
Query: 76 VKGLKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEA 134
+ + H ++I+ + ET+ R+YI+ME G L + I+ +G + E AR+ F QL A
Sbjct: 64 LATVNHRSIIKTYEIFETSDGRIYIVMELGVQGDLLEFIKCRGALHEDVARKMFRQLSSA 123
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC-RSNAADNSLSETFCGSYA 193
++YCH+ VVHRD+KCENLLLD D+NIKLSDFGF++ RC R + LS+TFCGS A
Sbjct: 124 VKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSK---RCLRDGSGRIVLSKTFCGSAA 180
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK-QVQNKVTFPKQPE 252
YA+PE+LQGIPY P + DIWS+GV+L+ MV G +P+DDS + ++L+ Q +++V FP+
Sbjct: 181 YAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKKMLRIQKEHRVDFPRSKN 240
Query: 253 VSTECKELISNILSP-VQTRPRLKTIAEDRWLK-PKPKS 289
++ ECK+LI IL P V R + I WL+ PKPK+
Sbjct: 241 LTGECKDLIYRILQPDVNRRLHIDEILSHSWLQPPKPKA 279
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6SA08|TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens GN=TSSK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 133/282 (47%), Positives = 184/282 (65%), Gaps = 10/282 (3%)
Query: 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV 76
++++ +GY VGK IG GSY +V A T+ VA+KI+SK +A DYL KFLPREI+V+
Sbjct: 18 SLMDEYGYEVGKAIGHGSYGSVYEAFYTKQKVMVAVKIISKKKASDDYLNKFLPREIQVM 77
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
K L+H LI F +AIE+T RVYII+E A+ G + + I+ G E A +WF QL +
Sbjct: 78 KVLRHKYLINFYRAIESTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFSQLTLGIA 137
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA-----HMRC----RSNAADNSLSET 187
Y H + +VHRD+K ENLLLD N+K+SDFGFA+ + C R + LS+T
Sbjct: 138 YLHSKSIVHRDLKLENLLLDKWENVKISDFGFAKMVPSNQPVGCSPSYRQVNCFSHLSQT 197
Query: 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF 247
+CGS+AYA PEIL+G+PY P LSD WSMGV+L+ +V LPFDD+++ +LL++ Q +VTF
Sbjct: 198 YCGSFAYACPEILRGLPYNPFLSDTWSMGVILYTLVVAHLPFDDTNLKKLLRETQKEVTF 257
Query: 248 PKQPEVSTECKELISNILSPVQTRPRLKTIAEDRW-LKPKPK 288
P +S ECK LI +L R + I +D W LK +P+
Sbjct: 258 PANHTISQECKNLILQMLRQATKRATILDIIKDSWVLKFQPE 299
|
May be involved in a signaling pathway during male germ cell development or mature sperm function (By similarity). Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9D2E1|TSSK3_MOUSE Testis-specific serine/threonine-protein kinase 3 OS=Mus musculus GN=Tssk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (640), Expect = 6e-66, Method: Compositional matrix adjust.
Identities = 120/267 (44%), Positives = 181/267 (67%), Gaps = 8/267 (2%)
Query: 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKG 78
L S+GY +GK IG G+Y+ VK A S +H VAIKI+ K+ P +++++FLPRE+++V+
Sbjct: 5 LLSNGYQLGKTIGEGTYSKVKEAFSKKHQRKVAIKIIDKMGGPEEFIQRFLPRELQIVRT 64
Query: 79 LKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
L H N+I+ + +E+ ++Y++ME AE G +FD + G + E RA+ F Q++EA++Y
Sbjct: 65 LDHKNIIQVYEMLESADGKIYLVMELAEGGDVFDCVLNGGPLPESRAKALFRQMVEAIRY 124
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
CH GV HRD+KCEN LL +N+KL+DFGFA+ + R LS+TFCGS AYA+P
Sbjct: 125 CHGCGVAHRDLKCENALLQG-FNLKLTDFGFAKVLPKSR-----RELSQTFCGSTAYAAP 178
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257
E+LQGIP+ D+WSMGVVL+ M+ LPFDD+ + ++L Q Q V+FP +STEC
Sbjct: 179 EVLQGIPHDSKKGDVWSMGVVLYVMLCASLPFDDTDIPKMLWQQQKGVSFPTHLGISTEC 238
Query: 258 KELISNILSP-VQTRPRLKTIAEDRWL 283
++L+ +L P + RP ++ ++ WL
Sbjct: 239 QDLLKRLLEPDMILRPSIEEVSWHPWL 265
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PN8|TSSK3_HUMAN Testis-specific serine/threonine-protein kinase 3 OS=Homo sapiens GN=TSSK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (620), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 115/267 (43%), Positives = 179/267 (67%), Gaps = 8/267 (2%)
Query: 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKG 78
L S+GY +GK IG G+Y+ VK A S +H VAIK++ K+ P +++++FLPRE+++V+
Sbjct: 5 LLSNGYQLGKTIGEGTYSKVKEAFSKKHQRKVAIKVIDKMGGPEEFIQRFLPRELQIVRT 64
Query: 79 LKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
L H N+I+ + +E+ ++ ++ME AE G +FD + G + E RA+ F Q++EA++Y
Sbjct: 65 LDHKNIIQVYEMLESADGKICLVMELAEGGDVFDCVLNGGPLPESRAKALFRQMVEAIRY 124
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
CH GV HRD+KCEN LL +N+KL+DFGFA+ + + LS+TFCGS AYA+P
Sbjct: 125 CHGCGVAHRDLKCENALLQG-FNLKLTDFGFAKVLPK-----SHRELSQTFCGSTAYAAP 178
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257
E+LQGIP+ D+WSMGVVL+ M+ LPFDD+ + ++L Q Q V+FP +S +C
Sbjct: 179 EVLQGIPHDSKKGDVWSMGVVLYVMLCASLPFDDTDIPKMLWQQQKGVSFPTHLSISADC 238
Query: 258 KELISNILSP-VQTRPRLKTIAEDRWL 283
++L+ +L P + RP ++ ++ WL
Sbjct: 239 QDLLKRLLEPDMILRPSIEEVSWHPWL 265
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9BXA6|TSSK6_HUMAN Testis-specific serine/threonine-protein kinase 6 OS=Homo sapiens GN=TSSK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 232 bits (591), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 120/272 (44%), Positives = 176/272 (64%), Gaps = 14/272 (5%)
Query: 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
+L GY +G+ IG GSY+ VK+A S ++ G VAIK+V + +APPD++ KFLPRE+ +++
Sbjct: 6 LLSELGYKLGRTIGEGSYSKVKVATSKKYKGTVAIKVVDRRRAPPDFVNKFLPRELSILR 65
Query: 78 GLKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
G++HP+++ + IE + ++YI+ME A L ++ G I ++AR F Q+ A++
Sbjct: 66 GVRHPHIVHVFEFIEVCNGKLYIVMEAAAT-DLLQAVQRNGRIPGVQARDLFAQIAGAVR 124
Query: 137 YCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFAR-AHMRCRSNAADNSLSETFCGSYAY 194
Y H+ +VHRD+KCEN+LL D +KL+DFGF R AH LS T+CGS AY
Sbjct: 125 YLHDHHLVHRDLKCENVLLSPDERRVKLTDFGFGRQAH-------GYPDLSTTYCGSAAY 177
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254
ASPE+L GIPY P D+WSMGVVL+ MV G +PFDDS + L ++ + V +P+ E+S
Sbjct: 178 ASPEVLLGIPYDPKKYDVWSMGVVLYVMVTGCMPFDDSDIAGLPRRQKRGVLYPEGLELS 237
Query: 255 TECKELISNIL--SPVQTRPRLKTIAEDRWLK 284
CK LI+ +L SP RP +A + WL+
Sbjct: 238 ERCKALIAELLQFSP-SARPSAGQVARNCWLR 268
|
Required for sperm production and function. Plays a role in DNA condensation during postmeiotic chromatin remodeling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 316 | ||||||
| 383852844 | 364 | PREDICTED: testis-specific serine/threon | 0.851 | 0.739 | 0.723 | 1e-116 | |
| 357614817 | 329 | putative cAMP-dependent protein kinase c | 0.933 | 0.896 | 0.668 | 1e-116 | |
| 380027639 | 345 | PREDICTED: testis-specific serine/threon | 0.863 | 0.791 | 0.716 | 1e-115 | |
| 242016558 | 386 | cAMP-dependent protein kinase catalytic | 0.905 | 0.740 | 0.680 | 1e-115 | |
| 328776257 | 351 | PREDICTED: testis-specific serine/threon | 0.863 | 0.777 | 0.709 | 1e-114 | |
| 270010686 | 327 | hypothetical protein TcasGA2_TC010125 [T | 0.844 | 0.816 | 0.724 | 1e-114 | |
| 91087563 | 340 | PREDICTED: similar to CG9222 CG9222-PA [ | 0.844 | 0.785 | 0.724 | 1e-114 | |
| 350401037 | 363 | PREDICTED: testis-specific serine/threon | 0.876 | 0.763 | 0.701 | 1e-114 | |
| 340709608 | 363 | PREDICTED: testis-specific serine/threon | 0.860 | 0.749 | 0.708 | 1e-113 | |
| 332019401 | 361 | Testis-specific serine/threonine-protein | 0.854 | 0.747 | 0.702 | 1e-111 |
| >gi|383852844|ref|XP_003701935.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1089), Expect = e-116, Method: Compositional matrix adjust.
Identities = 196/271 (72%), Positives = 231/271 (85%), Gaps = 2/271 (0%)
Query: 13 DRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPRE 72
D+K+TVLESHGY +GK IG+GSYATVK+A+S RH VAIKIVSK QAP +YLKKFLPRE
Sbjct: 27 DKKLTVLESHGYNLGKTIGSGSYATVKIAKSCRHDCQVAIKIVSKFQAPGEYLKKFLPRE 86
Query: 73 IEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL 132
IEVVKGL+HPNLIRFLQAIETTHRVYIIMEYA+NGSL DIIR +IDE+R+RRWF QLL
Sbjct: 87 IEVVKGLRHPNLIRFLQAIETTHRVYIIMEYAQNGSLLDIIRRDTFIDEVRSRRWFRQLL 146
Query: 133 EALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
EA+ YCH RGVVHRD+KCENLL+DS++N+KLSDFGFAR M+ ++ N LSETFCGSY
Sbjct: 147 EAIDYCHGRGVVHRDVKCENLLMDSNFNVKLSDFGFARGQMKPKNGI--NPLSETFCGSY 204
Query: 193 AYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE 252
AYASPEIL+GIPY P LSD+WSMGVVL+AMV+GRLPFDD++ N+LLKQVQ+++TFPK P+
Sbjct: 205 AYASPEILKGIPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYNQLLKQVQSRITFPKDPK 264
Query: 253 VSTECKELISNILSPVQTRPRLKTIAEDRWL 283
VS C+ LIS IL P +TR + I D WL
Sbjct: 265 VSQSCRSLISRILVPQRTRLHIDRIRNDVWL 295
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|357614817|gb|EHJ69292.1| putative cAMP-dependent protein kinase catalytic subunit [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 422 bits (1086), Expect = e-116, Method: Compositional matrix adjust.
Identities = 202/302 (66%), Positives = 243/302 (80%), Gaps = 7/302 (2%)
Query: 8 VQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKK 67
V+ DRK+TVLE+HGY +G+ IG+GSYATVK+A S RH+ VAIKI+SK QAP DYLKK
Sbjct: 13 VEAKTDRKLTVLETHGYILGRTIGSGSYATVKVATSERHNCQVAIKIISKFQAPGDYLKK 72
Query: 68 FLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRW 127
FLPREIEVVKGLKH NLIRFLQAIETTHRVYI+MEYAENGSL DIIR +IDE R RRW
Sbjct: 73 FLPREIEVVKGLKHENLIRFLQAIETTHRVYIVMEYAENGSLLDIIRKDQHIDEQRGRRW 132
Query: 128 FGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET 187
F QL+EA+ YCHERGVVHRDIKCENLL+D NIKLSDFGFAR HM+ ++ +LSET
Sbjct: 133 FKQLVEAVDYCHERGVVHRDIKCENLLMDHGLNIKLSDFGFARGHMKPKNGVY--ALSET 190
Query: 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF 247
FCGSYAYASPEIL+G+PY P SDIWSMGVVL+A+V+GRLPFDD++ +LLKQVQNKV+F
Sbjct: 191 FCGSYAYASPEILKGVPYRPQDSDIWSMGVVLYAIVYGRLPFDDTNYTQLLKQVQNKVSF 250
Query: 248 PKQPEVSTECKELISNILSPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMIQ 307
P++P+VSTEC++LI+ IL+P++ R ++ I D WL P ++ + ELD D Q
Sbjct: 251 PREPKVSTECRKLITKILAPLKLRSKIPQILADPWLSPSAPTK-----DEELDTNPDNAQ 305
Query: 308 TS 309
S
Sbjct: 306 AS 307
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380027639|ref|XP_003697528.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 422 bits (1084), Expect = e-115, Method: Compositional matrix adjust.
Identities = 197/275 (71%), Positives = 227/275 (82%), Gaps = 2/275 (0%)
Query: 9 QDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKF 68
D ++K+T+LESHGYT+GK IG GSYATVK+A+S RH VA+KIVSK QAP DYLKKF
Sbjct: 22 NDKSEKKLTILESHGYTLGKTIGAGSYATVKIAKSDRHDCQVAVKIVSKFQAPGDYLKKF 81
Query: 69 LPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWF 128
LPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA+ GSL DIIR +IDE R+RRWF
Sbjct: 82 LPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAQCGSLLDIIRRDTFIDEFRSRRWF 141
Query: 129 GQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETF 188
QLLEA+ YCH RGVVHRDIKCENLL+D ++NIKLSDFGFAR M+ ++ N LSETF
Sbjct: 142 RQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARGQMKPKNGT--NPLSETF 199
Query: 189 CGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP 248
CGSYAYASPEIL+G+PY P LSDIWSMGVVL+AMV+GRLPFDD++ ++LLKQVQNKV FP
Sbjct: 200 CGSYAYASPEILKGVPYLPQLSDIWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQNKVVFP 259
Query: 249 KQPEVSTECKELISNILSPVQTRPRLKTIAEDRWL 283
K+P VS C+ LIS IL P + R + I D WL
Sbjct: 260 KEPNVSQACRSLISRILVPQRIRMNIDNIRNDTWL 294
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242016558|ref|XP_002428853.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212513589|gb|EEB16115.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1083), Expect = e-115, Method: Compositional matrix adjust.
Identities = 196/288 (68%), Positives = 236/288 (81%), Gaps = 2/288 (0%)
Query: 13 DRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPRE 72
++K+TVLE+HGYT+GK IGTGSYATVK+ARS RH VA+KIVSK QAP DYLKKFLPRE
Sbjct: 42 EKKLTVLETHGYTLGKTIGTGSYATVKVARSERHDCLVAVKIVSKFQAPADYLKKFLPRE 101
Query: 73 IEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL 132
IEVVKGLKH NLIRFLQAIETTHRVYIIMEYAENGSL D+IR YIDE+RAR++F QL+
Sbjct: 102 IEVVKGLKHINLIRFLQAIETTHRVYIIMEYAENGSLLDVIRKDQYIDEVRARKYFRQLI 161
Query: 133 EALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
+A+ YCHERGVVHRDIKCENLL+D D N+KLSDFGFAR HMR ++ A LS+TFCGSY
Sbjct: 162 DAVDYCHERGVVHRDIKCENLLMDHDNNVKLSDFGFARGHMRIKNGVA--PLSDTFCGSY 219
Query: 193 AYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE 252
AYASPEIL+G+PY P LSDIWS GVVL+A+V+GRLPFDD++ N+LLKQVQ+K++FPK+P+
Sbjct: 220 AYASPEILKGVPYQPQLSDIWSTGVVLYAIVYGRLPFDDTNYNQLLKQVQSKISFPKEPK 279
Query: 253 VSTECKELISNILSPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELD 300
+S CK LI+ IL+PV+ R ++ I D W P + + D
Sbjct: 280 ISANCKSLITKILAPVKFRLKIPAIRSDPWFVQGPSDSSANGPQGSED 327
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328776257|ref|XP_395246.3| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 419 bits (1076), Expect = e-114, Method: Compositional matrix adjust.
Identities = 195/275 (70%), Positives = 227/275 (82%), Gaps = 2/275 (0%)
Query: 9 QDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKF 68
D ++ +T+LESHGYT+GK IG GSYATVK+A+S RH VA+KIVSK QAP DYLKKF
Sbjct: 28 NDKSEKXLTILESHGYTLGKPIGAGSYATVKIAKSDRHDCQVAVKIVSKFQAPGDYLKKF 87
Query: 69 LPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWF 128
LPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA+ GSL DIIR +IDE+R+RRWF
Sbjct: 88 LPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAQCGSLLDIIRRDTFIDELRSRRWF 147
Query: 129 GQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETF 188
QLLEA+ YCH RGVVHRDIKCENLL+D ++NIKLSDFGFAR M+ ++ N LSETF
Sbjct: 148 RQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARGQMKAKNGI--NPLSETF 205
Query: 189 CGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP 248
CGSYAYASPEIL+G+PY P LSD+WSMGVVL+AMV+GRLPFDD++ ++LLKQVQNKV FP
Sbjct: 206 CGSYAYASPEILKGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQNKVVFP 265
Query: 249 KQPEVSTECKELISNILSPVQTRPRLKTIAEDRWL 283
K+P VS C+ LIS IL P + R + I D WL
Sbjct: 266 KEPNVSQACRSLISRILVPQRIRMNIDNIRNDTWL 300
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270010686|gb|EFA07134.1| hypothetical protein TcasGA2_TC010125 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1073), Expect = e-114, Method: Compositional matrix adjust.
Identities = 195/269 (72%), Positives = 228/269 (84%), Gaps = 2/269 (0%)
Query: 14 RKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREI 73
+K TVLESHGY +GK IG+GSYATV++A S RH+ +VA+KIVSK AP DYLKKFLPREI
Sbjct: 27 KKQTVLESHGYILGKTIGSGSYATVRMAHSERHNMNVAVKIVSKFSAPADYLKKFLPREI 86
Query: 74 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLE 133
EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL +IIR YIDEIR+R+WF QL++
Sbjct: 87 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLLEIIRKDSYIDEIRSRKWFRQLVD 146
Query: 134 ALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193
A+ YCHERGVVHRDIKCENLLL+++Y IKLSDFGFAR HM+ ++ A LSETFCGSYA
Sbjct: 147 AVDYCHERGVVHRDIKCENLLLNTEYEIKLSDFGFARGHMKIKNGQA--PLSETFCGSYA 204
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEV 253
YASPEIL+GIPY P SDIWSMGVVLFAMV+GRLPFDD++ +L+KQV NKV FPK+P+V
Sbjct: 205 YASPEILKGIPYQPQFSDIWSMGVVLFAMVYGRLPFDDTNYRDLVKQVTNKVVFPKEPKV 264
Query: 254 STECKELISNILSPVQTRPRLKTIAEDRW 282
S CK LI+ IL+P++ R R+ I D W
Sbjct: 265 SLMCKALINKILAPLKARIRIPGIKTDPW 293
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|91087563|ref|XP_971036.1| PREDICTED: similar to CG9222 CG9222-PA [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1072), Expect = e-114, Method: Compositional matrix adjust.
Identities = 195/269 (72%), Positives = 228/269 (84%), Gaps = 2/269 (0%)
Query: 14 RKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREI 73
+K TVLESHGY +GK IG+GSYATV++A S RH+ +VA+KIVSK AP DYLKKFLPREI
Sbjct: 27 KKQTVLESHGYILGKTIGSGSYATVRMAHSERHNMNVAVKIVSKFSAPADYLKKFLPREI 86
Query: 74 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLE 133
EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL +IIR YIDEIR+R+WF QL++
Sbjct: 87 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLLEIIRKDSYIDEIRSRKWFRQLVD 146
Query: 134 ALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193
A+ YCHERGVVHRDIKCENLLL+++Y IKLSDFGFAR HM+ ++ A LSETFCGSYA
Sbjct: 147 AVDYCHERGVVHRDIKCENLLLNTEYEIKLSDFGFARGHMKIKNGQA--PLSETFCGSYA 204
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEV 253
YASPEIL+GIPY P SDIWSMGVVLFAMV+GRLPFDD++ +L+KQV NKV FPK+P+V
Sbjct: 205 YASPEILKGIPYQPQFSDIWSMGVVLFAMVYGRLPFDDTNYRDLVKQVTNKVVFPKEPKV 264
Query: 254 STECKELISNILSPVQTRPRLKTIAEDRW 282
S CK LI+ IL+P++ R R+ I D W
Sbjct: 265 SLMCKALINKILAPLKARIRIPGIKTDPW 293
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350401037|ref|XP_003486034.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1070), Expect = e-114, Method: Compositional matrix adjust.
Identities = 197/281 (70%), Positives = 232/281 (82%), Gaps = 4/281 (1%)
Query: 5 TVQVQDD--IDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP 62
TV+ ++D +++K+T+LESHGYT+GK IGTGSYATVK+A+S RH VA+KIVSK QAP
Sbjct: 17 TVEGKNDEKLEKKLTILESHGYTLGKTIGTGSYATVKIAKSNRHDCQVAVKIVSKFQAPG 76
Query: 63 DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEI 122
DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA GSL D+IR +IDE
Sbjct: 77 DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYARCGSLLDMIRRDTFIDEF 136
Query: 123 RARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182
R+RRWF QLLEA+ YCH RGVVHRDIKCENLL+D ++NIKLSDFGFAR M+ ++ A
Sbjct: 137 RSRRWFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARGQMKSKNGIA-- 194
Query: 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ 242
LSETFCGSYAYASPEIL+G+PY P LSD+WSMGVVL+AMV+GRLPFDD++ ++LLKQVQ
Sbjct: 195 PLSETFCGSYAYASPEILKGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQ 254
Query: 243 NKVTFPKQPEVSTECKELISNILSPVQTRPRLKTIAEDRWL 283
NKV FPK+P VS C+ LIS IL + R + I D WL
Sbjct: 255 NKVIFPKEPNVSQACRSLISRILVSQRIRLHIDHIRNDVWL 295
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340709608|ref|XP_003393396.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 415 bits (1067), Expect = e-113, Method: Compositional matrix adjust.
Identities = 194/274 (70%), Positives = 227/274 (82%), Gaps = 2/274 (0%)
Query: 10 DDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFL 69
+ +++K+T+LESHGYT+GK IGTGSYATVK+A+S RH VA+KIVSK QAP DYLKKFL
Sbjct: 24 EKLEKKLTILESHGYTLGKTIGTGSYATVKIAKSNRHDCQVAVKIVSKFQAPGDYLKKFL 83
Query: 70 PREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG 129
PREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA+ GSL D+IR +IDE R+RRWF
Sbjct: 84 PREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAQCGSLLDMIRRDTFIDEFRSRRWFR 143
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
QLLEA+ YCH RGVVHRDIKCENLL+D ++NIKLSDFGFAR M+ ++ A LSETFC
Sbjct: 144 QLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARGQMKSKNGIA--PLSETFC 201
Query: 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK 249
GSYAYASPEIL G+PY P LSD+WSMGVVL+AMV+GRLPFDD++ ++LLKQVQNKV FPK
Sbjct: 202 GSYAYASPEILMGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQNKVIFPK 261
Query: 250 QPEVSTECKELISNILSPVQTRPRLKTIAEDRWL 283
+P VS C+ LIS IL + R + I D WL
Sbjct: 262 EPNVSQACRSLISRILVSQRIRLDIDHIRNDVWL 295
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332019401|gb|EGI59887.1| Testis-specific serine/threonine-protein kinase 4 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 408 bits (1049), Expect = e-111, Method: Compositional matrix adjust.
Identities = 191/272 (70%), Positives = 225/272 (82%), Gaps = 2/272 (0%)
Query: 13 DRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPRE 72
++K+TVLESHGYT+GK IG GSYATVK+A+S R+ VA+KIVSK QAP +YL KFLPRE
Sbjct: 30 EKKLTVLESHGYTLGKTIGAGSYATVKVAKSDRYGYQVAVKIVSKFQAPGEYLTKFLPRE 89
Query: 73 IEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL 132
IEVVKGLKHPNLI FLQAIETTHRVYIIMEYA+NGSL DIIR YIDE+R+RRWF QLL
Sbjct: 90 IEVVKGLKHPNLIHFLQAIETTHRVYIIMEYAQNGSLLDIIRRDTYIDELRSRRWFRQLL 149
Query: 133 EALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
EA++YCHE G+VHRD+KCENLL+D +NIKLSDFGFAR M+ ++ + LS T+CGSY
Sbjct: 150 EAIEYCHEHGIVHRDVKCENLLMDFRFNIKLSDFGFARGQMKLKN--GEWPLSTTYCGSY 207
Query: 193 AYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE 252
AYASPEIL+GIPY P LSDIWSMGVVL+AMV GRLPFDD++ +LLKQVQN+V FPK P+
Sbjct: 208 AYASPEILRGIPYQPQLSDIWSMGVVLYAMVHGRLPFDDTNYAQLLKQVQNRVVFPKHPK 267
Query: 253 VSTECKELISNILSPVQTRPRLKTIAEDRWLK 284
VS C+ LIS IL P R R+ +I D WL+
Sbjct: 268 VSQPCRSLISRILVPQFARLRINSIKNDAWLE 299
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 316 | ||||||
| FB|FBgn0031784 | 337 | CG9222 [Drosophila melanogaste | 0.879 | 0.824 | 0.553 | 2.2e-82 | |
| UNIPROTKB|D4A7Q4 | 339 | D4A7Q4 "Uncharacterized protei | 0.487 | 0.454 | 0.506 | 1.8e-72 | |
| UNIPROTKB|E2RSP9 | 338 | TSSK4 "Uncharacterized protein | 0.487 | 0.455 | 0.5 | 2.3e-72 | |
| UNIPROTKB|I3LBD3 | 340 | TSSK4 "Uncharacterized protein | 0.487 | 0.452 | 0.5 | 2.3e-72 | |
| UNIPROTKB|F6RLA2 | 326 | TSSK4 "Uncharacterized protein | 0.860 | 0.834 | 0.496 | 1.9e-67 | |
| UNIPROTKB|E2R1G2 | 358 | TSSK2 "Uncharacterized protein | 0.851 | 0.751 | 0.483 | 6.5e-67 | |
| UNIPROTKB|Q9BXA7 | 367 | TSSK1B "Testis-specific serine | 0.927 | 0.798 | 0.457 | 6.5e-67 | |
| UNIPROTKB|G3N2D2 | 367 | TSSK1B "Testis-specific serine | 0.863 | 0.743 | 0.478 | 1.3e-66 | |
| UNIPROTKB|Q3SZW1 | 367 | TSSK1B "Testis-specific serine | 0.863 | 0.743 | 0.478 | 1.3e-66 | |
| UNIPROTKB|F1RK80 | 364 | TSSK1B "Uncharacterized protei | 0.863 | 0.75 | 0.468 | 1.7e-66 |
| FB|FBgn0031784 CG9222 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 826 (295.8 bits), Expect = 2.2e-82, P = 2.2e-82
Identities = 155/280 (55%), Positives = 205/280 (73%)
Query: 6 VQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYL 65
V+ D + T+LE HG +GK+IGTG+YA VK+ S + VA+KI+SKV+AP +Y
Sbjct: 58 VKADDKSKPQKTILEEHGIILGKVIGTGNYAKVKIGFSEEYGKRVAVKIISKVKAPSEYT 117
Query: 66 KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRAR 125
+KFLPREIE VKGL H NLI F Q+IET+HRVY+IM+ AENG+L D +R + ++DE ++R
Sbjct: 118 QKFLPREIEAVKGLHHENLITFYQSIETSHRVYLIMQLAENGTLLDYVRERKFLDEPQSR 177
Query: 126 RWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS 185
F QL+ A++Y H +GVVHRDIKCENLLLD ++N+KL DFGFAR R N LS
Sbjct: 178 TLFKQLVSAVEYIHSKGVVHRDIKCENLLLDENWNLKLIDFGFARKDTRTSDNQV--ILS 235
Query: 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV 245
+TFCGSYAYASPEIL+G+ Y P +SDIW+ GVV +AMVFGRLP+D S+V+ LLK++ +
Sbjct: 236 KTFCGSYAYASPEILKGVAYDPFMSDIWACGVVCYAMVFGRLPYDGSNVHILLKRINQSL 295
Query: 246 TFPKQPEVSTECKELISNILSPVQTRPRLKTIAEDRWLKP 285
FPK P S+ECK +I +IL+PV+ R + + ED W P
Sbjct: 296 VFPKSPSASSECKHMIMHILAPVKIRYNIPQVKEDPWYSP 335
|
|
| UNIPROTKB|D4A7Q4 D4A7Q4 "Uncharacterized protein" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 396 (144.5 bits), Expect = 1.8e-72, Sum P(2) = 1.8e-72
Identities = 83/164 (50%), Positives = 108/164 (65%)
Query: 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV 76
+V+E +GY VGK+IG GSY TV A T+ VA+KI+SK +A DYL KFLPREI+V+
Sbjct: 18 SVMEEYGYEVGKVIGHGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 77
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
K L+H LI F QAIETT RVYII+E A+ G + + I+ G E A +WF Q+ +
Sbjct: 78 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACSETLAGKWFSQMALGIA 137
Query: 137 YCHERGVVHR----------DIKCENLLLDSDYNIKLSDFGFAR 170
Y H +G+VHR D+K ENLLLD N+K+SDFGFA+
Sbjct: 138 YLHSKGIVHRLTPSLSAAGRDLKLENLLLDKRENVKISDFGFAK 181
|
|
| UNIPROTKB|E2RSP9 TSSK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 393 (143.4 bits), Expect = 2.3e-72, Sum P(2) = 2.3e-72
Identities = 82/164 (50%), Positives = 108/164 (65%)
Query: 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV 76
+V+E +GY +GK+IG GSY TV A T+ VA+KI+SK +A DYL KFLPREI+V+
Sbjct: 18 SVMEEYGYEMGKVIGNGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 77
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
K L+H LI F QAIETT RVYII+E A+ G + + I+ G E A +WF Q+ +
Sbjct: 78 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFSQMTLGIA 137
Query: 137 YCHERGVVHR----------DIKCENLLLDSDYNIKLSDFGFAR 170
Y H +G+VHR D+K ENLLLD N+K+SDFGFA+
Sbjct: 138 YLHSKGIVHRLTPSLSAAGRDLKLENLLLDKRENVKISDFGFAK 181
|
|
| UNIPROTKB|I3LBD3 TSSK4 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 392 (143.0 bits), Expect = 2.3e-72, Sum P(2) = 2.3e-72
Identities = 83/166 (50%), Positives = 108/166 (65%)
Query: 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV 76
+V+E +GY VGK+IG GSY TV A T+ VA+KI+SK +A DYL KFLPREI+V+
Sbjct: 18 SVMEEYGYEVGKVIGNGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 77
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
K L+H LI F QAIETT RVYII+E A+ G + + I+ G E A +WF Q+ +
Sbjct: 78 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFSQMTLGIA 137
Query: 137 YCHERGVVHR------------DIKCENLLLDSDYNIKLSDFGFAR 170
Y H +G+VHR D+K ENLLLD N+K+SDFGFA+
Sbjct: 138 YLHSKGIVHRPLLTPSLSAAGRDLKLENLLLDKRENVKISDFGFAK 183
|
|
| UNIPROTKB|F6RLA2 TSSK4 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
Identities = 140/282 (49%), Positives = 187/282 (66%)
Query: 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV 76
+V+E +GY VGK+IG GSY TV A T+ VA+KI+SK +A DYL KFLPREI+V+
Sbjct: 16 SVMEEYGYEVGKVIGNGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 75
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
K L+H LI F QAIETT RVYII+E A+ G + + I+ G E A +WF QL +
Sbjct: 76 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFSQLTLGIA 135
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR---AHMRCRSNAADNS------LSET 187
Y H +G+VHRD+K ENLLLD N+K+SDFGFA+ ++ R++ + LS+T
Sbjct: 136 YLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSNQSVRNSPSYRQMNCFSHLSQT 195
Query: 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF 247
+CGS+AYA PEIL G+PY P LSD WSMGV+L+ +V RLPFDD+++ +LLK+ Q +VTF
Sbjct: 196 YCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNLKKLLKETQKEVTF 255
Query: 248 PKQPEVSTECKELISNILSPVQTRPRLKTIAEDRW-LKPKPK 288
P +S ECK LI L R + I +D W LK +P+
Sbjct: 256 PPNYAISQECKNLILQTLRQAPKRATILDIIKDPWVLKFQPE 297
|
|
| UNIPROTKB|E2R1G2 TSSK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 680 (244.4 bits), Expect = 6.5e-67, P = 6.5e-67
Identities = 134/277 (48%), Positives = 193/277 (69%)
Query: 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
VL+ GY +G +G GSYA VK A S R +VA+KI+ + +AP D+L+KFLPREIE++
Sbjct: 6 VLKQRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPKDFLEKFLPREIEILA 65
Query: 78 GLKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
L H ++++ + ET+ +VYI+ME G L + I+ +G + E ARR F QL A++
Sbjct: 66 MLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALHEDDARRKFHQLSSAIK 125
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC-RSNAADNSLSETFCGSYAYA 195
YCH+ +VHRD+KCENLLLD D+NIKLSDFGF++ RC R ++ +LS+TFCGS AYA
Sbjct: 126 YCHDLDIVHRDLKCENLLLDKDFNIKLSDFGFSK---RCLRDDSGRLTLSKTFCGSAAYA 182
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK-QVQNKVTFPKQPEVS 254
+PE+LQGIPY P + DIWS+GV+L+ MV G +P+DDS + ++L+ Q +++V FP+ ++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKKMLRIQKEHRVDFPRSKNLT 242
Query: 255 TECKELISNILSP-VQTRPRLKTIAEDRWLKP-KPKS 289
ECK+LI +L P V R + I WL+P KPK+
Sbjct: 243 GECKDLIYRMLQPDVNRRLHIDEILSHSWLQPPKPKA 279
|
|
| UNIPROTKB|Q9BXA7 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 680 (244.4 bits), Expect = 6.5e-67, P = 6.5e-67
Identities = 139/304 (45%), Positives = 206/304 (67%)
Query: 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
VL+ GY +G +G GSYA VK A S R +VAIKI+ + +AP D+L+KFLPREIE++
Sbjct: 6 VLKRRGYLLGINLGEGSYAKVKSAYSERLKFNVAIKIIDRKKAPADFLEKFLPREIEILA 65
Query: 78 GLKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
L H ++I+ + ET+H +VYI+ME A G L ++I+ +G + E AR+ F QL A++
Sbjct: 66 MLNHCSIIKTYEIFETSHGKVYIVMELAVQGDLLELIKTRGALHEDEARKKFHQLSLAIK 125
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC-RSNAADNSLSETFCGSYAYA 195
YCH+ VVHRD+KC+NLLLD D+NIKLSDF F++ RC R ++ +LS+TFCGS AYA
Sbjct: 126 YCHDLDVVHRDLKCDNLLLDKDFNIKLSDFSFSK---RCLRDDSGRMALSKTFCGSPAYA 182
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK-QVQNKVTFPKQPEVS 254
+PE+LQGIPY P + DIWS+GV+L+ MV G +P+DDS++ ++L+ Q +++V FP+ ++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 255 TECKELISNILSP-VQTRPRLKTIAEDRWLKPKPK---SRGVDKAEAELDHYIDMIQTSA 310
ECK+LI ++L P V R + I W++PK + S ++K E E + + T
Sbjct: 243 GECKDLIYHMLQPDVNRRLHIDEILSHCWMQPKARGSPSVAINK-EGESSRGTEPLWTPE 301
Query: 311 SSTD 314
+D
Sbjct: 302 PGSD 305
|
|
| UNIPROTKB|G3N2D2 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 677 (243.4 bits), Expect = 1.3e-66, P = 1.3e-66
Identities = 135/282 (47%), Positives = 196/282 (69%)
Query: 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
VL+ GY +G +G GSYA VK A S R +VA+KI+ + +AP D+L+KFLPREIE++
Sbjct: 6 VLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEILA 65
Query: 78 GLKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
L H ++I+ + ET+ +VYI+ME G L + I+ +G + E AR+ F QL A++
Sbjct: 66 MLNHRSIIKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIK 125
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC-RSNAADNSLSETFCGSYAYA 195
YCH+ VVHRD+KCENLLLD D+NIKLSDFGF++ RC R ++ +LS+TFCGS AYA
Sbjct: 126 YCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSK---RCLRDDSGRLTLSKTFCGSAAYA 182
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK-QVQNKVTFPKQPEVS 254
+PE+LQGIPY P + DIWS+GV+L+ MV G +P+DDS++ ++L+ Q +++V FP+ ++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 255 TECKELISNILSP-VQTRPRLKTIAEDRWLKPKPKSRGVDKA 295
ECK+LI +L P V R + I W++PK +RG+ A
Sbjct: 243 GECKDLIYRMLQPDVTRRLHIDEILSHCWVQPK--ARGLSSA 282
|
|
| UNIPROTKB|Q3SZW1 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 677 (243.4 bits), Expect = 1.3e-66, P = 1.3e-66
Identities = 135/282 (47%), Positives = 196/282 (69%)
Query: 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
VL+ GY +G +G GSYA VK A S R +VA+KI+ + +AP D+L+KFLPREIE++
Sbjct: 6 VLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEILA 65
Query: 78 GLKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
L H ++I+ + ET+ +VYI+ME G L + I+ +G + E AR+ F QL A++
Sbjct: 66 MLNHRSIIKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIK 125
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC-RSNAADNSLSETFCGSYAYA 195
YCH+ VVHRD+KCENLLLD D+NIKLSDFGF++ RC R ++ +LS+TFCGS AYA
Sbjct: 126 YCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSK---RCLRDDSGRLTLSKTFCGSAAYA 182
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK-QVQNKVTFPKQPEVS 254
+PE+LQGIPY P + DIWS+GV+L+ MV G +P+DDS++ ++L+ Q +++V FP+ ++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 255 TECKELISNILSP-VQTRPRLKTIAEDRWLKPKPKSRGVDKA 295
ECK+LI +L P V R + I W++PK +RG+ A
Sbjct: 243 GECKDLIYRMLQPDVTRRLHIDEILSHCWVQPK--ARGLSSA 282
|
|
| UNIPROTKB|F1RK80 TSSK1B "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 676 (243.0 bits), Expect = 1.7e-66, P = 1.7e-66
Identities = 132/282 (46%), Positives = 196/282 (69%)
Query: 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
VL+ GY +G +G GSYA VK A S R +VA+KI+ + +AP D+L+KFLPREIE++
Sbjct: 6 VLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEILA 65
Query: 78 GLKHPNLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
L H ++++ + ET+ +VYI+ME G L + I+ +G + E AR+ F QL A++
Sbjct: 66 MLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIK 125
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC-RSNAADNSLSETFCGSYAYA 195
YCH+ +VHRD+KCENLLLD D+NIKLSDFGF++ RC R ++ +LS+TFCGS AYA
Sbjct: 126 YCHDMDIVHRDLKCENLLLDKDFNIKLSDFGFSK---RCLRDDSGRLTLSKTFCGSAAYA 182
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK-QVQNKVTFPKQPEVS 254
+PE+LQGIPY P + DIWS+GV+L+ MV G +P+DDS++ ++L+ Q +++V FP+ ++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 255 TECKELISNILSP-VQTRPRLKTIAEDRWLKPKPKSRGVDKA 295
ECK+LI +L P V R + + W++PK +RG+ A
Sbjct: 243 GECKDLIYRMLQPDVNRRLHIDEVLSHCWVQPK--ARGLSSA 282
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9BXA7 | TSSK1_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.4821 | 0.8575 | 0.7384 | yes | N/A |
| Q9D411 | TSSK4_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.4744 | 0.8892 | 0.8567 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 316 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-87 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-80 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-64 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-63 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-56 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-52 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-49 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-48 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-46 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-45 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-43 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-41 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-41 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-40 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-38 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-38 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-38 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-37 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-37 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-36 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-36 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-36 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-36 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-36 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-35 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-35 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-35 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-35 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-35 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-35 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-35 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-35 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-35 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-34 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-34 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-34 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-34 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-34 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-34 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-34 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-33 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-33 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-33 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-33 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-32 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-32 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-32 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-32 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-32 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-32 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-31 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-31 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-31 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-31 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-31 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-31 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-31 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-30 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-30 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-30 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-29 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-29 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-29 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-29 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-29 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-28 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-28 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-28 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-28 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-28 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-27 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-27 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-27 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-27 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-26 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-26 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-26 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-26 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-25 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-25 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-25 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-24 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-24 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-24 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-24 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-23 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-23 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-23 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-22 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-22 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-22 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-22 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-22 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-21 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-21 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-21 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-21 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-21 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-21 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-20 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-20 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-20 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-19 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-19 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-19 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-19 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-19 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-18 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-18 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-18 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-16 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-16 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-16 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 260 bits (668), Expect = 5e-87
Identities = 94/264 (35%), Positives = 150/264 (56%), Gaps = 14/264 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + + +G GS+ V LAR + VAIK++ K + D ++ + REI+++K LKHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++R E ++Y++MEY E G LFD+++ +G + E AR + Q+L AL+Y H +G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
VHRD+K EN+LLD D ++KL+DFG AR TF G+ Y +PE+L G
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ-------LDPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLKQVQNK--VTFPKQPEVSTECKEL 260
Y DIWS+GV+L+ ++ G+ PF D + EL K++ P + ++S E K+L
Sbjct: 172 GYG-KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDL 230
Query: 261 ISNILSP-VQTRPRLKTIAEDRWL 283
I +L + R + + +
Sbjct: 231 IRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 242 bits (621), Expect = 7e-80
Identities = 87/270 (32%), Positives = 140/270 (51%), Gaps = 20/270 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD---VAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
Y + + +G+GS+ TV A+ H G VA+KI+ K + REI +++ L
Sbjct: 1 YELLRKLGSGSFGTVYKAK---HKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLS 56
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
HPN++R + A E +Y++MEY E G LFD + G + E A++ Q+L L+Y H
Sbjct: 57 HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
G++HRD+K EN+LLD + +K++DFG A+ ++ +S TF G+ Y +PE+L
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLK------SSSSLTTFVGTPWYMAPEVL 170
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPF------DDSSVNELLKQVQNKVTFPKQPEVS 254
G D+WS+GV+L+ ++ G+ PF D + + + PK S
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS 230
Query: 255 TECKELISNILSP-VQTRPRLKTIAEDRWL 283
E K+LI L+ RP + I + W
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 5e-64
Identities = 80/195 (41%), Positives = 116/195 (59%), Gaps = 10/195 (5%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
+G G + TV LAR + VAIKI+ K L + L REIE++K L HPN+++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 90 AIETTHRVYIIMEYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDI 148
E + +Y++MEY E GSL D++ +G + E R Q+LE L+Y H G++HRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 149 KCENLLLDSD-YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP 207
K EN+LLDSD +KL+DFG + +D SL +T G+ AY +PE+L G Y
Sbjct: 119 KPENILLDSDNGKVKLADFGL------SKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 208 HLSDIWSMGVVLFAM 222
SDIWS+GV+L+ +
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 1e-63
Identities = 83/259 (32%), Positives = 135/259 (52%), Gaps = 13/259 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + K IG GS+ V L R +K + + L E++++K L HPN
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL-NEVKILKKLNHPN 60
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIR----GQGYIDEIRARRWFGQLLEALQYCH 139
+I++ ++ E ++ I+MEYA+ G L I+ E + WF QL AL+Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
R ++HRDIK +N+ L S+ +KL DFG ++ S+ D L++T G+ Y SPE+
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL----SSTVD--LAKTVVGTPYYLSPEL 174
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259
Q PY + SDIWS+G VL+ + + PF+ ++ EL ++ P + S+E +
Sbjct: 175 CQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRN 233
Query: 260 LISNILSPV-QTRPRLKTI 277
L+S++L + RP + I
Sbjct: 234 LVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 3e-56
Identities = 82/256 (32%), Positives = 145/256 (56%), Gaps = 27/256 (10%)
Query: 30 IGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEVVKG-------LKH 81
+G GS+ V L R + +G + A+K++ K + K +E+E + H
Sbjct: 1 LGKGSFGKVLLVRK-KDTGKLYAMKVLKK-----KKIIKR--KEVEHTLTERNILSRINH 52
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
P +++ A +T ++Y+++EYA G LF + +G E RAR + +++ AL+Y H
Sbjct: 53 PFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL 112
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
G+++RD+K EN+LLD+D +IKL+DFG + +++ S + TFCG+ Y +PE+L
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGL------AKELSSEGSRTNTFCGTPEYLAPEVLL 166
Query: 202 GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKEL 260
G Y D WS+GV+L+ M+ G+ PF E+ +++ ++ + FP+ +S E ++L
Sbjct: 167 GKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF--LSPEARDL 223
Query: 261 ISNILSPVQTRPRLKT 276
IS +L T+ RL +
Sbjct: 224 ISGLLQKDPTK-RLGS 238
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 8e-56
Identities = 74/248 (29%), Positives = 128/248 (51%), Gaps = 20/248 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+T G+++G GS+ +V LA +A+K V + L+ REI ++ L+HPN
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE-REIRILSSLQHPN 60
Query: 84 LIRFL--QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
++R+ + E + + I +EY GSL +++ G + E R++ Q+LE L Y H
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
G+VHRDIK N+L+DSD +KL+DFG A+ + + + G+ + +PE+++
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRL----GDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 202 GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ--NKVTFPKQP-----EVS 254
G Y +DIWS+G + M G+ P+ +EL + K+ +P +S
Sbjct: 177 GEEY-GRAADIWSLGCTVIEMATGKPPW-----SELGNPMAALYKIGSSGEPPEIPEHLS 230
Query: 255 TECKELIS 262
E K+ +
Sbjct: 231 EEAKDFLR 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-52
Identities = 86/262 (32%), Positives = 138/262 (52%), Gaps = 27/262 (10%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLK----KFLPREIEVVKGL 79
+ GKIIG GS++TV LA+ + + AIKI+ K Q +K K++ E EV+ L
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL----IKEKKVKYVKIEKEVLTRL 58
Query: 80 K-HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
HP +I+ + +Y ++EYA NG L IR G +DE R + ++L AL+Y
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFAR--------------AHMRCRSNAADNSL 184
H +G++HRD+K EN+LLD D +IK++DFG A+ A +
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 185 SETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN- 243
+F G+ Y SPE+L P SD+W++G +++ M+ G+ PF S+ +++
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGK-SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237
Query: 244 KVTFPKQPEVSTECKELISNIL 265
+ +FP P + K+LI +L
Sbjct: 238 EYSFP--PNFPPDAKDLIEKLL 257
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-49
Identities = 71/242 (29%), Positives = 131/242 (54%), Gaps = 6/242 (2%)
Query: 30 IGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFL 88
I G+Y V LA+ +GD+ AIK++ K + E +++ + P +++
Sbjct: 1 ISKGAYGRVFLAKKKS-TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 89 QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDI 148
+ + +Y++MEY G L ++ G +DE AR + +++ AL+Y H G++HRD+
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 149 KCENLLLDSDYNIKLSDFGFARAHMRCRSN--AADNSLSETFCGSYAYASPEILQGIPYA 206
K +N+L+DS+ ++KL+DFG ++ + R D + G+ Y +PE++ G ++
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHS 179
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKELISNIL 265
D WS+G +L+ + G PF + E+ + + N K+ +P+ EVS E +LIS +L
Sbjct: 180 KT-VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLL 238
Query: 266 SP 267
P
Sbjct: 239 VP 240
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 166 bits (419), Expect = 2e-48
Identities = 84/260 (32%), Positives = 137/260 (52%), Gaps = 14/260 (5%)
Query: 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y + + +G GS+ V LAR + VA+K+++K + REI+++ L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 83 -NLIRFLQAIETTHRVYIIMEYAENGSLFDIIR---GQGYIDEIRARRWFGQLLEALQYC 138
N+++ + +Y++MEY + GSL D+++ +G + E A Q+L AL+Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 139 HERGVVHRDIKCENLLLDSDYN-IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H +G++HRDIK EN+LLD D +KL DFG A+ S ++ +L T G+ Y +P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 198 EILQGI--PYAPHLSDIWSMGVVLFAMVFGRLPFDDSS----VNELLKQVQNKVTFPKQP 251
E+L G+ YA SDIWS+G+ L+ ++ G PF+ ++ LK + T
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 252 EVSTECKELISNILSPVQTR 271
+S ELIS S + +
Sbjct: 238 PLSPSNPELISKAASDLLKK 257
|
Length = 384 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 8e-47
Identities = 84/256 (32%), Positives = 136/256 (53%), Gaps = 22/256 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLK----KFLPREIEVVKGL 79
+ K +GTGS+ V L R A+KI+SK +K + + E +++ +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK----AKIVKLKQVEHVLNEKRILQSI 58
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
+HP L+ + + +Y++MEY G LF +R G E AR + Q++ AL+Y H
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+V+RD+K ENLLLDSD IK++DFGFA+ R + T CG+ Y +PEI
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAK---RVKGRTY------TLCGTPEYLAPEI 169
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVSTECK 258
+ Y D W++G++++ M+ G PF D + ++ ++ ++ KV FP S + K
Sbjct: 170 ILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS--FFSPDAK 226
Query: 259 ELISNILSPVQTRPRL 274
+LI N+L T+ RL
Sbjct: 227 DLIRNLLQVDLTK-RL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 3e-46
Identities = 85/239 (35%), Positives = 136/239 (56%), Gaps = 14/239 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y +G +IG G++ V + +GD VAIK +S + + LK + +EI+++K LKHP
Sbjct: 2 YQLGDLIGRGAFGVVYKGLN-LETGDFVAIKQISLEKIKEEALKSIM-QEIDLLKNLKHP 59
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
N+++++ +IET+ +YII+EYAENGSL II+ G E + Q+L+ L Y HE+G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSL-SETFCGSYAYASPEILQ 201
V+HRDIK N+L D +KL+DFG A + D S + G+ + +PE+++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA-------TKLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 202 GIPYAPHLSDIWSMGVVLFAMVFGRLP-FDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259
A SDIWS+G + ++ G P +D + + L + VQ+ P +S E K+
Sbjct: 173 MSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP-PLPEGISPELKD 229
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-46
Identities = 70/255 (27%), Positives = 125/255 (49%), Gaps = 30/255 (11%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + + IG G + V AR R +VAIK++ K+++ + + EI+++K KHPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKK--EKIINEIQILKKCKHPN 58
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ---------GYIDEIRARRWFGQLLEA 134
++++ + ++I+ME+ GSL D+++ Y+ + +LL+
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYV--CK------ELLKG 110
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194
L+Y H G++HRDIK N+LL SD +KL DFG + + +D T G+ +
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLS-------AQLSDTKARNTMVGTPYW 163
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLKQVQNKV-TFPKQPE 252
+PE++ G PY +DIWS+G+ + G+ P+ + + L K N +
Sbjct: 164 MAPEVINGKPYDY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEK 222
Query: 253 VSTECKELISNILSP 267
S E K+ + L
Sbjct: 223 WSDEFKDFLKKCLQK 237
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-45
Identities = 83/271 (30%), Positives = 138/271 (50%), Gaps = 25/271 (9%)
Query: 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
G IG G++ V A + +A+K + ++Q K + E++V++ LKHPNL++
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 87 FLQAIETTHR--VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVV 144
+ +E HR VYI MEY G+L +++ +DE R + QLLE L Y H G+V
Sbjct: 64 YY-GVEV-HREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS-----ETFCGSYAYASPEI 199
HRDIK N+ LD + IKL DFG C +N+ + ++ G+ AY +PE+
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFG-------CAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 200 LQGIPYAPHL--SDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQV--QNKVTFPKQPEVS 254
+ G H +DIWS+G V+ M G+ P+ + + +++ V +K P ++S
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS 234
Query: 255 TECKELISNILS--PVQTRPRLKTIAEDRWL 283
E K+ + L P + RP + + ++
Sbjct: 235 PEGKDFLDRCLESDPKK-RPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-43
Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 34/277 (12%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYL------KKFLPREIEVVK 77
Y V + IG GS+ TV+ R + K + DY K+ L E+ +++
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEI-------DYGNMTEKEKQQLVSEVNILR 54
Query: 78 GLKHPNLIRFLQAI--ETTHRVYIIMEYAENGSLFDII----RGQGYIDEIRARRWFGQL 131
LKHPN++R+ I + +YI+MEY E G L +I + + YI+E R QL
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 132 LEALQYCHERG-----VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186
L AL CH R V+HRD+K N+ LD++ N+KL DFG A + D+S ++
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA------KILGHDSSFAK 168
Query: 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT 246
T+ G+ Y SPE L + Y SDIWS+G +++ + PF + +L +++
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDE-KSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF 227
Query: 247 FPKQPEVSTECKELISNIL--SPVQTRPRLKTIAEDR 281
S+E E+I ++L P RP + + +
Sbjct: 228 RRIPYRYSSELNEVIKSMLNVDP-DKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 88/289 (30%), Positives = 151/289 (52%), Gaps = 36/289 (12%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSK--VQAPPDYLKKFLPREIEVVKGLKHPNL 84
K++G GS+ V LA + + ++ A+K++ K + D + + + G KHP L
Sbjct: 1 KVLGKGSFGKVLLAE-LKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVV 144
+ +T R++ +MEY G L I+ G DE RAR + +++ LQ+ HERG++
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIP 204
+RD+K +N+LLDS+ +IK++DFG C+ + TFCG+ Y +PEIL P
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGM------CKEGILGGVTTSTFCGTPDYIAPEILSYQP 172
Query: 205 YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK-VTFPKQPEVSTECKELISN 263
Y P + D W++GV+L+ M+ G+ PF+ +EL + + V +P+ +S E K ++ +
Sbjct: 173 YGPAV-DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW--LSKEAKSILKS 229
Query: 264 ILS---------------PVQTRPRLKTI----AEDRWLKP--KPKSRG 291
L+ ++ P + I E + +KP KPK +G
Sbjct: 230 FLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKG 278
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 4e-41
Identities = 73/242 (30%), Positives = 124/242 (51%), Gaps = 15/242 (6%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
+G G + V+L + + A+K V K ++ + E E+++ HP +++ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIK 149
+ +Y++MEY G L+ I+R +G DE AR + ++ A +Y H RG+++RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 150 CENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHL 209
ENLLLDS+ +KL DFGFA+ + TFCG+ Y +PEI+ Y
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK-------KLKSGQKTWTFCGTPEYVAPEIILNKGYD-FS 172
Query: 210 SDIWSMGVVLFAMVFGRLPF-----DDSSVNELLKQVQNKVTFPKQPEVSTECKELISNI 264
D WS+G++L+ ++ GR PF D + + + K+ FP + K+LI +
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY--IDKAAKDLIKQL 230
Query: 265 LS 266
L
Sbjct: 231 LR 232
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 1e-40
Identities = 81/240 (33%), Positives = 131/240 (54%), Gaps = 12/240 (5%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
K++G G++ V L R A+KI+ K V D + L E V++ +HP L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLQNTRHPFLTA 59
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+ +T R+ +MEYA G LF + + E RAR + +++ AL Y H VV+R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K ENL+LD D +IK++DFG C+ +D + +TFCG+ Y +PE+L+ Y
Sbjct: 120 DLKLENLMLDKDGHIKITDFGL------CKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKELISNIL 265
+ D W +GVV++ M+ GRLPF + +L + + ++ FP+ +S E K L++ +L
Sbjct: 174 RAV-DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--LSPEAKSLLAGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 6e-40
Identities = 74/244 (30%), Positives = 117/244 (47%), Gaps = 18/244 (7%)
Query: 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLK-KFLPREIEVVKGLKHPNL 84
K++G GS V R A+K K+ D K L RE++ ++ + P +
Sbjct: 5 RVKVLGQGSSGVVYKVRHKPTGKIYALK---KIHVDGDEEFRKQLLRELKTLRSCESPYV 61
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH-ERGV 143
++ A + I++EY + GSL D+++ G I E Q+L+ L Y H +R +
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRDIK NLL++S +K++DFG + + N D TF G+ Y SPE +QG
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGIS----KVLENTLDQCN--TFVGTVTYMSPERIQGE 175
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN---ELLKQVQNKVTFPKQPE--VSTECK 258
Y + +DIWS+G+ L G+ PF EL++ + P P S E +
Sbjct: 176 SY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEFSPEFR 233
Query: 259 ELIS 262
+ IS
Sbjct: 234 DFIS 237
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 83/240 (34%), Positives = 132/240 (55%), Gaps = 12/240 (5%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
K++G G++ V L R A+KI+ K V D + + E V++ +HP L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHPFLTA 59
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
A +T R+ +MEYA G LF + + E RAR + +++ AL+Y H R VV+R
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
DIK ENL+LD D +IK++DFG C+ +D + +TFCG+ Y +PE+L+ Y
Sbjct: 120 DIKLENLMLDKDGHIKITDFGL------CKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKELISNIL 265
+ D W +GVV++ M+ GRLPF + L + + ++ FP+ +S E K L++ +L
Sbjct: 174 RAV-DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT--LSPEAKSLLAGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 3e-38
Identities = 66/262 (25%), Positives = 118/262 (45%), Gaps = 15/262 (5%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSG----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
T+GK +G G++ V + G +VA+K K A +++FL RE +++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVK-TLKEDASEQQIEEFL-REARIMRKLD 59
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCH 139
HPN+++ L +YI+MEY E G L +R + + + Q+ ++Y
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+ +HRD+ N L+ + +K+SDFG +R + +PE
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-----PIRWMAPES 174
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258
L+ + SD+WS GV+L+ + G P+ S E+L+ ++N P+ P E
Sbjct: 175 LKEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELY 233
Query: 259 ELISNILSP-VQTRPRLKTIAE 279
+L+ + + RP + E
Sbjct: 234 DLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 5e-38
Identities = 80/247 (32%), Positives = 128/247 (51%), Gaps = 13/247 (5%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV-KGLKHPNLIR 86
K+IG GS+ V LAR A+K++ K +K + E V+ K +KHP L+
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+ +T ++Y +++Y G LF ++ + E RAR + ++ AL Y H +V+R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K EN+LLDS +I L+DFG C+ N N + TFCG+ Y +PE+L PY
Sbjct: 121 DLKPENILLDSQGHIVLTDFGL------CKENIEHNGTTSTFCGTPEYLAPEVLHKQPY- 173
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ--PEVSTECKELISNI 264
D W +G VL+ M++G PF + E+ + NK P Q P ++ + L+ +
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---PLQLKPNITNSARHLLEGL 230
Query: 265 LSPVQTR 271
L +T+
Sbjct: 231 LQKDRTK 237
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-38
Identities = 73/258 (28%), Positives = 131/258 (50%), Gaps = 16/258 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
+ V ++G G + V++ R + +GD+ A+K++ K F E +++ P
Sbjct: 3 FDVKSLVGRGHFGEVQVVRE-KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCHER 141
+ + A + +Y++MEY G L ++ R + DE A+ + +L+ A+ H+
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
G VHRDIK EN+L+D +IKL+DFG A R A S+ G+ Y +PE+L
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSA-----ARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 202 GIPYAPHLS-----DIWSMGVVLFAMVFGRLPFDDSSVNELLKQV---QNKVTFPKQPEV 253
+ + D WS+GV+ + M++GR PF + + + + Q + FP+ P+V
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236
Query: 254 STECKELISNILSPVQTR 271
S++ +LI ++L + R
Sbjct: 237 SSDFLDLIQSLLCGQKER 254
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 75/247 (30%), Positives = 128/247 (51%), Gaps = 13/247 (5%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV-VKGLKHPNLIR 86
K+IG GS+ V LA+ A+K++ K +K + E V +K +KHP L+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+ +T ++Y +++Y G LF ++ + E RAR + ++ AL Y H +++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K EN+LLDS ++ L+DFG C+ + + TFCG+ Y +PE+L+ PY
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL------CKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ--PEVSTECKELISNI 264
+ D W +G VL+ M++G PF E+ + NK P + P +S + L+ +
Sbjct: 175 RTV-DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---PLRLKPNISVSARHLLEGL 230
Query: 265 LSPVQTR 271
L +T+
Sbjct: 231 LQKDRTK 237
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 4e-37
Identities = 80/264 (30%), Positives = 133/264 (50%), Gaps = 17/264 (6%)
Query: 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLK--KFLPREIEVVKGLKHPNL 84
G+++G+GS+ +V + A+K VS + K L +EI ++ L+HPN+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVV 144
+++L +YI +E GSL +++ G E R + Q+L L+Y H+R V
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE-ILQGI 203
HRDIK N+L+D++ +KL+DFG A+ + + S +++F GS + +PE I Q
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVV-------EFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNKVTFPKQPE-VSTECKELI 261
Y +DIWS+G + M G+ P+ V + K ++K P P+ +S E K+ I
Sbjct: 178 GYG-LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL-PPIPDHLSDEAKDFI 235
Query: 262 SNILSPVQTRPRLKTIAEDRWLKP 285
L Q P L+ A + P
Sbjct: 236 LKCL---QRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 7e-37
Identities = 65/264 (24%), Positives = 113/264 (42%), Gaps = 18/264 (6%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSG----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
T+GK +G G++ V +VA+K + K A +++FL RE +++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFL-REARIMRKLD 59
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR--GQGYIDEIRARRWFGQLLEALQYC 138
HPN+++ L + I+MEY G L D +R + + Q+ ++Y
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
+ +HRD+ N L+ + +K+SDFG +R + +PE
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-----PIRWMAPE 174
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257
L+ + SD+WS GV+L+ + G P+ S E+L+ ++ PK P E
Sbjct: 175 SLKEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPEL 233
Query: 258 KELISNI--LSPVQTRPRLKTIAE 279
+L+ P RP + E
Sbjct: 234 YKLMLQCWAEDPED-RPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-36
Identities = 82/261 (31%), Positives = 141/261 (54%), Gaps = 18/261 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + K IG GS+ + LA++ S IK + + P K+ +E+ ++ +KHPN
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE-KEASKKEVILLAKMKHPN 60
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYI--DEIRARRWFGQLLEALQYCHER 141
++ F + + R++I+MEY + G L I Q + E + WF Q+ L++ H+R
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 142 GVVHRDIKCENLLLDSDYNI-KLSDFGFARAHMRCRSNAADNS--LSETFCGSYAYASPE 198
++HRDIK +N+ L + + KL DFG AR ++S L+ T G+ Y SPE
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIAR--------QLNDSMELAYTCVGTPYYLSPE 172
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258
I Q PY + +DIWS+G VL+ + + PF+ +++++L+ ++ P P S + +
Sbjct: 173 ICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLR 231
Query: 259 ELISNI--LSPVQTRPRLKTI 277
LIS + +SP + RP + +I
Sbjct: 232 SLISQLFKVSP-RDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-36
Identities = 76/257 (29%), Positives = 136/257 (52%), Gaps = 17/257 (6%)
Query: 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
+ V K +G GSY +V + + A+K V + + ++ EI ++ + HP
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHP 59
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY----IDEIRARRWFGQLLEALQYC 138
N+I + +A +++ I+MEYA G L I + I E R F QLL LQ
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
HE+ ++HRD+K N+LL ++ +K+ D G ++ ++++T G+ Y +PE
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISK--------VLKKNMAKTQIGTPHYMAPE 171
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258
+ +G PY+ + SDIWS+G +L+ M PF+ S+ +L +VQ + +P P + ++
Sbjct: 172 VWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQ-- 227
Query: 259 ELISNILSPVQTRPRLK 275
+L + I S +Q +P+L+
Sbjct: 228 DLQNFIRSMLQVKPKLR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-36
Identities = 72/224 (32%), Positives = 126/224 (56%), Gaps = 11/224 (4%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPNLI 85
+++G GS+ V LAR + SG + A+K++ K V D ++ + + + HP L
Sbjct: 1 RVLGKGSFGKVMLARL-KESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
+ +T R++ +ME+ G L I+ DE RAR + ++ AL + H++G+++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+K +N+LLD + + KL+DFG C+ + + TFCG+ Y +PEILQ + Y
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGM------CKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 206 APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFP 248
P D W+MGV+L+ M+ G PF+ + ++L + + N +V +P
Sbjct: 174 GP-SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-36
Identities = 72/224 (32%), Positives = 123/224 (54%), Gaps = 11/224 (4%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
K++G GS+ V LA AIK++ K V D + + + + KHP L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 87 FLQAIETTHRVYIIMEYAENGSL-FDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
+T R++ +MEY G L F I R + + DE R+R + ++ AL + H GV++
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKF-DEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+K +N+LLD++ + KL+DFG C+ + + TFCG+ Y +PEILQ + Y
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGM------CKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 206 APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFP 248
P + D W++GV+++ M+ G+ PF+ + ++L + + + V +P
Sbjct: 174 GPSV-DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 71/221 (32%), Positives = 116/221 (52%), Gaps = 19/221 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y V ++G G+Y V R+ + +G+ VAIK + + D K L RE++V++ L+H
Sbjct: 3 YEVLGVVGEGAYGVVLKCRN-KATGEIVAIKKFKESEDDEDVKKTAL-REVKVLRQLRHE 60
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
N++ +A R+Y++ EY E L + G + R + QLL+A+ YCH
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA----YASPE 198
++HRDIK EN+L+ +KL DFGFARA +R R + Y Y +PE
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARA-LRARPASP--------LTDYVATRWYRAPE 171
Query: 199 ILQG-IPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNEL 237
+L G Y + D+W++G ++ ++ G F DS +++L
Sbjct: 172 LLVGDTNYGKPV-DVWAIGCIMAELLDGEPLFPGDSDIDQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-36
Identities = 68/248 (27%), Positives = 131/248 (52%), Gaps = 23/248 (9%)
Query: 28 KIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKF----LPREIEVVKGLKHP 82
K I G++ +V LA+ R +GD AIK++ K + + R I +++G P
Sbjct: 2 KPISKGAFGSVYLAKK-RSTGDYFAIKVLKK--SDMIAKNQVTNVKAERAIMMIQGES-P 57
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
+ + + ++ +Y++MEY G +I+ G + E A+++ +++ ++ H+RG
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
++HRDIK ENLL+D ++KL+DFG +R + ++ F G+ Y +PE + G
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL----------ENKKFVGTPDYLAPETILG 167
Query: 203 IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPE--VSTECKE 259
+ +SD WS+G V+F +FG PF + + + + ++ +P++ + S E +
Sbjct: 168 VG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVD 226
Query: 260 LISNILSP 267
LI+ +L
Sbjct: 227 LINRLLCM 234
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 15/226 (6%)
Query: 25 TVGKIIGTGSYATVKLAR----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
+GK +G G++ V VA+K + K A + ++FL E ++K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFL-EEASIMKKLS 59
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCH 139
HPN++R L +YI+ EY G L D +R G + + Q+ + ++Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC-GSYAYASPE 198
+ VHRD+ N L+ + +K+SDFG +R D + +PE
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE-----DDYYRKRGGGKLPIKWMAPE 174
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
L+ + SD+WS GV+L+ + G P+ S E+L+ +++
Sbjct: 175 SLKDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 77/279 (27%), Positives = 135/279 (48%), Gaps = 37/279 (13%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKK----FLPREIEVVKG 78
+ V K+IG G++ V L R + +G V A+K++ K D +K+ + E +++
Sbjct: 3 FEVIKVIGRGAFGEVWLVRD-KDTGQVYAMKVLRK----SDMIKRNQIAHVRAERDILAD 57
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
P +++ + + +Y++MEY G L +++ + E AR + +L+ AL
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFG----FARAH-------------MRCRSNAAD 181
H+ G +HRDIK +N+L+D+D +IKL+DFG +A R
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 182 NSLSETFC------GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN 235
+ G+ Y +PE+L+G PY D WS+GV+L+ M++G PF ++
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQ 236
Query: 236 ELLKQV---QNKVTFPKQPEVSTECKELISNILSPVQTR 271
E ++ + + FP P VS E +LI +L + R
Sbjct: 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDR 275
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-35
Identities = 67/204 (32%), Positives = 112/204 (54%), Gaps = 8/204 (3%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK-GLKHPNLIR 86
++IG GSYA V L + A+K++ K D ++ E V + HP L+
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+T R++ ++E+ G L ++ Q + E AR + ++ AL + HERG+++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K +N+LLD++ +IKL+D+G C+ + TFCG+ Y +PEIL+G Y
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGM------CKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFD 230
+ D W++GV++F M+ GR PFD
Sbjct: 175 FSV-DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 82/241 (34%), Positives = 132/241 (54%), Gaps = 13/241 (5%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
K++G G++ V L + A+KI+ K V D + L E V++ +HP L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-ENRVLQNSRHPFLTA 59
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH-ERGVVH 145
+ +T R+ +MEYA G LF + + E RAR + +++ AL Y H E+ VV+
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+K ENL+LD D +IK++DFG C+ D + +TFCG+ Y +PE+L+ Y
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGL------CKEGIKDGATMKTFCGTPEYLAPEVLEDNDY 173
Query: 206 APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKELISNI 264
+ D W +GVV++ M+ GRLPF + +L + + ++ FP+ +S E K L+S +
Sbjct: 174 GRAV-DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--LSPEAKSLLSGL 230
Query: 265 L 265
L
Sbjct: 231 L 231
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 3e-35
Identities = 82/263 (31%), Positives = 135/263 (51%), Gaps = 19/263 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y K IG GS+ L +S IK ++ + P ++ +E+ V+ +KHPN
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE-REESRKEVAVLSNMKHPN 60
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYI--DEIRARRWFGQLLEALQYCHER 141
++++ ++ E +YI+M+Y E G L+ I Q + E + WF Q+ AL++ H+R
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNS---LSETFCGSYAYASPE 198
++HRDIK +N+ L D IKL DFG AR NS L+ T G+ Y SPE
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVL---------NSTVELARTCIGTPYYLSPE 171
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258
I + PY + SDIW++G VL+ M + F+ ++ L+ ++ P S + +
Sbjct: 172 ICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLR 230
Query: 259 ELISNIL--SPVQTRPRLKTIAE 279
L+S + +P + RP + +I E
Sbjct: 231 NLVSQLFKRNP-RDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 87/281 (30%), Positives = 137/281 (48%), Gaps = 30/281 (10%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSK--VQAPPDYLKKFLPREIEVVKGLKHPNLI 85
K++G GS+ V LA + AIK + K V D + R + + +HP L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRV-LALAWEHPFLT 59
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
+T ++ +MEY G L I+ G DE RAR + +++ LQ+ H++G+++
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+K +N+LLD D +IK++DFG C+ N + TFCG+ Y +PEIL+G Y
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGM------CKENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 206 APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-FPKQPEVSTECKELISNI 264
D WS GV+L+ M+ G+ PF +EL + N FP+ +S E K+ +S +
Sbjct: 174 N-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRW--ISKEAKDCLSKL 230
Query: 265 L-----------SPVQTRPRLKTI----AEDRWLKP--KPK 288
++ P + I E R + P KPK
Sbjct: 231 FERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 5e-35
Identities = 76/258 (29%), Positives = 132/258 (51%), Gaps = 15/258 (5%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
+++G G++ V L R V IK + Q D + E +V+K L HPN+I +
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-RLAAQNECQVLKLLSHPNIIEY 64
Query: 88 LQAIETTHRVYIIMEYAENGSLFDII--RGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
+ + I+MEYA G+L + I R +DE +F Q+L AL + H + ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILH 124
Query: 146 RDIKCENLLLDSDYNI-KLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIP 204
RD+K +N+LLD + K+ DFG ++ + S + T G+ Y SPE+ +G P
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKI-------LSSKSKAYTVVGTPCYISPELCEGKP 177
Query: 205 YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNI 264
Y SDIW++G VL+ + + F+ +++ L+ ++ + P S + ++LI ++
Sbjct: 178 YN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSM 236
Query: 265 LS--PVQTRPRLKTIAED 280
L+ P + RP+L I
Sbjct: 237 LNLDPSK-RPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 6e-35
Identities = 79/240 (32%), Positives = 127/240 (52%), Gaps = 12/240 (5%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
K++G G++ V L R A+KI+ K V D + L E V+K +HP L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLKNTRHPFLTS 59
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+ +T R+ +MEY G LF + + E R R + +++ AL Y H +V+R
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K ENL+LD D +IK++DFG C+ D + +TFCG+ Y +PE+L+ Y
Sbjct: 120 DLKLENLMLDKDGHIKITDFGL------CKEGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKELISNIL 265
+ D W +GVV++ M+ GRLPF + +L + + + FP+ +S + K L+S +L
Sbjct: 174 RAV-DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT--LSADAKSLLSGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-35
Identities = 73/258 (28%), Positives = 138/258 (53%), Gaps = 16/258 (6%)
Query: 22 HGYTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
+ +G+ +GTGS+ V++A+ + +G+ AIK + K + + + +E ++ L
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKH-KGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
HP ++ + + + +RVY ++E+ G LF +R G A+ + +L+ A +Y H
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
+ +++RD+K ENLLLD+ ++K++DFGFA+ D + T CG+ Y +PE++
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-------KVPDRTF--TLCGTPEYLAPEVI 187
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLKQVQNKVTFPKQPEVSTECKE 259
Q + + D W+MGV+L+ + G PF DD+ K + ++ FP ++
Sbjct: 188 QSKGHGKAV-DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW--FDGRARD 244
Query: 260 LISNILSPVQTRPRLKTI 277
L+ +L T+ RL T+
Sbjct: 245 LVKGLLQTDHTK-RLGTL 261
|
Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 31/266 (11%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
K++G G V L R A+K++ K + K + E E++ L HP L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVH 145
+ +T + ++M+Y G LF +++ Q + E AR + ++L AL+Y H G+V+
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 146 RDIKCENLLLDSDYNIKLSDF----------GFARAHMRCRSNAADNSLSET-------- 187
RD+K EN+LL +I LSDF +R S + + +
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 188 -----FCGSYAYASPEILQGIPYAPHLS--DIWSMGVVLFAMVFGRLPFDDSSVNELLKQ 240
F G+ Y +PE++ G H S D W++G++L+ M++G PF S+ +E
Sbjct: 187 FRSNSFVGTEEYIAPEVISG---DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSN 243
Query: 241 VQNK-VTFPKQPEVSTECKELISNIL 265
+ K VTFP P VS+ ++LI +L
Sbjct: 244 ILKKEVTFPGSPPVSSSARDLIRKLL 269
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 21/265 (7%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
K +GTG++ V L R A+K+++ + ++ + E V+K + HP +IR
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
+Y++MEY G LF +R G + +++ AL+Y H + +V+RD
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRD 126
Query: 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP 207
+K EN+LLD + +IKL+DFGFA+ +R R + T CG+ Y +PE++Q +
Sbjct: 127 LKPENILLDKEGHIKLTDFGFAK-KLRDR--------TWTLCGTPEYLAPEVIQSKGHNK 177
Query: 208 HLSDIWSMGVVLFAMVFGRLPFDDSSVNELL-KQVQNKVTFPKQPEVSTECKELISNILS 266
+ D W++G++++ M+ G PF D + + K + K+ FP+ + K+LI +L
Sbjct: 178 AV-DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH--LDLYAKDLIKKLLV 234
Query: 267 PVQTRPRL---KTIAED----RWLK 284
+TR RL K A+D RW K
Sbjct: 235 VDRTR-RLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 20/222 (9%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD-YLKKFLPREIEVVKGLKHPNLIRFL 88
+G G+ V H I V ++ + ++K + RE++++ P ++ F
Sbjct: 9 LGAGNSGVVSKVL---HRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 89 QAIETTHRVYIIMEYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHR 146
A + I MEY + GSL I+ QG I E + +L+ L Y HE ++HR
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K N+L++S IKL DFG S NSL++TF G+ +Y +PE +QG Y+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGV--------SGQLVNSLAKTFVGTSSYMAPERIQGNDYS 177
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDS-----SVNELLKQVQN 243
SDIWS+G+ L + GR P+ + ELL+ + N
Sbjct: 178 VK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN 218
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 76/257 (29%), Positives = 118/257 (45%), Gaps = 46/257 (17%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLP----REIEVVKGL 79
Y + +G G+Y V AR + VA+K + D ++ +P REI ++K L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-----RLDNEEEGIPSTALREISLLKEL 55
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAEN--GSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
KHPN+++ L I T ++Y++ EY + D G + + QLL L Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGP--LSPNLIKSIMYQLLRGLAY 113
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH---MRCRSNAADNSLSETFCGSYAY 194
CH ++HRD+K +N+L++ D +KL+DFG ARA +R ++ T Y
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE-----VVTLW----Y 164
Query: 195 ASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPF-------------------DDSSV 234
+PEIL G Y+ + DIWS+G + M+ G+ F + S
Sbjct: 165 RAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW 223
Query: 235 NELLKQVQNKVTFPKQP 251
+ K K TFPK P
Sbjct: 224 PGVTKLPDYKPTFPKFP 240
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-34
Identities = 74/245 (30%), Positives = 127/245 (51%), Gaps = 9/245 (3%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV-KGLKHPNLIR 86
K+IG GS+ V LA+ A+K++ K +K + E V+ K +KHP L+
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+ +TT ++Y ++++ G LF ++ + E RAR + ++ AL Y H +V+R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K EN+LLDS ++ L+DFG C+ A + + TFCG+ Y +PE+++ PY
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL------CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY- 173
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILS 266
+ D W +G VL+ M++G PF V E+ + +K +P S ++ +L
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-PLVLRPGASLTAWSILEELLE 232
Query: 267 PVQTR 271
+ R
Sbjct: 233 KDRQR 237
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 68/229 (29%), Positives = 113/229 (49%), Gaps = 26/229 (11%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIK-IVSKVQAPPDYLKKFLPREIEVVKGLK- 80
Y V K +G G++ +V LAR+ + +G+ VAIK + K + + + RE++ ++ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARN-KETGELVAIKKMKKKFYSWEECMNL---REVKSLRKLNE 56
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDII--RGQGYIDEIRARRWFGQLLEALQYC 138
HPN+++ + +Y + EY E G+L+ ++ R E R Q+L+ L +
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA----Y 194
H+ G HRD+K ENLL+ +K++DFG AR +R R D Y Y
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRPPYTD----------YVSTRWY 164
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-VNELLKQVQ 242
+PEIL DIW++G ++ + R F SS +++L K
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS 213
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 74/258 (28%), Positives = 124/258 (48%), Gaps = 25/258 (9%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + IG G+ V A +VAIK + + + + EI ++K KHPN
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPN 76
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERG 142
++ + + ++++MEY + GSL DII ++E + ++L+ L+Y H +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFA-----RAHMRCRSNAADNSLSETFCGSYAYASP 197
V+HRDIK +N+LL D ++KL+DFGFA R NS+ G+ + +P
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR-------NSV----VGTPYWMAP 185
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLP-FDDSSVNELLKQVQNKVTFPKQPE-VST 255
E+++ Y P + DIWS+G++ M G P + + L + K PE S
Sbjct: 186 EVIKRKDYGPKV-DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSP 244
Query: 256 ECKELISNILSP-VQTRP 272
E K+ ++ L + RP
Sbjct: 245 EFKDFLNKCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 7e-34
Identities = 77/268 (28%), Positives = 124/268 (46%), Gaps = 40/268 (14%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA----PPDYLKKFLPREIEVVKGL 79
Y IG G+Y V AR+ + VA+K + P + REI++++ L
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI-----REIKLLQKL 55
Query: 80 KHPNLIRFLQAIETTHR---VYIIMEYAEN--GSLFDIIRGQGYIDEIRARRWFGQLLEA 134
+HPN++R L+ I T+ +Y++ EY ++ L D + E + + + QLLE
Sbjct: 56 RHPNIVR-LKEIVTSKGKGSIYMVFEYMDHDLTGLLD--SPEVKFTESQIKCYMKQLLEG 112
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA- 193
LQY H G++HRDIK N+L+++D +KL+DFG AR ++ Y
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR------------PYTKRNSADYTN 160
Query: 194 ------YASPEILQG-IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT 246
Y PE+L G Y P + D+WS+G +L + G+ F S+ E L+++
Sbjct: 161 RVITLWYRPPELLLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCG 219
Query: 247 FPKQPEVSTECKELIS-NILSPVQTRPR 273
P E +L L P + R
Sbjct: 220 SP-TDENWPGVSKLPWFENLKPKKPYKR 246
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 75/221 (33%), Positives = 122/221 (55%), Gaps = 14/221 (6%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV-KGLKHPNLIR 86
++IG GSYA V L R ++ A+K+V K D ++ E V + +P L+
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+TT R+++++EY G L ++ Q + E AR + ++ AL + HERG+++R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K +N+LLD+D +IKL+D+G C+ + TFCG+ Y +PEIL+G Y
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM------CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFD------DSSVNELLKQV 241
+ D W++GV++F M+ GR PFD D + + L QV
Sbjct: 175 FSV-DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 69/277 (24%), Positives = 112/277 (40%), Gaps = 43/277 (15%)
Query: 28 KIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
K +G G++ V + G +VA+K K A + K FL +E V+K L HPN+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVK-TLKEDASEEERKDFL-KEARVMKKLGHPNV 58
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG--------QLLE--- 133
+R L +Y+++EY E G L Y+ + R LL
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDL------LDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 134 ----ALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
++Y + VHRD+ N L+ D +K+SDFG +R +
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV--------YDDDYYRKK 164
Query: 190 GS----YAYASPEILQGIPYAPHLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQNK 244
+ +PE L+ + SD+WS GV+L+ G P+ S E+L+ ++
Sbjct: 165 TGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG 223
Query: 245 VTFPKQPE-VSTECKELISNILSPV-QTRPRLKTIAE 279
+PE E EL+ + + RP + E
Sbjct: 224 -YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 38/272 (13%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y IG G+Y V AR VAIK + K L REI+++K L HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL-REIKLLKELNHPN 59
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCHERG 142
+I+ L +Y++ E+ + L+ +I+ + + E + + QLL+ L +CH G
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
++HRD+K ENLL++++ +KL+DFG A RS + + + Y +PE+L G
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLA------RSFGSPVRPYTHYVVTRWYRAPELLLG 172
Query: 203 IPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLKQVQ------------------- 242
DIWS+G + ++ R F S +++L K +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232
Query: 243 NKVTFPKQ---------PEVSTECKELISNIL 265
K +FPK+ P S + +L+S +L
Sbjct: 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQML 264
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 75/243 (30%), Positives = 125/243 (51%), Gaps = 10/243 (4%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG GS+ V R A+K + K E V+ + P ++
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIK 149
+ ++ ++Y+++ + G LF ++ +G D RAR + +LL AL+ H+ V++RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 150 CENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHL 209
EN+LLD +I L DFG C+ N D+ + TFCG+ Y +PE+L G Y +
Sbjct: 121 PENILLDYQGHIALCDFGL------CKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV 174
Query: 210 SDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKELISNILSPV 268
D W++GV+L+ M+ G PF D +VNE+ +++ Q + FP + K+L+ +LS
Sbjct: 175 -DWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG--FDRDAKDLLIGLLSRD 231
Query: 269 QTR 271
TR
Sbjct: 232 PTR 234
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 5e-33
Identities = 78/237 (32%), Positives = 125/237 (52%), Gaps = 18/237 (7%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV-KGLKHPNLIR 86
++IG GSYA V L R + A+K+V K D ++ E V + HP L+
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+T R++ ++EY G L ++ Q + E AR + ++ AL Y HERG+++R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K +N+LLDS+ +IKL+D+G C+ + TFCG+ Y +PEIL+G Y
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFD--------DSSVNELLKQV--QNKVTFPKQPEV 253
+ D W++GV++F M+ GR PFD D + + L QV + ++ P+ V
Sbjct: 175 FSV-DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 230
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-33
Identities = 69/250 (27%), Positives = 126/250 (50%), Gaps = 8/250 (3%)
Query: 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLK--KFLPREIEVVKGLKHPNL 84
GK++G G++ V L ++A+K V P+ K L EI+++K L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVV 144
+++ + + I MEY GS+ D ++ G + E R++ Q+LE ++Y H +V
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIP 204
HRDIK N+L DS N+KL DFG A R ++ + + ++ G+ + SPE++ G
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFG---ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 205 YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQP-EVSTECKELISN 263
Y +D+WS+G + M+ + P+ + + ++ + T P+ P VS + + +
Sbjct: 184 YG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242
Query: 264 IL-SPVQTRP 272
+ RP
Sbjct: 243 TFVENAKKRP 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 75/240 (31%), Positives = 125/240 (52%), Gaps = 13/240 (5%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSK--VQAPPDYLKKFLPREIEVVKGLKHPNLI 85
++G GS+ V LA AIKI+ K V D + + + + G K P L
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLT 64
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
+ +T R+Y +MEY G L I+ G E A + ++ L + H +G+++
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+K +N++LDS+ +IK++DFG C+ N D ++TFCG+ Y +PEI+ PY
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGM------CKENMWDGVTTKTFCGTPDYIAPEIIAYQPY 178
Query: 206 APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPK--QPEVSTECKELIS 262
+ D W+ GV+L+ M+ G+ PF+ +EL + + ++ V +PK E CK L++
Sbjct: 179 GKSV-DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 66/236 (27%), Positives = 120/236 (50%), Gaps = 10/236 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQ---APPDYLKKFLPREIEVVKGLK 80
+ G+ +GTG++++ AR + +A+K V+ V+ + + + + L +EI ++ L
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
HP++IR L A + +E+ GS+ ++ G E + QLL L Y HE
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 141 RGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
++HRD+K NLL+DS ++++DFG A A + + A G+ A+ +PE+
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAA-ARLAAKGTGAG-EFQGQLLGTIAFMAPEV 179
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN---ELLKQVQNKVTFPKQPE 252
L+G Y D+WS+G V+ M + P++ + L+ ++ + T P PE
Sbjct: 180 LRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 74/253 (29%), Positives = 126/253 (49%), Gaps = 10/253 (3%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV-KGLKHPNLIR 86
K+IG GS+ V LA+ A+K++ K + + E V+ K LKHP L+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+ +T ++Y +++Y G LF ++ + E RAR + ++ A+ Y H +++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K EN+LLDS ++ L+DFG C+ + TFCG+ Y +PE+L+ PY
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL------CKEGVEPEETTSTFCGTPEYLAPEVLRKEPY- 173
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILS 266
D W +G VL+ M++G PF V+++ + +K + +L+ +L
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAACDLLVGLLH 232
Query: 267 PVQTRPRLKTIAE 279
Q R RL A+
Sbjct: 233 KDQRR-RLGAKAD 244
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 84/310 (27%), Positives = 145/310 (46%), Gaps = 33/310 (10%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
++G GS+ V LA AIKI+ K V D ++ + + + K P L +
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQ 65
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+T R+Y +MEY G L I+ G E A + ++ L + H +G+++R
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K +N++LD++ +IK++DFG C+ N + TFCG+ Y +PEI+ PY
Sbjct: 126 DLKLDNVMLDAEGHIKIADFGM------CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKELISNIL 265
+ D W+ GV+L+ M+ G+ PFD +EL + + ++ V++PK +S E + +L
Sbjct: 180 KSV-DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS--LSKEAVSICKGLL 236
Query: 266 SP---------------VQTRPRLKTI----AEDRWLKP--KPKSRGVDKAEAELDHYID 304
+ ++ + I E R ++P KPK +G AE D +
Sbjct: 237 TKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAE-NFDKFFT 295
Query: 305 MIQTSASSTD 314
+ D
Sbjct: 296 REPPVLTPPD 305
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 70/248 (28%), Positives = 128/248 (51%), Gaps = 9/248 (3%)
Query: 27 GKIIGTGSYATVKLARSTRHSGDVAIK--IVSKVQAPPDYLKK----FLPREIEVVKGLK 80
G +IG+GS+ +V L + +A+K + V A K+ L REI ++K L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
H N++++L + + I +EY GS+ ++ G +E R + Q+L+ L Y H
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
RG++HRDIK N+L+D+ IK+SDFG ++ + N + GS + +PE++
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE-VSTECKE 259
+ Y +DIWS+G ++ M+ G+ PF D + + + ++ + P+ P +S+E +
Sbjct: 185 KQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS-PEIPSNISSEAID 242
Query: 260 LISNILSP 267
+
Sbjct: 243 FLEKTFEI 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 70/251 (27%), Positives = 127/251 (50%), Gaps = 21/251 (8%)
Query: 30 IGTGSYATVKLARSTRHSGD-VAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
+G G Y V LA+ + +G+ VA+K + K + + ++ L E +++ K L++
Sbjct: 9 VGQGGYGQVFLAKK-KDTGEIVALKRMKKSLLFKLNEVRHVL-TERDILTTTKSEWLVKL 66
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
L A + +Y+ MEY G ++ G + E AR + ++ EA+ HE G +HRD
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP 207
+K EN L+D+ +IKL+DFG ++ + + + + GS Y +PE+L+G Y
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKGIV---------TYANSVVGSPDYMAPEVLRGKGYD- 176
Query: 208 HLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQP-------EVSTECKEL 260
D WS+G +L+ + G PF S+ NE + ++ ++P +S E +L
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236
Query: 261 ISNILSPVQTR 271
I+ +++ R
Sbjct: 237 ITKLINDPSRR 247
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 66/238 (27%), Positives = 122/238 (51%), Gaps = 13/238 (5%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG GS V +A VA+K K+ ++ L E+ +++ +HPN++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIK 149
+ ++++ME+ E G+L DI+ ++E + +L+AL + H +GV+HRDIK
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 150 CENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHL 209
+++LL SD +KLSDFGF C + + ++ G+ + +PE++ +PY +
Sbjct: 143 SDSILLTSDGRVKLSDFGF------CAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 210 SDIWSMGVVLFAMVFGRLP-FDDSSVNELLKQVQNKVTFPKQP-EVSTECKELISNIL 265
DIWS+G+++ MV G P F++ + + + N K +VS + + +L
Sbjct: 197 -DIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 84/282 (29%), Positives = 142/282 (50%), Gaps = 28/282 (9%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
K++G GS+ V LA A+K + K V D ++ + + + ++P L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+T ++ +ME+ G L I+ +G D RA + +++ LQ+ H +G+++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K +N++LD D +IK++DFG C+ N ++ + TFCG+ Y +PEILQG+ Y
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGM------CKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE-VSTECKELISNIL 265
+ D WS GV+L+ M+ G+ PF +EL + + +V P P ++ E K+++ +
Sbjct: 175 FSV-DWWSFGVLLYEMLIGQSPFHGDDEDELFESI--RVDTPHYPRWITKESKDILEKLF 231
Query: 266 SPVQTR-----------PRLKTI----AEDRWLKP--KPKSR 290
TR P KTI E R L P KPK +
Sbjct: 232 ERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVK 273
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-32
Identities = 81/269 (30%), Positives = 135/269 (50%), Gaps = 14/269 (5%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSK--VQAPPDYLKKFLPREIEVVKGLKH-PNLIR 86
IG G++ V R A+K++SK + A + R I V L P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+ +T +Y++ +Y G LF ++ +G E RA+ + +L+ AL++ H+ +V+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI-LQGIPY 205
D+K EN+LLD+ +I L DFG ++A N DN + TFCG+ Y +PE+ L Y
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKA------NLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 206 APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ-NKVTFPKQPEVSTECKELISNI 264
H+ D WS+GV++F M G PF ++ + + KV FPK +S E ++ + +
Sbjct: 175 TKHV-DFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN-VLSDEGRQFVKGL 232
Query: 265 LSPVQTRPRLKTIAEDRWLKPKPKSRGVD 293
L+ + RL + LK P +D
Sbjct: 233 LNR-NPQHRLGAHRDAVELKEHPFFADID 260
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-31
Identities = 77/253 (30%), Positives = 125/253 (49%), Gaps = 26/253 (10%)
Query: 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP------DYLKK----FLPREIEVV 76
G++IG G+Y V LA + +A+K +V+ P D +K L EIE +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVK---QVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
K L H N++++L T + I +EY GS+ +R G +E R + Q+LE L
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYAS 196
Y H +G++HRD+K +NLL+D+D K+SDFG ++ N + S+ GS + +
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ----GSVFWMA 178
Query: 197 PEI--LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254
PE+ Y+ + DIWS+G V+ M GR P+ D + ++ NK + P P
Sbjct: 179 PEVIHSYSQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP-- 235
Query: 255 TECKELISNILSP 267
++ N+
Sbjct: 236 ----DVSMNLSPV 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + K IG+G+Y V A R VAIK +S V K+ L REI++++ L+H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHEN 60
Query: 84 LIRFL-----QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+I L + E + VYI+ E E L +I+ + + + + Q+L L+Y
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H V+HRD+K N+L++S+ ++K+ DFG AR L+E + Y +PE
Sbjct: 120 HSANVIHRDLKPSNILVNSNCDLKICDFGLARG--VDPDEDEKGFLTEYVVTRW-YRAPE 176
Query: 199 IL-------QGIPYAPHLSDIWSMGVVLFAMVFGR 226
+L + I DIWS+G + ++ +
Sbjct: 177 LLLSSSRYTKAI-------DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-31
Identities = 75/238 (31%), Positives = 127/238 (53%), Gaps = 11/238 (4%)
Query: 29 IIGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
++G GS+ V LA AIKI+ K V D ++ + + + K P L +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
+T R+Y +MEY G L I+ G E +A + ++ L + H RG+++RD
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP 207
+K +N++LDS+ +IK++DFG C+ + D + TFCG+ Y +PEI+ PY
Sbjct: 127 LKLDNVMLDSEGHIKIADFGM------CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 208 HLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPK--QPEVSTECKELIS 262
+ D W+ GV+L+ M+ G+ PFD +EL + + ++ V++PK E + CK L++
Sbjct: 181 SV-DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 79/264 (29%), Positives = 134/264 (50%), Gaps = 22/264 (8%)
Query: 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKK----FLPREIE 74
+++ + V K+IG G++ V+L R A+K++SK + +K+ F E +
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF----EMIKRSDSAFFWEERD 95
Query: 75 VVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEA 134
++ +++ A + +Y++MEY G L +++ I E AR + +++ A
Sbjct: 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLA 154
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC-RSNAADNSLSETFCGSYA 193
L H G +HRD+K +N+LLD ++KL+DFG C + +A +T G+
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG------TCMKMDANGMVRCDTAVGTPD 208
Query: 194 YASPEILQ---GIPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLKQV--QNKVTF 247
Y SPE+L+ G Y D WS+GV L+ M+ G PF DS V K + +N +TF
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF 268
Query: 248 PKQPEVSTECKELISNILSPVQTR 271
P E+S + K+LI L+ + R
Sbjct: 269 PDDIEISKQAKDLICAFLTDREVR 292
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-31
Identities = 59/255 (23%), Positives = 126/255 (49%), Gaps = 26/255 (10%)
Query: 23 GYTVGKIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKK----FLPREIEVVK 77
+ + ++IG G++ V + + R + + A+K ++K ++K + E +++
Sbjct: 1 HFELLRVIGKGAFGKVCIVQK-RDTKKMFAMKYMNKQ----KCVEKGSVRNVLNERRILQ 55
Query: 78 GLKHPNLIRFLQAIETTHRVYIIMEYAENGSL-FDIIRGQGYIDEIRARRWFGQLLEALQ 136
L HP L+ + + +Y++++ G L + + + + E + + W +++ AL+
Sbjct: 56 ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ-KVKFSEEQVKFWICEIVLALE 114
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYAS 196
Y H +G++HRDIK +N+LLD ++ ++DF A ++L+ + G+ Y +
Sbjct: 115 YLHSKGIIHRDIKPDNILLDEQGHVHITDFNIAT-------KVTPDTLTTSTSGTPGYMA 167
Query: 197 PEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD--DSSVNELL--KQVQNKVTFPKQPE 252
PE+L Y+ D WS+GV + + G+ P+ ++ + + KQ V +P
Sbjct: 168 PEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP--AT 224
Query: 253 VSTECKELISNILSP 267
STE + I+ +L
Sbjct: 225 WSTEAIDAINKLLER 239
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-31
Identities = 76/264 (28%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y +++G G++ L R T V K V+ + + L EI ++ L+HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVILSLLQHPN 60
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDII--RGQGYIDEIRARRWFGQLLEALQYCHER 141
+I + + + I MEYA G+L+D I + +E + Q++ A+ Y H+
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
G++HRDIK N+ L IKL DFG ++ ++ S++ET G+ Y SPE+ Q
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKIL------GSEYSMAETVVGTPYYMSPELCQ 174
Query: 202 GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261
G+ Y SDIW++G VL+ ++ + FD ++ L+ ++ P S+E L+
Sbjct: 175 GVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV 233
Query: 262 SNILSPVQTRPRLKTIAE--DRWL 283
++L Q + T E D+ L
Sbjct: 234 HSLLQ--QDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-31
Identities = 72/252 (28%), Positives = 136/252 (53%), Gaps = 24/252 (9%)
Query: 28 KIIGTGSYATVKLAR--STRHSGDV-AIKIVSK---VQAPPDYLKKFLPREI-EVVKGLK 80
+++GTG+Y V L R +G + A+K++ K VQ R++ E V+
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR-- 63
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
P L+ A +T ++++I++Y G LF + + + E R + +++ AL + H+
Sbjct: 64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ 123
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
G+++RDIK EN+LLDS+ ++ L+DFG ++ + + + + S FCG+ Y +PE++
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL---AEEEERAYS--FCGTIEYMAPEVI 178
Query: 201 QGIPYAPHLS--DIWSMGVVLFAMVFGRLPF----DDSSVNELLKQVQ-NKVTFPKQPEV 253
+G H D WS+GV+ F ++ G PF + +S +E+ +++ +K FP +
Sbjct: 179 RG-GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP--KTM 235
Query: 254 STECKELISNIL 265
S E ++ I +L
Sbjct: 236 SAEARDFIQKLL 247
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-31
Identities = 71/245 (28%), Positives = 135/245 (55%), Gaps = 18/245 (7%)
Query: 28 KIIGTGSYATVKLARST--RHSGDV-AIKIVSK---VQAPPDYLKKFLPREIEVVKGLKH 81
K++G G Y V R +G + A+K++ K V+ D R I ++ +KH
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI--LEAVKH 59
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
P ++ + A +T ++Y+I+EY G LF + +G E A + ++ AL++ H++
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
G+++RD+K EN+LLD+ ++KL+DFG C+ + + +++ TFCG+ Y +PEIL
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGL------CKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 202 GIPYAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLKQVQNKVTFPKQPEVSTECKEL 260
+ + D WS+G +++ M+ G PF ++ + K ++ K+ P P ++ E ++L
Sbjct: 174 RSGHGKAV-DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP--PYLTPEARDL 230
Query: 261 ISNIL 265
+ +L
Sbjct: 231 LKKLL 235
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 9e-31
Identities = 78/259 (30%), Positives = 129/259 (49%), Gaps = 16/259 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPR-EIEVVKGLKHP 82
Y V +++G GS+ L + A+K +++ P R E ++ +KHP
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMK---EIRLPKSSSAVEDSRKEAVLLAKMKHP 58
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHE 140
N++ F ++ E +YI+MEY + G L I+ Q E +WF Q+ +Q+ HE
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
+ V+HRDIK +N+ L + +KL DFG AR + + + T+ G+ Y PEI
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL------TSPGAYACTYVGTPYYVPPEIW 172
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260
+ +PY + SDIWS+G +L+ + + PF +S L+ +V P S E + L
Sbjct: 173 ENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSL 231
Query: 261 ISNIL--SPVQTRPRLKTI 277
I + +P ++RP TI
Sbjct: 232 IKQMFKRNP-RSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 9e-31
Identities = 69/206 (33%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT + IG G+ TV A +VAIK ++ Q P K+ + EI V++ KHPN
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK---KELIINEILVMRENKHPN 77
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ +L + ++++MEY GSL D++ + +DE + + L+AL++ H V
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQV 136
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRDIK +N+LL D ++KL+DFGF C + S T G+ + +PE++
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGF------CAQITPEQSKRSTMVGTPYWMAPEVVTRK 190
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPF 229
Y P + DIWS+G++ MV G P+
Sbjct: 191 AYGPKV-DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 69/239 (28%), Positives = 118/239 (49%), Gaps = 10/239 (4%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG GS+ V A+K + + ++ E V+ L +IR+ +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQID-LSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 90 AIETTHRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRD 147
+ ++ I+MEYAENG L +++ Q + E + R+F Q+L L + H + ++HRD
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRD 126
Query: 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP 207
IK NL LD+ N+K+ D G A + + + + + T G+ Y SPE+ + PY
Sbjct: 127 IKSLNLFLDAYDNVKIGDLGVA------KLLSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 208 HLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILS 266
SD+W++GVVL+ G+ PFD ++ L+ ++ V P S + +LI L+
Sbjct: 181 K-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-30
Identities = 75/259 (28%), Positives = 130/259 (50%), Gaps = 12/259 (4%)
Query: 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y +++G GSY V L R IK ++ ++ +K +E +++ LKHP
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN-LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 83 NLIRFLQAIETTH-RVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCH 139
N++ + ++ E +YI+M + E G L+ ++ Q + E + WF Q+ ALQY H
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
E+ ++HRD+K +N+ L IK+ D G AR ++ T G+ Y SPE+
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL------ENQCDMASTLIGTPYYMSPEL 173
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259
PY + SD+W++G ++ M + F+ +N L+ ++ P + S E E
Sbjct: 174 FSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGE 232
Query: 260 LISNILSP-VQTRPRLKTI 277
LI+ +LS + RP +K+I
Sbjct: 233 LIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 66/185 (35%), Positives = 99/185 (53%), Gaps = 17/185 (9%)
Query: 51 AIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAI--ETTHRVYIIMEYAENGS 108
A+K ++ P L+K + RE+E+ K K P ++++ A E++ + I MEY E GS
Sbjct: 30 ALKTITT--DPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGS 87
Query: 109 LFDI---IRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLS 164
L I ++ +G I E + +L+ L Y H R ++HRDIK N+LL +KL
Sbjct: 88 LDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLC 147
Query: 165 DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF 224
DFG S NSL+ TF G+ Y +PE +QG PY+ SD+WS+G+ L +
Sbjct: 148 DFGV--------SGELVNSLAGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQ 198
Query: 225 GRLPF 229
R PF
Sbjct: 199 NRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 61/200 (30%), Positives = 110/200 (55%), Gaps = 20/200 (10%)
Query: 30 IGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFL 88
IG+G+Y V AR +G+ VAIK++ K++ D+ + + +EI ++K +HPN++ +
Sbjct: 11 IGSGTYGDVYKARD-IATGELVAIKVI-KLEPGDDF--EIIQQEISMLKECRHPNIVAYF 66
Query: 89 QAIETTHRVYIIMEYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
+ +++I+MEY GSL DI +G + E++ + L+ L Y HE G +HRD
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRD 126
Query: 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE--TFCGSYAYASPEILQ---G 202
IK N+LL D ++KL+DFG + A + ++++ +F G+ + +PE+
Sbjct: 127 IKGANILLTEDGDVKLADFGVS-AQL-------TATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 203 IPYAPHLSDIWSMGVVLFAM 222
Y DIW++G+ +
Sbjct: 179 GGYD-GKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 6e-30
Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + ++IG G+ A V A ++ VAIK + + L +E++ + HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV--DELRKEVQAMSQCNHPN 60
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIR---GQGYIDEIRARRWFGQLLEALQYCHE 140
++++ + ++++M Y GSL DI++ +G +DE ++L+ L+Y H
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFAR--AHMRCRSNAADNSLSETFCGSYAYASPE 198
G +HRDIK N+LL D ++K++DFG + A R+ TF G+ + +PE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK----TFVGTPCWMAPE 176
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF 229
+++ + +DIWS G+ + G P+
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 70/206 (33%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT + IG G+ TV A +VAIK ++ + P K+ + EI V+K LK+PN
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPN 77
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ FL + ++++MEY GSL D++ + +DE + + L+AL++ H V
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVT-ETCMDEAQIAAVCRECLQALEFLHANQV 136
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRDIK +N+LL D ++KL+DFGF C + S T G+ + +PE++
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGF------CAQITPEQSKRSTMVGTPYWMAPEVVTRK 190
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPF 229
Y P + DIWS+G++ MV G P+
Sbjct: 191 AYGPKV-DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 69/217 (31%), Positives = 112/217 (51%), Gaps = 10/217 (4%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSK--VQAPPDYLKKFLPREIEVVKGLKHPNLI 85
K++G GS+ V LA + AIK + K V D + + + + +HP L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLT 59
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
+T ++ +MEY G L I+ D RA + +++ LQ+ H +G+V+
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+K +N+LLD+D +IK++DFG C+ N ++ + TFCG+ Y +PEIL G Y
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGM------CKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 206 APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ 242
D WS GV+L+ M+ G+ PF EL + ++
Sbjct: 174 N-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 79/271 (29%), Positives = 134/271 (49%), Gaps = 27/271 (9%)
Query: 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIV-----SKVQAPPDYLKKFLPREIEVVK 77
+ + K IG G ++ V A VA+K V +A D LK EI+++K
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-----EIDLLK 57
Query: 78 GLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR----GQGYIDEIRARRWFGQLLE 133
L HPN+I++L + + + I++E A+ G L +I+ + I E ++F QL
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 134 ALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193
AL++ H + ++HRDIK N+ + + +KL D G R ++ AA + G+
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAA-----HSLVGTPY 171
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN--ELLKQVQNKVTFPKQP 251
Y SPE + Y SDIWS+G +L+ M + PF +N L K+++ K +P P
Sbjct: 172 YMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLP 229
Query: 252 --EVSTECKELISNILSPV-QTRPRLKTIAE 279
S E ++L+S ++P + RP + + +
Sbjct: 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 73/255 (28%), Positives = 127/255 (49%), Gaps = 11/255 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKF--LPREIEVVKGLKH 81
+ +GK++G G++ V L ++A+K V P+ K+ L EI+++K L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 82 PNLIRFLQAIETTHR--VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
++++ + + I ME+ GS+ D ++ G + E R++ Q+LE + Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFA-RAHMRCRSNAADNSLSETFCGSYAYASPE 198
+VHRDIK N+L DS N+KL DFG + R C S S++ G+ + SPE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWMSPE 179
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQP-EVSTEC 257
++ G Y +DIWS+G + M+ + P+ + + ++ + T P P VS C
Sbjct: 180 VISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238
Query: 258 KELISNILSPVQTRP 272
++ + I + RP
Sbjct: 239 RDFLKRIFVEAKLRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 29 IIGTGSYATVKLARSTRHSGDVAIK------IVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
++G G + V LA + AIK I+++ + +K R E +HP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEK---RIFETANSERHP 62
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
L+ +T V +MEYA G L I E RA + ++ LQY HE
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENK 121
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
+V+RD+K +NLLLD++ +K++DFG C+ + TFCG+ + +PE+L
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGL------CKEGMGFGDRTSTFCGTPEFLAPEVLTE 175
Query: 203 IPYAPHLSDIWSMGVVLFAMVFGRLPF--DD 231
Y + D W +GV+++ M+ G PF DD
Sbjct: 176 TSYTRAV-DWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 67/216 (31%), Positives = 114/216 (52%), Gaps = 10/216 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD-YLKKFLPREIEVVKGLKHP 82
Y ++G GSY V + VAIK +++ D +KK REI ++K L+H
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
NL+ ++ R+Y++ E+ ++ L D+ + +DE R R++ Q+L +++CH
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
++HRDIK EN+L+ +KL DFGFA R+ AA + + + Y +PE+L G
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFA------RTLAAPGEVYTDYVATRWYRAPELLVG 174
Query: 203 IPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNEL 237
DIW++G ++ M+ G F DS +++L
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 77/272 (28%), Positives = 136/272 (50%), Gaps = 26/272 (9%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-- 81
Y ++IG G+Y V + VA+KI++ + P D + + RE+ ++ L+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN-LDTPDDDVSD-IQREVALLSQLRQSQ 60
Query: 82 -PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
PN+ ++ + R++IIMEYAE GS+ +++ G I E ++L AL+Y H+
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHK 119
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
GV+HRDIK N+L+ + N+KL DFG A ++S TF G+ + +PE++
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVA------ALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ--NKVTFPKQPE--VSTE 256
Y +DIWS+G+ ++ M G P+ D + + + K P+ + S
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDV---DAFRAMMLIPKSKPPRLEDNGYSKL 230
Query: 257 CKELISNILSPVQTRPRLKTIAED----RWLK 284
+E ++ L P+ + AE+ +W+K
Sbjct: 231 LREFVAACL---DEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-28
Identities = 84/283 (29%), Positives = 139/283 (49%), Gaps = 24/283 (8%)
Query: 2 IDSTVQVQDDIDRKVTVLE--SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQ 59
ID+ + + I RK+ L+ + Y V K+IG G++ V+L R A+K++SK +
Sbjct: 21 IDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE 80
Query: 60 APPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYI 119
F E +++ P +++ A + +Y++MEY G L +++ +
Sbjct: 81 MIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-V 139
Query: 120 DEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFA-----RAHMR 174
E A+ + +++ AL H G++HRD+K +N+LLD ++KL+DFG +R
Sbjct: 140 PEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199
Query: 175 CRSNAADNSLSETFCGSYAYASPEILQ---GIPYAPHLSDIWSMGVVLFAMVFGRLPF-D 230
C +T G+ Y SPE+L+ G Y D WS+GV LF M+ G PF
Sbjct: 200 C----------DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249
Query: 231 DSSVNELLKQV--QNKVTFPKQPEVSTECKELISNILSPVQTR 271
DS V K + +N + FP+ E+S K LI L+ + R
Sbjct: 250 DSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVR 292
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-28
Identities = 78/266 (29%), Positives = 125/266 (46%), Gaps = 23/266 (8%)
Query: 29 IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLP--REIEVVKGLKHPNLIR 86
++G G+Y V AR +AIK + P + P EI + LKH N+++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPLHEEIALHSYLKHRNIVQ 69
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIR---GQGYIDEIRARRWFGQLLEALQYCHERGV 143
+L + I ME GSL ++R G +E + Q+LE L+Y H+ +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 144 VHRDIKCENLLLDSDYN--IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL- 200
VHRDIK +N+L+++ Y+ +K+SDFG + A N +ETF G+ Y +PE++
Sbjct: 130 VHRDIKGDNVLVNT-YSGVVKISDFG------TSKRLAGINPCTETFTGTLQYMAPEVID 182
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNKVTFPKQPE-VSTECK 258
+G +DIWS+G + M G+ PF + + +V P+ PE +S E K
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK 242
Query: 259 ELISNILSP-VQTRPRLKTIAEDRWL 283
I P R + +D +L
Sbjct: 243 NFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 29 IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFL 88
+G GSY +V A VAIK+V V+ + K EI ++K P ++++
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIK----EISILKQCDSPYIVKYY 64
Query: 89 QAIETTHRVYIIMEYAENGSLFDIIRGQGYI---DEIRARRWFGQLLEALQYCHERGVVH 145
+ ++I+MEY GS+ DI++ +EI A Q L+ L+Y H +H
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA--ILYQTLKGLEYLHSNKKIH 122
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD-NSLSETFCGSYAYASPEILQGIP 204
RDIK N+LL+ + KL+DFG + D + T G+ + +PE++Q I
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVS-------GQLTDTMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 205 YAPHLSDIWSMGVVLFAMVFGRLPFDD 231
Y + +DIWS+G+ M G+ P+ D
Sbjct: 176 YN-NKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 78/259 (30%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKG 78
+++ Y V K+IG G++ V+L R A+K++SK + F E +++
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
P +++ A + +Y++MEY G L +++ + E AR + +++ AL
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAI 158
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H G +HRD+K +N+LLD ++KL+DFG + N +T G+ Y SPE
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-----KMNKEGMVRCDTAVGTPDYISPE 213
Query: 199 ILQ---GIPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLKQV--QNKVTFPKQPE 252
+L+ G Y D WS+GV L+ M+ G PF DS V K + +N +TFP +
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273
Query: 253 VSTECKELISNILSPVQTR 271
+S E K LI L+ + R
Sbjct: 274 ISKEAKNLICAFLTDREVR 292
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 63/198 (31%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 30 IGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFL 88
IG GSY V R+ R +G VAIK + + P +KK REI ++K LKHPNL+ +
Sbjct: 9 IGEGSYGVVFKCRN-RETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLI 66
Query: 89 QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDI 148
+ +++++ EY ++ L ++ + + E ++ Q L+A+ +CH+ +HRD+
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDV 126
Query: 149 KCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG-IPYAP 207
K EN+L+ IKL DFGFAR + ++ + + Y +PE+L G Y P
Sbjct: 127 KPENILITKQGQIKLCDFGFARI-----LTGPGDDYTD-YVATRWYRAPELLVGDTQYGP 180
Query: 208 HLSDIWSMGVVLFAMVFG 225
+ D+W++G V ++ G
Sbjct: 181 PV-DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-28
Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT + IG G+ TV A +VAIK ++ Q P K+ + EI V++ K+PN
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPN 77
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ +L + ++++MEY GSL D++ + +DE + + L+AL + H V
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRDIK +N+LL D ++KL+DFGF C + S T G+ + +PE++
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGF------CAQITPEQSKRSTMVGTPYWMAPEVVTRK 190
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPF 229
Y P + DIWS+G++ MV G P+
Sbjct: 191 AYGPKV-DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-28
Identities = 64/216 (29%), Positives = 112/216 (51%), Gaps = 16/216 (7%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG G+Y V R+ + VA+K + ++++ + + REI ++K L+HPN++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 90 AIETTHRVYIIMEY--AENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
+ R+Y+I E+ + D + Y+D + + Q+L+ + +CH R V+HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 148 IKCENLLLDSDYNIKLSDFGFARAH---MRCRSNAADNSLSETFCGSYAYASPEILQGIP 204
+K +NLL+D+ IKL+DFG ARA +R ++ + Y +PE+L G P
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV---------TLWYRAPEVLLGSP 177
Query: 205 YAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLK 239
DIWS+G + M + F DS +++L +
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-28
Identities = 80/270 (29%), Positives = 141/270 (52%), Gaps = 15/270 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT + IG G+ TV A +VAI+ ++ Q P K+ + EI V++ K+PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPN 78
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ +L + ++++MEY GSL D++ + +DE + + L+AL++ H V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRDIK +N+LL D ++KL+DFGF C + S T G+ + +PE++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGF------CAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLKQVQNKVTFPKQPE-VSTECKELI 261
Y P + DIWS+G++ M+ G P+ +++ + L N + PE +S ++ +
Sbjct: 192 AYGPKV-DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250
Query: 262 SNILS-PVQTRPRLKTIAEDRWLK-PKPKS 289
+ L V+ R K + + ++LK KP S
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 69/216 (31%), Positives = 111/216 (51%), Gaps = 17/216 (7%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG G+Y V AR+ VA+K + ++ + + REI ++K L HPN+++ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 90 AIETTHRVYIIMEYAENG--SLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
I T +++Y++ E+ D G I + + QLL+ L +CH V+HRD
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSG-IPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125
Query: 148 IKCENLLLDSDYNIKLSDFGFARAH---MRCRSNAADNSLSETFCGSYAYASPEILQGIP 204
+K +NLL++++ IKL+DFG ARA +R ++ + Y +PEIL G
Sbjct: 126 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 176
Query: 205 YAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLK 239
Y DIWS+G + MV R F DS +++L +
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 68/225 (30%), Positives = 117/225 (52%), Gaps = 18/225 (8%)
Query: 30 IGTGSYATVKLARSTRHSGD-VAIKIV---SKVQAPPDYLKKFLPREIEVVKGLKHPNLI 85
+G G+YATV R+ R +G+ VA+K + ++ P + REI ++K LKH N++
Sbjct: 8 LGEGTYATVYKGRN-RTTGEIVALKEIHLDAEEGTPSTAI-----REISLMKELKHENIV 61
Query: 86 RFLQAIETTHRVYIIMEYAENG--SLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
R I T +++ ++ EY + D +G +D + + QLL+ + +CHE V
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRD+K +NLL++ +KL+DFG ARA N+ S + Y +P++L G
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAF-----GIPVNTFSNEVVTLW-YRAPDVLLGS 175
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP 248
DIWS+G ++ M+ GR F ++ + L ++ + P
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTP 220
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 20/219 (9%)
Query: 30 IGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFL 88
IG G+Y TV A++ R + + VA+K V + + + REI ++K LKH N++R
Sbjct: 8 IGEGTYGTVFKAKN-RETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 89 QAIETTHRVYIIMEYAENG--SLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+ + ++ ++ EY + FD G ID + + QLL+ L +CH V+HR
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHR 123
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAH---MRCRSNAADNSLSETFCGSYAYASPEILQGI 203
D+K +NLL++ + +KL+DFG ARA +RC S +E + Y P++L G
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARAFGIPVRCYS-------AEVV--TLWYRPPDVLFGA 174
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLP-FDDSSVNELLKQV 241
D+WS G + + P F + V++ LK++
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIK-I-VSKVQAPPDYLKKFLPREIEVVKGLKH 81
Y GK +G G+YA V AR VAIK I + + + D + REI++++ LKH
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR------GQGYIDEIRARRWFGQLLEAL 135
PN+I L + ++ E+ E L +I+ I + + L L
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADI-----KSYMLMTLRGL 115
Query: 136 QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
+Y H ++HRD+K NLL+ SD +KL+DFG AR+ + N + Y
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF------GSPNRKMTHQVVTRWYR 169
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF 229
+PE+L G + D+WS+G + FA + R+PF
Sbjct: 170 APELLFGARHYGVGVDMWSVGCI-FAELLLRVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 65/211 (30%), Positives = 111/211 (52%), Gaps = 9/211 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIV-----SKVQAPPDYLKKFLPREIEVVKG 78
+T G+++G G+Y TV T +A+K V + + A +Y K L E++++K
Sbjct: 2 WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEK--LQEEVDLLKS 58
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
LKH N++++L + + I ME+ GS+ I+ G + E ++ Q+L+ + Y
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H VVHRDIK N++L + IKL DFG AR + +++ ++ G+ + +PE
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF 229
++ Y SDIWS+G +F M G+ P
Sbjct: 179 VINESGYG-RKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 5e-27
Identities = 73/255 (28%), Positives = 140/255 (54%), Gaps = 20/255 (7%)
Query: 30 IGTGSYATVKLARSTRHSG-DVAIKIVS--KVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
IG GS V +AR +HSG VA+K++ K Q ++ L E+ +++ +H N++
Sbjct: 29 IGEGSTGIVCIARE-KHSGRQVAVKMMDLRKQQR-----RELLFNEVVIMRDYQHQNVVE 82
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
++ ++++ME+ + G+L DI+ Q ++E + +L+AL Y H +GV+HR
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALTDIV-SQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
DIK +++LL D +KLSDFGF C + D ++ G+ + +PE++ PY
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGF------CAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILS 266
+ DIWS+G+++ MV G P+ S + +K++++ P + + + + ++ + L
Sbjct: 196 TEV-DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--PPKLKNAHKISPVLRDFLE 252
Query: 267 PVQTR-PRLKTIAED 280
+ TR P+ + A++
Sbjct: 253 RMLTREPQERATAQE 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-27
Identities = 71/252 (28%), Positives = 125/252 (49%), Gaps = 11/252 (4%)
Query: 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKF--LPREIEVVKGLKHPNL 84
GK++G G++ V L ++A K V P+ K+ L EI+++K L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 85 IRFLQAIE--TTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
+++ + + I MEY GS+ D ++ G + E R++ Q+LE + Y H
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFA-RAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
+VHRDIK N+L DS N+KL DFG + R C S S++ G+ + SPE++
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT----GTPYWMSPEVIS 182
Query: 202 GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQP-EVSTECKEL 260
G Y +D+WS+G + M+ + P+ + + ++ + T P+ P +S ++
Sbjct: 183 GEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241
Query: 261 ISNILSPVQTRP 272
+ I + RP
Sbjct: 242 LGCIFVEARHRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 70/229 (30%), Positives = 118/229 (51%), Gaps = 8/229 (3%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ V ++G G+Y V R VAIK + + +K+ RE+++++ LK N
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE-VKETTLRELKMLRTLKQEN 61
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ +A ++Y++ EY E L + + + R + QL++A+ +CH+ +
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
VHRDIK ENLL+ + +KL DFGFAR S ++ + +E + + Y SPE+L G
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARN----LSEGSNANYTE-YVATRWYRSPELLLGA 176
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE 252
PY + D+WS+G +L + G+ F S + L +Q KV P E
Sbjct: 177 PYGKAV-DMWSVGCILGELSDGQPLFPGESEIDQLFTIQ-KVLGPLPAE 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 70/249 (28%), Positives = 134/249 (53%), Gaps = 19/249 (7%)
Query: 28 KIIGTGSYATVKLARS-TRHSGD--VAIKIVSK---VQAPPDYLKKFLPREI-EVVKGLK 80
K++GTG+Y V L R T H A+K++ K VQ R + E V+ +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
P L+ A +T ++++I++Y G +F + + E R + G+++ AL++ H+
Sbjct: 64 SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK 123
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
G+V+RDIK EN+LLDS+ ++ L+DFG ++ + + + + +FCG+ Y +PEI+
Sbjct: 124 LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL-----SEEKERTYSFCGTIEYMAPEII 178
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPF----DDSSVNELLKQVQNKVTFPKQPEVSTE 256
+G D WS+G+++F ++ G PF + ++ +E+ +++ K P + E
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-KCDPPFPSFIGPE 237
Query: 257 CKELISNIL 265
++L+ +L
Sbjct: 238 AQDLLHKLL 246
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 68/223 (30%), Positives = 110/223 (49%), Gaps = 31/223 (13%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG G+Y V AR VA+K + +++ + + REI ++K L HPN++R L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 90 AIETTHRVYIIMEYAENG--SLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
+ + +++Y++ E+ + D G +D + + QLL+ + YCH V+HRD
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124
Query: 148 IKCENLLLDSDYNIKLSDFGFARAH---MRCRSNAADNSLSETFCGSYA-------YASP 197
+K +NLL+D + +KL+DFG ARA +R +Y Y +P
Sbjct: 125 LKPQNLLIDREGALKLADFGLARAFGVPVR----------------TYTHEVVTLWYRAP 168
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLK 239
EIL G DIWS+G + MV R F DS +++L +
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 41/275 (14%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y + IG G++ V A+ R +G+ VA+K V+ ++ + REI+ ++ +HP
Sbjct: 2 YKILGRIGEGAHGIVFKAKD-RETGETVALKKVA-LRRLEGGIPNQALREIKALQACQHP 59
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHER 141
+++ L ++MEY L +++R + + E + + + LL+ + Y H
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
G++HRD+K NLL+ +D +K++DFG AR S S + Y +PE+L
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLF----SEEEPRLYSHQ-VATRWYRAPELLY 173
Query: 202 GIP-YAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLKQVQ----------------- 242
G Y P + D+W++G + ++ G F ++ + +L +
Sbjct: 174 GARKYDPGV-DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232
Query: 243 --NKVTFPKQ---------PEVSTECKELISNILS 266
NK+TFP+ P+ S E +L+ +L
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLV 267
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 80/321 (24%), Positives = 134/321 (41%), Gaps = 66/321 (20%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKK----FLPREIEVVKGL 79
+ K IG G++ V L R + A+K + K D L + + E +++
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA----DVLMRNQAAHVKAERDILAEA 58
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
+ +++ + + +Y +M+Y G + ++ G +E AR + +L A++ H
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH 118
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARA--------------HMRCRSNAADNSLS 185
+ G +HRDIK +N+L+D D +IKL+DFG H R S S
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 186 E-----------------------TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAM 222
E + G+ Y +PE+L Y L D WS+GV+L+ M
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 237
Query: 223 VFGRLPFDDSSVNELLKQV---QNKVTFPKQPEVSTECKELISNILSPVQTRPRLKTIAE 279
+ G+ PF + E +V + + P Q ++S E +LI RL AE
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLIL----------RLCCGAE 287
Query: 280 DRW-------LKPKPKSRGVD 293
DR +K P +G+D
Sbjct: 288 DRLGKNGADEIKAHPFFKGID 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 66/242 (27%), Positives = 126/242 (52%), Gaps = 16/242 (6%)
Query: 28 KIIGTGSYATVKLAR--STRHSGDV-AIKIVSKVQAP-PDYLKKFLPREIEVVKGLKHPN 83
K++G GS+ V L R + +G + A+K++ K D ++ + R+I + HP
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILA--EVNHPF 59
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+++ A +T ++Y+I+++ G LF + + E + + +L AL + H G+
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
++RD+K EN+LLD + +IKL+DFG + + + +FCG+ Y +PE++
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGL------SKESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKELIS 262
+ +D WS GV++F M+ G LPF E + + + K+ P+ +S E + L+
Sbjct: 174 GHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF--LSPEAQSLLR 230
Query: 263 NI 264
+
Sbjct: 231 AL 232
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 5e-26
Identities = 84/266 (31%), Positives = 135/266 (50%), Gaps = 22/266 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIK-IVSKVQAPPDYLKKFLPREIEVVKGLK-H 81
Y + + +G G+Y V A R VA+K I + D + F REI ++ L H
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66
Query: 82 PNLIRFLQAI--ETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
PN+++ L I E +Y++ EY E L +IR ++++ R QLL+AL+Y H
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIR-ANILEDVHKRYIMYQLLKALKYIH 124
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA----YA 195
V+HRD+K N+LL+SD +KL+DFG AR+ N + L++ Y Y
Sbjct: 125 SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD-----YVATRWYR 179
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-VNELLKQVQNKVT-FPKQPEV 253
+PEIL G D+WS+G +L M+ G+ F +S +N+L K ++ V P ++
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE--VIGPPSAEDI 237
Query: 254 STECKELISNILSPVQTRPRLKTIAE 279
+ + +L + +RPR K + E
Sbjct: 238 ESIKSPFAATMLDSLPSRPR-KPLDE 262
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + IG+G+Y V A TR VAIK + P K+ L RE+++++ KH N
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDN 65
Query: 84 LIRFLQAIETTHR----VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
+I + VY++M+ E+ L II + E R + QLL L+Y H
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA----YA 195
V+HRD+K NLL++ D +++ DFG AR S+ ++ F Y Y
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS---SSPTEHK---YFMTEYVATRWYR 178
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGR 226
+PE+L +P D+WS+G + M+ GR
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-26
Identities = 61/212 (28%), Positives = 110/212 (51%), Gaps = 18/212 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+T+ + IG GS+ V A R + VAIK++ +A + + + +EI+ + + P
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI--EDIQQEIQFLSQCRSPY 60
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIR----GQGYIDEIRARRWFGQLLEALQYCH 139
+ ++ + +++IIMEY GS D+++ + YI I R ++L L+Y H
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFI-LR----EVLLGLEYLH 115
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
E G +HRDIK N+LL + ++KL+DFG + + + + TF G+ + +PE+
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVS-GQLTSTMSKRN-----TFVGTPFWMAPEV 169
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
++ Y +DIWS+G+ + G P D
Sbjct: 170 IKQSGYD-EKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 69/269 (25%), Positives = 133/269 (49%), Gaps = 30/269 (11%)
Query: 23 GYTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVS-------KVQAPPDYLKKFLPREIE 74
Y V + +G+G++ V R + + +A+K ++ K + D + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 75 VVK-GLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDII-----RGQGYIDEIRARRW- 127
++K L+HPN++R+ + R+YI+M+ E L + + Q + +E R W
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE---RIWN 117
Query: 128 -FGQLLEALQYCH-ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS 185
F Q++ AL+Y H E+ +VHRD+ N++L D + ++DFG A+ S
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-------ESKL 170
Query: 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV 245
+ G+ Y+ PEI++ PY +D+W+ G +L+ M + PF +++ L ++ V
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229
Query: 246 TFPKQPEV-STECKELISNILSP-VQTRP 272
P + S + ++I++ L+P + RP
Sbjct: 230 YEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 71/258 (27%), Positives = 129/258 (50%), Gaps = 17/258 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLK-----KFLPREIEVVKG 78
+ +GK++G G++ V L ++A+K +V PD + L EI+++K
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVK---QVPFDPDSQETSKEVNALECEIQLLKN 60
Query: 79 LKHPNLIRFLQAIE--TTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
L+H ++++ + ++ I +EY GS+ D ++ G + E RR+ Q+L+ +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFA-RAHMRCRSNAADNSLSETFCGSYAYA 195
Y H +VHRDIK N+L DS N+KL DFG + R C S S++ G+ +
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GTPYWM 176
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE-VS 254
SPE++ G Y +D+WS+ + M+ + P+ + + ++ + T P P+ VS
Sbjct: 177 SPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235
Query: 255 TECKELISNILSPVQTRP 272
C++ + I + RP
Sbjct: 236 DACRDFLKQIFVEEKRRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-25
Identities = 72/254 (28%), Positives = 139/254 (54%), Gaps = 28/254 (11%)
Query: 28 KIIGTGSYATVKLAR--STRHSGDV-AIKIVSK---VQAPPDYLKKFLPREIEVVKGLKH 81
K++GTG+Y V L R S SG + A+K++ K VQ R++ L+H
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV-----LEH 60
Query: 82 ----PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
P L+ A +T ++++I++Y G LF + + E + + G+++ AL++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H+ G+++RDIK EN+LLDS+ ++ L+DFG ++ + + +FCG+ Y +P
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-----EDEVERAYSFCGTIEYMAP 175
Query: 198 EILQGIPYAPHLS-DIWSMGVVLFAMVFGRLPF----DDSSVNELLKQV-QNKVTFPKQP 251
+I++G + D WSMGV+++ ++ G PF + +S E+ +++ +++ +P+
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ-- 233
Query: 252 EVSTECKELISNIL 265
E+S K++I +L
Sbjct: 234 EMSALAKDIIQRLL 247
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 63/217 (29%), Positives = 118/217 (54%), Gaps = 13/217 (5%)
Query: 30 IGTGSYATVKLARSTRHSG-DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFL 88
IG GS V +A + +H+G VA+K K+ ++ L E+ +++ H N++
Sbjct: 30 IGEGSTGIVCIA-TEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 89 QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDI 148
+ ++++ME+ E G+L DI+ +E A +L AL Y H +GV+HRDI
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL-SVLRALSYLHNQGVIHRDI 144
Query: 149 KCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPH 208
K +++LL SD IKLSDFGF C + + ++ G+ + +PE++ +PY
Sbjct: 145 KSDSILLTSDGRIKLSDFGF------CAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 209 LSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV 245
+ DIWS+G+++ M+ G P+ + + ++++++ +
Sbjct: 199 V-DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 73/265 (27%), Positives = 124/265 (46%), Gaps = 23/265 (8%)
Query: 28 KIIGTGSYATVKLARSTRHSGD---VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
K +G GS+ V+ + G VA+K + + D + FL +E ++ L H NL
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK-LSDIMDDFL-KEAAIMHSLDHENL 58
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIR--GQGYIDEIRARRWFGQLLEALQYCHERG 142
IR L + TH + ++ E A GSL D +R G+ + Q+ ++Y +
Sbjct: 59 IR-LYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCG-SYAYASPEILQ 201
+HRD+ N+LL SD +K+ DFG MR D+ + E +A+ +PE L+
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGL----MRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 202 GIPYAPHLSDIWSMGVVLFAM-VFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260
++ H SD+W GV L+ M +G P+ S +++LK++ + ++PE C +
Sbjct: 174 TRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPE---ACPQD 229
Query: 261 ISNIL-----SPVQTRPRLKTIAED 280
I N++ RP + E
Sbjct: 230 IYNVMLQCWAHNPADRPTFAALREF 254
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 63/203 (31%), Positives = 112/203 (55%), Gaps = 18/203 (8%)
Query: 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNL 84
+GKI G G+++ V A+S + AIK + K + + REI+ ++ L HPN+
Sbjct: 4 LGKI-GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--REIQALRRLSPHPNI 60
Query: 85 IRFLQAI--ETTHRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHER 141
+R ++ + T R+ ++ E + +L+++I+G+ + E R + + QLL++L + H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE-IL 200
G+ HRDIK EN+L+ D +KL+DFG CR + +E + + Y +PE +L
Sbjct: 120 GIFHRDIKPENILIK-DDILKLADFG------SCRGIYSKPPYTE-YISTRWYRAPECLL 171
Query: 201 QGIPYAPHLSDIWSMGVVLFAMV 223
Y P + DIW++G V F ++
Sbjct: 172 TDGYYGPKM-DIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 77/270 (28%), Positives = 136/270 (50%), Gaps = 33/270 (12%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSK--------VQAPPDYLKKFLPREIEVVKGL 79
K+I G+Y V L R A+K ++K +Q + F+ R+I +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQ------QVFVERDI--LTFA 58
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
++P ++ + ET + ++MEY E G +++ G + AR +F + + AL+Y H
Sbjct: 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFAR-AHMRCRSNAADNS--------LSETFCG 190
G+VHRD+K +NLL+ S +IKL+DFG ++ M +N + L + CG
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 191 SYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPK 249
+ Y +PE++ Y + D W+MG++L+ + G +PF + EL QV + + +P+
Sbjct: 179 TPEYIAPEVILRQGYGKPV-DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237
Query: 250 QPE-VSTECKELISNILSPVQTRP--RLKT 276
E + + ++LIS +L + P RL T
Sbjct: 238 GDEALPADAQDLISRLL---RQNPLERLGT 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 80/262 (30%), Positives = 136/262 (51%), Gaps = 32/262 (12%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKK-----FLPREIEVVKGLKH 81
K+IG G++ V + + +++G V A+KI++K + LK+ F +V G +
Sbjct: 7 KVIGRGAFGEVAVVK-MKNTGQVYAMKILNKW----EMLKRAETACFREERDVLVNGDRR 61
Query: 82 PNLIRFLQ-AIETTHRVYIIMEYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCH 139
I L A + + +Y++M+Y G L ++ + + + E AR + +++ A+ H
Sbjct: 62 --WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSL-SETFCGSYAYASPE 198
+ G VHRDIK +N+LLD + +I+L+DFG C AD ++ S G+ Y SPE
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFG------SCLRLLADGTVQSNVAVGTPDYISPE 173
Query: 199 ILQGIP-----YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV---QNKVTFPKQ 250
ILQ + Y P D WS+GV ++ M++G PF S+ E ++ + FP
Sbjct: 174 ILQAMEDGKGRYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232
Query: 251 -PEVSTECKELISNILSPVQTR 271
+VS E K+LI ++ +TR
Sbjct: 233 VTDVSEEAKDLIRRLICSPETR 254
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 28/213 (13%)
Query: 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
IG+G+ TV A+K++ D +++ + REIE+++ + HPN+++
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVK 136
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDI-IRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
+ + +++E+ + GSL I + ++ ++ AR Q+L + Y H R +VH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV-AR----QILSGIAYLHRRHIVH 191
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMR----CRSNAADNSLSETFCGSYAYASPEIL- 200
RDIK NLL++S N+K++DFG +R + C S+ G+ AY SPE +
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV----------GTIAYMSPERIN 241
Query: 201 ----QGIPYAPHLSDIWSMGVVLFAMVFGRLPF 229
G Y + DIWS+GV + GR PF
Sbjct: 242 TDLNHGA-YDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-24
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 28 KIIGTGSYATVKLARSTRHSGD----VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
K +G G + V+L R + VA+K + F REIE+++ L H N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVK-SLNHSGEEQHRSDF-EREIEILRTLDHEN 67
Query: 84 LIRFLQAIETTHR--VYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHE 140
++++ E + +IMEY +GSL D ++ + I+ R + Q+ + + Y
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
+ +HRD+ N+L++S+ +K+SDFG A+ + E+ YA PE L
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA---PECL 184
Query: 201 QGIPYAPHLSDIWSMGVVLFAM 222
+ ++ SD+WS GV L+ +
Sbjct: 185 RTSKFSSA-SDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 4e-24
Identities = 69/247 (27%), Positives = 115/247 (46%), Gaps = 36/247 (14%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK--- 80
Y IG G+Y TV AR VA+K V +V + + REI ++K L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 81 HPNLIRFLQ--AIETTHR---VYIIMEYAENGSLFDIIRGQGYID--------EIRARRW 127
HPN++R L T R + ++ E+ + D+ Y+ +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ----DL---ATYLSKCPKPGLPPETIKDL 112
Query: 128 FGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET 187
QLL + + H +VHRD+K +N+L+ SD +K++DFG AR + ++ T
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY--------SFEMALT 164
Query: 188 FC-GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLP-FDDSSVNELLKQVQNKV 245
+ Y +PE+L YA + D+WS+G + FA +F R P F +S + L ++ + +
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPV-DMWSVGCI-FAELFRRRPLFRGTSEADQLDKIFDVI 222
Query: 246 TFPKQPE 252
P + E
Sbjct: 223 GLPSEEE 229
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 67/274 (24%), Positives = 133/274 (48%), Gaps = 33/274 (12%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKG----- 78
Y + +++G+G+ TV A+ A+K+V ++ + +
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVD--------MEGMSEADKNRAQAEVCCL 85
Query: 79 --------LK-HPNLI-RFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYID----EIRA 124
+K H + + + E + ++++YA G L I+ + + E A
Sbjct: 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEA 145
Query: 125 RRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSL 184
F Q+L A+ + H + ++HRDIK N+LL S+ +KL DFGF++ + + + +
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY----AATVSDDV 201
Query: 185 SETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK 244
TFCG+ Y +PEI + PY+ +D++S+GV+L+ ++ + PFD ++ E++ +
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260
Query: 245 VTFPKQPEVSTECKELISNIL-SPVQTRPRLKTI 277
P P +S E +E+++ +L S + RP +
Sbjct: 261 RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 7e-24
Identities = 61/222 (27%), Positives = 118/222 (53%), Gaps = 22/222 (9%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
+G G++ V A+ A KI+ ++++ + L+ F+ EI+++ KHPN++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII-QIESE-EELEDFMV-EIDILSECKHPNIVGLYE 69
Query: 90 AIETTHRVYIIMEYAENGSLFDII----RGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
A ++++I++E+ + G+L I+ RG + E + R Q+LEAL + H V+H
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERG---LTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL----- 200
RD+K N+LL D ++KL+DFG + N + +TF G+ + +PE++
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVS------AKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ 242
+ PY + +DIWS+G+ L + P + + +L ++
Sbjct: 181 KDNPY-DYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL 221
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 8e-24
Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 36/269 (13%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPN 83
T K +G+G + V L + R DVAIK++ + + D+++ E +V+ L HPN
Sbjct: 7 TFLKELGSGQFGVVHLGK-WRGKIDVAIKMIREGAMSEDDFIE-----EAKVMMKLSHPN 60
Query: 84 LIRFLQAIETTHR-VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL-------EAL 135
L++ L + T R ++I+ EY NG L + Y+ E + + LL EA+
Sbjct: 61 LVQ-LYGVCTKQRPIFIVTEYMANGCLLN------YLRERKGKLGTEWLLDMCSDVCEAM 113
Query: 136 QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA-- 193
+Y G +HRD+ N L+ D +K+SDFG AR + D+ + + +
Sbjct: 114 EYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL-------DDQYTSSQGTKFPVK 166
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVF--GRLPFDDSSVNELLKQVQNKVTFPKQP 251
+A PE+ ++ SD+WS GV+++ VF G++P++ S +E+++ V +
Sbjct: 167 WAPPEVFDYSRFSSK-SDVWSFGVLMWE-VFSEGKMPYERFSNSEVVESVSAGYRLYRPK 224
Query: 252 EVSTECKELISNILSP-VQTRPRLKTIAE 279
TE ++ + + RP K +
Sbjct: 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-23
Identities = 62/217 (28%), Positives = 118/217 (54%), Gaps = 13/217 (5%)
Query: 30 IGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFL 88
IG GS V +A + + SG VA+K K+ ++ L E+ +++ +H N++
Sbjct: 28 IGEGSTGIVCIA-TVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 89 QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDI 148
+ ++++ME+ E G+L DI+ ++E + +L+AL H +GV+HRDI
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 149 KCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPH 208
K +++LL D +KLSDFGF C + + ++ G+ + +PE++ +PY P
Sbjct: 143 KSDSILLTHDGRVKLSDFGF------CAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 209 LSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV 245
+ DIWS+G+++ MV G P+ + + +K +++ +
Sbjct: 197 V-DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-23
Identities = 71/251 (28%), Positives = 123/251 (49%), Gaps = 14/251 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + K IG G ++ V A VA+K V + ++ +EI+++K L HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDII----RGQGYIDEIRARRWFGQLLEALQYCH 139
+I++L + + + I++E A+ G L +I + + I E ++F QL A+++ H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
R V+HRDIK N+ + + +KL D G R ++ + + + G+ Y SPE
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHSLVGTPYYMSPER 177
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNEL-LKQVQNKVTFPKQP--EVSTE 256
+ Y SDIWS+G +L+ M + PF +N L Q + +P P S +
Sbjct: 178 IHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236
Query: 257 CKELISNILSP 267
+EL+S + P
Sbjct: 237 LRELVSMCIYP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 66 KKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRA 124
K F E V + +K +PN I+ ++ T +IM+Y ++G LFD+++ +G + E
Sbjct: 52 KNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEV 111
Query: 125 RRWFGQLLEALQYCHERGVVHRDIKCENLLLD-SDYNIKLSDFGFARAHMRCRSNAADNS 183
++ QL+EAL H+ ++H DIK EN+L D + I L D+G C+ +
Sbjct: 112 KKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL------CKIIGTPSC 165
Query: 184 LSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS-----SVNELL 238
G+ Y SPE ++G Y D W++GV+ + ++ G+ PF + + LL
Sbjct: 166 YD----GTLDYFSPEKIKGHNYDVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLL 220
Query: 239 KQVQNKVTFPKQPEVSTECKELISNIL 265
K+ Q K+ F K VS + + ++L
Sbjct: 221 KRQQKKLPFIKN--VSKNANDFVQSML 245
|
Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 3e-23
Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
Y IG G+Y V A VAIK +S + + ++ L REI++++ K
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-FCQRTL-REIKILRRFK 61
Query: 81 HPNLIRFL-----QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEAL 135
H N+I L + E+ + VYI+ E E L+ +I+ Q ++ + + Q+L L
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSND-HIQYFLYQILRGL 119
Query: 136 QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNS--LSETFCGSYA 193
+Y H V+HRD+K NLLL+++ ++K+ DFG AR D++ L+E + +
Sbjct: 120 KYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA----DPEHDHTGFLTE-YVATRW 174
Query: 194 YASPEI-LQGIPYAPHLSDIWSMGVVLFAMVFGR 226
Y +PEI L Y + DIWS+G +L M+ R
Sbjct: 175 YRAPEIMLNSKGYTKAI-DIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-23
Identities = 67/221 (30%), Positives = 112/221 (50%), Gaps = 29/221 (13%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLP----REIEVVKG 78
+ + IG G+Y V AR + +G+ VA+K KV+ D K+ P REI++++
Sbjct: 9 FDIIGQIGEGTYGQVYKARD-KDTGELVALK---KVRL--DNEKEGFPITAIREIKILRQ 62
Query: 79 LKHPNLIRFLQAI----------ETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWF 128
L H N++ + + + Y++ EY ++ + + G + E + +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 129 GQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETF 188
QLLE L YCH++ +HRDIKC N+LL++ IKL+DFG AR + N+ ++
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY-----NSEESRPYTNK 177
Query: 189 CGSYAYASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLP 228
+ Y PE+L G Y P + D+WS G +L +F + P
Sbjct: 178 VITLWYRPPELLLGEERYGPAI-DVWSCGCIL-GELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 5e-23
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 29/227 (12%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+G IG G + V L VA+K + FL E V+ L+HPNL
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQ---AFLA-EASVMTTLRHPNL 62
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL-------EALQY 137
++ L + + +YI+ EY GSL D +R +G RA Q L E ++Y
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG-----RAVITLAQQLGFALDVCEGMEY 117
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
E+ VHRD+ N+L+ D K+SDFG A+ L + +P
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEA---SQGQDSGKL------PVKWTAP 168
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
E L+ ++ SD+WS G++L+ + FGR+P+ + +++ V+
Sbjct: 169 EALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 8e-23
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 21/232 (9%)
Query: 30 IGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
+G G++ +V SG +VA+K + + KK RE V+ L HP ++R
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG--KKEFLREASVMAQLDHPCIVR 60
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
L + + ++ME A G L ++ + I + Q+ + Y + VHR
Sbjct: 61 -LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA---YASPEILQGI 203
D+ N+LL + + K+SDFG +RA A + T G + YA PE I
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRA-----LGAGSDYYRATTAGRWPLKWYA-PE---CI 170
Query: 204 PYA--PHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPE 252
Y SD+WS GV L+ +G P+ + E++ +++ P+ E
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-23
Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 16/213 (7%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVS---KVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
+G G+YATV RS VA+K + + AP + RE+ ++K LKH N++
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-----REVSLLKNLKHANIVT 67
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG-QLLEALQYCHERGVVH 145
I T + ++ EY ++ L + G + + + F QLL L YCH+R ++H
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+K +NLL++ +KL+DFG ARA +S +E + Y P++L G
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARA----KSVPTKTYSNEVV--TLWYRPPDVLLGSTE 180
Query: 206 APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL 238
D+W +G +L+ M GR F S+V E L
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 75/281 (26%), Positives = 135/281 (48%), Gaps = 21/281 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + K+IG G++ V + + A+KI++K + E +V+ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCHERG 142
+ A + + +Y++M+Y G L ++ + + + E AR + +++ A+ H+
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSL-SETFCGSYAYASPEILQ 201
VHRDIK +N+L+D + +I+L+DFG C D ++ S G+ Y SPEILQ
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG------SCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 202 GIP-----YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN---KVTFPKQ-PE 252
+ Y P D WS+GV ++ M++G PF S+ E ++ N + FP Q +
Sbjct: 177 AMEDGKGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235
Query: 253 VSTECKELISNILSPVQTRPRLKTIAEDRWLKPKPKSRGVD 293
VS + K+LI ++ + R I + K P G+D
Sbjct: 236 VSEDAKDLIRRLICSREHRLGQNGIED---FKQHPFFTGID 273
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 60/198 (30%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
H Y + + +G+G+Y V AR+ H+G++A + K++ D+ + +EI +VK KH
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEPGDDF--SLIQQEIFMVKECKH 65
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
N++ + + + +++I MEY GSL DI G + E++ + L+ L Y H +
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI-- 199
G +HRDIK N+LL + ++KL+DFG A A + ++F G+ + +PE+
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVA------AKITATIAKRKSFIGTPYWMAPEVAA 179
Query: 200 LQGIPYAPHLSDIWSMGV 217
++ L DIW++G+
Sbjct: 180 VEKNGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-22
Identities = 66/244 (27%), Positives = 115/244 (47%), Gaps = 20/244 (8%)
Query: 28 KIIGTGSYATVKLAR-STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
+ +GTGS+ V LA VAIK K + + E +++ + HP +
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+ + +Y+++E+ G F +R + Q++ +Y +V+R
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR 155
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K ENLLLD D IK++DFGFA+ ++ + T CG+ Y +PEIL + +
Sbjct: 156 DLKPENLLLDKDGFIKMTDFGFAKVV---------DTRTYTLCGTPEYIAPEILLNVGHG 206
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL----KQVQNKVTFPKQPEVSTECKELIS 262
+D W++G+ ++ ++ G PF NE L K ++ + FPK + CK L+
Sbjct: 207 -KAADWWTLGIFIYEILVGCPPF---YANEPLLIYQKILEGIIYFPKF--LDNNCKHLMK 260
Query: 263 NILS 266
+LS
Sbjct: 261 KLLS 264
|
Length = 340 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-22
Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 24/235 (10%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
+G G+ +V + +G V K V + A K+ L RE++++ + P ++ F
Sbjct: 13 LGAGNGGSVSKVKH-IPTGTVMAKKVVHIGAKSSVRKQIL-RELQIMHECRSPYIVSFYG 70
Query: 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH-ERGVVHRDI 148
A + + + ME+ + GSL I + G I + ++E L Y + ++HRDI
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDI 130
Query: 149 KCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPH 208
K N+L++S IKL DFG S NS+++TF G+ Y SPE +QG Y
Sbjct: 131 KPSNILVNSRGQIKLCDFGV--------SGELINSIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 209 LSDIWSMGVVLFAMVFGRLPFDDS-----------SVNELLKQVQNKVTFPKQPE 252
SD+WS+G+ + + G+ PF S + +LL+Q+ + P+ P
Sbjct: 183 -SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-PRLPS 235
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-22
Identities = 72/258 (27%), Positives = 128/258 (49%), Gaps = 17/258 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + K IG G ++ V A VA+K V + +EI+++K L HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIR----GQGYIDEIRARRWFGQLLEALQYCH 139
+I++ + + + I++E A+ G L +I+ + I E ++F QL AL++ H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
R V+HRDIK N+ + + +KL D G R ++ + + + G+ Y SPE
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHSLVGTPYYMSPER 177
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPF--DDSSVNELLKQVQNKVTFPKQP--EVST 255
+ Y SDIWS+G +L+ M + PF D ++ L K+++ + +P P S
Sbjct: 178 IHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-QCDYPPLPSDHYSE 235
Query: 256 ECKELISNILSP-VQTRP 272
E ++L++ ++P + RP
Sbjct: 236 ELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 55/159 (34%), Positives = 83/159 (52%), Gaps = 10/159 (6%)
Query: 71 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQ 130
RE++V+ P ++ F A + + I ME+ + GSL +++ G I E +
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA 107
Query: 131 LLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
+L L Y E ++HRD+K N+L++S IKL DFG S +S++ +F
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--------SGQLIDSMANSFV 159
Query: 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLP 228
G+ +Y SPE LQG Y SDIWS+G+ L M GR P
Sbjct: 160 GTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-22
Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVS-KVQAPPDYLKKFLPREIEVVKGLKHPN 83
T+G+IIG G + V T VA+K + V A + FL E V+ L H N
Sbjct: 9 TLGEIIGEGEFGAVLQGEYTGQK--VAVKNIKCDVTA-----QAFL-EETAVMTKLHHKN 60
Query: 84 LIRFLQAIETTHR-VYIIMEYAENGSLFDIIR--GQGYIDEIRARRWFGQLLEALQYCHE 140
L+R L I H +YI+ME G+L + +R G+ + I+ ++ + E ++Y
Sbjct: 61 LVRLLGVI--LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
+ +VHRD+ N+L+ D K+SDFG AR DNS + +PE L
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM----GVDNSKLPV-----KWTAPEAL 169
Query: 201 QGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQ 242
+ ++ SD+WS GV+L+ + +GR P+ S+ E+ + V+
Sbjct: 170 KHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-22
Identities = 71/259 (27%), Positives = 125/259 (48%), Gaps = 18/259 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + K+IG G++ V + + A+KI++K + E V+
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCHERG 142
+ A + + +Y++M+Y G L ++ + + + E AR + +++ A+ H+
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSL-SETFCGSYAYASPEILQ 201
VHRDIK +N+LLD + +I+L+DFG C D ++ S G+ Y SPEILQ
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG------SCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 202 GI-----PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN---KVTFPKQ-PE 252
+ Y P D WS+GV ++ M++G PF S+ E ++ N + FP +
Sbjct: 177 AMEDGMGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD 235
Query: 253 VSTECKELISNILSPVQTR 271
VS E K+LI ++ + R
Sbjct: 236 VSEEAKDLIQRLICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 5e-22
Identities = 75/306 (24%), Positives = 136/306 (44%), Gaps = 49/306 (16%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKK----FLPREIEVVKGLKHP 82
K+IG G++ V+L + + +G + A+K + K + L+K + E +++ +P
Sbjct: 7 KVIGRGAFGEVRLVQK-KDTGHIYAMKKLRK----SEMLEKEQVAHVRAERDILAEADNP 61
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
+++ + + + +Y+IMEY G + ++ + E R + + + A+ H+ G
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFG----FARAHMR-----CRSNAADNSLSETF----- 188
+HRDIK +NLLLD+ +IKLSDFG ++H N L
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 189 ------------------CGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD 230
G+ Y +PE+ Y D WS+GV+++ M+ G PF
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPFC 240
Query: 231 DSSVNELLKQVQN---KVTFPKQPEVSTECKELISNILSPVQTRPRLKTIAEDRWLKPKP 287
+ E +++ N + FP + +S E K+LI + + R + E +K P
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNE---IKSHP 297
Query: 288 KSRGVD 293
+GVD
Sbjct: 298 FFKGVD 303
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-22
Identities = 71/245 (28%), Positives = 111/245 (45%), Gaps = 41/245 (16%)
Query: 29 IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLP----REIEVVKGLKHPNL 84
IG G+Y V AR T VA+K KV+ D + +P REI ++ L+HPN+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALK---KVRM--DNERDGIPISSLREITLLLNLRHPNI 68
Query: 85 IRFLQAIETTH--RVYIIMEYAEN--GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
+ + + H ++++MEY E SL D + +++ QLL LQY HE
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC--LMLQLLRGLQYLHE 126
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
++HRD+K NLLL +K++DFG AR ++ + Y +PE+L
Sbjct: 127 NFIIHRDLKVSNLLLTDKGCLKIADFGLAR-----TYGLPAKPMTPKVV-TLWYRAPELL 180
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260
G D+W++G +L ELL +K P + E+ E +L
Sbjct: 181 LGCTTYTTAIDMWAVGCIL---------------AELLA---HKPLLPGKSEI--EQLDL 220
Query: 261 ISNIL 265
I +L
Sbjct: 221 IIQLL 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 7e-22
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 25/223 (11%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHP 82
+ + ++IG G+Y V AR + VAIKI+ + D ++ + E +++ HP
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---ED-EEEEIKEEYNILRKYSNHP 63
Query: 83 NLIRF----LQAIETTHR--VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG----QLL 132
N+ F ++ + ++++ME GS+ D+++G + W + L
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123
Query: 133 EALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
L Y HE V+HRDIK +N+LL + +KL DFG + + N TF G+
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRN----TFIGTP 177
Query: 193 AYASPEIL----QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
+ +PE++ Q SD+WS+G+ + G+ P D
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-22
Identities = 74/302 (24%), Positives = 135/302 (44%), Gaps = 44/302 (14%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKK----FLPREIEVVKGLKHPN 83
K+IG G++ V+L + A+KI+ K D L+K + E +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKA----DMLEKEQVAHIRAERDILVEADGAW 62
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+++ + + +Y+IME+ G + ++ + + E + + + + A+ H+ G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 144 VHRDIKCENLLLDSDYNIKLSDFG------------------------FARAHMRCRSNA 179
+HRDIK +NLLLD+ ++KLSDFG F+ +M + A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 180 AD-----NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV 234
L+ + G+ Y +PE+ Y L D WS+GV+++ M+ G PF +
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 235 NELLKQVQN---KVTFPKQPEVSTECKELISNILSPVQTRPRLKTIAEDRWLKPKPKSRG 291
E ++V N + FP + +S + K+LI + + R + E +K P G
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEE---IKSHPFFEG 298
Query: 292 VD 293
VD
Sbjct: 299 VD 300
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-22
Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVS---KVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
+G G+YATV RS VA+K + + AP + RE+ ++K LKH N++
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-----REVSLLKDLKHANIVT 68
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEI-------RARRWFGQLLEALQYCH 139
I T + ++ EY + D+ + Y+D+ + + QLL L YCH
Sbjct: 69 LHDIIHTEKSLTLVFEYLDK----DL---KQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
R V+HRD+K +NLL++ +KL+DFG ARA +S +E + Y P+I
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYSNEVV--TLWYRPPDI 175
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL 238
L G D+W +G + + M GR F S+V E L
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-21
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG GS+ V R VAIKI+ +A + + + +EI V+ P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPYVTKYYG 69
Query: 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIK 149
+ +++IIMEY GS D++R G DE + ++L+ L Y H +HRDIK
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 150 CENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS-ETFCGSYAYASPEILQGIPYAPH 208
N+LL ++KL+DFG A D + TF G+ + +PE++Q Y
Sbjct: 129 AANVLLSEQGDVKLADFGVA-------GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 209 LSDIWSMGVVLFAMVFGRLPFDD 231
+DIWS+G+ + G P D
Sbjct: 182 -ADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 61/286 (21%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
K +G G++ V LAR A+K + K + E +++ + ++R
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
+ + +Y +M+Y G + ++ G E AR + +L A++ H+ G +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 148 IKCENLLLDSDYNIKLSDFGF--------------------------------------- 168
IK +N+L+D D +IKL+DFG
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 169 ----------ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVV 218
AR H RC L+ + G+ Y +PE+L Y L D WS+GV+
Sbjct: 187 DRLKPLERRAARQHQRC--------LAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVI 237
Query: 219 LFAMVFGRLPFDDSSVNELLKQV---QNKVTFPKQPEVSTECKELI 261
L+ M+ G+ PF + E +V Q + P Q ++S E +LI
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-21
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA----PPDYLKKFLPREIEVVKGL 79
Y + + +G GS+ TV L + + + +K++ ++ P + ++ E +++ L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ--EAQLLSKL 59
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRAR----RWFGQLLEAL 135
HP +++F + II EY E L + + + + WF QLL +
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 136 QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
Y H+R ++HRD+K +N+ L ++ +K+ DFG +R M L+ TF G+ Y
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM------GSCDLATTFTGTPYYM 172
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAM 222
SPE L+ Y SDIWS+G +L+ M
Sbjct: 173 SPEALKHQGYDSK-SDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 41/270 (15%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKK----FLPREIEVVKGLKHPN 83
K+IG G++ V+L + A+KI+ K D L+K + E +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKA----DMLEKEQVGHIRAERDILVEADSLW 62
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+++ + + +Y+IME+ G + ++ + + E + + + + A+ H+ G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFA----RAHMRCRSNAADNSLSETF----------- 188
+HRDIK +NLLLDS ++KLSDFG +AH ++SL F
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 189 --------------CGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV 234
G+ Y +PE+ Y L D WS+GV+++ M+ G PF +
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 235 NELLKQVQN---KVTFPKQPEVSTECKELI 261
E K+V N + FP + +S + K+LI
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 57/168 (33%), Positives = 88/168 (52%), Gaps = 10/168 (5%)
Query: 71 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQ 130
RE++V+ P ++ F A + + I ME+ + GSL +++ G I E +
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 111
Query: 131 LLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
+++ L Y E+ ++HRD+K N+L++S IKL DFG S +S++ +F
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--------SGQLIDSMANSFV 163
Query: 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNEL 237
G+ +Y SPE LQG Y+ SDIWSMG+ L M GR P EL
Sbjct: 164 GTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-21
Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 51/253 (20%)
Query: 27 GKIIGTGSYATVKLARSTRHSG-----------DVAIKIVSKVQAPPDYLKKFLPREIEV 75
K++G+G++ TV + G VAIK++ + + P K+ L E V
Sbjct: 12 IKVLGSGAFGTV-------YKGVWIPEGEKVKIPVAIKVL-REETSPKANKEIL-DEAYV 62
Query: 76 VKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRAR---RWFGQLL 132
+ + HP+++R L I + +V +I + G L D +R D I ++ W Q+
Sbjct: 63 MASVDHPHVVRLL-GICLSSQVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIA 119
Query: 133 EALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
+ + Y E+ +VHRD+ N+L+ + ++K++DFG A+ L + Y
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK-------------LLDVDEKEY 166
Query: 193 AYA---------SPEILQGIPYAPHLSDIWSMGVVLFA-MVFGRLPFDDSSVNELLKQVQ 242
+ E + Y H SD+WS GV ++ M FG P++ E+ ++
Sbjct: 167 HAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
Query: 243 NKVTFPKQPEVST 255
P QP + T
Sbjct: 226 KGERLP-QPPICT 237
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-21
Identities = 71/221 (32%), Positives = 108/221 (48%), Gaps = 28/221 (12%)
Query: 30 IGTGSYATVKLARSTRHSGD-VAIKIVSKVQ---APPDYLKKFLPREIEVVKGLKHPNLI 85
+G GSYATV RS + +G VA+K + AP + RE ++K LKH N++
Sbjct: 13 LGEGSYATVYKGRS-KLTGQLVALKEIRLEHEEGAPFTAI-----REASLLKDLKHANIV 66
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
I T + ++ EY + + G + R + QLL L YCH+R V+H
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH 126
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSL-SETFCGSYA---YASPEILQ 201
RD+K +NLL+ +KL+DFG ARA S+ S+T+ Y P++L
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARA----------KSVPSKTYSNEVVTLWYRPPDVLL 176
Query: 202 G-IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS--VNELLK 239
G Y+ L D+W +G + + M GR F S+ ++L K
Sbjct: 177 GSTEYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHK 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 7e-21
Identities = 74/250 (29%), Positives = 116/250 (46%), Gaps = 39/250 (15%)
Query: 44 TRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98
T+H GD V +K V+ + P REI+++K + H +I + A V
Sbjct: 112 TKH-GDEQRKKVIVKAVTGGKTPG--------REIDILKTISHRAIINLIHAYRWKSTVC 162
Query: 99 IIMEYAENGSLFDIIRGQGYI---DEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL 155
++M + LF + G + I +R +LLEAL Y H RG++HRD+K EN+ L
Sbjct: 163 MVMPKYKC-DLFTYVDRSGPLPLEQAITIQR---RLLEALAYLHGRGIIHRDVKTENIFL 218
Query: 156 DSDYNIKLSDFGFARAHMRCRSNAADNSLSE-TFCGSYAYASPEILQGIPYAPHLSDIWS 214
D N L DFG A C+ +A ++ + G+ SPE+L PY +DIWS
Sbjct: 219 DEPENAVLGDFGAA-----CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWS 272
Query: 215 MGVVLFAMVFGRLPF-------DDSSVNELLKQVQ-NKVTFPKQPEVSTECKEL--ISNI 264
G+VLF M + S + +++ +Q + + FP Q + CK + +
Sbjct: 273 AGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP-QNGSTNLCKHFKQYAIV 331
Query: 265 LSPVQTRPRL 274
L P T P +
Sbjct: 332 LRPPYTIPPV 341
|
Length = 392 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-21
Identities = 70/233 (30%), Positives = 112/233 (48%), Gaps = 19/233 (8%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVS---KVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
+G G+YATV RS VA+K + + AP + RE+ ++K LKH N++
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-----REVSLLKDLKHANIVT 68
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWF-GQLLEALQYCHERGVVH 145
+ T + ++ EY + L + G I + + F Q+L L YCH R V+H
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+K +NLL++ +KL+DFG ARA +S +E + Y P++L G
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARA----KSVPTKTYSNEVV--TLWYRPPDVLLGSSE 181
Query: 206 APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ---PEVST 255
D+W +G + F M GR F S+V + L + + P + P +S+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-21
Identities = 67/265 (25%), Positives = 118/265 (44%), Gaps = 25/265 (9%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+T+ + +G+G + V VAIKI+ + F +E++ +K L+H +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRV-RVAIKILK--SDDLLKQQDFQ-KEVQALKRLRHKH 63
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFG-QLLEALQYCHER 141
LI VYII E E GSL +R +G + + + Q+ E + Y E+
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
+HRD+ N+L+ D K++DFG AR ++D + Y + +PE
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI------PYKWTAPEAAS 177
Query: 202 GIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260
++ SD+WS G++L+ M +G++P+ + +E+ Q+ P +C +
Sbjct: 178 HGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPA----KCPQE 232
Query: 261 ISNIL------SPVQTRPRLKTIAE 279
I I+ P RP K + E
Sbjct: 233 IYKIMLECWAAEPED-RPSFKALRE 256
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 45/288 (15%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
K +G G++ V LA A+K + K + E +++ + +++
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
+ + +Y +M+Y G + ++ E+ AR + +L A++ H+ G +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 148 IKCENLLLDSDYNIKLSDFGFAR--------------AHMR---------------CR-- 176
IK +N+L+D D +IKL+DFG +H+R CR
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 177 ----------SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGR 226
+ L+ + G+ Y +PE+L Y L D WS+GV+LF M+ G+
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 227 LPFDDSSVNELLKQV---QNKVTFPKQPEVSTECKELISNILSPVQTR 271
PF + E +V +N + P Q ++S E +LI+ + + R
Sbjct: 246 PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEER 293
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-20
Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 15/252 (5%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG GS+ V R VAIKI+ +A + + + +EI V+ P + R+
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPYITRYYG 69
Query: 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIK 149
+ +++IIMEY GS D+++ G ++E ++L+ L Y H +HRDIK
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 150 CENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE-TFCGSYAYASPEILQGIPYAPH 208
N+LL ++KL+DFG A D + TF G+ + +PE+++ Y
Sbjct: 129 AANVLLSEQGDVKLADFGVA-------GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY-DF 180
Query: 209 LSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILSPV 268
+DIWS+G+ + G P D +L + + + S KE + L+
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN-- 238
Query: 269 QTRPRLKTIAED 280
PR + A++
Sbjct: 239 -KDPRFRPTAKE 249
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 68/231 (29%), Positives = 117/231 (50%), Gaps = 23/231 (9%)
Query: 5 TVQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDY 64
+V+V D TVL+ Y K IG+G+ V A T +VAIK +S+ +
Sbjct: 4 SVEVGDST---FTVLKR--YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH 58
Query: 65 LKKFLPREIEVVKGLKHPNLIRFLQA------IETTHRVYIIMEYAENGSLFDIIRGQGY 118
K+ RE+ ++K + H N+I L +E VY++ME + +L +I Q
Sbjct: 59 AKRAY-RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI--QMD 114
Query: 119 IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178
+D R Q+L +++ H G++HRD+K N+++ SD +K+ DFG AR
Sbjct: 115 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------- 167
Query: 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF 229
A + + + + Y +PE++ G+ Y ++ DIWS+G ++ M+ G + F
Sbjct: 168 AGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 72/271 (26%), Positives = 127/271 (46%), Gaps = 14/271 (5%)
Query: 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKG 78
H Y + ++G T +TR S D K+V+K V + + E+ +
Sbjct: 65 REHMYVLTTLVGRN--PTTAAFVATRGS-DPKEKVVAKFVMLNDERQAAYARSELHCLAA 121
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY----IDEIRARRWFGQLLEA 134
H +++ ++ ++ +IMEY G L I+ + E F Q++ A
Sbjct: 122 CDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA 181
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194
L H R ++HRD+K N+ L IKL DFGF++ + S++ ++ +FCG+ Y
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY----SDSVSLDVASSFCGTPYY 237
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254
+PE+ + Y+ +D+WS+GV+L+ ++ PF S E+++QV P VS
Sbjct: 238 LAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVS 296
Query: 255 TECKELISNILSPVQT-RPRLKTIAEDRWLK 284
+ K L+ +LS RP + + +LK
Sbjct: 297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 5e-20
Identities = 68/222 (30%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG G+Y V AR + +A+K + +++ + + REI ++K ++H N++R
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 90 AIETTHRVYIIMEYAE------NGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+ + R+Y++ EY + S D + I + + Q+L + YCH V
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI-----KTYLYQILRGIAYCHSHRV 123
Query: 144 VHRDIKCENLLLDSDYN-IKLSDFGFARAH-MRCRSNAADNSLSETFCGSYA---YASPE 198
+HRD+K +NLL+D N +KL+DFG ARA + R TF Y +PE
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR----------TFTHEVVTLWYRAPE 173
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLK 239
IL G + DIWS+G + MV + F DS ++EL K
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
|
Length = 294 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-20
Identities = 63/223 (28%), Positives = 113/223 (50%), Gaps = 12/223 (5%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG+G+Y V AR+ AIK++ K++ D+ + +EI ++K KH N++ +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI-KLEPGEDF--AVVQQEIIMMKDCKHSNIVAYFG 73
Query: 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIK 149
+ +++I ME+ GSL DI G + E + + L+ L Y H +G +HRDIK
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIK 133
Query: 150 CENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI--LQGIPYAP 207
N+LL + ++KL+DFG + A + A + ++F G+ + +PE+ ++
Sbjct: 134 GANILLTDNGHVKLADFGVS-AQI-----TATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 208 HLSDIWSMGVVLFAMVFGRLP-FDDSSVNELLKQVQNKVTFPK 249
L DIW++G+ + + P FD + L ++ PK
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-20
Identities = 69/231 (29%), Positives = 109/231 (47%), Gaps = 28/231 (12%)
Query: 25 TVGKIIGTGSYATV---KLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
T+ K+IG G + V +L + DVAIK + K + FL E ++ H
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFL-TEASIMGQFDH 64
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ----- 136
PN+IR + + V II EY ENGSL ++ E + GQL+ L+
Sbjct: 65 PNIIRLEGVVTKSRPVMIITEYMENGSL------DKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 137 --YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCG--SY 192
Y E VHRD+ N+L++S+ K+SDFG +R R + + T G
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR---RLEDS---EATYTTKGGKIPI 172
Query: 193 AYASPEILQGIPYAPHLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQ 242
+ +PE + + SD+WS G+V++ M +G P+ D S +++K V+
Sbjct: 173 RWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-20
Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 90 AIETTHRVYIIMEYAENGSL-FDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
A ET + ++M G L + I G+ E RA + Q++ L++ H+R +V+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP 207
+K EN+LLD N+++SD G A ++ + G+ Y +PE+LQG Y
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA-VELK------GGKKIKGRAGTPGYMAPEVLQGEVYD- 172
Query: 208 HLSDIWSMGVVLFAMVFGRLPFDDSSV---NELLKQ--VQNKVTFPKQ--PEVSTECKEL 260
D +++G L+ M+ GR PF E LK+ ++ V +P + PE C+ L
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232
Query: 261 I 261
+
Sbjct: 233 L 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 77/285 (27%), Positives = 133/285 (46%), Gaps = 25/285 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT K +G+G+Y +V A R VAIK +S+ + K+ RE+ ++K ++H N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHEN 75
Query: 84 LIRFLQAIETT------HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
+I L + Y++M Y + I G ++ + + Q+L L+Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSED-KVQYLVYQMLCGLKY 132
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H G++HRD+K NL ++ D +K+ DFG AR AD ++ + + Y +P
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMT-GYVVTRWYRAP 183
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257
E++ + DIWS+G ++ M+ G+ F + L Q+ KVT PE +
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL-KVTGVPGPEFVQKL 242
Query: 258 KELISNILSPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEA--ELD 300
++ + S +++ P+ + L PK + VD E ELD
Sbjct: 243 EDKAAK--SYIKSLPKYPR-KDFSTLFPKASPQAVDLLEKMLELD 284
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 73/234 (31%), Positives = 113/234 (48%), Gaps = 22/234 (9%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLP----REIEVVKGLKHPNLI 85
+G GSYATV S + VA+K++S ++ +P RE ++KGLKH N++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT------EEGVPFTAIREASLLKGLKHANIV 66
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
I T + + EY +I+ G + R + QLL L Y H + ++H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG-IP 204
RD+K +NLL+ +KL+DFG ARA +S + SE + Y P++L G
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARA----KSIPSQTYSSEVV--TLWYRPPDVLLGATD 180
Query: 205 YAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNKVTFPKQ---PEVS 254
Y+ L DIW G + M+ G+ F S V E L+++ + P + P VS
Sbjct: 181 YSSAL-DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-19
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 8/200 (4%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
+G GSYATV +S + VA+K++ + RE ++KGLKH N++
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI--REASLLKGLKHANIVLLHD 70
Query: 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIK 149
I T + ++ EY + + G + + + QLL L Y H+R ++HRD+K
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK 130
Query: 150 CENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHL 209
+NLL+ +KL+DFG ARA S+ N + + Y P++L G
Sbjct: 131 PQNLLISDTGELKLADFGLARAK-SVPSHTYSNEVVTLW-----YRPPDVLLGSTEYSTC 184
Query: 210 SDIWSMGVVLFAMVFGRLPF 229
D+W +G + M+ G F
Sbjct: 185 LDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 77/295 (26%), Positives = 129/295 (43%), Gaps = 30/295 (10%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG G++ V R VA+K + V K+ RE++++ KH N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66
Query: 90 AIETTH-----RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVV 144
++ H +Y++ E ++ L II + + + Q+L L+Y H G++
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGIL 125
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET--FCGSYAYASPEILQG 202
HRDIK NLL++S+ +K+ DFG AR D S T Y Y +PEIL G
Sbjct: 126 HRDIKPGNLLVNSNCVLKICDFGLARVE------EPDESKHMTQEVVTQY-YRAPEILMG 178
Query: 203 IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELIS 262
+ DIWS+G + ++ R+ F S + L + + + P + + C+ +
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238
Query: 263 NILSPVQ---TRPRLKTIAED----------RWLKPKPKSRGVDKAEAELDHYID 304
+IL + P L T++ R L P R + A+A Y+D
Sbjct: 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKR-ISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 61/225 (27%), Positives = 109/225 (48%), Gaps = 25/225 (11%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
T K +GTG + VK + R DVAIK++ + D +F+ E +V+ L H L
Sbjct: 7 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSED---EFI-EEAKVMMKLSHEKL 61
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLE-------ALQY 137
++ +YI+ EY NG L + Y+ E R QLLE + Y
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLN------YLREHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
+ +HRD+ N L+D +K+SDFG +R + + +S+ F ++ P
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL---DDEYTSSVGSKF--PVRWSPP 170
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQV 241
E+L ++ SD+W+ GV+++ + G++P++ + +E +++V
Sbjct: 171 EVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 78/285 (27%), Positives = 139/285 (48%), Gaps = 34/285 (11%)
Query: 3 DSTVQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP 62
D+ + D TVL+ Y K IG+G+ V A +VAIK +S+
Sbjct: 7 DNNFYSVEIGDSTFTVLKR--YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ 64
Query: 63 DYLKKFLPREIEVVKGLKHPNLIRFL------QAIETTHRVYIIMEYAENGSLFDIIRGQ 116
+ K+ RE+ ++K + H N+I L +++E VYI+ME + +L +I Q
Sbjct: 65 THAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--Q 120
Query: 117 GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176
+D R Q+L +++ H G++HRD+K N+++ SD +K+ DFG AR
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------ 174
Query: 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE 236
A + + + + Y +PE++ G+ Y ++ DIWS+G ++ M+ G + F + +
Sbjct: 175 -TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGT---D 229
Query: 237 LLKQVQNKVTFPKQPEVSTECKELISNILSPVQTRPRLKTIAEDR 281
+ Q NKV ++ T C E + + +P ++T E+R
Sbjct: 230 HIDQ-WNKVI----EQLGTPCPEFMKKL------QPTVRTYVENR 263
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 56/168 (33%), Positives = 86/168 (51%), Gaps = 10/168 (5%)
Query: 71 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQ 130
RE++V+ P ++ F A + + I ME+ + GSL +++ I E +
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA 111
Query: 131 LLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
+L L Y E+ ++HRD+K N+L++S IKL DFG S +S++ +F
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV--------SGQLIDSMANSFV 163
Query: 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNEL 237
G+ +Y SPE LQG Y+ SDIWSMG+ L + GR P EL
Sbjct: 164 GTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-19
Identities = 68/235 (28%), Positives = 117/235 (49%), Gaps = 29/235 (12%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSK-----VQAPPDYLKKFLPREIEVVKGLKHPNL 84
+G+G+Y +V A TR VA+K +S+ + A Y RE+ ++K +KH N+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY------RELRLLKHMKHENV 76
Query: 85 IRFLQ------AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
I L +IE + VY++ L +I++ Q DE + QLL L+Y
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDE-HVQFLIYQLLRGLKYI 134
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H G++HRD+K N+ ++ D +++ DFG AR AD+ ++ + + Y +PE
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--------QADDEMT-GYVATRWYRAPE 185
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEV 253
I+ + DIWS+G ++ ++ G+ F + + LK++ V P PEV
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP-SPEV 239
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-19
Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 36/234 (15%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG G++ V + + +VA+K + PPD +KFL +E E++K HPN+++ +
Sbjct: 3 IGKGNFGDVYKGV-LKGNTEVAVK-TCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLIG 59
Query: 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEA---LQYCHERGVVHR 146
+YI+ME GSL +R + + + ++ L+A ++Y + +HR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKNCIHR 117
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA-----------YA 195
D+ N L+ + +K+SDFG +R E G Y +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---------------EEEGGIYTVSDGLKQIPIKWT 162
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFP 248
+PE L Y SD+WS G++L+ G P+ S + +++++ P
Sbjct: 163 APEALNYGRYTS-ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP 215
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 50 VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-THRVYIIMEYAENGS 108
VAIK++ ++ + RE + L HPN++ L + E ++ + EY +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 109 LFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL---DSDYNIKLSD 165
L +++ G + R Q+L+AL H +G+VHRD+K +N+++ + K+ D
Sbjct: 66 LREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLD 125
Query: 166 FGF------ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVL 219
FG R L G+ Y +PE L+G P P+ SD+++ G++
Sbjct: 126 FGIGTLLPGVRDADVATLTRTTEVL-----GTPTYCAPEQLRGEPVTPN-SDLYAWGLIF 179
Query: 220 FAMVFGRLPFDDSSVNELLKQ 240
+ G+ +SV E+L Q
Sbjct: 180 LECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 13/218 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + ++IG GSY V A T VAIK ++ V + L REI++++ L+HP+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRIL-REIKLLRLLRHPD 60
Query: 84 LIRFLQAIETTHR-----VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
++ + R +Y++ E E+ L +I+ + + + QLL AL+Y
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H V HRD+K +N+L ++D +K+ DFG AR ++ + + Y +PE
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAF---NDTPTAIFWTDYVATRWYRAPE 176
Query: 199 ILQGI--PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV 234
+ Y P + DIWS+G + ++ G+ F +V
Sbjct: 177 LCGSFFSKYTPAI-DIWSIGCIFAEVLTGKPLFPGKNV 213
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 6e-19
Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 22/223 (9%)
Query: 11 DIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLP 70
++D K Y K IG G+Y V A+++ + VAIK ++ K+ L
Sbjct: 2 EVDTK--------YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL- 52
Query: 71 REIEVVKGLKHPNLIRFLQAIETTHR-----VYIIMEYAENGSLFDIIRGQGYIDEIRAR 125
REI++++ L H N+I + HR VYI+ E + L IIR + + +
Sbjct: 53 REIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQ 111
Query: 126 RWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS 185
+ QLL L+Y H V+HRD+K NLLL+++ ++K+ DFG AR ++ + ++
Sbjct: 112 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-----TSEKGDFMT 166
Query: 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLP 228
E + A +L Y + D+WS+G + FA + GR P
Sbjct: 167 EYVVTRWYRAPELLLNCSEYTTAI-DVWSVGCI-FAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-19
Identities = 84/299 (28%), Positives = 145/299 (48%), Gaps = 46/299 (15%)
Query: 5 TVQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDY 64
+VQV D TVL+ Y K IG+G+ V A T +VA+K +S+ +
Sbjct: 9 SVQVADS---TFTVLKR--YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 63
Query: 65 LKKFLPREIEVVKGLKHPNLIRFL------QAIETTHRVYIIMEYAENGSLFDIIRGQGY 118
K+ RE+ ++K + H N+I L +++E VY++ME + +L +I +
Sbjct: 64 AKRAY-RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHME-- 119
Query: 119 IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178
+D R Q+L +++ H G++HRD+K N+++ SD +K+ DFG AR
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------T 172
Query: 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS----- 233
A N + + + Y +PE++ G+ Y ++ DIWS+G ++ +V G + F +
Sbjct: 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQW 231
Query: 234 --------------VNELLKQVQNKV-TFPKQPEVSTECKELISNILSPVQT-RPRLKT 276
+N L V+N V P+ P +S E EL + + P ++ R +LKT
Sbjct: 232 NKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFE--ELFPDWIFPSESERDKLKT 288
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-19
Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 37/268 (13%)
Query: 30 IGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLK---HPNLI 85
IG G+Y TV AR HSG VA+K V +VQ D L RE+ ++K L+ HPN++
Sbjct: 8 IGVGAYGTVYKARD-PHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 86 RFLQAIETTH-----RVYIIMEYAENGSLFDIIRGQGYIDEIRA--------RRWFGQLL 132
R + T+ +V ++ E+ + D+ + Y+D++ + Q L
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ----DL---RTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 133 EALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
L + H +VHRD+K EN+L+ S +KL+DFG AR + + +L+ +
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY------SCQMALTPVVVTLW 172
Query: 193 AYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLP-FDDSSVNELLKQVQNKVTFPKQP 251
Y +PE+L YA + D+WS+G + FA +F R P F +S + L ++ + + P +
Sbjct: 173 -YRAPEVLLQSTYATPV-DMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229
Query: 252 EVSTECKELISNILSPVQTRPRLKTIAE 279
+ + L SP RP + E
Sbjct: 230 DWPRDVT-LPRGAFSPRGPRPVQSVVPE 256
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 9e-19
Identities = 65/249 (26%), Positives = 115/249 (46%), Gaps = 26/249 (10%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP--PDYLKKFLPREIEVVKGLKHPNLI 85
K +G+G+Y TV A R VAIK K+ P + K RE+ ++K +KH N+I
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHMKHENVI 77
Query: 86 RFL------QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
L +++ H Y++M + G+ + + E R + Q+L+ L+Y H
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH 135
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
G++HRD+K NL ++ D +K+ DFG AR D+ ++ + Y +PE+
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMTGYVVTRW-YRAPEV 186
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEV----ST 255
+ + DIWS+G ++ M+ G+ F + L ++ P + V S
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 256 ECKELISNI 264
+ K + +
Sbjct: 247 DAKNYVKKL 255
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 22/233 (9%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHP 82
Y +G+G+Y V A T+ VAIK +S+ Q+ + + RE+ ++K + H
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 83 NLIRFL------QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
N+I L ++E VY++ L +I++ Q D+ + Q+L L+
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDD-HIQFLVYQILRGLK 132
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYAS 196
Y H G++HRD+K N+ ++ D +K+ DFG AR D+ ++ + + Y +
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--------HTDDEMT-GYVATRWYRA 183
Query: 197 PEI-LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP 248
PEI L + Y DIWS+G ++ ++ G+ F S + LK++ N V P
Sbjct: 184 PEIMLNWMHYN-QTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 64/268 (23%), Positives = 122/268 (45%), Gaps = 35/268 (13%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
K +G G + V +A +H+ K+ K P + E V+K L+H L++
Sbjct: 12 KKLGAGQFGEVWMATYNKHT-----KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK- 65
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVH 145
L A+ T +YII E+ GSL D ++ + + Q+ E + + +R +H
Sbjct: 66 LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY--AYASPEILQGI 203
RD++ N+L+ + K++DFG AR DN + + + +PE I
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARV-------IEDNEYTAREGAKFPIKWTAPE---AI 175
Query: 204 PYAPHL--SDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC-KE 259
+ SD+WS G++L +V +GR+P+ S E+++ ++ P+ C +E
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR----PENCPEE 231
Query: 260 LISNILSPVQTRPR-------LKTIAED 280
L + ++ + RP ++++ +D
Sbjct: 232 LYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 76/255 (29%), Positives = 120/255 (47%), Gaps = 35/255 (13%)
Query: 3 DSTVQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP 62
D + +DI+R + Y +G IIG GS+ V A S VAIK KV P
Sbjct: 51 DEEKMIDNDINRS----PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK---KVLQDP 103
Query: 63 DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY---------IIMEYAE---NGSLF 110
Y RE+ ++K L H N+I FL+ T ++ME+ + +
Sbjct: 104 QYKN----RELLIMKNLNHINII-FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMK 158
Query: 111 DIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFA 169
R + + + QL AL Y H + + HRD+K +NLL+D + + +KL DFG A
Sbjct: 159 HYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218
Query: 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQG-IPYAPHLSDIWSMGVVLFAMVFGRLP 228
+ N S ++ S Y +PE++ G Y H+ D+WS+G ++ M+ G
Sbjct: 219 K-------NLLAGQRSVSYICSRFYRAPELMLGATNYTTHI-DLWSLGCIIAEMILGYPI 270
Query: 229 FD-DSSVNELLKQVQ 242
F SSV++L++ +Q
Sbjct: 271 FSGQSSVDQLVRIIQ 285
|
Length = 440 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 29 IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDY---LKKFLPREIEVVKGLKHPNLI 85
I+G G+ TV A +A+K++ P D L+K + E+E++ P +I
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVI-----PLDITVELQKQIMSELEILYKCDSPYII 62
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
F A +R+ I E+ + GSL D+ R I E R +++ L Y ++H
Sbjct: 63 GFYGAFFVENRISICTEFMDGGSL-DVYRK---IPEHVLGRIAVAVVKGLTYLWSLKILH 118
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+K N+L+++ +KL DFG + + NS+++T+ G+ AY +PE + G Y
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLV--------NSIAKTYVGTNAYMAPERISGEQY 170
Query: 206 APHLSDIWSMGVVLFAMVFGRLPF 229
H SD+WS+G+ + GR P+
Sbjct: 171 GIH-SDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 44/158 (27%), Positives = 84/158 (53%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + K I G++ V L R +S A+K+V K + + E + + K P
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ ++++ + VY++MEY G + ++ GY DE A ++ ++ AL Y H G+
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181
+HRD+K +N+L+ ++ +IKL+DFG ++ + N D
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMD 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-18
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG GS+ V R VAIKI+ +A + + + +EI V+ P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPYVTKYYG 69
Query: 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIK 149
+ +++IIMEY GS D++ G +DE + ++L+ L Y H +HRDIK
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 150 CENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET-FCGSYAYASPEILQGIPYAPH 208
N+LL +KL+DFG A D + F G+ + +PE+++ Y
Sbjct: 129 AANVLLSEHGEVKLADFGVA-------GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 209 LSDIWSMGVVLFAMVFGRLPFDD 231
+DIWS+G+ + G P +
Sbjct: 182 -ADIWSLGITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-18
Identities = 73/267 (27%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 13 DRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPRE 72
D TVL+ Y K IG+G+ V A +VAIK +S+ + K+ RE
Sbjct: 10 DSTFTVLKR--YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RE 66
Query: 73 IEVVKGLKHPNLIRFL------QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARR 126
+ ++K + H N+I L +++E VY++ME + +L +I Q +D R
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSY 123
Query: 127 WFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186
Q+L +++ H G++HRD+K N+++ SD +K+ DFG AR A + +
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMT 176
Query: 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT 246
+ + Y +PE++ G+ Y ++ DIWS+G ++ MV ++ F + +V ++
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 247 FPKQPEVSTECKELISNILSPVQTRPR 273
P PE + + + N V+ RP+
Sbjct: 236 TP-CPEFMKKLQPTVRNY---VENRPK 258
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 4e-18
Identities = 64/251 (25%), Positives = 121/251 (48%), Gaps = 18/251 (7%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFL- 88
+G+G+Y +V A T+ VA+K +S+ + K+ RE+ ++K +KH N+I L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 89 -----QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+++E + VY++ + L +I++ Q D+ + Q+L L+Y H +
Sbjct: 84 VFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDD-HVQFLIYQILRGLKYIHSADI 141
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRD+K NL ++ D +K+ DFG AR D+ ++ + + Y +PEI+
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMT-GYVATRWYRAPEIMLNW 192
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISN 263
+ DIWS+G ++ ++ GR F + + LK + V P + E N
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 252
Query: 264 ILSPVQTRPRL 274
+ + P++
Sbjct: 253 YIQSLTQMPKM 263
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-18
Identities = 65/266 (24%), Positives = 127/266 (47%), Gaps = 17/266 (6%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG GS+ V AR R+S VAIK +S + + + +E+ ++ L+HPN I++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 90 AIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDI 148
H +++MEY GS D++ + + E+ L+ L Y H ++HRD+
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141
Query: 149 KCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPH 208
K N+LL +KL DFG +A+ + + F G+ + +PE++ + +
Sbjct: 142 KAGNILLSEPGLVKLGDFG----------SASIMAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 209 LS--DIWSMGVVLFAMVFGRLP-FDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL 265
D+WS+G+ + + P F+ ++++ L QN+ + S + + + L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 266 SPV-QTRPRLKTIAEDRWL-KPKPKS 289
+ Q RP + + + R++ + +P +
Sbjct: 252 QKIPQDRPTSEVLLKHRFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-18
Identities = 85/333 (25%), Positives = 137/333 (41%), Gaps = 65/333 (19%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
+G GS V A + VA+K + P +K L REI++++ L H N+++ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHAL-REIKIIRRLDHDNIVKVYE 69
Query: 90 AIETTHR--------------VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEAL 135
+ + VYI+ EY E L +++ QG + E AR + QLL L
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGL 127
Query: 136 QYCHERGVVHRDIKCENLLLDS-DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194
+Y H V+HRD+K N+ +++ D +K+ DFG AR S+ LSE + Y
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG--YLSEGLVTKW-Y 184
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF-------------------DDSSVN 235
SP +L D+W+ G + M+ G+ F + N
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRN 244
Query: 236 ELLK----QVQNKVTFPKQP------EVSTECKELISNILSPVQTRPRLKTIAEDRWLKP 285
ELL V+N P++P V+ E + + IL+ P + AE+ + P
Sbjct: 245 ELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILT---FNPMDRLTAEEALMHP 301
Query: 286 ----------KPKSRGVDKAEAELDHYIDMIQT 308
+P S E ELD + M +
Sbjct: 302 YMSCYSCPFDEPVSLHPFHIEDELDDILLMTEI 334
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-18
Identities = 68/270 (25%), Positives = 131/270 (48%), Gaps = 17/270 (6%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG GS+ V AR R + VAIK +S + + + +E++ ++ +KHPN I +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 90 AIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDI 148
H +++MEY GS D++ + + E+ L+ L Y H ++HRDI
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 151
Query: 149 KCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPH 208
K N+LL +KL+DFG +A+ S + +F G+ + +PE++ + +
Sbjct: 152 KAGNILLTEPGQVKLADFG----------SASIASPANSFVGTPYWMAPEVILAMDEGQY 201
Query: 209 LS--DIWSMGVVLFAMVFGRLP-FDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL 265
D+WS+G+ + + P F+ ++++ L QN+ + E S + + + L
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL 261
Query: 266 SPV-QTRPRLKTIAEDRW-LKPKPKSRGVD 293
+ Q RP + + + + L+ +P++ +D
Sbjct: 262 QKIPQDRPTSEELLKHMFVLRERPETVLID 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-18
Identities = 57/246 (23%), Positives = 96/246 (39%), Gaps = 49/246 (19%)
Query: 25 TVGKIIGTGSYATV-----KLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
T+ + +G GS+ V K VAIK V++ + + ++ FL E V+K
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FL-NEASVMKEF 66
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR----------GQGYIDEIRARRWFG 129
+++R L + T ++ME G L +R G G + +
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR-------------AHMRCR 176
++ + + Y + VHRD+ N ++ D +K+ DFG R + R
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVN 235
+ +PE L+ + SD+WS GVVL+ M P+ S
Sbjct: 187 -----------------WMAPESLKDGVFTT-KSDVWSFGVVLWEMATLAEQPYQGLSNE 228
Query: 236 ELLKQV 241
E+LK V
Sbjct: 229 EVLKFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-18
Identities = 60/244 (24%), Positives = 111/244 (45%), Gaps = 26/244 (10%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVS----KVQAPPDYLKKFLPREIEVVKGLKHPN 83
K +G G + V + +S VA+K + VQA FL E ++K L+H
Sbjct: 12 KKLGAGQFGEVWMG-YYNNSTKVAVKTLKPGTMSVQA-------FL-EEANLMKTLQHDK 62
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHER 141
L+R + +YII EY GSL D ++ G + + + Q+ E + Y +
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY--AYASPEI 199
+HRD++ N+L+ K++DFG AR DN + + + +PE
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARV-------IEDNEYTAREGAKFPIKWTAPEA 175
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258
+ + SD+WS G++L+ +V +G++P+ S ++++ +Q P+ E
Sbjct: 176 INFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELY 234
Query: 259 ELIS 262
+++
Sbjct: 235 DIMK 238
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-18
Identities = 66/266 (24%), Positives = 117/266 (43%), Gaps = 25/266 (9%)
Query: 28 KIIGTGSYATV---KLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
++IG G + V +L + VAIK + K + FL E ++ HPN+
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLS-EASIMGQFDHPNI 67
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGV 143
I + + V II E+ ENG+L +R G I+ + ++Y E
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY 127
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA--YASPEILQ 201
VHRD+ N+L++S+ K+SDFG +R + +D + + + G + +PE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 202 GIPYAPHLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260
+ SD+WS G+V++ M +G P+ D S +++ ++ P + T +L
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQL 243
Query: 261 ISNILSPVQTRPRLKTIAEDRWLKPK 286
+ L +DR +PK
Sbjct: 244 M------------LDCWQKDRNARPK 257
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 71 REIEVVKGLKHPNLIRFLQAI---ETTHRVYIIMEYAENG--SLFDIIRGQGYIDEIRAR 125
REI ++ L+HPN++ ++ + ++Y++MEY E+ SL + ++ E++
Sbjct: 53 REINILLKLQHPNIVT-VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC- 110
Query: 126 RWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD-NSL 184
QLL + + H+ ++HRD+K NLLL++ +K+ DFG AR S L
Sbjct: 111 -LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR---EYGSPLKPYTQL 166
Query: 185 SETFCGSYAYASPEILQGIPYAPHLSDIWSMG 216
T Y +PE+L G D+WS+G
Sbjct: 167 VVTLW----YRAPELLLGAKEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 53/199 (26%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
+G G++ V A++ A K++ + L+ ++ EI+++ HPN+++ L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDT--KSEEELEDYMV-EIDILASCDHPNIVKLLD 69
Query: 90 AIETTHRVYIIMEYAENGSLFDI-IRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDI 148
A + ++I++E+ G++ + + + + E + R Q LEAL Y HE ++HRD+
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 149 KCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL-----QGI 203
K N+L D +IKL+DFG + + R ++F G+ + +PE++ +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQR------RDSFIGTPYWMAPEVVMCETSKDR 183
Query: 204 PYAPHLSDIWSMGVVLFAM 222
PY + +D+WS+G+ L M
Sbjct: 184 PY-DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 55/202 (27%), Positives = 107/202 (52%), Gaps = 22/202 (10%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
+G G++ V A++ A K++ + L+ ++ EIE++ HP +++ L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMV-EIEILATCNHPYIVKLLG 76
Query: 90 AIETTHRVYIIMEYAENGS----LFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
A +++I++E+ G+ + ++ RG + E + + Q+LEALQY H ++H
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI-----L 200
RD+K N+LL D +IKL+DFG + +++ ++F G+ + +PE+ +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR------RDSFIGTPYWMAPEVVMCETM 187
Query: 201 QGIPYAPHLSDIWSMGVVLFAM 222
+ PY + +DIWS+G+ L M
Sbjct: 188 KDTPY-DYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 16/217 (7%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
+G G Y V ++S VA+K + + +++FL +E V+K +KHPNL++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFL-KEAAVMKEIKHPNLVQLLG 69
Query: 90 AIETTHRVYIIMEYAENGSLFDIIR--GQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
YII E+ G+L D +R + ++ + Q+ A++Y ++ +HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP 207
+ N L+ ++ +K++DFG +R M + A + +PE L ++
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPI----KWTAPESLAYNKFSI 184
Query: 208 HLSDIWSMGVVLFAM-VFGRLPF---DDSSVNELLKQ 240
SD+W+ GV+L+ + +G P+ D S V ELL++
Sbjct: 185 K-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 220
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 66/231 (28%), Positives = 113/231 (48%), Gaps = 22/231 (9%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
K +G G + V + H+ VAIK + + P+ FL E ++K L+HP L+R
Sbjct: 12 KKLGAGQFGEVWMGYYNGHT-KVAIKSLKQGSMSPE---AFL-AEANLMKQLQHPRLVR- 65
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWF---GQLLEALQYCHERGVV 144
L A+ T +YII EY ENGSL D ++ I + + Q+ E + + + +
Sbjct: 66 LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIP 204
HRD++ N+L+ K++DFG AR A + + F + +PE I
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA---KF--PIKWTAPE---AIN 176
Query: 205 YAPHL--SDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPE 252
Y SD+WS G++L +V +GR+P+ + E+++ ++ P +P+
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP-RPD 226
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-17
Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 41/232 (17%)
Query: 49 DVAIKIV-SKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENG 107
VA+K + +P +L+ E +++K L+H L++ +YI+ EY G
Sbjct: 32 KVAVKTLKPGTMSPEAFLQ-----EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKG 86
Query: 108 SLFDIIRGQGYIDEIRARR------WFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNI 161
SL D ++ E + R Q+ E + Y R +HRD+ N+L+ +
Sbjct: 87 SLLDFLKS----GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVC 142
Query: 162 KLSDFGFARAHMRCRSNAADNSLSETFCGS---YAYASPE-ILQG---IPYAPHLSDIWS 214
K++DFG AR + G+ + +PE G I SD+WS
Sbjct: 143 KIADFGLARLIE--------DDEYTAREGAKFPIKWTAPEAANYGRFTIK-----SDVWS 189
Query: 215 MGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL 265
G++L +V +GR+P+ + E+L+QV+ P+ P C E + +++
Sbjct: 190 FGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPP----NCPEELYDLM 237
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-17
Identities = 65/221 (29%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 23 GYTVGKIIGTGSYATVKLARSTRHSGD--VAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
Y + K +G G+Y V AR+ S + VAIK ++ V + K+ L RE+++++ +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFR 59
Query: 81 -HPNL-------IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL 132
H N+ I F + +Y+ E E L IIR + + + + Q+L
Sbjct: 60 GHKNITCLYDMDIVFPGNF---NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 133 EALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNS--LSETFCG 190
L+Y H V+HRD+K NLL+++D +K+ DFG AR N +N+ ++E +
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG---FSENPGENAGFMTE-YVA 171
Query: 191 SYAYASPEILQGIPYAPHLS--DIWSMGVVLFAMVFGRLPF 229
+ Y +PEI+ + + + D+WS+G +L A + GR P
Sbjct: 172 TRWYRAPEIM--LSFQSYTKAIDVWSVGCIL-AELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-17
Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 38/265 (14%)
Query: 28 KIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
+ IG G + V L + G+ VA+K + D + E V+ L+H NL++
Sbjct: 12 QTIGKGEFGDVMLGD---YRGNKVAVKCIKN-----DATAQAFLAEASVMTQLRHSNLVQ 63
Query: 87 FLQAI-ETTHRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGV 143
L I E +YI+ EY GSL D +R +G + ++ + EA++Y
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF 123
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
VHRD+ N+L+ D K+SDFG + +S +T + +PE L+
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEA---------SSTQDTGKLPVKWTAPEALREK 174
Query: 204 PYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN--KVTFPKQPEVSTECKEL 260
++ SD+WS G++L+ + FGR+P+ + +++ +V+ K+ P C +
Sbjct: 175 KFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG------CPPV 227
Query: 261 ISNI------LSPVQTRPRLKTIAE 279
+ ++ L RP + E
Sbjct: 228 VYDVMKQCWHLDAAT-RPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 30 IGTGSYATVKLARS--TRHSGDVAIKIVSKVQAPPDYLKKFLP---REIEVVKGLKHPNL 84
IG G+Y V A+ + + AIK K + + REI +++ LKH N+
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIK---KFKGDKEQYTGISQSACREIALLRELKHENV 64
Query: 85 IRFLQAI--ETTHRVYIIMEYAENGSLFDIIR-----GQGYIDEIRARRWFGQLLEALQY 137
+ ++ VY++ +YAE+ L+ II+ + I + Q+L + Y
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 138 CHERGVVHRDIKCENLLLDSDYN----IKLSDFGFARA-HMRCRSNAADNSLSETFCGSY 192
H V+HRD+K N+L+ + +K+ D G AR + + A + + T
Sbjct: 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW--- 180
Query: 193 AYASPEILQGIPYAPHLS---DIWSMGVVLFA 221
Y +PE+L G A H + DIW++G + FA
Sbjct: 181 -YRAPELLLG---ARHYTKAIDIWAIGCI-FA 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-17
Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 9/221 (4%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG G++ V R + VA+K + PPD KFL +E ++K HPN++R +
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFL-QEARILKQYSHPNIVRLIG 60
Query: 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRAR-RWFGQLLEALQYCHERGVVHRDI 148
+YI+ME + G +R +G +++ + ++Y + +HRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 149 KCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPH 208
N L+ +K+SDFG +R A+ + + + +PE L Y+
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEED-GVYASTGGMKQI---PVKWTAPEALNYGRYSSE 176
Query: 209 LSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQNKVTFP 248
SD+WS G++L+ A G +P+ + S + + ++ V P
Sbjct: 177 -SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP 216
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-16
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 50 VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL 109
VAIK + P+ FL +E +V+K L+H L++ L A+ + +YI+ EY GSL
Sbjct: 33 VAIKTLKPGTMSPE---AFL-QEAQVMKKLRHEKLVQ-LYAVVSEEPIYIVTEYMSKGSL 87
Query: 110 FDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFG 167
D ++G+ Y+ + Q+ + Y VHRD++ N+L+ + K++DFG
Sbjct: 88 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 147
Query: 168 FARAHMRCRSNAADNSLSETFCGSY--AYASPEILQGIPYAPHLSDIWSMGVVLFAMVF- 224
AR DN + + + +PE + SD+WS G++L +
Sbjct: 148 LARL-------IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTK 199
Query: 225 GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISN 263
GR+P+ E+L QV+ P PE +L+
Sbjct: 200 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 26/281 (9%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLK-KFLPREIEVVKGLKHPNLIRFL 88
+G G+Y +V H + +++ D K + E++++ P ++ F
Sbjct: 9 LGKGNYGSVYKVL---HRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 89 QAIETTHRVYIIMEYAENGSLFDIIRG---QGYIDEIRARRWFGQLLEALQYCHER-GVV 144
A VY+ MEY + GSL + G I E RR +++ L++ E ++
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIP 204
HRD+K N+L++ + +KL DFG S SL++T G +Y +PE ++
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGV--------SGNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 205 YAPHL-----SDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV--TFPKQP-EVSTE 256
+ SD+WS+G+ + M GR P+ + + Q+ V P P S +
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 257 CKELISNILSPV-QTRPRLKTIAEDRWLKPKPKSRGVDKAE 296
++ ++ L+ + RP + E WL K K+ VD AE
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLV-KYKNADVDMAE 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 67/232 (28%), Positives = 107/232 (46%), Gaps = 43/232 (18%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIK-IVSKVQAPPDYLKKFLP----REIEVVKG 78
Y + +G G++ V AR + VA+K I+ + K P REI+++K
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE------KDGFPITALREIKILKK 63
Query: 79 LKHPNLIRFLQAI-----ETTHR---VYIIMEYA--------ENGSLFDIIRGQGYIDEI 122
LKHPN++ + ++ + VY++ Y EN S+ + E
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--------KLTES 115
Query: 123 RARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN---- 178
+ + + QLLE + Y HE ++HRDIK N+L+D+ +K++DFG AR + N
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 179 AADNSLSETFC-GSYAYASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLP 228
+ T + Y PE+L G Y + DIW +G V FA +F R P
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCV-FAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-16
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 28/198 (14%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVS-----KVQAPPDYLKKFLPREIEVVKGLKHPNL 84
IG GS+ V AR R + VAIK +S + D +K E+ ++ L+HPN
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-----EVRFLQQLRHPNT 77
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDII---RGQGYIDEIRARRWFGQLLEALQYCHER 141
I + H +++MEY GS DI+ + EI A L+ L Y H
Sbjct: 78 IEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAA--ICHGALQGLAYLHSH 134
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
+HRDIK N+LL +KL+DFG A + +N +F G+ + +PE++
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFG--SASLVSPAN--------SFVGTPYWMAPEVIL 184
Query: 202 GIPYAPHLS--DIWSMGV 217
+ + D+WS+G+
Sbjct: 185 AMDEGQYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-16
Identities = 71/271 (26%), Positives = 117/271 (43%), Gaps = 35/271 (12%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD---VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
T+G+ IG G + V + VA+K K P +KFL +E +++ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFL-QEAYIMRQFDH 66
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG-QLLEALQYCHE 140
P++++ L + T + V+I+ME A G L ++ Y ++ + + QL AL Y
Sbjct: 67 PHIVK-LIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
+ VHRDI N+L+ S +KL DFG +R L + SY AS L
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY------------LEDE---SYYKASKGKL 170
Query: 201 QGIPYAPH---------LSDIWSMGVVLFA-MVFGRLPFDDSSVNELLKQVQNKVTFPKQ 250
AP SD+W GV ++ ++ G PF N+++ +++N P
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP 230
Query: 251 PEVSTECKELISNILS--PVQTRPRLKTIAE 279
P L++ + P + RPR +
Sbjct: 231 PNCPPTLYSLMTKCWAYDPSK-RPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-16
Identities = 66/238 (27%), Positives = 103/238 (43%), Gaps = 47/238 (19%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKI----VSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ IG G+Y V AR VA+K + + PP L REI +++ L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL-----REISLLQMLSESI 61
Query: 84 LIRFLQAIETTHR------VYIIMEYAENGSLFDII---RGQGY-IDEIRARRWFGQLLE 133
I L +E +Y++ EY ++ + RG G + + + QLL+
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 134 ALQYCHERGVVHRDIKCENLLLDSDYN-IKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
+ +CH+ GV+HRD+K +NLL+D +K++D G RA SY
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-------------SIPVKSY 168
Query: 193 A-------YASPEILQGIPYAPHLS---DIWSMGVVLFAMVFGRLPF-DDSSVNELLK 239
Y +PE+L G + H S DIWS+G + M + F DS + +LL
Sbjct: 169 THEIVTLWYRAPEVLLG---STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH 223
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 17/238 (7%)
Query: 19 LESHGYTVGKIIGTGSYATV---KLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV 75
+++ + K+IG G + V +L + VAIK + K + FL E +
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFL-SEASI 58
Query: 76 VKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEA 134
+ HPN+I + + V I+ EY ENGSL +R G I+ +
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASG 118
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGS--- 191
++Y + G VHRD+ N+L++S+ K+SDFG +R D + T G
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL------EDDPEAAYTTRGGKIP 172
Query: 192 YAYASPEILQGIPYAPHLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQNKVTFP 248
+ +PE + + SD+WS G+V++ M +G P+ + S +++K ++ P
Sbjct: 173 IRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 2e-16
Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 56/289 (19%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y V K IG G + V L + R K +S + + K L E+ V++ LKH N
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAIS-YRGLKEREKSQLVIEVNVMRELKHKN 73
Query: 84 LIRFLQAI--ETTHRVYIIMEYAENGSL----------FDIIRGQGYIDEIRARRWFGQL 131
++R++ + ++YI+ME+ + G L F I +D R QL
Sbjct: 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR------QL 127
Query: 132 LEALQYCH--------ERGVVHRDIKCENLLLDSDYN-----------------IKLSDF 166
L AL YCH ER V+HRD+K +N+ L + K+ DF
Sbjct: 128 LHALAYCHNLKDGPNGER-VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 167 GFARAHMRCRSNAADNSLSETFCGSYAYASPEIL-QGIPYAPHLSDIWSMGVVLFAMVFG 225
G ++ N S++ + G+ Y SPE+L SD+W++G +++ + G
Sbjct: 187 GLSK-------NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 226 RLPFDDS-SVNELLKQVQNKVTFPKQPEVSTECKELISNILS-PVQTRP 272
+ PF + + ++L+ +++ P + + S E LI N+L+ + RP
Sbjct: 240 KTPFHKANNFSQLISELKRGPDLPIKGK-SKELNILIKNLLNLSAKERP 287
|
Length = 1021 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 62/248 (25%), Positives = 118/248 (47%), Gaps = 16/248 (6%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89
IG GS+ V A ++ + VA+K +S + + + +E++ ++ LKHPN I +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 90 AIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDI 148
H +++MEY GS D++ + + E+ L+ L Y H ++HRDI
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 149 KCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPH 208
K N+LL +KL+DFG +A+ +S + +F G+ + +PE++ + +
Sbjct: 148 KAGNILLTEPGQVKLADFG----------SASKSSPANSFVGTPYWMAPEVILAMDEGQY 197
Query: 209 LS--DIWSMGVVLFAMVFGRLP-FDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL 265
D+WS+G+ + + P F+ ++++ L QN + E + + + L
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCL 257
Query: 266 SPV-QTRP 272
+ Q RP
Sbjct: 258 QKIPQERP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-16
Identities = 58/223 (26%), Positives = 108/223 (48%), Gaps = 21/223 (9%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPN 83
T K +G+G + V L + VAIK +++ + D+++ E +V+ L HP
Sbjct: 7 TFMKELGSGQFGVVHLGKWRAQI-KVAIKAINEGAMSEEDFIE-----EAKVMMKLSHPK 60
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERG 142
L++ +YI+ E+ ENG L + +R QG + + + E ++Y
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY--AYASPEIL 200
+HRD+ N L+ S +K+SDFG R + D+ + + + ++ PE+
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL-------DDEYTSSSGAKFPVKWSPPEVF 173
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVF--GRLPFDDSSVNELLKQV 241
Y+ SD+WS GV+++ VF G++PF+ S E+++ +
Sbjct: 174 NFSKYSSK-SDVWSFGVLMWE-VFTEGKMPFEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 76/314 (24%), Positives = 138/314 (43%), Gaps = 56/314 (17%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPR---EIEVVKGLKHPNL 84
K+IG G++ V+L + A+K + K + + K L E +V+ P +
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM---FKKDQLAHVKAERDVLAESDSPWV 63
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFD-IIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+ + + +Y+IME+ G L +I+ + +++ R + + + A++ H+ G
Sbjct: 64 VSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV-TRFYMAECVLAIEAVHKLGF 122
Query: 144 VHRDIKCENLLLDSDYNIKLSDF----GFARAH-----------------MRCRSNAADN 182
+HRDIK +N+L+D +IKLSDF GF + H + R++ A +
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 183 SLSETF--------------------CGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAM 222
S++ T G+ Y +PEI Y D WS+G ++F
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAIMFEC 241
Query: 223 VFGRLPFDDSSVNELLKQVQN---KVTFPKQPEVSTECKELISNILSPVQTRPRLKTIAE 279
+ G PF + +E +++ N + FP +S E ++LI +++ + R E
Sbjct: 242 LIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHE 301
Query: 280 DRWLKPKPKSRGVD 293
+K P RGVD
Sbjct: 302 ---IKSHPFFRGVD 312
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 24/223 (10%)
Query: 30 IGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLK---HPNLI 85
IG G+Y V AR ++ G VA+K V +VQ + + RE+ V++ L+ HPN++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 86 RFLQAIETTH-----RVYIIMEYAENG--SLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
R + ++ ++ E+ + + D + G E + QLL L +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-IKDMMFQLLRGLDFL 126
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H VVHRD+K +N+L+ S IKL+DFG AR + + + + Y +PE
Sbjct: 127 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQMALTSVVVTLWYRAPE 179
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF--DDSSVNELLK 239
+L YA + D+WS+G + FA +F R P S V++L K
Sbjct: 180 VLLQSSYATPV-DLWSVGCI-FAEMFRRKPLFRGSSDVDQLGK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 49/139 (35%), Positives = 72/139 (51%), Gaps = 25/139 (17%)
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFG---FARAHMRCRSNAADNSLSE 186
QLL A+ Y H G++HRDIK EN+L++ +I L DFG FAR S ++
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG---SWSTPFHYGIA- 323
Query: 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLF------AMVFG------RLPFDDSSV 234
G+ +PE+L G PY P + DIWS G+V+F A +F R P+ D+ +
Sbjct: 324 ---GTVDTNAPEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPY-DAQI 378
Query: 235 NELLKQVQNKV-TFPKQPE 252
+++Q Q V FP+
Sbjct: 379 LRIIRQAQVHVDEFPQHAG 397
|
Length = 461 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-16
Identities = 61/239 (25%), Positives = 108/239 (45%), Gaps = 21/239 (8%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSK-VQAPPDYLKKFLPREIEVVKGLKHPNLIRFL 88
IG+G + V L VAIK + + + D+++ E +V+ L HP L++
Sbjct: 12 IGSGQFGLVWLG-YWLEKRKVAIKTIREGAMSEEDFIE-----EAQVMMKLSHPKLVQLY 65
Query: 89 QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL---EALQYCHERGVVH 145
+ ++ E+ E+G L D +R Q + G L E + Y V+H
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+ N L+ + +K+SDFG R + + +S F ++SPE+ Y
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVL---DDQYTSSTGTKF--PVKWSSPEVFSFSKY 178
Query: 206 APHLSDIWSMGVVLFAMVF--GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELIS 262
+ SD+WS GV+++ VF G+ P+++ S +E+++ + K S EL+
Sbjct: 179 SSK-SDVWSFGVLMWE-VFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-16
Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 12/146 (8%)
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
PN++ + I + V++++++AE G L+ I I E +RW +++ AL H
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFG-FARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
G+V RD+ N+LLD +I+L+ F ++ C A +N Y +PE+
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN----------MYCAPEV- 153
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGR 226
GI D WS+G +LF ++ G+
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 72 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL-FDIIR-GQGYIDEIRARRWFG 129
E E+++ + P ++ A E+ + ++M G L + I G+ ++ R +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Q+ + + H +V+RD+K EN+LLD N +LSD G A D
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-------VELKDGKTITQRA 155
Query: 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS----SVNELLKQ-VQNK 244
G+ Y +PEIL+ PY+ + D ++MG ++ MV GR PF D + EL ++ ++++
Sbjct: 156 GTNGYMAPEILKEEPYSYPV-DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE 214
Query: 245 VTFPKQPEVSTECKELISNILS 266
V F Q + E K++ L+
Sbjct: 215 VKFEHQ-NFTEESKDICRLFLA 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-15
Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 38/269 (14%)
Query: 28 KIIGTGSYATV---KLARSTRHSGDVAIKIVSKVQAPPDYLKK----FLPREIEVVKGLK 80
K+IG G + V L R VAIK + P Y +K FL E ++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK-----PGYTEKQRQDFL-SEASIMGQFS 64
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCH 139
H N+IR + II EY ENG+L +R G + + ++Y
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA------ 193
+ VHRD+ N+L++S+ K+SDFG +R L + G+Y
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRV------------LEDDPEGTYTTSGGKI 172
Query: 194 ---YASPEILQGIPYAPHLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQNKVTFPK 249
+ +PE + + SD+WS G+V++ M FG P+ D S +E++K + + P
Sbjct: 173 PIRWTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA 231
Query: 250 QPEVSTECKELISNI-LSPVQTRPRLKTI 277
+ + +L+ RPR I
Sbjct: 232 PMDCPSAVYQLMLQCWQQDRARRPRFVDI 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 76/269 (28%), Positives = 126/269 (46%), Gaps = 37/269 (13%)
Query: 17 TVLE-SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV 75
TV E ++ Y + +G G++ V AR +VAIK + K + P L K RE+++
Sbjct: 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKL 62
Query: 76 VKGLKHPNLIR----FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQL 131
+K L+H N+I F+ +E +Y + E G+ + +++ + + Q+
Sbjct: 63 LKHLRHENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQI 117
Query: 132 LEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGS 191
L L+Y H GVVHRD+K N+L++ + ++K+ DFG AR D ++
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ--------DPQMTGYVSTR 169
Query: 192 YAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGR--LPFDD-----SSVNELLKQVQNK 244
Y Y +PEI+ DIWS G + M+ G+ P D S + +LL +
Sbjct: 170 Y-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228
Query: 245 VTFPKQPEVSTECKELISNILSPVQTRPR 273
V ++T C E N L VQ+ P+
Sbjct: 229 V-------INTICSE---NTLRFVQSLPK 247
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-15
Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 44/231 (19%)
Query: 26 VGKIIGTGSYATVKLARSTRHSG-----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
+GK +G G + V A + R G VA+K++ + + + L E ++K +
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD--LLSEFNLLKQVN 61
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-----GQGYIDEIRARR--------- 126
HP++I+ A + +I+EYA+ GSL +R G Y+ R
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 127 ------------WFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174
W Q+ +QY E +VHRD+ N+L+ +K+SDFG +R
Sbjct: 122 RALTMGDLISFAW--QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR---- 175
Query: 175 CRSNAADNSLSETFCGS--YAYASPEILQGIPYAPHLSDIWSMGVVLFAMV 223
++S + G + + E L Y SD+WS GV+L+ +V
Sbjct: 176 --DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-15
Identities = 66/282 (23%), Positives = 129/282 (45%), Gaps = 31/282 (10%)
Query: 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
S + + + IG G+Y V + ++ A+KI+ + + + + E ++K L
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALS 72
Query: 81 -HPNLIRFL-----QAIETTHRVYIIMEYAENGSLFDIIRG---QG-YIDEIRARRWFGQ 130
HPN+++F + ++ ++++++E GS+ D+++G +G ++E +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 131 LLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR--AHMRCRSNAADNSLSETF 188
L LQ+ H +HRD+K N+LL ++ +KL DFG + R R N T
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN--------TS 184
Query: 189 CGSYAYASPEIL----QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQN 243
G+ + +PE++ Q D+WS+G+ + G P D + L K +N
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244
Query: 244 KVTFPKQPEV-STECKELISNILSP-VQTRPRLKTIAEDRWL 283
QPE+ S E + I L+ + RP + + + ++
Sbjct: 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-15
Identities = 59/219 (26%), Positives = 110/219 (50%), Gaps = 13/219 (5%)
Query: 30 IGTGSYATVK--LARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
+G+G++ TVK + + + VA+KI+ K LK L RE V++ L +P ++R
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
+ E + ++ME AE G L ++ ++ E Q+ ++Y E VHRD
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY--AYASPEILQGIPY 205
+ N+LL + + K+SDFG ++A A +N G + + +PE + +
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKA-----LGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 206 APHLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQN 243
+ SD+WS GV+++ A +G+ P+ NE+ + +++
Sbjct: 176 SSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-15
Identities = 57/201 (28%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 28 KIIGTGSYATVKLARST---RHSGD-VAIKIVSKVQ-APPDYLKKFLPREIEVVKGLKHP 82
+ +G G++ +V+L R ++G+ VA+K K+Q + ++L+ F REIE++K L+H
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDF-EREIEILKSLQHD 65
Query: 83 NLIRFLQAIETTHR--VYIIMEYAENGSLFD-IIRGQGYIDEIRARRWFGQLLEALQYCH 139
N++++ + R + ++MEY GSL D + + + +D + + Q+ + ++Y
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+ VHRD+ N+L++S+ +K+ DFG + + + E+ YA PE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA---PES 182
Query: 200 LQGIPYAPHLSDIWSMGVVLF 220
L ++ SD+WS GVVL+
Sbjct: 183 LTESKFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 52/186 (27%), Positives = 95/186 (51%), Gaps = 18/186 (9%)
Query: 90 AIETTHRVYIIMEYAENGSL----FDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
A +T + ++M G L +++ E RA + Q++ L++ H+R +++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+K EN+LLD+D N+++SD G A S ++ + G+ + +PE+LQG Y
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLA------VELKDGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 206 APHLSDIWSMGVVLFAMVFGRLPF---DDSSVNELLKQ--VQNKVTFPKQPEVSTECKEL 260
+ D +++GV L+ M+ R PF + N+ LKQ + + VT+P + S K
Sbjct: 175 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK--FSPASKSF 231
Query: 261 ISNILS 266
+L+
Sbjct: 232 CEALLA 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 63/259 (24%), Positives = 115/259 (44%), Gaps = 19/259 (7%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKV--QAPPDYLKKFLPREIEVVKGLKHPNLI 85
K++G+G++ TV V I + K +A K + E V+ + +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRAR---RWFGQLLEALQYCHERG 142
R L I T V +I + G L D +R D I ++ W Q+ + + Y ER
Sbjct: 73 RLL-GICLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR 129
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY--AYASPEIL 200
+VHRD+ N+L+ + ++K++DFG A+ AD G + + E +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLL------GADEKEYHAEGGKVPIKWMALESI 183
Query: 201 QGIPYAPHLSDIWSMGVVLFA-MVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259
Y H SD+WS GV ++ M FG P+D +E+ ++ P+ P + +
Sbjct: 184 LHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 242
Query: 260 LISNI-LSPVQTRPRLKTI 277
++ + +RP+ + +
Sbjct: 243 IMVKCWMIDADSRPKFREL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 65/266 (24%), Positives = 124/266 (46%), Gaps = 27/266 (10%)
Query: 28 KIIGTGSYATVK----LARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
K++G+G++ TV + VAIKI+++ P ++ F+ E ++ + HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMD-EALIMASMDHPH 70
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRAR---RWFGQLLEALQYCHE 140
L+R L + + + ++ + +G L D + + D I ++ W Q+ + + Y E
Sbjct: 71 LVRLL-GVCLSPTIQLVTQLMPHGCLLDYV--HEHKDNIGSQLLLNWCVQIAKGMMYLEE 127
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFAR--AHMRCRSNAADNSLSETFCGSYAYASPE 198
R +VHRD+ N+L+ S ++K++DFG AR NA + +
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA-------- 179
Query: 199 ILQGIPYAP--HLSDIWSMGVVLFA-MVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255
L+ I Y H SD+WS GV ++ M FG P+D E+ ++ P+ P +
Sbjct: 180 -LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTI 238
Query: 256 EC-KELISNILSPVQTRPRLKTIAED 280
+ ++ + +RP+ K +A +
Sbjct: 239 DVYMVMVKCWMIDADSRPKFKELAAE 264
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 65/257 (25%), Positives = 104/257 (40%), Gaps = 57/257 (22%)
Query: 50 VAIKIV-SKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR-VYIIMEYAENG 107
VA+K + P D+L E +++K L+HP LI+ L A+ T +YI+ E + G
Sbjct: 33 VAVKTLKPGTMDPKDFL-----AEAQIMKKLRHPKLIQ-LYAVCTLEEPIYIVTELMKYG 86
Query: 108 SLFDIIRGQGY-------IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN 160
SL + ++G + ++ A Q+ + Y + +HRD+ N+L+ +
Sbjct: 87 SLLEYLQGGAGRALKLPQLIDMAA-----QVASGMAYLEAQNYIHRDLAARNVLVGENNI 141
Query: 161 IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHL------SDIWS 214
K++DFG AR A + A I P A SD+WS
Sbjct: 142 CKVADFGLARVIKEDIYEAREG------------AKFPIKWTAPEAALYNRFSIKSDVWS 189
Query: 215 MGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILSPVQTRPR 273
G++L +V +GR+P+ + E+L+QV P P
Sbjct: 190 FGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP-----------------CPPGCPKE 232
Query: 274 LKTIAEDRWLKPKPKSR 290
L I D W K P R
Sbjct: 233 LYDIMLDCW-KEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 71/293 (24%), Positives = 124/293 (42%), Gaps = 55/293 (18%)
Query: 25 TVGKIIGTGSYATVKLARST-------RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
T+GK +G G + V +A + + + VA+K++ D L E+E++K
Sbjct: 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD--LVSEMEMMK 75
Query: 78 GL-KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG------- 129
+ KH N+I L A +Y+I+EYA G+L + +R ARR G
Sbjct: 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR---------ARRPPGMEYSYDI 126
Query: 130 ------------------QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR- 170
Q+ ++Y + +HRD+ N+L+ + +K++DFG AR
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 171 -AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAM-VFGRLP 228
++ + L + +PE L Y H SD+WS GV+++ + G P
Sbjct: 187 VNNIDYYKKTTNGRL------PVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSP 239
Query: 229 FDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILSPVQT-RPRLKTIAED 280
+ V EL K ++ K + E ++ + + + RP K + ED
Sbjct: 240 YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 37/283 (13%)
Query: 26 VGKIIGTGSYATVKLARSTRHSGD-------VAIKIVSKVQAPPDYLKKFLPREIEVVKG 78
+GK +G G + V +A + + VA+K++ D L E+E++K
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSD--LISEMEMMKM 79
Query: 79 L-KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-----GQGY--------IDEIRA 124
+ KH N+I L A +Y+I+EYA G+L + +R G Y +++
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 125 RRWFG---QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR--AHMRCRSNA 179
+ Q+ ++Y + +HRD+ N+L+ D +K++DFG AR H+
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAM-VFGRLPFDDSSVNELL 238
+ L + +PE L Y H SD+WS GV+L+ + G P+ V EL
Sbjct: 200 TNGRL------PVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
Query: 239 KQVQNKVTFPKQPEVSTECKELISNILSPVQT-RPRLKTIAED 280
K ++ K + E ++ + V + RP K + ED
Sbjct: 253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 29 IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLP----REIEVVKGLKHPNL 84
IG G++ V AR + VA+K V K+ P REI++++ LKH N+
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENE-----KEGFPITALREIKILQLLKHENV 73
Query: 85 IRFLQAIETTHR--------VYIIMEYAEN--GSLFDIIRGQGYIDEIRARRWFGQLLEA 134
+ ++ T Y++ E+ E+ L + + EI+ + LL
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK--KVMKMLLNG 131
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194
L Y H ++HRD+K N+L+ D +KL+DFG ARA N+ N + + Y
Sbjct: 132 LYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSL-SKNSKPNRYTNRVVTLW-Y 189
Query: 195 ASPEILQGI-PYAPHLSDIWSMGVVLFAM 222
PE+L G Y P + D+W G ++ M
Sbjct: 190 RPPELLLGERDYGPPI-DMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 61/250 (24%), Positives = 107/250 (42%), Gaps = 32/250 (12%)
Query: 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
V+ S GYTV K + GS V +A V +KI K ++ L + +
Sbjct: 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNV---- 114
Query: 78 GLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
HP++IR + + +++ + + + + + +A Q+LE L+Y
Sbjct: 115 --NHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H + ++HRD+K EN+ ++ + + D G A+ + A L G+ +P
Sbjct: 173 LHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV-----VAPAFLG--LAGTVETNAP 225
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDD----------SSVNELLKQVQ---- 242
E+L Y +DIWS G+VLF M+ + F+D S + LLK +
Sbjct: 226 EVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV 284
Query: 243 NKVTFPKQPE 252
+ FP+ P
Sbjct: 285 HPEEFPRDPG 294
|
Length = 357 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 59/244 (24%), Positives = 114/244 (46%), Gaps = 19/244 (7%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
+++G G + V A R +G + A K + K + + E ++++ + ++
Sbjct: 6 RVLGKGGFGEV-CACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 87 FLQAIETTHRVYIIMEYAENGSL-FDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVV 144
A ET + +++ G L F I G+ +E RA + ++ L+ H+ +V
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIP 204
+RD+K EN+LLD +I++SD G A + + + G+ Y +PE+++
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVGTVGYMAPEVVKNER 177
Query: 205 YAPHLSDIWSMGVVLFAMVFGRLPFDD-------SSVNELLKQVQNKVTFPKQPEVSTEC 257
Y D W++G +L+ M+ G+ PF V L+K+VQ + + P+ + C
Sbjct: 178 YT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236
Query: 258 KELI 261
K L+
Sbjct: 237 KMLL 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 76/292 (26%), Positives = 125/292 (42%), Gaps = 55/292 (18%)
Query: 25 TVGKIIGTGSYATVKLARS-----TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
T+GK +G G++ V A + + VA+K++ K A L + E+E++K +
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLV-SEMEMMKMI 72
Query: 80 -KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG--------- 129
KH N+I L +Y+++EYA +G+L D +RARR G
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDF---------LRARRPPGEYASPDDPR 123
Query: 130 ----------------QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA-- 171
Q+ +++ + +HRD+ N+L+ D+ +K++DFG AR
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFA-MVFGRLPFD 230
H+ + L + +PE L Y H SD+WS GV+L+ G P+
Sbjct: 184 HIDYYRKTTNGRL------PVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYP 236
Query: 231 DSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL--SPVQTRPRLKTIAED 280
V EL K ++ K + E L+ + P Q RP K + ED
Sbjct: 237 GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQ-RPTFKQLVED 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV-KGLKHPNLIRFL 88
IG+G+ V R + +A+K + + + K+ L +++VV K P +++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRIL-MDLDVVLKSHDCPYIVKCY 80
Query: 89 QAIETTHRVYIIMEYAENGSLFD--IIRGQGYIDEIRARRWFGQLLEALQYCHER-GVVH 145
T V+I ME + D + R QG I E + +++AL Y E+ GV+H
Sbjct: 81 GYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIH 138
Query: 146 RDIKCENLLLDSDYNIKLSDFGFA------RAHMRCRSNAADNSLSETFCGSYAYASPEI 199
RD+K N+LLD+ N+KL DFG + +A R G AY +PE
Sbjct: 139 RDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-------------AGCAAYMAPER 185
Query: 200 LQGIPYAPHL---SDIWSMGVVLFAMVFGRLPFD 230
+ P +D+WS+G+ L + G+ P+
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-14
Identities = 49/190 (25%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
P ++ A T ++ I++ G L + G E R + +++ L++ H R
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
VV+RD+K N+LLD ++++SD G A + + +A+ G++ Y +PE+LQ
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMAPEVLQ 168
Query: 202 -GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEV----STE 256
G+ Y +D +S+G +LF ++ G PF + K +++T E+ S E
Sbjct: 169 KGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVELPDSFSPE 225
Query: 257 CKELISNILS 266
+ L+ +L
Sbjct: 226 LRSLLEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 57/247 (23%), Positives = 97/247 (39%), Gaps = 38/247 (15%)
Query: 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKF-----------LPREIE 74
G +G G+Y V+ A T VAIK V ++ D K RE++
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 75 VVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEA 134
++ +KH N++ + + ++M+ L ++ + + E + + Q+L
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH-----MRCRSNAADNSLSETFC 189
L H+ +HRD+ N+ ++S K++DFG AR + S E
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 190 GSYA---YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT 246
Y +PE+L G D+WS+G + FA ELL K
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCI-FA--------------ELLTG---KPL 233
Query: 247 FPKQPEV 253
FP + E+
Sbjct: 234 FPGENEI 240
|
Length = 335 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 19/226 (8%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
K +G G + V + + + VA+K + P+ FL E +++K L+H L++
Sbjct: 12 KKLGNGQFGEVWMG-TWNGNTKVAVKTLKPGTMSPE---SFL-EEAQIMKKLRHDKLVQ- 65
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIR-GQG-YIDEIRARRWFGQLLEALQYCHERGVVH 145
L A+ + +YI+ EY GSL D ++ G+G + Q+ + Y +H
Sbjct: 66 LYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH 125
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY--AYASPEILQGI 203
RD++ N+L+ K++DFG AR DN + + + +PE
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARL-------IEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 204 PYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFP 248
+ SD+WS G++L +V GR+P+ + E+L+QV+ P
Sbjct: 179 RFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 59/235 (25%), Positives = 109/235 (46%), Gaps = 13/235 (5%)
Query: 19 LESHGYTVGKIIGTGSYATV---KLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV 75
L++ + +I+GTG + + L ++ VAI + + + FL E
Sbjct: 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLA-EALT 59
Query: 76 VKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEA 134
+ H N++R I + + I+ EY NG+L +R +G + + L
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194
++Y E G VH+ + +L++SD K+S GF R +S A ++S +
Sbjct: 120 MKYLSEMGYVHKGLAAHKVLVNSDLVCKIS--GFRRLQ-EDKSEAIYTTMSGK--SPVLW 174
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQNKVTFP 248
A+PE +Q ++ SD+WS G+V++ M +G P+ D S +++K V++ P
Sbjct: 175 AAPEAIQYHHFSS-ASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 21/220 (9%)
Query: 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
+GK V LA+ + VA+K ++ + LK L +EI + L+HP
Sbjct: 3 LTLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQLQHP 59
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYID---EIRARRWFGQLLEALQYCH 139
N++ ++ + +Y++ GS D+++ + + E+ +L AL Y H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIH 118
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA----DNSLSETFCGSYAYA 195
+G +HR +K ++LL D + LS ++ M D S + +
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSV-SMIKHGKRQRVVHDFPKSSVK--NLPWL 175
Query: 196 SPEILQ----GIPYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
SPE+LQ G Y SDI+S+G+ + G +PF D
Sbjct: 176 SPEVLQQNLQG--YNEK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 131 LLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCG 190
+L A+QY HE ++HRDIK EN+ ++ ++ L DFG A C + + + G
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA-----CFPVDINANKYYGWAG 245
Query: 191 SYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGR 226
+ A +PE+L PY P + DIWS G+VLF M
Sbjct: 246 TIATNAPELLARDPYGPAV-DIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 31/241 (12%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFL 88
IG G+Y V + + A+KI+ P + + + E +++ L HPN+++F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILD----PISDVDEEIEAEYNILQSLPNHPNVVKFY 85
Query: 89 QAIETTHR-----VYIIMEYAENGSLFDII-----RGQGYIDEIRARRWFGQLLEALQYC 138
+ +++++E GS+ +++ GQ + + + +G LL LQ+
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL-GLQHL 144
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFAR--AHMRCRSNAADNSLSETFCGSYAYAS 196
H ++HRD+K N+LL ++ +KL DFG + R R N T G+ + +
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN--------TSVGTPFWMA 196
Query: 197 PEIL---QGIPYA-PHLSDIWSMGVVLFAMVFGRLP-FDDSSVNELLKQVQNKVTFPKQP 251
PE++ Q Y+ D+WS+G+ + G P FD V L K +N P
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP 256
Query: 252 E 252
E
Sbjct: 257 E 257
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-13
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-PNLIR 86
+++G G+Y V R + AIK++ + +K+ EI ++K H N+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ----EINMLKKYSHHRNIAT 67
Query: 87 FLQAIETTH------RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG----QLLEALQ 136
+ A + +++++ME+ GS+ D+I+ W ++L L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLS 125
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC--RSNAADNSLSETFCGSYAY 194
+ H+ V+HRDIK +N+LL + +KL DFG + R R N TF G+ +
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--------TFIGTPYW 177
Query: 195 ASPEIL--QGIPYAPH--LSDIWSMGVVLFAMVFGRLPFDD 231
+PE++ P A + SD+WS+G+ M G P D
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 37/242 (15%)
Query: 10 DDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFL 69
DDID + + + +++G G+Y V R + AIK++ + + +K
Sbjct: 4 DDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL-- 61
Query: 70 PREIEVVKGLKHPNLIR-----FLQAIETTH--RVYIIMEYAENGSLFDIIR---GQGYI 119
EI ++K H I F++ H +++++ME+ GS+ D+++ G
Sbjct: 62 --EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 120 DEIRARRWFG----QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175
++ W ++L L + H V+HRDIK +N+LL + +KL DFG + R
Sbjct: 120 ED-----WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174
Query: 176 --RSNAADNSLSETFCGSYAYASPEIL--QGIPYAP--HLSDIWSMGVVLFAMVFGRLPF 229
R N TF G+ + +PE++ P A + SDIWS+G+ M G P
Sbjct: 175 VGRRN--------TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
Query: 230 DD 231
D
Sbjct: 227 CD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 55/293 (18%)
Query: 25 TVGKIIGTGSYATVKLARS-------TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
T+GK +G G + V +A + VA+K++ D L E+E++K
Sbjct: 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD--LVSEMEMMK 72
Query: 78 GL-KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG------- 129
+ KH N+I L A +Y+++EYA G+L + +R ARR G
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLR---------ARRPPGMDYSFDT 123
Query: 130 ------------------QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR- 170
Q+ ++Y + +HRD+ N+L+ D +K++DFG AR
Sbjct: 124 CKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 171 -AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAM-VFGRLP 228
++ + L + +PE L Y H SD+WS GV+L+ + G P
Sbjct: 184 VHNIDYYKKTTNGRL------PVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSP 236
Query: 229 FDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILSPVQT-RPRLKTIAED 280
+ V EL K ++ K + E ++ V + RP K + ED
Sbjct: 237 YPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-13
Identities = 58/264 (21%), Positives = 119/264 (45%), Gaps = 28/264 (10%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
+++G G++ V + + VA+K K P + KFL E ++K HPN+++
Sbjct: 1 ELLGKGNFGEV-FKGTLKDKTPVAVK-TCKEDLPQELKIKFL-SEARILKQYDHPNIVKL 57
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEA---LQYCHERGVV 144
+ +YI+ME G +R + DE++ ++ L+A + Y + +
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIP 204
HRD+ N L+ + +K+SDFG +R + + S S + +PE L
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGR 170
Query: 205 YAPHLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQN--KVTFPKQPEVSTECKELI 261
Y+ SD+WS G++L+ G P+ + + +QV+ +++ P++ C + +
Sbjct: 171 YSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQK------CPDDV 223
Query: 262 SNILSPV-----QTRPRLKTIAED 280
++ + RP+ + ++
Sbjct: 224 YKVMQRCWDYKPENRPKFSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 53 KIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDI 112
K+ K P + + +E +++K L+H L+ L A+ + +YI+ E+ GSL D
Sbjct: 32 KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP-LYAVVSEEPIYIVTEFMGKGSLLDF 90
Query: 113 IR-GQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170
++ G G Y+ + Q+ + + Y +HRD++ N+L+ + K++DFG AR
Sbjct: 91 LKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR 150
Query: 171 AHMRCRSNAADNSLSETFCGSY--AYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRL 227
DN + + + +PE + SD+WS G++L +V GR+
Sbjct: 151 L-------IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRV 202
Query: 228 PFDDSSVNELLKQVQNKVTFP 248
P+ E+L+QV+ P
Sbjct: 203 PYPGMVNREVLEQVERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 72/292 (24%), Positives = 118/292 (40%), Gaps = 55/292 (18%)
Query: 25 TVGKIIGTGSYATVKLARS-------TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
+GK +G G + V A + + VA+K++ D L E+E++K
Sbjct: 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD--LISEMELMK 72
Query: 78 GL-KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG------- 129
+ KH N+I L +Y+I+EYA G+L + +R ARR G
Sbjct: 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLR---------ARRPPGPDYTFDI 123
Query: 130 ------------------QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171
Q+ ++Y R +HRD+ N+L+ D +K++DFG AR
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 172 --HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAM-VFGRLP 228
+ ++ L + +PE L Y H SD+WS G++++ + G P
Sbjct: 184 VHDIDYYKKTSNGRL------PVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSP 236
Query: 229 FDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILSPVQT-RPRLKTIAE 279
+ V EL K ++ K + E L+ V T RP K + E
Sbjct: 237 YPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 50/189 (26%), Positives = 91/189 (48%), Gaps = 16/189 (8%)
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
P ++ A T ++ I++ G L + G E R + +++ L++ H R
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
VV+RD+K N+LLD ++++SD G A + + +A+ G++ Y +PE+LQ
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMAPEVLQ 168
Query: 202 -GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEV----STE 256
G Y +D +S+G +LF ++ G PF + K +++T E+ S E
Sbjct: 169 KGTAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTVNVELPDSFSPE 225
Query: 257 CKELISNIL 265
K L+ +L
Sbjct: 226 LKSLLEGLL 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 9e-13
Identities = 39/101 (38%), Positives = 57/101 (56%), Gaps = 6/101 (5%)
Query: 123 RARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182
+ R QLL A++Y H++ ++HRDIK EN+ L+ D I L DFG A + R
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE----- 322
Query: 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV 223
+ + G+ A SPEIL G Y ++DIWS G++L M+
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 60/258 (23%), Positives = 111/258 (43%), Gaps = 40/258 (15%)
Query: 29 IIGTGSYATVKLARSTRH--SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLI 85
+IG G++ V AR + D AIK + + + D+ + E+EV+ L HPN+I
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNII 59
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRG-------------QGYIDEIRAR---RWFG 129
L A E +Y+ +EYA +G+L D +R + ++ +
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
+ + Y ++ +HRD+ N+L+ +Y K++DFG +R E +
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------------EVYV 166
Query: 190 GSYAYASP---EILQGIPYAPHL--SDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
P ++ + Y+ + SD+WS GV+L+ +V G P+ + EL +++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226
Query: 244 KVTFPKQPEVSTECKELI 261
K E +L+
Sbjct: 227 GYRLEKPLNCDDEVYDLM 244
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 43/236 (18%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYL-KKFLPREIEVV-KGLKHPNLIRF 87
IG G++ TV H I V ++++ D +K L +++VV + P +++F
Sbjct: 12 IGRGAFGTV---NKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 88 LQAIETTHRVYIIMEYAENGSLFDI----------IRGQGYIDEIRARRWFGQL----LE 133
A+ +I ME L DI + I E G++ ++
Sbjct: 69 YGALFREGDCWICME------LMDISLDKFYKYVYEVLKSVIPE----EILGKIAVATVK 118
Query: 134 ALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETF-CGS 191
AL Y E ++HRD+K N+LLD + NIKL DFG S +S+++T G
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI--------SGQLVDSIAKTRDAGC 170
Query: 192 YAYASPEILQGIPYAPH--LSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV 245
Y +PE + + SD+WS+G+ L+ + G+ P+ N + Q+ V
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP--KWNSVFDQLTQVV 224
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 63/246 (25%), Positives = 101/246 (41%), Gaps = 50/246 (20%)
Query: 28 KIIGTGSYATVKLARSTRHSGD------VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
+G+G++ V +T G VA+K + K A K+FL +E ++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFL-KEAHLMSNFNH 58
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL---EALQYC 138
PN+++ L YIIME E G L +R R R+ LL E L C
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDA------RVERFGPPLLTLKELLDIC 112
Query: 139 ----------HERGVVHRDIKCENLLL-----DSDYNIKLSDFGFAR-----AHMRCRSN 178
+ +HRD+ N L+ D+D +K+ DFG AR + R
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172
Query: 179 AADNSLSETFCGSYAYASPE-ILQGIPYAPHLSDIWSMGVVLFA-MVFGRLPFDDSSVNE 236
+ +PE +L G + SD+WS GV+++ + G+ P+ + E
Sbjct: 173 GLLP---------VRWMAPESLLDGK-FTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQE 221
Query: 237 LLKQVQ 242
+L+ V
Sbjct: 222 VLQHVT 227
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 28 KIIGTGSYATVKLARSTRHSGD----VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+++G G + V L + VA+K + + +EI ++K L H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ--NTSGWKKEINILKTLYHEN 67
Query: 84 LIRFLQAIETT--HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
++++ + +IMEY GSL D + + ++ + + Q+ E + Y H +
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-KHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARA------HMRCRSNAADNSLSETFCGSYAYA 195
+HRD+ N+LLD+D +K+ DFG A+A + R R + D+ + + YA
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED-GDSPV-------FWYA 178
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMV 223
E L+ ++ + SD+WS GV L+ ++
Sbjct: 179 -VECLKENKFS-YASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-12
Identities = 58/243 (23%), Positives = 116/243 (47%), Gaps = 21/243 (8%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKF--LPREIEVVKGLKHPNLIRF 87
+G G + V+L R + ++ K P L +EIE+++ L H N++++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 88 --LQAIETTHRVYIIMEYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCHERGVV 144
+ + + + +IME+ +GSL + + R + I+ + ++ Q+ + + Y R V
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYV 131
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE-ILQGI 203
HRD+ N+L++S++ +K+ DFG +A ++ ++ + + +PE ++Q
Sbjct: 132 HRDLAARNVLVESEHQVKIGDFGLTKA---IETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSS---VNELLKQV---QNKVTFPKQPEVSTEC 257
Y SD+WS GV L+ + L + DS + LK + ++T + V E
Sbjct: 189 FYIA--SDVWSFGVTLYEL----LTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242
Query: 258 KEL 260
K L
Sbjct: 243 KRL 245
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 67/303 (22%), Positives = 128/303 (42%), Gaps = 38/303 (12%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + ++IG G V LA S VA+K + + + LKK RE ++ L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRAR-----------RWFGQLL 132
++ VY M Y E +L +++ + + F ++
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 133 EALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET----- 187
++Y H +GV+HRD+K +N+LL + + D+G A + D + E
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 188 -------FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ 240
G+ Y +PE L G+P A +DI+++GV+L+ M+ P+ + ++
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYR----RKKGRK 238
Query: 241 VQNKVTFPKQPEVSTECKELISNILSPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELD 300
+ + EV+ +E + P ++ +K +A D P + V + + +L+
Sbjct: 239 ISYRDVILSPIEVAPY-RE-----IPPFLSQIAMKALAVD----PAERYSSVQELKQDLE 288
Query: 301 HYI 303
++
Sbjct: 289 PHL 291
|
Length = 932 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 61/258 (23%), Positives = 112/258 (43%), Gaps = 40/258 (15%)
Query: 29 IIGTGSYATV--KLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLI 85
+IG G++ V + + + AIK++ + + D+ + E+EV+ L HPN+I
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH--RDFAGELEVLCKLGHHPNII 66
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRG-------------QGYIDEIRAR---RWFG 129
L A E +YI +EYA G+L D +R G + ++ ++
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
+ +QY E+ +HRD+ N+L+ + K++DFG +R E +
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGE-------------EVYV 173
Query: 190 GSYAYASP---EILQGIPYAPHL--SDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
P ++ + Y+ + SD+WS GV+L+ +V G P+ + EL +++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233
Query: 244 KVTFPKQPEVSTECKELI 261
K E EL+
Sbjct: 234 GYRMEKPRNCDDEVYELM 251
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 46/199 (23%), Positives = 89/199 (44%), Gaps = 17/199 (8%)
Query: 72 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL-FDIIR-GQGYIDEIRARRWFG 129
E ++++ + ++ A ET + +++ G L F I G DE RA +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
++ L+ H +V+RD+K EN+LLD +I++SD G A + +
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIP------EGETIRGRV 162
Query: 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-------SSVNELLKQVQ 242
G+ Y +PE+++ Y D W +G +++ M+ G+ PF V +K+ Q
Sbjct: 163 GTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ 221
Query: 243 NKVTFPKQPEVSTECKELI 261
+ + + C++L+
Sbjct: 222 EEYSEKFSEAARSICRQLL 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 64/265 (24%), Positives = 105/265 (39%), Gaps = 63/265 (23%)
Query: 50 VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL 109
VAIK + K A P ++F +E E++ L+HPN++ L ++ EY +G L
Sbjct: 38 VAIKTL-KENAEPKVQQEFR-QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL 95
Query: 110 FDIIRGQGYIDEIRARRWFG----------------QLLEALQYCHERGVVHRDIKCENL 153
+ + ++ A Q+ ++Y VHRD+ N
Sbjct: 96 HEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC 155
Query: 154 LLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY-----------AYASPE-ILQ 201
L+ +K+SDFG +R + + Y + PE IL
Sbjct: 156 LVGEGLTVKISDFGLSR---------------DIYSADYYRVQSKSLLPVRWMPPEAILY 200
Query: 202 GIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPE-------- 252
G + SDIWS GVVL+ + +G P+ S E+++ ++++ P PE
Sbjct: 201 G-KFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP-CPEDCPARVYA 257
Query: 253 VSTECKELISNILSPVQTRPRLKTI 277
+ EC N + RPR K I
Sbjct: 258 LMIEC----WNEIPA--RRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 58/252 (23%), Positives = 109/252 (43%), Gaps = 14/252 (5%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
+++G G + V A R +G + A K + K + + E ++++ + ++
Sbjct: 6 RVLGKGGFGEV-CACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 87 FLQAIETTHRVYIIMEYAENGSL-FDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVV 144
A ET + +++ G L F I G +E RA + ++L L+ H V
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIP 204
+RD+K EN+LLD +I++SD G A + G+ Y +PE+L
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLA-------VKIPEGESIRGRVGTVGYMAPEVLNNQR 177
Query: 205 YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVS--TECKELIS 262
Y D W +G +++ M+ G+ PF ++V +V ++ + +E + I
Sbjct: 178 YTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236
Query: 263 NILSPVQTRPRL 274
+L + RL
Sbjct: 237 KMLLTKDPKQRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 46/176 (26%), Positives = 83/176 (47%), Gaps = 19/176 (10%)
Query: 131 LLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETF- 188
+++AL+Y H + V+HRD+K N+L++ + +KL DFG S +S+++T
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI--------SGYLVDSVAKTID 163
Query: 189 CGSYAYASPEILQGIPYAPHL---SDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNK 244
G Y +PE + SD+WS+G+ + + GR P+D + + LKQV +
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-E 222
Query: 245 VTFPKQPE--VSTECKELISNILSPVQT-RPRLKTIAEDRWLKPKPKSRGVDKAEA 297
P+ P S E ++ ++ L RP + + + + S+ D A
Sbjct: 223 EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH-LSKNTDVASF 277
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 66/263 (25%), Positives = 115/263 (43%), Gaps = 21/263 (7%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKV---QAPPDYLKKFLPREIEVVKGLKHPNL 84
K++G+G++ TV +V I + KV P K+ L E V+ G+ P +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAGVGSPYV 71
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGV 143
R L I T V ++ + G L D +R + I W Q+ + + Y E +
Sbjct: 72 CRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFAR-AHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
VHRD+ N+L+ S ++K++DFG AR + AD G L+
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD--------GGKVPIKWMALES 182
Query: 203 IPYA--PHLSDIWSMGVVLFA-MVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259
I + H SD+WS GV ++ M FG P+D E+ ++ P+ P + +
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYM 242
Query: 260 LISN--ILSPVQTRPRLKTIAED 280
++ ++ + RPR + + ++
Sbjct: 243 IMVKCWMIDS-ECRPRFRELVDE 264
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 58/245 (23%), Positives = 115/245 (46%), Gaps = 23/245 (9%)
Query: 30 IGTGSYATVK--LARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
+G+G++ VK + + + DVAIK++ K + + + RE E++ L +P ++R
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMM-REAEIMHQLDNPYIVRM 60
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRAR---RWFGQLLEALQYCHERGVV 144
+ E + ++ME A G L + G+ DEI Q+ ++Y + V
Sbjct: 61 IGVCEA-EALMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY--AYASPEILQG 202
HRD+ N+LL + + K+SDFG ++A A D+ G + + +PE +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKA-----LGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 203 IPYAPHLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261
++ SD+WS G+ ++ A +G+ P+ E++ ++ K+ + EC +
Sbjct: 173 RKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG----KRLDCPAECPPEM 227
Query: 262 SNILS 266
++
Sbjct: 228 YALMK 232
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 45/254 (17%)
Query: 71 REIEVVKGLKHPNLIRFLQAIETTH---RVYIIMEYAENGSLFDIIR-------GQGYID 120
REI +++ LKHPN+I LQ + +H +V+++ +YAE+ L+ II+ + +
Sbjct: 47 REIALLRELKHPNVIS-LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQ 104
Query: 121 EIRA--RRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD----YNIKLSDFGFARAHMR 174
R + Q+L+ + Y H V+HRD+K N+L+ + +K++D GFAR
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF----- 229
AD + ++ Y +PE+L G + DIW++G + FA + P
Sbjct: 165 PLKPLAD---LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI-FAELLTSEPIFHCRQ 220
Query: 230 -DDSSVN----ELLKQVQNKVTFP---------KQPEVSTECKELISNILSPVQTRPRLK 275
D + N + L ++ N + FP K PE ST K+ N T L
Sbjct: 221 EDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRN----TYTNCSLI 276
Query: 276 TIAEDRWLKPKPKS 289
E +KP K+
Sbjct: 277 KYMEKHKVKPDSKA 290
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 61/261 (23%), Positives = 103/261 (39%), Gaps = 46/261 (17%)
Query: 46 HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAE 105
H+ VAIK + + P + + +E ++ L HPN++ L + V ++ EY
Sbjct: 33 HAQLVAIKTLKDINNPQQWGE--FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90
Query: 106 NGSL--FDIIRG---------------QGYIDEIRARRWFGQLLEALQYCHERGVVHRDI 148
G L F I+R + +D Q+ ++Y VH+D+
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDL 150
Query: 149 KCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP- 207
N+L+ ++K+SD G +R E + Y P+ L I + P
Sbjct: 151 AARNILIGEQLHVKISDLGLSR---------------EIYSADYYRVQPKSLLPIRWMPP 195
Query: 208 ---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257
SDIWS GVVL+ + FG P+ S E+++ V+ + P +
Sbjct: 196 EAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRM 255
Query: 258 KELISNILSPVQT-RPRLKTI 277
L++ + RPR K I
Sbjct: 256 YSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 62/259 (23%), Positives = 112/259 (43%), Gaps = 42/259 (16%)
Query: 29 IIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNL 84
+IG G++ V AR + G D AIK + + + D+ + E+EV+ L HPN+
Sbjct: 14 VIGEGNFGQVLKAR-IKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNI 70
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRA----------------RRWF 128
I L A E +Y+ +EYA +G+L D +R ++ A +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 129 GQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETF 188
+ + Y ++ +HRD+ N+L+ +Y K++DFG +R E +
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------------EVY 177
Query: 189 CGSYAYASP---EILQGIPYAPHL--SDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQ 242
P ++ + Y+ + SD+WS GV+L+ +V G P+ + EL +++
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237
Query: 243 NKVTFPKQPEVSTECKELI 261
K E +L+
Sbjct: 238 QGYRLEKPLNCDDEVYDLM 256
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 43/275 (15%)
Query: 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKF--LPREIEVVKGLKHPNL 84
K++G+G + TV + I + K + F + + + L H +
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGV 143
+R L I + ++ + + GSL D +R + +D R W Q+ + + Y E +
Sbjct: 72 VRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFAR---------AHMRCRSNAADNSLSETFCGSYAY 194
VHR++ N+LL SD ++++DFG A + ++ +L G Y
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT- 189
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEV 253
H SD+WS GV ++ M+ +G P+ +E+ ++ QP++
Sbjct: 190 -------------HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA-QPQI 235
Query: 254 ST--------ECKELISNILSPVQTRPRLKTIAED 280
T +C + N+ RP K +A +
Sbjct: 236 CTIDVYMVMVKCWMIDENV------RPTFKELANE 264
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 71 REIEVVKGLKHPNLIRFLQAIETTH---RVYIIMEYAENGSLFDIIRGQG---------Y 118
REI +++ LKHPN+I LQ + +H +V+++ +YAE+ L+ II+
Sbjct: 47 REIALLRELKHPNVIA-LQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQ 104
Query: 119 IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD----YNIKLSDFGFARAHMR 174
+ + Q+L+ + Y H V+HRD+K N+L+ + +K++D GFAR
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVL 219
AD + ++ Y +PE+L G + DIW++G +
Sbjct: 165 PLKPLAD---LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 8e-11
Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 17/222 (7%)
Query: 30 IGTG--SYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
IG G + +V LAR T V ++I ++LK L E+ + +HPN++
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKA-LQNEVVLSHFFRHPNIMTS 64
Query: 88 LQAIETTHRVYII---MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVV 144
T +++I M Y SL +G + + FG L L Y H+ G +
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGAL-RGLNYLHQNGYI 123
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS----ETFCGSY-AYASPEI 199
HR+IK ++L+ D + LS +H+ + F S + SPE+
Sbjct: 124 HRNIKASHILISGDGLVSLSGL----SHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 200 LQGIPYAPHL-SDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ 240
L+ Y ++ SDI+S+G+ + GR+PF D ++L Q
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 61/247 (24%), Positives = 95/247 (38%), Gaps = 56/247 (22%)
Query: 30 IGTGSYATVKLA--RSTRHSGD---VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+G G++ V L D VA+K + K A D K F RE E++ +H N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFE-REAELLTNFQHENI 70
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG-------YIDEIRARRWFGQLLE---- 133
++F ++ EY E+G L +R G D QLL+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 134 ---ALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCG 190
+ Y + VHRD+ N L+ D +K+ DFG +R + +
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---------------DVYTT 175
Query: 191 SY-----------AYASPEILQGIPYAPHL--SDIWSMGVVLFAM-VFGRLPF---DDSS 233
Y + PE I Y SD+WS GVVL+ + +G+ P+ +
Sbjct: 176 DYYRVGGHTMLPIRWMPPE---SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
Query: 234 VNELLKQ 240
V E + Q
Sbjct: 233 VIECITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 41/205 (20%)
Query: 49 DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQA-IETTHRVYIIMEYAENG 107
+V +K V K A + L +E ++ GL H N++ L IE +++ Y G
Sbjct: 37 EVFVKTV-KDHASEIQVTLLL-QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWG 94
Query: 108 SLFDIIRGQGYIDE-----IRARRW--FG-QLLEALQYCHERGVVHRDIKCENLLLDSDY 159
+L ++ + + ++ Q+ + Y H+RGV+H+DI N ++D +
Sbjct: 95 NLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL 154
Query: 160 NIKLSDFGFARAHMRCRSNAADNSLS-ETFCGSY-----------AYASPEILQGIPYAP 207
+K+ DN+LS + F Y + + E L Y+
Sbjct: 155 QVKI----------------TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS- 197
Query: 208 HLSDIWSMGVVLFAMV-FGRLPFDD 231
SD+WS GV+L+ ++ G+ P+ +
Sbjct: 198 SASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 56/283 (19%), Positives = 112/283 (39%), Gaps = 44/283 (15%)
Query: 19 LESHGYTVGKIIGTGSYATVKLARSTR--HSGDVAIKIVSKVQAPPDYLKKFLPREIEVV 76
++ H + + +G G++ V LA D + V ++ D +K RE E++
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG-------------YIDEIR 123
L+H ++++F + ++ EY ++G L +R G + + +
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 124 ARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNS 183
Q+ + Y + VHRD+ N L+ + +K+ DFG +R
Sbjct: 122 MLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR------------- 168
Query: 184 LSETFCGSYAYASPEILQGIPYAP----------HLSDIWSMGVVLFAM-VFGRLPFDDS 232
+ + Y + I + P SD+WS+GVVL+ + +G+ P+
Sbjct: 169 --DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
Query: 233 SVNELLKQVQNKVTFPKQPEVSTECKELISNILSPVQTRPRLK 275
S NE+++ + + E +L +L Q P ++
Sbjct: 227 SNNEVIECITQGRVLQRPRTCPKEVYDL---MLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 39/135 (28%), Positives = 64/135 (47%), Gaps = 19/135 (14%)
Query: 50 VAIKIV---SKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAEN 106
VA+K++ + A D+LK EI+++ LK PN+IR L T+ + +I EY EN
Sbjct: 49 VAVKMLREDANKNARNDFLK-----EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103
Query: 107 GSLFDII-----RGQGYIDEIRA------RRWFGQLLEALQYCHERGVVHRDIKCENLLL 155
G L + + ++ Q+ ++Y VHRD+ N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
Query: 156 DSDYNIKLSDFGFAR 170
+Y IK++DFG +R
Sbjct: 164 GKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 38/148 (25%), Positives = 78/148 (52%), Gaps = 7/148 (4%)
Query: 28 KIIGTGSYATV---KLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
++IG G + V L S A+K ++++ + +++FL +E ++K HPN+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFL-KEGIIMKDFSHPNV 58
Query: 85 IRFLQ-AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG-QLLEALQYCHERG 142
+ L + + +++ Y ++G L + IR + + ++ FG Q+ + ++Y +
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFAR 170
VHRD+ N +LD + +K++DFG AR
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 36/124 (29%), Positives = 57/124 (45%), Gaps = 25/124 (20%)
Query: 63 DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEI 122
D+LK EI+++ LK+PN+IR L + + +I EY ENG L + + EI
Sbjct: 63 DFLK-----EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQR----EI 113
Query: 123 RAR----------------RWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDF 166
+ Q+ ++Y VHRD+ N L+ + Y IK++DF
Sbjct: 114 ESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF 173
Query: 167 GFAR 170
G +R
Sbjct: 174 GMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 33/235 (14%)
Query: 27 GKIIGTGSYATVKLARSTRHS---GDVAIKIVSKVQAPPDYL--KKFLPREIEVVKGL-K 80
GK +G G++ K+ +T + D +K+ K+ P + ++ L E++++ L
Sbjct: 40 GKTLGAGAFG--KVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWF----------GQ 130
H N++ L A + +I EY G L + +R R R F Q
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR--------RKRESFLTLEDLLSFSYQ 149
Query: 131 LLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCG 190
+ + + + + +HRD+ N+LL +K+ DFG AR M SN
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN-DSNYV--VKGNARLP 206
Query: 191 SYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELL-KQVQN 243
A I + Y SD+WS G++L+ + G P+ V+ K ++
Sbjct: 207 VKWMAPESIFNCV-YTF-ESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 13/219 (5%)
Query: 29 IIGTG--SYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
+IG G TV LAR V ++ ++ ++A + + FL E+ V K HPN++
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHPNIVP 63
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDII--RGQGYIDEIRARRWFGQLLEALQYCHERGVV 144
+ + ++++ + GS D+I + E+ +L+AL Y H G V
Sbjct: 64 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYV 123
Query: 145 HRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA----YASPEIL 200
HR +K ++L+ D + LS R+++ ++ + F + SPE+L
Sbjct: 124 HRSVKASHILISVDGKVYLSGL---RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVL 180
Query: 201 Q-GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL 238
Q + SDI+S+G+ + G +PF D ++L
Sbjct: 181 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 17/134 (12%)
Query: 50 VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL 109
VA+K++ + A + + FL +E++++ L PN+ R L + +IMEY ENG L
Sbjct: 49 VAVKVL-RPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 110 FDIIRGQGYIDEIRARRW------FGQLL-------EALQYCHERGVVHRDIKCENLLLD 156
+ Q ++ E F LL ++Y VHRD+ N L+
Sbjct: 107 NQFL--QKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164
Query: 157 SDYNIKLSDFGFAR 170
+Y IK++DFG +R
Sbjct: 165 KNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 10/142 (7%)
Query: 90 AIETTHRVYIIMEYAENGSL-FDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147
A ET + +++ G L F I G DE RA + +L L+ +V+RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127
Query: 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP 207
+K EN+LLD +I++SD G A + G+ Y +PE++ Y
Sbjct: 128 LKPENILLDDRGHIRISDLGLA-------VQIPEGETVRGRVGTVGYMAPEVINNEKYT- 179
Query: 208 HLSDIWSMGVVLFAMVFGRLPF 229
D W +G +++ M+ G+ PF
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 55/228 (24%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSK---VQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
IG G + V L + H G ++V K A PD FL +E++ + L HPN+++
Sbjct: 3 IGNGWFGKVLLGEA--HRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQ 59
Query: 87 FL-QAIETTHRVYIIMEYAENGSLFDIIRGQ-----GYIDEIRARRWFGQLLEALQYCHE 140
L Q IE+ + +++E+ G L + +R + +R ++ L + H+
Sbjct: 60 CLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
+H D+ N L +D ++K+ D+G A + + + +PE++
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGL--ALEQYPEDYYITKDCHAV--PLRWLAPELV 174
Query: 201 ----QGIPYAPHL--SDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQV 241
Q + S+IWS+GV ++ + P+ D S ++LKQV
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 52/291 (17%), Positives = 116/291 (39%), Gaps = 59/291 (20%)
Query: 25 TVGKIIGTGSYATV---KLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
+GKI+G G + +V +L++ VA+K + +++FL E +K H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDH 60
Query: 82 PNLIRFL------QAIETTHRVYIIMEYAENGSLFDII------RGQGYIDEIRARRWFG 129
PN+++ + +++ + +I+ + ++G L + + ++
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
+ ++Y R +HRD+ N +L D + ++DFG ++ + +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK---------------KIYS 165
Query: 190 GSY-----------AYASPEILQGIPYAPHLSDIWSMGVVLFA-MVFGRLPF---DDSSV 234
G Y + + E L Y SD+W+ GV ++ G+ P+ ++ +
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEI 224
Query: 235 NELLKQVQNKVTFPKQPEVSTECKELISNILS-----PVQTRPRLKTIAED 280
+ L+ KQPE +C + + +++ + RP + E
Sbjct: 225 YDYLRHGNRL----KQPE---DCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 63/245 (25%), Positives = 101/245 (41%), Gaps = 41/245 (16%)
Query: 30 IGTGSYATVKLAR-----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
IG G++ V AR VA+K++ K +A D F RE ++ HPN+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQ-REAALMAEFDHPNI 70
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRG-------QGYIDEIRARRWFG-------- 129
++ L + ++ EY G L + +R AR+
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 130 -QLLEALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182
QL A Q Y ER VHRD+ N L+ + +K++DFG +R +AD
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYSADY 185
Query: 183 -SLSETFCGSYAYASPEILQGIPYAPHL--SDIWSMGVVLFAMV-FGRLPFDDSSVNELL 238
SE + PE I Y + SD+W+ GVVL+ + +G P+ + E++
Sbjct: 186 YKASENDAIPIRWMPPE---SIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242
Query: 239 KQVQN 243
V++
Sbjct: 243 YYVRD 247
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 59/249 (23%), Positives = 106/249 (42%), Gaps = 45/249 (18%)
Query: 50 VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL 109
VA+K V++ + + ++ FL E V+KG +++R L + ++ME +G L
Sbjct: 39 VAVKTVNESASLRERIE-FL-NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 96
Query: 110 FDIIRGQGYIDEIRARRWFGQLLEALQ----------YCHERGVVHRDIKCENLLLDSDY 159
+R E R L E +Q Y + + VHRD+ N ++ D+
Sbjct: 97 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 156
Query: 160 NIKLSDFGFARAHMRCRSNAADNSLSETFCGSY-----------AYASPEILQGIPYAPH 208
+K+ DFG R + ET Y + +PE L+ +
Sbjct: 157 TVKIGDFGMTR------------DIYET---DYYRKGGKGLLPVRWMAPESLKDGVFTTS 201
Query: 209 LSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILSP 267
SD+WS GVVL+ + P+ S ++LK V + + QP+ C E +++++
Sbjct: 202 -SDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GYLDQPD---NCPERVTDLMRM 256
Query: 268 V-QTRPRLK 275
Q P+++
Sbjct: 257 CWQFNPKMR 265
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-08
Identities = 61/244 (25%), Positives = 104/244 (42%), Gaps = 31/244 (12%)
Query: 28 KIIGTGSYATVKLARS--TRHSGDVAIKIVSKVQAPPD-YLKKFLPREIEVVKGLKHPNL 84
+G G + V LA++ G + +V +Q D L+ RE+++ + L H N+
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGV 143
+R L Y+I+EY + G L +R + ++++ + AL G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 144 --------VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
VHRD+ N L+ S +K+S ++ D SE + A
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK----------DVYNSEYYKLRNALI 180
Query: 196 -----SPEILQGIPYAPHLSDIWSMGVVLFAMVF--GRLPFDDSSVNELLKQVQNKVTFP 248
+PE +Q ++ SD+WS GV+++ VF G LPF S E+L ++Q
Sbjct: 181 PLRWLAPEAVQEDDFSTK-SDVWSFGVLMWE-VFTQGELPFYGLSDEEVLNRLQAGKLEL 238
Query: 249 KQPE 252
PE
Sbjct: 239 PVPE 242
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 39/253 (15%)
Query: 50 VAIKIVS-KVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGS 108
VAIK + K + P L++ E + L+HPN++ L + + +I Y +
Sbjct: 38 VAIKTLKDKAEGP---LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD 94
Query: 109 L--FDIIRGQ----GYIDEIRARR----------WFGQLLEALQYCHERGVVHRDIKCEN 152
L F ++R G D+ + + Q+ +++ VVH+D+ N
Sbjct: 95 LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154
Query: 153 LLLDSDYNIKLSDFGFARAHMRCRSNAAD------NSLSETFCGSYAYASPEILQGIPYA 206
+L+ N+K+SD G R AAD NSL + SPE + ++
Sbjct: 155 VLVFDKLNVKISDLGLFR-----EVYAADYYKLMGNSLLPI-----RWMSPEAIMYGKFS 204
Query: 207 PHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL 265
SDIWS GVVL+ + +G P+ S ++++ ++N+ P + L+
Sbjct: 205 ID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECW 263
Query: 266 SPVQT-RPRLKTI 277
+ + RPR K I
Sbjct: 264 NEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 61/274 (22%), Positives = 115/274 (41%), Gaps = 49/274 (17%)
Query: 30 IGTGSYATVKLARSTRHS--GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
+G G++ V LA S D + V ++ P +K RE E++ L+H ++++F
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQG-----YID--EIRARRWFG---------QL 131
+ ++ EY ++G L +R G +D +A+ G Q+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 132 LEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGS 191
+ Y + VHRD+ N L+ ++ +K+ DFG +R + +
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---------------DVYSTD 177
Query: 192 YAYASPEILQGIPYAP----------HLSDIWSMGVVLFAM-VFGRLPFDDSSVNELLKQ 240
Y + I + P SD+WS GV+L+ + +G+ P+ S E+++
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237
Query: 241 V-QNKVTFPKQPEVSTECKELISNILSPVQTRPR 273
+ Q +V ++P V KE+ +L Q P+
Sbjct: 238 ITQGRVL--ERPRVCP--KEVYDIMLGCWQREPQ 267
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 25 TVGKIIGTGSYA---------TVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV 75
T+ + +G GS+ VK TR VAIK V++ + + ++ FL E V
Sbjct: 9 TMSRELGQGSFGMVYEGIAKGVVKDEPETR----VAIKTVNEAASMRERIE-FL-NEASV 62
Query: 76 VKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR----------GQGYIDEIRAR 125
+K +++R L + +IME G L +R Q +
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 126 RWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR--AHMRCRSNAADNS 183
+ G++ + + Y + VHRD+ N ++ D+ +K+ DFG R
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 184 LSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAM-VFGRLPFDDSSVNELLKQV 241
L + SPE L+ + + SD+WS GVVL+ + P+ S ++L+ V
Sbjct: 183 L------PVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 60/288 (20%), Positives = 125/288 (43%), Gaps = 54/288 (18%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSG--DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
+GK +G G + +V + + VA+K + ++ FL E +K HP
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHP 60
Query: 83 NLIRFLQA-IETTHR-----VYIIMEYAENGSL--FDIIRGQG----YIDEIRARRWFGQ 130
N++R + ++T +I+ + ++G L F + G Y+ ++
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 131 LLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCG 190
+ ++Y + +HRD+ N +L+ + N+ ++DFG ++ + + G
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK---------------KIYNG 165
Query: 191 SY-----------AYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPF---DDSSVN 235
Y + + E L Y SD+WS GV ++ + G+ P+ ++S +
Sbjct: 166 DYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
Query: 236 ELLKQVQNKVTFPKQPEVSTEC-KELISN--ILSPVQTRPRLKTIAED 280
+ L+Q N++ KQP + L+S+ +L+P + RP +T+ +
Sbjct: 225 DYLRQ-GNRL---KQPPDCLDGLYSLMSSCWLLNP-KDRPSFETLRCE 267
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 42/145 (28%), Positives = 60/145 (41%), Gaps = 33/145 (22%)
Query: 125 RRWFGQLLEALQYCHERGVVHRDIKCENLLLD-SDYNIKLSDFGFARAHMRCRSNAADNS 183
+ Q+L AL H G+VHRD+K +N++ + K+ D G A A +R N
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLG-AAADLR----VGINY 312
Query: 184 LSETFCGSYAYASPEILQGI-----PYAPH------LS------------DIWSMGVVLF 220
+ + F YA+PE Q I P AP LS DI+S G++
Sbjct: 313 IPKEFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 221 AMVFGRLPFDDS--SVNELLKQVQN 243
M F L D + N LK+
Sbjct: 371 QMAFPNLRSDSNLIQFNRQLKRNDY 395
|
Length = 566 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 63/284 (22%), Positives = 108/284 (38%), Gaps = 70/284 (24%)
Query: 28 KIIGTGSYATVKLAR--STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLI 85
K IG G + V L S V +K + +V A KFL E + + L+H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKEL-RVSASVQEQMKFL-EEAQPYRSLQHSNLL 58
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRA-----RRWFGQLLEALQYCHE 140
+ L ++ME+ G L +R + + +R ++ L + H+
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
+H D+ N LL +D +K+ D+G +H + + + Y +P+ L
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGL--SHNKYKED--------------YYVTPDQL 162
Query: 201 QGIPY---APHL----------------SDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQ 240
+P AP L S++WS+GV ++ + G P+ S ++L
Sbjct: 163 W-VPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY 221
Query: 241 V--QNKVTFPKQPEVSTECKELISNILSPVQTRPRLKTIAEDRW 282
+ ++ PK PRLK DRW
Sbjct: 222 TVREQQLKLPK----------------------PRLKLPLSDRW 243
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 29/144 (20%)
Query: 50 VAIKIV---SKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAEN 106
VA+KI+ + A D+LK E++++ LK PN+IR L + +I EY EN
Sbjct: 49 VAVKILRPDANKNARNDFLK-----EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 107 GSLFDIIRGQGYIDEIRARRWFG--------------------QLLEALQYCHERGVVHR 146
G L + ++D+ Q+ ++Y VHR
Sbjct: 104 GDLNQFLSSH-HLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162
Query: 147 DIKCENLLLDSDYNIKLSDFGFAR 170
D+ N L+ + IK++DFG +R
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 57/254 (22%), Positives = 92/254 (36%), Gaps = 65/254 (25%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKI---VSKVQAPPDYLKKFLPREIEVV 76
T+ + +G G++ V GD VA+K Q D+L + L ++
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL-----IM 63
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEAL- 135
H N++R + +I++E G L +R E R R L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLR------ENRPRPERPSSLTMKD 117
Query: 136 ------------QYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAA 180
+Y E +HRDI N LL K++DFG AR
Sbjct: 118 LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR---------- 167
Query: 181 DNSLSETFCGSY-----------AYASPE-ILQGIPYAPHLSDIWSMGVVLF-AMVFGRL 227
+ + SY + PE L GI + +D+WS GV+L+ G +
Sbjct: 168 -----DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK--TDVWSFGVLLWEIFSLGYM 220
Query: 228 PFDDSSVNELLKQV 241
P+ + E+++ V
Sbjct: 221 PYPGRTNQEVMEFV 234
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 8e-07
Identities = 58/279 (20%), Positives = 120/279 (43%), Gaps = 49/279 (17%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD---VAIKIV-SKVQAPPDYLKKFLPREIEVVKGL 79
+T+G+++G G + +V+ A+ G VA+K++ + + + D +++FL RE +K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFL-REAACMKEF 58
Query: 80 KHPNLIRFLQAIETTHRV-------YIIMEYAENGSLFDIIRGQGYIDEI------RARR 126
HPN+I+ L + R +I+ + ++G L + +E R
Sbjct: 59 DHPNVIK-LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 127 WFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186
+ + ++Y + +HRD+ N +L+ + + ++DFG ++ +
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK---------------K 162
Query: 187 TFCGSY-----------AYASPEILQGIPYAPHLSDIWSMGVVLFA-MVFGRLPFDDSSV 234
+ G Y + + E L Y H SD+W+ GV ++ M G+ P+
Sbjct: 163 IYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVEN 221
Query: 235 NELLKQVQNKVTFPKQPEVSTECKELISNILSPV-QTRP 272
+E+ + + P+ + EL+ SP + RP
Sbjct: 222 SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRP 260
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 43/243 (17%), Positives = 97/243 (39%), Gaps = 29/243 (11%)
Query: 49 DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR----FLQAIETTHRVYIIMEYA 104
+V I+ K L EI+ ++ + N+++ + ++ R+ +I+EY
Sbjct: 45 EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 105 ENGSLFDIIRGQGYID-EIRARRWFGQL--LEALQYCHERGVVHRDIKCENLLLDSDYNI 161
G L +++ + + + + L L ++++ + L+ +Y +
Sbjct: 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNL--YKYTNKPYKNLTSVSFLVTENYKL 162
Query: 162 KLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHL--SDIWSMGVVL 219
K+ G + + Y S ++L I ++ + DI+S+GVVL
Sbjct: 163 KIICHGLEKILSSPPFKNVNFM---------VYFSYKMLNDI-FSEYTIKDDIYSLGVVL 212
Query: 220 FAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILSPVQ-----TRPRL 274
+ + G++PF++ + E+ + NK ++ +C I I+ RP +
Sbjct: 213 WEIFTGKIPFENLTTKEIYDLIINKN---NSLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
Query: 275 KTI 277
K I
Sbjct: 270 KEI 272
|
Length = 283 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 43/123 (34%), Positives = 56/123 (45%), Gaps = 25/123 (20%)
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Q+L L+ H G+VHRDIK ENLL+ D +K+ DFG A D F
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG----------AAVDMCTGINFN 366
Query: 190 GSYA-----YASPEIL---QGIPYAPHLSDIWSMGVVL--FAMVFGRLP-FDDSSVNELL 238
Y Y+ PE L Q P AP +M +L FA ++GR FD + LL
Sbjct: 367 PLYGMLDPRYSPPEELVMPQSCPRAPAP----AMAALLSPFAWLYGRPDLFDSYTAGVLL 422
Query: 239 KQV 241
Q+
Sbjct: 423 MQM 425
|
Length = 507 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 52/231 (22%), Positives = 90/231 (38%), Gaps = 49/231 (21%)
Query: 30 IGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+G G++ V LA + VA+K + + + ++ RE E++ L+H ++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHI 69
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARR--------WFGQLLE--- 133
+RF + ++ EY +G L +R G +I A GQ+L
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 134 ----ALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
+ Y VHRD+ N L+ +K+ DFG +R + +
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR---------------DIYS 174
Query: 190 GSYAYASPEILQGIPYAP----------HLSDIWSMGVVLFAM-VFGRLPF 229
Y + I + P SDIWS GVVL+ + +G+ P+
Sbjct: 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 48/218 (22%), Positives = 87/218 (39%), Gaps = 34/218 (15%)
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWF----GQLLEA 134
L H +L++ L + ++ EY + G L + + + W QL A
Sbjct: 58 LSHKHLVK-LYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLH---WKLDVAKQLASA 113
Query: 135 LQYCHERGVVHRDIKCENLLL-----DSDYN--IKLSDFGFARAHMRCRSNAADNSLSET 187
L Y ++ +VH ++ +N+L+ + Y IKLSD G + R +
Sbjct: 114 LHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-REERVERI---- 168
Query: 188 FCGSYAYASPEILQGIPYAPHL-SDIWSMGVVLFAMVF-GRLPFDDSSVNELLK--QVQN 243
+ +PE ++ + + +D WS G L + G P S +E + Q Q+
Sbjct: 169 -----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223
Query: 244 KVTFPKQPEVSTECKELISNILSPVQT-RPRLKTIAED 280
++ P E++ LI+ + T RP + I D
Sbjct: 224 RLPMPDCAELA----NLINQCWTYDPTKRPSFRAILRD 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 6/110 (5%)
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Q+ +++ + VHRD+ N+L+ +K+ DFG AR MR SN S TF
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR-DSNYI--SKGSTFL 303
Query: 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAM-VFGRLPFDDSSVNELL 238
+ +PE + Y LSD+WS G++L+ + G P+ + +NE
Sbjct: 304 -PLKWMAPESIFNNLYTT-LSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-06
Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 33/232 (14%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVS--KVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
IG G + V L+ +G VA +V K A +FL ++ + + L+HPN+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTG-VARVVVKELKANASSKEQNEFL-QQGDPYRILQHPNILQC 60
Query: 88 L-QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLE----------ALQ 136
L Q +E ++ EY E G L + Y+ + + R QLL +
Sbjct: 61 LGQCVEAI-PYLLVFEYCELGDL------KSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYAS 196
+ H+ +H D+ N L SD +K+ D+G + + + + C + +
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE----DDKCVPLRWLA 169
Query: 197 PEI---LQGIPYAPH---LSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQV 241
PE+ G S++W++GV L+ + P+ S E+L V
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 36/131 (27%), Positives = 59/131 (45%), Gaps = 14/131 (10%)
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR----CRSNAADNSLS 185
Q+ +++ R +HRD+ N+LL + +K+ DFG AR + R +A L
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNK 244
+ +PE + Y SD+WS GV+L+ + G P+ +NE Q
Sbjct: 242 --------WMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD 292
Query: 245 VTFPKQPEVST 255
T + PE +T
Sbjct: 293 GTRMRAPENAT 303
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Q+ +++ + VHRD+ N+LL +K+ DFG AR M + + S TF
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS---TFL 301
Query: 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPF 229
+ +PE + Y LSD+WS G++L+ + G P+
Sbjct: 302 -PVKWMAPESIFDNLYTT-LSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 33/131 (25%), Positives = 60/131 (45%), Gaps = 14/131 (10%)
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR----CRSNAADNSLS 185
Q+ + +++ R +HRD+ N+LL + +K+ DFG AR + R A L
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNK 244
+ +PE + Y SD+WS GV+L+ + G P+ ++E + +
Sbjct: 247 --------WMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 297
Query: 245 VTFPKQPEVST 255
T + P+ +T
Sbjct: 298 GTRMRAPDYTT 308
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 45/195 (23%), Positives = 83/195 (42%), Gaps = 38/195 (19%)
Query: 52 IKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFD 111
+K ++ V + P EI + L+HPN+++ + + Y+I EY E +L +
Sbjct: 720 VKEINDVNSIP-------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSE 772
Query: 112 IIRGQGYIDEIRARRWFGQLLEALQYCHER---GVVHRDIKCENLLLDSDYNIKLSDFGF 168
++R + R R+ + +AL++ H R VV ++ E +++D
Sbjct: 773 VLRNLSW---ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD--------- 820
Query: 169 ARAHMRCRSNAADNSLSETFC------GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAM 222
H+R SL C S AY +PE + SDI+ G++L +
Sbjct: 821 -EPHLRL-------SLPGLLCTDTKCFISSAYVAPETRETKDITEK-SDIYGFGLILIEL 871
Query: 223 VFGRLPFD-DSSVNE 236
+ G+ P D + V+
Sbjct: 872 LTGKSPADAEFGVHG 886
|
Length = 968 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 16/133 (12%)
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYN-IKLSDFGFARAHMR----CRSNAADNSL 184
Q+ +++ R +HRD+ N+LL S+ N +K+ DFG AR + R A L
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL-SENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 185 SETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
+ +PE + Y SD+WS GV+L+ + G P+ ++E +
Sbjct: 240 K--------WMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290
Query: 244 KVTFPKQPEVSTE 256
+ T + PE +T
Sbjct: 291 EGTRMRAPEYATP 303
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 60/247 (24%), Positives = 104/247 (42%), Gaps = 40/247 (16%)
Query: 6 VQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYL 65
V + +DID + + + + ++G G++ V A + A+KIV V P Y
Sbjct: 118 VVLGEDID-----VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYT 169
Query: 66 K------KFLP--REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG 117
+ +F+ R+ + + R+ Q ET H ++ +Y L D I G
Sbjct: 170 RDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-ETGHMCIVMPKYGP--CLLDWIMKHG 226
Query: 118 YIDEIRARRWFGQLLEALQYCH-ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR-- 174
+ Q AL Y H E ++H D+K EN+L+++ SD R
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMET------SDTVVDPVTNRAL 280
Query: 175 ----CR------SNAADNSLSET-FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV 223
CR D S T + Y SPE++ G+ + + +D+WSMG +++ +
Sbjct: 281 PPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELY 339
Query: 224 FGRLPFD 230
G+L +D
Sbjct: 340 TGKLLYD 346
|
Length = 467 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 16/39 (41%), Positives = 25/39 (64%)
Query: 131 LLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFA 169
+L L+Y HE G+ H DIK EN+++D + + D+G A
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 28/107 (26%), Positives = 50/107 (46%), Gaps = 6/107 (5%)
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Q+ + + + + +HRD+ N+LL K+ DFG AR M N ++ +
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM----NDSNYVVKGNAR 275
Query: 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVN 235
+ +PE + Y SD+WS G++L+ + G+ P+ VN
Sbjct: 276 LPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVN 321
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 31/165 (18%)
Query: 130 QLLEALQYCHERGVVHRDIKCENLLL-------DSDYNIKLSDFGFARAHMRCRSNAADN 182
QL AL Y ++ +VH ++ +N+LL + IKLSD G +
Sbjct: 125 QLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFT----------- 173
Query: 183 SLS-ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQ 240
+LS E + +PE + G +D WS G L + F G +P + + +E +
Sbjct: 174 ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233
Query: 241 VQNKVTFPKQPEVSTECKE---LISNILS--PVQTRPRLKTIAED 280
+ K P+ CKE LIS L+ P Q RP +TI D
Sbjct: 234 YEKKHRLPE-----PSCKELATLISQCLTYEPTQ-RPSFRTILRD 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 316 | |||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| KOG0577|consensus | 948 | 100.0 | ||
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4278|consensus | 1157 | 100.0 | ||
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1094|consensus | 807 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0200|consensus | 609 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG0576|consensus | 829 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0664|consensus | 449 | 100.0 | ||
| KOG1024|consensus | 563 | 100.0 | ||
| KOG2052|consensus | 513 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1167|consensus | 418 | 100.0 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345|consensus | 378 | 99.97 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1164|consensus | 322 | 99.95 | ||
| KOG1163|consensus | 341 | 99.95 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1165|consensus | 449 | 99.94 | ||
| KOG0590|consensus | 601 | 99.94 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0195|consensus | 448 | 99.92 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG0603|consensus | 612 | 99.91 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1240|consensus | 1431 | 99.89 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG0606|consensus | 1205 | 99.88 | ||
| KOG1166|consensus | 974 | 99.88 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG4158|consensus | 598 | 99.85 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1033|consensus | 516 | 99.83 | ||
| KOG1023|consensus | 484 | 99.83 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG0590|consensus | 601 | 99.75 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| KOG1243|consensus | 690 | 99.67 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.58 | |
| KOG0601|consensus | 524 | 99.57 | ||
| KOG0606|consensus | 1205 | 99.54 | ||
| KOG1266|consensus | 458 | 99.54 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.46 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.44 | |
| KOG0601|consensus | 524 | 99.38 | ||
| KOG3087|consensus | 229 | 99.37 | ||
| KOG3741|consensus | 655 | 99.37 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.27 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.25 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.23 | |
| KOG2137|consensus | 700 | 99.22 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.18 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.05 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.02 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.89 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.87 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.72 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.67 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.67 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.59 | |
| KOG1035|consensus | 1351 | 98.59 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.4 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.38 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.35 | |
| KOG1235|consensus | 538 | 98.34 | ||
| PRK10593 | 297 | hypothetical protein; Provisional | 98.32 | |
| KOG2268|consensus | 465 | 98.2 | ||
| KOG2270|consensus | 520 | 98.17 | ||
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.16 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.15 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.13 | |
| KOG0576|consensus | 829 | 98.1 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.09 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.08 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.0 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.93 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.89 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.87 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.68 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.67 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.59 | |
| KOG1093|consensus | 725 | 97.48 | ||
| PLN02236 | 344 | choline kinase | 97.4 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.3 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.2 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.2 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.14 | |
| KOG1826|consensus | 2724 | 96.98 | ||
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.97 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.9 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.7 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.55 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.44 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.37 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.29 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 96.24 | |
| KOG1236|consensus | 565 | 96.1 | ||
| PTZ00296 | 442 | choline kinase; Provisional | 96.06 |
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-56 Score=388.17 Aligned_cols=279 Identities=29% Similarity=0.560 Sum_probs=244.1
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
+......+|...+.||+|||+.+|.+++..+|..||+|++.+.........+.+.+|+++.+.|+|||||+++++|++.+
T Consensus 12 i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 12 IEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN 91 (592)
T ss_pred eecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence 33334477999999999999999999999999999999999877767777888999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
++|+|.|+|+.++|..++++.+++++.+++.++.||+.||.|||+.+|+|||||..|+|++++.+|||+|||+|....
T Consensus 92 nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le-- 169 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE-- 169 (592)
T ss_pred ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec--
Confidence 999999999999999999998999999999999999999999999999999999999999999999999999997642
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCH
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (316)
.........+||+.|.|||++....++-. +||||+||+||.|+.|++||...+..+.+..+... ....+..+|.
T Consensus 170 ----~~~Erk~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-~Y~~P~~ls~ 243 (592)
T KOG0575|consen 170 ----YDGERKKTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-EYSMPSHLSA 243 (592)
T ss_pred ----CcccccceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-CcccccccCH
Confidence 12245556789999999999998888877 99999999999999999999999999999888654 2333347999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhhCCCC-CCCCCCCChhhHHHhHhHH
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAEDRWL-KPKPKSRGVDKAEAELDHY 302 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~~~~~-~~~~~~~~~~~~~~~~~~~ 302 (316)
+.++||.+|| .+|.+|||+++|+.|+|| ++..-.+....+...-.++
T Consensus 244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~~l~~~p~~ 292 (592)
T KOG0575|consen 244 EAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSSCLTMVPRF 292 (592)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCccccccCCcC
Confidence 9999999999 699999999999999999 4444333344444443333
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=367.15 Aligned_cols=259 Identities=30% Similarity=0.482 Sum_probs=231.5
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC-eEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-RVY 98 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~ 98 (316)
...+.+.++.||+|..|+||+|+++.+++.+|+|++.... +....+++.+|+++++.++|||||++|+.|..+. ...
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 3447888899999999999999999999999999994433 3344667789999999999999999999999988 499
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
++||||+||||+.+++..+.+++..+.+++.++++||.|||+ .+|+||||||+|+|++..|.|||||||.+....+
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--- 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--- 231 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh---
Confidence 999999999999999998899999999999999999999996 8999999999999999999999999999866432
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcccCCCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS-----SVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~ 252 (316)
.......||..|||||.+.+..++.+ +||||||+.++|+.+|++||... +.-+....+....++..+..
T Consensus 232 -----S~a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 232 -----SIANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG 305 (364)
T ss_pred -----hhcccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 25667789999999999999888887 99999999999999999999774 66777777777666666665
Q ss_pred -CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 253 -VSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 253 -~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
+|++++.||..|| ++|.+|||+.++++|||++.....
T Consensus 306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 9999999999999 799999999999999999987763
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-56 Score=372.47 Aligned_cols=266 Identities=34% Similarity=0.594 Sum_probs=229.3
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchH----HHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDY----LKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
....+.|.+.+.||+|+||.|-+|..+++|+.||||++++....... ....+++|+++|++++||+||+++++|..
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 33567799999999999999999999999999999999875443311 12335699999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC---CCeEEeeccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD---YNIKLSDFGFAR 170 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~---~~~~l~Df~~~~ 170 (316)
....|+||||++||.|.+.+-.++.+.+...+.++.|++.|+.|||+.||+||||||+|||+..+ -.+||+|||+|.
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999999888889999999999999999999999999999999999999765 569999999997
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhccc--
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIP--YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE-LLKQVQNKV-- 245 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~-- 245 (316)
. ..........+||+.|.|||++.+.. .+..+.|+|||||++|-+++|.+||.+..... ..+++.++.
T Consensus 328 ~-------~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 328 V-------SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred c-------cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 5 33445566788999999999996654 44445899999999999999999998765554 777776653
Q ss_pred -CCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 246 -TFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 246 -~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
.++.+..++++..+||.+|| -||++|||++|+|+||||+..+-.+
T Consensus 401 f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 401 FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 34556789999999999999 5999999999999999999777544
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-54 Score=358.00 Aligned_cols=262 Identities=28% Similarity=0.540 Sum_probs=238.5
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
....++|++++.||+|+||.||.++...+++.+|+|++++.........+....|..++..++||.||+++..|++....
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 46689999999999999999999999999999999999886665555567788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
|+|+||+.||.|...+++.+.+++..++-++..|+.||.|||+.||+||||||+|||++.+|+++|+|||+++..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~----- 175 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED----- 175 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999753
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHH
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
..........+||+.|+|||++.+..++.. +|+||||+++|+|++|..||.+.+.....+.+..+.....+..++.+.
T Consensus 176 -~~~~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~a 253 (357)
T KOG0598|consen 176 -LKDGDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEA 253 (357)
T ss_pred -ccCCCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHH
Confidence 333344445789999999999999888777 999999999999999999999999999999998886555556699999
Q ss_pred HHHHHHhc-CCCCCCC----CHHHHhhCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRP----RLKTIAEDRWLKPK 286 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rp----s~~~il~~~~~~~~ 286 (316)
++++..+| .+|++|. ++++|-+||||.+.
T Consensus 254 rdll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 254 RDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 99999999 6999995 89999999999654
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-54 Score=370.16 Aligned_cols=286 Identities=30% Similarity=0.558 Sum_probs=243.0
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 96 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 96 (316)
.-..++|...+.||.|+|++|++|++..+++.||||++.+.-...+.-...+..|-.+|.+| +||+|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34578899999999999999999999999999999999765443333345577888899999 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.|+|+||+++|.|.++|++.+.+++...+.++.+|+.||+|||++|||||||||+|||++++++++|+|||.|..+.+..
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998876544
Q ss_pred CcC---CCC--CCC--cccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC
Q psy11194 177 SNA---ADN--SLS--ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK 249 (316)
Q Consensus 177 ~~~---~~~--~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (316)
... ..+ ... ...+||..|.+||++........ +|+|+|||++|+|+.|.+||.+.+...+.+.|... .+..
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-~y~f 306 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-DYEF 306 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-cccC
Confidence 331 111 111 44789999999999988777666 99999999999999999999999988888888764 3555
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHhHHHHH
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDM 305 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (316)
++.+++.+++||.++| .+|++|+++.+|.+||||.+.+=..--...=-+|+-|+.+
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p~ 363 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYKPA 363 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCCCc
Confidence 6789999999999999 7999999999999999998876544222222344444433
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-53 Score=364.69 Aligned_cols=274 Identities=27% Similarity=0.485 Sum_probs=241.6
Q ss_pred ccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 13 DRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 13 ~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
+.+...+..++|++++.||+|+||.||+|+.+.+|..+|+|++++.........+.++.|-.+|...++|+||+++..|+
T Consensus 132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred HhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 34445678899999999999999999999999999999999999877766666777889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
+..+.|+||||++||.+.++|.+.+.|++..++.++.+++.||..||+.|++|+||||+|+|++..|++||+|||++.-+
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998533
Q ss_pred ccc---------------cCc-CCC--C-----------------------CCCcccccccCccCcccccCCCCCCCchh
Q psy11194 173 MRC---------------RSN-AAD--N-----------------------SLSETFCGSYAYASPEILQGIPYAPHLSD 211 (316)
Q Consensus 173 ~~~---------------~~~-~~~--~-----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~D 211 (316)
... ... ... . .......|||.|+|||++.+..+.-. +|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cD 370 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CD 370 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-cc
Confidence 210 000 000 0 01223479999999999999887766 99
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cccCCCCCCCCCHHHHHHHHHhcCCCCCCCC---HHHHhhCCCCCC
Q psy11194 212 IWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ---NKVTFPKQPEVSTECKELISNILSPVQTRPR---LKTIAEDRWLKP 285 (316)
Q Consensus 212 i~slG~ll~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~p~~Rps---~~~il~~~~~~~ 285 (316)
+||||||+|||+.|.+||.+.++.+....+. ....+|....++++.++||.+||++|.+|.. ++||.+||||.+
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCcccc
Confidence 9999999999999999999999999998884 4678888889999999999999999999985 999999999977
Q ss_pred CC
Q psy11194 286 KP 287 (316)
Q Consensus 286 ~~ 287 (316)
.+
T Consensus 451 v~ 452 (550)
T KOG0605|consen 451 VD 452 (550)
T ss_pred CC
Confidence 64
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-51 Score=355.97 Aligned_cols=260 Identities=42% Similarity=0.796 Sum_probs=231.3
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC-c-hHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCC
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP-P-DYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH 95 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~-~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 95 (316)
....+|.+.+.||+|+||.|+.|.+..++..||+|++...... . ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567899999999999999999999999999999977654221 1 234567889999999998 999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-CCeEEeeccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHMR 174 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~-~~~~l~Df~~~~~~~~ 174 (316)
..++||||+.||.|.+++.+.+++++..++.++.|++.|++|+|+.|++||||||+||+++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999988889999999999999999999999999999999999999999 999999999996531
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEV 253 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (316)
.........+|++.|+|||++.+.. +...++||||+|++||.|++|+.||.+.+.......+..+ .+..+..+
T Consensus 173 -----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-~~~~p~~~ 246 (370)
T KOG0583|consen 173 -----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-EFKIPSYL 246 (370)
T ss_pred -----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-CccCCCCc
Confidence 3445666778999999999999988 8888899999999999999999999998888888776655 33444456
Q ss_pred -CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 254 -STECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 254 -~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
|++++.|+.+|| .+|.+|+++.+|++||||+.
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999 69999999999999999997
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=338.53 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=217.9
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|+.+.++|+|++|.||+++++.+|+.||||.+..... +....+...+|+++|++++|+|+|.++++|...+...+||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 578899999999999999999999999999999965544 3445666779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
|||+..-|.++-+....++...+++++.|++.|+.|+|+++++||||||+|||++.+|.+||||||+|+... ..
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~------~p 154 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS------AP 154 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc------CC
Confidence 999874455444445569999999999999999999999999999999999999999999999999998753 12
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN------------------ 243 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~------------------ 243 (316)
......+..|.+|+|||.+.+...+.+..||||+||++.||++|.+.|++.+.-+....+..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 23334456799999999998866555669999999999999999999998765555444432
Q ss_pred --ccCCCCC----------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 244 --KVTFPKQ----------PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 244 --~~~~~~~----------~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+..+|.+ +.++..+.+|+..|| -||.+|++.++++.||||.+.-+
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 2333332 457788999999999 49999999999999999965544
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-51 Score=341.99 Aligned_cols=261 Identities=35% Similarity=0.642 Sum_probs=232.0
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
..+|.+.+.||.|+|++||+|+++.++..||||.+.+..... ...+.+..|+.+|+.++|||||++++++..++..++|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~-k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK-KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH-HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 467999999999999999999999999999999998876533 3466677999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC------CCeEEeeccccccccc
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD------YNIKLSDFGFARAHMR 174 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~------~~~~l~Df~~~~~~~~ 174 (316)
||||+||+|..++++.+.+++..++.++.||+.||++||+++|+||||||.|||++.. -.+||+|||+|+..
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L-- 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL-- 165 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC--
Confidence 9999999999999999899999999999999999999999999999999999999764 34899999999874
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC--CCCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP--KQPE 252 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 252 (316)
....+....+|++.|||||++....|+.+ +|+||+|+++|++++|..||......+....++.+.... .+..
T Consensus 166 -----~~~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 166 -----QPGSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAE 239 (429)
T ss_pred -----CchhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhh
Confidence 34556677889999999999998888887 999999999999999999999999999988887654322 2235
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
++..+.+++..+| .+|.+|.+..+-..|+++...+..+
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~ 278 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDR 278 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcccc
Confidence 7777889999999 6999999999999999998776443
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-51 Score=328.15 Aligned_cols=257 Identities=29% Similarity=0.534 Sum_probs=233.5
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
..-++|++++.||.|+||.|.+++++.+|..+|+|++.+..--.-...+...+|..+|+.+.||.++++++.+.+.+..+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 67789999999999999999999999999999999998765555555667789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+||||.+||-|..++++.+++++..++-++.+|+.||+|||++++++|||||+|||++.+|.+||+|||+|...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v------ 194 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV------ 194 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999653
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
.......+||+.|+|||++....++.. +|+||||+++|||+.|.+||.+.++.++.+++.++. ...+..++.+++
T Consensus 195 ---~~rT~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~-v~fP~~fs~~~k 269 (355)
T KOG0616|consen 195 ---SGRTWTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK-VKFPSYFSSDAK 269 (355)
T ss_pred ---cCcEEEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc-ccCCcccCHHHH
Confidence 233556789999999999999888877 999999999999999999999999999999987763 444567999999
Q ss_pred HHHHHhc-CCCCCC-----CCHHHHhhCCCCCCC
Q psy11194 259 ELISNIL-SPVQTR-----PRLKTIAEDRWLKPK 286 (316)
Q Consensus 259 ~li~~~l-~~p~~R-----ps~~~il~~~~~~~~ 286 (316)
+||..+| .|-.+| +..++|..||||++.
T Consensus 270 dLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 270 DLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 9999999 587777 567899999999844
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-51 Score=358.94 Aligned_cols=262 Identities=37% Similarity=0.646 Sum_probs=241.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
-|++.+.||.|+.|.|-.|++..+|+.+|||++.+.....+....-+.+|+.+++.++||||++++++++.....|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 48999999999999999999999999999999987755555455668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
|++||-|++++-+.+++++.+..+++.||+.|+.|+|..+++|+||||+|+|++..+++||+|||+|.. ....
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL-------e~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL-------EVPG 165 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec-------ccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999955 4455
Q ss_pred CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q psy11194 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELIS 262 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 262 (316)
......+|++.|.|||++.+.+|...++||||-|+|||.|++|++||.+.+...++.+++.+. +..+..+|+++++||.
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~-f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV-FEMPSNISSEAQDLLR 244 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-ccCCCcCCHHHHHHHH
Confidence 667778899999999999999999999999999999999999999999999999999998873 5555789999999999
Q ss_pred Hhc-CCCCCCCCHHHHhhCCCCCCCCCCCCh
Q psy11194 263 NIL-SPVQTRPRLKTIAEDRWLKPKPKSRGV 292 (316)
Q Consensus 263 ~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~ 292 (316)
+|| -||+.|.|+++|++|||+.+.+.....
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 999 599999999999999999998886654
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=349.81 Aligned_cols=261 Identities=26% Similarity=0.459 Sum_probs=221.1
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCC-e
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH-R 96 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~ 96 (316)
...++|.+.++||.|.||.||+|+...+|+.||||.++..-..-+. .-.+ +|++.|++++ ||||+++.+++.+.. .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nL-REvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNL-REVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHH-HHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4467899999999999999999999999999999999664443222 2224 8999999998 999999999998877 9
Q ss_pred EEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
.++|||||+. +|..+++. +..+++..++.|+.||++||+|+|.+|++|||+||+|||+..+..+||+|||+|+.
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe---- 159 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE---- 159 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc----
Confidence 9999999976 99999976 45699999999999999999999999999999999999999999999999999976
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN------------ 243 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~------------ 243 (316)
.........++.|.+|+|||++....+++.+.|+|++||+++|+.+-++.|++.+.-+.+-++.+
T Consensus 160 ---v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 ---VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ---cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 33334455567899999999998877777779999999999999999999998765555544432
Q ss_pred --------ccCCCCC---------CCCCHHHHHHHHHhcC-CCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 244 --------KVTFPKQ---------PEVSTECKELISNILS-PVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 244 --------~~~~~~~---------~~~~~~~~~li~~~l~-~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
++.+|.. +..+.++.+||.+||+ ||.+|||+.++++||||+.....
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 1222221 3488999999999997 99999999999999999876554
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-50 Score=336.87 Aligned_cols=262 Identities=31% Similarity=0.528 Sum_probs=218.9
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC--eEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH--RVY 98 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 98 (316)
..+|...+.||+|+||+||++.+.++|...|+|.+....... .+.+.+|+.++++++||+||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 567999999999999999999999999999999997763322 566889999999999999999999743333 799
Q ss_pred EEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC-CCCeEEeeccccccccccc
Q psy11194 99 IIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS-DYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~-~~~~~l~Df~~~~~~~~~~ 176 (316)
++|||+++|||.+++++.+ .+++..++.+..||+.||+|||++|++|+||||+|||++. ++.+||+|||++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~-- 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES-- 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc--
Confidence 9999999999999999866 7999999999999999999999999999999999999999 79999999999876432
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHH-hcccCCCCCCCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQV-QNKVTFPKQPEVS 254 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~-~~~~~~~~~~~~~ 254 (316)
............|++.|+|||++.......+++|||||||++.||+||..||.. ....+..-.+ .....++.+..+|
T Consensus 171 -~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 171 -KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS 249 (313)
T ss_pred -ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence 111222334467899999999998643444459999999999999999999987 3333333333 3343345566799
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+.++||..|+ .+|++|||++++|+|||.+....
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999 69999999999999999987665
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=315.57 Aligned_cols=262 Identities=26% Similarity=0.417 Sum_probs=221.2
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
.+|...+.||+|.||.||+|++..+|+.||+|.++.....+.-....+ +|++.|+.++|+||+.++++|...+...+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~tal-REIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTAL-REIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHH-HHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 578889999999999999999999999999999987755444333444 9999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||++. +|+..++. ...++..+++.++.++++||+|||.+.++||||||+|+|++.+|.+||+|||+++.+..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~------ 153 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS------ 153 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC------
Confidence 99976 99999976 45699999999999999999999999999999999999999999999999999987632
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-----------
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK----------- 249 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 249 (316)
..........|.+|+|||.+.+...+....|+||.||++.||+.|.+.|++.+.-+....+-.....|.
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 223333346789999999998766666569999999999999999999988776666666543222111
Q ss_pred ----------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 250 ----------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 250 ----------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
.+..+....+|+..|+ -+|.+|+++.|+++|+||...+-...
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP 292 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence 1336678899999999 59999999999999999996655443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=337.92 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=221.9
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|.+..+++.+|+|++...........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999987543333333456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|.+++...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.+|.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~------- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------- 153 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 261 (316)
......|++.|+|||++.+..++.+ +|||||||++|+|++|..||......+..+.+.... ...+..++..++++|
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li 229 (291)
T cd05612 154 --RTWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLI 229 (291)
T ss_pred --CcccccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHH
Confidence 1122357889999999988776655 999999999999999999999988888777776543 333456799999999
Q ss_pred HHhc-CCCCCCCC-----HHHHhhCCCCCCCCC
Q psy11194 262 SNIL-SPVQTRPR-----LKTIAEDRWLKPKPK 288 (316)
Q Consensus 262 ~~~l-~~p~~Rps-----~~~il~~~~~~~~~~ 288 (316)
.+|| .+|.+||+ ++++++||||+....
T Consensus 230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 9999 59999995 999999999986543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=345.71 Aligned_cols=267 Identities=31% Similarity=0.525 Sum_probs=234.8
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
..|...++||+|+.|.||.|....++..||+|.+....... .+.+-+|+.+++..+|+|||.+++.|...+..|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 45888999999999999999999999999999998877665 566779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||++||+|.+.+.... +++.++..|+..+++||+|||..||+|+|||.+||+++.+|.+||+|||++..+.. .
T Consensus 350 Eym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~------~ 422 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE------E 422 (550)
T ss_pred eecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc------c
Confidence 9999999999998754 99999999999999999999999999999999999999999999999999876432 2
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--CCCCCCCCHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--FPKQPEVSTECKE 259 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 259 (316)
........||+.|+|||+.....|..+ .||||||++++||+-|.+||-..++...+..+..... ...+..+|+++++
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 224455679999999999999999998 9999999999999999999998888887777765443 3445679999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhH
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAEL 299 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~ 299 (316)
|+.+|| .|+.+|+++.++|+||||+-......+.-++...
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~pLi~~~ 542 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLKMAKPESSLNPLILAA 542 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHhHHHHHHH
Confidence 999999 6999999999999999997666655555544443
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-51 Score=344.30 Aligned_cols=278 Identities=25% Similarity=0.422 Sum_probs=249.4
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
....|...++||+|.||.||+|.+..+++.||+|++.......+ .+.+++|+.++.+++++||.++|+.+..+...++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchh--hHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 35568888999999999999999999999999999988766554 6678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
+||||.||++.++++.+..+++..+..++.+++.|+.|||..+.+|+||++.||++..+|.|+|+|||.+.....
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~----- 163 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN----- 163 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec-----
Confidence 999999999999999988789999999999999999999999999999999999999999999999999865421
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
.........||+.|||||++....|+.+ +||||||++.++|.+|.+|+....+..+.-.+.+..++.....+++.+++
T Consensus 164 -~~~rr~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kE 241 (467)
T KOG0201|consen 164 -TVKRRKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKE 241 (467)
T ss_pred -hhhccccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHH
Confidence 1222356779999999999997778777 99999999999999999999998887666666666556666689999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHhHHHHHh
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMI 306 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (316)
|+..|| ++|+.|||+.++|+|+|++..+....+...+.++++|+...
T Consensus 242 FV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~~~~~~~ 289 (467)
T KOG0201|consen 242 FVEACLDKNPEFRPSAKELLKHKFIKRAKKTSELKELIDRYKRWRVKK 289 (467)
T ss_pred HHHHHhhcCcccCcCHHHHhhhHHHHhcCCchHHHHHHHHHHHHhhcc
Confidence 999999 69999999999999999999888888999999999999863
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=331.22 Aligned_cols=273 Identities=26% Similarity=0.462 Sum_probs=232.0
Q ss_pred cccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 14 RKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 14 ~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
...+-.+.+.|++...||.|..++||+|+....++.||||.+.......+ .+.+++|+..++.++||||++++.+|..
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 34566788999999999999999999999999999999999998877665 5678899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
++..|+||.++.+||+.++++. ...+++..+..|+.++++||.|||.+|-+|||||+.|||++.+|.|+|+|||.+.-
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeee
Confidence 9999999999999999999986 34599999999999999999999999999999999999999999999999998765
Q ss_pred cccccCcCCCCCCCcccccccCccCccc-ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC---
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEI-LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF--- 247 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~-~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 247 (316)
+...+ ...........|++.|+|||+ ......++.++||||||++..||.+|+.||....+.++.-.-..+..+
T Consensus 176 l~~~G--~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 176 LFDSG--DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL 253 (516)
T ss_pred ecccC--ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence 54322 111122256679999999999 444444444599999999999999999999998888776554443222
Q ss_pred ------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 248 ------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 248 ------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
......+..++++|..|| +||.+|||++++++|+||+..+...
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 122347789999999999 7999999999999999998876643
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=330.40 Aligned_cols=271 Identities=29% Similarity=0.449 Sum_probs=236.1
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
+...+.-++|++++.||.|.-|+||+|+...++..+|+|++.+.......-...++.|..+|..++||.++.+|..|+.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 45677888999999999999999999999999999999999887665554456677899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
...|+|||||+||.|..+++++ +.+++..++-++..++.||+|||..|||+|||||+|||+.++|++-|+||.++...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999874 46999999999999999999999999999999999999999999999999986432
Q ss_pred ccc------------------------------cCc--------------------CCCCCCCcccccccCccCcccccC
Q psy11194 173 MRC------------------------------RSN--------------------AADNSLSETFCGSYAYASPEILQG 202 (316)
Q Consensus 173 ~~~------------------------------~~~--------------------~~~~~~~~~~~~~~~~~aPE~~~~ 202 (316)
.-. ... ......+...+||-.|.|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 100 000 001122334578899999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCC----HHH
Q psy11194 203 IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKELISNIL-SPVQTRPR----LKT 276 (316)
Q Consensus 203 ~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps----~~~ 276 (316)
..+... +|+|+||+++|||++|.-||.+.+.++....+ .+...+|..+.++..+++||+++| +||++|.. +.|
T Consensus 310 ~GHgsA-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 310 EGHGSA-VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CCCCch-hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 999987 99999999999999999999998888877666 556778888889999999999999 89999999 999
Q ss_pred HhhCCCCCCC
Q psy11194 277 IAEDRWLKPK 286 (316)
Q Consensus 277 il~~~~~~~~ 286 (316)
|.+||||++.
T Consensus 389 IK~HpFF~gV 398 (459)
T KOG0610|consen 389 IKRHPFFEGV 398 (459)
T ss_pred hhcCccccCC
Confidence 9999999765
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=341.34 Aligned_cols=258 Identities=25% Similarity=0.473 Sum_probs=224.2
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
....++|.+.+.||+|+||.||+|++..+++.+|+|++...........+.+.+|+.+++.++||||+++++++..++..
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 33467899999999999999999999999999999999764332222345677999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~--- 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--- 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999865321
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHH
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
......|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+....+..+.+..+. .+.+..++..+
T Consensus 171 ------~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~ 242 (329)
T PTZ00263 171 ------RTFTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRA 242 (329)
T ss_pred ------CcceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHH
Confidence 1123457889999999988777655 999999999999999999999888888777776553 34445689999
Q ss_pred HHHHHHhc-CCCCCCCC-----HHHHhhCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRPR-----LKTIAEDRWLKPK 286 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps-----~~~il~~~~~~~~ 286 (316)
++||.+|| .+|.+||+ +++++.||||.+.
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999 69999997 7999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=343.31 Aligned_cols=264 Identities=24% Similarity=0.446 Sum_probs=221.3
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|.+..+++.+|+|++...........+.+.+|+.++..++|++|+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997644333333456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC--
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA-- 179 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~-- 179 (316)
||++|++|.+++.+.+.+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999986532110000
Q ss_pred ---------------------------CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy11194 180 ---------------------------ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS 232 (316)
Q Consensus 180 ---------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~ 232 (316)
..........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCCCC
Confidence 00001123468999999999988777765 99999999999999999999988
Q ss_pred CHHHHHHHHhcc---cCCCCCCCCCHHHHHHHHHhcCC---CCCCCCHHHHhhCCCCCCC
Q psy11194 233 SVNELLKQVQNK---VTFPKQPEVSTECKELISNILSP---VQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 233 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~---p~~Rps~~~il~~~~~~~~ 286 (316)
...+....+... ..++....+++++.++|.+|+.+ +..||+++++++||||++.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence 888877777542 33444456899999999998843 3457999999999999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=344.94 Aligned_cols=257 Identities=30% Similarity=0.528 Sum_probs=230.8
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+....... ...+++|+++++.++||||+.++++|+...+.|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~-l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE-LKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH-HHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 5799999999999999999999999999999999887665544 455779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+.| +|..++..++.++++.+..++.+++.||.|||++++.|+|+||.||++..+|.+|+||||+|+... ..
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~------~~ 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS------TN 153 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcc------cC
Confidence 99977 999999999999999999999999999999999999999999999999999999999999998642 23
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 261 (316)
........|++.|+|||...+.+++.. +|.|||||++||++.|++||......+..+.|..... +.+...+..+.+|+
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v-~~p~~~S~~f~nfl 231 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV-KPPSTASSSFVNFL 231 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC-CCcccccHHHHHHH
Confidence 344556679999999999998888877 9999999999999999999998888888888766532 23347999999999
Q ss_pred HHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 262 SNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 262 ~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+.+| +||.+|.+..+++.|||+++.-+
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhhhh
Confidence 9999 79999999999999999976543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=344.26 Aligned_cols=265 Identities=25% Similarity=0.462 Sum_probs=223.1
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.++..++||||+++++++......++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997643333333456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC-
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA- 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~- 180 (316)
||+++++|.+++...+.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999865321110000
Q ss_pred -------------------------------CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy11194 181 -------------------------------DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF 229 (316)
Q Consensus 181 -------------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~ 229 (316)
.........|++.|+|||++....++.+ +|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCCCC
Confidence 0001112358999999999988777766 99999999999999999999
Q ss_pred CCCCHHHHHHHHhcc---cCCCCCCCCCHHHHHHHHHhcCCCCCCCC---HHHHhhCCCCCCCC
Q psy11194 230 DDSSVNELLKQVQNK---VTFPKQPEVSTECKELISNILSPVQTRPR---LKTIAEDRWLKPKP 287 (316)
Q Consensus 230 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~p~~Rps---~~~il~~~~~~~~~ 287 (316)
...+..+....+... ...+....+++++.+||..||.+|.+|++ ++++++||||.+.+
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCC
Confidence 988877776666442 23444446899999999999988999997 99999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=322.29 Aligned_cols=248 Identities=29% Similarity=0.453 Sum_probs=217.6
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeee-EEEeCCe-
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ-AIETTHR- 96 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~- 96 (316)
..-.+|+++++||+|.||.||+|++..+|..+|.|.+..... +....+.+-.|+.+|++|+||||+++++ .|.++..
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 345569999999999999999999999999999999985444 3444666779999999999999999998 5655555
Q ss_pred EEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--cC--ccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 97 VYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHE--RG--VVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~--~~--~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
.++|||+|.+|+|...++. ...+++..+|+++.|++.||+++|+ .. ++||||||.|||++.+|.|||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 8999999999999999964 4569999999999999999999998 34 89999999999999999999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP 248 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (316)
++.+. .........+|||.||+||.+...+++.+ +||||+||++|||+.-+.||.+.+..+..+++..+.-.|
T Consensus 175 ~r~l~------s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 175 GRFLS------SKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP 247 (375)
T ss_pred HhHhc------chhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC
Confidence 98753 23334456789999999999999999888 999999999999999999999999999999999986555
Q ss_pred CC-CCCCHHHHHHHHHhc-CCCCCCCCH
Q psy11194 249 KQ-PEVSTECKELISNIL-SPVQTRPRL 274 (316)
Q Consensus 249 ~~-~~~~~~~~~li~~~l-~~p~~Rps~ 274 (316)
.+ ..+|..+..+|..|+ .||+.||+.
T Consensus 248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 248 LPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 66 568999999999999 599999985
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=337.38 Aligned_cols=255 Identities=28% Similarity=0.473 Sum_probs=219.9
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997643332223455678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||++|++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc---CCCCC----CCCC
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV---TFPKQ----PEVS 254 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~----~~~~ 254 (316)
......|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+....+.... ..+.. ..++
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 2234458899999999988766665 999999999999999999999888877766664322 22222 1468
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
.++.++|.+|| .+|.+||+++++++||||.+.
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999 589999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-48 Score=336.70 Aligned_cols=251 Identities=32% Similarity=0.533 Sum_probs=215.5
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENG 107 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 107 (316)
+.||+|+||.||+|.+..+|+.+|+|++.............+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997643322223344668999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcc
Q psy11194 108 SLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET 187 (316)
Q Consensus 108 sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~ 187 (316)
+|.+++...+.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.... ........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~------~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI------SDGATMKT 154 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc------cCCCcccc
Confidence 999999888889999999999999999999999999999999999999999999999999886421 11112233
Q ss_pred cccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-C
Q psy11194 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-S 266 (316)
Q Consensus 188 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~ 266 (316)
..|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+.......+... ....+..++.++.++|.+|| .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred eecCccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccC
Confidence 458999999999988777666 99999999999999999999988877777666543 23444678999999999999 6
Q ss_pred CCCCCC-----CHHHHhhCCCCCCC
Q psy11194 267 PVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 267 ~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
+|++|| ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999 89999999999774
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=342.09 Aligned_cols=264 Identities=28% Similarity=0.545 Sum_probs=224.8
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|.+.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.++..++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999997643322223456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC----
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS---- 177 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~---- 177 (316)
||+++++|.+++.+.+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 9999999999998877899999999999999999999999999999999999999999999999999865432210
Q ss_pred -------------------cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy11194 178 -------------------NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL 238 (316)
Q Consensus 178 -------------------~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~ 238 (316)
............|++.|+|||++.+..++.+ +|||||||++|+|++|..||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 0000112234468899999999988777666 99999999999999999999988877776
Q ss_pred HHHhc---ccCCCCCCCCCHHHHHHHHHhcCCCCCCCC-HHHHhhCCCCCCC
Q psy11194 239 KQVQN---KVTFPKQPEVSTECKELISNILSPVQTRPR-LKTIAEDRWLKPK 286 (316)
Q Consensus 239 ~~~~~---~~~~~~~~~~~~~~~~li~~~l~~p~~Rps-~~~il~~~~~~~~ 286 (316)
..+.. ....+....+++++.++|..||.+|.+||+ ++++++||||++.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCC
Confidence 66654 344555556899999999999999999999 9999999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=336.99 Aligned_cols=262 Identities=23% Similarity=0.429 Sum_probs=224.2
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEccCC-ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARSTRHS-GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
....+..++|.+.+.||+|+||.||+|.+..++ ..+|+|.+...........+.+.+|+.++..++||||+++++++..
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 102 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD 102 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence 345667788999999999999999999876554 6899999875433233334557789999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
+...++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999986532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEV 253 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (316)
. ......|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+.......+..+. ...+..+
T Consensus 183 ~---------~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~ 251 (340)
T PTZ00426 183 T---------RTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFPKFL 251 (340)
T ss_pred C---------CcceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCC
Confidence 1 1123458889999999987766655 999999999999999999999988877777776553 2334568
Q ss_pred CHHHHHHHHHhc-CCCCCCC-----CHHHHhhCCCCCCCC
Q psy11194 254 STECKELISNIL-SPVQTRP-----RLKTIAEDRWLKPKP 287 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~~ 287 (316)
+..+.++|.+|| .+|.+|+ +++++++||||.+..
T Consensus 252 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999 5899995 999999999998754
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=337.72 Aligned_cols=260 Identities=26% Similarity=0.467 Sum_probs=226.8
Q ss_pred hhhhcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCccee
Q psy11194 8 VQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87 (316)
Q Consensus 8 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 87 (316)
...+.....+++....+.+++.||+|-||.||.|.+..+ ..|++|.+...... .+.+.+|+.++++|+|++||++
T Consensus 192 ~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l 266 (468)
T KOG0197|consen 192 QTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKL 266 (468)
T ss_pred CCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEE
Confidence 333444556788888899999999999999999987743 38999999776544 2345599999999999999999
Q ss_pred eeEEEeCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEee
Q psy11194 88 LQAIETTHRVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSD 165 (316)
Q Consensus 88 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~D 165 (316)
++++..+...+|||||++.|+|.++++. +..+...+...++.||+.|++||+++++|||||..+||||+++..+||+|
T Consensus 267 ~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsD 346 (468)
T KOG0197|consen 267 YGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISD 346 (468)
T ss_pred EEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcc
Confidence 9999998899999999999999999986 55699999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcc
Q psy11194 166 FGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNK 244 (316)
Q Consensus 166 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~ 244 (316)
||+|+.... ..-.......-+..|+|||++....++.+ |||||||++|||++| |+.||+.+...++.+.+.++
T Consensus 347 FGLAr~~~d-----~~Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G 420 (468)
T KOG0197|consen 347 FGLARLIGD-----DEYTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG 420 (468)
T ss_pred cccccccCC-----CceeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc
Confidence 999984221 11112222234667999999999888888 999999999999999 99999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy11194 245 VTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIA 278 (316)
Q Consensus 245 ~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il 278 (316)
.++|.+..+|+++.++|..|| .+|++|||++.+.
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 999999999999999999999 6999999999554
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=321.51 Aligned_cols=263 Identities=27% Similarity=0.445 Sum_probs=222.2
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe-----C
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-----T 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 94 (316)
....|...+.||.|++|.|..|.+..+|+.||+|.+...-.......+.+ +|+++++.++|+||+.+.+++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtl-RElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTL-RELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHH-HHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34556678999999999999999999999999999975554444444544 99999999999999999999865 3
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
+.+|+|+|+++ ..|...++.+..+++..+..++.|++.||+|+|+.|++||||||.|++++.+..+|++|||+|+....
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 46899999994 49999999988899999999999999999999999999999999999999999999999999987532
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-----
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK----- 249 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 249 (316)
. ...........|.+|+|||.+.....++++.||||.|||+.||++|+..|++.+.-+.+..+......|.
T Consensus 178 ~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 178 F----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred c----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 2 3344445667899999999998877777779999999999999999999998877666655543222221
Q ss_pred -------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 250 -------------------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 250 -------------------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+..++...+|+.+|| -||.+|+|++|+|+||||.+.+.
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 1568899999999999 59999999999999999965543
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=329.10 Aligned_cols=262 Identities=37% Similarity=0.687 Sum_probs=239.4
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|++.+.||.|.||.|-+|.....|+.||||.+++....++...-.+++|+.++..|+||||+.++++|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 46789999999999999999999999999999999999888777777789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||..+|.|.+++.+.+.+++.+.+.++.||+.|+-|+|.++++|+|||.+|||++.++++||.|||++..+
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly------- 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY------- 203 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
.........+|++.|.+||+..+.++.....|.||||++||.|+.|.+||.+-+...+..++..+--.. +..|.....
T Consensus 204 ~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P~~PSdA~g 281 (668)
T KOG0611|consen 204 ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--PETPSDASG 281 (668)
T ss_pred ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--CCCCchHHH
Confidence 233445567899999999999999998888999999999999999999999999999999998875333 346778899
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
||++|| -+|..|.|+++|..|.|++=.-+.+
T Consensus 282 LIRwmLmVNP~RRATieDiAsHWWvNwgy~~~ 313 (668)
T KOG0611|consen 282 LIRWMLMVNPERRATIEDIASHWWVNWGYNMP 313 (668)
T ss_pred HHHHHHhcCcccchhHHHHhhhheeecccccc
Confidence 999999 6999999999999999996544433
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=343.28 Aligned_cols=264 Identities=25% Similarity=0.449 Sum_probs=220.6
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
.+|++++.||+|+||.||+|++..+++.+|+|++...........+.+.+|+.++..++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986543222222455778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc---
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN--- 178 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~--- 178 (316)
||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..+......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999997532100000
Q ss_pred ----------------------------------CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh
Q psy11194 179 ----------------------------------AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF 224 (316)
Q Consensus 179 ----------------------------------~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~ 224 (316)
...........|++.|+|||++.+..++.+ +|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeehhh
Confidence 000011123468999999999988777665 999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhc---ccCCCCCCCCCHHHHHHHHHhcCCCCCCC---CHHHHhhCCCCCCC
Q psy11194 225 GRLPFDDSSVNELLKQVQN---KVTFPKQPEVSTECKELISNILSPVQTRP---RLKTIAEDRWLKPK 286 (316)
Q Consensus 225 g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~p~~Rp---s~~~il~~~~~~~~ 286 (316)
|..||......+....+.. ....+....+++++.++|.+|+.+|.+|+ ++.+++.||||+..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCC
Confidence 9999998887766555543 23344445689999999999888999999 99999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=341.50 Aligned_cols=264 Identities=23% Similarity=0.445 Sum_probs=218.7
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|.+.+.||.|+||.||+|.+..+++.||+|++...........+.+++|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986543322333456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc---
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN--- 178 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~--- 178 (316)
||++|++|.+++...+.+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998643210000
Q ss_pred -------CCC-------------------------------CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHH
Q psy11194 179 -------AAD-------------------------------NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLF 220 (316)
Q Consensus 179 -------~~~-------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~ 220 (316)
... ........|++.|+|||++.+..++.+ +|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchhhh
Confidence 000 000112458899999999988777665 99999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhc---ccCCCCCCCCCHHHHHHHHHhcCCCCC---CCCHHHHhhCCCCCCC
Q psy11194 221 AMVFGRLPFDDSSVNELLKQVQN---KVTFPKQPEVSTECKELISNILSPVQT---RPRLKTIAEDRWLKPK 286 (316)
Q Consensus 221 ~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~p~~---Rps~~~il~~~~~~~~ 286 (316)
+|++|..||...+..+....+.. ...++....++.++.+||.+||.+|.+ |+++.+++.||||++.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999988877776666643 233444446899999999999965554 5699999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=331.64 Aligned_cols=259 Identities=26% Similarity=0.476 Sum_probs=221.5
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC--Ce
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HR 96 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 96 (316)
...+.|+.++.||+|.||.||+|++..+|+.||+|.++......+...- ..+|+.+|++|+||||+++.+..... ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t-~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPIT-AIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHH-HHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 3456788999999999999999999999999999999987765554444 44999999999999999999998776 68
Q ss_pred EEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
+|+|||||+. +|.-++...+ .+++.+++.++.||+.||.|+|.+|++|||||.+|||++.+|.+||+|||+|+.+...
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999976 9999988743 5999999999999999999999999999999999999999999999999999876533
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc----------
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV---------- 245 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 245 (316)
. .......+.|.+|+|||.+.+...+..+.|+||.||||.||++|++.|.+...-+.++.|-+..
T Consensus 272 ~-----~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 272 G-----SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred C-----CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 2 2235556679999999999988777777999999999999999999999877776666664311
Q ss_pred -CCCC-----------------CCCCCHHHHHHHHHhcC-CCCCCCCHHHHhhCCCCC
Q psy11194 246 -TFPK-----------------QPEVSTECKELISNILS-PVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 246 -~~~~-----------------~~~~~~~~~~li~~~l~-~p~~Rps~~~il~~~~~~ 284 (316)
.+|. ...++....+|+..||+ ||.+|.|+.++|.++||.
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 1110 13478899999999996 999999999999999993
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=330.65 Aligned_cols=253 Identities=26% Similarity=0.521 Sum_probs=216.3
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCce-EEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~-v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
..+......+.+.||.|+||+||+|.+. |.. ||+|++......... .+.+.+|+.++..++||||++++|++....
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4555666777788999999999999777 456 999999776555444 667889999999999999999999999887
Q ss_pred -eEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccCCCCCCeeeCCCC-CeEEeeccccc
Q psy11194 96 -RVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERG-VVHRDIKCENLLLDSDY-NIKLSDFGFAR 170 (316)
Q Consensus 96 -~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~-~~H~dl~p~nil~~~~~-~~~l~Df~~~~ 170 (316)
..++||||+++|+|.+++.. ...++...+..++.||+.|+.|||+++ +||+||||+|||++.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999977 577999999999999999999999999 99999999999999997 99999999997
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cccCC
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQG--IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ-NKVTF 247 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-~~~~~ 247 (316)
...... .......||..|+|||++.+ ..++.+ +||||||+++|||+||..||.+....+....+. .+.++
T Consensus 193 ~~~~~~------~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp 265 (362)
T KOG0192|consen 193 EKVISK------TSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP 265 (362)
T ss_pred eecccc------ccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 632111 22333668999999999994 456555 999999999999999999999998877766665 55555
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 248 PKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 248 ~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+.+..+++.+..+|..|| .+|..||++.+++.
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 556669999999999999 69999999988863
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=340.38 Aligned_cols=264 Identities=26% Similarity=0.440 Sum_probs=221.2
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++++.||+|+||.||+|++..+++.+|+|++...........+.+.+|+.+++.++|+||+++++.+......++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68999999999999999999999999999999876433333335567799999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc----
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN---- 178 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~---- 178 (316)
|+++++|.+++.+.+.+++..++.++.||+.||+|||+.|++|+||||+|||++.+|.++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999999999988778999999999999999999999999999999999999999999999999987532100000
Q ss_pred -------------------------------------CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHH
Q psy11194 179 -------------------------------------AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFA 221 (316)
Q Consensus 179 -------------------------------------~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ 221 (316)
...........|++.|+|||++.+..++.+ +|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHHHHH
Confidence 000011123468899999999988777765 999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHhc---ccCCCCCCCCCHHHHHHHHHhcCCCCCCCC---HHHHhhCCCCCCCC
Q psy11194 222 MVFGRLPFDDSSVNELLKQVQN---KVTFPKQPEVSTECKELISNILSPVQTRPR---LKTIAEDRWLKPKP 287 (316)
Q Consensus 222 l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~p~~Rps---~~~il~~~~~~~~~ 287 (316)
|++|..||...+..+....+.. ....+....+++++.++|.+|+.+|.+|++ ++++++||||+...
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 9999999998877766655543 234445567899999999998889999987 99999999997754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=306.85 Aligned_cols=261 Identities=32% Similarity=0.577 Sum_probs=235.8
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.....-++|.+.+.||+|.||.||.|+.++++-.||+|++.+..........++++|+++...|+||||++++++|.+..
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 34556789999999999999999999999999999999998877666666788999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIR--GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
..|+++||..+|+|...++ ....+++...+.++.|++.|+.|+|.++++||||+|+|+|++..|..+++|||.+..-
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~- 174 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA- 174 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec-
Confidence 9999999999999999998 5567999999999999999999999999999999999999999999999999988541
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEV 253 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (316)
........+||..|.+||...+..++.. .|+|++|++.|+++.|..||.+....+..+.+.+.. ...+..+
T Consensus 175 -------p~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-~~~p~~i 245 (281)
T KOG0580|consen 175 -------PSNKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-LKFPSTI 245 (281)
T ss_pred -------CCCCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-ccCCccc
Confidence 1344556679999999999999999888 999999999999999999999998888888886642 3334789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
+.+++++|..|| .+|.+|.+..++++|||+...
T Consensus 246 s~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 246 SGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999 699999999999999998753
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=324.11 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=208.6
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||.|+||.||+|.+..++..||+|++....... ....+.+|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 467999999999999999999999999999999986543221 133456899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|||+++ +|.+++... ..++...+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~----- 155 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV----- 155 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC-----
Confidence 999976 999988654 4589999999999999999999999999999999999999999999999999864211
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-------------
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT------------- 246 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 246 (316)
.........+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 156 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 156 -PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred -CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 111122345788999999987654444559999999999999999999988776665544422110
Q ss_pred -------CCC---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 247 -------FPK---------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 247 -------~~~---------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
++. .+.++.++.+||.+|| .+|.+|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 110 1346889999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=334.75 Aligned_cols=260 Identities=26% Similarity=0.460 Sum_probs=220.6
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|.+.+.||+|+||.||+|.+..+|+.+|+|++...........+.+.+|+.+++.++|++|+++++++......++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654433334566788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||+++++|.+++.+. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++..... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~-----~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA-----N 155 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCC-----C
Confidence 999999999999875 6799999999999999999999999999999999999999999999999999865321 1
Q ss_pred CCCCCcccccccCccCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---cCCCCCCC
Q psy11194 181 DNSLSETFCGSYAYASPEILQG-----IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK---VTFPKQPE 252 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~ 252 (316)
.........+++.|+|||++.. ....+.++|||||||++|+|++|..||...........+... ..++..+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK 235 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence 1112223457889999999863 222334499999999999999999999887777766666543 34455567
Q ss_pred CCHHHHHHHHHhcCCCCCCCCHHHHhhCCCCCCC
Q psy11194 253 VSTECKELISNILSPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 253 ~~~~~~~li~~~l~~p~~Rps~~~il~~~~~~~~ 286 (316)
++.++.+||..||.+|.+||++++++.||||...
T Consensus 236 ~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 236 VSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCC
Confidence 8999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=330.21 Aligned_cols=252 Identities=33% Similarity=0.542 Sum_probs=214.6
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENG 107 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 107 (316)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997643323333445668999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcc
Q psy11194 108 SLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET 187 (316)
Q Consensus 108 sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~ 187 (316)
+|..++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.... ........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~------~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI------SDGATMKT 154 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhcccc------CCCCcccc
Confidence 999999887889999999999999999999999999999999999999999999999999875421 11111223
Q ss_pred cccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-C
Q psy11194 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-S 266 (316)
Q Consensus 188 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~ 266 (316)
..|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+.......+... ....+..+++++.++|..|| .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred ccCCcCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccC
Confidence 458899999999988777665 99999999999999999999988877776666433 22334578999999999999 5
Q ss_pred CCCCCC-----CHHHHhhCCCCCCCC
Q psy11194 267 PVQTRP-----RLKTIAEDRWLKPKP 287 (316)
Q Consensus 267 ~p~~Rp-----s~~~il~~~~~~~~~ 287 (316)
+|.+|| ++.++++||||.+..
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 999998 999999999998744
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=330.23 Aligned_cols=251 Identities=30% Similarity=0.520 Sum_probs=214.7
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENG 107 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 107 (316)
+.||+|+||.||+|.+..+|+.+|+|++.............+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999997654333333445668999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcc
Q psy11194 108 SLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET 187 (316)
Q Consensus 108 sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~ 187 (316)
+|..++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.... ........
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~------~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI------TDAATMKT 154 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCC------Cccccccc
Confidence 999999887789999999999999999999999999999999999999999999999999985421 11112233
Q ss_pred cccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-C
Q psy11194 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-S 266 (316)
Q Consensus 188 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~ 266 (316)
..|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+....+... ....+..++.++.++|.+|| .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-DIKFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred ccCCcCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-CccCCCCCCHHHHHHHHHHcCC
Confidence 458899999999987777665 99999999999999999999888777776665433 23444678999999999999 6
Q ss_pred CCCCCC-----CHHHHhhCCCCCCC
Q psy11194 267 PVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 267 ~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
+|.+|+ +++++++||||.+.
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999997 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=329.15 Aligned_cols=249 Identities=28% Similarity=0.502 Sum_probs=213.7
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCH
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL 109 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 109 (316)
||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999998754332222344566899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccc
Q psy11194 110 FDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189 (316)
Q Consensus 110 ~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~ 189 (316)
.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.... ..........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~------~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNM------KDDDKTNTFC 154 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCc------cCCCcccccc
Confidence 9999888889999999999999999999999999999999999999999999999999986421 1112223445
Q ss_pred cccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCC
Q psy11194 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPV 268 (316)
Q Consensus 190 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p 268 (316)
|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+....+... ....+..+++++.++|.+|| .+|
T Consensus 155 gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred CCcccCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHcCCCH
Confidence 8899999999988777665 99999999999999999999988888777666543 23344578999999999999 599
Q ss_pred CCCC---CHHHHhhCCCCCCC
Q psy11194 269 QTRP---RLKTIAEDRWLKPK 286 (316)
Q Consensus 269 ~~Rp---s~~~il~~~~~~~~ 286 (316)
.+|| ++.+++.||||...
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCC
Confidence 9997 57999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=336.38 Aligned_cols=264 Identities=23% Similarity=0.451 Sum_probs=221.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|.+..+++.+|+|+++..........+.+++|+.++..++|++++++++.+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999999999999999997543323333556778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC--
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA-- 179 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~-- 179 (316)
||++|++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.+|.++|+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999986432110000
Q ss_pred ---------------------------CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy11194 180 ---------------------------ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS 232 (316)
Q Consensus 180 ---------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~ 232 (316)
..........|++.|+|||++.+..++.. +|||||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCCCC
Confidence 00011123468999999999988777766 99999999999999999999988
Q ss_pred CHHHHHHHHhcc---cCCCCCCCCCHHHHHHHHHhcCCCCCCC---CHHHHhhCCCCCCC
Q psy11194 233 SVNELLKQVQNK---VTFPKQPEVSTECKELISNILSPVQTRP---RLKTIAEDRWLKPK 286 (316)
Q Consensus 233 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~p~~Rp---s~~~il~~~~~~~~ 286 (316)
........+... ..++....++.+++++|.+|+.+|.+|+ +++++++||||++.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCC
Confidence 888777766542 2334444589999999999888888888 58999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=335.77 Aligned_cols=264 Identities=25% Similarity=0.428 Sum_probs=219.1
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
.|++++.||+|+||.||+|++..+++.+|+|++...........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999976544333345567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc----
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN---- 178 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~---- 178 (316)
|++|++|.+++.+.+.+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999987533110000
Q ss_pred -------------------------------------CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHH
Q psy11194 179 -------------------------------------AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFA 221 (316)
Q Consensus 179 -------------------------------------~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ 221 (316)
...........|++.|+|||++.+..++.+ +|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhHHHH
Confidence 000001123468999999999988777665 999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHhc---ccCCCCCCCCCHHHHHHHHHhc-C--CCCCCCCHHHHhhCCCCCCCC
Q psy11194 222 MVFGRLPFDDSSVNELLKQVQN---KVTFPKQPEVSTECKELISNIL-S--PVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 222 l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l-~--~p~~Rps~~~il~~~~~~~~~ 287 (316)
|++|..||...+..+....+.. ....+....+++++.+||.+|+ . +|..||++++++.||||++..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 9999999988777665555432 2344545568999999999976 2 455699999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=323.21 Aligned_cols=258 Identities=20% Similarity=0.280 Sum_probs=212.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.++..++|++++++++++...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 47889999999999999999999999999999876443322223446689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 103 YAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 103 ~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|+++++|..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE------ 154 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC------
Confidence 9999999988754 33589999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cccCCCCCCCCCHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ---NKVTFPKQPEVSTEC 257 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 257 (316)
........|+..|+|||++.+..++.+ +|||||||++|+|++|+.||...........+. .......+..++.++
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 232 (285)
T cd05631 155 -GETVRGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDA 232 (285)
T ss_pred -CCeecCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHH
Confidence 111123457899999999988777766 999999999999999999998654322222221 222233445689999
Q ss_pred HHHHHHhc-CCCCCCCC-----HHHHhhCCCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRPR-----LKTIAEDRWLKPKPK 288 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps-----~~~il~~~~~~~~~~ 288 (316)
.+||..|| .+|.+||+ ++++++||||.+...
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 233 KSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 99999999 59999997 899999999987553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=312.15 Aligned_cols=275 Identities=30% Similarity=0.526 Sum_probs=234.7
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
+-.+.|++.+.||+|.|+.|+++.+..+|+.+++|.+........ ..+.+.+|+.+-+.|+||||+++.+........+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 346779999999999999999999999999999999865444332 4667899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC---CCCeEEeecccccccccc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~---~~~~~l~Df~~~~~~~~~ 175 (316)
+|+|++.|+.|..-+-.....++..+..++.||+.||.|+|.+||||+|++|+|+++-. .-.+||+|||++...
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l--- 163 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV--- 163 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe---
Confidence 99999999998665543356889999999999999999999999999999999999943 345999999999653
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---cCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK---VTFPKQPE 252 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~ 252 (316)
.......+..|++.|+|||+....++... +|||+-|++||-|+.|++||.+.+...+.+++..+ ...+.++.
T Consensus 164 ----~~g~~~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~ 238 (355)
T KOG0033|consen 164 ----NDGEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDT 238 (355)
T ss_pred ----CCccccccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCc
Confidence 23445556779999999999999888776 99999999999999999999999999999999775 34556788
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC---hhhHHHhHhHH
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG---VDKAEAELDHY 302 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~---~~~~~~~~~~~ 302 (316)
++++.++|+++|| .||.+|.|+.|+|.|||+.+.++... +....+.+++|
T Consensus 239 is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkf 292 (355)
T KOG0033|consen 239 VTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKF 292 (355)
T ss_pred CCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHh
Confidence 9999999999999 59999999999999999988776554 33444444444
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=322.55 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=208.8
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|++..+++.+++|++....... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 47999999999999999999999999999999987654332 22445668999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||++++++..+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-----~~ 154 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-----GS 154 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc-----cc
Confidence 9999877766655556799999999999999999999999999999999999999999999999999865321 11
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----------------
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK----------------- 244 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 244 (316)
........++..|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 111223457889999999987776655 99999999999999999999876554433222110
Q ss_pred ---cCCCC-----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 245 ---VTFPK-----------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 245 ---~~~~~-----------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
...+. ...+|.++.+||.+|| .+|++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00111 1236889999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=328.22 Aligned_cols=266 Identities=32% Similarity=0.594 Sum_probs=223.1
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchH-----------HHhhHHHHHHHHhcCCCCCccee
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDY-----------LKKFLPREIEVVKGLKHPNLIRF 87 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~ 87 (316)
..-++|++.+.||+|.||.|-+|++..+++.||+|++.+......+ -.+.+++|+.++++|.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3467899999999999999999999999999999999763222111 12568899999999999999999
Q ss_pred eeEEEe--CCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEe
Q psy11194 88 LQAIET--THRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLS 164 (316)
Q Consensus 88 ~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~ 164 (316)
+++..+ .+.+|+|+|||..|.+...- ..++ +++.++++++.+++.||+|||..|++||||||+|+|++++|+|||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 999965 55899999999988765432 2344 9999999999999999999999999999999999999999999999
Q ss_pred ecccccccccccCcCCCCCCCcccccccCccCcccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy11194 165 DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG---IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV 241 (316)
Q Consensus 165 Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~ 241 (316)
|||.+..+..... ...........||+.|+|||...+ ..+...+.||||+|++||.|+.|..||.+....+..+++
T Consensus 253 DFGVs~~~~~~~~-~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 253 DFGVSNEFPQGSD-EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred ccceeeecccCCc-cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 9999865432211 112222233679999999999876 556777789999999999999999999998888888777
Q ss_pred hc-ccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 242 QN-KVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 242 ~~-~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
.. ...+|..+.+.+.+++||.+|| +||.+|.++.+|..|||...-
T Consensus 332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 54 5667887889999999999999 799999999999999999544
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=324.51 Aligned_cols=258 Identities=25% Similarity=0.410 Sum_probs=206.0
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|.+.+.||.|+||.||+|.+..+++.+|+|++........ ...+.+|+.+++.++||||+++++++..+...++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999875433221 23355899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|||+++ +|.+++.. .+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----- 155 (303)
T cd07869 82 FEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV----- 155 (303)
T ss_pred EECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC-----
Confidence 999965 78777755 45689999999999999999999999999999999999999999999999998854211
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcccCCC----------
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-VNELLKQVQNKVTFP---------- 248 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~---------- 248 (316)
.........++..|+|||++.+....+.++|||||||++|+|++|..||.+.. ..+..+.+......+
T Consensus 156 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 156 -PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred -CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 11112234578899999998765544555999999999999999999998643 222222221100000
Q ss_pred ------------C---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 249 ------------K---------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 249 ------------~---------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
. ....+..+.+||..|| .+|++|||++++++||||++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0 0124578899999999 5999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=334.23 Aligned_cols=264 Identities=28% Similarity=0.460 Sum_probs=221.1
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..++|++.+.||+|+||.||+|.+..+++.+|+|++...........+.+.+|+.+++.++||||+++++++..++.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 45667899999999999999999999999999999999975433222234456789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++||||++|++|.+++... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~-- 194 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-- 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC--
Confidence 99999999999999998764 489999999999999999999999999999999999999999999999999865321
Q ss_pred CcCCCCCCCcccccccCccCcccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---cCCCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIP---YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK---VTFPKQ 250 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~ 250 (316)
..........|++.|+|||++.+.. ..+.++|||||||++|+|++|..||...+.......+... ..++..
T Consensus 195 ---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 195 ---NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred ---CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence 1111123345899999999986532 2344599999999999999999999988877777776543 334444
Q ss_pred CCCCHHHHHHHHHhc-CCCCC--CCCHHHHhhCCCCCCC
Q psy11194 251 PEVSTECKELISNIL-SPVQT--RPRLKTIAEDRWLKPK 286 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~--Rps~~~il~~~~~~~~ 286 (316)
..+|.++.+||..|| .+|.+ |++++++++||||+..
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 568999999999999 47876 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=326.92 Aligned_cols=259 Identities=26% Similarity=0.409 Sum_probs=217.4
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
+..++|++.+.||+|+||.||+|++..++..+++|++..... ....+.+.+|+.+++.++||||+++++++..++..+
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 457899999999999999999999999999999999875432 233556789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+||||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence 9999999999999998877899999999999999999999986 699999999999999999999999998864321
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------------
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-------------- 243 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-------------- 243 (316)
.......++..|+|||++.+..++.+ +|||||||++|+|++|+.||...+..+....+..
T Consensus 157 -----~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 157 -----SMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred -----cccccCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 11223457889999999988776665 9999999999999999999987665554332211
Q ss_pred --------------------------------ccCCC-CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 244 --------------------------------KVTFP-KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 244 --------------------------------~~~~~-~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
..... ....++.++++||.+|| .+|++|||++++++||||+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 00001 11246889999999999 59999999999999999987554
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=327.40 Aligned_cols=252 Identities=28% Similarity=0.518 Sum_probs=213.4
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998754322222234455777888776 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|..++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~------~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI------FNGKTTS 154 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecC------cCCCccc
Confidence 9999999888889999999999999999999999999999999999999999999999999875421 1112223
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
...|++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+..+....+.... ...+..++.++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred ccccCccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcc
Confidence 3468899999999987776665 999999999999999999999988888877776543 3334568999999999999
Q ss_pred CCCCCCCCH------HHHhhCCCCCCCC
Q psy11194 266 SPVQTRPRL------KTIAEDRWLKPKP 287 (316)
Q Consensus 266 ~~p~~Rps~------~~il~~~~~~~~~ 287 (316)
.+|.+||++ ++++.||||+...
T Consensus 233 ~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 233 KNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred cCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 699999998 9999999997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=325.62 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=217.4
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC-CCcceeeeEEEeCCeEEEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-PNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 101 (316)
+|++.+.||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+.| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999976433222224456688888888865 56888999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~------~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI------FG 154 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecC------CC
Confidence 999999999999887889999999999999999999999999999999999999999999999999875321 11
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 261 (316)
........|+..|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+.... ...+..++.++.++|
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li 232 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSIC 232 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHH
Confidence 112233458899999999988777665 999999999999999999999888887777776542 334457899999999
Q ss_pred HHhc-CCCCCCCCH-----HHHhhCCCCCCC
Q psy11194 262 SNIL-SPVQTRPRL-----KTIAEDRWLKPK 286 (316)
Q Consensus 262 ~~~l-~~p~~Rps~-----~~il~~~~~~~~ 286 (316)
.+|| .+|.+|++. +++++||||...
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999 699999986 899999999764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=334.96 Aligned_cols=261 Identities=26% Similarity=0.473 Sum_probs=230.6
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCC
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH 95 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 95 (316)
..+.-++|.+++.||+|.||.|++|..+.+++.+|||++++..-......+..+.|..++...+ ||.++.++.+|++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3667889999999999999999999999999999999998876655555777888999998885 999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
+.|+||||+.||++..+ ...+.+++..++-++..++.||.|||++||||||||.+|||+|.+|.+||+|||+++.
T Consensus 443 ~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe---- 517 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE---- 517 (694)
T ss_pred eEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc----
Confidence 99999999999995443 3345699999999999999999999999999999999999999999999999999865
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCH
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (316)
...........+||+.|+|||++....|+.. .|+|||||+||+|+.|..||++.+-+++.+.|... ....+..+|.
T Consensus 518 --~m~~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-~~~yP~~ls~ 593 (694)
T KOG0694|consen 518 --GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-EVRYPRFLSK 593 (694)
T ss_pred --cCCCCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CCCCCCcccH
Confidence 2334445667889999999999999888877 99999999999999999999999999999888654 2334456999
Q ss_pred HHHHHHHHhc-CCCCCCCCH-----HHHhhCCCCCCC
Q psy11194 256 ECKELISNIL-SPVQTRPRL-----KTIAEDRWLKPK 286 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~-----~~il~~~~~~~~ 286 (316)
+..++|+++| ++|++|..+ ++|.+||||...
T Consensus 594 ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 594 EAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 9999999999 799999965 899999999654
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=310.08 Aligned_cols=261 Identities=23% Similarity=0.358 Sum_probs=218.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--CCeEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVY 98 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 98 (316)
-+.|+.+..|++|+||.||+|+++.+++.||+|.++........-...+ +|+.+|.+++|||||.+-++... -+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsL-REIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSL-REINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhH-HHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3458899999999999999999999999999999987664433334445 89999999999999999888753 44699
Q ss_pred EEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 99 IIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+|||||+. +|..++...+ ++...+++.++.|+++|++|||.+.|+||||||+|+|+...|.+|++|||+|+.+..
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs--- 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS--- 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC---
Confidence 99999976 9999998744 799999999999999999999999999999999999999999999999999987632
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC--------
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK-------- 249 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 249 (316)
.........-|.+|+|||.+.+...++.+.|+||+|||+.|++++.+.|++....+..+++-.....|.
T Consensus 230 ---p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 230 ---PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred ---CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 123344556789999999998887777779999999999999999999999877776666643211111
Q ss_pred ------------C-----------CCCCHHHHHHHHHhcC-CCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 250 ------------Q-----------PEVSTECKELISNILS-PVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 250 ------------~-----------~~~~~~~~~li~~~l~-~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
. ..+++.-.+|+..+|. ||.+|.|+++.|+|+||.+.+..
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 0 1256888999999995 99999999999999999885543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=331.70 Aligned_cols=264 Identities=28% Similarity=0.475 Sum_probs=219.7
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..++|++.+.||+|+||.||+|.+..+++.+|+|++...........+.+.+|+.+++.++||||+++++++..+..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 44567889999999999999999999999999999999875433333334557789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++||||+++++|.+++... .+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~-- 194 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE-- 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc--
Confidence 99999999999999999765 489999999999999999999999999999999999999999999999999865321
Q ss_pred CcCCCCCCCcccccccCccCcccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---cCCCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIP---YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK---VTFPKQ 250 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~ 250 (316)
..........|++.|+|||++.+.. ..+.++|+|||||++|+|++|..||...+.......+... ..++..
T Consensus 195 ---~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 271 (370)
T cd05621 195 ---TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271 (370)
T ss_pred ---CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence 1111123446899999999986543 2334599999999999999999999988877776666543 334444
Q ss_pred CCCCHHHHHHHHHhcC-CC--CCCCCHHHHhhCCCCCCC
Q psy11194 251 PEVSTECKELISNILS-PV--QTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 251 ~~~~~~~~~li~~~l~-~p--~~Rps~~~il~~~~~~~~ 286 (316)
..++..++++|..||. ++ ..|++++++++||||+..
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 5689999999999994 43 348999999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=326.76 Aligned_cols=260 Identities=27% Similarity=0.483 Sum_probs=206.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-----CeE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----HRV 97 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 97 (316)
+|++.+.||+|+||.||+|.+..+|..||+|.+......... ...+.+|+.+++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD-ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchh-HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 689999999999999999999999999999998653322222 33466899999999999999999988543 257
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
++||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~- 157 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT- 157 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc-
Confidence 99999995 5999999887789999999999999999999999999999999999999999999999999986532111
Q ss_pred cCCCCCCCcccccccCccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQG--IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN------------ 243 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~------------ 243 (316)
..........++..|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.+.......+..
T Consensus 158 --~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 158 --PTAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred --CccccccCCCCCCCcCCHHHHhccccccCc-hhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 11112233458899999999865 34444 49999999999999999999987654332221111
Q ss_pred ---------------ccCCC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 244 ---------------KVTFP---KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 244 ---------------~~~~~---~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
....+ ..+.+++++.++|.+|| .+|++|||++++++||||+....
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00111 11357889999999999 59999999999999999977555
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=323.75 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=213.1
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHH---hcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV---KGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
|++.+.||+|++|.||+|.+..+++.||+|++...........+.+.+|..++ ..++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 68899999999999999999999999999999754322222234455666555 456799999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|||+++++|...+.. +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~------~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM------G 153 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCC------C
Confidence 999999999988865 459999999999999999999999999999999999999999999999999875421 1
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (316)
.........|++.|+|||.+.+..++.+ +|||||||++|+|++|..||.+.+..+....+.... ...+..++..+.++
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~l 231 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSREAISI 231 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHH
Confidence 1122234568899999999988777665 999999999999999999999888887777665542 23345689999999
Q ss_pred HHHhc-CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 261 ISNIL-SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 261 i~~~l-~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
|.+|| .+|.+|| +++++++||||.+.
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 99999 6999999 79999999999774
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=325.68 Aligned_cols=250 Identities=28% Similarity=0.526 Sum_probs=207.8
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|.+..+++.||+|++...........+.+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999999999999999999765433333345577899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|..++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~------~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI------RPGDTTS 154 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc------cCCCccc
Confidence 9999999887889999999999999999999999999999999999999999999999999885311 1112223
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HH-HHHHHHhcccCCCCCCCCCHHH
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS--------VN-ELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
...|+..|+|||++.+..++.+ +|+|||||++|+|++|..||.... .. ...+.+.. .....+..++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CCCCCCCCCCHHH
Confidence 3468899999999988777665 999999999999999999996311 11 12222322 2334455789999
Q ss_pred HHHHHHhc-CCCCCCCC------HHHHhhCCCCCC
Q psy11194 258 KELISNIL-SPVQTRPR------LKTIAEDRWLKP 285 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps------~~~il~~~~~~~ 285 (316)
.++|.+|| .+|.+||+ ++++++||||..
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999 59999987 799999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=329.48 Aligned_cols=265 Identities=28% Similarity=0.475 Sum_probs=221.4
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
...+..++|++.+.||+|+||.||+|++..+++.+|+|++...........+.+.+|..+++.++||||+++++.+....
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 35566789999999999999999999999999999999987543323333455778999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++||||++|++|.+++... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~- 194 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK- 194 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc-
Confidence 999999999999999999764 489999999999999999999999999999999999999999999999999865321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---cCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIP---YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK---VTFPK 249 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~ 249 (316)
..........|++.|+|||++.... ..+.++|||||||++|+|++|..||...+.......+... ..++.
T Consensus 195 ----~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 195 ----EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred ----CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 1111223456899999999986543 2344599999999999999999999988887777776543 34455
Q ss_pred CCCCCHHHHHHHHHhcCC-CC--CCCCHHHHhhCCCCCCC
Q psy11194 250 QPEVSTECKELISNILSP-VQ--TRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l~~-p~--~Rps~~~il~~~~~~~~ 286 (316)
...++.+++++|..||.+ +. .|++++++++||||++.
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 567999999999999954 33 38899999999999774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=323.75 Aligned_cols=263 Identities=32% Similarity=0.524 Sum_probs=232.9
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHR 96 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 96 (316)
.-....|++.+.||+|.||.||.++...+|+.+|+|.+.+.........+.+.+|+.+++.+. ||||+.++++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 445667999999999999999999999999999999998877655444567889999999998 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC----CCeEEeeccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD----YNIKLSDFGFARAH 172 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~----~~~~l~Df~~~~~~ 172 (316)
+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|++|+||||+|+|+... +.++++|||++...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999776 49999999999999999999999999999999999999643 57999999999763
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---cCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK---VTFPK 249 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~ 249 (316)
. ........+|++.|+|||++....+... +||||+|+++|.|++|..||.+.........+..+ +..+.
T Consensus 190 ~-------~~~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~ 261 (382)
T KOG0032|consen 190 K-------PGERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEP 261 (382)
T ss_pred c-------CCceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCC
Confidence 2 2445566789999999999998888877 99999999999999999999998877777777665 44556
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
+..++..++++|..|| .||..|+++.++|+|||++.....
T Consensus 262 w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 262 WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence 6789999999999999 699999999999999999986443
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=327.38 Aligned_cols=251 Identities=31% Similarity=0.530 Sum_probs=213.6
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENG 107 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 107 (316)
+.||+|+||.||+|.+..+|+.+|+|++.............+..|+.++..++||||+++++++......++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997643333333445568899999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 108 SLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 108 sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
+|..++.....+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~------~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI------KDGATMK 154 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecC------CCCcccc
Confidence 999999887889999999999999999999997 799999999999999999999999999885421 1111222
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
...|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+.......+... ....+..+++++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred cccCCcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHhh
Confidence 3458899999999988777665 99999999999999999999988877776666443 23344568999999999999
Q ss_pred CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 266 SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 266 ~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
.+|++|+ ++.++++||||.+.
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 6999996 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=324.81 Aligned_cols=251 Identities=29% Similarity=0.494 Sum_probs=213.1
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|.+..+++.+|+|++...........+.+..|..++..+ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999999764332222234455788888766 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|..++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~------~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL------NGVTTT 154 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc------CCcccc
Confidence 99999998878899999999999999999999999999999999999999999999999998864211 111223
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
...|+..|+|||++.+..++.+ +|||||||++|+|++|..||...+..+..+.+.... ...+..++.++.++|..||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VLYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred ccccCccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhc
Confidence 3457899999999988777666 999999999999999999999988888877776543 2334468999999999999
Q ss_pred CCCCCCC-------CHHHHhhCCCCCCC
Q psy11194 266 SPVQTRP-------RLKTIAEDRWLKPK 286 (316)
Q Consensus 266 ~~p~~Rp-------s~~~il~~~~~~~~ 286 (316)
.+|++|| +++++++||||...
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 6999999 99999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=321.98 Aligned_cols=256 Identities=28% Similarity=0.481 Sum_probs=217.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
+|.+.+.||+|+||.||+|.+..+++.+|+|++...........+....|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999764332222233455677777777 5899999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|..++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~------~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM------WD 154 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecC------CC
Confidence 999999999999887789999999999999999999999999999999999999999999999999885421 11
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 261 (316)
........|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+....+.... ...+..++.++.+++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 232 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAIC 232 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHH
Confidence 112234458899999999988777766 999999999999999999999988888777776542 334456899999999
Q ss_pred HHhc-CCCCCCCCH-----HHHhhCCCCCCC
Q psy11194 262 SNIL-SPVQTRPRL-----KTIAEDRWLKPK 286 (316)
Q Consensus 262 ~~~l-~~p~~Rps~-----~~il~~~~~~~~ 286 (316)
.+|| .+|.+|++. .++++||||+..
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 9999 699999984 899999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=322.09 Aligned_cols=252 Identities=28% Similarity=0.499 Sum_probs=210.6
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|.+..+|+.||+|.+...........+.+..|..++... +||+|+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999764321111233445677777654 899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|..++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~------~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV------FGDNRAS 154 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecc------cCCCcee
Confidence 9999999887789999999999999999999999999999999999999999999999999875321 1112223
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
...|+..|+|||++.+..++.+ +|||||||++|+|++|..||...+..+..+.+.... ...+..++.+++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-PHYPRWITKESKDILEKLFE 232 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHcc
Confidence 4458899999999988777666 999999999999999999999888877777765442 2334468999999999999
Q ss_pred CCCCCCCCH-HHHhhCCCCCCCC
Q psy11194 266 SPVQTRPRL-KTIAEDRWLKPKP 287 (316)
Q Consensus 266 ~~p~~Rps~-~~il~~~~~~~~~ 287 (316)
.+|++||++ ++++.||||....
T Consensus 233 ~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 233 RDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CCHHHcCCChHHHHcCCCcCCCC
Confidence 699999998 5899999997753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=324.04 Aligned_cols=258 Identities=26% Similarity=0.482 Sum_probs=211.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEc---cCCceEEEEEeecCCCC-chHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeE
Q psy11194 23 GYTVGKIIGTGSYATVKLARST---RHSGDVAIKIVSKVQAP-PDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~---~~~~~v~vK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 97 (316)
+|++.+.||+|+||.||+|++. .+++.+|+|++...... .....+.+..|+.++..+ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998864 46889999998753221 122244567899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
++||||+++++|.+++.+...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-- 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-- 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc--
Confidence 999999999999999988778999999999999999999999999999999999999999999999999998653211
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcccCCCCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS----SVNELLKQVQNKVTFPKQPEV 253 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~ 253 (316)
.........|+..|+|||++.+....+.++|||||||++|+|++|..||... ....+...+.. ...+.+..+
T Consensus 159 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (332)
T cd05614 159 ---EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFI 234 (332)
T ss_pred ---CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-CCCCCCCCC
Confidence 1111223458899999999977554444599999999999999999999642 23333333333 233445678
Q ss_pred CHHHHHHHHHhc-CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 254 STECKELISNIL-SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
+..+.++|.+|| .+|++|| +++++++||||++.
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999 6999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=321.27 Aligned_cols=251 Identities=31% Similarity=0.534 Sum_probs=210.1
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+ +||||+++++++......++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999764322222233344566666654 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|..++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~------~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN------GEGKAS 154 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC------CCCccc
Confidence 99999998877899999999999999999999999999999999999999999999999999864211 112233
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
...|++.|+|||.+.+..++.+ +|||||||++|+|++|..||.+.+..+....+... ....+..++.++.++|..||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred cccCCccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHcc
Confidence 4468899999999988777665 99999999999999999999998888777776553 23344568999999999999
Q ss_pred CCCCCCCCH-HHHhhCCCCCCC
Q psy11194 266 SPVQTRPRL-KTIAEDRWLKPK 286 (316)
Q Consensus 266 ~~p~~Rps~-~~il~~~~~~~~ 286 (316)
.+|.+||++ .++++||||...
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 233 RDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CCHHHcCCChHHHHcCcccCCC
Confidence 699999987 488899999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=321.71 Aligned_cols=251 Identities=31% Similarity=0.544 Sum_probs=213.3
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|.+..+++.+|+|++.............+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999764322222234455788888877 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|...+.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~------~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI------LGGVTTS 154 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecC------cCCCccc
Confidence 9999999888789999999999999999999999999999999999999999999999999885321 1111222
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
...++..|+|||++.+..++.+ +|+|||||++|+|++|..||...+..+....+.... ...+..++.++.++|.+||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VRYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred ceecCccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcc
Confidence 3457889999999988777766 999999999999999999999888877777665442 2334568999999999999
Q ss_pred CCCCCCCCH-----HHHhhCCCCCCC
Q psy11194 266 SPVQTRPRL-----KTIAEDRWLKPK 286 (316)
Q Consensus 266 ~~p~~Rps~-----~~il~~~~~~~~ 286 (316)
.+|.+||++ .++++||||...
T Consensus 233 ~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 699999999 999999999774
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=323.39 Aligned_cols=252 Identities=29% Similarity=0.537 Sum_probs=210.5
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHH-HHHhcCCCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREI-EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|.+..+|+.||+|++.............+..|. .+++.++||||+++++.+......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999999999999999998754322221122233444 356788999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|..++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~------~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI------EHSKTTS 154 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccc------cCCCccc
Confidence 9999999888889999999999999999999999999999999999999999999999999885421 1112223
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
...|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+..+.+.... ....+.++.++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred cccCChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhh
Confidence 4458899999999988776665 999999999999999999999988888777765542 3344568999999999999
Q ss_pred CCCCCCCCH----HHHhhCCCCCCCC
Q psy11194 266 SPVQTRPRL----KTIAEDRWLKPKP 287 (316)
Q Consensus 266 ~~p~~Rps~----~~il~~~~~~~~~ 287 (316)
.+|.+||++ +++++||||....
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 699999987 6999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=321.60 Aligned_cols=251 Identities=25% Similarity=0.509 Sum_probs=212.8
Q ss_pred eeeeecCCeEEEEEEEc---cCCceEEEEEeecCCCC-chHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEec
Q psy11194 28 KIIGTGSYATVKLARST---RHSGDVAIKIVSKVQAP-PDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~---~~~~~v~vK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
+.||+|+||.||+|.+. .+++.+|+|++...... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999864 46789999998753221 112234566899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCC
Q psy11194 104 AENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNS 183 (316)
Q Consensus 104 ~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~ 183 (316)
+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... ....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~------~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI------HEGT 155 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecc------cCCC
Confidence 9999999999888889999999999999999999999999999999999999999999999999885421 1111
Q ss_pred CCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Q psy11194 184 LSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISN 263 (316)
Q Consensus 184 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 263 (316)
......|++.|+|||++.+..++.+ +||||||+++|+|++|..||...+.......+... ....+..+++.+.++|.+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-KLNLPPYLTPEARDLLKK 233 (323)
T ss_pred cccccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHH
Confidence 2223458899999999988776655 99999999999999999999988887777776554 334456789999999999
Q ss_pred hc-CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 264 IL-SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 264 ~l-~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
|| .+|++|| +++++++||||...
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99 6999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=322.11 Aligned_cols=251 Identities=31% Similarity=0.540 Sum_probs=207.4
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|.+..+++.+|+|++.............+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999999865433333345567888888776 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|..++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~------~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR------PGDTTS 154 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC------CCCccc
Confidence 99999998878899999999999999999999999999999999999999999999999998854211 111223
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhcccCCCCCCCCCHHH
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS---------SVNELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
...|+..|+|||++.+..++.+ +|||||||++|+|++|..||... ......+.+.. .....+..++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCCCCCCHHH
Confidence 3468899999999988777665 99999999999999999999521 11222233322 2334446789999
Q ss_pred HHHHHHhc-CCCCCCCC------HHHHhhCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRPR------LKTIAEDRWLKPK 286 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps------~~~il~~~~~~~~ 286 (316)
.++|.+|| .+|.+||+ ++++++||||...
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999 59999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=321.02 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=215.5
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
+..++|++.+.||.|+||.||+|.+..++..+++|.+..... ......+.+|+.+++.++|+||+++++++...+..+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 457899999999999999999999999999999998866432 223456779999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+||||+++++|.+++...+.+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--- 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---
Confidence 9999999999999998877899999999999999999999975 799999999999999999999999999864321
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---------------
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ--------------- 242 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~--------------- 242 (316)
.......++..|+|||++.+..++.+ +|+|||||++|++++|..||......+....+.
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 157 -----SMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred -----hccccCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 11123357889999999987666655 999999999999999999998655444332211
Q ss_pred -----------------------------cccCCCC-CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 243 -----------------------------NKVTFPK-QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 243 -----------------------------~~~~~~~-~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
....... ....+.++++||.+|| .+|++|||+++++.||||+....+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~ 308 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAE 308 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCccc
Confidence 1100011 1236789999999999 699999999999999999876543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=319.54 Aligned_cols=252 Identities=29% Similarity=0.487 Sum_probs=210.7
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhc-CCCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKG-LKHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|++..+++.||+|++...........+....|..++.. ++||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999976432111112334467777765 4899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~------~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENM------LGDAKTC 154 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECC------CCCCcee
Confidence 9999999887779999999999999999999999999999999999999999999999999885421 1111223
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
...|+..|+|||++.+..++.+ +|||||||++|+|++|..||...+..+..+.+.... ...+..++.++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFV 232 (316)
T ss_pred eecCCccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhc
Confidence 3457889999999988777665 999999999999999999999888887777765443 2334468999999999999
Q ss_pred CCCCCCCCHH-HHhhCCCCCCCC
Q psy11194 266 SPVQTRPRLK-TIAEDRWLKPKP 287 (316)
Q Consensus 266 ~~p~~Rps~~-~il~~~~~~~~~ 287 (316)
.+|.+||++. +++.||||....
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 233 REPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred cCHhhcCCChHHHHcCcccCCCC
Confidence 6999999996 899999997753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=312.17 Aligned_cols=271 Identities=26% Similarity=0.437 Sum_probs=228.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||.|++|.||+|.+..+++.+++|.+....... ....+.+|+.+++.++|+|++++++++..+...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch--HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47889999999999999999999999999999987554222 2345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|.+++... ++++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM----- 152 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-----
Confidence 999999999999865 69999999999999999999999999999999999999999999999999986643211
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCC-CCHHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE-VSTECKEL 260 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l 260 (316)
.......++..|+|||.+.+..++.+ +|+||||+++|++++|..||...++......+........... ++.++.++
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred -cccccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence 11223346778999999988776655 9999999999999999999988777666666655543333333 78999999
Q ss_pred HHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHhHH
Q psy11194 261 ISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHY 302 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~ 302 (316)
+.+|| .+|++||+++++++||||+...+.+=+......+++|
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~~~~~~~~ 273 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIERIKKW 273 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCCcccHHHHHHHHHHhc
Confidence 99999 6999999999999999999988875566666666655
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=320.22 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=213.1
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||++.+..+++.||+|++...........+.+.+|..++..++|++|+++++++..+...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997533222223455778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||++|++|.+++.+ ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-----~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA-----D 155 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCC-----C
Confidence 99999999999976 45699999999999999999999999999999999999999999999999998865321 1
Q ss_pred CCCCCcccccccCccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc---CC-CCCCC
Q psy11194 181 DNSLSETFCGSYAYASPEILQG----IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV---TF-PKQPE 252 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~-~~~~~ 252 (316)
.........|++.|+|||++.. ....+.++|||||||++|+|++|..||...+..+....+.... .. +....
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD 235 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC
Confidence 1111223458899999999863 2233344999999999999999999999887777666664321 22 22235
Q ss_pred CCHHHHHHHHHhcC-C--CCCCCCHHHHhhCCCCCCC
Q psy11194 253 VSTECKELISNILS-P--VQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 253 ~~~~~~~li~~~l~-~--p~~Rps~~~il~~~~~~~~ 286 (316)
++.+++++|.+||. + +..|++++++++||||.+.
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 89999999999994 3 3448899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=317.13 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=211.5
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|.+.+.||+|+||.||+|++..+++.+|+|.+........ ...+.+|+.+++.++||||+++++++..++..++
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 34779999999999999999999999999999999875443221 2345589999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 100 IMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
||||+++ +|.+++... ..++...++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 157 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--- 157 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC---
Confidence 9999976 888887653 45899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC------------
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT------------ 246 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 246 (316)
........++..|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 158 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 158 ---TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred ---ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 11122234678899999987654444559999999999999999999988776555444322110
Q ss_pred --------CC---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 247 --------FP---------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 247 --------~~---------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+ ..+.++.++.+||.+|| .+|.+|||++++++||||+..+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 01 11347889999999999 59999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=318.82 Aligned_cols=257 Identities=29% Similarity=0.489 Sum_probs=216.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 101 (316)
+|...+.||+|+||.||+|.+..+|+.||+|++...........+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999999999999999987643222222344557888888875 678889999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|..++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~------~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV------D 154 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC------C
Confidence 9999999999998888899999999999999999999999999999999999999999999999998864211 1
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 261 (316)
........|++.|+|||++.+..++.+ +|||||||++|+|++|..||...........+.... ...+..++.++.+++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li 232 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSIC 232 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHH
Confidence 111223457899999999988777665 999999999999999999999988887777765532 334456899999999
Q ss_pred HHhc-CCCCCCCC-----HHHHhhCCCCCCCC
Q psy11194 262 SNIL-SPVQTRPR-----LKTIAEDRWLKPKP 287 (316)
Q Consensus 262 ~~~l-~~p~~Rps-----~~~il~~~~~~~~~ 287 (316)
.+|| .+|.+|++ .+++++||||....
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 233 KGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred HHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 9999 69999997 57999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=303.25 Aligned_cols=255 Identities=28% Similarity=0.505 Sum_probs=222.6
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCC-----CchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA-----PPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 95 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 95 (316)
++|..-+.||+|..+.|-++.+..+|+.+++|++..... ......+.-.+|+.+|+++ .||+|+++.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 457777889999999999999999999999999965322 2233344555899999998 5999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++|+|.++.|-|.+++.+.-.+++...++|+.|+..|++|||..+|||+||||+|||++++-+++|+|||+++...
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~-- 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE-- 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC--
Confidence 999999999999999999988789999999999999999999999999999999999999999999999999997643
Q ss_pred cCcCCCCCCCcccccccCccCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---cCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQ-----GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK---VTF 247 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~ 247 (316)
........+||++|.|||.+. +.+.+++..|+|+.|+|||.|+.|.+||-+-.+.-....+.++ +.-
T Consensus 175 -----~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 175 -----PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred -----CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 223344578999999999873 4455566699999999999999999999988888888888775 355
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 248 PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 248 ~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
|++..+|...++||.+|| -||.+|.|++|+|+||||
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 667789999999999999 599999999999999999
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=308.12 Aligned_cols=260 Identities=27% Similarity=0.507 Sum_probs=217.7
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc------hHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP------DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
+|.+...||.|++|.||+|.+..+++.+++|.+....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5788899999999999999998889999999886543322 1223567889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++++||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999987643211
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
.............++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.......+........+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 11111111223347788999999987766655 99999999999999999999887665555555554444455678999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+.++|.+|| .+|.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999999 599999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=313.66 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=201.8
Q ss_pred cCeEEeeeeeecCCeEEEEEEEcc-CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC---CCCCcceeeeEEE-----
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTR-HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL---KHPNLIRFLQAIE----- 92 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~----- 92 (316)
++|++.+.||+|+||.||+|.+.. .++.+|+|.+......... ...+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999864 4678999998764433221 22234666666655 6999999999885
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
.....++||||++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999996 4999998653 358999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK- 249 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 249 (316)
.... ........++..|+|||.+....++.+ +|||||||++|+|++|..||.+....+....+......+.
T Consensus 159 ~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 159 IYSF-------QMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred eccC-------CcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 5321 122334457889999999987776665 9999999999999999999988776665555433211110
Q ss_pred -------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 250 -------------------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 250 -------------------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.+.++..+.++|.+|| .+|++|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1347788999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=334.04 Aligned_cols=267 Identities=25% Similarity=0.440 Sum_probs=225.6
Q ss_pred ccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 13 DRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 13 ~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
++.......++|.+.+.||+|+||.||+|.+..+|+.||+|++........ ....+.+|+..+..++|++++++++.+.
T Consensus 23 d~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~~l~~~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 23 DEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEA-DKNRAQAEVCCLLNCDFFSIVKCHEDFA 101 (496)
T ss_pred CcccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHH-HHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence 334455667899999999999999999999999999999999976554332 3445678999999999999999988775
Q ss_pred eCC--------eEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC
Q psy11194 93 TTH--------RVYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN 160 (316)
Q Consensus 93 ~~~--------~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~ 160 (316)
... ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL 181 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC
Confidence 332 36899999999999999864 346899999999999999999999999999999999999999999
Q ss_pred eEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy11194 161 IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ 240 (316)
Q Consensus 161 ~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~ 240 (316)
++|+|||+++.+... ..........|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+....
T Consensus 182 vkL~DFGls~~~~~~----~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~ 256 (496)
T PTZ00283 182 VKLGDFGFSKMYAAT----VSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256 (496)
T ss_pred EEEEecccCeecccc----ccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 999999998654311 11122234568899999999988777665 9999999999999999999999888888887
Q ss_pred HhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 241 VQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
+..+...+.+..+++++.+++..|| .+|.+||++.++++|||++.
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 257 TLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 7776666667789999999999999 59999999999999999864
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=312.44 Aligned_cols=256 Identities=19% Similarity=0.294 Sum_probs=212.2
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||+|+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999998999999999875443333233445689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 103 YAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 103 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE------ 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 99999999888643 4589999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---ccCCCCCCCCCHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN---KVTFPKQPEVSTEC 257 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 257 (316)
........++..|+|||++.+..++.+ +||||+|+++|++++|..||.+.......+.+.. ......+..++..+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05605 155 -GETIRGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAA 232 (285)
T ss_pred -CCccccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHH
Confidence 111123357889999999987776665 9999999999999999999987655433322221 22233345689999
Q ss_pred HHHHHHhc-CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
.++|..|| .+|.+|| +++++++||||...
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 99999999 6999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=327.49 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=217.3
Q ss_pred hcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-C-----CCc
Q psy11194 11 DIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-H-----PNL 84 (316)
Q Consensus 11 ~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i 84 (316)
+|.....+...-+|.+.+.||+|+||.|.+|.+.++++.||||+++....- .++...|+.+|..++ | -|+
T Consensus 175 dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f----~~Q~~~Ei~iL~~ln~~d~~~~~n~ 250 (586)
T KOG0667|consen 175 DYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF----LRQAQIEIRILELLNKHDPDDKYNI 250 (586)
T ss_pred ceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH----HHHHHHHHHHHHHHhccCCCCCeeE
Confidence 455555556666999999999999999999999999999999999775432 444558999999996 3 489
Q ss_pred ceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC--CC
Q psy11194 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD--YN 160 (316)
Q Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~--~~ 160 (316)
|+++++|...++.|+|+|.++ .+|.++++.+. +++...++.++.||+.||.+||+.||||+||||+|||+... ..
T Consensus 251 Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 251 VRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred EEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCc
Confidence 999999999999999999995 59999998754 59999999999999999999999999999999999999654 46
Q ss_pred eEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy11194 161 IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ 240 (316)
Q Consensus 161 ~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~ 240 (316)
+||+|||.++.. ........-+..|+|||++.+.++... .||||||||++||++|.+.|++.+..+.+..
T Consensus 330 vKVIDFGSSc~~---------~q~vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~ 399 (586)
T KOG0667|consen 330 IKVIDFGSSCFE---------SQRVYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLAR 399 (586)
T ss_pred eeEEeccccccc---------CCcceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHH
Confidence 999999998642 222225556788999999999999988 9999999999999999999998877766655
Q ss_pred HhcccCCCC--------------------------------------------------CC------------CCCHHHH
Q psy11194 241 VQNKVTFPK--------------------------------------------------QP------------EVSTECK 258 (316)
Q Consensus 241 ~~~~~~~~~--------------------------------------------------~~------------~~~~~~~ 258 (316)
+.+....|. .+ .-...+.
T Consensus 400 I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~ 479 (586)
T KOG0667|consen 400 IIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFI 479 (586)
T ss_pred HHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHH
Confidence 543111110 01 1234778
Q ss_pred HHHHHhcC-CCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 259 ELISNILS-PVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 259 ~li~~~l~-~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
++|.+||. ||..|+|..++|+||||......
T Consensus 480 dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 480 DFLKRCLEWDPAERITPAQALNHPFLTGTSLE 511 (586)
T ss_pred HHHHHHhccCchhcCCHHHHhcCccccccccc
Confidence 99999995 99999999999999999855443
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=323.17 Aligned_cols=256 Identities=22% Similarity=0.362 Sum_probs=206.4
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
+...+|++.+.||+|+||.||+|.+..+++.||+|.... +.+.+|+.+++.++||||+++++++......+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 455789999999999999999999999999999997432 23458999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+|+|++. ++|..++.....++...++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~---- 234 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD---- 234 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc----
Confidence 9999995 58999988777799999999999999999999999999999999999999999999999999864221
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHH-h--------
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-------VNELLKQV-Q-------- 242 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-------~~~~~~~~-~-------- 242 (316)
..........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.... .......+ .
T Consensus 235 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 235 -INANKYYGWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred -ccccccccccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 11112234568999999999988776665 999999999999999997764321 11111111 0
Q ss_pred ------------------cccCCCC-------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 243 ------------------NKVTFPK-------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 243 ------------------~~~~~~~-------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
.....+. ...++.++.+||.+|| .+|++|||++++++||||+..+...
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 386 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPY 386 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCC
Confidence 0000000 0135678999999999 5999999999999999998876543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=329.53 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=204.0
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC--
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-- 94 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 94 (316)
......+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 61 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 61 NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECF 133 (440)
T ss_pred ccCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence 3445678999999999999999999999999999999885432 2234799999999999999998887432
Q ss_pred ------CeEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC-CeEE
Q psy11194 95 ------HRVYIIMEYAENGSLFDIIR----GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY-NIKL 163 (316)
Q Consensus 95 ------~~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~-~~~l 163 (316)
...++||||+++ +|.+++. ....+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|
T Consensus 134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceee
Confidence 246799999975 7877764 345699999999999999999999999999999999999998664 6999
Q ss_pred eecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy11194 164 SDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN 243 (316)
Q Consensus 164 ~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~ 243 (316)
+|||++..... ........+++.|+|||++.+....+.++|||||||++|+|++|.+||.+....+....+..
T Consensus 213 ~DFGla~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 213 CDFGSAKNLLA-------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred eccccchhccC-------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999975421 11122345788999999987654444459999999999999999999988765544433322
Q ss_pred cc------------------CCC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 244 KV------------------TFP----------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 244 ~~------------------~~~----------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.. .++ .+...|.++.+||.+|| .+|.+|||+.++++||||.+...
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 11 011 11246789999999999 59999999999999999976544
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=323.64 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=206.9
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC---CCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL---KHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
||+|+||.||+|++..+++.||+|++................|..++..+ +||+|+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999998653322211122233455555554 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|..++...+.+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~------~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANL------TDNKTTN 154 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCC------CCCCCcc
Confidence 9999999888889999999999999999999999999999999999999999999999999985421 1112223
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
...|+..|+|||++.+....+.++|||||||++|+|++|..||...+..+....+..+........++.++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~ 234 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLN 234 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcC
Confidence 4458899999999876543444599999999999999999999988888877777654332223458999999999999
Q ss_pred CCCCCCC----CHHHHhhCCCCCCCC
Q psy11194 266 SPVQTRP----RLKTIAEDRWLKPKP 287 (316)
Q Consensus 266 ~~p~~Rp----s~~~il~~~~~~~~~ 287 (316)
.+|.+|| +++++++||||....
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccCCC
Confidence 5999998 799999999997643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=318.68 Aligned_cols=253 Identities=30% Similarity=0.528 Sum_probs=209.3
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|.+..+++.+|+|++...........+.+.+|..++..+ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999999865443333455677899988888 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|..++...+.+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~------~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL------GPGDTTS 154 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceecc------CCCCcee
Confidence 9999999887789999999999999999999999999999999999999999999999999885321 1111223
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS------SVNELLKQVQNKVTFPKQPEVSTECKEL 260 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (316)
...|++.|+|||++.+..++.+ +|||||||++|+|++|..||... ...+.............+..++..+.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l 233 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV 233 (327)
T ss_pred cccCCcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 3458899999999988777665 99999999999999999999531 2222222222222344556689999999
Q ss_pred HHHhc-CCCCCCCC------HHHHhhCCCCCCCC
Q psy11194 261 ISNIL-SPVQTRPR------LKTIAEDRWLKPKP 287 (316)
Q Consensus 261 i~~~l-~~p~~Rps------~~~il~~~~~~~~~ 287 (316)
|.+|| .+|.+|++ ++++++||||....
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 99999 69999998 57999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=323.31 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=210.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC-----eE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-----RV 97 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 97 (316)
+|++.+.||+|+||.||+|.+..+|+.||+|.+........ ..+.+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV-SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH-HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47889999999999999999999999999999865433222 2345668999999999999999999998776 78
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
++|+||+. ++|.+.+.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-- 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-- 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC--
Confidence 99999996 589888887778999999999999999999999999999999999999999999999999998653211
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-------------
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK------------- 244 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------- 244 (316)
.........++..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 157 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 157 ---ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ---ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 1112223346788999999877554455599999999999999999999887766554444221
Q ss_pred -----------cCC-------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 245 -----------VTF-------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 245 -----------~~~-------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
... ......++++.+||.+|| .+|.+|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 011 112346889999999999 599999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=320.26 Aligned_cols=251 Identities=30% Similarity=0.530 Sum_probs=210.0
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHH-HHhcCCCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIE-VVKGLKHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|.+..+|+.+|+|++.............+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997543222222233334444 56778999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|..++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~------~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGI------AQSDTTT 154 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCC------CCCCCcc
Confidence 9999999888889999999999999999999999999999999999999999999999999885421 1112223
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
...|+..|+|||++.+..++.+ +|||||||++|+|++|..||...+..+....+.... ....+..+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVLRPGASLTAWSILEELLE 232 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccCCCCCCHHHHHHHHHHhc
Confidence 4458899999999988777665 999999999999999999999888887777766542 3334568999999999999
Q ss_pred CCCCCCCCH----HHHhhCCCCCCC
Q psy11194 266 SPVQTRPRL----KTIAEDRWLKPK 286 (316)
Q Consensus 266 ~~p~~Rps~----~~il~~~~~~~~ 286 (316)
.+|.+||++ .++++||||...
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 699999977 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=304.57 Aligned_cols=258 Identities=25% Similarity=0.463 Sum_probs=215.8
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch--HHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD--YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
++|.+.+.||+|++|.||.|.+..+++.+++|.+........ ...+.+.+|+.+++.++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 579999999999999999999999999999999875443222 123457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|+||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~-- 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS-- 159 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc--
Confidence 999999999999998877899999999999999999999999999999999999999999999999999865321110
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-ccCCCCCCCCCHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECK 258 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 258 (316)
.........++..|+|||.+.+...+.+ +||||||+++|++++|+.||...+.......... ......+..++..+.
T Consensus 160 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 160 -SGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred -ccccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHH
Confidence 0111122346778999999988776555 9999999999999999999987666554444433 333444557899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
++|.+|| .+|.+|||++++++||||
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999 589999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=310.93 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=205.1
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCH
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL 109 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 109 (316)
||+|+||.||++.+..+++.+|+|.+...........+.+..|+.+++.++|++|+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998754433322234566899999999999999999999999999999999999999
Q ss_pred HHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCC
Q psy11194 110 FDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS 185 (316)
Q Consensus 110 ~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~ 185 (316)
..++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~------~~~~ 154 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG------QSKT 154 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC------Cccc
Confidence 888742 346999999999999999999999999999999999999999999999999998653211 1112
Q ss_pred cccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcccCCCCCCCCCHHHHHHH
Q psy11194 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN----ELLKQVQNKVTFPKQPEVSTECKELI 261 (316)
Q Consensus 186 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li 261 (316)
....+++.|+|||++.+..++.+ +|+||||+++|+|++|+.||...... .....+... ....+..++..+.+++
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHH
Confidence 23457889999999988777665 99999999999999999999764322 222222211 2233456899999999
Q ss_pred HHhc-CCCCCCC-----CHHHHhhCCCCCCCC
Q psy11194 262 SNIL-SPVQTRP-----RLKTIAEDRWLKPKP 287 (316)
Q Consensus 262 ~~~l-~~p~~Rp-----s~~~il~~~~~~~~~ 287 (316)
.+|| .+|++|| +++++++||||+...
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 9999 6999999 889999999998744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=303.90 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=218.4
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCC-cceeeeEEEeCC----
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN-LIRFLQAIETTH---- 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~---- 95 (316)
...|..+++||+|+||+||+|+...+|..||+|.++..... +.......+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45578888999999999999999999999999999876553 222334459999999999999 999999998877
Q ss_pred --eEEEEEecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 96 --RVYIIMEYAENGSLFDIIRGQG----YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 96 --~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
..++||||++. .|..++.... .++...++.++.||+.||+|||+++|+||||||.||++++.|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 78999999966 9999997643 5888899999999999999999999999999999999999999999999999
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP- 248 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 248 (316)
+.+. -.........+|.+|+|||++.+...++...||||+|||+.||++++..|++....+....+-+....|
T Consensus 168 ra~~------ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 168 RAFS------IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred HHhc------CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 7532 111224455689999999999888666666999999999999999999999887766665554322111
Q ss_pred ------------------CC----------CCCCHHHHHHHHHhcC-CCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 249 ------------------KQ----------PEVSTECKELISNILS-PVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 249 ------------------~~----------~~~~~~~~~li~~~l~-~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
.+ +..++...+++..||. +|.+|.|++.+++||||++......
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~ 313 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS 313 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence 11 2234588899999995 8999999999999999999877554
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=311.09 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=211.8
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|.+.+.||.|++|.||+|.+..+++.|++|.+........ ...+.+|+.+++.++||||+++++++..+...++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999999865433221 23455899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|||+++ +|..++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~----- 156 (301)
T cd07873 83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI----- 156 (301)
T ss_pred Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC-----
Confidence 999975 89888865 44689999999999999999999999999999999999999999999999998854221
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-------------
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT------------- 246 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 246 (316)
.........++..|+|||.+.+....+.++||||||+++|+|++|+.||...+..+....+.....
T Consensus 157 -~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 157 -PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred -CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 111122234678899999987655445559999999999999999999988776655443322111
Q ss_pred -------CCC---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 247 -------FPK---------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 247 -------~~~---------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+. ...+++.+.+||.+|| .+|.+|||++++++||||+...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 010 1347889999999999 59999999999999999988775
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=317.34 Aligned_cols=251 Identities=28% Similarity=0.519 Sum_probs=209.2
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHH-HHHhcCCCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREI-EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|++..+++.+|+|++.............+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999998754322222222333444 467888999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|...+.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||++.... .......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~------~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV------EPEETTS 154 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCC------CCCCccc
Confidence 9999999887789999999999999999999999999999999999999999999999999885421 1112223
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
...+++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+..+.+... ....++..+.++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHcc
Confidence 3457899999999987776665 99999999999999999999988887777776554 33444578999999999999
Q ss_pred CCCCCCCCH----HHHhhCCCCCCC
Q psy11194 266 SPVQTRPRL----KTIAEDRWLKPK 286 (316)
Q Consensus 266 ~~p~~Rps~----~~il~~~~~~~~ 286 (316)
.+|.+||++ .++++|+||.+.
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 699999875 599999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=308.02 Aligned_cols=255 Identities=31% Similarity=0.523 Sum_probs=220.1
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|++|.||+|.+..+++.+++|++...........+.+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999987644333333456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999988888999999999999999999999999999999999999999999999999988653211
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 261 (316)
.....+++.|+|||.+.+...+.. +|+||||+++|+|++|..||...+.......+..+ ..+.+..++..+.++|
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 229 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLI 229 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHH
Confidence 223347788999999877665555 99999999999999999999888776666665533 3344556899999999
Q ss_pred HHhc-CCCCCCC-----CHHHHhhCCCCCCCC
Q psy11194 262 SNIL-SPVQTRP-----RLKTIAEDRWLKPKP 287 (316)
Q Consensus 262 ~~~l-~~p~~Rp-----s~~~il~~~~~~~~~ 287 (316)
.+|| .+|.+|+ +++++++||||+...
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 9999 5899999 999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=306.55 Aligned_cols=255 Identities=26% Similarity=0.438 Sum_probs=213.6
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC-----
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 95 (316)
.-.|.-.+++|.|+||.||.|....+++.+|||.+-..... -.+|+.+++.++||||+++..+|....
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 34588999999999999999999999999999988554432 238999999999999999988885322
Q ss_pred eEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-CCeEEeeccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFAR 170 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~-~~~~l~Df~~~~ 170 (316)
...+||||++. +|..+++. +..++...++-+..||..||+|||+.|++||||||.|+|++.+ |.+||||||.|+
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 44689999977 99999984 5669999999999999999999999999999999999999976 999999999998
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC--
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP-- 248 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 248 (316)
..... ........+..|+|||.+.+...++.+.||||.||++.||+.|++.|++.+..+....+.+.+..|
T Consensus 175 ~L~~~-------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 175 VLVKG-------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred eeccC-------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 75322 222445678899999999988877777999999999999999999999988777665554321111
Q ss_pred --------------------------CCCCCCHHHHHHHHHhcC-CCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 249 --------------------------KQPEVSTECKELISNILS-PVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 249 --------------------------~~~~~~~~~~~li~~~l~-~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
.....++++.+|+.++|. +|.+|.++.+++.||||+......
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 124578999999999996 899999999999999998877663
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=319.25 Aligned_cols=250 Identities=25% Similarity=0.480 Sum_probs=211.6
Q ss_pred eeeeecCCeEEEEEEEc---cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecC
Q psy11194 28 KIIGTGSYATVKLARST---RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 104 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~---~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 104 (316)
+.||+|+||.||++.+. .+|+.+|+|++........ ....+.+|+.++..++||||+++++++..+...++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 57999999999998863 5788999999976433221 1334568999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCC
Q psy11194 105 ENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSL 184 (316)
Q Consensus 105 ~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~ 184 (316)
++++|.+++.+...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~------~~~~ 154 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID------HEKK 154 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC------CCCc
Confidence 9999999998877899999999999999999999999999999999999999999999999998864321 1112
Q ss_pred CcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHh
Q psy11194 185 SETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNI 264 (316)
Q Consensus 185 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 264 (316)
.....|++.|+|||.+.+..++.+ +|||||||++|+|++|..||...+..+....+.... ...+..+++.+.++|..|
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRAL 232 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHH
Confidence 223457889999999987666655 999999999999999999999888877777665432 334456899999999999
Q ss_pred c-CCCCCCCC-----HHHHhhCCCCCCC
Q psy11194 265 L-SPVQTRPR-----LKTIAEDRWLKPK 286 (316)
Q Consensus 265 l-~~p~~Rps-----~~~il~~~~~~~~ 286 (316)
| .+|.+||+ +++++.||||+..
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 9 69999999 7889999999865
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=301.03 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=217.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|.+.+.||+|++|.||+|.+..+++.+++|.+........ ....+.+|+.+++.++|||++++++++...+..++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH-HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 58889999999999999999999999999999875443333 34557789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 103 YAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 103 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|+++++|.+++... ..++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~----- 154 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----- 154 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc-----
Confidence 99999999999763 56899999999999999999999999999999999999999999999999988654211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (316)
........++..|+|||+..+...+.+ +|+||||+++|+|++|..||...+.......+......+....++..+.++
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd08529 155 -TNFANTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQL 232 (256)
T ss_pred -cchhhccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHH
Confidence 111223346788999999988776665 999999999999999999999888777777766655444445789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 261 ISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
|.+|+ .+|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 99999 589999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=317.79 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=203.8
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC----
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH---- 95 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 95 (316)
..++|++.+.||+|+||.||+|.+..+|+.+|+|++......... ...+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH-AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhH-HHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 357899999999999999999999999999999998654333222 344568999999999999999999986443
Q ss_pred --eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 --RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 --~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
..++||||+++ +|...+.. .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999966 67666643 38899999999999999999999999999999999999999999999999985421
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--------
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-------- 245 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 245 (316)
.........++..|+|||++.+..+..+ +|||||||++|+|++|..||.+.+.......+....
T Consensus 175 -------~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 175 -------TNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred -------cCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 1122233457889999999988777776 999999999999999999998766543322221100
Q ss_pred ---------------CCC------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 246 ---------------TFP------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 246 ---------------~~~------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
..+ .....++++++||.+|| .+|++|||+.++++||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000 01124678999999999 59999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=328.60 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=218.4
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccC-CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRH-SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
..|.+.+.||+|++|.||+|....+ +..+++|.+... .......+++|+.++..++||||+++++++..++..++|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3499999999999999999998877 778888876432 222345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 101 MEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
|||++|++|.+++.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+...
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~- 222 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS- 222 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc-
Confidence 999999999988753 346899999999999999999999999999999999999999999999999998754211
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
..........|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+..+....+..+...+.+..++.+
T Consensus 223 ---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~ 298 (478)
T PTZ00267 223 ---VSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSG 298 (478)
T ss_pred ---cccccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHH
Confidence 11112334558999999999988766665 99999999999999999999988888888777666555555678999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
+.++|..|| .+|++||++++++.|+|++.
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999 69999999999999999864
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=319.89 Aligned_cols=258 Identities=31% Similarity=0.551 Sum_probs=234.4
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe-EEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR-VYI 99 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~l 99 (316)
.++|..++.+|+|+||.++.++++.+++.+++|.+......... .+...+|+.+++++.||||+.+.++|..++. .++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 56899999999999999999999999999999999877665443 3356699999999999999999999988887 999
Q ss_pred EEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 100 IMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
||+||+||+|.+.+.+++ .++++.+..++.|++.|+.|||++.++||||++.|||++.++.|+|+|||+|+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~--- 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP--- 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC---
Confidence 999999999999997643 599999999999999999999999999999999999999999999999999977431
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHH
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
.........||+.|++||.+.+.++..+ +|||||||.+||+++-+.+|...+......++......|.+...+.++
T Consensus 159 ---~~~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el 234 (426)
T KOG0589|consen 159 ---EDSLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSEL 234 (426)
T ss_pred ---chhhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHH
Confidence 2235666789999999999999999998 999999999999999999999999999999998888888889999999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
+.+|..|| .+|+.||++.++|.+|.++.-
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 99999999 699999999999999988743
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=316.32 Aligned_cols=261 Identities=25% Similarity=0.424 Sum_probs=214.3
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|.+.+.||+|+||.||++.+..+++.+|+|++.............+..|..++..++|++|+++++.+......++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986533222223445778899999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||+++++|.+++.+ ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++..... .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~-----~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-----D 155 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheeccc-----C
Confidence 99999999999976 45699999999999999999999999999999999999999999999999998864321 1
Q ss_pred CCCCCcccccccCccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc---CCCC-CCC
Q psy11194 181 DNSLSETFCGSYAYASPEILQG----IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV---TFPK-QPE 252 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~-~~~ 252 (316)
.........|++.|+|||++.. ....+.++|||||||++|+|++|..||...+..+....+.... .++. ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence 1112223468999999999863 2223344999999999999999999999888877777765432 1222 235
Q ss_pred CCHHHHHHHHHhcC-C--CCCCCCHHHHhhCCCCCCCC
Q psy11194 253 VSTECKELISNILS-P--VQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 253 ~~~~~~~li~~~l~-~--p~~Rps~~~il~~~~~~~~~ 287 (316)
++.++.+||.+||. + +..|++++++++||||++..
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 79999999999993 3 33478999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=316.49 Aligned_cols=251 Identities=31% Similarity=0.569 Sum_probs=209.0
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHH-HhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYL-KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+||.||+|++..+++.+|+|++.......... ...+..+..+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999997543221111 22233333456788999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|..++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~------~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI------EHNGTTS 154 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccc------cCCCCcc
Confidence 9999999887789999999999999999999999999999999999999999999999999986421 1112223
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
...|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+..+.+... .....+.++..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred cccCCccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CcCCCCCCCHHHHHHHHHHcc
Confidence 4458899999999988777665 99999999999999999999988887777666543 23344578999999999999
Q ss_pred CCCCCCCCHH----HHhhCCCCCCC
Q psy11194 266 SPVQTRPRLK----TIAEDRWLKPK 286 (316)
Q Consensus 266 ~~p~~Rps~~----~il~~~~~~~~ 286 (316)
.+|.+||++. ++++|+||.+.
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCCC
Confidence 6999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=318.48 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=208.6
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
...+|+..+.||.|+||.||+|.+..+++.|++|++.... .......+.+|+.+++.++|+||+++++++...+..++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3567889999999999999999999999999999985433 23335567799999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||+++++|... ...++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~---- 221 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT---- 221 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc----
Confidence 9999999998653 33677888999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcccccccCccCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcccCCCCCCC
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGI----PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE---LLKQVQNKVTFPKQPE 252 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 252 (316)
........|+..|+|||.+... .+...++|||||||++|+|++|..||......+ ....+...........
T Consensus 222 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (353)
T PLN00034 222 --MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299 (353)
T ss_pred --cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence 1111234578899999987432 233345999999999999999999997433322 2222222333344457
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
++.++.+||..|| .+|++||++.++++||||....-.
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~ 337 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence 8999999999999 599999999999999999886443
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=316.23 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=212.7
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|.+.+.||+|+||.||++++..+++.+|+|++...........+.+.+|..++..++|++|+++++++..++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986533222223455778899999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||++|++|.+++.+ ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..... .
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-----~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ-----D 155 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccC-----C
Confidence 99999999999976 45799999999999999999999999999999999999999999999999999865321 1
Q ss_pred CCCCCcccccccCccCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CCCC---CCC
Q psy11194 181 DNSLSETFCGSYAYASPEILQGI----PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TFPK---QPE 252 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~---~~~ 252 (316)
.........|++.|+|||++.+. ...+.++||||||+++|+|++|+.||...+..+....+.... ..+. ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD 235 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcccc
Confidence 11112234588999999998652 222344999999999999999999999888777766665432 1221 234
Q ss_pred CCHHHHHHHHHhcC-CCCC--CCCHHHHhhCCCCCCC
Q psy11194 253 VSTECKELISNILS-PVQT--RPRLKTIAEDRWLKPK 286 (316)
Q Consensus 253 ~~~~~~~li~~~l~-~p~~--Rps~~~il~~~~~~~~ 286 (316)
++.+++++|.+||. ++.. |++++++++||||++.
T Consensus 236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 78999999999995 3332 5799999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=310.62 Aligned_cols=265 Identities=28% Similarity=0.472 Sum_probs=220.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|++|.||+|.+..+++.+++|.+...........+.+..|+.++..++|++|+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999997755443334556778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 102 EYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 102 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999999753 469999999999999999999999999999999999999999999999999886542211100
Q ss_pred C-----------------------CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy11194 180 A-----------------------DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE 236 (316)
Q Consensus 180 ~-----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~ 236 (316)
. .........|+..|+|||.+.+..++.+ +||||||+++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 0 0011123357888999999987766655 999999999999999999998877666
Q ss_pred HHHHHh-cccCCCCCCCCCHHHHHHHHHhc-CCCCCCCC----HHHHhhCCCCCCCC
Q psy11194 237 LLKQVQ-NKVTFPKQPEVSTECKELISNIL-SPVQTRPR----LKTIAEDRWLKPKP 287 (316)
Q Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps----~~~il~~~~~~~~~ 287 (316)
....+. .....+....++..+.++|.+|| .+|++||+ +++++.||||+..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 555544 33334444457999999999999 69999999 99999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=306.72 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=201.6
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCH
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL 109 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 109 (316)
||+|+||.||++.+..+|+.+++|.+.............+..|+.+++.++||||+++++++..+...++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999998653332222233455799999999999999999999999999999999999999
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcc
Q psy11194 110 FDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET 187 (316)
Q Consensus 110 ~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~ 187 (316)
..++... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~-------~~~~~~ 153 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD-------GKTITQ 153 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC-------Cceeec
Confidence 9888543 3588999999999999999999999999999999999999999999999998865321 111123
Q ss_pred cccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcccCCCCCCCCCHHHHHHHHH
Q psy11194 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV----NELLKQVQNKVTFPKQPEVSTECKELISN 263 (316)
Q Consensus 188 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 263 (316)
..++..|+|||++.+..++.+ +|||||||++|+|++|..||..... .+................++.++.++|..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL 232 (277)
T ss_pred cCCCCCccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHH
Confidence 357889999999988776655 9999999999999999999976432 22222222221111224689999999999
Q ss_pred hc-CCCCCCCCH----HHHhhCCCCCCC
Q psy11194 264 IL-SPVQTRPRL----KTIAEDRWLKPK 286 (316)
Q Consensus 264 ~l-~~p~~Rps~----~~il~~~~~~~~ 286 (316)
|| .+|.+||++ ++++.||||+..
T Consensus 233 ~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 233 FLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HhccCHhhCCCCccchhhhhcChhhcCC
Confidence 99 699999999 778899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=315.79 Aligned_cols=256 Identities=21% Similarity=0.391 Sum_probs=205.5
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQA 90 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 90 (316)
+++..++|++.+.||+|+||.||+|.+. .+++.||+|++...... .....+.+|+.++..+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA--SEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--HHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 5677889999999999999999999752 34568999998643322 2234567899999999 89999999998
Q ss_pred EEeC-CeEEEEEecCCCCCHHHHHHhC-----------------------------------------------------
Q psy11194 91 IETT-HRVYIIMEYAENGSLFDIIRGQ----------------------------------------------------- 116 (316)
Q Consensus 91 ~~~~-~~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------- 116 (316)
+... ...+++|||+++|+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8654 4688999999999999998642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcc
Q psy11194 117 ---------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET 187 (316)
Q Consensus 117 ---------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~ 187 (316)
.+++...+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++....... .......
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~----~~~~~~~ 235 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP----DYVRKGS 235 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc----chhcccC
Confidence 247788899999999999999999999999999999999999999999999986532111 0111122
Q ss_pred cccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHhcccCCCCCCCCCHHHHHHHHHhc
Q psy11194 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSV-NELLKQVQNKVTFPKQPEVSTECKELISNIL 265 (316)
Q Consensus 188 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 265 (316)
..++..|+|||++.+..++.+ +||||||+++|+|++ |..||..... ......+..+.....+..+++++.++|.+||
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 314 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACW 314 (338)
T ss_pred CCCCccccCcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 335678999999987777666 999999999999997 9999987553 3344455555445555678999999999999
Q ss_pred -CCCCCCCCHHHHhh
Q psy11194 266 -SPVQTRPRLKTIAE 279 (316)
Q Consensus 266 -~~p~~Rps~~~il~ 279 (316)
.+|.+|||+.++++
T Consensus 315 ~~dp~~RPs~~el~~ 329 (338)
T cd05102 315 QGDPKERPTFSALVE 329 (338)
T ss_pred cCChhhCcCHHHHHH
Confidence 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=309.35 Aligned_cols=253 Identities=33% Similarity=0.608 Sum_probs=208.1
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEec
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
|++.+.||+|+||+||+|.+..+++.+|+|++......... .....+|+.+++.++||||+++++++......++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999776544332 22234699999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCC
Q psy11194 104 AENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNS 183 (316)
Q Consensus 104 ~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~ 183 (316)
+++++|.+++...+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+... .....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~------~~~~~ 153 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL------SENNE 153 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES------TSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc
Confidence 999999999997777999999999999999999999999999999999999999999999999998642 11222
Q ss_pred CCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc------CCCCCCCCCHHH
Q psy11194 184 LSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV------TFPKQPEVSTEC 257 (316)
Q Consensus 184 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 257 (316)
......++..|+|||+.......+.++|+||||+++|+|++|..||...........+.... ........+.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 33344578899999998833344444999999999999999999999874333332222111 111112234899
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.++|..|| .+|++||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999 599999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=307.48 Aligned_cols=280 Identities=25% Similarity=0.450 Sum_probs=225.6
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|.+.+.||+|++|.||++.+..+++.|++|.+...........+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999999999999999987654333333456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC----
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS---- 177 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~---- 177 (316)
||++|++|.++++..+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999999998878899999999999999999999999999999999999999999999999998753110000
Q ss_pred -----cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CCCC-C
Q psy11194 178 -----NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TFPK-Q 250 (316)
Q Consensus 178 -----~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~-~ 250 (316)
............++..|+|||.+....++.+ +|+||||+++|++++|..||.+....+......... ..+. .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0000111122346778999999887777665 999999999999999999999888777776665432 2222 2
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCC---HHHHhhCCCCCCCCCCCChhhHHHhHhHHHHHh
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPR---LKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMI 306 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps---~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (316)
..++.++.++|.+|| .+|.+||+ +.++++||||...+ .....+.+.+++...
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~----~~~~~~~~~~~~~~~ 295 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD----WNGLLRQKAEFIPQL 295 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC----HHHHhhcCCCCCCCC
Confidence 357999999999999 59999998 79999999997643 344445555544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=306.87 Aligned_cols=256 Identities=21% Similarity=0.326 Sum_probs=210.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
.|++.+.||+|+||.||+|.+..+++.+++|.+.............+.+|+.+++.++|++++++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999876544333334456689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 103 YAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 103 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~------- 153 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP------- 153 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecC-------
Confidence 99999999988543 358999999999999999999999999999999999999999999999999885421
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcccCCCCCCCCCHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN---ELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
.........++..|+|||++.+..++.+ +|+||||+++|+|++|..||...... .................+++++
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05630 154 EGQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDA 232 (285)
T ss_pred CCccccCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHH
Confidence 1111123357889999999988776665 99999999999999999999864322 1222222222223345689999
Q ss_pred HHHHHHhc-CCCCCCCC-----HHHHhhCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRPR-----LKTIAEDRWLKPK 286 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps-----~~~il~~~~~~~~ 286 (316)
.+||..|| .+|++||| ++++++||||+..
T Consensus 233 ~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 233 RSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 99999999 59999999 9999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=302.15 Aligned_cols=259 Identities=25% Similarity=0.429 Sum_probs=213.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC---chHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP---PDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
+|++.+.||.|+||.||+|.+. +++.+++|.+...... .....+.+.+|+.+++.++|+|++++++++......++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5888999999999999999764 6788999998654322 12223557889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
++||+++++|.+++.+...+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999887789999999999999999999999999999999999999999999999999886543221111
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc--cCCCCCCCCCHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK--VTFPKQPEVSTEC 257 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 257 (316)
..........++..|+|||.+.+..++.. +|+||||+++|++++|..||...+.......+... ...+.+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 12222233457889999999988776665 99999999999999999999876655444333322 2233445689999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.++|.+|| .+|.+||++.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999 699999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=298.60 Aligned_cols=253 Identities=29% Similarity=0.544 Sum_probs=214.3
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe-CCeEEEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-THRVYIIM 101 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 101 (316)
+|++.+.||.|++|.||.|.+..+++.+++|.+........ ..+.+.+|+.+++.++|+|++++++.+.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-ERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHH-HHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 58999999999999999999998899999999865433222 24457789999999999999999998864 44689999
Q ss_pred ecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 102 EYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 102 e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||+++++|.+++.. ...+++.++..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~----- 154 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN----- 154 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc-----
Confidence 99999999999875 34589999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
.........+++.|+|||...+..++.+ +|+||||++++++++|..||...+.......+..+...+.+...++++.+
T Consensus 155 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd08223 155 -QCDMASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGE 232 (257)
T ss_pred -cCCccccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHH
Confidence 1112233457888999999988777666 99999999999999999999887777766666555444455678999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
++.+|+ .+|.+||++.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999 599999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=313.53 Aligned_cols=260 Identities=35% Similarity=0.645 Sum_probs=230.2
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
.=|.+.+.||+|.|..|-+|++.-+|..||||++.+..... .....+.+|+..++.+.|||||++|++...+...|++.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34888999999999999999999999999999998876643 34566779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee-CCCCCeEEeecccccccccccCcC
Q psy11194 102 EYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL-DSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 102 e~~~~~sL~~~l~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~-~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|.-++|.|.++|- ....+.+...++++.||+.|+.|+|+..+||+||||+||++ ..-|-|||.|||++..+.+.
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---- 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---- 172 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc----
Confidence 9999999999984 45569999999999999999999999999999999999877 45699999999998665422
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
......+|+..|-|||++.+..+...+.||||||+|||-|++|+.||...+..+..-.+... ....+..++.++++
T Consensus 173 ---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC-KYtvPshvS~eCrd 248 (864)
T KOG4717|consen 173 ---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC-KYTVPSHVSKECRD 248 (864)
T ss_pred ---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-cccCchhhhHHHHH
Confidence 23445678999999999999999999999999999999999999999988888887777665 34455679999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
||..|| .||.+|.+.++|..++|+|+.++.-
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 999999 7999999999999999999988754
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=315.58 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=205.9
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 94 (316)
..++|++.+.||+|+||.||+|.+..+++.+|+|++......... ...+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh-HHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 357899999999999999999999999999999998754433332 34456899999999999999999987543
Q ss_pred -CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 95 -HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 95 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
...++||||+++ +|...+.. .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 357999999965 78777754 38889999999999999999999999999999999999999999999999986431
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-----
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP----- 248 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 248 (316)
.........++..|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+......+
T Consensus 178 -------~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 178 -------TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred -------CCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 1112233457889999999988777666 999999999999999999998877655544443211110
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 249 ------------------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 249 ------------------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
.....+..+++||.+|| .+|.+|||++++++||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00113567899999999 59999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=305.05 Aligned_cols=271 Identities=27% Similarity=0.431 Sum_probs=226.2
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
..|+..+.||.|++|.||+|.+..++..+++|++...... .....+.+|+.+++.+.|++++++++++......++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4578889999999999999999988999999998654322 22456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|.+++.. +++++..+..++.+++.||.+||+.+++|+||+|+||+++.++.++++|||++......
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~------ 154 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT------ 154 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC------
Confidence 99999999999876 45899999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 261 (316)
........++..|+|||.+.+...+.+ +|+||||+++|+|++|..||....+......+...........++..+.++|
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFI 233 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHH
Confidence 111222346778999999887666665 9999999999999999999988777776666655544444456889999999
Q ss_pred HHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC-hhhHHHhHhHH
Q psy11194 262 SNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG-VDKAEAELDHY 302 (316)
Q Consensus 262 ~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~-~~~~~~~~~~~ 302 (316)
..|| .+|.+||++++++.|+||.....+.. ++...+++++|
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd06640 234 DACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFKRW 276 (277)
T ss_pred HHHcccCcccCcCHHHHHhChHhhhcchhhhHHHHHHHHHHhc
Confidence 9999 68999999999999999988877655 55555555554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=304.49 Aligned_cols=261 Identities=30% Similarity=0.489 Sum_probs=218.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||.|++|.||+|.+..+++.+++|.+....... .+.+.+|+.+++.++|||++++++++......++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch---HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 357999999999999999999999999999999986543322 34567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
+||+++++|..++... .+++.++..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~----- 168 (296)
T cd06655 95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE----- 168 (296)
T ss_pred EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc-----
Confidence 9999999999998764 5899999999999999999999999999999999999999999999999987653211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCCCCHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV--TFPKQPEVSTECK 258 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 258 (316)
........++..|+|||.+.+..++.+ +|+||||+++|++++|..||...+.......+.... ....+..+++.+.
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06655 169 -QSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246 (296)
T ss_pred -cccCCCcCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 111223357788999999987766665 999999999999999999998877665544443322 2223456889999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCCh
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGV 292 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~ 292 (316)
++|.+|| .+|.+||++.+++.||||+........
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~ 281 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSL 281 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhChHhhhccccccC
Confidence 9999999 599999999999999999876654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=305.43 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=199.8
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC---CCCCcceeeeEEEe-----C
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL---KHPNLIRFLQAIET-----T 94 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~ 94 (316)
+|++.+.||+|++|.||+|.+..+++.+|+|.+......... .....+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL-PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC-chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 589999999999999999999999999999998754322211 12234566666555 79999999998854 3
Q ss_pred CeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
...++++|++++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 468999999975 898888753 34899999999999999999999999999999999999999999999999998653
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC-----
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF----- 247 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~----- 247 (316)
.. ........++..|+|||++.+..++.+ +|||||||++|+|++|..||...........+......
T Consensus 159 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 159 SC-------QMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred cC-------cccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 21 111223456888999999987776665 99999999999999999999876655544443221100
Q ss_pred -C--------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 248 -P--------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 248 -~--------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+ ..+.++.++.++|.+|| .||++|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 11357888999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=305.83 Aligned_cols=260 Identities=23% Similarity=0.407 Sum_probs=216.8
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||.|++|.||+|.+..++..+++|+..... ....+.+.+|+.+++.++|+|++++++.+..+...++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 457999999999999999999998889999999986432 22244566899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|||+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~----- 155 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS----- 155 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc-----
Confidence 999999999999876 35699999999999999999999999999999999999999999999999998754211
Q ss_pred CCCCCCcccccccCccCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--CCCCCC
Q psy11194 180 ADNSLSETFCGSYAYASPEILQG-----IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--FPKQPE 252 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 252 (316)
.........++..|+|||.+.. ..++. ++|+||||+++|+|++|..||...+.......+..... ...+..
T Consensus 156 -~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~-~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (280)
T cd06611 156 -TLQKRDTFIGTPYWMAPEVVACETFKDNPYDY-KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSK 233 (280)
T ss_pred -cccccceeecchhhcCHHHHhhcccCCCCCCc-cccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCccc
Confidence 1111223457788999998742 22333 49999999999999999999998877776666655432 223446
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
++.++.++|..|| .+|.+||+++++++||||....+.+
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 272 (280)
T cd06611 234 WSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNK 272 (280)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchhH
Confidence 8899999999999 6899999999999999998875443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=315.69 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=206.1
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC------
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------ 94 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 94 (316)
.++|.+.+.||.|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 478999999999999999999999999999999986543222 2234456899999999999999999887533
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
...+++++++ +++|.++++. ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 3578999998 6799988865 4599999999999999999999999999999999999999999999999999865321
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--------
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-------- 246 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 246 (316)
......++..|+|||++.+....+.++|||||||++|+|++|..||...+..+....+.....
T Consensus 171 ---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 171 ---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred ---------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 122345788999999987754444559999999999999999999987665544433322110
Q ss_pred ----------------CCC------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 247 ----------------FPK------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 247 ----------------~~~------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+. ....++.+.+||.+|| .+|.+|||+.++++||||.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 000 1235677899999999 59999999999999999976543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=314.66 Aligned_cols=255 Identities=25% Similarity=0.418 Sum_probs=204.3
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 94 (316)
..++|++.+.||+|+||.||+|.+..+++.+|+|.+......... ...+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHH-HHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 357899999999999999999999999999999998654433332 34456899999999999999999988543
Q ss_pred -CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 95 -HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 95 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
...++||||+++ +|...+.. .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999966 77777654 38899999999999999999999999999999999999999999999999986421
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--------
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-------- 245 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 245 (316)
.........++..|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+....
T Consensus 171 -------~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 171 -------TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred -------CccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 1122233457889999999988777666 999999999999999999998766443332221100
Q ss_pred ---------------C--------------CC----CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 246 ---------------T--------------FP----KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 246 ---------------~--------------~~----~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
. .+ .....+.++++||.+|| .+|++|||++++++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 00 01124578899999999 599999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=301.29 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=208.8
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|++|.||+|.+..+++.+++|.+..... ....+.+.+|+.++..++||||+++++.+...+..++|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 468899999999999999999999999999999865432 222445778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|..+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~------- 147 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN------- 147 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-------
Confidence 99999998654 3478889999999999999999999999999999999999999999999999864321
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcccCC-CCCCCC
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV-------NELLKQVQNKVTF-PKQPEV 253 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~ 253 (316)
.......++..|+|||++.+..++.+ +|+||||+++|+|++|..||..... ......+...... ......
T Consensus 148 -~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (279)
T cd06619 148 -SIAKTYVGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225 (279)
T ss_pred -ccccCCCCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcC
Confidence 12223457889999999987766665 9999999999999999999965321 1222222221111 122357
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
++++.++|.+|| .+|.+||+++++++||||+.......
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~ 264 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccH
Confidence 889999999999 69999999999999999988866544
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=300.49 Aligned_cols=253 Identities=22% Similarity=0.365 Sum_probs=212.7
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEc---cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARST---RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~---~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
++.++|++.+.||+|+||.||+|.+. ..+..+++|.++.... ....+.+.+|+..+..++||||+++++++....
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 46788999999999999999999865 3456899999865432 222445778999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999999999976 34689999999999999999999999999999999999999999999999997644211
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEV 253 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (316)
. .........++..|+|||.+.+..++.+ +|||||||++|++++ |..||.+....+..+.+..+...+.+..+
T Consensus 160 ~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (266)
T cd05064 160 E-----AIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNC 233 (266)
T ss_pred c-----chhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCC
Confidence 0 0001111224567999999987776665 999999999999875 99999998888888888877777777789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+..+.+++.+|| .+|.+||++++|++
T Consensus 234 ~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 234 PNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 999999999999 58999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=297.68 Aligned_cols=253 Identities=31% Similarity=0.560 Sum_probs=217.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||+|++|.+|.+.+..+|+.+++|.+........ ..+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH-HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875433222 24457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 103 YAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 103 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|+++++|.+.+... ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++++|||.+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~----- 154 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----- 154 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc-----
Confidence 99999999998653 35889999999999999999999999999999999999999999999999988653211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (316)
........++..|+|||+..+...+.+ +|+||||++++++++|..||...+..+....+..+...+.+..++.++.++
T Consensus 155 -~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (256)
T cd08218 155 -VELARTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNL 232 (256)
T ss_pred -hhhhhhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHH
Confidence 111122346778999999987766665 999999999999999999999888888777776666555666789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 261 ISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
|.+|| .+|.+||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999 589999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=305.94 Aligned_cols=256 Identities=28% Similarity=0.434 Sum_probs=211.2
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|.+..++..+++|.+..... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 469999999999999999999999999999998865322 223445678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 152 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID------ 152 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc------
Confidence 999999999999888889999999999999999999997 5899999999999999999999999998754311
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--------------
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-------------- 246 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 246 (316)
.......++..|+|||++.+..++.+ +|+||||+++|++++|..||...+.............
T Consensus 153 --~~~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 153 --SMANSFVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred --cccccCCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 11223457889999999877666655 9999999999999999999976554443332221100
Q ss_pred ---------------------CCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 247 ---------------------FPK--QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 247 ---------------------~~~--~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+. ...++.++.++|.+|| .+|++||+++++++||||.....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 000 1136789999999999 59999999999999999976543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=305.23 Aligned_cols=264 Identities=25% Similarity=0.383 Sum_probs=214.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC--chHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP--PDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
+|.+.+.||.|++|.||+|.+..+++.|++|.+...... .......+..|+.+++.++|+||+++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588899999999999999999989999999999765443 122234466899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|||+ +++|.+++.... .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--- 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC---
Confidence 9999 889999998765 79999999999999999999999999999999999999999999999999986542211
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-----------
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP----------- 248 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 248 (316)
.......++..|.|||.+.+....+.++|+|||||++|++++|..+|......+....+......+
T Consensus 157 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 ---RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred ---ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 111222356789999998654444555999999999999999988887666544444432211100
Q ss_pred ----------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChh
Q psy11194 249 ----------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVD 293 (316)
Q Consensus 249 ----------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~ 293 (316)
.....+.++.++|.+|| .+|.+|||+.++++|+||.+...+.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~~ 295 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS 295 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCCC
Confidence 01335789999999999 5999999999999999999988876654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=301.75 Aligned_cols=266 Identities=24% Similarity=0.412 Sum_probs=218.4
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
..++.|++++.||.|++|.||+|.+..++..+++|...... ....+.+.+|+.+++.++|+|++++++.+..+...+
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 34577999999999999999999999999999999986532 223455678999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 99 IIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+||||+++++|..++.+ ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--- 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--- 162 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc---
Confidence 99999999999988754 45689999999999999999999999999999999999999999999999998754211
Q ss_pred cCCCCCCCcccccccCccCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--CCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQG-----IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--FPKQ 250 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 250 (316)
.........++..|+|||.+.. ..++ .++|+|||||++|+|++|..||...+.......+..... ...+
T Consensus 163 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T cd06644 163 ---TLQRRDSFIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP 238 (292)
T ss_pred ---cccccceecCCccccCceeeccccccCCCCC-chhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCC
Confidence 1111223346778999999853 2233 349999999999999999999987776665555543322 2233
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhh
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDK 294 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~ 294 (316)
..++.++.++|.+|| .+|++||+++++++||||......+....
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~ 283 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRE 283 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchhHHH
Confidence 467899999999999 59999999999999999998877665433
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=302.28 Aligned_cols=258 Identities=20% Similarity=0.301 Sum_probs=214.1
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
.|+..+.||.|+||.||+|.+..+++.+|+|.+.............+.+|+.+++.++|++++++.+.+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999876543333334456689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 103 YAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 103 ~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|+++++|..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE------ 154 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC------
Confidence 9999999988854 33699999999999999999999999999999999999999999999999998854211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---cCCCCCCCCCHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK---VTFPKQPEVSTEC 257 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 257 (316)
........++..|+|||++.+..++.+ +|+||||+++|+|++|..||.........+.+... ........++.++
T Consensus 155 -~~~~~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05632 155 -GESIRGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEA 232 (285)
T ss_pred -CCcccCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHH
Confidence 111123357899999999987776665 99999999999999999999876654433333221 1223345688999
Q ss_pred HHHHHHhc-CCCCCCCC-----HHHHhhCCCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRPR-----LKTIAEDRWLKPKPK 288 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps-----~~~il~~~~~~~~~~ 288 (316)
.+|+..|| .+|++||+ +++++.|+||.....
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 99999999 69999999 899999999988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=302.52 Aligned_cols=249 Identities=18% Similarity=0.259 Sum_probs=207.6
Q ss_pred eeccCeEEe--eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe---
Q psy11194 19 LESHGYTVG--KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--- 93 (316)
Q Consensus 19 ~~~~~y~~~--~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 93 (316)
+..+++... ..|++|+++.||+|.. +|+.||+|++...........+.+.+|+.++..++||||+++++++.+
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 334444444 5699999999999976 588999999977655554445677899999999999999999999876
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 94 -THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 94 -~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
....++||||+++|+|.+++.+.+.++......++.+++.||.+||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 447899999999999999998877899999999999999999999984 899999999999999999999999999864
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-ccCCC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQG--IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFP 248 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~ 248 (316)
.... .....++..|+|||++.+ ..++. ++|||||||++|+|++|..||.+.+..+....+.. ...++
T Consensus 173 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~-k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 242 (283)
T PHA02988 173 LSSP---------PFKNVNFMVYFSYKMLNDIFSEYTI-KDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK 242 (283)
T ss_pred hccc---------cccccCcccccCHHHhhhccccccc-hhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 3211 112346788999999865 34444 49999999999999999999999888887777643 34445
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 249 KQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 249 ~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+..+++++.++|.+|| .+|++|||++++++
T Consensus 243 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 45578999999999999 59999999999984
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=302.14 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=203.7
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||.|++|.||+|.+..++..|++|.+........ ....+.+|+.+++.++|||++++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG-VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC-chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999998999999999865433222 23456689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 103 YAENGSLFDIIRG---QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 103 ~~~~~sL~~~l~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|++ ++|.+++.. +..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 153 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI----- 153 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC-----
Confidence 997 489888854 24689999999999999999999999999999999999999999999999998864311
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--------------
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-------------- 245 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 245 (316)
.........++..|+|||++.+....+.++|+||||+++|+|++|+.||................
T Consensus 154 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 154 -PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred -CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 11112233467889999998665444445999999999999999999998655433222111000
Q ss_pred --------------CCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 246 --------------TFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 246 --------------~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.......+++++.++|.+|| .+|.+|||++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00012347899999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=301.14 Aligned_cols=252 Identities=23% Similarity=0.421 Sum_probs=216.1
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||.|++|.||+|.+..+++.+++|++...........+.+.+|+.+++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999998999999999986554443445667899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
|++|++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~------- 153 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD------- 153 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC-------
Confidence 9999999999988778999999999999999999999999999999999999999999999999988653211
Q ss_pred CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS---VNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
.......++..|.|||.+.+.....+ +|+||||+++|++++|..||.... .......... .....+..++..+.+
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 231 (258)
T cd05578 154 TLTTSTSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAID 231 (258)
T ss_pred ccccccCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHH
Confidence 12223446778999999987776655 999999999999999999998766 3444333332 334455678999999
Q ss_pred HHHHhc-CCCCCCCCH--HHHhhCCCC
Q psy11194 260 LISNIL-SPVQTRPRL--KTIAEDRWL 283 (316)
Q Consensus 260 li~~~l-~~p~~Rps~--~~il~~~~~ 283 (316)
+|.+|| .+|.+||++ +++++||||
T Consensus 232 ~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 232 AINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999 699999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=294.70 Aligned_cols=253 Identities=29% Similarity=0.468 Sum_probs=219.1
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||.|++|.||.+++..+++.+++|.+......... ...+.+|+.+++.++|+||+++++++......+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE-RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH-HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 589999999999999999999999999999998765443332 4456799999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 103 YAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 103 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 99999999999764 458999999999999999999999999999999999999999999999999886542211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (316)
.......+++.|.|||...+..++.+ +|+||||+++|+|++|..||......+....+..+...+....++.++.++
T Consensus 156 --~~~~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd08221 156 --SMAETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISL 232 (256)
T ss_pred --ccccccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHH
Confidence 12233457889999999987766655 999999999999999999999888888777776655555556789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 261 ISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
|.+|| .+|.+||+++++++|||+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 99999 589999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=298.23 Aligned_cols=259 Identities=24% Similarity=0.435 Sum_probs=211.3
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC--chHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--CCeE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP--PDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRV 97 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 97 (316)
.+|.+.+.||+|++|.||+|.+..+++.+++|.+...... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4789999999999999999999999999999998754332 22234567789999999999999999998865 4678
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
++++||+++++|.+++...+.++...++.++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~- 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC- 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc-
Confidence 8999999999999999887779999999999999999999999999999999999999999999999999886532111
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-CCCCCCCCHH
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-FPKQPEVSTE 256 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 256 (316)
..........++..|+|||.+.+..++.. +|+|||||++|+|++|..||................. ...+..+++.
T Consensus 161 --~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 161 --MSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH 237 (266)
T ss_pred --ccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence 01111122346788999999987666655 9999999999999999999987766555544433322 2223457889
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
+.++| .|| .+|.+||+++++++||||+.
T Consensus 238 ~~~li-~~~~~~p~~Rp~~~eil~hp~~~~ 266 (266)
T cd06651 238 ARDFL-GCIFVEARHRPSAEELLRHPFAQL 266 (266)
T ss_pred HHHHH-HHhcCChhhCcCHHHHhcCccccC
Confidence 99999 566 79999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=298.74 Aligned_cols=251 Identities=29% Similarity=0.561 Sum_probs=213.9
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCH
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL 109 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 109 (316)
||.|++|.||+|.+..+++.+++|++...........+.+.+|+.+++.++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999988999999999765554444456788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccc
Q psy11194 110 FDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189 (316)
Q Consensus 110 ~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~ 189 (316)
.+++.+...++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~-------~~~~~~~ 153 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-------QKTWTFC 153 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc-------ccccccc
Confidence 999988777999999999999999999999999999999999999999999999999998653211 1122335
Q ss_pred cccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhc-ccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS--VNELLKQVQN-KVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 190 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l- 265 (316)
++..|+|||.+....++.+ +|+||||+++|++++|..||.... ..+....+.. ......+...++++.++|.+||
T Consensus 154 ~~~~~~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 232 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR 232 (262)
T ss_pred CCcCccChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHcc
Confidence 6788999999877666655 999999999999999999998766 5555555543 2233444456899999999999
Q ss_pred CCCCCCCC-----HHHHhhCCCCCCCCC
Q psy11194 266 SPVQTRPR-----LKTIAEDRWLKPKPK 288 (316)
Q Consensus 266 ~~p~~Rps-----~~~il~~~~~~~~~~ 288 (316)
.+|.+||+ ++++++||||++...
T Consensus 233 ~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 233 RNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred CChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 69999999 999999999997643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=296.55 Aligned_cols=259 Identities=25% Similarity=0.454 Sum_probs=212.2
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC--chHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--CCeE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP--PDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRV 97 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 97 (316)
++|++.+.||+|++|.||.|.+..+++.|++|.+...... .....+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999999999999999998643322 22234567889999999999999999999876 3568
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+++|||+++++|.+++.+...+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998877789999999999999999999999999999999999999999999999998865321110
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CCCCCCCCCHH
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TFPKQPEVSTE 256 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 256 (316)
.........++..|+|||.+.+...+.. +|+||||+++|+|++|+.||................ ....+..++..
T Consensus 162 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 162 ---SGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH 237 (265)
T ss_pred ---cccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence 0011122347788999999987666555 999999999999999999998765555444443322 22234467889
Q ss_pred HHHHHHHhcCCCCCCCCHHHHhhCCCCC
Q psy11194 257 CKELISNILSPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 257 ~~~li~~~l~~p~~Rps~~~il~~~~~~ 284 (316)
+.++|.+|+.+|.+||+++++++|||++
T Consensus 238 ~~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 238 CRDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 9999999998899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=300.63 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=209.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||+|++|.||+|.+..+|+.+++|++....... .....+.+|+.+++.++|||++++++++..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 5899999999999999999999899999999987654322 224557799999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 103 YAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 103 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
|+ +++|.+++.. ...+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~-----~ 153 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE-----E 153 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC-----C
Confidence 99 9999999865 456999999999999999999999999999999999999999999999999988654211 1
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-------------
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP------------- 248 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 248 (316)
........++..|+|||.+.+....+.++||||||+++|+|++|..+|.+.........+......+
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 1122234578889999998765554556999999999999999988887766554444333211111
Q ss_pred ----------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCC
Q psy11194 249 ----------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 249 ----------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~ 284 (316)
..+..+.++.++|.+|| .+|++||+++++++||||.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 01346789999999999 5999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=301.95 Aligned_cols=257 Identities=28% Similarity=0.481 Sum_probs=214.6
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
..+|++.+.||+|++|.||+|.+..+++.+++|.+....... .+.+.+|+.+++.++|+|++++++.+..+...++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 468999999999999999999999899999999987644332 34567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|||+++++|.+++.+. .++..++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~----- 169 (296)
T cd06654 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE----- 169 (296)
T ss_pred ecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc-----
Confidence 9999999999998754 5899999999999999999999999999999999999999999999999987643211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCCCCHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV--TFPKQPEVSTECK 258 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 258 (316)
........+++.|+|||.+.+...+.+ +|||||||++|+|++|..||....+........... ..+.+..++..+.
T Consensus 170 -~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (296)
T cd06654 170 -QSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (296)
T ss_pred -ccccCcccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHH
Confidence 111223357788999999887666655 999999999999999999998776644433333222 1223446889999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
++|.+|| .+|.+||+++++++||||...+.
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 9999999 59999999999999999976544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=300.67 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=208.2
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|++|.||+|.+..+|+.+++|++....... ...+.+.+|+.+++.++|+|++++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 47999999999999999999999899999999986543222 12345668999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|..++.....+++..++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----- 154 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG----- 154 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc-----
Confidence 999998888888776679999999999999999999999999999999999999999999999999986542111
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----------------
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK----------------- 244 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 244 (316)
.......++..|+|||.+.+....+.++|+||||+++|+|++|..||.+....+....+...
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 155 -DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred -ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 01122346778999999876443444599999999999999999999876654443332210
Q ss_pred ---cCCCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 245 ---VTFPK----------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 245 ---~~~~~----------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
...+. .+.++..+.+||.+|| .+|++||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 01111 1346889999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=294.51 Aligned_cols=252 Identities=30% Similarity=0.504 Sum_probs=215.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||+|++|.||+|.+..++..+++|.+......... .+.+.+|+.+++.++||+++++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHH-HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 589999999999999999999999999999999765443332 4567799999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC-CeEEeecccccccccccCcC
Q psy11194 103 YAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY-NIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 103 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~-~~~l~Df~~~~~~~~~~~~~ 179 (316)
|+++++|.+++... ..+++..+..++.+++.++.+||++|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS----- 154 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC-----
Confidence 99999999999763 3589999999999999999999999999999999999998654 579999999865321
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
........++..|+|||.+.....+.+ +|+||||+++|+|++|..||...+.......+......+.+..++..+.+
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 231 (256)
T cd08220 155 --KSKAYTVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQ 231 (256)
T ss_pred --CccccccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHH
Confidence 112223456788999999987666655 99999999999999999999988777777666665555555678999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
++..|| .+|.+|||++++++||||
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhCCCC
Confidence 999999 599999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=322.90 Aligned_cols=254 Identities=20% Similarity=0.344 Sum_probs=200.0
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC------CCCcceeeeEEEe
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK------HPNLIRFLQAIET 93 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~ 93 (316)
..++|++.+.||+|+||.||+|.+..+++.||||+++.... .......|+.+++.++ +.+++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 45789999999999999999999999999999999865322 1223445666666664 4458888888875
Q ss_pred C-CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCC------------
Q psy11194 94 T-HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDY------------ 159 (316)
Q Consensus 94 ~-~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~------------ 159 (316)
+ ...++||+++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|++|+||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4 5789999998 77999999887789999999999999999999998 5999999999999998665
Q ss_pred ----CeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy11194 160 ----NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN 235 (316)
Q Consensus 160 ----~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~ 235 (316)
.++|+|||.+... ........++..|+|||++.+..+..+ +|||||||++|+|++|+.||.+.+..
T Consensus 282 ~~~~~vkl~DfG~~~~~---------~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDE---------RHSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred CCCceEEECCCCccccC---------ccccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 4999999987431 112234568899999999988777766 99999999999999999999876655
Q ss_pred HHHHHHhcccC-CC------------------------C----------------CCCCCHHHHHHHHHhc-CCCCCCCC
Q psy11194 236 ELLKQVQNKVT-FP------------------------K----------------QPEVSTECKELISNIL-SPVQTRPR 273 (316)
Q Consensus 236 ~~~~~~~~~~~-~~------------------------~----------------~~~~~~~~~~li~~~l-~~p~~Rps 273 (316)
+....+..... +| . ....++.+.+||..|| .||.+|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 44433322110 00 0 0012456789999999 59999999
Q ss_pred HHHHhhCCCCCCCCC
Q psy11194 274 LKTIAEDRWLKPKPK 288 (316)
Q Consensus 274 ~~~il~~~~~~~~~~ 288 (316)
++|+++||||+....
T Consensus 432 a~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 432 ARQMTTHPYVLKYYP 446 (467)
T ss_pred HHHHhcCccccccCC
Confidence 999999999987433
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=299.19 Aligned_cols=269 Identities=25% Similarity=0.398 Sum_probs=221.8
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
-|++.+.||.|+||.||+|.+..+++.+++|........ ...+.+.+|+.++..++|||++++++++......++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 377888999999999999999889999999987544322 224567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
|+++++|.+++... .++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 83 ~~~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~------~ 155 (277)
T cd06641 83 YLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT------Q 155 (277)
T ss_pred eCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc------h
Confidence 99999999998754 5899999999999999999999999999999999999999999999999987543211 1
Q ss_pred CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q psy11194 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELIS 262 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 262 (316)
.......++..|+|||.+.+...+.+ +|+||||+++|++++|..||...........+...........++.++.++|.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 234 (277)
T ss_pred hhhccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence 11122346778999999877666655 99999999999999999999887776666666555444444568999999999
Q ss_pred Hhc-CCCCCCCCHHHHhhCCCCCCCCCCCC-hhhHHHhHhH
Q psy11194 263 NIL-SPVQTRPRLKTIAEDRWLKPKPKSRG-VDKAEAELDH 301 (316)
Q Consensus 263 ~~l-~~p~~Rps~~~il~~~~~~~~~~~~~-~~~~~~~~~~ 301 (316)
.|| .+|.+||++.++++||||.....+.. ....++.+++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 275 (277)
T cd06641 235 ACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELIDRYKR 275 (277)
T ss_pred HHccCChhhCcCHHHHHhCHHHhhhhhccchHHHHHHHhhc
Confidence 999 58999999999999999998766544 3333444443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=299.31 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=212.1
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC---CCCcceeeeEEEeCCeEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 99 (316)
.|++.+.||+|++|.||+|.+..+++.+++|.+....... ..+.+.+|+.+++.++ ||+++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch--hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788899999999999999999999999999986543222 2345668899999886 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||+++++|.++++.. .+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--- 155 (277)
T ss_pred EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---
Confidence 99999999999998764 69999999999999999999999999999999999999999999999999886542111
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC-CCCHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQP-EVSTECK 258 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 258 (316)
.......++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+.......... ..+.++.
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (277)
T cd06917 156 ---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLR 232 (277)
T ss_pred ---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHH
Confidence 112233577889999998664444445999999999999999999998877665554443332222222 3788999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
++|..|| .+|.+||++.++++|+||+....
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 9999999 58999999999999999977664
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=303.21 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=203.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||.|++|.||+|++..+|+.+++|.+....... .....+.+|+.+++.++|||++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 5899999999999999999999999999999986543322 123446689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 103 YAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 103 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
|+++ +|.+++.. .+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++..... .
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~------~ 152 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI------P 152 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC------C
Confidence 9975 88887764 56699999999999999999999999999999999999999999999999998864321 1
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhcccC--------------
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLKQVQNKVT-------------- 246 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~-~~~~~~~~~~~~~~~~~-------------- 246 (316)
........++..|+|||.+.+....+.++||||||+++|+|++|..|+ .+.+..+..+.+.+...
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 111122346788999999876554445599999999999999988875 44444433333221100
Q ss_pred ----C----------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 247 ----F----------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 247 ----~----------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
. ...+.+++++.++|.+|| .+|.+|||++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 011347889999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=295.85 Aligned_cols=257 Identities=29% Similarity=0.471 Sum_probs=219.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||.|++|.||+|.+..+++.+++|.+...... .....+.+|+..+..++|+|++++++++......++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4689999999999999999999999999999998765432 23556779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||+++++|.+++.....+++..+..++.|++.|+.+||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~---- 154 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL---- 154 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC----
Confidence 999999999999887789999999999999999999999 999999999999999999999999999886532111
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcccCCCCCCC-CCHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS---SVNELLKQVQNKVTFPKQPE-VSTE 256 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~ 256 (316)
.......++..|.|||.+.+...+.+ +|+||||+++|++++|..||... ...+....+........... ++..
T Consensus 155 --~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (264)
T cd06623 155 --DQCNTFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE 231 (264)
T ss_pred --CcccceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHH
Confidence 11123346788999999888766555 99999999999999999999776 45555555555444444555 8999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
+.++|..|| .+|++||+++++++||||+..+
T Consensus 232 l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 232 FRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred HHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 999999999 5899999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=301.56 Aligned_cols=261 Identities=29% Similarity=0.464 Sum_probs=215.7
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|++.+.||+|++|.||+|.+..+++.|++|.+....... .+.+.+|+.+++.++|+|++++++++......++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 3478999999999999999999998899999999986543322 3456789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||+++++|.+++.+. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 94 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~---- 168 (297)
T cd06656 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 168 (297)
T ss_pred eecccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC----
Confidence 99999999999998764 4899999999999999999999999999999999999999999999999988643211
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCCCCHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV--TFPKQPEVSTEC 257 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 257 (316)
........+++.|+|||.+.+..++.+ +|+||||+++|++++|..||...+.......+.... ....+..++..+
T Consensus 169 --~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T cd06656 169 --QSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF 245 (297)
T ss_pred --ccCcCcccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHH
Confidence 111223357788999999987666655 999999999999999999997765543322222211 112334578999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
.+++.+|| .+|.+||+++++++||||+.....+.
T Consensus 246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 246 RDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 99999999 59999999999999999986665554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=296.32 Aligned_cols=258 Identities=24% Similarity=0.457 Sum_probs=212.6
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||.|++|.||+|....++..+++|+........ ..+.+.+|+..++.++|++++++++.+...+..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999988889999999986544333 3556789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 102 EYAENGSLFDIIRGQ---GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 102 e~~~~~sL~~~l~~~---~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
|++++++|.+++... ..+++..+..++.|++.||++||+.|++|+||+|+||++++++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999763 45899999999999999999999999999999999999999999999999988654322111
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC--C---CCCC
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP--K---QPEV 253 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~---~~~~ 253 (316)
. ........++..|+|||.+......+.++|+||||+++|+|++|..||................... . ...+
T Consensus 159 ~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06610 159 T--RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236 (267)
T ss_pred c--ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence 0 0122333577889999998776444445999999999999999999998766655444443322111 1 1357
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
++++.+++..|| .+|.+||+++++++||||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 899999999999 599999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=306.37 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=217.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
+.|+..+.||.|++|.||+|.+..++..+++|.+...... ...+.+.+|+.+++.++||||+++++++......++|+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 3467778899999999999999988999999988644322 23456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|.+++.. +.+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++.++++|||++......
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~------ 154 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT------ 154 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc------
Confidence 99999999998875 45899999999999999999999999999999999999999999999999988653211
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 261 (316)
........++..|+|||.+.+..++.+ +|+||||+++|++++|..||...........+...........++.++.++|
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (277)
T cd06642 155 QIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFV 233 (277)
T ss_pred chhhhcccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHH
Confidence 111122346788999999988766655 9999999999999999999987766666555544443334456789999999
Q ss_pred HHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 262 SNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 262 ~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
.+|| .+|.+||++.++++||||.......+
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~ 264 (277)
T cd06642 234 EACLNKDPRFRPTAKELLKHKFITRYTKKTS 264 (277)
T ss_pred HHHccCCcccCcCHHHHHHhHHHHHHhhhHH
Confidence 9999 59999999999999999988776554
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=298.36 Aligned_cols=255 Identities=24% Similarity=0.428 Sum_probs=211.6
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEec
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
|++.+.||+|++|.||+|.+..++..+++|.+.... ....+.+.+|+.+++.++|||++++++++..++..++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 688899999999999999999999999999885432 22244566899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 104 AENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 104 ~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
+++++|..++.+ ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~------~~ 157 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR------TI 157 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc------cc
Confidence 999999998764 45699999999999999999999999999999999999999999999999998864321 11
Q ss_pred CCCcccccccCccCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCCCCH
Q psy11194 183 SLSETFCGSYAYASPEILQ-----GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV--TFPKQPEVST 255 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 255 (316)
.......++..|+|||++. +..++. ++|+|||||++|+|++|..||...+..+....+.... ..+.+..++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDY-KADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCc-cchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCH
Confidence 1122335788899999974 223443 4999999999999999999998877666555554332 2233456889
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
++.++|.+|| .+|.+||+++++++||||.....
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 9999999999 69999999999999999988765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=307.45 Aligned_cols=261 Identities=23% Similarity=0.384 Sum_probs=204.2
Q ss_pred Eeeeeeec--CCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEec
Q psy11194 26 VGKIIGTG--SYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 26 ~~~~ig~g--~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
++++||+| ++++||++.+..+|+.||+|.+....... ...+.+++|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 78899999999999999999986654432 3356788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC-C
Q psy11194 104 AENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA-A 180 (316)
Q Consensus 104 ~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~-~ 180 (316)
+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++||+............ .
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999965 3458999999999999999999999999999999999999999999999998653321111000 0
Q ss_pred CCCCCcccccccCccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-C-----------
Q psy11194 181 DNSLSETFCGSYAYASPEILQGI--PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-T----------- 246 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~----------- 246 (316)
.........++..|+|||++.+. .++. ++|||||||++|+|++|..||................ .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 01111223456779999998753 3444 4999999999999999999998654433322211110 0
Q ss_pred ---------------------------------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 247 ---------------------------------FPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 247 ---------------------------------~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+....+++++.+||.+|| .+|++|||++++++||||+..++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~ 315 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 315 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence 0011235778999999999 59999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=297.81 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=207.8
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|++.+.||+|+||.||+|.+..+++.+++|+........ ...+++|+.+++.++|||++++++++..+...++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~---~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD---FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch---HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 4668999999999999999999999899999999986543322 3457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~----- 158 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA----- 158 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc-----
Confidence 999999999999998777899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCcccccccCccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcccCCCC---CCCC
Q psy11194 180 ADNSLSETFCGSYAYASPEILQG--IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPK---QPEV 253 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~---~~~~ 253 (316)
.........++..|+|||.+.. ....+.++|+||||+++|+|++|..||....+......+ ......+. ...+
T Consensus 159 -~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06646 159 -TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW 237 (267)
T ss_pred -cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccccc
Confidence 1111122346788999998742 222334599999999999999999999765544332222 11222221 2346
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhCCC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAEDRW 282 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~~~ 282 (316)
+.++.++|.+|| .+|++||+++++++|+|
T Consensus 238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 238 SSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 899999999999 69999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=297.16 Aligned_cols=259 Identities=25% Similarity=0.455 Sum_probs=211.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc---hHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP---DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
+|+..+.||+|++|.||+|.+..+++.+++|++....... ....+.+.+|+.+++.++|+|++++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999987543221 2234567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC-CeEEeecccccccccccCc
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY-NIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~-~~~l~Df~~~~~~~~~~~~ 178 (316)
|+||+++++|.+++.+.+++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~-- 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG-- 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc--
Confidence 999999999999998878899999999999999999999999999999999999998776 59999999986643211
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh-cccCCCCCCCCC
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN---ELLKQVQ-NKVTFPKQPEVS 254 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~-~~~~~~~~~~~~ 254 (316)
...........++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .....+. .......+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 111112223457789999999877666655 99999999999999999999754322 2222222 222333445688
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~ 284 (316)
+++.+++.+|| .+|.+||++.+++.||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999 6999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=293.59 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=212.8
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCC--CchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA--PPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
+|+..+.||+|++|.||+|.+..+++.+++|.+..... ......+.+.+|+.+++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 57788999999999999999998899999999876442 2223345677999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
+||+++++|.+++.+...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~----- 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF----- 155 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc-----
Confidence 999999999999988777999999999999999999999999999999999999999999999999988653211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-ccCCCCCCCCCHHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKE 259 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 259 (316)
.......++..|+|||.+......+.++|+||||+++|++++|..||...........+.. ......+..+++.+.+
T Consensus 156 --~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 156 --SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred --ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence 1122345778899999987655233449999999999999999999987665554444443 2223334568899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
++.+|| .+|.+||+++++++|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999 599999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=299.14 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=208.6
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|.+.+.||+|++|.||+|.+..+++.+++|+++..... ....+.+|+.+++.++|||++++++++......++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 456899999999999999999999999999999998654322 13446689999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|+||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~----- 158 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA----- 158 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC-----
Confidence 999999999999998888899999999999999999999999999999999999999999999999998865321
Q ss_pred CCCCCCcccccccCccCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcccCCCC---CCC
Q psy11194 180 ADNSLSETFCGSYAYASPEILQ---GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPK---QPE 252 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~---~~~ 252 (316)
.........++..|+|||.+. ..... .++|+|||||++|+|++|..||....+....... ......+. ...
T Consensus 159 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06645 159 -TIAKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236 (267)
T ss_pred -cccccccccCcccccChhhhccccCCCCC-chhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCC
Confidence 111122345788999999874 22344 4499999999999999999999765544333222 22222221 124
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAEDRW 282 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~~~ 282 (316)
++..+.++|.+|| .+|++||+++++++|||
T Consensus 237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 237 WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 7889999999999 59999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=300.53 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=212.6
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++++.||+|++|.||+|.+..+++.+++|.+..... ....+.+.+|+.+++.++|+|++++++.+...+..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 468899999999999999999999999999998865322 222345668999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 102 EYAENGSLFDIIRGQ---GYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 102 e~~~~~sL~~~l~~~---~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
||+++++|..++... ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999999998763 369999999999999999999996 5999999999999999999999999998864321
Q ss_pred cCCCCCCCcccccccCccCcccccCCCC-----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hcccCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPY-----APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV---QNKVTFPK 249 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~ 249 (316)
.......++..|+|||.+.+... .+.++|+|||||++|++++|..||...........+ ........
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd06622 156 -----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230 (286)
T ss_pred -----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC
Confidence 11222346778999999854332 234499999999999999999999776554444333 33333444
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
+..++.++.++|.+|| .+|.+||++++++.||||......
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 5568999999999999 699999999999999999777654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=300.39 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=214.3
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCC-----ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHS-----GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
..++|++.+.||+|++|.||+|.+...+ ..+++|.+.... .....+.+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4568999999999999999999876554 578999886443 223345677999999999999999999999998
Q ss_pred CeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQ----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD 158 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~ 158 (316)
...+++|||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999753 457889999999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11194 159 YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNEL 237 (316)
Q Consensus 159 ~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~ 237 (316)
+.++|+|||++....... .........++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 161 LTVKISDFGLSRDIYSAD----YYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CcEEECCCcceeeccccc----cccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999986432111 1111222345678999999887776665 999999999999998 9999999888888
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 238 LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
...+......+.+..++.++.+++.+|| .+|.+||++.+++++
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8888877666667789999999999999 599999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=312.23 Aligned_cols=266 Identities=24% Similarity=0.374 Sum_probs=230.7
Q ss_pred hhhhhcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCc---e-EEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC
Q psy11194 7 QVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSG---D-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82 (316)
Q Consensus 7 ~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~---~-v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 82 (316)
.+...+.+..|++..++-.+.++||+|+||.||+|.....+. . ||+|...............+.+|++++++++||
T Consensus 142 ~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~ 221 (474)
T KOG0194|consen 142 FLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHP 221 (474)
T ss_pred eecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCC
Confidence 356678888999999999999999999999999999875432 3 899998764433444455667999999999999
Q ss_pred CcceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCe
Q psy11194 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNI 161 (316)
Q Consensus 83 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~ 161 (316)
||++++|+...+...++|||+|+||+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-.+|+|+..++.+
T Consensus 222 NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 222 NVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred CEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeE
Confidence 99999999999999999999999999999998866 49999999999999999999999999999999999999999999
Q ss_pred EEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy11194 162 KLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQ 240 (316)
Q Consensus 162 ~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~ 240 (316)
||+|||+++.-. ...........+..|+|||.+....++.+ +||||||+++||+++ |..||.+....++...
T Consensus 302 KISDFGLs~~~~------~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~k 374 (474)
T KOG0194|consen 302 KISDFGLSRAGS------QYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNYEVKAK 374 (474)
T ss_pred EeCccccccCCc------ceeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHHHHHHH
Confidence 999999986421 11111112235678999999999877666 999999999999998 8899999999999999
Q ss_pred H-hcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 241 V-QNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 241 ~-~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+ ..+.+.+.+...|.++..++.+|+ .+|++||++.++.+
T Consensus 375 I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 375 IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 9 778889988899999999999999 69999999988864
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=300.54 Aligned_cols=255 Identities=27% Similarity=0.485 Sum_probs=208.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|++|.||+|.+..+++.+++|.+....... ...+.+.+|+.+++.++||||+++++++..++..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999998889999999986544433 23455678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|..+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~----- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG----- 154 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-----
Confidence 999999999888776679999999999999999999999999999999999999999999999999886532111
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN------------------ 243 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~------------------ 243 (316)
.......++..|+|||.+.+....+.++||||||+++|+|++|+.||......+....+..
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 1122234678899999987644444459999999999999999999976554333222211
Q ss_pred --ccCCC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 244 --KVTFP----------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 244 --~~~~~----------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
....+ ..+.++..+.+++.+|| .+|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00011 12357889999999999 589999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=294.23 Aligned_cols=252 Identities=22% Similarity=0.366 Sum_probs=215.4
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
++...+|.+.+.||+|++|.||+|.+..+++.+++|....... ....+.+|+.+++.++|++++++++++..+...
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 4567789999999999999999999999999999999864321 134566899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
+++|||+++++|.+++... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999999999653 35899999999999999999999999999999999999999999999999998654211
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
.. ........+..|+|||.+.+...+.. +||||||+++|+|++ |..||.+.+..+....+......+.+..++
T Consensus 158 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (263)
T cd05052 158 TY-----TAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCP 231 (263)
T ss_pred ee-----eccCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Confidence 10 11111223567999999887777666 999999999999998 999999988888888888777777777899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.++.++|.+|| .+|++||++.++++
T Consensus 232 ~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 232 PKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=293.11 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=211.2
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||.|++|.||+|.+..+++.+++|++...... ..+.+.+|+.+++.++|||++++++++......+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 46899999999999999999999988999999999754432 245677999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 155 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--- 155 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh---
Confidence 9999999999999775 679999999999999999999999999999999999999999999999999886532111
Q ss_pred CCCCCCcccccccCccCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-cCC---CCCCC
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGI---PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK-VTF---PKQPE 252 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~~~---~~~~~ 252 (316)
.......++..|+|||.+.+. ..+. ++|+||||+++|+|++|..||...........+... ... .....
T Consensus 156 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~-~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 156 ---AKRKSFIGTPYWMAPEVAAVERKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred ---hccccccCCccccCchhhcccccCCcCc-hhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 112233567789999998765 4554 499999999999999999999887665554444332 111 12234
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAEDRW 282 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~~~ 282 (316)
.+.++.++|.+|| .+|.+|||+.+++.|+|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 6789999999999 58999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=292.42 Aligned_cols=253 Identities=32% Similarity=0.521 Sum_probs=215.7
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--CCeEEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVYII 100 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 100 (316)
+|++.+.||.|++|.||+|.+..+++.+++|++...... ....+.+..|+.+++.++|+|++++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 588999999999999999999999999999998654443 3334557789999999999999999998753 4568999
Q ss_pred EecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 101 MEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCH-----ERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh-----~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
+||+++++|.+++.. ...+++..++.++.+|+.||.+|| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 457999999999999999999999 88999999999999999999999999999865
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
..... .......++..|+|||.+.+...+.+ +|+||||+++|++++|..||...+.....+.+........+.
T Consensus 160 ~~~~~------~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd08217 160 LGHDS------SFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPY 232 (265)
T ss_pred ccCCc------ccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCcc
Confidence 42111 11223357888999999987666555 999999999999999999999888777777777765555566
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
..+..+.+++.+|| .+|.+||+++++++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 78999999999999 599999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=291.01 Aligned_cols=258 Identities=29% Similarity=0.485 Sum_probs=212.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|.+.+.||+|++|.||+|.+..+++.+++|.+...... ....+.+..|+.+++.++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 689999999999999999999889999999998765543 3345668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
|+++++|.+++.....+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~--~ 157 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM--G 157 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc--c
Confidence 99999999999887779999999999999999999999999999999999999999999999999986643211111 0
Q ss_pred CCCcccccccCccCcccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccc--CCCCCCCCCHHH
Q psy11194 183 SLSETFCGSYAYASPEILQGIP--YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN-ELLKQVQNKV--TFPKQPEVSTEC 257 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~ 257 (316)
.......++..|+|||.+.... ....++||||||+++|++++|+.||...+.. .....+.... ..+....++..+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 1012345678899999987654 2334499999999999999999999765322 2222233222 233333458999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.++|.+|| .+|.+||++++++.|||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999 589999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=295.01 Aligned_cols=252 Identities=24% Similarity=0.417 Sum_probs=205.6
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeC-----
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT----- 94 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~----- 94 (316)
...|++.+.||+|+||.||+|.+..+++.+++|.+...... ...+.+|+.++..+ +|+|++++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 45688999999999999999999999999999998654322 23466889999888 699999999998653
Q ss_pred -CeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 95 -HRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 95 -~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
...+++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4689999999999999999763 4589999999999999999999999999999999999999999999999999865
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-c
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQG-----IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK-V 245 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~ 245 (316)
... .........++..|+|||++.. ..++. ++|+|||||++|+|++|..||............... .
T Consensus 161 ~~~------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06637 161 LDR------TVGRRNTFIGTPYWMAPEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 233 (272)
T ss_pred ccc------ccccCCcccccccccCHhHhccccCcCCCCCc-hhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCC
Confidence 321 1111223457888999999853 23444 499999999999999999999876655544443332 2
Q ss_pred CCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 246 TFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 246 ~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.......++.++.+||.+|| .+|.+|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 22333467899999999999 599999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=296.26 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=199.4
Q ss_pred eeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHh---cCCCCCcceeeeEEEeCCeEEEEEecCC
Q psy11194 29 IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK---GLKHPNLIRFLQAIETTHRVYIIMEYAE 105 (316)
Q Consensus 29 ~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~---~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 105 (316)
.||+|+||.||+|.+..+++.+++|.+...............+|..+++ ..+||+++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999987654332222222334443333 3469999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCC
Q psy11194 106 NGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS 185 (316)
Q Consensus 106 ~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~ 185 (316)
+++|.+++...+.+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--------~~ 152 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KP 152 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--------Cc
Confidence 9999999988788999999999999999999999999999999999999999999999999988543211 11
Q ss_pred cccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcccCCCCCCCCCHHHHHHHHH
Q psy11194 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN--ELLKQVQNKVTFPKQPEVSTECKELISN 263 (316)
Q Consensus 186 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~ 263 (316)
....++..|+|||.+.+....+.++|+||+||++|+|++|..||...... ..............+..++.++.++|.+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHH
Confidence 22357889999999865343334499999999999999999999753321 1222222222334445689999999999
Q ss_pred hc-CCCCCCC-----CHHHHhhCCCCCCCC
Q psy11194 264 IL-SPVQTRP-----RLKTIAEDRWLKPKP 287 (316)
Q Consensus 264 ~l-~~p~~Rp-----s~~~il~~~~~~~~~ 287 (316)
|| .+|.+|| ++.++++||||++..
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 99 6999999 699999999998854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=295.75 Aligned_cols=255 Identities=22% Similarity=0.390 Sum_probs=207.9
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeC----
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT---- 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~---- 94 (316)
..++|.+.+.||.|++|.||+|.+..+++.+++|++...... ...+.+|+.++..+ +|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 357799999999999999999999999999999998654322 34466889899988 799999999998653
Q ss_pred -CeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 95 -HRVYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 95 -~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
...++|+||+++++|.++++. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 368999999999999998853 456899999999999999999999999999999999999999999999999988
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY----APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV 245 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~----~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (316)
...... ........++..|+|||.+..... .+.++|+|||||++|+|++|+.||...........+....
T Consensus 176 ~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 176 AQLTST------RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred hhcccc------cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 653211 111223357788999999754321 2344999999999999999999998877665555554432
Q ss_pred CC--CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCC
Q psy11194 246 TF--PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 246 ~~--~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~ 284 (316)
.. ......+..+.++|.+|| .+|++||++.++++||||+
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 22 223457789999999999 6999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=294.31 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=209.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc-------hHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP-------DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
+|.+.+.||.|++|.||+|.+..+|+.+++|.++...... ....+.+.+|+.+++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6889999999999999999998899999999886432211 112345778999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++|+||+++++|.+++.+.+.++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++++|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988788999999999999999999999999999999999999999999999999988653211
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cccCCC----C
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ-NKVTFP----K 249 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~----~ 249 (316)
..........++..|+|||.+.... ..+.++|+||||+++|++++|..||...........+. .....+ .
T Consensus 162 ----~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 162 ----YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ----ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 1111122334678899999987654 23444999999999999999999997665544333322 111111 1
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
...++.++.++|.+|| .+|.+||+++++++|||+
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 2357899999999999 599999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=290.85 Aligned_cols=250 Identities=30% Similarity=0.509 Sum_probs=214.7
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||.|++|.||++.+..++..+++|.++..... ...+.+.+|+.+++.++|+|++++++.+..++..++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 588999999999999999999999999999998654332 234567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 103 YAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 103 ~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~----- 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----- 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-----
Confidence 9999999998864 345899999999999999999999999999999999999999999999999988654211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (316)
........++..|+|||++.+...+.+ +|+||||+++|+|++|..||...+.......+..+...+.+..++..+.++
T Consensus 154 -~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (255)
T cd08219 154 -GAYACTYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSL 231 (255)
T ss_pred -ccccccccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHH
Confidence 111223457788999999988776666 999999999999999999999888877777776665555666789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhhCC
Q psy11194 261 ISNIL-SPVQTRPRLKTIAEDR 281 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~~~ 281 (316)
|.+|| .+|.+||++.+++.-.
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhcc
Confidence 99999 6999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=297.88 Aligned_cols=275 Identities=23% Similarity=0.349 Sum_probs=222.1
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|.+.+.||+|++|.||+|.+..+++.|++|.+...........+.+.+|+.+++.++|||++++++++......++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34669999999999999999999998999999999876544444444567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 100 IMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
|+||+.| +|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---- 167 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---- 167 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC----
Confidence 9999975 77777753 45699999999999999999999999999999999999999999999999998754211
Q ss_pred CCCCCCCcccccccCccCcccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-CCCCCC
Q psy11194 179 AADNSLSETFCGSYAYASPEILQG---IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP-KQPEVS 254 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 254 (316)
.....++..|+|||++.+ ..++. ++||||||+++|++++|..||...+.......+....... ....++
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~-~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (307)
T cd06607 168 ------ANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWS 240 (307)
T ss_pred ------CCCccCCccccCceeeeccCCCCCCc-ccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhC
Confidence 112346778999998742 23444 4999999999999999999998877666554444332222 123478
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHhHHHHHh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMI 306 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (316)
.++.++|.+|| .+|.+||++.+++.||||+............++.+.....+
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVREL 293 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCCcHHHHHHHHHHHHHhhhc
Confidence 89999999999 59999999999999999998776555555555555544443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=296.61 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=211.4
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||.|++|.||+|.+..+++.+++|.+...... .....+.+|+.+++.++||||+++++.+......++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 3678889999999999999999999999999998765432 22445668999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 102 EYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 102 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||+++++|.+++... ..+++..+..++.|++.|+++||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999999875 679999999999999999999999 999999999999999999999999999885432111
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcccCCCCCCC-C
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS-----SVNELLKQVQNKVTFPKQPE-V 253 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~-~ 253 (316)
.....++..|+|||.+.+.....+ +|+||||+++|++++|..||... ...+..+.+........+.. +
T Consensus 156 -----~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06605 156 -----AKTFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF 229 (265)
T ss_pred -----hhcccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhc
Confidence 111446778999999987766655 99999999999999999999754 22333333333332233333 7
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
+.++.++|.+|| .+|.+|||+.+++.||||+.-
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 899999999999 599999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=298.44 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=214.8
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
+..++|++.+.||+|++|.||+|.+..+|+.+++|++..... ....+.+.+|+.+++.++||||+++++++.....++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 456789999999999999999999999999999999865432 223456779999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+|+||+++++|.+++.+.+.++...+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~--- 156 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN--- 156 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh---
Confidence 999999999999999887789999999999999999999997 5899999999999999999999999998754311
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHhcccC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN-----------ELLKQVQNKVT 246 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~ 246 (316)
.......++..|+|||++.+...+.+ +|+|||||++|++++|..||...... +....+.....
T Consensus 157 -----~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd06620 157 -----SIADTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230 (284)
T ss_pred -----hccCccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence 11123457889999999877666665 99999999999999999999865432 12222222211
Q ss_pred CCCC-CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 247 FPKQ-PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 247 ~~~~-~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
.... ..++.++.+||.+|| .+|.+|||++++++|+||.......
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~ 276 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence 2211 237889999999999 5899999999999999997655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=301.80 Aligned_cols=265 Identities=24% Similarity=0.427 Sum_probs=220.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
+.|.....||+|++|.||++.+..++..+++|.+..... ...+.+.+|+..++.++|+|++++++.+...+..++||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 456667889999999999999998999999998854322 22455779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|.+++... .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 99 e~~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~------ 171 (292)
T cd06658 99 EFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE------ 171 (292)
T ss_pred eCCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc------
Confidence 999999999988654 5899999999999999999999999999999999999999999999999988643211
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC--CCCCCCCHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF--PKQPEVSTECKE 259 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 259 (316)
........++..|+|||.+.+...+.+ +|+||||+++|++++|..||...+.......+...... +.....+..+.+
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG 250 (292)
T ss_pred cccCceeecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHH
Confidence 111223457888999999977666665 99999999999999999999887776665555443322 223357899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHH
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEA 297 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~ 297 (316)
+|..|| .+|.+|||++++++||||......+......+
T Consensus 251 li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~~~~~~~ 289 (292)
T cd06658 251 FLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVPLMR 289 (292)
T ss_pred HHHHHccCChhHCcCHHHHhhChhhhccCCccccchhhh
Confidence 999999 69999999999999999998888877655544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=310.49 Aligned_cols=256 Identities=27% Similarity=0.393 Sum_probs=204.5
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEc--cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARST--RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
+...+|.+.+.||.|+||.||+|... ..++.+++|.+... ....+|+.+++.++||||+++++++.....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 34567999999999999999999764 34578999987542 224589999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++||+++. ++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999999995 5899999777789999999999999999999999999999999999999999999999999986542211
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhc----------
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN---ELLKQVQN---------- 243 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~~---------- 243 (316)
.........|+..|+|||++....++.+ +|||||||++|+|++|..||.+.... .....+.+
T Consensus 240 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 240 ----DTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred ----ccccccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 1111224468899999999988777665 99999999999999999999654321 11111110
Q ss_pred ----------------ccCC--CC-----CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 244 ----------------KVTF--PK-----QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 244 ----------------~~~~--~~-----~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.... .. ....+.++.++|..|| .+|.+|||+.+++.||||+..+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 0000 00 0235678899999999 59999999999999999977554
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=328.69 Aligned_cols=262 Identities=29% Similarity=0.463 Sum_probs=211.3
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--C
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--T 94 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 94 (316)
......+|.+++.||+|+||.||+|.+..++..+++|++........ ....+..|+.++..++||||++++++|.. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~-~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER-EKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHH-HHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34456789999999999999999999999999999999876544333 34557789999999999999999998854 4
Q ss_pred CeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc-------CccccCCCCCCeeeCC------
Q psy11194 95 HRVYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHER-------GVVHRDIKCENLLLDS------ 157 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~-------~~~H~dl~p~nil~~~------ 157 (316)
..+++||||+++++|.+++.. .+.+++..++.|+.||+.||.|||+. +|+|+||+|+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 578999999999999999864 35699999999999999999999985 4999999999999954
Q ss_pred -----------CCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCC--CCCCCchhHHHHHHHHHHHHh
Q psy11194 158 -----------DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI--PYAPHLSDIWSMGVVLFAMVF 224 (316)
Q Consensus 158 -----------~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~ 224 (316)
.+.++|+|||++.... .........+++.|+|||++... .+.. ++|||||||++|+|++
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~-------~~s~~~s~vGTp~YmAPEvL~ge~~~~s~-KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIG-------IESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccc-------ccccccccCCCccccCHHHHhccCCCCCc-hhHHHHHHHHHHHHHH
Confidence 2348999999986532 11222344689999999998542 3444 4999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 225 GRLPFDDSS-VNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 225 g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
|..||.... .......+......+ ....+.++.+||..|| .+|.+||++.++|.||||+....
T Consensus 239 Gk~PF~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 239 GKTPFHKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred CCCCCCcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 999997654 344444444443332 2457899999999999 59999999999999999975543
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=295.47 Aligned_cols=263 Identities=20% Similarity=0.311 Sum_probs=214.6
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEcc-----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTR-----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAI 91 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 91 (316)
+++..++|++.+.||+|+||.||+|.... .+..+++|.+....... ....+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR--ERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 35667899999999999999999997542 34579999876443222 233456899999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCe
Q psy11194 92 ETTHRVYIIMEYAENGSLFDIIRGQ----------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNI 161 (316)
Q Consensus 92 ~~~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~ 161 (316)
......++||||+++++|.+++... ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 9999999999999999999999642 235667889999999999999999999999999999999999999
Q ss_pred EEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy11194 162 KLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQ 240 (316)
Q Consensus 162 ~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~ 240 (316)
+|+|||+++....... ........++..|+|||.+.+...+.+ +|+|||||++|++++ |..||.+....+..+.
T Consensus 159 ~L~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~ 233 (288)
T cd05061 159 KIGDFGMTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 233 (288)
T ss_pred EECcCCcccccccccc----ccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999998864321110 011111224567999999887666665 999999999999998 8999999888888777
Q ss_pred HhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh------CCCCCCC
Q psy11194 241 VQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE------DRWLKPK 286 (316)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~------~~~~~~~ 286 (316)
+......+.+..+++.+.+++.+|| .+|++|||+.++++ ||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 7665555555678899999999999 59999999999987 9999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=296.66 Aligned_cols=253 Identities=29% Similarity=0.466 Sum_probs=204.4
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||.|++|.||+|.+..+++.+++|.+........ ....+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc-cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 58899999999999999999999999999998865433221 23456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 103 YAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 103 ~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|+. ++|.+++.. ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~----- 153 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP----- 153 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-----
Confidence 996 589988865 346899999999999999999999999999999999999999999999999988643211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--------------
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-------------- 246 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 246 (316)
........++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.+...
T Consensus 154 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 154 -VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred -ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 11112233577899999887655444559999999999999999999987654433322221110
Q ss_pred -----CC---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 247 -----FP---------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 247 -----~~---------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
++ ..+.++.++.++|.+|| .+|.+||++++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00 01347889999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=309.25 Aligned_cols=257 Identities=21% Similarity=0.359 Sum_probs=207.7
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEE-----ccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARS-----TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQA 90 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~-----~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 90 (316)
+.+..++|++.+.||+|+||.||+|.+ ..++..||+|++....... ..+.+.+|+.++..+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH--HHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 345567899999999999999999974 3456689999986543322 245567899999999 89999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHHhC------------------------------------------------------
Q psy11194 91 IETTHRVYIIMEYAENGSLFDIIRGQ------------------------------------------------------ 116 (316)
Q Consensus 91 ~~~~~~~~lv~e~~~~~sL~~~l~~~------------------------------------------------------ 116 (316)
+......++||||+++|+|.+++...
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 99999999999999999999998642
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 117 ---------------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 117 ---------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 14778889999999999999999999999999999999999999999999998653211
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHhcccCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSV-NELLKQVQNKVTFPKQPEV 253 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 253 (316)
. .........++..|+|||++.+..++.+ +||||||+++|+|++ |..||..... ....+.+..+.....+...
T Consensus 268 ~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (375)
T cd05104 268 S----NYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECA 342 (375)
T ss_pred c----cccccCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCC
Confidence 1 1111122334567999999988777666 999999999999998 8999987543 3455555655555555567
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+.++.++|..|| .+|++|||+.++++.
T Consensus 343 ~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 343 PSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 899999999999 599999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=294.91 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=210.0
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEcc-----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTR-----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
.+..++|++.+.||+|++|.||+|.+.. +++.+++|.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4567889999999999999999998642 3567999987543322 22344668999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeE
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQ----------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIK 162 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~ 162 (316)
.....++||||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999999998652 2357788999999999999999999999999999999999999999
Q ss_pred EeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11194 163 LSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQV 241 (316)
Q Consensus 163 l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~ 241 (316)
|+|||++........ ........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||......+..+.+
T Consensus 160 l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 160 IGDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred ECCCCCccccCCcce----eecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999998864321110 011112234678999999987776665 999999999999998 78999988888887777
Q ss_pred hcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 242 QNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
......+.+..++..+.+++.+|| .+|++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666555556678999999999999 599999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=296.83 Aligned_cols=260 Identities=33% Similarity=0.597 Sum_probs=218.0
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 100 (316)
++|.+.+.||+|++|.||+|.+..++..+++|++...........+.+..|..++..+. |+||+++++++......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999987654433333456778999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||++++++|.+++...+.++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++++|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999887899999999999999999999999999999999999999999999999999875432221100
Q ss_pred --------------CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC
Q psy11194 181 --------------DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT 246 (316)
Q Consensus 181 --------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (316)
.........++..|+|||.......+.. +|+||||++++++++|..||...........+... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~ 238 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL-E 238 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-C
Confidence 0112223346788999999887665555 99999999999999999999887765555554422 2
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCH----HHHhhCCCC
Q psy11194 247 FPKQPEVSTECKELISNIL-SPVQTRPRL----KTIAEDRWL 283 (316)
Q Consensus 247 ~~~~~~~~~~~~~li~~~l-~~p~~Rps~----~~il~~~~~ 283 (316)
...+..+++.+.++|..|| .+|.+||++ +++++||||
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 3344568999999999999 589999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=307.69 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=197.7
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
....+|++.+.||+|+||.||+|.+..+++.|++|+.... ....|+.+++.++|+||+++++++......+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 4456799999999999999999999999999999975332 1236899999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 99 IIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+|++++.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 134 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~---- 208 (357)
T PHA03209 134 MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV---- 208 (357)
T ss_pred EEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccc----
Confidence 99999965 88888754 4569999999999999999999999999999999999999999999999999885421
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCH----------HHHHHHHhccc-
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGR-LPFDDSSV----------NELLKQVQNKV- 245 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~-~p~~~~~~----------~~~~~~~~~~~- 245 (316)
.........|+..|+|||++.+..++.+ +|||||||++|+|+++. .+|..... ......+....
T Consensus 209 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~ 284 (357)
T PHA03209 209 ---VAPAFLGLAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV 284 (357)
T ss_pred ---cCcccccccccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhcc
Confidence 1112223457889999999988777666 99999999999999854 44433111 11111111100
Q ss_pred ---CCC----------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 246 ---TFP----------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 246 ---~~~----------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
.++ ....++..+.+||.+|| .+|.+|||++++++||||+.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 285 HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000 01245677888999999 59999999999999999986
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=311.26 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=201.7
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
.+.+|.+.+.||+|+||.||+|.+..+++.|++|.... ..+.+|+.+++.++|+||+++++++......++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 46689999999999999999999999999999996322 224589999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 100 IMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
||+++. ++|..++.. ...+++..++.++.|++.||.|||+.|++|+||||+|||++.++.++|+|||+++......
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-- 314 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-- 314 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc--
Confidence 999995 588888865 3469999999999999999999999999999999999999999999999999986542211
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHhcccC----
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD--------SSVNELLKQVQNKVT---- 246 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~--------~~~~~~~~~~~~~~~---- 246 (316)
.........|+..|+|||++.+..++.+ +|||||||++|+|++|..++.. ....++...+.....
T Consensus 315 --~~~~~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 315 --STPFHYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred --ccccccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 1111223458999999999988777665 9999999999999987654422 112233333222110
Q ss_pred CC-----------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 247 FP-----------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 247 ~~-----------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
++ ....++..+.+||..|| .||.+|||+.|+|+||||+++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~~ 461 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQSK 461 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCCC
Confidence 00 00135668999999999 599999999999999999864
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=290.09 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=212.4
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
++..++|++.+.||+|++|.||+|.+. .++.+++|.++..... .+.+.+|+.+++.++|+|++++++++...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence 456788999999999999999999865 4568999998654322 34467899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
+++|||+++++|.+++.... .++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999999997643 6899999999999999999999999999999999999999999999999998764311
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
. .........+..|+|||.+.+...+.+ +|+||||+++|+|++ |+.||.+.........+......+.+..++
T Consensus 157 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (261)
T cd05068 157 I-----YEAREGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCP 230 (261)
T ss_pred c-----ccccCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence 0 001111223457999999887776666 999999999999999 999999988888888887766666667789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..+.+++.+|| .+|.+||+++++++
T Consensus 231 ~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 231 KELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999999 59999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=322.46 Aligned_cols=269 Identities=28% Similarity=0.470 Sum_probs=219.9
Q ss_pred hhhhcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcce
Q psy11194 8 VQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIR 86 (316)
Q Consensus 8 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~ 86 (316)
...+......+++..++++.+.|.+|||+.||.|++...|..+|+|.+-.. ++...+.+++|+.++++|. |+|||.
T Consensus 23 ~~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~ 99 (738)
T KOG1989|consen 23 SENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVS 99 (738)
T ss_pred cccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceee
Confidence 455667778899999999999999999999999999988899999998554 4555788999999999996 999999
Q ss_pred eeeEE-Ee------CCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeee
Q psy11194 87 FLQAI-ET------THRVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERG--VVHRDIKCENLLL 155 (316)
Q Consensus 87 ~~~~~-~~------~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~H~dl~p~nil~ 155 (316)
+++.. .. .-.++++||||.||+|.++++. +..|++.++++|+.++++|+++||... +||||||.+|||+
T Consensus 100 yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl 179 (738)
T KOG1989|consen 100 YIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL 179 (738)
T ss_pred EeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE
Confidence 99943 11 1257899999999999999974 456999999999999999999999997 9999999999999
Q ss_pred CCCCCeEEeecccccccccccCcCCCCC---CCcccccccCccCcccc---cCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy11194 156 DSDYNIKLSDFGFARAHMRCRSNAADNS---LSETFCGSYAYASPEIL---QGIPYAPHLSDIWSMGVVLFAMVFGRLPF 229 (316)
Q Consensus 156 ~~~~~~~l~Df~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~---~~~~~~~~~~Di~slG~ll~~l~~g~~p~ 229 (316)
..+|++||||||.++.-........+-. .......|+.|+|||.+ .+...+.+ +|||+|||+||-|++...||
T Consensus 180 s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PF 258 (738)
T KOG1989|consen 180 SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPF 258 (738)
T ss_pred cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCc
Confidence 9999999999999865322111000000 00123478999999986 55666666 99999999999999999999
Q ss_pred CCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 230 DDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
....... .+...+.+|..+.++..+.+||+.|| .+|.+||++.+++++-+.
T Consensus 259 e~sg~la---Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 259 EESGKLA---ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred CcCccee---EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 8643322 23456678887899999999999999 599999999999876543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=298.42 Aligned_cols=261 Identities=27% Similarity=0.380 Sum_probs=209.5
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC--CeE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRV 97 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 97 (316)
..++|++.+.||+|++|.||+|.+..+|+.|++|++......... ...+.+|+.+++.++|+|++++++++... +..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI-PISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC-cchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 457899999999999999999999999999999998754432221 22344799999999999999999998754 568
Q ss_pred EEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
++||||+.+ +|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999965 88888875 3568999999999999999999999999999999999999999999999999986542111
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC---------
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF--------- 247 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 247 (316)
.......++..|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+......
T Consensus 163 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 163 ------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 11112234678999999876544445599999999999999999999988777666555432111
Q ss_pred -----------CC---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 248 -----------PK---------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 248 -----------~~---------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+. ....++++.++|..|| .+|++|||++++++||||+...-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 00 0125888999999999 59999999999999999975443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=291.88 Aligned_cols=251 Identities=22% Similarity=0.440 Sum_probs=212.7
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
.+..++|++.+.||+|++|.||+|.+. ++..+++|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 456789999999999999999999865 556799998754322 245677899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
++++||+++++|.+++.. ...++...+..++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999999999965 345889999999999999999999999999999999999999999999999998653211
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
.........++..|+|||.+....++.+ +||||||+++|+|++ |..||...........+......+....++
T Consensus 157 -----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (261)
T cd05072 157 -----EYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCP 230 (261)
T ss_pred -----ceeccCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 1111122234567999999877666655 999999999999998 999999888888888887777777777889
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.++.+++.+|| .+|++||+++++.+
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 231 DELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999 58999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=334.50 Aligned_cols=266 Identities=28% Similarity=0.448 Sum_probs=233.1
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..++|.+++.||+|+||.|..++.+.+++.||+|++.+-..........|..|-.++...+.+.|+.++..|+++++
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 45678899999999999999999999999999999999977322222225678889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.|+||||++||.|..++.+..++++.-++.++..|+.||..||+.|+|||||||+|||++..|+++|+|||.+-.+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm---- 225 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM---- 225 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhc----
Confidence 9999999999999999998879999999999999999999999999999999999999999999999999988654
Q ss_pred CcCCCCCCCcccccccCccCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---ccCCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGI----PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN---KVTFPK 249 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~ 249 (316)
...+.-.+...+|||.|.+||++... ..+...+|+||+|+++|||+.|.-||.....-+.+.+|.. .+.+|.
T Consensus 226 -~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~ 304 (1317)
T KOG0612|consen 226 -DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD 304 (1317)
T ss_pred -CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence 23445556677899999999998432 2333449999999999999999999998888888888865 466776
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCC---HHHHhhCCCCCCCC
Q psy11194 250 QPEVSTECKELISNILSPVQTRPR---LKTIAEDRWLKPKP 287 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l~~p~~Rps---~~~il~~~~~~~~~ 287 (316)
...+|.+.++||.+++++|+.|.. ++++..||||.+.+
T Consensus 305 ~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred ccccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCC
Confidence 677999999999999999999888 99999999997654
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=292.17 Aligned_cols=251 Identities=26% Similarity=0.444 Sum_probs=211.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||.|++|.||+|.+..++..+++|.+..... .+.+.+|+.+++.++|+|++++++++......+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3679999999999999999999998889999999865322 45678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
+||+++++|.+++.. ...+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~---- 152 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---- 152 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC----
Confidence 999999999999975 456899999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCCCCHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV--TFPKQPEVSTEC 257 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 257 (316)
........++..|+|||.+.+...+.+ +||||||+++|+|++|..||...........+.... ....+..++.++
T Consensus 153 --~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd06612 153 --MAKRNTVIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEF 229 (256)
T ss_pred --ccccccccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHH
Confidence 111223346778999999887766555 999999999999999999998766655444433221 122334578899
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.++|.+|| .+|.+|||+.++++||||
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999 599999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=300.40 Aligned_cols=255 Identities=22% Similarity=0.390 Sum_probs=212.5
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCce----EEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGD----VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~----v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
.+...+|++.+.||+|+||.||+|.+..++.. |++|++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 46678899999999999999999998766553 89998864322 2234557789999999999999999999876
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
. ..+++++|+++|+|.+++... ..++...+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5 567999999999999999764 45899999999999999999999999999999999999999999999999999764
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
..... .........+..|+|||.+.+..++.+ +||||||+++|+|++ |..||.+....+....+......+.+.
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd05108 160 GADEK----EYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234 (316)
T ss_pred cCCCc----ceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCC
Confidence 31111 011112223567999999988777666 999999999999997 999999888887777777777777777
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.++..+.+++..|| .+|.+||++.+++.+
T Consensus 235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88999999999999 599999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=288.44 Aligned_cols=253 Identities=32% Similarity=0.541 Sum_probs=219.3
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|.+.+.||.|++|.||+|.+..++..+++|++........ ....+.+|+.+++.++|+|++++.+.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChH-HHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999998999999999876544322 34557789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 103 YAENGSLFDIIRGQ----GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 103 ~~~~~sL~~~l~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
++++++|.+.+.+. ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999763 679999999999999999999999999999999999999999999999999886542211
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
.......+++.|+|||.......+.+ +|+||+|++++++++|..||...+..+...........+.+..++..+.
T Consensus 158 ----~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd08215 158 ----DLAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELR 232 (258)
T ss_pred ----ceecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 12233457788999999877776665 9999999999999999999988888887777766555555567899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+++.+|| .+|.+||+++++++||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999 589999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=298.02 Aligned_cols=254 Identities=21% Similarity=0.344 Sum_probs=202.8
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEcc----------------CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTR----------------HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~----------------~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 82 (316)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.++..++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCC
Confidence 356789999999999999999998542 234699999865432 22345577999999999999
Q ss_pred CcceeeeEEEeCCeEEEEEecCCCCCHHHHHHhC-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCc
Q psy11194 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ-------------------GYIDEIRARRWFGQLLEALQYCHERGV 143 (316)
Q Consensus 83 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~ 143 (316)
||+++++++...+..++||||+++++|.+++... ..++...+..++.||+.||.|||+.|+
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999999999999999999999999998642 136778899999999999999999999
Q ss_pred cccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHH
Q psy11194 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV 223 (316)
Q Consensus 144 ~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~ 223 (316)
+|+||+|+||+++.++.++|+|||++....... .........++..|+|||++....++.+ +||||||+++|+|+
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~ 234 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGD----YYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEIL 234 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCc----eeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHH
Confidence 999999999999999999999999986532111 1111223345678999999887776665 99999999999998
Q ss_pred h--CCCCCCCCCHHHHHHHHhcc-------cCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 224 F--GRLPFDDSSVNELLKQVQNK-------VTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 224 ~--g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+ +..||......+....+... .....++.++..+.++|.+|| .+|++|||+++|.+
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 6 66888877766665544321 112234568899999999999 59999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=315.80 Aligned_cols=269 Identities=21% Similarity=0.358 Sum_probs=226.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
-|.|+..||.|+||.||+|..+.++-..|.|++..... ...+.+.-|+.+|..|+||+|+++++.|..++..|++.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse---EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE---EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch---hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 38899999999999999999888877778888744322 224556689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 103 YAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 103 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||.||-.+..+-+ +.+|++.++..++.|++.||.|||+.+|+|+||+..|||++-+|.++|.|||.+.. +...
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAK------n~~t 183 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAK------NKST 183 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccccc------chhH
Confidence 9999999888865 55699999999999999999999999999999999999999999999999998743 2223
Q ss_pred CCCCcccccccCccCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--CCCCCCCCH
Q psy11194 182 NSLSETFCGSYAYASPEILQ----GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--FPKQPEVST 255 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 255 (316)
-.......||++|+|||+.. ....++.++||||||++|.+|..+.+|-...++..++-++.+..+ ...+...+.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~ 263 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR 263 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence 33445667999999999863 223334449999999999999999999999999888877765433 233467899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHh
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELD 300 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~ 300 (316)
.+.+++..|| ++|..||++.++++|||+++.+....+-.+..|.+
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireLlAEak 309 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRELLAEAK 309 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHHHHHHHHH
Confidence 9999999999 79999999999999999999888766655555543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=290.98 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=213.3
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccC---CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRH---SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..++|++.+.||+|+||.||+|.+... ...+++|.+..... ......+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 457899999999999999999988644 44789998765432 2234456789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
.+++|||+++++|.+++.. .+.++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999999999966 346899999999999999999999999999999999999999999999999998764311
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
. .........++..|+|||.+.+..++.+ +||||||+++|++++ |..||......+..+.+......+.+..++
T Consensus 160 ~----~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd05033 160 E----ATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCP 234 (266)
T ss_pred c----cceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 1 1111112234567999999987776665 999999999999998 999998888888888887776666667789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
..+.+++.+|| .+|++||++++++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999 599999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=298.50 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=208.4
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceE--EEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeC
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDV--AIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT 94 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v--~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 94 (316)
.++-++|++.+.||+|+||.||+|.+..++..+ ++|.... .........+.+|+.++..+ +|+||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 356678999999999999999999988777654 5555432 22233345677899999999 899999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQG----------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD 158 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~ 158 (316)
+.+++|+||+++++|.+++.+.. .+++..++.++.|++.||++||+.|++|+||+|+||+++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999996432 47899999999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11194 159 YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNEL 237 (316)
Q Consensus 159 ~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~ 237 (316)
+.++|+|||++..... .........+..|+|||.+.+..++.+ +||||||+++|++++ |..||...+..+.
T Consensus 161 ~~~kl~dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~ 232 (303)
T cd05088 161 YVAKIADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232 (303)
T ss_pred CcEEeCccccCcccch-------hhhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCChHHH
Confidence 9999999998853210 001111123567999999877666655 999999999999998 9999988888887
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 238 LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.+.+........+..+++++.++|.+|| .+|++||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 233 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7777666555555668899999999999 589999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=282.16 Aligned_cols=261 Identities=23% Similarity=0.394 Sum_probs=207.3
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
...+.+++|++.+.||.|||+.||.+....+++.||+|.+......+ .+...+|+++.++++|||+++++++...+.
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~---~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED---IEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH---HHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 45678899999999999999999999988899999999998776322 455679999999999999999988774433
Q ss_pred -----eEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeCCCCCeEEe
Q psy11194 96 -----RVYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERG--VVHRDIKCENLLLDSDYNIKLS 164 (316)
Q Consensus 96 -----~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~H~dl~p~nil~~~~~~~~l~ 164 (316)
..|++++|...|||.+.+++ +..+++.++.+|+.++++||++||+.. +.|+||||.||++.+.+.+++.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 48999999999999999964 447999999999999999999999998 9999999999999999999999
Q ss_pred ecccccccccccCcCCC---CCCCcccccccCccCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--H
Q psy11194 165 DFGFARAHMRCRSNAAD---NSLSETFCGSYAYASPEILQ---GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN--E 236 (316)
Q Consensus 165 Df~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~--~ 236 (316)
|||.++....--....+ -........+..|+|||.+. +...+.+ +|||||||++|.|+.|..||...... .
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er-tDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER-TDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc-cchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 99988653211000000 00011224688999999984 3334444 99999999999999999999642110 0
Q ss_pred H-HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 237 L-LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+ .........+|....+|+.+.++|.+|| .||.+||++.+++.+
T Consensus 251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0 0111224566777779999999999999 699999999999864
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=289.95 Aligned_cols=253 Identities=32% Similarity=0.570 Sum_probs=214.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|.+.+.||+|++|.||+|.+..+|..+++|.+........ ..+.+.+|+.+++.++|+|++++++.+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch-hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58999999999999999999999999999999876433222 24557789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC-eEEeecccccccccccCcC
Q psy11194 103 YAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN-IKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~-~~l~Df~~~~~~~~~~~~~ 179 (316)
|+++++|.+++.... .+++..+..++.+++.||.+||+.+++|+||+|+||+++.++. ++++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS---- 155 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC----
Confidence 999999999986533 4799999999999999999999999999999999999988865 699999988653211
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
........++..|+|||+..+...+.+ +|+||||+++|++++|..||...+..+....+......+..+.++.++.+
T Consensus 156 --~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd08225 156 --MELAYTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRS 232 (257)
T ss_pred --cccccccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHH
Confidence 111122347788999999877666655 99999999999999999999887777666666555444555678999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+|.+|| .+|++|||+.++++||||
T Consensus 233 ~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 233 LISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999 599999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=300.00 Aligned_cols=248 Identities=24% Similarity=0.415 Sum_probs=188.5
Q ss_pred eeeeeecCCeEEEEEEEc--cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--CCeEEEEEe
Q psy11194 27 GKIIGTGSYATVKLARST--RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVYIIME 102 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 102 (316)
...||+|+||.||+|++. .+++.+++|.+..... ...+.+|+.+++.++||||+++++++.. ....+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 357999999999999865 4677899999865432 2235689999999999999999999854 457899999
Q ss_pred cCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee----CCCCCeEEeecccc
Q psy11194 103 YAENGSLFDIIRGQ---------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL----DSDYNIKLSDFGFA 169 (316)
Q Consensus 103 ~~~~~sL~~~l~~~---------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~----~~~~~~~l~Df~~~ 169 (316)
|+.+ +|..++... ..+++..++.++.||+.||.|||+.|++|+||+|+||++ +..+.++|+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9954 888887531 248999999999999999999999999999999999999 45578999999998
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHH
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV---------NELLKQ 240 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---------~~~~~~ 240 (316)
...... ...........+++.|+|||++.+....+.++||||+||++|+|++|..||..... ......
T Consensus 160 ~~~~~~---~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 160 RLFNSP---LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred eccCCC---CccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 654211 11111223345788999999998765455559999999999999999999964321 011111
Q ss_pred HhcccC------------CC-------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCC
Q psy11194 241 VQNKVT------------FP-------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRW 282 (316)
Q Consensus 241 ~~~~~~------------~~-------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~ 282 (316)
+..... .+ .....+.++.+||.+|| .||.+|||++++++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 100000 00 00123567889999999 59999999999999999
Q ss_pred C
Q psy11194 283 L 283 (316)
Q Consensus 283 ~ 283 (316)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=294.24 Aligned_cols=255 Identities=19% Similarity=0.303 Sum_probs=211.4
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEcc-----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTR-----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
+..++|.+.+.||+|++|.||+|.+.. .+..+++|....... ......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 456789999999999999999999876 667899998754332 2223446689999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC---CeEE
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQG-------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY---NIKL 163 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~---~~~l 163 (316)
....++||||+++++|.+++.+.. .+++..+..++.||+.||.|||+.+++|+||+|+||+++.++ .++|
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 899999999999999999997542 489999999999999999999999999999999999998664 5999
Q ss_pred eecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q psy11194 164 SDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQ 242 (316)
Q Consensus 164 ~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~ 242 (316)
+|||++........ .........+..|+|||++.+..++.+ +|||||||++|+|++ |..||.........+.+.
T Consensus 161 ~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 161 ADFGMARDIYRASY----YRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred ccCccccccCCccc----eecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999865421110 011112223467999999987777666 999999999999997 999999888888887777
Q ss_pred cccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 243 NKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.......+..++..+.+++.+|| .+|.+|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 236 GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 66556666778999999999999 589999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=288.70 Aligned_cols=248 Identities=24% Similarity=0.418 Sum_probs=208.6
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|+||.||+|... .+..+++|.+...... .+.+.+|+.+++.++||||+++++++......++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 467899999999999999999765 4568999987543322 34466899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|||+++++|.+++.. .+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~--- 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc---
Confidence 999999999999975 3458999999999999999999999999999999999999999999999999886532110
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
........++..|+|||.+.+..+..+ +|+||||+++|++++ |+.||...+..+....+..+.....+...+.++.
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 231 (256)
T cd05114 155 --YTSSSGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVY 231 (256)
T ss_pred --eeccCCCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 011112234567999999987666665 999999999999999 9999998888888888877666655666889999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhh
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~ 279 (316)
+++.+|| .+|.+||+++++++
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999 58999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=295.52 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=202.0
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCe----
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHR---- 96 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~---- 96 (316)
++|++.+.||+|++|.||+|.+..+++.|++|.......... ....+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG-IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC-CchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999865433221 2334668999999995 6999999999977665
Q ss_pred -EEEEEecCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC-CCCeEEeecccc
Q psy11194 97 -VYIIMEYAENGSLFDIIRG-----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS-DYNIKLSDFGFA 169 (316)
Q Consensus 97 -~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~-~~~~~l~Df~~~ 169 (316)
.+++|||+++ +|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 88888754 235899999999999999999999999999999999999998 889999999988
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC---
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--- 246 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 246 (316)
..+... ........+++.|+|||++.+....+.++|+||||+++|+|++|..||.+....+....+.....
T Consensus 159 ~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 159 RAFSIP------VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred eecCCC------ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 653211 11112224577899999886644444559999999999999999999987654443322211100
Q ss_pred ---------------CC---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCC
Q psy11194 247 ---------------FP---------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 247 ---------------~~---------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~ 284 (316)
.+ ..+.++.++.++|..|| .+|.+||++++++.||||+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 01357899999999999 5999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=308.13 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=206.9
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccC-----CceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRH-----SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQA 90 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 90 (316)
+.+..++|++.+.||+|+||.||+|++... +..||+|.+....... ..+.+.+|+.+++.+ +|+||++++++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD--EREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH--HHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 456778899999999999999999986433 3479999986544322 245577899999999 89999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHHhC------------------------------------------------------
Q psy11194 91 IETTHRVYIIMEYAENGSLFDIIRGQ------------------------------------------------------ 116 (316)
Q Consensus 91 ~~~~~~~~lv~e~~~~~sL~~~l~~~------------------------------------------------------ 116 (316)
+......++||||+++++|.+++...
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 99999999999999999999998532
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 117 ----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 117 ----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
.++++..+.+++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~---- 266 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS---- 266 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc----
Confidence 247888899999999999999999999999999999999999999999999986532111
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhcccCCCCCCCCCHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNE-LLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
.........++..|+|||++.+..++.+ +|||||||++|+|++ |..||....... ....+..+...+.+..+++++.
T Consensus 267 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 345 (374)
T cd05106 267 NYVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIY 345 (374)
T ss_pred ceeeccCCCCccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHH
Confidence 0111122234567999999987666665 999999999999997 999998765443 3344444445555556799999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhh
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~ 279 (316)
++|..|| .+|.+|||+.++++
T Consensus 346 ~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 346 SIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=292.57 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=207.4
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCC---
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH--- 95 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~--- 95 (316)
..++|++.+.||.|++|.||+|.+..+++.+++|++..... ..+.+.+|+.+++.+ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 35789999999999999999999988899999999865433 235577999999998 6999999999997644
Q ss_pred ---eEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 96 ---RVYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 96 ---~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
..++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999999864 35799999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI----PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK 244 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (316)
+...... ........++..|+|||.+... ...+.++||||||+++|++++|..||...........+...
T Consensus 160 ~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 160 SAQLDST------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred ceecccc------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 8643211 1112234478889999987532 22233499999999999999999999876655555555443
Q ss_pred cCC--CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 245 VTF--PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 245 ~~~--~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
... .....++.++.++|.+|| .+|++|||++++++|||+
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 234 PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 221 122337889999999999 599999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=294.43 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=204.3
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCH
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL 109 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 109 (316)
||+|+||.||+|.+..+|+.+++|.+.............+..|+.+++.++||+++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999998754332222344456899999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcc
Q psy11194 110 FDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET 187 (316)
Q Consensus 110 ~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~ 187 (316)
.+++.+.. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-------~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-------GKKIKG 153 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------CCcccc
Confidence 99997654 699999999999999999999999999999999999999999999999998865321 111223
Q ss_pred cccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cccCCCCCCCCCHHHHHHHHHh
Q psy11194 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ---NKVTFPKQPEVSTECKELISNI 264 (316)
Q Consensus 188 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~ 264 (316)
..++..|+|||.+.+..++.+ +|+||||+++|+|++|+.||...........+. .......+..+++.+.++|.+|
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHH
Confidence 346778999999877665555 999999999999999999997654321111111 1223334456899999999999
Q ss_pred c-CCCCCCC-----CHHHHhhCCCCCCCC
Q psy11194 265 L-SPVQTRP-----RLKTIAEDRWLKPKP 287 (316)
Q Consensus 265 l-~~p~~Rp-----s~~~il~~~~~~~~~ 287 (316)
| .+|.+|| ++.+++.||||....
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 9 6999999 888899999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=294.97 Aligned_cols=253 Identities=22% Similarity=0.374 Sum_probs=212.5
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEcc-----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTR-----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
...+|.+.+.||+|++|.||+|.+.. +++.+++|.+...... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 45679999999999999999998753 3578999998654332 2345678999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQ--------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN 160 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~--------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~ 160 (316)
...++||||+++++|.+++... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 9999999999999999999753 23788899999999999999999999999999999999999999
Q ss_pred eEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy11194 161 IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLK 239 (316)
Q Consensus 161 ~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~ 239 (316)
++|+|||.+...... ..........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+..+..+
T Consensus 161 ~kl~d~g~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 161 VKIGDFGMSRDVYTT----DYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred EEECCcccceecccC----cceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999988643211 11111222334678999999988777666 999999999999998 999999888888888
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 240 QVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+..+.....+..++..+.+++.+|| .+|.+||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 88776655555678999999999999 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=289.88 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=208.8
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
.+|++.+.||+|+||.||+|++..+++.+++|.+.............+.+|+.+++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999887644444444556778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 102 EYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 102 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~-- 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch--
Confidence 99999999998853 345899999999999999999999999999999999999999999999999988653211
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcccCCCCC-CCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS--VNELLKQVQNKVTFPKQ-PEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~-~~~~ 254 (316)
........++..|+|||.+.+...+.+ +|+||||+++|+|++|..||.... .......+......+.. ...+
T Consensus 160 ----~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 160 ----TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred ----hHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 111122347788999999987666655 999999999999999999996543 34455555443333332 3578
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
..+.++|.+|| .+|++||+++++++.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 89999999999 599999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=289.01 Aligned_cols=250 Identities=22% Similarity=0.410 Sum_probs=209.8
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|.+.+.||+|++|.||.|.... +..+++|.+...... .+.+.+|+.+++.++||||+++++++......++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 45789999999999999999997653 456999987643322 3446789999999999999999999998889999
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 100 IMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+|||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~--- 153 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--- 153 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC---
Confidence 99999999999999763 46899999999999999999999999999999999999999999999999988653211
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
.........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||......+....+..+...+.....+..+
T Consensus 154 --~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05113 154 --EYTSSVGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKV 230 (256)
T ss_pred --ceeecCCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 0011112234567999999987666665 999999999999998 999999888887777777766666666789999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.+++.+|| .+|.+||++.+++++
T Consensus 231 ~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 231 YAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999 599999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=292.90 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=199.5
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeC--CeEEEE
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETT--HRVYII 100 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv 100 (316)
|++.+.||+|++|.||+|.+..+++.+++|.+......... .. ..+|+..+..+. |+|++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~-~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VN-NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hh-HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 67899999999999999999999999999998654332221 22 236888888885 99999999999887 889999
Q ss_pred EecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
+||+++ +|.+.+.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+.....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~----- 151 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS----- 151 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc-----
Confidence 999975 88887765 356899999999999999999999999999999999999999 9999999999865321
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--------------
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-------------- 245 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 245 (316)
........++..|+|||.+......+.++|||||||++|+|++|..||...+..+....+....
T Consensus 152 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 152 --KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred --CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 1111223467889999987554444455999999999999999999998776555443332110
Q ss_pred -----CCCC---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 246 -----TFPK---------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 246 -----~~~~---------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.++. .+.++.++.++|.+|| .+|++||+++++++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0110 1346899999999999 599999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=292.66 Aligned_cols=258 Identities=23% Similarity=0.391 Sum_probs=203.3
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHH-HHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIE-VVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
++|++.+.||+|+||.||+|.+..+|+.||+|.+........ ..+.+ .|.. .++.++|||++++++++......+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~-~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLL-MDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHH-HHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999876433222 22333 4554 46667899999999999999999999
Q ss_pred EecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 101 MEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
|||++ ++|.+++.. ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99996 488888753 34689999999999999999999997 999999999999999999999999999865321
Q ss_pred cCcCCCCCCCcccccccCccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcccCCCC-
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQG----IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-VNELLKQVQNKVTFPK- 249 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~- 249 (316)
........++..|+|||.+.+ ..++. ++|+||||+++|+|++|..||.... ..+....+........
T Consensus 157 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd06617 157 ------SVAKTIDAGCKPYMAPERINPELNQKGYDV-KSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229 (283)
T ss_pred ------ccccccccCCccccChhhcCCcccccccCc-cccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC
Confidence 111122346778999998854 22334 4999999999999999999997532 2222223332222222
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
...+|.++.++|..|| .+|.+||+++++++||||+....++
T Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 271 (283)
T cd06617 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKN 271 (283)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccccc
Confidence 2357899999999999 6999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=292.70 Aligned_cols=254 Identities=27% Similarity=0.378 Sum_probs=199.4
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|.+.+.||+|++|.||+|.+..+|+.+++|++........ ...+.+|+.+++.++|+||+++++++..+...++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC--cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999865433221 22455899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
+||+. ++|.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~----- 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI----- 155 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC-----
Confidence 99996 577766644 45688889999999999999999999999999999999999999999999998864211
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcccCC-----------
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV-NELLKQVQNKVTF----------- 247 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~~~----------- 247 (316)
.........++..|+|||.+.+....+.++||||||+++|+|++|..||..... .+....+......
T Consensus 156 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 156 -PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred -CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 111122234678899999987644333449999999999999999999976442 1222211110000
Q ss_pred -------------C-------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 248 -------------P-------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 248 -------------~-------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+ .....+..+.+++.+|+ .+|++|||+++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00123678999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=294.45 Aligned_cols=248 Identities=26% Similarity=0.468 Sum_probs=204.5
Q ss_pred EEeeeeeecCCeEEEEEEEc----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 25 TVGKIIGTGSYATVKLARST----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 25 ~~~~~ig~g~~g~vy~~~~~----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.+.+.||.|.||.||+|... ..+..|+||.+.... .....+.+.+|+..++.++||||+++++++......++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence 46788999999999999988 345579999985422 233356677899999999999999999999988889999
Q ss_pred EecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 101 MEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+||+++++|.+++... ..++...+..++.||+.||.|||+.+++|++|+++||+++.++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~--- 156 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK--- 156 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence 9999999999999875 67999999999999999999999999999999999999999999999999998654110
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
..............|+|||.+.....+.+ +||||||+++|++++ |..||...+..+....+.+....+.+..++..+
T Consensus 157 -~~~~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (259)
T PF07714_consen 157 -SKYKNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDI 234 (259)
T ss_dssp -SSEEESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHH
T ss_pred -ccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccceeccchhHHH
Confidence 11112223346678999999877665554 999999999999999 789999999999888988887777777899999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.++|..|| .+|++|||+.++++
T Consensus 235 ~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999 59999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=292.92 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=201.2
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||.|++|.||+|.+..+++.|++|.+........ ...+.+|+.+++.++|+||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC--chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 4789999999999999999999998999999999875432211 22345799999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|||+.+ +|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 155 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV----- 155 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC-----
Confidence 999975 99998865 34689999999999999999999999999999999999999999999999998754211
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcccC------------
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-VNELLKQVQNKVT------------ 246 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~~------------ 246 (316)
.........++..|+|||.+.+....+.++||||+|+++|+|++|..||.... ..+....+.....
T Consensus 156 -~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 156 -PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred -CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 01111122356789999998764433445999999999999999999997654 3322222211000
Q ss_pred --------CC---------CCCCCC--HHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 247 --------FP---------KQPEVS--TECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 247 --------~~---------~~~~~~--~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.+ ....++ .++.++|.+|| .+|++|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 001234 78899999999 589999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=297.22 Aligned_cols=270 Identities=27% Similarity=0.409 Sum_probs=231.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
-|.++++||+|++|.||+|.++.+|..+|+|.+..... .+.+-.|+.++++|+.|+||++|+.+......|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 37788999999999999999999999999999866543 3445589999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 103 YAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 103 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||..||..+.++- +.++++.++..++..-++||+|||...-+|+||+..|||++.+|..||.|||.+-.+. ..
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT------DT 182 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT------DT 182 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh------hh
Confidence 9999999999964 6679999999999999999999999999999999999999999999999999885432 11
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCCCCHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV--TFPKQPEVSTECKE 259 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 259 (316)
........||+.|+|||++....++.. +||||||++..+|.-|++||.+..+...+-.+.... .+..+...|.++.+
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~D 261 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFND 261 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHH
Confidence 122334569999999999999888888 999999999999999999999877766554443332 22233458899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHhHHHH
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYID 304 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (316)
+++.|| +.|++|.|+-++++|||+++.+...-+...+++..+..-
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~A~e~~~ 307 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQDAQEKAI 307 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHHHHHHHH
Confidence 999999 899999999999999999999998877777777666543
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=309.75 Aligned_cols=263 Identities=24% Similarity=0.405 Sum_probs=221.6
Q ss_pred hhhhcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCccee
Q psy11194 8 VQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87 (316)
Q Consensus 8 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 87 (316)
-++......|++..+...+.+.||+|.||+||+|++.. .||||++......++ ..+.|++|+.++++-+|.||+-+
T Consensus 378 r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLF 453 (678)
T KOG0193|consen 378 RQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLF 453 (678)
T ss_pred ccCCccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheee
Confidence 34444456788899999999999999999999998874 599999987776665 57789999999999999999999
Q ss_pred eeEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeec
Q psy11194 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDF 166 (316)
Q Consensus 88 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df 166 (316)
.|++..+.. .+|+.+|+|.||..++.-. ..+.......|+.||++|+.|||.++|+|+|||..|||+.++++|+|+||
T Consensus 454 MG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 454 MGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred ehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecc
Confidence 999998887 9999999999999999643 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCcCCCCCCCcccccccCccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Q psy11194 167 GFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI--PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK 244 (316)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (316)
|++..-... ....-.....+...|+|||++... ...+..+||||||+++|||++|..||.....++++-++-++
T Consensus 533 GLatvk~~w----~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG 608 (678)
T KOG0193|consen 533 GLATVKTRW----SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG 608 (678)
T ss_pred cceeeeeee----ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence 998653221 222223334577889999998643 33344499999999999999999999987888887777777
Q ss_pred cCCCCC----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 245 VTFPKQ----PEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 245 ~~~~~~----~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
...+.. ..++.++++|+..|| .++++||.+.+||.
T Consensus 609 ~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 609 YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 555543 357789999999999 59999999999986
|
|
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=309.75 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=224.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
.|.-+..||.|+||-||.|++..+...||||.+.-.......--+.+-.|+..|.+++|||.+.+-++|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 37778889999999999999999999999999977665554444556699999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 103 YAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 103 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||- ||-.+++.- ..++-+.++..|+.+.+.||+|||+.+.||+|||..|||+++.|.|||+|||.+....+
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------- 178 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-------
Confidence 995 488888864 45699999999999999999999999999999999999999999999999998865433
Q ss_pred CCCCcccccccCccCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-CCCCCCHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQ---GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP-KQPEVSTEC 257 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 257 (316)
....+||+.|+|||++. ...++.+ +||||||++..+|.-.++|+.+++.......|.....+. ..+..|..+
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F 254 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF 254 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHH
Confidence 34456899999999984 3456666 999999999999999999999999888877776554333 345789999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHH
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEA 297 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~ 297 (316)
++|+..|| +.|.+|||.+++++|+|..--.-...+-.+++
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLIq 295 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLIQ 295 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHHH
Confidence 99999999 68999999999999999976555554545444
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=294.21 Aligned_cols=253 Identities=22% Similarity=0.398 Sum_probs=211.0
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
++.++|.+.+.||+|+||.||++.+. .++..+++|.+.... ....+.+.+|+.+++.++||+++++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 46788999999999999999999853 234568888875432 2234557799999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQG-------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN 160 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~-------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~ 160 (316)
....++|+||+++++|.+++...+ .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999997533 4899999999999999999999999999999999999999999
Q ss_pred eEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy11194 161 IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLK 239 (316)
Q Consensus 161 ~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~ 239 (316)
++|+|||++....... .........++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||......+...
T Consensus 159 ~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 159 VKIGDFGMSRDVYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred EEeccCCccccccCCc----eeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999986432110 1111122334678999999987666665 999999999999998 999999888888888
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 240 QVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+..+...+.+..++.++.+++.+|| .+|.+|||++++++
T Consensus 234 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 234 CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 88777655556678999999999999 58999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=290.38 Aligned_cols=249 Identities=26% Similarity=0.485 Sum_probs=204.4
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHH-HhcCCCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV-VKGLKHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||.|++|.||+|.+..+|+.+++|++.............+..|... ....+|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 569999999999999999999999999865433222112223344443 4455899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|.++++..+.+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----------~~ 151 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----------NK 151 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------cc
Confidence 99999998878899999999999999999999999999999999999999999999999998754211 22
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CC--CCCCCCCHHHHHHHHH
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TF--PKQPEVSTECKELISN 263 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~ 263 (316)
...++..|+|||.+.+..++.+ +||||||+++|++++|..||...+.......+.... .. .....++.++.++|.+
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 230 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKM-SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230 (260)
T ss_pred cCCCCcCccChhhhcCCCCcch-hhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHH
Confidence 3346778999999887665554 999999999999999999999888877766664432 12 2233589999999999
Q ss_pred hc-CCCCCCC---CHHHHhhCCCCCCCC
Q psy11194 264 IL-SPVQTRP---RLKTIAEDRWLKPKP 287 (316)
Q Consensus 264 ~l-~~p~~Rp---s~~~il~~~~~~~~~ 287 (316)
|| .+|.+|| ++++++.||||...+
T Consensus 231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 231 LLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred HccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 99 6999999 557999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.94 Aligned_cols=256 Identities=25% Similarity=0.462 Sum_probs=214.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
..|.-.+.||+|++|.||++.+..+++.+++|++...... ..+.+.+|+.+++.++|||++++++++...+..++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 3566678999999999999999888999999988543321 2344668999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+++++|.+++.. ..++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+..... .
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~------~ 168 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK------E 168 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc------C
Confidence 99999999999987 5689999999999999999999999999999999999999999999999998754211 1
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC--CCCCCCHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP--KQPEVSTECKE 259 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 259 (316)
........++..|+|||...+..++.+ +|+||||+++|+|++|..||...++......+....... ....++..+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (285)
T cd06648 169 VPRRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRS 247 (285)
T ss_pred CcccccccCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHH
Confidence 111123447888999999887666655 999999999999999999998877777666665543222 22347899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+|.+|| .+|++||++.++++||||.....
T Consensus 248 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 248 FLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 999999 58999999999999999988665
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=293.47 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=207.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|++|.||+|.+..+++.|++|.+....... ...+.+.+|+.+++.++|+||+++++++...+..++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE-DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc-cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 47999999999999999999999999999999986543322 23456779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||++++.+..+..+...++...+..++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~----- 154 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP----- 154 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc-----
Confidence 999987777767666679999999999999999999999999999999999999999999999999986532111
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN------------------ 243 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~------------------ 243 (316)
........++..|+|||++.+....+.++|+||||+++|++++|..||......+....+..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 11222344678899999998873444559999999999999999999976544333222211
Q ss_pred --ccCCC-----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 244 --KVTFP-----------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 244 --~~~~~-----------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
...++ .+..++.++.++|.+|| .+|++||+++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000 11235899999999999 589999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=287.72 Aligned_cols=245 Identities=22% Similarity=0.400 Sum_probs=204.9
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENG 107 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 107 (316)
+.||+|++|.||+|++..+++.+++|.+.... .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36999999999999999899999999875433 2233456779999999999999999999999999999999999999
Q ss_pred CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 108 SLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 108 sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
+|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~ 154 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV----YASTGG 154 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccc----ccccCC
Confidence 999999764 458999999999999999999999999999999999999999999999999986432110 000011
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 265 (316)
....+..|+|||.+.+..+..+ +|+||||+++|++++ |..||...........+......+.+..++..+.+++.+||
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCW 233 (252)
T ss_pred CCCCceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHc
Confidence 1123456999999987776665 999999999999997 99999888877777777666666666678999999999999
Q ss_pred -CCCCCCCCHHHHhh
Q psy11194 266 -SPVQTRPRLKTIAE 279 (316)
Q Consensus 266 -~~p~~Rps~~~il~ 279 (316)
.+|++|||+.++++
T Consensus 234 ~~~p~~Rps~~~~~~ 248 (252)
T cd05084 234 EYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCChhhCcCHHHHHH
Confidence 58999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=284.69 Aligned_cols=253 Identities=32% Similarity=0.528 Sum_probs=216.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||+|++|.||+|.+..+++.+++|......... ...+.+.+|+.++..++|++++++++++...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH-HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 5889999999999999999999899999999997765432 334568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
++++++|.+++.....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~------ 153 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS------ 153 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc------
Confidence 99999999999887889999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q psy11194 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELIS 262 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 262 (316)
.......++..|+|||...+.....+ +|+|+||+++|++++|..||..................+.+..++..+.++|.
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLM 232 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 11223346788999999877665444 99999999999999999999876655554444444444555678999999999
Q ss_pred Hhc-CCCCCCCCHHHHhhCCCC
Q psy11194 263 NIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 263 ~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+|| .+|++||++.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 999 699999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=292.69 Aligned_cols=252 Identities=27% Similarity=0.435 Sum_probs=204.7
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||.|++|.||+|++..+|+.+++|.+........ ...+.+|+.+++.++|+|++++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT--PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc--hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999876543221 2345589999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 103 YAENGSLFDIIRGQ---GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 103 ~~~~~sL~~~l~~~---~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|+++ +|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---- 153 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---- 153 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC----
Confidence 9976 888888653 35899999999999999999999999999999999999999999999999988643211
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC------------
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF------------ 247 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 247 (316)
........++..|++||++.+....+.++|+||||+++|++++|..||.+.+..+....+......
T Consensus 154 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 154 --VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred --ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence 111122345778999999866544444599999999999999999999876655544433221100
Q ss_pred -------C---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 248 -------P---------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 248 -------~---------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+ ..+.++..+.++|..|| .+|.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 01246789999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=286.50 Aligned_cols=258 Identities=24% Similarity=0.449 Sum_probs=212.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCC--CCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC--CeE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQ--APPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRV 97 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 97 (316)
.+|.+.+.||+|++|.||+|.+..+++.+++|.+.... .........+++|+.+++.++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875432 11222345678999999999999999999998653 468
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
++++||+++++|.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 89999999999999998877799999999999999999999999999999999999999999999999999875421110
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-ccCCCCCCCCCHH
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTE 256 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 256 (316)
.........++..|+|||.+.+...+.+ +|+||||+++|+|++|+.||...........+.. ......+..++++
T Consensus 162 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 162 ---SGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDA 237 (264)
T ss_pred ---cCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHH
Confidence 1111123347788999999987666555 9999999999999999999987665555444433 2233345678999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHhhCCCC
Q psy11194 257 CKELISNILSPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 257 ~~~li~~~l~~p~~Rps~~~il~~~~~ 283 (316)
+.++|.+||.+|..||++.+++.|||.
T Consensus 238 ~~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhcCcccCccHHHHhcCCCC
Confidence 999999999878999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=292.55 Aligned_cols=253 Identities=23% Similarity=0.420 Sum_probs=204.6
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEE-----e
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIE-----T 93 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~ 93 (316)
..++|++.+.||+|++|.||+|.+..+++.+++|+....... ...+.+|+.+++.+ +|||++++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 567899999999999999999999999999999987543221 34566899999998 6999999999874 3
Q ss_pred CCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
+..+++||||+++++|.+++.. ...+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 4578999999999999998752 346889999999999999999999999999999999999999999999999998
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQG-----IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK 244 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (316)
..... .........++..|+|||++.. ..++. ++|||||||++|+|++|..||...............
T Consensus 172 ~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 172 AQLTS------TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDA-RCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred eeccc------CCCccccccCCCcccChhhhchhhhccccccc-hhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 65321 1111223357889999998753 22333 499999999999999999999876654444333332
Q ss_pred cC--CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 245 VT--FPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 245 ~~--~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.. ...+..++..+.++|.+|| .+|.+|||+.++++|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 21 1123346889999999999 599999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=289.27 Aligned_cols=258 Identities=32% Similarity=0.484 Sum_probs=209.0
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC--CeEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRVYI 99 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 99 (316)
++|...+.||.|++|.||+|.+..+++.+++|.+...... .....+.+|+.+++.++||||+++++++... ..+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 4789999999999999999999989999999998754332 2245567899999999999999999988653 47899
Q ss_pred EEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 100 IMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999988753 34589999999999999999999999999999999999999999999999998754321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcccCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS-----SVNELLKQVQNKVTFPKQ 250 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~ 250 (316)
.......++..|+|||.+.+..++.+ +|+||||+++|+|++|..||... ...+....+.........
T Consensus 158 -------~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 158 -------SLAGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred -------cccccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 11112346778999999987777766 99999999999999999999765 233444443332111111
Q ss_pred ------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 251 ------PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 251 ------~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
...++.+.++|.+|| .+|++|||+.++++||||+....+.
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~ 276 (287)
T cd06621 230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK 276 (287)
T ss_pred cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence 234678999999999 5999999999999999997777654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=292.32 Aligned_cols=275 Identities=21% Similarity=0.328 Sum_probs=222.8
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEec
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
|...+.||+|++|.||+|.+..+++.+++|.+...........+.+.+|+.+++.++|||++++++++......++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 77778899999999999999989999999998765444444445577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 104 AENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 104 ~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
+.+ +|.+++.. ..++++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--------- 172 (313)
T cd06633 103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--------- 172 (313)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---------
Confidence 965 78777754 4568999999999999999999999999999999999999999999999999874311
Q ss_pred CCCcccccccCccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CCCCCCCCCHHHHH
Q psy11194 183 SLSETFCGSYAYASPEILQG--IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TFPKQPEVSTECKE 259 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 259 (316)
......++..|+|||.+.. ....+.++|+||||+++|+|++|..||...+.......+.... .......++..+.+
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 1123357788999999842 2223344999999999999999999998776655554443322 22223457889999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHhHHHHHhhcc
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMIQTS 309 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (316)
++.+|| .+|.+||++.+++.||||...+..+......+...+.+..++++
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDNL 302 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCCchhHHHHHHHHHHHHHHhhhhHH
Confidence 999999 58999999999999999999887777666666666666655543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.38 Aligned_cols=262 Identities=26% Similarity=0.417 Sum_probs=205.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-----C
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----H 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 95 (316)
+++|++.+.||+|++|.||+|.+..+|+.|++|.+...... .....+.+|+.+++.++|+|++++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ--TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 57899999999999999999999999999999998643222 1234456899999999999999999887543 3
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++++||+.+ +|..++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 57999999965 88888765 45999999999999999999999999999999999999999999999999998653221
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC---------
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--------- 246 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--------- 246 (316)
. ..........++..|+|||.+.+....+.++||||||+++|+|++|+.||.+.+.......+.....
T Consensus 160 ~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 160 H---DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred c---cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 1 1111223345788899999876544344459999999999999999999976554333222211000
Q ss_pred ------------CC---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 247 ------------FP---------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 247 ------------~~---------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
.+ ..+..+.++.++|.+|| .+|++|||+.++++||||......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00 01346788999999999 599999999999999999776643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=301.88 Aligned_cols=267 Identities=27% Similarity=0.433 Sum_probs=212.2
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE----eCCe
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE----TTHR 96 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~ 96 (316)
..+|++.+.||+|++|.||+|.+..+|+.|++|.+........ ....+.+|+.+++.++||||+++++++. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT-LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc-chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 4789999999999999999999999999999999875433222 2344568999999999999999998875 3357
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++|+||+. ++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 899999995 5999999877779999999999999999999999999999999999999999999999999986543211
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc------------
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK------------ 244 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------ 244 (316)
. ..........++..|+|||.+.+....+.++||||||+++|+|++|+.||.+.+.......+...
T Consensus 162 ~--~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 162 T--EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred c--CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 1 11122233457888999999866444455599999999999999999999876544332221110
Q ss_pred ------------cCCC------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 245 ------------VTFP------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 245 ------------~~~~------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
.... ..+..+.++.++|..|| .+|.+||++++++.||||...+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 0000 01346899999999999 59999999999999999987666554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=287.92 Aligned_cols=250 Identities=23% Similarity=0.429 Sum_probs=208.5
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
.+...+|++.+.||+|++|.||+|.+..+ ..+++|........ .+.+.+|+.+++.++|+||+++++.+.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 75 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCc
Confidence 35667899999999999999999987655 46999998653332 2346789999999999999999998754 567
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
++||||+++++|.+++.+. ..+++..+..++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999999999753 35889999999999999999999999999999999999999999999999998653211
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
.........++..|+|||...+...+.. +|+||||+++|++++ |..||.+....+....+......+....++
T Consensus 156 -----~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd05071 156 -----EYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 229 (262)
T ss_pred -----ccccccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccC
Confidence 1111122335677999999877666665 999999999999999 899999888888777777766666667799
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..+.++|.+|+ .+|.+||++.++++
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999 59999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=319.52 Aligned_cols=261 Identities=23% Similarity=0.385 Sum_probs=226.3
Q ss_pred hcccccceeeccCeEEeeeeeecCCeEEEEEEEcc-----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcc
Q psy11194 11 DIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTR-----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLI 85 (316)
Q Consensus 11 ~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 85 (316)
+-+....++...+.+..+.||+|.||.||+|+-.. ...-||||.++..... ...+.|++|+.++..++|||||
T Consensus 475 ~~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIV 552 (774)
T KOG1026|consen 475 NPDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIV 552 (774)
T ss_pred CCccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeE
Confidence 34555677888889999999999999999998543 2346899988665433 3467799999999999999999
Q ss_pred eeeeEEEeCCeEEEEEecCCCCCHHHHHHh----------CC----CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q psy11194 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRG----------QG----YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCE 151 (316)
Q Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----------~~----~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ 151 (316)
+++|+|..++..++|+||+..|+|.++++. +. +|+..+.+.|+.|||.|+.||.+..+||+||-.+
T Consensus 553 rLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATR 632 (774)
T KOG1026|consen 553 RLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATR 632 (774)
T ss_pred EEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhh
Confidence 999999999999999999999999999963 11 3889999999999999999999999999999999
Q ss_pred CeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q psy11194 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFD 230 (316)
Q Consensus 152 nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~ 230 (316)
|+||.++-.|||+|||+++..- ....-.......-+.+|||||.+....++++ |||||+|++|||+++ |.-||.
T Consensus 633 NCLVge~l~VKIsDfGLsRdiY----ssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 633 NCLVGENLVVKISDFGLSRDIY----SSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred hceeccceEEEecccccchhhh----hhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCccc
Confidence 9999999999999999987532 1111122223445779999999999999998 999999999999998 999999
Q ss_pred CCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy11194 231 DSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIA 278 (316)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il 278 (316)
+...+++++.+.++.-.+.+..+|.++..||..|| ..|++||++.+|-
T Consensus 708 glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 708 GLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred ccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 99999999999999888888899999999999999 6899999999885
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=285.03 Aligned_cols=255 Identities=29% Similarity=0.507 Sum_probs=213.4
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC--CeEEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRVYII 100 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 100 (316)
+|.+.+.||+|++|.||+|.+..+++.+++|+....... ....+.+.+|+.+++.++|+|++++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588899999999999999999989999999998765543 23355677999999999999999999999988 899999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
+|++++++|.+++.....+++..++.++.+++.+|++||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999999999988778999999999999999999999999999999999999999999999999988654321110
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc-ccCCCCCCCCCHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-VNELLKQVQN-KVTFPKQPEVSTECK 258 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~ 258 (316)
.......++..|.|||.........+ +|+||||+++|+|++|..||...+ .......+.. ......+..++..+.
T Consensus 158 --~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 158 --EGTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred --ccccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence 11233457788999999887665555 999999999999999999998765 3333333322 223334456799999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
++|.+|+ .+|.+||++.+++.||||
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9999999 589999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=293.32 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=206.2
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||.|++|.||+|.+..+|+.+++|.+....... ...+.+.+|+.+++.++|||++++++++......++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999986544322 22345668999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC-CCCeEEeecccccccccccCc
Q psy11194 102 EYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS-DYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~-~~~~~l~Df~~~~~~~~~~~~ 178 (316)
||+++ +|.+.+.... .+++..++.++.||+.||.+||+.+++|+||+|+||+++. ++.++|+|||++.....
T Consensus 81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~---- 155 (294)
T PLN00009 81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI---- 155 (294)
T ss_pred ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCC----
Confidence 99965 8888876533 2578889999999999999999999999999999999985 45799999998864321
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC-----------
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF----------- 247 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------- 247 (316)
.........++..|+|||++.+....+.++||||||+++|+|++|..||......+....+......
T Consensus 156 --~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 --PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred --CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 1111123346788999999866444444599999999999999999999876654443332211000
Q ss_pred -----------C------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 248 -----------P------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 248 -----------~------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+ ..+.+++++.+++.+|| .+|++||+++++++||||.+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 0 11357889999999999 58999999999999999987654
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.66 Aligned_cols=254 Identities=21% Similarity=0.349 Sum_probs=211.2
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEc----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARST----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.-.+|++.+.||+|+||.||+|... ..+..+++|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3467999999999999999999853 3456899999865332 223456778999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQ-----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD 158 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~-----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~ 158 (316)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 237888899999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11194 159 YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNEL 237 (316)
Q Consensus 159 ~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~ 237 (316)
+.++|+|||++....... .........++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.+......
T Consensus 161 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 161 LHVKISDLGLSREIYSAD----YYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CcEEeccccccccccCCc----ceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999986532111 0111222334567999999987666665 999999999999998 9999988888888
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 238 LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.+.+......+.+..+++.+.+++.+|| .+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 8888777666666778999999999999 599999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.31 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=203.9
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 94 (316)
..++|++.+.||+|++|.||+|.+..+++.+++|.+........ ....+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT-HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChh-HHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 46889999999999999999999999999999999865433222 234456899999999999999999988643
Q ss_pred -CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 95 -HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 95 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
...++||||+.+ +|.+.+... ++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 888888754 8999999999999999999999999999999999999999999999999986532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-----
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP----- 248 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 248 (316)
. ........++..|+|||.+.+..+..+ +|||||||++|+|++|+.||...+.......+......+
T Consensus 170 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 170 T-------SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred C-------CCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 1 111223346788999999988777766 999999999999999999998766544333322110000
Q ss_pred --------------------------------C-----CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCC
Q psy11194 249 --------------------------------K-----QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 249 --------------------------------~-----~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~ 284 (316)
. ....+.+++++|.+|| .+|++|||+.+++.||||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 0 1134667899999999 5999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=287.99 Aligned_cols=249 Identities=25% Similarity=0.451 Sum_probs=209.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
..+|++.+.||+|++|.||+|.+. +++.+++|.+...... ...+.+|+.+++.++|+||+++++++...+..++|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 467899999999999999999876 4668999988643332 23456899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|||+++++|.+++.. ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~--- 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--- 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc---
Confidence 999999999999975 3468999999999999999999999999999999999999999999999999886532110
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
........++..|+|||.+.+..++.+ +|+||||+++|++++ |..||......+....+......+.+..++.++.
T Consensus 155 --~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05059 155 --YTSSQGTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVY 231 (256)
T ss_pred --ccccCCCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 000111123457999999987776665 999999999999998 8999988888888888877776677777999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+++.+|| .+|++|||++++++.
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999 589999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=291.92 Aligned_cols=252 Identities=28% Similarity=0.434 Sum_probs=203.3
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEec
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
|++.+.||.|++|.||+|.+..+|+.+++|++........ ..+.+.+|+.+++.++|||++++++++......++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG-VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc-chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999876543222 233466899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 104 AENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 104 ~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
++ ++|.+++.... .+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~------ 152 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP------ 152 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC------
Confidence 95 59999987655 6899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc----------------
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV---------------- 245 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------- 245 (316)
........++..|+|||++.+....+.++|+||||+++|+|++|..||...+.......+.+..
T Consensus 153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1111222457789999988665443445999999999999999999998765543322221100
Q ss_pred ------C------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 246 ------T------FPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 246 ------~------~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
. ....+.++..+.++|.+|| .+|.+||+++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 0012457789999999999 589999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=292.41 Aligned_cols=249 Identities=25% Similarity=0.425 Sum_probs=206.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCc--eEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSG--DVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~--~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 98 (316)
++|++.+.||+|+||.||+|.+..++. .+++|.+.... .....+.+.+|+.++.++ +||||+++++++......+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877665 46777765322 222245577899999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeE
Q psy11194 99 IIMEYAENGSLFDIIRGQ----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIK 162 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~ 162 (316)
+++||+++++|.+++.+. ..++...+..++.|++.||++||+.|++|+||+|+||+++.++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999999653 2488899999999999999999999999999999999999999999
Q ss_pred EeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11194 163 LSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQV 241 (316)
Q Consensus 163 l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~ 241 (316)
|+|||++..... .........+..|+|||.+....++.+ +|||||||++|+|++ |..||......+....+
T Consensus 160 l~dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 160 IADFGLSRGEEV-------YVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred ECCcCCCccccc-------eeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999998753110 001111123457999999887666655 999999999999997 99999998888888888
Q ss_pred hcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 242 QNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
......+.+..++.++.++|.+|| .+|.+||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 232 PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 776666666679999999999999 589999999999743
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=286.00 Aligned_cols=259 Identities=28% Similarity=0.503 Sum_probs=214.3
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
+.||+|+++.|-.+....+|..||||++.+..... ...+-+|+.++.+++ |+||++++++|+++..+|+|||.+.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs---R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS---RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchH---HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 56999999999999999999999999998774433 334559999999995 99999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC---CCeEEeecccccccc--cccCcCCC
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD---YNIKLSDFGFARAHM--RCRSNAAD 181 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~---~~~~l~Df~~~~~~~--~~~~~~~~ 181 (316)
|+|...|.+...+++.++.++..+|+.||.+||.+||.|+||||+|||.... ..||||||.+..-.. ...+ ...
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s-pas 239 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS-PAS 239 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC-CCC
Confidence 9999999999999999999999999999999999999999999999999654 349999998764321 1111 112
Q ss_pred CCCCcccccccCccCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHh
Q psy11194 182 NSLSETFCGSYAYASPEILQ----GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS---------------SVNELLKQVQ 242 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---------------~~~~~~~~~~ 242 (316)
.......+|+..|||||+.. ...++++.+|.||||+++|-|+.|++||.+. .++...+.++
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 22233456888999999862 3456667799999999999999999999642 2556667776
Q ss_pred ccc-CCC--CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 243 NKV-TFP--KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 243 ~~~-~~~--~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
++. .+| .+..+|.+.+++|..+| .++.+|.++.+++.|||++....+.
T Consensus 320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence 653 333 45679999999999999 7999999999999999998766543
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=289.79 Aligned_cols=256 Identities=27% Similarity=0.520 Sum_probs=212.6
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCH
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL 109 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 109 (316)
||.|++|.||+|.+..+|+.+++|++...........+.+.+|+.+++.++|||++++++.+..++..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999988999999998665443334456677899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC--CCCCCCcc
Q psy11194 110 FDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA--ADNSLSET 187 (316)
Q Consensus 110 ~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~--~~~~~~~~ 187 (316)
.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 9999887789999999999999999999999999999999999999999999999999886432110000 00112223
Q ss_pred cccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CCCCCCCCCHHHHHHHHHhc-
Q psy11194 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 188 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l- 265 (316)
..++..|+|||.......+.. +|+||||+++|++++|..||......+....+..+. .++.....+..+.+++.+||
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 446778999999877665554 999999999999999999999888888777776532 23322234999999999999
Q ss_pred CCCCCCCCH---HHHhhCCCCCCC
Q psy11194 266 SPVQTRPRL---KTIAEDRWLKPK 286 (316)
Q Consensus 266 ~~p~~Rps~---~~il~~~~~~~~ 286 (316)
.+|.+|||+ .++++||||.+.
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccCC
Confidence 589999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=299.97 Aligned_cols=262 Identities=25% Similarity=0.378 Sum_probs=208.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-----C
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----H 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 95 (316)
..+|.+.+.||+|++|.||+|.+..+++.|++|.+......... ...+.+|+.+++.++|+|++++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID-AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch-hHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 56899999999999999999999999999999998754332222 23455899999999999999999988644 3
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++|+||+. ++|.+++...+.+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5799999995 599999988788999999999999999999999999999999999999999999999999998653211
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----------
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK----------- 244 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------- 244 (316)
........++..|+|||.+......+.++|+||||+++|+|++|..||.+.+.......+...
T Consensus 162 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 162 ------GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ------cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 112223346788999998865433444599999999999999999999776543332222110
Q ss_pred -------------cCC------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 245 -------------VTF------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 245 -------------~~~------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
... ...+.+++++.++|.+|| .+|++|||++++++||||.......
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 000 012457899999999999 5999999999999999997755443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=301.95 Aligned_cols=280 Identities=24% Similarity=0.365 Sum_probs=214.7
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEe
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIET 93 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 93 (316)
.+..+.+..|++++.||.||.+.||++...+.+ .+++|.+...... .....-+.+|+.+|.+|+ |..|++++++-..
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D-~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEAD-NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcC-HHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 456678888999999999999999999866554 5555555443333 333555779999999995 8999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
++..|+|||+-+. .|..+++.... .+.-.++.+..|++.|+.++|..||||.||||.|+++ -.|.+||+|||+|...
T Consensus 432 d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 432 DGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAI 509 (677)
T ss_pred CceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhccc
Confidence 9999999998854 99999987654 3334888999999999999999999999999999999 4679999999999664
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCC----------CCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPY----------APHLSDIWSMGVVLFAMVFGRLPFDDSS-VNELLKQV 241 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~----------~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~ 241 (316)
. ..+.+......+||+.||+||.+..... -..++||||||||||+|+.|+.||.... .-.-+..+
T Consensus 510 ~----~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI 585 (677)
T KOG0596|consen 510 Q----PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI 585 (677)
T ss_pred C----ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh
Confidence 3 3445566777889999999998832211 2234999999999999999999997643 22222222
Q ss_pred hcc-cCCCCCCCC-CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC-hhhHHHhHhHH
Q psy11194 242 QNK-VTFPKQPEV-STECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG-VDKAEAELDHY 302 (316)
Q Consensus 242 ~~~-~~~~~~~~~-~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~-~~~~~~~~~~~ 302 (316)
..- ...+.+..- ..++.+++..|| .||.+||++.++|+|||++.++-+.. +.++.+..-+|
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~~m~~~~~~~~k~ 650 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVEQMAKLTTNEMKY 650 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccchHHHHHHHHHHHh
Confidence 221 111222111 234999999999 69999999999999999999776655 55555555444
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=295.24 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=206.4
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC--CeEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRVY 98 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 98 (316)
.++|++.+.||.|++|.||+|.+..+++.+++|.+........ ....+.+|+.++..++||||+++++++... ...+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-FPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc-chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 3579999999999999999999998999999999975543322 233455899999999999999999998877 8999
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 99 IIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+|+||+++ +|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 99999975 999988764 358999999999999999999999999999999999999999999999999886542110
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC----------
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF---------- 247 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 247 (316)
.......++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+......
T Consensus 161 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 161 -----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred -----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 11222346778999999876554445599999999999999999999877665554443221100
Q ss_pred --------------------CCCCC-CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 248 --------------------PKQPE-VSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 248 --------------------~~~~~-~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
..+.. +++.+.++|.+|| .+|++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00111 5888999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=290.25 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=200.4
Q ss_pred eeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHH---HHHhcCCCCCcceeeeEEEeCCeEEEEEecCC
Q psy11194 29 IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREI---EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAE 105 (316)
Q Consensus 29 ~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~---~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 105 (316)
.||+|+||.||+|.+..+++.||+|.+................|. ..+....||+++++++++......++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999989999999998764432221112222333 34444579999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCC
Q psy11194 106 NGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS 185 (316)
Q Consensus 106 ~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~ 185 (316)
|++|..++...+.+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+..... ...
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~--------~~~ 152 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--------KKP 152 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc--------cCC
Confidence 999999998878899999999999999999999999999999999999999999999999998864321 111
Q ss_pred cccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q psy11194 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS---SVNELLKQVQNKVTFPKQPEVSTECKELIS 262 (316)
Q Consensus 186 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 262 (316)
....++..|+|||.+.+....+.++||||+|+++|+|++|..||... ......... .......+..++.++.+++.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~ 231 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLE 231 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHHHH
Confidence 23357889999999875433334499999999999999999999765 333332222 22234444567999999999
Q ss_pred Hhc-CCCCCCC-----CHHHHhhCCCCCCCC
Q psy11194 263 NIL-SPVQTRP-----RLKTIAEDRWLKPKP 287 (316)
Q Consensus 263 ~~l-~~p~~Rp-----s~~~il~~~~~~~~~ 287 (316)
+|| .+|.+|| +++++++||||.+..
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 999 6899999 999999999998755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=289.79 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=213.0
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCC-----ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHS-----GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
++..++|.+.+.||+|+||.||+|.+...+ ..+++|....... ......+.+|+.+++.++|+|++++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 466789999999999999999999876433 7899999754332 222345668999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeE
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQ----------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIK 162 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~ 162 (316)
.....++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 999999999999999999999642 2367889999999999999999999999999999999999999999
Q ss_pred EeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11194 163 LSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQV 241 (316)
Q Consensus 163 l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~ 241 (316)
|+|||+++....... ........++..|+|||.+.+...+.+ +||||||+++|++++ |..||...+..+..+.+
T Consensus 160 l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 160 IGDFGMTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred ECCcccchhhccCcc----cccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 999999865322110 111122335678999999877666665 999999999999998 99999988888888888
Q ss_pred hcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 242 QNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
......+.+..++.++.++|.+|| .+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 235 IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 766666666778999999999999 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=294.20 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=202.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC-----
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 95 (316)
.++|++.+.||+|++|.||+|.+..+++.|++|.+........ ....+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-chhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4579999999999999999999999999999999865433221 1223457999999999999999999986544
Q ss_pred ---eEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 96 ---RVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 96 ---~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
..++||||+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 45999999965 888887654 3689999999999999999999999999999999999999999999999999865
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc------
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV------ 245 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------ 245 (316)
....... .........++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+.......+....
T Consensus 169 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 169 FSLSKNS--KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccCCccc--CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 4321111 11112234467889999988665433445999999999999999999998776554433332210
Q ss_pred --------------CCCC-----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 246 --------------TFPK-----------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 246 --------------~~~~-----------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
..+. ....+..+.++|.+|| .+|.+|||++++++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0000 0113567889999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=293.50 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=214.7
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccC-----CceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRH-----SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQ 89 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 89 (316)
.+.+..++|++.+.||+|++|.||++..... ...+++|.+...... . ....+.+|+.+++.+ +|+||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~-~-~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-K-DLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH-H-HHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3566788999999999999999999987643 367899988654322 2 234467899999999 7999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCe
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRG----------------QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENL 153 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~----------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ni 153 (316)
++...+.++++|||+++++|..+++. ...+++..+..++.|++.||.|||+.+++|+||+|+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 99999999999999999999999954 23588999999999999999999999999999999999
Q ss_pred eeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy11194 154 LLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDS 232 (316)
Q Consensus 154 l~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~ 232 (316)
+++.++.++|+|||.+........ ........++..|+|||++.+..++.+ +|||||||++|++++ |..||...
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDY----YRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred EEcCCCeEEeCccccccccccccc----eeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCC
Confidence 999999999999999865422110 011111224567999999877776666 999999999999997 99999998
Q ss_pred CHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 233 SVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
...+....+........+..++..+.+|+.+|| .+|.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 239 PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 888888888777666666778999999999999 589999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=285.59 Aligned_cols=251 Identities=27% Similarity=0.448 Sum_probs=208.8
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|++|.||+|.+..+|+.+++|.++..........+.+.+|+.+++.++|++++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999899999999987544444444556779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 102 EYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 102 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
||+++++|.+++.. ...++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999999864 345899999999999999999999999999999999999999999999999987643211
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcccCCCCCC-CCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS--SVNELLKQVQNKVTFPKQP-EVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~-~~~ 254 (316)
........++..|.|||.+.+..++.+ +|+||||+++|++++|..||... +..+..+.+..+...+.+. .++
T Consensus 160 ----~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 160 ----TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred ----CcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 111122346778999999887666665 99999999999999999999653 3344555555444344433 688
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..+.++|.+|| .+|.+|||+.++++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 89999999999 58999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=263.17 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=215.1
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|.-.++||+|.+|+||+|+...+++.||+|.++.....+..-.. ..+|+-+++.++|.||++++++...+...-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpss-alreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSS-ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHH-HHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 456678899999999999999999999999999876654433233 3489999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 103 YAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 103 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||.. .|..+... ++.++.+.++.++.|++.||.++|+.++.|+|++|.|.+++.+|..|+.|||+++.+.....
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr---- 156 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR---- 156 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE----
Confidence 9955 89998866 56799999999999999999999999999999999999999999999999999987531110
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCC----------
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQ---------- 250 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 250 (316)
. ......+.+|++|.++.+...++...|+||-||++.|+.. |++.|++.+..+....+-.....|..
T Consensus 157 -c-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 -C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred -e-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 0 1122468899999999998877777999999999999986 89999999988887776432211110
Q ss_pred ------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 251 ------------------PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 251 ------------------~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
+.++..-+++++.+| ++|.+|.+++++++||||.+..
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 234456679999999 7999999999999999998754
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=294.74 Aligned_cols=258 Identities=29% Similarity=0.477 Sum_probs=213.4
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
..+|.+.+.||+|+||.||++.+..+++.+++|.+...... ..+.+.+|+.+++.++|||++++++++...+..++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 56899999999999999999998888999999998543222 234567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
+||+++++|.+++.+. .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~----- 168 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE----- 168 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc-----
Confidence 9999999999999764 4889999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCCCCHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV--TFPKQPEVSTECK 258 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 258 (316)
........++..|+|||.+....++.+ +|+||||+++|++++|..||...+.......+.... ..+....++..+.
T Consensus 169 -~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (293)
T cd06647 169 -QSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246 (293)
T ss_pred -ccccccccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence 111223347788999999877666655 999999999999999999998766544433332221 2223345788999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
++|.+|| .+|.+||++++++.|+||+.....
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~ 278 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence 9999999 599999999999999999877643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.48 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=205.2
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEE------
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIE------ 92 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~------ 92 (316)
....|++.+.||.|+||.||+|.+..+++.+++|+...... ....+..|+.++..+ +|+|++++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 45689999999999999999999999999999999855322 134467888989888 6999999999985
Q ss_pred eCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
.....+++|||+++++|.+++.. ...+++..++.++.||+.|+.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 34678999999999999999965 3458899999999999999999999999999999999999999999999999876
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQG-----IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV 245 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (316)
..... ........++..|+|||.+.. ..++.+ +|+||||+++|+|++|..||....+......+....
T Consensus 170 ~~~~~------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~-~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 242 (282)
T cd06636 170 QLDRT------VGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 242 (282)
T ss_pred hhhcc------ccCCCcccccccccCHhhcCcccCcCcCCCcc-cchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC
Confidence 43211 111223457888999998753 234444 999999999999999999997766554444333322
Q ss_pred C-CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 246 T-FPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 246 ~-~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
. ......++.++.++|.+|| .+|.+||++.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 2 2223458999999999999 599999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=286.45 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=212.6
Q ss_pred eeeeecCCeEEEEEEEccC---CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecC
Q psy11194 28 KIIGTGSYATVKLARSTRH---SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 104 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 104 (316)
+.||+|+||.||+|.+... +..+++|.+....... ..+.+.+|+..+..++|+|++++++++......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999998866 8899999987654433 3556779999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 105 ENGSLFDIIRGQ---------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 105 ~~~sL~~~l~~~---------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 67999999999999999999999999999999999999999999999999998654321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
.. ........++..|+|||.+.....+.+ +||||||+++|+|++ |..||......+..+.+..+...+.+..++
T Consensus 159 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd00192 159 DY----YRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCP 233 (262)
T ss_pred cc----cccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence 11 112233446778999999887665555 999999999999999 699999998888888888777677777889
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.++.+++.+|| .+|.+|||+++++++
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 234 DELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred hHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999 589999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=289.95 Aligned_cols=249 Identities=25% Similarity=0.428 Sum_probs=213.4
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
...+|++.+.||.|++|.||+|.+.. ++.+++|++...... ..+.+.+|+.+++.++|+|++++++++......++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 45679999999999999999999887 889999998654321 24457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 100 IMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
||||+++++|.+++.. ...++...+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 9999999999999975 3458999999999999999999999999999999999999999999999999886532111
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
.......++..|+|||.+....+..+ +||||||+++|+|++ |..||......+....+......+.+..++..
T Consensus 159 -----~~~~~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05148 159 -----YLSSDKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQE 232 (261)
T ss_pred -----ccccCCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHH
Confidence 11112234567999999887666665 999999999999998 89999988888888888777777777789999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+.++|.+|| .+|.+|||+.++++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 233 IYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=287.47 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=201.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
+.......||+|+||.||+|.+..++..+++|.+..... ...+.+.+|+.+++.++|+||+++++++..++..++++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344445689999999999999998899999998765432 22456779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC-CCCeEEeecccccccccccC
Q psy11194 102 EYAENGSLFDIIRGQ-GYI--DEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS-DYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 102 e~~~~~sL~~~l~~~-~~l--~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~-~~~~~l~Df~~~~~~~~~~~ 177 (316)
||+++++|.+++... ..+ +...+..++.|++.||++||+.|++|+||+|+||+++. ++.++|+|||.+......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 162 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI-- 162 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--
Confidence 999999999999764 445 88899999999999999999999999999999999976 678999999988643211
Q ss_pred cCCCCCCCcccccccCccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-hcccCCCCCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE-LLKQV-QNKVTFPKQPEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~-~~~~~~~~~~~~~ 254 (316)
........++..|+|||.+.+.. ....++|+||||+++|+|++|..||....... ..... ........+..++
T Consensus 163 ----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06624 163 ----NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238 (268)
T ss_pred ----CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence 11122234678899999986533 23344999999999999999999997543221 11111 1122223345688
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+++.+++.+|| .+|.+|||+.++++||||
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999 589999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=293.14 Aligned_cols=262 Identities=25% Similarity=0.457 Sum_probs=216.3
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
.|.....||+|+||.||+|.+..+++.+++|.+....... .+.+.+|+.++..++|||++++++++..+...++++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch---HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 3555668999999999999999899999999986543322 3456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
|+++++|..++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~------~~ 171 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK------DV 171 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc------cc
Confidence 9999999998765 4589999999999999999999999999999999999999999999999998754321 11
Q ss_pred CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--CCCCCCCCHHHHHH
Q psy11194 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--FPKQPEVSTECKEL 260 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 260 (316)
.......++..|+|||.+.+...+.+ +|+||||+++|+|++|..||......+....+..... ......++..+.++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 250 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDF 250 (297)
T ss_pred ccccceecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHH
Confidence 11223457889999999987666655 9999999999999999999988777666665544321 22234578999999
Q ss_pred HHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhH
Q psy11194 261 ISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKA 295 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~ 295 (316)
|..|| .+|.+||+++++++||||....-......+
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~~~~~ 286 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQTGLPECLVPL 286 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccCCCcccccch
Confidence 99999 599999999999999999887665554333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=290.77 Aligned_cols=258 Identities=28% Similarity=0.458 Sum_probs=216.8
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..+.|++.+.||+|++|.||+|.+..++..+++|++..... ..+.+.+|+..++.++|+|++++++++......++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45669999999999999999999998899999999875443 24456689999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 100 IMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
++||+++++|.+++.... .++...+..++.+++.||++||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--- 169 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--- 169 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc---
Confidence 999999999999998765 7999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC--CCCCCCCHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF--PKQPEVSTE 256 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 256 (316)
........++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.......+...... +....++.+
T Consensus 170 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd06614 170 ---KSKRNSVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPE 245 (286)
T ss_pred ---hhhhccccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHH
Confidence 011122346778999999887766655 99999999999999999999887776655554433222 222348899
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+.++|.+|| .+|.+||++.++++|+||...-.
T Consensus 246 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 246 FKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 999999999 58999999999999999988443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=290.41 Aligned_cols=276 Identities=22% Similarity=0.334 Sum_probs=223.3
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
+.|...+.||+|+||.||+|.+..++..+++|.+.............+.+|+.+++.++|+|++++++++..+...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 44888999999999999999999899999999987654444444456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||+.| +|.+.+.. ..++++..+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 99976 77777643 55699999999999999999999999999999999999999999999999998754211
Q ss_pred CCCCCcccccccCccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-CCCCCCCCHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQG--IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-FPKQPEVSTEC 257 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 257 (316)
.....++..|+|||.+.. ....+.++|+||||+++|+|++|..||...........+..... ......++..+
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 253 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF 253 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHH
Confidence 112346778999999742 22233449999999999999999999988776666555544332 33334678999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHhHHHHHhhc
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMIQT 308 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (316)
.++|.+|| .+|.+||++.++++|+|+.............+...+.+...++
T Consensus 254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (317)
T cd06635 254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELDN 305 (317)
T ss_pred HHHHHHHccCCcccCcCHHHHHhChhhhccCcccchhhHHHHHHHHHHHHhh
Confidence 99999999 5899999999999999997766655555555666656555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=305.35 Aligned_cols=260 Identities=40% Similarity=0.714 Sum_probs=234.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
-..|.+.+.||.|.|+.|..|++.-++..||+|.+.+...+...... +.+|+.+++.++||||++++.+...+..+++|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k-~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQK-LGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHH-HHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 34699999999999999999999999999999999887776665444 77999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|||+.+|.+++++.+.+...+..+..++.|++.|++|+|+++++|+|||++|++++.+-+++|+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~------- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD------- 206 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-------
Confidence 9999999999999999989999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (316)
........+|++.|.|||++.+..+...++|+||+|+++|.|+.|.+||.+....+....+..+ .+..+-.++.++.++
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g-k~rIp~~ms~dce~l 285 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG-KYRIPFYMSCDCEDL 285 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee-eecccceeechhHHH
Confidence 4455667789999999999999999988899999999999999999999998877777666544 233334589999999
Q ss_pred HHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 261 ISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
|+++| -+|.+|++++++++|.|.+...+.
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 99999 699999999999999999888776
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=292.66 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=211.6
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEcc-------CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCccee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTR-------HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRF 87 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~ 87 (316)
..++..++|.+.+.||+|+||.||+|.+.. +...+++|.+..... ......+.+|+.+++.+ +|+||+++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 355667899999999999999999998643 224699999865432 22234566899999999 79999999
Q ss_pred eeEEEeCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q psy11194 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQ----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCE 151 (316)
Q Consensus 88 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ 151 (316)
++++......++||||+++++|.+++... ..++...+..++.|++.||+|||+.|++|+||+|+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 99999999999999999999999999753 24788899999999999999999999999999999
Q ss_pred CeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q psy11194 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFD 230 (316)
Q Consensus 152 nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~ 230 (316)
||+++.++.++|+|||.+......... .......++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchh----hccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999988643211100 00111123467999999987666655 999999999999998 899999
Q ss_pred CCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 231 DSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.....+....+......+.+..++.++.++|.+|| .+|.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 245 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 88888888888777666666778999999999999 589999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=287.75 Aligned_cols=254 Identities=22% Similarity=0.388 Sum_probs=211.4
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCc----eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSG----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
.+..++|++.+.||+|+||.||+|.+..++. .||+|+...... ....+.+.+|+..+..++||||+++++++..
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 4567899999999999999999999877666 478998865432 2224556789999999999999999999875
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
. ..+++++|+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 S-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred C-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 4 56789999999999999976 456999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
..... ........++..|+|||...+..++.+ +|||||||++|+|++ |..||...........+......+.+.
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T cd05109 160 DIDET----EYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP 234 (279)
T ss_pred ccccc----eeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCc
Confidence 31111 001112234567999999987766665 999999999999998 999999888888877777776667777
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.++..+.++|.+|| .+|++||++.++++
T Consensus 235 ~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 235 ICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 89999999999999 59999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=284.86 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=203.3
Q ss_pred eeeecCCeEEEEEEE--ccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 29 IIGTGSYATVKLARS--TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 29 ~ig~g~~g~vy~~~~--~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
.||+|+||.||+|.+ ..++..+++|++..... .....+.+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999965 35678899999865433 33345567789999999999999999998754 567899999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|.||+++.++.++|+|||++......... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---YKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe---eeecC
Confidence 999999988778999999999999999999999999999999999999999999999999998653211100 00111
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 265 (316)
...++..|+|||.+.....+.+ +|+||||+++|++++ |..||......+..+.+.+....+.+..+++++.++|..||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~ 235 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW 235 (257)
T ss_pred CCCCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHh
Confidence 1223568999999876665555 999999999999998 99999988888888888877666666779999999999999
Q ss_pred -CCCCCCCCHHHHhh
Q psy11194 266 -SPVQTRPRLKTIAE 279 (316)
Q Consensus 266 -~~p~~Rps~~~il~ 279 (316)
.+|++||++++|.+
T Consensus 236 ~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 236 TYGVDERPGFAVVEL 250 (257)
T ss_pred ccCchhCcCHHHHHH
Confidence 59999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=283.89 Aligned_cols=246 Identities=26% Similarity=0.492 Sum_probs=211.3
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
+..++|++.+.||.|++|.||+|... |+.+++|.+..... ..+.+.+|+.+++.++|+|++++++++......+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 46788999999999999999999765 78999999865433 2455678999999999999999999999899999
Q ss_pred EEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 99 IIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
+||||+++++|.++++... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999997654 69999999999999999999999999999999999999999999999999986542110
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (316)
.....+..|+|||.+....+..+ +|+||||+++|++++ |..||......+....+........+..+++
T Consensus 157 ---------~~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05039 157 ---------DSGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPP 226 (256)
T ss_pred ---------ccCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCH
Confidence 11223567999999877666655 999999999999997 9999998888888877777655555567899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
++.++|.+|| .+|++|||++++++.
T Consensus 227 ~~~~li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 227 EVYKVMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHH
Confidence 9999999999 589999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=285.35 Aligned_cols=250 Identities=22% Similarity=0.393 Sum_probs=208.9
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
.+..++|++.+.||+|++|.||+|.+. .+..+++|.+...... .+.+.+|+.+++.++|++++++++++. ....
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence 456778999999999999999999765 5567999998654432 234778999999999999999999885 4567
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
+++|||+++++|.+++... ..+++..++.++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 8999999999999999753 35899999999999999999999999999999999999999999999999998653211
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
.........++..|+|||.+.+...+.+ +|+||||+++|++++ |..||.+.+..+..+.+......+.+...+
T Consensus 156 -----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (260)
T cd05070 156 -----EYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCP 229 (260)
T ss_pred -----ccccccCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence 0111112224567999999877666655 999999999999999 999999888888888887776666677789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..+.+++.+|| .+|.+|||++++.+
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999 59999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=281.76 Aligned_cols=249 Identities=28% Similarity=0.523 Sum_probs=209.9
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|.+.+.||+|++|.||+|.+..++..+++|+...... .....+.+|+.+++.++|++++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48889999999999999999998899999999866543 224567799999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 103 YAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 103 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
|+++++|.+++... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~----- 152 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK----- 152 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc-----
Confidence 99999999999775 579999999999999999999999999999999999999999999999999886532111
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--CCCCCCCCHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--FPKQPEVSTECKE 259 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 259 (316)
......++..|+|||.+.....+.+ +|+||||+++|++++|..||...+..+.......... .+....++..+.+
T Consensus 153 --~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (253)
T cd05122 153 --ARNTMVGTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229 (253)
T ss_pred --cccceecCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHH
Confidence 0233457788999999877665554 9999999999999999999987755555444433222 2222234899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRW 282 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~ 282 (316)
+|.+|| .+|++|||+.++++|||
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999 69999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=295.01 Aligned_cols=257 Identities=23% Similarity=0.367 Sum_probs=200.3
Q ss_pred CeEEeeeeeecCCeEEEEEEEcc--CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC--CeEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTR--HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRVY 98 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 98 (316)
+|.+.+.||+|++|.||+|.+.. +++.+|+|.+...........+.+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58899999999999999999988 7899999999764322222234466899999999999999999999888 8899
Q ss_pred EEEecCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC----CCCeEEeecccc
Q psy11194 99 IIMEYAENGSLFDIIRG-----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS----DYNIKLSDFGFA 169 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~----~~~~~l~Df~~~ 169 (316)
+||||+++ +|.+++.. ...+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999965 77777643 236899999999999999999999999999999999999998 899999999998
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHH
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE---------LLKQ 240 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~---------~~~~ 240 (316)
....... ..........++..|+|||++.+....+.++||||||+++|+|++|+.||....... ....
T Consensus 160 ~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 160 RLFNAPL---KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccCCCc---ccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 6542211 111122234567889999988765444445999999999999999999997544322 0000
Q ss_pred Hh-------------------------cc--cCCC---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 241 VQ-------------------------NK--VTFP---------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 241 ~~-------------------------~~--~~~~---------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+. .. ...+ .....+.++.++|.+|| .+|++|||+.++++||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00 00 0001 00146778999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=286.58 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=211.2
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCc---eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
...+|++.+.||+|+||.||+|.+..++. .+++|.+..... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 45789999999999999999998765443 689998754332 2234567789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
.++||||+++++|.+++... +.++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999764 45899999999999999999999999999999999999999999999999998654321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
.... .......++..|+|||.+.+..++.+ +|+||||+++|++++ |..||......+....+......+....++
T Consensus 160 ~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd05066 160 PEAA---YTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP 235 (267)
T ss_pred ccee---eecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCC
Confidence 1100 01111123457999999987776665 999999999999886 999999888887777777776667777789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+.+.+++.+|+ .+|.+||++.++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHHcccCchhCCCHHHHHH
Confidence 99999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=287.72 Aligned_cols=263 Identities=31% Similarity=0.525 Sum_probs=229.7
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
...+..++|..++.||+|.||.|.+++.+.+++.+|+|++++...-.......-..|-.+|+.++||.+..+..+|+..+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34556788999999999999999999999999999999998754433222233337888999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
+.|+||||.+||.|.-.+.+...+++...+-+...|+.||.|||+.++|++|||.+|.+++.+|++||.|||++..
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE---- 317 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE---- 317 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh----
Confidence 9999999999999999998888899999999999999999999999999999999999999999999999999864
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-ccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 254 (316)
...........+|++.|.|||++....+... .|+|.+|+++|+|++|++||.+.+.+...+.+.- ..++| ..++
T Consensus 318 --~I~~g~t~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP--r~ls 392 (516)
T KOG0690|consen 318 --EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP--RTLS 392 (516)
T ss_pred --cccccceeccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC--ccCC
Confidence 3344445566789999999999998888877 9999999999999999999999999988887743 34444 5699
Q ss_pred HHHHHHHHHhc-CCCCCCC-----CHHHHhhCCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRP-----RLKTIAEDRWLKPKP 287 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~~ 287 (316)
++.+.|+..+| +||.+|. .+.||.+|+||....
T Consensus 393 ~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 393 PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred HHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 99999999999 7999997 689999999997543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=297.81 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=214.3
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC-----eE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-----RV 97 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 97 (316)
+|.+.+.||.|++|.||+|.+..+++.+++|.+...... ....+.+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 689999999999999999999988999999998654322 222455778999999999999999999987765 78
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+++|+|+++ +|.+++.+...+++..++.++.+++.||.+||+.|++|+||+|.||+++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999974 8999998877899999999999999999999999999999999999999999999999999875432110
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC--------
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK-------- 249 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 249 (316)
.........++..|+|||.+.+....+.++|+||||+++|+|++|..||.+....+....+......+.
T Consensus 159 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 159 ---EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred ---ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 011122334678899999998873444459999999999999999999988777665555443221111
Q ss_pred ----------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 250 ----------------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 250 ----------------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
.+.++.++.++|.+|| .+|.+||++++++.||||+..+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 1346889999999999 599999999999999999776654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=283.91 Aligned_cols=251 Identities=23% Similarity=0.427 Sum_probs=212.8
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
++..++|++.+.||.|++|.||+|.+. .+..+++|.+...... .+.+.+|+.+++.++|+|++++++++......
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 467889999999999999999999865 4578999998754332 34467899999999999999999999998999
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
+++||++++++|.+++... ..++...+..++.+++.|+.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999999999764 35899999999999999999999999999999999999999999999999988653210
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
..........+..|+|||.+.+...+.+ +|+||||+++|++++ |+.||.+.........+......+.+...+
T Consensus 157 -----~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (261)
T cd05034 157 -----EYTAREGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCP 230 (261)
T ss_pred -----hhhhhhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 0011112223567999999987666655 999999999999998 999999888888888887777667777789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.++.+++.+|| .+|.+||+++++.+
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 231 EELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999999999 58999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=283.70 Aligned_cols=251 Identities=30% Similarity=0.471 Sum_probs=216.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+|++.+.||+|++|.||++.+..+++.+++|.+........ ....+.+|+.+++.++|+||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK-EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH-HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58999999999999999999998999999999876544332 23455689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 103 YAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 103 ~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
|+++++|.+++.. ...+++..++.++.+++.||.+||+.|++|+||+|.||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999999865 346899999999999999999999999999999999999999999999999998654211
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
......++..|+|||...+...+.+ +|+||||+++|++++|+.||...+..+....+......+.....+.++.
T Consensus 157 -----~~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd08530 157 -----MAKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230 (256)
T ss_pred -----CcccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHH
Confidence 1222346788999999987666655 9999999999999999999998888877777766554555567899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+++.+|| .+|.+||++.++++||++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999 599999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=283.50 Aligned_cols=246 Identities=31% Similarity=0.549 Sum_probs=212.1
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCH
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL 109 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 109 (316)
||+|++|.||++.+..+++.+++|++.............+..|+.+++.++|++++++++.+..+...+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999998776544433455677899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccc
Q psy11194 110 FDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189 (316)
Q Consensus 110 ~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~ 189 (316)
.+++.....+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+....... .......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------SRTNTFC 154 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC------CcccCCc
Confidence 9999887789999999999999999999999999999999999999999999999999886532111 1223345
Q ss_pred cccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCC
Q psy11194 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPV 268 (316)
Q Consensus 190 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p 268 (316)
++..|+|||...+...+.. +|+||||+++|++++|..||...+.......+.. ...+.+...+..+.++|.+|| .+|
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred CCccccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCH
Confidence 6778999999887666555 9999999999999999999988777666666655 345555667999999999999 699
Q ss_pred CCCCCH---HHHhhCCCC
Q psy11194 269 QTRPRL---KTIAEDRWL 283 (316)
Q Consensus 269 ~~Rps~---~~il~~~~~ 283 (316)
.+||++ ++++.||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=321.28 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=220.0
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCc-----eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSG-----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~-----~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
.+...+..+...||+|.||.||.|....... .|++|.+...... .....+.+|..+++.++||||++++|++.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~--~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE--QEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 3557889999999999999999999765333 3788877554433 33556779999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEee
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQ-------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSD 165 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~-------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~D 165 (316)
+...+++++|||+||+|..++++. ..++..+...++.+||+|+.||+++++||+||..+|+|++....|||.|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999999864 3599999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcc
Q psy11194 166 FGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNK 244 (316)
Q Consensus 166 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~ 244 (316)
||+|+...... ..........+..|||||.+....++++ +||||||+++||+++ |..||++.+..++...+.++
T Consensus 846 FGlArDiy~~~----yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g 920 (1025)
T KOG1095|consen 846 FGLARDIYDKD----YYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG 920 (1025)
T ss_pred cchhHhhhhch----heeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC
Confidence 99998332111 1111111234578999999999888888 999999999999999 99999999999999988888
Q ss_pred cCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 245 VTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 245 ~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+.+.+..+|..+.++|.+|| .+|++||++..|++
T Consensus 921 gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 921 GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 799999999999999999999 59999999999997
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=286.17 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=211.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCc---eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
..+|++.+.||+|+||.||+|.+..+++ .|++|.+.... .....+.+..|+.+++.++||||+++++++..+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999887665 59999886532 233345678999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
++||||+++++|.+++.. .+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999975 3458999999999999999999999999999999999999999999999999886532211
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (316)
..... ........+..|+|||.+.+..++.+ +||||||+++|++++ |..||...+..+....+......+.+..++.
T Consensus 161 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 238 (269)
T cd05065 161 SDPTY-TSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238 (269)
T ss_pred ccccc-ccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence 11100 00011112457999999987777665 999999999999886 9999998888888888777766777778899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+.+++..|| .+|.+||++++++.
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999 58999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=288.84 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=205.8
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC--CeEEEEE
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRVYIIM 101 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 101 (316)
|.+.+.||.|++|.||+|.+..+++.+++|.+....... ...+.+.+|+.+++.++|+|++++++++... ...++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE-GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999999999999999998764222 2234466899999999999999999999887 8999999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||+++ +|.+++... ..+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~---- 154 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN---- 154 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC----
Confidence 99975 899988765 569999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-----------
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK----------- 249 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 249 (316)
........++..|+|||.+.+....+.++||||||+++|+|++|..||...........+......+.
T Consensus 155 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 -SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 11122234567899999876544444459999999999999999999988776655554432111100
Q ss_pred ------------------CCC-CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 250 ------------------QPE-VSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 250 ------------------~~~-~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
... ++..+.++|.+|| .+|.+||+++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011 3889999999999 599999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=285.07 Aligned_cols=255 Identities=23% Similarity=0.384 Sum_probs=212.1
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCc---eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
+..++|...+.||+|++|.||+|.+..+++ .+++|.+..... ....+.+.+|+.+++.++|+|++++.+++....
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 456789999999999999999999876554 688998755432 222455778999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
..++||||+++++|.+++.. .+.+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999999975 35689999999999999999999999999999999999999999999999998865421
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEV 253 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (316)
..... ........+..|+|||++.+..++.+ +||||||+++|++++ |..||......+....+......+....+
T Consensus 160 ~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 235 (268)
T cd05063 160 DPEGT---YTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDC 235 (268)
T ss_pred ccccc---eeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCC
Confidence 11100 00111122457999999987666665 999999999999997 99999888888888888777667776778
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+.++.+++.+|+ .+|.+||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=293.45 Aligned_cols=247 Identities=22% Similarity=0.376 Sum_probs=187.0
Q ss_pred eeeeecCCeEEEEEEEcc--CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE--eCCeEEEEEec
Q psy11194 28 KIIGTGSYATVKLARSTR--HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE--TTHRVYIIMEY 103 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~ 103 (316)
..||+|+||.||+|.... ++..+++|.+..... ...+.+|+.+++.++||||+++++++. .+...++|+||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999998653 567899998865432 223568999999999999999999884 45678999999
Q ss_pred CCCCCHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee----CCCCCeEEeeccccc
Q psy11194 104 AENGSLFDIIRG---------QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL----DSDYNIKLSDFGFAR 170 (316)
Q Consensus 104 ~~~~sL~~~l~~---------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~----~~~~~~~l~Df~~~~ 170 (316)
+.+ +|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 965 88887742 1248899999999999999999999999999999999999 456789999999987
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHH
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN---------ELLKQV 241 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------~~~~~~ 241 (316)
...... ..........+++.|+|||++.+....+.++|||||||++|+|++|..||...... .....+
T Consensus 161 ~~~~~~---~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 161 LFNSPL---KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ccCCCc---ccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 542111 11111233457889999999877554455599999999999999999999643211 000000
Q ss_pred hcccC-------------------------------------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 242 QNKVT-------------------------------------FPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 242 ~~~~~-------------------------------------~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
..... .......+..+.+||.+|| .||.+|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000 0001124567889999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=283.75 Aligned_cols=250 Identities=24% Similarity=0.425 Sum_probs=209.7
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
.+..++|++.+.||+|+||.||+|... +++.+++|.+...... ...+.+|+.+++.++|+|++++++++. .+..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 456788999999999999999999854 5678999998654432 345678999999999999999998874 4578
Q ss_pred EEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
+++|||+++++|.+++.. ...++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~- 154 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED- 154 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC-
Confidence 999999999999999865 33589999999999999999999999999999999999999999999999998865321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
..........++..|+|||++.....+.+ +||||||+++|++++ |+.||.+.+..+....+......+.+...+
T Consensus 155 ----~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (260)
T cd05067 155 ----NEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCP 229 (260)
T ss_pred ----CCcccccCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Confidence 11111122334678999999887666655 999999999999998 999999888888888877776666667789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.++.++|.+|| .+|++||+++++++
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=283.27 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=204.7
Q ss_pred eeeeecCCeEEEEEEEccCC---ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecC
Q psy11194 28 KIIGTGSYATVKLARSTRHS---GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 104 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~---~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 104 (316)
+.||+|+||.||+|.....+ ..+++|.+...... ...+.+.+|+.+++.+.|+|++++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876544 68999998755443 23455778999999999999999999876 45679999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCC
Q psy11194 105 ENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSL 184 (316)
Q Consensus 105 ~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~ 184 (316)
++++|.+++.....+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~---~~~ 154 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY---YRA 154 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc---ccc
Confidence 99999999988778999999999999999999999999999999999999999999999999998654211110 011
Q ss_pred CcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Q psy11194 185 SETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISN 263 (316)
Q Consensus 185 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 263 (316)
.....++..|+|||.+.+..++.+ +||||||+++|++++ |..||...+..+....+......+.+..++..+.++|.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS 233 (257)
T ss_pred ccCccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 111123457999999987776665 999999999999998 999999888888888887777777777899999999999
Q ss_pred hc-CCCCCCCCHHHHhh
Q psy11194 264 IL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 264 ~l-~~p~~Rps~~~il~ 279 (316)
|| .+|.+||++.++++
T Consensus 234 cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 234 CWKYRPEDRPTFSELES 250 (257)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 99 58999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=289.90 Aligned_cols=252 Identities=21% Similarity=0.366 Sum_probs=208.8
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEcc-----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTR-----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
...+|.+.+.||+|++|.||+|.+.. ++..+++|.+..... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 45679999999999999999998543 344688888654322 2235577999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQG----------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD 158 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~ 158 (316)
...++||||+++++|.+++...+ .+++..++.++.||+.||++||++|++|+||+|+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997532 37889999999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11194 159 YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNEL 237 (316)
Q Consensus 159 ~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~ 237 (316)
+.++|+|||.+...... ..........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||......+.
T Consensus 160 ~~~~l~dfg~a~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 160 LLVKIGDFGMSRDVYST----DYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred CcEEECCCCcccccCCC----ceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999998643211 11111223345678999999887666665 999999999999998 9999988888888
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 238 LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+.+..+........++..+.+++.+|| .+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 7777766555555668999999999999 69999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=295.42 Aligned_cols=268 Identities=22% Similarity=0.335 Sum_probs=212.0
Q ss_pred ccCeEE-eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchH-----------HHhhHHHHHHHHhcCCCCCcceee
Q psy11194 21 SHGYTV-GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDY-----------LKKFLPREIEVVKGLKHPNLIRFL 88 (316)
Q Consensus 21 ~~~y~~-~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~ 88 (316)
.++|.. .+.||.|++|.||+|.+..+++.|++|.+......... ....+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 567764 57799999999999999999999999998654332210 011356899999999999999999
Q ss_pred eEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 89 QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 89 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
+++..+...++||||++ ++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999999996 49999998877799999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCcC--------CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy11194 169 ARAHMRCRSNA--------ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ 240 (316)
Q Consensus 169 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~ 240 (316)
+.......... ..........++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 86543111000 0011112234577899999987655445559999999999999999999988776655544
Q ss_pred HhcccCCC---------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 241 VQNKVTFP---------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 241 ~~~~~~~~---------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
+......+ .....+.++.++|..|| .+|++||++++++.||||+.....
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 32211000 01245788999999999 599999999999999999877654
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=286.43 Aligned_cols=254 Identities=21% Similarity=0.343 Sum_probs=207.5
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCc----eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSG----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
.+..++|++.+.||.|+||.||+|.+..++. .+++|.+..... ......+..|+..+..++||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~ 80 (279)
T cd05111 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEITDHMLAMGSLDHAYIVRLLGICPG 80 (279)
T ss_pred cCCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc--hHHHHHHHHHHHHHhcCCCCCcceEEEEECC
Confidence 3566789999999999999999999877766 466777643222 1223446678888899999999999998764
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
...++++||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 456789999999999999975 456899999999999999999999999999999999999999999999999998654
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
.... .........++..|+|||.+.+..++.+ +||||||+++|++++ |..||.+.......+.+..+...+.+.
T Consensus 160 ~~~~----~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T cd05111 160 YPDD----KKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ 234 (279)
T ss_pred cCCC----cccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC
Confidence 2111 1111223345678999999987776665 999999999999998 999999888888777777766666666
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.++..+.+++..|+ .+|++|||+.++++
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 235 ICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 78889999999999 69999999999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=286.94 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=206.6
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
.+|++.+.||+|++|.||+|.+..+++.+++|.+.............+.+|+.+++.++|+|++++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888999999999999999999899999999887654444444556778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 102 EYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 102 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 99999999999863 346899999999999999999999999999999999999999999999999987653211
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcccCCCCC-CCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV--NELLKQVQNKVTFPKQ-PEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~-~~~~ 254 (316)
........++..|+|||.+.+...+.+ +|+||||+++|+|++|..||..... .+..+.+......+.+ ..++
T Consensus 160 ----~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 160 ----TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred ----CcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 111223357788999999987766655 9999999999999999999975433 3444444433222222 3578
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+++.++|.+|| .+|.+|||+.+|++
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999 59999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=285.10 Aligned_cols=252 Identities=27% Similarity=0.478 Sum_probs=208.4
Q ss_pred ccCeEEe-eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEE----eC
Q psy11194 21 SHGYTVG-KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIE----TT 94 (316)
Q Consensus 21 ~~~y~~~-~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~----~~ 94 (316)
.++|++. +.||-|-.|.|..+.++.+++.+|+|++... ...++|+++--.. .|||||.+++++. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 4556654 4599999999999999999999999998653 2355888776666 5999999999884 34
Q ss_pred CeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC---CCeEEeecccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD---YNIKLSDFGFA 169 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~---~~~~l~Df~~~ 169 (316)
....+|||.++||.|+..++..+ .+++.++..|+.||..|+.|||+.+|.||||||+|+|+... -.+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 56789999999999999998754 49999999999999999999999999999999999999654 55999999999
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhc--
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN----ELLKQVQN-- 243 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~----~~~~~~~~-- 243 (316)
+. ...+......+.|+.|.|||++....+... +|+||+|+++|-|+.|.+||.+.... .....+..
T Consensus 212 K~-------t~~~~~L~TPc~TPyYvaPevlg~eKydks-cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 212 KE-------TQEPGDLMTPCFTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ 283 (400)
T ss_pred cc-------cCCCccccCCcccccccCHHHhCchhcCCC-CCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence 65 333455566778999999999987775554 99999999999999999999765432 33344443
Q ss_pred -ccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 244 -KVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 244 -~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.++.+++..+|+..+++|+.+| .+|.+|.|+++++.|||+..-..
T Consensus 284 y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 284 YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 3445566779999999999999 59999999999999999976544
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=296.96 Aligned_cols=257 Identities=21% Similarity=0.365 Sum_probs=205.7
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEcc-----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTR-----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQA 90 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 90 (316)
|.+..++|++.+.||+|+||.||+|.+.. +++.|++|++...... . ..+.+.+|+.++..+ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-~-~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-S-EYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH-H-HHHHHHHHHHHHHhhccCcchhheeee
Confidence 45677899999999999999999997543 3578999998654322 2 234466899999999 79999999998
Q ss_pred EEe-CCeEEEEEecCCCCCHHHHHHhC-----------------------------------------------------
Q psy11194 91 IET-THRVYIIMEYAENGSLFDIIRGQ----------------------------------------------------- 116 (316)
Q Consensus 91 ~~~-~~~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------- 116 (316)
+.. +...++++||+++++|.+++...
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 864 45788999999999999998532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCccc
Q psy11194 117 --------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETF 188 (316)
Q Consensus 117 --------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~ 188 (316)
.+++...+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........ .......
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~----~~~~~~~ 235 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGDA 235 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc----hhhccCC
Confidence 2578899999999999999999999999999999999999999999999999875432111 1112223
Q ss_pred ccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHhcccCCCCCCCCCHHHHHHHHHhc-
Q psy11194 189 CGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVN-ELLKQVQNKVTFPKQPEVSTECKELISNIL- 265 (316)
Q Consensus 189 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l- 265 (316)
.++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+.... .....+........+...++++.+++.+||
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 314 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWH 314 (337)
T ss_pred CCCccccCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHcc
Confidence 35667999999988777776 999999999999997 99999875443 334444444444455668899999999999
Q ss_pred CCCCCCCCHHHHhhC
Q psy11194 266 SPVQTRPRLKTIAED 280 (316)
Q Consensus 266 ~~p~~Rps~~~il~~ 280 (316)
.+|++||+++++++|
T Consensus 315 ~~p~~RPs~~ell~~ 329 (337)
T cd05054 315 NNPEDRPTFSELVEI 329 (337)
T ss_pred CChhhCcCHHHHHHH
Confidence 599999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=290.28 Aligned_cols=254 Identities=21% Similarity=0.327 Sum_probs=211.9
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccC-----CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRH-----SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
...+|.+.+.||.|+||.||+|.+..+ +..+++|++..... ....+.+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 456688899999999999999987543 56899999865432 23345677899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC
Q psy11194 95 HRVYIIMEYAENGSLFDIIRG----------------QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD 158 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~----------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~ 158 (316)
...+++++|+.+++|.+++.. ...++...+..++.|++.||.+||+.|++|+||+|+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 999999999999999999852 1347888899999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11194 159 YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNEL 237 (316)
Q Consensus 159 ~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~ 237 (316)
+.++|+|||++....... .........+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 161 LNVKISDLGLFREVYAAD----YYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CceEecccccccccccch----heeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999876532111 1111222335678999999877666665 999999999999998 8999998888888
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 238 LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.+.+......+.+..++..+.+++..|| .+|.+||++.+|+..
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 236 IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 8888877666666789999999999999 699999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=299.99 Aligned_cols=257 Identities=22% Similarity=0.397 Sum_probs=209.0
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccC-----CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRH-----SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQ 89 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~ 89 (316)
.+.+..++|++.+.||.|+||.||+|.+... +..||+|++..... ....+.+.+|+.++..+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 5666788999999999999999999987533 34699999865433 222456779999999996 999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhC-----------------------------------------------------
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQ----------------------------------------------------- 116 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------- 116 (316)
++......++||||+++|+|.+++...
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999987532
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCe
Q psy11194 117 -------------------------------------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENL 153 (316)
Q Consensus 117 -------------------------------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ni 153 (316)
..+++..+..++.|++.||.|||+.+++|+||+|+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2377788899999999999999999999999999999
Q ss_pred eeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy11194 154 LLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDS 232 (316)
Q Consensus 154 l~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~ 232 (316)
+++.++.++|+|||++........ ........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSN----YVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred EEeCCCEEEEEeCCcceecccccc----ccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999999999865422111 111222345678999999987666665 999999999999997 99999875
Q ss_pred CHH-HHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 233 SVN-ELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
... .....+..+..++.+..++.++.++|.+|| .+|++||++.++.+
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred chhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 443 444555666566666778999999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=282.24 Aligned_cols=249 Identities=22% Similarity=0.400 Sum_probs=206.2
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
+...+|.+.+.||.|++|.||+|.+..+ ..+++|.+...... .+.+.+|+.+++.++|++++++++++. ....+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 4457899999999999999999987654 46899987653322 345678999999999999999998875 45678
Q ss_pred EEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 99 IIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
++|||+.+++|.+++... ..++...+..++.+++.||.+||+.|++|+||+|+||++++++.++|+|||.+......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~- 155 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN- 155 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC-
Confidence 999999999999999753 34889999999999999999999999999999999999999999999999998653211
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (316)
.........++..|+|||...+...+.. +|+||||+++|++++ |..||.+....+....+......+.+...+.
T Consensus 156 ----~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (260)
T cd05069 156 ----EYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE 230 (260)
T ss_pred ----cccccCCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 1111122235667999999877666555 999999999999999 9999998888888777777666666667899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+.+++.+|| .+|.+||+++++++
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 231 SLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=287.84 Aligned_cols=253 Identities=21% Similarity=0.355 Sum_probs=209.9
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
+...++...++||+|+||.||+|... .++..+++|...... ....+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 35678899999999999999999743 245678888765432 2335568899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQG---------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD 158 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~---------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~ 158 (316)
....+++|||+++++|.+++...+ .+++..+..++.|++.|++|||+.|++|+||+|+||+++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999997542 47889999999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11194 159 YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNEL 237 (316)
Q Consensus 159 ~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~ 237 (316)
+.++|+|||++....... .........++..|+|||.+.+..++.+ +|||||||++|+|++ |..||......+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTD----YYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCEEECCCCceeEcCCCc----eeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 999999999886432110 0011122234578999999887776665 999999999999998 9999988887777
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 238 LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
...+..+.....+..+++.+.++|.+|| .+|.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 234 IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7777776666666678999999999999 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=315.85 Aligned_cols=256 Identities=22% Similarity=0.337 Sum_probs=205.0
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|.+..+|+.||+|+++..........+.+.+|+.++..++||||+++++++...+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999999999999999997654444444566779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 102 EYAENGSLFDIIRGQ-----------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 102 e~~~~~sL~~~l~~~-----------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
||++|++|.+++... ...+...+..++.||+.||++||+.|++||||||+||+++.+|.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998631 235567789999999999999999999999999999999999999999999997
Q ss_pred ccccccCc------------CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy11194 171 AHMRCRSN------------AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL 238 (316)
Q Consensus 171 ~~~~~~~~------------~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~ 238 (316)
........ ...........|++.|+|||.+.+...+.+ +|||||||++|+|++|..||...+.....
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 64211000 001111223468999999999988777665 99999999999999999999875544433
Q ss_pred HHH--hcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy11194 239 KQV--QNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIA 278 (316)
Q Consensus 239 ~~~--~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il 278 (316)
... ...........+++.+.+++.+|| .+|++||+..+.+
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 221 111112223468899999999999 5999998765544
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=296.45 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=208.8
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe----
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR---- 96 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 96 (316)
.++|++...||.|++|.||+|.+..++..+++|++........ ..+.+.+|+.+++.++|+|++++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI-HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhh-HHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 5679999999999999999999999999999998865432222 23446689999999999999999988866554
Q ss_pred --EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 97 --VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 97 --~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 89999999 6699999876 4599999999999999999999999999999999999999999999999999865321
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-----
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK----- 249 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 249 (316)
......++..|+|||.+.+....+.++||||||+++|++++|+.||.+....+....+......+.
T Consensus 171 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 171 ---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ---------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 122234677899999986543444459999999999999999999987766555444433211110
Q ss_pred -------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 250 -------------------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 250 -------------------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
....++++.++|.+|| .+|.+|||+.++++||||+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 1246889999999999 599999999999999999766554
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=294.64 Aligned_cols=265 Identities=26% Similarity=0.435 Sum_probs=208.5
Q ss_pred hcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeE
Q psy11194 11 DIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQA 90 (316)
Q Consensus 11 ~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 90 (316)
+.....+.+ ..+|.+.+.||+|++|.||+|.+..+|+.+|+|.+........ ....+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~ 82 (342)
T cd07879 5 EVNKTVWEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHMQHENVIGLLDV 82 (342)
T ss_pred hhhhhhhcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccccc-chhHHHHHHHHHHhcCCCCccchhhe
Confidence 444445555 4589999999999999999999998999999999865432222 23446689999999999999999999
Q ss_pred EEeC------CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEe
Q psy11194 91 IETT------HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLS 164 (316)
Q Consensus 91 ~~~~------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~ 164 (316)
+... ...++|++|+.. +|..++. ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~ 159 (342)
T cd07879 83 FTSAVSGDEFQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKIL 159 (342)
T ss_pred ecccccCCCCceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEe
Confidence 8654 346999999964 7777653 358999999999999999999999999999999999999999999999
Q ss_pred ecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Q psy11194 165 DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK 244 (316)
Q Consensus 165 Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (316)
|||++.... .......++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+.......+...
T Consensus 160 dfg~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~ 230 (342)
T cd07879 160 DFGLARHAD---------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230 (342)
T ss_pred eCCCCcCCC---------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999885421 11123346778999999876443444599999999999999999999877655444333221
Q ss_pred cCC------------------------CC------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 245 VTF------------------------PK------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 245 ~~~------------------------~~------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
... +. .+..+..+.++|.+|| .+|.+||++++++.||||...+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 110 00 1346788999999999 599999999999999999776553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=282.22 Aligned_cols=244 Identities=25% Similarity=0.450 Sum_probs=206.3
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE-eCCeE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE-TTHRV 97 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~ 97 (316)
+..++|.+.+.||+|++|.||++... |+.+++|....... .+.+.+|+.+++.++|++++++++++. ..+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999999654 77899998754321 345678999999999999999999764 55678
Q ss_pred EEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
++++||+++++|.+++.+.. .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence 99999999999999997643 488999999999999999999999999999999999999999999999998864321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
.......+..|+|||++.....+.+ +|||||||++|+|++ |+.||......+....+...........++
T Consensus 155 --------~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd05082 155 --------TQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 225 (256)
T ss_pred --------cCCCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Confidence 1112224567999999877666655 999999999999997 999999888888888777766666667789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+.+.++|.+|| .+|++|||+.++++
T Consensus 226 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 226 PVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999 59999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=285.67 Aligned_cols=245 Identities=26% Similarity=0.473 Sum_probs=198.1
Q ss_pred cCeEEeeee--eecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEE
Q psy11194 22 HGYTVGKII--GTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 22 ~~y~~~~~i--g~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 98 (316)
++|.+.+.+ |+|+||.||++.+..++..+++|......... .|......+ +|||++++++.+...+..+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456666666 99999999999999999999999986543221 122222222 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC-CeEEeecccccccccccC
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY-NIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~-~~~l~Df~~~~~~~~~~~ 177 (316)
+||||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT--- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC---
Confidence 9999999999999998877899999999999999999999999999999999999999888 999999998864321
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhc--ccCCCCCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNEL-LKQVQN--KVTFPKQPEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~-~~~~~~--~~~~~~~~~~~ 254 (316)
.....++..|+|||++.+..++.+ +|+||||+++|+|++|..||........ ...+.. ....+....++
T Consensus 163 -------~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T PHA03390 163 -------PSCYDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVS 234 (267)
T ss_pred -------CccCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccC
Confidence 112346788999999988776665 9999999999999999999975443321 111111 22233445689
Q ss_pred HHHHHHHHHhc-CCCCCCCC-HHHHhhCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPR-LKTIAEDRWLKP 285 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps-~~~il~~~~~~~ 285 (316)
+.+.++|.+|| .+|.+||+ ++++++||||..
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999 58999996 699999999974
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=288.11 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=207.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEcc-----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTR-----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
+|++.+.||+|+||.||+|.+.. ..+.+++|.+..... ....+.+.+|+.+++.++||||+++++.+......
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 57889999999999999998753 224688888754432 22245577899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCe
Q psy11194 98 YIIMEYAENGSLFDIIRGQ------------------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENL 153 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ni 153 (316)
++++||+.+++|.+++... ..++...+..++.|++.||.+||+.+++|+||+|+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2478889999999999999999999999999999999
Q ss_pred eeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy11194 154 LLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDS 232 (316)
Q Consensus 154 l~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~ 232 (316)
+++.++.++|+|||++........ ........++..|+|||.+.+...+.+ +||||||+++|+|++ |..||.+.
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDS----YVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEcCCCcEEeccccccccccCccc----hhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999865321111 011122234568999999877666655 999999999999998 99999998
Q ss_pred CHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 233 SVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+....+.+......+.+..++.++.+++..|| .+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 234 APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 888888888777767667778999999999999 58999999999974
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=294.20 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=202.8
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC------
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------ 94 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 94 (316)
+.+|.+.+.||.|++|.||+|.+..+|+.|++|.+...... ..+.+.+|+.+++.++|||++++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---hHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 47899999999999999999999999999999998655432 234566899999999999999998776543
Q ss_pred --------CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC-CCCeEEee
Q psy11194 95 --------HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS-DYNIKLSD 165 (316)
Q Consensus 95 --------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~-~~~~~l~D 165 (316)
...++|+||+++ +|.+++.. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++.++++|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 357899999974 89888865 35899999999999999999999999999999999999974 56789999
Q ss_pred cccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc
Q psy11194 166 FGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV 245 (316)
Q Consensus 166 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (316)
||.+...... ...........++..|+|||.+......+.++|||||||++|+|++|..||......+.........
T Consensus 159 fg~~~~~~~~---~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 159 FGLARIVDPH---YSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred cccceecCCc---cccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9988653211 1111111223467789999987654444455999999999999999999998765544433322111
Q ss_pred CC-----------------------C------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 246 TF-----------------------P------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 246 ~~-----------------------~------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
.. + ..+.++.++.+||.+|| .+|.+|||+++++.||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 00 0 01357889999999999 5999999999999999998443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.01 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=213.4
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEc-------cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCccee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARST-------RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRF 87 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~-------~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~ 87 (316)
.+++...+|.+.+.||+|+||.||+|+.. ..+..+++|....... ....+.+.+|+.+++.+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchhe
Confidence 35678899999999999999999999753 2344789998764322 22245577999999999 79999999
Q ss_pred eeEEEeCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q psy11194 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQ----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCE 151 (316)
Q Consensus 88 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ 151 (316)
++++......+++|||+++++|.+++... ..++...+..++.||+.||.|||+.|++|+||+|+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999999753 24778889999999999999999999999999999
Q ss_pred CeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q psy11194 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFD 230 (316)
Q Consensus 152 nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~ 230 (316)
||+++.++.++|+|||.+........ ........++..|+|||++.+..++.+ +||||||+++|++++ |..||.
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccc----cccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999865421111 111112234567999999987766666 999999999999998 889999
Q ss_pred CCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 231 DSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.....+..+.+........+..++.++.++|.+|| .+|.+|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 242 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred cCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 88888888888777666666778999999999999 589999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=295.46 Aligned_cols=265 Identities=28% Similarity=0.472 Sum_probs=209.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeC--CeE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT--HRV 97 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~ 97 (316)
.++|++.+.||+|++|.||+|.+..+++.+++|.+......... ...+.+|+.++..+ +||||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~-~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD-AQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh-hhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 57899999999999999999999988999999988653322222 33456899999999 999999999998643 468
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
++||||+++ +|..++... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 999999975 999998876 689999999999999999999999999999999999999999999999998875432211
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC----------
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF---------- 247 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 247 (316)
.. .........++..|+|||.+.+....+.++|+||||+++|+|++|+.||......+....+......
T Consensus 163 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 163 NP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred cc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 11 1112223457888999998866554455599999999999999999999876555443332111100
Q ss_pred --------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 248 --------------------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 248 --------------------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
...+.++.++.++|..|| .+|.+|||+.++++||||+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 011347899999999999 599999999999999999776544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=291.03 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=203.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC------
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------ 94 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 94 (316)
.++|++.+.||.|++|.||+|.+..+++.+++|.+......... .....+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-PITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc-chhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 57899999999999999999999999999999998654332211 22355899999999999999999887543
Q ss_pred --CeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 95 --HRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 95 --~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
...++|++|+.+ +|...+.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 346999999965 77777654 44699999999999999999999999999999999999999999999999999875
Q ss_pred cccccCcCC-----CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC
Q psy11194 172 HMRCRSNAA-----DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT 246 (316)
Q Consensus 172 ~~~~~~~~~-----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (316)
......... .........++..|+|||.+.+....+.++||||||+++|+|++|..||.+.+.....+.+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 432221111 111112334677899999886544344459999999999999999999987766655444322110
Q ss_pred CC-----------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 247 FP-----------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 247 ~~-----------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.+ .....++.+.++|.+|| .+|.+|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 00234578899999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=289.98 Aligned_cols=258 Identities=25% Similarity=0.402 Sum_probs=205.7
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC---
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH--- 95 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 95 (316)
...++|++.+.||+|++|.||+|.+..+|+.+++|+++....... ....+.+|+.+++.++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG-FPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC-chHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456789999999999999999999999999999999876433222 1334568999999999999999999987654
Q ss_pred -------eEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecc
Q psy11194 96 -------RVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFG 167 (316)
Q Consensus 96 -------~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~ 167 (316)
..++|+||+++ +|...+... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999976 777777653 468999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC
Q psy11194 168 FARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF 247 (316)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (316)
.+....... ........++..|+|||.+.+....+.++|||||||++|+|++|+.||...+..+....+......
T Consensus 162 ~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 162 LARLYNSEE-----SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred ccccccCCc-----ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 886543211 011122235678999998865443344599999999999999999999876655544444331100
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 248 -----------------------------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 248 -----------------------------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.....++..+.++|..|| .+|.+||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 012246899999999999 599999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=288.34 Aligned_cols=258 Identities=25% Similarity=0.445 Sum_probs=214.1
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEec
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
|.....||+|++|.||++....++..+++|.+..... .....+.+|+.+++.++|+|++++++.+...+..++||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 3344679999999999999999999999998754322 2245577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCC
Q psy11194 104 AENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNS 183 (316)
Q Consensus 104 ~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~ 183 (316)
+++++|.+++.. ..+++..+..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~------~~~ 171 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK------EVP 171 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc------ccc
Confidence 999999998765 4589999999999999999999999999999999999999999999999998754321 111
Q ss_pred CCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--CCCCCCCCHHHHHHH
Q psy11194 184 LSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--FPKQPEVSTECKELI 261 (316)
Q Consensus 184 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 261 (316)
......++..|+|||.+.+..++.+ +|+||+|+++|+|++|..||......+....+..... ......++..+.++|
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFL 250 (292)
T ss_pred cccccccCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHH
Confidence 1223446788999999877666655 9999999999999999999988777666655544332 223346789999999
Q ss_pred HHhc-CCCCCCCCHHHHhhCCCCCCCCCCCCh
Q psy11194 262 SNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGV 292 (316)
Q Consensus 262 ~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~ 292 (316)
.+|| .+|.+||++.++++||||.....+...
T Consensus 251 ~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~~ 282 (292)
T cd06657 251 DRLLVRDPAQRATAAELLKHPFLAKAGPPSCI 282 (292)
T ss_pred HHHHhCCcccCcCHHHHhcChHHhccCCCccc
Confidence 9999 699999999999999999888865553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=287.44 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=210.0
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEcc-----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTR-----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
+..++|++.+.||+|+||.||+|.+.. +++.+++|.+..... ......+.+|+.+++.++|||++++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 356789999999999999999998753 567899998864332 2234557789999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQ----------------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCE 151 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~----------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ 151 (316)
....++++||+++++|.+++... ..+++..++.++.|++.||.+||+.+++|+||+|+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 99999999999999999999642 13778889999999999999999999999999999
Q ss_pred CeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q psy11194 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFD 230 (316)
Q Consensus 152 nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~ 230 (316)
||+++.++.++|+|||++........ .........+..|+|||.+.+..++.+ +|||||||++|+|++ |..||.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADY----YKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred heEecCCCceEECccccceecccCcc----ccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999998864321110 111112224567999999887776665 999999999999997 889998
Q ss_pred CCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 231 DSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+....+....+..+...+.+..++.++.++|.+|| .+|.+|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 GMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 88888888777766555555678999999999999 59999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=289.35 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=209.8
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEcc-------CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceee
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTR-------HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFL 88 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~ 88 (316)
+.+...+|.+.+.||+|++|.||+|.+.. .+..+++|.+..... ......+.+|+.+++.+ +||||++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 45667899999999999999999997632 344689998764332 22244567899999999 699999999
Q ss_pred eEEEeCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCC
Q psy11194 89 QAIETTHRVYIIMEYAENGSLFDIIRGQ----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCEN 152 (316)
Q Consensus 89 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~n 152 (316)
+++......+++|||+++++|.+++... ..++...+..++.|++.||.|||++|++|+||+|+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 9999999999999999999999999652 248888999999999999999999999999999999
Q ss_pred eeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q psy11194 153 LLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDD 231 (316)
Q Consensus 153 il~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~ 231 (316)
|+++.++.++|+|||.+......... .......++..|+|||.+.+..++.+ +||||||+++|++++ |..||..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYY----KKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred EEEcCCCcEEEccccccccccccccc----cccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999998653211110 00111123457999999887666665 999999999999998 8999999
Q ss_pred CCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 232 SSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
....+....+........+..++.++.++|.+|| .+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 240 IPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8888888888776655556678999999999999 58999999999884
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=273.29 Aligned_cols=275 Identities=24% Similarity=0.397 Sum_probs=218.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 100 (316)
++.+.+..||.|..|.|++++...+|..+|||.++.... .+...+.+ +.+.+....+ +|+||+.+|+|..+..+++.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRIL-mDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRIL-MDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHH-HhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 344577889999999999999999999999999966544 44444444 6677776664 99999999999999999999
Q ss_pred EecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 101 MEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
||.+ +..++.++++ .+++++..+-++...+++||.||-. +|++|||+||+|||+++.|++||||||++-.+.
T Consensus 170 MelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv----- 243 (391)
T KOG0983|consen 170 MELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV----- 243 (391)
T ss_pred HHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee-----
Confidence 9999 4488888876 5679999999999999999999985 589999999999999999999999999986543
Q ss_pred CCCCCCCcccccccCccCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcccCC--CCCCC
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGI---PYAPHLSDIWSMGVVLFAMVFGRLPFDDS-SVNELLKQVQNKVTF--PKQPE 252 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~~--~~~~~ 252 (316)
.+.......|-+.|+|||-+.-. .+.-. +||||||++++||.||.+||.+- ..-++...+....++ +...+
T Consensus 244 --dSkAhtrsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~g 320 (391)
T KOG0983|consen 244 --DSKAHTRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMG 320 (391)
T ss_pred --cccccccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccC
Confidence 22333344578899999998533 34444 99999999999999999999873 233445555443332 22234
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHhHHHHHhhccccC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMIQTSASS 312 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (316)
+|+.+++|+..|| +|+.+||...++|+|||+..-+.-. -+.-+||.+-+.++.|-
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~-----~dVa~WF~dV~~~~~~~ 376 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE-----VDVASWFKDVMAKTESP 376 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh-----ccHHHHHHHHHhccccc
Confidence 8999999999999 7999999999999999998766532 34556777777666443
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=280.69 Aligned_cols=250 Identities=22% Similarity=0.427 Sum_probs=209.0
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
.+..++|++.+.||+|++|.||+|.+. .+..+++|.+..... ..+.+.+|+.+++.++|+|++++++++.. ..+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 456789999999999999999999755 455799998764321 23456789999999999999999999887 778
Q ss_pred EEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
+++|||+++++|.+++.+ ...++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999999976 335788899999999999999999999999999999999999999999999988653211
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
.........++..|+|||.+.....+.+ +|+||||+++|++++ |..||...+.......+......+.....+
T Consensus 156 -----~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (260)
T cd05073 156 -----EYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 229 (260)
T ss_pred -----CcccccCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCC
Confidence 1111112234567999999977666555 999999999999998 999999888888887777777666667889
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.++.+++.+|+ .+|++||+++++++
T Consensus 230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 230 EELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999 59999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=287.93 Aligned_cols=256 Identities=21% Similarity=0.393 Sum_probs=209.0
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQA 90 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 90 (316)
+.+..++|.+.+.||+|+||.||+|.+. .++..+++|.+..... ....+.+.+|+.+++.+ +|+||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 5677889999999999999999999863 3445799998765432 22245677999999999 79999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 91 IETTHRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 91 ~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
+...+..+++|||+++++|.+++.... .+++.++..++.+++.||+|||+.+++|+||+|+||+++.++.++++|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997533 389999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhcccC
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNE-LLKQVQNKVT 246 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~-~~~~~~~~~~ 246 (316)
+....... .........++..|+|||.+.....+.+ +||||||+++|++++ |..||......+ ..+.+..+..
T Consensus 188 ~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 262 (302)
T cd05055 188 ARDIMNDS----NYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262 (302)
T ss_pred cccccCCC----ceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence 86532111 0011122335678999999887766665 999999999999998 999998766544 3444455555
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 247 FPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 247 ~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+.+...++++.+++.+|| .+|++|||+.++++
T Consensus 263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5555678999999999999 58999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=283.54 Aligned_cols=251 Identities=18% Similarity=0.335 Sum_probs=206.4
Q ss_pred eEEeeeeeecCCeEEEEEEEccC---CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe----
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRH---SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR---- 96 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 96 (316)
|.+.+.||+|+||.||.|....+ +..+|+|.+........ ..+.+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS-EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHH-HHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56789999999999999987643 46899999875443322 24457789999999999999999998865443
Q ss_pred --EEEEEecCCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 97 --VYIIMEYAENGSLFDIIRG------QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 97 --~~lv~e~~~~~sL~~~l~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
.++++||+++++|..++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 7999999999999999843 13589999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCC
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTF 247 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 247 (316)
+......... ........+..|+|||.+.+..++.+ +|||||||++|++++ |..||.+....+..+.+..+...
T Consensus 160 ~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (273)
T cd05035 160 SKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL 234 (273)
T ss_pred eeeccccccc----cccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 8654321110 11111224567999999877666665 999999999999999 99999988888888888777666
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 248 PKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 248 ~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
..+..++.++.+++.+|| .+|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 667789999999999999 589999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=289.58 Aligned_cols=262 Identities=24% Similarity=0.329 Sum_probs=205.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 99 (316)
-++|...+.||+|++|.||++.+..+++.+++|.+...... .....+.+|+..+..+. |+||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 34677778899999999999999999999999998754433 22445678999999986 9999999999999999999
Q ss_pred EEecCCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 100 IMEYAENGSLFDIIR-----GQGYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 100 v~e~~~~~sL~~~l~-----~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
+||++.+ +|.++.. ....+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999954 7766542 235699999999999999999999975 99999999999999999999999999986432
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcccCC---
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGI--PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV-NELLKQVQNKVTF--- 247 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~~~--- 247 (316)
. ........++..|+|||.+.+. ...+.++||||||+++|++++|..||..... .+....+......
T Consensus 160 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 160 D-------SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232 (288)
T ss_pred c-------CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC
Confidence 1 1111223467789999998765 2334449999999999999999999976442 1122222211111
Q ss_pred -CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCCh
Q psy11194 248 -PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGV 292 (316)
Q Consensus 248 -~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~ 292 (316)
.....++.++.+||.+|| .+|++|||++++++||||+........
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~~~ 279 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVD 279 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcchh
Confidence 111247899999999999 699999999999999999987665443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=284.57 Aligned_cols=255 Identities=18% Similarity=0.336 Sum_probs=212.0
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEcc----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTR----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
.++.++|++.+.||+|+||.||+|.+.. .+..+++|.+.... .....+.+.+|+.+++.++|+|++++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3578899999999999999999999875 25688999875332 23335567789999999999999999998765
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEe
Q psy11194 94 -THRVYIIMEYAENGSLFDIIRGQ--------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLS 164 (316)
Q Consensus 94 -~~~~~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~ 164 (316)
....+++++|+++++|.+++... ..+++..+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 56789999999999999998652 358999999999999999999999999999999999999999999999
Q ss_pred ecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc
Q psy11194 165 DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQN 243 (316)
Q Consensus 165 Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~ 243 (316)
|||+++.+....... ......++..|+|||++.+..++.+ +||||||+++|++++ |..||...++.+....+..
T Consensus 160 d~g~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 234 (280)
T cd05043 160 DNALSRDLFPMDYHC----LGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD 234 (280)
T ss_pred CCCCcccccCCceEE----eCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc
Confidence 999987543211110 1112234667999999987766666 999999999999998 9999998888888887777
Q ss_pred ccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 244 KVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 244 ~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
....+....+++++.+++.+|| .+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 7666666678999999999999 59999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=287.45 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=210.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
...|...+.||+|++|.||+|++..++..+++|.+...........+.+.+|+.+++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 45588889999999999999999989999999998754333333344566899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
+||+.+ +|.+++.. ...+++..+..++.+++.|+.+||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 999964 88777643 45689999999999999999999999999999999999999999999999998854321
Q ss_pred CCCCCCcccccccCccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-CCCCCCCCHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQG--IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-FPKQPEVSTE 256 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 256 (316)
.....++..|+|||.+.+ ....+.++|||||||++|+|++|..||...+..+....+..... ......++..
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHH
Confidence 122346778999999742 12233349999999999999999999987766655554444332 2233468899
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+.++|.+|| .+|.+||+++++++|||+....-
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 999999999 58999999999999999988543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=280.46 Aligned_cols=244 Identities=23% Similarity=0.388 Sum_probs=201.8
Q ss_pred eeeecCCeEEEEEEEc--cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 29 IIGTGSYATVKLARST--RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 29 ~ig~g~~g~vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
.||+|+||.||+|.+. ..+..+++|+...... ....+.+.+|+.+++.++|+||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999765 3455689998865432 3335567899999999999999999998754 578999999999
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCC
Q psy11194 107 GSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS 185 (316)
Q Consensus 107 ~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~ 185 (316)
++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......... ....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~ 155 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY---YKAR 155 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc---eecc
Confidence 999999974 456999999999999999999999999999999999999999999999999998653211110 0111
Q ss_pred cccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHh
Q psy11194 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNI 264 (316)
Q Consensus 186 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 264 (316)
....++..|+|||.+.+..++.+ +||||||+++|++++ |..||......+....+..+...+.+..+++++.++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC 234 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 11223567999999877666655 999999999999996 9999999888888888888777777778899999999999
Q ss_pred c-CCCCCCCCHHHHhh
Q psy11194 265 L-SPVQTRPRLKTIAE 279 (316)
Q Consensus 265 l-~~p~~Rps~~~il~ 279 (316)
| .+|++||++.++++
T Consensus 235 ~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 235 WIYKWEDRPNFAKVEE 250 (257)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9 59999999999964
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=282.42 Aligned_cols=253 Identities=22% Similarity=0.387 Sum_probs=212.2
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCc----eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSG----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
.+...+|++.+.||+|+||.||+|.+..+|+ .+++|....... ......+.+|+.++..++|||++++++++..
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4567889999999999999999999876655 588888755433 2234557789999999999999999999987
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
...++|+||+++++|.+++.+. ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 7889999999999999999763 46999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
...... .......++..|+|||.+....++.+ +|+||||+++|++++ |..||......++...+..+...+.+.
T Consensus 160 ~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T cd05057 160 DVDEKE----YHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234 (279)
T ss_pred cCcccc----eecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC
Confidence 311110 11111223567999999877666665 999999999999998 999999988888888888777777777
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIA 278 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il 278 (316)
..+..+.+++.+|| .+|.+||++.+++
T Consensus 235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 78999999999999 6999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=283.19 Aligned_cols=251 Identities=19% Similarity=0.370 Sum_probs=204.7
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCc--eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC------C
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSG--DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------H 95 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~--~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 95 (316)
+.+.+.||+|+||.||+|.+..++. .+++|.+....... ...+.+.+|+.+++.++|+||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR-SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567889999999999999877665 58999886543322 2345577899999999999999999987432 2
Q ss_pred eEEEEEecCCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRG------QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
..++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999988742 234889999999999999999999999999999999999999999999999998
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCC
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFP 248 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 248 (316)
......... .......++..|+|||...+..++.+ +||||||+++|++++ |..||......+..+.+..+...+
T Consensus 160 ~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 160 KKIYNGDYY----RQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234 (272)
T ss_pred cccCcccce----ecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 754211100 01112235667999999988776665 999999999999999 899999888888888887776666
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 249 KQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 249 ~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
....++..+.++|.+|| .+|.+|||+++++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 66778999999999999 599999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=283.00 Aligned_cols=253 Identities=26% Similarity=0.462 Sum_probs=208.1
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC--chHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP--PDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
+|.+.+.||+|++|.||+|.+...+..+++|+....... .......+..|+.+++.++|||++++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 689999999999999999998877777777776543321 111123355788999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 101 MEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
+||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999998853 346999999999999999999999999999999999999964 6799999998865321
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
.........++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...........+........+..++.+
T Consensus 158 ----~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd08222 158 ----SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQ 232 (260)
T ss_pred ----CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHH
Confidence 1112223346778999999877666665 99999999999999999999877776666666555444445578899
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+.++|.+|| .+|++||+++++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999 589999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=302.31 Aligned_cols=247 Identities=27% Similarity=0.483 Sum_probs=213.8
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
|++--+...-++.||.|+.|-||+|+.. ++.||||.++.. -..+++-|++|+|+||+.+.++|....-
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCce
Confidence 4444444556788999999999999877 679999987442 2367889999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
+||+||||..|.|.++++....++......|..+|+.|+.|||.+.|||+|||.-||||..+..|||+|||.++....
T Consensus 187 yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~-- 264 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD-- 264 (904)
T ss_pred eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998865421
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cccCCCCCCCCCH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ-NKVTFPKQPEVST 255 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 255 (316)
....-...||..|||||++.+.+.+.+ .||||||++||||+||..||.+.+...++=-+- .....|.+..+|+
T Consensus 265 -----~STkMSFaGTVaWMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 265 -----KSTKMSFAGTVAWMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPD 338 (904)
T ss_pred -----hhhhhhhhhhHhhhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCch
Confidence 122334569999999999999888887 999999999999999999999877776654443 3456777888999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.++=||++|| ..|.+|||+++|+.|-=+
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 9999999999 589999999999998644
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=291.51 Aligned_cols=259 Identities=26% Similarity=0.400 Sum_probs=213.4
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccC-------CceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCccee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRH-------SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRF 87 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~ 87 (316)
.+++...+|.+.+.||+|+||.||.|.+... +..+++|....... ....+.+.+|+.+++.+ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC--HHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 4667778999999999999999999986432 23689998764322 22245577899999999 79999999
Q ss_pred eeEEEeCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q psy11194 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQ----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCE 151 (316)
Q Consensus 88 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ 151 (316)
++++......++++||+++++|.+++.+. ..++...+..++.|++.||.|||+.|++|+||+|+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 99999999999999999999999999652 23778889999999999999999999999999999
Q ss_pred CeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q psy11194 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFD 230 (316)
Q Consensus 152 nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~ 230 (316)
||+++.++.++|+|||+++....... ........++..|+|||++.+..++.+ +||||||+++|+|++ |..||.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccc----cccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999865321110 001111223457999999988777666 999999999999998 899999
Q ss_pred CCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCC
Q psy11194 231 DSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDR 281 (316)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~ 281 (316)
.....+....+......+.+..++.++.++|.+|| .+|.+||++.+++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 239 GIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 98888888888777666666778999999999999 5899999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=288.14 Aligned_cols=258 Identities=25% Similarity=0.400 Sum_probs=206.3
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe-CCeEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-THRVY 98 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 98 (316)
..++|++.+.||.|++|.||+|.+..+++.+++|.+........ ..+.+.+|+.+++.++|||++++.+++.. ....+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccc-hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 56789999999999999999999999999999998865433222 23456689999999999999999999865 56789
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+++||+ +++|.++++.. .++...+..++.|++.||.+||+.|++|+||+|.||+++.++.++|+|||.+....
T Consensus 87 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~----- 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD----- 159 (328)
T ss_pred EEeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-----
Confidence 999999 56899888753 48888999999999999999999999999999999999999999999999885421
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc--------------
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK-------------- 244 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 244 (316)
.......++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+.+.
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 160 ----PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred ----CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 11122345778999999866444445599999999999999999999876543322211110
Q ss_pred -------------cCCC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 245 -------------VTFP---KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 245 -------------~~~~---~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
...+ ..+.+++++.++|.+|| .+|++||++++++.||||...+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 0011 11357889999999999 599999999999999999666554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=292.11 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=205.9
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC-----
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 95 (316)
.++|++.+.||.|++|.||+|.+..++..||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 6679999999999999999999999999999999854332 2223445678999999999999999999986543
Q ss_pred -eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 96 -RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 96 -~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
..++|++++ +++|.+++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 458999999 7799988875 4599999999999999999999999999999999999999999999999998864211
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-C-------
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-T------- 246 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~------- 246 (316)
......++..|+|||.+.+....+.++|+||||+++|++++|..||...+.......+.... .
T Consensus 171 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 171 ---------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ---------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 11223467789999998764434455999999999999999999998765443322221100 0
Q ss_pred ----------------C------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 247 ----------------F------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 247 ----------------~------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
. ...+.+++++.++|.+|| .+|.+|||+.++++||||+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0 011357889999999999 59999999999999999977533
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=281.31 Aligned_cols=254 Identities=23% Similarity=0.392 Sum_probs=209.4
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccC---CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRH---SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
++..++|.+.+.||+|++|.||+|.+... ...+++|....... ....+.+.+|+.+++.++|||++++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 35677899999999999999999987643 34688898754432 2334567789999999999999999998875
Q ss_pred CeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
...++||||+++++|.+++.+.. .++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 45689999999999999997643 58999999999999999999999999999999999999999999999999886532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
... ........++..|+|||.+....++.+ +||||||+++|++++ |..||......+....+..+...+.+..
T Consensus 159 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (270)
T cd05056 159 DES-----YYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPN 232 (270)
T ss_pred ccc-----ceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence 111 001112223467999999877666655 999999999999986 9999998887777777777766677778
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
++..+.++|.+|+ .+|.+|||+.++++.
T Consensus 233 ~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999 589999999998853
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=285.19 Aligned_cols=266 Identities=23% Similarity=0.367 Sum_probs=208.2
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT 94 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 94 (316)
...+..++|++.+.||+|++|.||+|.+..+++.+++|.+....... . ...+..|+..+... .|+||+++++++...
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-E-NKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-H-HHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 34567788999999999999999999999889999999987543322 2 22333566655555 599999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
...+++|||+.+ +|.+++.. ...+++..+..++.+++.|+.|||+ .|++|+||+|+||+++.++.++|+|||++...
T Consensus 87 ~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999999954 88888765 4569999999999999999999997 59999999999999999999999999988543
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhccc--C
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIP---YAPHLSDIWSMGVVLFAMVFGRLPFDDSSV-NELLKQVQNKV--T 246 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~--~ 246 (316)
.. ........++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||..... .+....+.... .
T Consensus 166 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T cd06618 166 VD-------SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238 (296)
T ss_pred cC-------CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC
Confidence 21 11112234677899999986543 223349999999999999999999976433 23333333222 2
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 247 FPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 247 ~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
.+....++.++.++|.+|| .+|.+||+++++++||||+.......
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~ 284 (296)
T cd06618 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284 (296)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHH
Confidence 2222347899999999999 59999999999999999998665444
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=284.32 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=201.2
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEEEEe
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 102 (316)
|.+.+.||+|++|.||+|....+++.+++|.+........ .....+|+..+..++ |++++++++++..++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999988899999999865433222 222346889999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 103 YAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|+ +++|.+.+.... .+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~------ 151 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS------ 151 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC------
Confidence 99 679998887654 689999999999999999999999999999999999999999999999998865321
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC------------
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP------------ 248 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 248 (316)
........++..|+|||++......+.++|+||||+++++|++|+.||......+....+......+
T Consensus 152 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 152 -RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred -CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 1111223467789999988654444455999999999999999999998765544433322111100
Q ss_pred -----------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 249 -----------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 249 -----------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
..+..+..+.++|.+|| .+|++||++++++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 01123688999999999 599999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=277.88 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=208.9
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
..+|++.+.||+|++|.||+|.+. .++.+++|.+...... ...+.+|+.+++.++||+++++++++......++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457999999999999999999875 4678999988644332 23467899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
+||+++++|.+++... +.+++..++.++.+++.++++||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc---
Confidence 9999999999999753 458999999999999999999999999999999999999999999999999886432110
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
........++..|+|||.+.+..+..+ +|+||||+++|++++ |..||.........+.+..+.....+...+..+.
T Consensus 155 --~~~~~~~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05112 155 --YTSSTGTKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVY 231 (256)
T ss_pred --ccccCCCccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 001112224567999999987666655 999999999999998 9999998888888888877655555566899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+++.+|| .+|.+|||+.+++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHh
Confidence 9999999 589999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=292.28 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=204.1
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC------
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------ 94 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 94 (316)
.++|.+.+.||+|+||.||+|.+..+++.||+|++........ ..+.+.+|+.+++.++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH-HHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4779999999999999999999998999999999865432222 234566899999999999999999988543
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
...+++++++ +++|.++++.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~- 171 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD- 171 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc-
Confidence 3468888887 77999888754 58999999999999999999999999999999999999999999999999885421
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--------
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-------- 246 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 246 (316)
.......++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.....
T Consensus 172 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 172 --------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred --------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 1122334678899999987644344459999999999999999999987665444333221100
Q ss_pred ----------------CCC------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 247 ----------------FPK------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 247 ----------------~~~------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+. ....+.++.++|..|| .+|.+||++.++++||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 000 1235788999999999 59999999999999999985444
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=286.22 Aligned_cols=254 Identities=20% Similarity=0.363 Sum_probs=206.5
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCC----------------ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHS----------------GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~----------------~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 82 (316)
+..++|++.+.||+|+||.||+|.+...+ ..+++|.+...... ...+.+.+|+.++..++||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDP 79 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCC
Confidence 35678999999999999999999876543 45789987654332 2355677899999999999
Q ss_pred CcceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q psy11194 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG-----------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCE 151 (316)
Q Consensus 83 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ 151 (316)
|++++++++..+...++++|++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999999999999999999999999999997654 6899999999999999999999999999999999
Q ss_pred CeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh--CCCCC
Q psy11194 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF--GRLPF 229 (316)
Q Consensus 152 nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~ 229 (316)
||+++.++.++|+|||.+...... ..........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSS----DYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred ceeecCCCceEEccccceeecccC----cceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCC
Confidence 999999999999999988643211 11111223345678999999877666655 999999999999998 77888
Q ss_pred CCCCHHHHHHHHhcc-------cCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 230 DDSSVNELLKQVQNK-------VTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 230 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
......+........ ...+.+..++.++.+++.+|| .+|.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 877666665555432 112233457899999999999 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=281.26 Aligned_cols=242 Identities=25% Similarity=0.429 Sum_probs=199.4
Q ss_pred eeeeecCCeEEEEEEEccCCce--EEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEEEEecC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGD--VAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYA 104 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~--v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~ 104 (316)
+.||+|+||.||+|.+..++.. +++|...... .....+.+.+|+.++..+ +||||+++++++...+..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 3589999999999999877764 5777765322 222345577899999999 7999999999999999999999999
Q ss_pred CCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 105 ENGSLFDIIRGQG----------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 105 ~~~sL~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999996532 478899999999999999999999999999999999999999999999998
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCC
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTF 247 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 247 (316)
+..... .........+..|+|||++....++.+ +|+||||+++|+|++ |..||...+..+....+......
T Consensus 159 ~~~~~~-------~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 230 (270)
T cd05047 159 SRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 230 (270)
T ss_pred ccccch-------hhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC
Confidence 743110 000111123557999999877666555 999999999999997 99999988888877777766655
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 248 PKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 248 ~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+.+..++.++.+++.+|+ .+|.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 566678999999999999 58999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=277.16 Aligned_cols=244 Identities=20% Similarity=0.382 Sum_probs=203.1
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENG 107 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 107 (316)
+.||+|++|.||+|... ++..+++|++..... ......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999854 678999998865432 223445778999999999999999999999999999999999999
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 108 SLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 108 sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
+|.+++.. ...+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~ 152 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-----YSSSG 152 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-----cccCC
Confidence 99999865 3458999999999999999999999999999999999999999999999999885422110 00111
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 265 (316)
...++..|+|||++.+..++.+ +||||||+++|++++ |..||...........+........+..++..+.+++.+|+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCW 231 (250)
T ss_pred CCCCcccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 1223567999999987666665 999999999999998 99999988888777777776665656678999999999999
Q ss_pred -CCCCCCCCHHHHhhC
Q psy11194 266 -SPVQTRPRLKTIAED 280 (316)
Q Consensus 266 -~~p~~Rps~~~il~~ 280 (316)
.+|++||++.++++.
T Consensus 232 ~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 232 DYKPENRPKFSELQKE 247 (250)
T ss_pred ccCcccCCCHHHHHHH
Confidence 599999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=301.93 Aligned_cols=262 Identities=23% Similarity=0.434 Sum_probs=221.0
Q ss_pred ceeeccCe-EEeeeeeecCCeEEEEEEEccCCceEEEEEeecCC-CCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 17 TVLESHGY-TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQ-APPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 17 ~~~~~~~y-~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
......+| +....||+|+|.+||+|.|..+|..||--.++... .......+.+..|+.+|+.|+||||+++++++.+.
T Consensus 34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 33344454 45567999999999999999999988875543321 12233357788999999999999999999999876
Q ss_pred Ce--EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeCCC-CCeEEeecccc
Q psy11194 95 HR--VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG--VVHRDIKCENLLLDSD-YNIKLSDFGFA 169 (316)
Q Consensus 95 ~~--~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~H~dl~p~nil~~~~-~~~~l~Df~~~ 169 (316)
.. ..+|+|.+..|+|..|+++.+.++...++.|+.||++||.|||+.. |+|||||.+||||+.+ |.|||+|+|+|
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence 65 8899999999999999999999999999999999999999999885 9999999999999876 89999999999
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhcccCCC
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLKQVQNKVTFP 248 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~ 248 (316)
... .........|||.|||||... -.|+.. .||||||+-+.||.|+.+||. ..++-++++++.++.++.
T Consensus 194 tl~--------r~s~aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 194 TLL--------RKSHAKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA 263 (632)
T ss_pred HHh--------hccccceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH
Confidence 753 223344467999999999987 345554 999999999999999999996 588999999999998777
Q ss_pred CCCCC-CHHHHHHHHHhcCCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 249 KQPEV-STECKELISNILSPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 249 ~~~~~-~~~~~~li~~~l~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
....+ +++++++|.+||...++|||+.|+|.||||+.-..
T Consensus 264 sl~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g 304 (632)
T KOG0584|consen 264 ALSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGG 304 (632)
T ss_pred HhhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccc
Confidence 65544 79999999999976999999999999999988633
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=288.70 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=204.5
Q ss_pred CeEEeeeeeecCCeEEEEEEEccC--CceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEe----CC
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRH--SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET----TH 95 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~ 95 (316)
+|.+.+.||+|+||.||+|.+..+ +..+|+|.+........ ..+.+.+|+.+++.+ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI-LAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccch-hHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 588999999999999999999877 88999999865332222 233456899999999 59999999987543 24
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..+++++++. ++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5789999995 599999988788999999999999999999999999999999999999999999999999998754321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC---------
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--------- 246 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--------- 246 (316)
... .........++..|+|||.+.+....+.++|+||||+++|++++|..||...+.......+.....
T Consensus 159 ~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 159 PGE--NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred ccc--ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 111 111123345788999999876644344459999999999999999999987665444332221100
Q ss_pred ---------------CC------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 247 ---------------FP------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 247 ---------------~~------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
.+ ..+..+..+.+++.+|| .+|.+|||+.+++.||||...+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 00 11346789999999999 5999999999999999997544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=286.08 Aligned_cols=254 Identities=21% Similarity=0.355 Sum_probs=203.1
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCC--------------ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCc
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHS--------------GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~--------------~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 84 (316)
+..++|++.+.||+|+||.||+|.+...+ ..+++|.++.... ....+.+.+|+.+++.++|+|+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence 45678999999999999999999875432 2489998865432 2234567799999999999999
Q ss_pred ceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCC
Q psy11194 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCEN 152 (316)
Q Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~n 152 (316)
+++++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 999999999999999999999999999985421 36888999999999999999999999999999999
Q ss_pred eeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCC
Q psy11194 153 LLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF--GRLPFD 230 (316)
Q Consensus 153 il~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~ 230 (316)
|+++.++.++|+|||++...... ..........++..|+|||++.+..++.+ +|+||||+++|+|++ |..||.
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSG----DYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred EEEcCCCcEEecccccccccccC----cceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCc
Confidence 99999999999999998653211 11111222334678999999887776665 999999999999988 678888
Q ss_pred CCCHHHHHHHHhcc-------cCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 231 DSSVNELLKQVQNK-------VTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 231 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.....+....+... ......+.++..+.+++.+|| .+|.+|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 77766655544221 112234457899999999999 59999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=284.64 Aligned_cols=252 Identities=29% Similarity=0.467 Sum_probs=204.8
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEec
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
|+..+.||+|++|.||+|....+++.+++|........ ....+.+..|+.+++.++|++++++++++......++|+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 67788999999999999999999999999999765422 22244566899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 104 AENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 104 ~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
+++ +|.+++.+. ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~------ 152 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL------ 152 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc------
Confidence 975 999999875 569999999999999999999999999999999999999999999999999886532111
Q ss_pred CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC----------------
Q psy11194 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT---------------- 246 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 246 (316)
........+..|+|||.+.+....+.++|+||||+++|++++|..||...........+.+...
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 1112223466799999987763444459999999999999999999987665544333321110
Q ss_pred ---CC---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 247 ---FP---------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 247 ---~~---------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
++ ..+..+..+.++|.+|| .+|++||++++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00 11235789999999999 699999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=277.82 Aligned_cols=249 Identities=24% Similarity=0.422 Sum_probs=211.0
Q ss_pred eEEeeeeeecCCeEEEEEEEccCC----ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHS----GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~----~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
+++.+.||.|+||.||++.+...+ ..+++|.+....... ..+.+.+|+..++.++|+||+++++++...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 356788999999999999988766 789999986544321 24567799999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 100 IMEYAENGSLFDIIRGQGY--IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+||++++++|.+++..... +++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976444 89999999999999999999999999999999999999999999999999865432211
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
.......++..|+|||.+.+.....+ +|+||||+++++|++ |..||...+.....+.+......+.....+.+
T Consensus 159 -----~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T smart00219 159 -----YKKKGGKLPIRWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPE 232 (258)
T ss_pred -----cccccCCCcccccChHHhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHH
Confidence 11111225678999999866555555 999999999999998 89999988888888888777766667778999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+.+++.+|| .+|++|||+.++++.
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHHHHHCcCChhhCcCHHHHHhh
Confidence 999999999 599999999999863
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=283.76 Aligned_cols=259 Identities=26% Similarity=0.474 Sum_probs=208.7
Q ss_pred CeEEeeeeeecCCeEEEEEEEc---cCCceEEEEEeecCCCC-chHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeE
Q psy11194 23 GYTVGKIIGTGSYATVKLARST---RHSGDVAIKIVSKVQAP-PDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~---~~~~~v~vK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 97 (316)
+|++.+.||.|++|.||.|.+. .+|+.+++|++...... .....+.+.+|+.++..+ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 36889999998653321 112245567899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
++|+||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-- 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc--
Confidence 999999999999999988778999999999999999999999999999999999999999999999999988653211
Q ss_pred cCCCCCCCcccccccCccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcccCCCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFDDSS----VNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~ 252 (316)
.........++..|+|||.+.... ....++||||||+++|+|++|..||.... .....+.+... ..+.+..
T Consensus 159 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 234 (290)
T cd05613 159 ---EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQE 234 (290)
T ss_pred ---cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-CCCCCcc
Confidence 111112334778899999986532 23344999999999999999999996432 23333333222 2344456
Q ss_pred CCHHHHHHHHHhc-CCCCCCC-----CHHHHhhCCCCCCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRP-----RLKTIAEDRWLKPKP 287 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~~ 287 (316)
+++.+.+++.+|| .+|.+|| +++++++||||+...
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 8999999999999 6999997 899999999998865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=281.78 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=201.5
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC---CCCCcceeeeEEEeCCe----
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL---KHPNLIRFLQAIETTHR---- 96 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~---- 96 (316)
|++.+.||+|++|.||+|.+..+++.+++|.+........ ....+.+|+.+++.+ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch-hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6788999999999999999988899999999975444322 223344677766655 59999999999987776
Q ss_pred -EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 97 -VYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 97 -~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
.+++||++++ +|.+++.... .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8999887633 48999999999999999999999999999999999999999999999999886542
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-----
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP----- 248 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 248 (316)
.. .......++..|+|||.+.+..++.+ +|+||||+++|+|++|+.||......+....+......+
T Consensus 159 ~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 159 FE-------MALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred CC-------cccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence 11 11122346778999999988776666 999999999999999999998877666555443211100
Q ss_pred ------------C---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 249 ------------K---------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 249 ------------~---------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
. .+.++..+.++|.+|| .+|.+||++++++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 1235678899999999 599999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=293.80 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=201.5
Q ss_pred eeeeec--CCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCC
Q psy11194 28 KIIGTG--SYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAE 105 (316)
Q Consensus 28 ~~ig~g--~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 105 (316)
..||.| ++|+||+|.+..+|+.||+|++........ ..+.+++|+.+++.++||||+++++++..+...++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHH-HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456766 999999999999999999999876544333 34678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC-C
Q psy11194 106 NGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD-N 182 (316)
Q Consensus 106 ~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~-~ 182 (316)
+++|.+++.+. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++++||+.+............ .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999999763 34899999999999999999999999999999999999999999999999755332111100000 0
Q ss_pred CCCcccccccCccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc----------------
Q psy11194 183 SLSETFCGSYAYASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV---------------- 245 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------- 245 (316)
.......++..|+|||++.+.. ..+.++|||||||++|+|++|..||......+.........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 0011122456799999986632 22344999999999999999999998765444332221110
Q ss_pred ------------------------------CCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 246 ------------------------------TFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 246 ------------------------------~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
..+....++..+.+||.+|| .+|++|||++++++||||...+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 01112235678999999999 599999999999999999776663
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=277.54 Aligned_cols=242 Identities=26% Similarity=0.461 Sum_probs=204.6
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|++.+.||+|+||.||.+. .+++.+++|....... .+.+.+|+.+++.++|||++++++++... ..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 45779999999999999999985 4677899998854321 34567899999999999999999998664 4789
Q ss_pred EEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 100 IMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+|||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~--- 152 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM--- 152 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc---
Confidence 999999999999997543 489999999999999999999999999999999999999999999999998854211
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
.......+..|+|||.+.+..++.+ +|+||||+++|+|++ |..||......+....+..+...+....++.+
T Consensus 153 ------~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (254)
T cd05083 153 ------GVDNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPAD 225 (254)
T ss_pred ------cCCCCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHH
Confidence 0111223567999999877666665 999999999999997 99999998888888888777666666678999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+.+++.+|| .+|.+||+++++++
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=284.13 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=202.5
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEcc----------------CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTR----------------HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~----------------~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 82 (316)
+..++|++.+.||+|+||.||+|.+.. ++..+++|+...... ....+.+.+|+.+++.++|+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~ 79 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDP 79 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCC
Confidence 346789999999999999999986432 334689998865432 22345677999999999999
Q ss_pred CcceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q psy11194 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG-----------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCE 151 (316)
Q Consensus 83 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ 151 (316)
||+++++++...+..+++|||+++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~ 159 (296)
T cd05095 80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159 (296)
T ss_pred CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 99999999999999999999999999999986532 3667789999999999999999999999999999
Q ss_pred CeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh--CCCCC
Q psy11194 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF--GRLPF 229 (316)
Q Consensus 152 nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~ 229 (316)
||+++.++.++|+|||++....... .........++..|+|||+.....++.+ +|+|||||++|+|++ |..||
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGD----YYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCc----ceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999986532111 0111222334567999998877666665 999999999999998 77899
Q ss_pred CCCCHHHHHHHHhc-------ccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 230 DDSSVNELLKQVQN-------KVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 230 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
......+....... ....+.+..++..+.+++.+|| .+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 87766665543321 1223445568899999999999 69999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=283.75 Aligned_cols=252 Identities=29% Similarity=0.464 Sum_probs=205.9
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEec
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
|.+.+.||.|++|.||+|.+..+++.+++|.+........ ....+.+|+.+++.++|++++++++++..+...++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG-IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch-hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 5678899999999999999998999999999866544322 245566899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 104 AENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 104 ~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
+++ +|..++.. ...+++..+..++.+++.||.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~------ 152 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV------ 152 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc------
Confidence 976 88888765 4579999999999999999999999999999999999999999999999999886542111
Q ss_pred CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC--------------
Q psy11194 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP-------------- 248 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 248 (316)
.......++..|+|||.+.+....+.++|+||||+++|++++|+.||...+..+....+......+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 112223467789999998776444555999999999999999999998777655444432211000
Q ss_pred ---------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 249 ---------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 249 ---------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
..+.++.++.++|.+|| .+|.+||++++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11246889999999999 599999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=290.69 Aligned_cols=257 Identities=20% Similarity=0.364 Sum_probs=204.0
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQA 90 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 90 (316)
+.+..++|++.+.||+|+||.||+|.+. .+++.||+|.++...... ..+.+.+|+.++..+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChH--HHHHHHHHHHHHHhccCCccHhhhcce
Confidence 4567889999999999999999999843 456789999986543322 234566899999999 68999999998
Q ss_pred EEe-CCeEEEEEecCCCCCHHHHHHhC-----------------------------------------------------
Q psy11194 91 IET-THRVYIIMEYAENGSLFDIIRGQ----------------------------------------------------- 116 (316)
Q Consensus 91 ~~~-~~~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------- 116 (316)
+.. ....+++|||+++++|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 865 44678999999999999998642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 117 --------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 117 --------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
..++...+..++.|++.||+|||+.|++|+||+|.||+++.++.++|+|||++....... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~ 235 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP----DY 235 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc----ch
Confidence 136778889999999999999999999999999999999999999999999986532111 01
Q ss_pred CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHhcccCCCCCCCCCHHHHHH
Q psy11194 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVN-ELLKQVQNKVTFPKQPEVSTECKEL 260 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l 260 (316)
.......++..|+|||.+.+..++.+ +||||||+++|++++ |..||...... .....+..+...+.+...++++.++
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 314 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 11122234567999999877666665 999999999999997 99999775433 3444455555555555678999999
Q ss_pred HHHhc-CCCCCCCCHHHHhhC
Q psy11194 261 ISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~~ 280 (316)
+..|| .+|.+|||+.++++|
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 99999 599999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=289.55 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=217.8
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..+.|+....||+|+||.|+-++...+|+-+|.|.+.+.............+|-.++++++.+.||.+-..|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 45567889999999999999999999999999999988765433222223445589999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
.++|+..|+||+|.-.|-+.+ .+++..+.-++.+|+.||++||+.+||+|||||+|||+|+.|++.|+|+|+|..+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~- 338 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP- 338 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC-
Confidence 999999999999988886644 69999999999999999999999999999999999999999999999999997642
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hcccCCCCCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV---QNKVTFPKQP 251 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~ 251 (316)
.........||.+|||||++.+..++.. .|+|||||++|+|+.|+.||..-....-.+.+ ........+.
T Consensus 339 ------~g~~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~ 411 (591)
T KOG0986|consen 339 ------EGKPIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD 411 (591)
T ss_pred ------CCCccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc
Confidence 2233334479999999999999886666 99999999999999999999753322222222 2222334446
Q ss_pred CCCHHHHHHHHHhc-CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 252 EVSTECKELISNIL-SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
.+|++++++.+.+| ++|++|. .+.++.+||||++.
T Consensus 412 kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 412 KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 79999999999999 7999987 56799999999874
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=275.17 Aligned_cols=244 Identities=23% Similarity=0.392 Sum_probs=204.6
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENG 107 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 107 (316)
+.||+|++|.||+|.+.. ++.+++|.+...... .....+.+|+.+++.++|++|+++++++......++|+||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999887 899999988664443 23456779999999999999999999999999999999999999
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCc
Q psy11194 108 SLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186 (316)
Q Consensus 108 sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~ 186 (316)
+|.+++.. ...++...+..++.+++.+|.+||+++++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~----~~~~~~ 153 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI----YTVSDG 153 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc----ceeccc
Confidence 99999965 4468999999999999999999999999999999999999999999999999886432110 000111
Q ss_pred ccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc
Q psy11194 187 TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL 265 (316)
Q Consensus 187 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 265 (316)
....+..|+|||.+.+..++.+ +|+||||+++|++++ |..||...........+......+.+...+.++.+++.+||
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 232 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCW 232 (251)
T ss_pred cCcceeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHh
Confidence 1223556999999877666655 999999999999998 89999888877777777766656666678999999999999
Q ss_pred -CCCCCCCCHHHHhh
Q psy11194 266 -SPVQTRPRLKTIAE 279 (316)
Q Consensus 266 -~~p~~Rps~~~il~ 279 (316)
.+|.+||+++++++
T Consensus 233 ~~~p~~Rp~~~ell~ 247 (251)
T cd05041 233 AYDPENRPSFSEIYN 247 (251)
T ss_pred ccChhhCcCHHHHHH
Confidence 58999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=282.93 Aligned_cols=255 Identities=22% Similarity=0.382 Sum_probs=202.1
Q ss_pred eccCeEEeeeeeecCCeEEEEEEE----ccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARS----TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT- 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~----~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 94 (316)
+++-|++++.||+|+||.||.|.. ..++..+++|.+..... ....+.+.+|+.+++.+.|||++++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 456789999999999999999974 34677899999865432 22345688999999999999999999998765
Q ss_pred -CeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 95 -HRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 95 -~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
...++||||++|++|.+++.+. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 5789999999999999999764 35899999999999999999999999999999999999999999999999998654
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------------CHHHH
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS---------------SVNEL 237 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---------------~~~~~ 237 (316)
..... .........++..|+|||++.+..++.+ +||||||+++|+|++++.|.... .....
T Consensus 160 ~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 160 ETDKE---YYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccCcc---ceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 21111 0011122345667999999887666665 99999999999999976654211 11222
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 238 LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
...+..+...+.+..++..+.+++.+|| .+|.+||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 3333444455556678999999999999 599999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=279.83 Aligned_cols=254 Identities=21% Similarity=0.374 Sum_probs=208.5
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEcc-----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTR-----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
+..++|++.+.||.|+||.||+|+... ..+.+++|....... ....+.+.+|+.+++.++|+|++++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 79 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCRE 79 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence 345789999999999999999999653 345789998754332 2234567799999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEe
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQG---------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLS 164 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~---------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~ 164 (316)
....++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 899999999999999999997654 68999999999999999999999999999999999999999999999
Q ss_pred ecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc
Q psy11194 165 DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQN 243 (316)
Q Consensus 165 Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~ 243 (316)
|||++..... ..........++..|+|||.+.+...... +||||||+++|++++ |..||...........+..
T Consensus 160 ~~~~~~~~~~-----~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~ 233 (275)
T cd05046 160 LLSLSKDVYN-----SEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA 233 (275)
T ss_pred ccccccccCc-----ccccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc
Confidence 9998754211 11111222345677999999877666655 999999999999998 8899987777766666653
Q ss_pred c-cCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 244 K-VTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 244 ~-~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+ ...+....++..+.+++.+|| .+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 3 234445578999999999999 599999999999865
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=292.88 Aligned_cols=258 Identities=22% Similarity=0.411 Sum_probs=209.1
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQ 89 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~ 89 (316)
.+.+..++|.+.+.||+|+||.||+|++. ..++.||+|++....... ..+.+.+|+.++..+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS--EKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh--HHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 37778889999999999999999999864 345689999997543322 2345678999999997 999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhCC----------------------------------------------------
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQG---------------------------------------------------- 117 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------------------------------------------- 117 (316)
++......++|+||+++|+|.+++.+.+
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999986421
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q psy11194 118 ----------------------------------------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCE 151 (316)
Q Consensus 118 ----------------------------------------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ 151 (316)
.++...+..++.||+.||+|||+.+++|+||+|+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 3567778999999999999999999999999999
Q ss_pred CeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q psy11194 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFD 230 (316)
Q Consensus 152 nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~ 230 (316)
||+++.++.++|+|||++........ ........++..|+|||.+.+..+..+ +||||||+++|++++ |..||.
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSN----YISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccc----cccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999865321110 011122345678999999987766665 999999999999998 899998
Q ss_pred CCCHHH-HHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 231 DSSVNE-LLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 231 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.....+ ....+..+...+.+..++.++.+++.+|| .+|.+||++++|++.
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 344 ELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 755444 34445555555566678999999999999 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=275.90 Aligned_cols=245 Identities=24% Similarity=0.424 Sum_probs=202.2
Q ss_pred eeeeecCCeEEEEEEEcc-CCc--eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecC
Q psy11194 28 KIIGTGSYATVKLARSTR-HSG--DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 104 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~-~~~--~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 104 (316)
+.||+|++|.||+|.+.. .++ .+++|.+...... ...+.+.+|+.+++.++||||+++++.+.. ...++|+||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 5899998765543 335667799999999999999999999988 8899999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 105 ENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 105 ~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~---~~~ 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE---DHY 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccc---cce
Confidence 9999999997653 68999999999999999999999999999999999999999999999999987643211 111
Q ss_pred CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc-ccCCCCCCCCCHHHHHH
Q psy11194 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKEL 260 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 260 (316)
.......++..|+|||.+.....+.+ +||||||+++|+|++ |..||......+....+.. ....+.+...|..+.++
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV 233 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence 11112345678999999887776666 999999999999998 9999988777776666653 33344445688999999
Q ss_pred HHHhc-CCCCCCCCHHHHhh
Q psy11194 261 ISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~ 279 (316)
+.+|| .+|.+||++.++++
T Consensus 234 i~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 234 MLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHCCCCcccCCCHHHHHH
Confidence 99999 58999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=280.43 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=195.4
Q ss_pred eEEeeeeeecCCeEEEEEE----EccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--CCeE
Q psy11194 24 YTVGKIIGTGSYATVKLAR----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRV 97 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~----~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 97 (316)
|++.+.||+|+||.||.+. ...++..+++|.+..... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 4999999999999998765 335677899999865432 1224456689999999999999999998765 3468
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+++|||+++++|.+++... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999999999865 499999999999999999999999999999999999999999999999999865421110
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHHHh
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV---------------NELLKQVQ 242 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---------------~~~~~~~~ 242 (316)
.........++..|+|||.+.....+.+ +||||||+++|+|++|..||..... ....+.+.
T Consensus 163 ---~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 163 ---YYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred ---hhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 0011112234567999999877666665 9999999999999999999854321 11112222
Q ss_pred cccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 243 NKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.....+.+..++.++.+++..|| .+|++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 33334445668899999999999 58999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=282.62 Aligned_cols=255 Identities=22% Similarity=0.403 Sum_probs=209.8
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCc----eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSG----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
.+..++|++.+.||+|++|.||+|.+..+|. .+++|....... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 3567889999999999999999999877766 468887754332 2223346789999999999999999999875
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
. ..+++++|+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 4 4678999999999999987643 5899999999999999999999999999999999999999999999999998754
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
..... ........++..|+|||.+.+...+.+ +||||||+++|++++ |..||.+....+..+.+..+...+.+.
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd05110 160 EGDEK----EYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 234 (303)
T ss_pred cCccc----ccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence 21111 111122334668999999887666665 999999999999997 999998887777777777776666667
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.++..+.+++..|+ .+|++||+++++++.
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78999999999999 599999999999865
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=295.63 Aligned_cols=262 Identities=30% Similarity=0.536 Sum_probs=222.2
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
.+.||.|-||+||-|.+.++|+.||||++.+....... ..++++|+.+|+++.||+||.+--.|+..+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 36799999999999999999999999999887765544 46788999999999999999999999999999999999977
Q ss_pred CCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC---CCeEEeecccccccccccCcCCCC
Q psy11194 107 GSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD---YNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 107 ~sL~~~l~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~---~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
.-|+-.+. +.+++++..-+.++.||+.||.|||.+||+|+||||+|||+... -.+||||||+|++. .+.
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI-------gEk 720 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII-------GEK 720 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeec-------chh
Confidence 55555553 45679999999999999999999999999999999999999654 56999999999873 344
Q ss_pred CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---ccCCCCCCCCCHHHHH
Q psy11194 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN---KVTFPKQPEVSTECKE 259 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 259 (316)
.......||+.|.|||++.++.++.. -|+||.|+|+|--+.|..||.. .+++.++++. ..+...+..++++..+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~Aid 797 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAID 797 (888)
T ss_pred hhhhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHH
Confidence 44556679999999999999999887 8999999999999999999964 3444555543 2344455789999999
Q ss_pred HHHHhcC-CCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhH
Q psy11194 260 LISNILS-PVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAEL 299 (316)
Q Consensus 260 li~~~l~-~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~ 299 (316)
||..+|. ..++|-|.+..+.|||+|+-..-.+.-+++..+
T Consensus 798 lIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~i 838 (888)
T KOG4236|consen 798 LINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRI 838 (888)
T ss_pred HHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhh
Confidence 9999995 799999999999999999987766665555544
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=302.72 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=192.6
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCc-eEEEEE--------------eecCCCCchHHHhhHHHHHHHHhcCCCCCcc
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSG-DVAIKI--------------VSKVQAPPDYLKKFLPREIEVVKGLKHPNLI 85 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~-~v~vK~--------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 85 (316)
.++|++.+.||+|+||.||++....... ..+.|. +.+...........+.+|+.++..++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987653322 222221 1111111222345577999999999999999
Q ss_pred eeeeEEEeCCeEEEEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC
Q psy11194 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQ-----GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN 160 (316)
Q Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~ 160 (316)
++++++...+..+++++++.+ +|.+++... .......++.++.||+.||.|||+.|++|+||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999954 777776432 22446678899999999999999999999999999999999999
Q ss_pred eEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCC---HHH
Q psy11194 161 IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRL-PFDDSS---VNE 236 (316)
Q Consensus 161 ~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~-p~~~~~---~~~ 236 (316)
++|+|||++..+.. ..........|+..|+|||++.+..++.+ +|||||||++|+|++|.. |+.... ..+
T Consensus 306 vkL~DFGla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 306 IVLGDFGTAMPFEK-----EREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred EEEEeCCCceecCc-----ccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999865421 11112223568899999999988777665 999999999999999765 443221 122
Q ss_pred HHHHHhcc----cCCC--------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 237 LLKQVQNK----VTFP--------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 237 ~~~~~~~~----~~~~--------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
..+.+... ..++ ....++..+.++|.+|| .||.+|||+.|++.||||..
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 22222110 0000 01135677888999999 59999999999999999987
Q ss_pred CCC
Q psy11194 286 KPK 288 (316)
Q Consensus 286 ~~~ 288 (316)
...
T Consensus 460 ~~~ 462 (501)
T PHA03210 460 EEE 462 (501)
T ss_pred CCc
Confidence 654
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=300.10 Aligned_cols=254 Identities=31% Similarity=0.493 Sum_probs=212.1
Q ss_pred eeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCC
Q psy11194 29 IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGS 108 (316)
Q Consensus 29 ~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~s 108 (316)
.||+|.+|+||.|+|..+...+|||.+...... ..+-+..|+.+-+.++|.|||+++|++...+++-++||..+|||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr---~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR---EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch---hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 599999999999999999999999998654432 25568899999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC-CCCeEEeecccccccccccCcCCCCCC
Q psy11194 109 LFDIIRG-QGYI--DEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS-DYNIKLSDFGFARAHMRCRSNAADNSL 184 (316)
Q Consensus 109 L~~~l~~-~~~l--~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~-~~~~~l~Df~~~~~~~~~~~~~~~~~~ 184 (316)
|.++++. -+++ .+..+..+..||+.||+|||++.|||||||-+||+++. .|.+||+|||.++.....++ .
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP------~ 732 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP------C 732 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc------c
Confidence 9999986 4567 78889999999999999999999999999999999964 58999999999877643333 2
Q ss_pred CcccccccCccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-hcccCCCCCCCCCHHHHHHH
Q psy11194 185 SETFCGSYAYASPEILQGI-PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNEL-LKQV-QNKVTFPKQPEVSTECKELI 261 (316)
Q Consensus 185 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~li 261 (316)
.....||..|||||++... ..+.+++|||||||++.||.||++||-.....+. .-++ .-...++.+..++.+.+.+|
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 3345589999999999543 3344559999999999999999999976543332 2222 33445667778999999999
Q ss_pred HHhc-CCCCCCCCHHHHhhCCCCCCC-CCCCC
Q psy11194 262 SNIL-SPVQTRPRLKTIAEDRWLKPK-PKSRG 291 (316)
Q Consensus 262 ~~~l-~~p~~Rps~~~il~~~~~~~~-~~~~~ 291 (316)
.+|. .+|.+|||+.++|.+||+++. ++.++
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~ 844 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRP 844 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccCCCCCCC
Confidence 9999 589999999999999999988 33343
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=279.71 Aligned_cols=259 Identities=25% Similarity=0.479 Sum_probs=207.4
Q ss_pred CeEEeeeeeecCCeEEEEEEEc---cCCceEEEEEeecCCCC-chHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeE
Q psy11194 23 GYTVGKIIGTGSYATVKLARST---RHSGDVAIKIVSKVQAP-PDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~---~~~~~v~vK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 97 (316)
+|++.+.||+|++|.||+|.+. .+++.+++|++...... .....+.+.+|+.++..+ +||+++++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 45778999998753321 122244567899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
++||||+++++|.+++.....+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-- 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc--
Confidence 999999999999999987777999999999999999999999999999999999999999999999999988653211
Q ss_pred cCCCCCCCcccccccCccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcccCCCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFDDSS----VNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~ 252 (316)
.........++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... ..+..+.+... ..+.+..
T Consensus 159 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 234 (288)
T cd05583 159 ---EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-KPPFPKT 234 (288)
T ss_pred ---cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-CCCCCcc
Confidence 111122344778899999986644 22334999999999999999999996432 22333333222 2344556
Q ss_pred CCHHHHHHHHHhc-CCCCCCCC---HHHHhhCCCCCCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRPR---LKTIAEDRWLKPKP 287 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps---~~~il~~~~~~~~~ 287 (316)
++..+.++|.+|| .+|++||| +.++++||||+...
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 8999999999999 69999998 56779999997764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=278.87 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=198.3
Q ss_pred eccCeEEeeeeeecCCeEEEEEEE----ccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARS----TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-- 93 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~----~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 93 (316)
+.++|++.+.||+|+||.||+|.. ..++..+++|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 356899999999999999999973 4568899999976432 2234567799999999999999999998753
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
....++|+||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 34689999999999999999754 45899999999999999999999999999999999999999999999999998754
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------H
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN----------------E 236 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~----------------~ 236 (316)
...... ........++..|+|||...+..++.+ +|+||||+++|+|++|..++...... .
T Consensus 159 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 159 PQDKEY---YKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cCCCcc---eeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 211100 000111123445999999877666655 99999999999999987665432211 1
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 237 LLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..+.+......+....++.++.++|.+|| .+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 12233334445555678999999999999 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=305.04 Aligned_cols=150 Identities=28% Similarity=0.522 Sum_probs=138.8
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.............+..|+.++..++|++|+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999765554444456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
|||+.|++|.+++...+.+++..++.++.||+.||.|||..|++|+||+|+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999887789999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=273.69 Aligned_cols=247 Identities=19% Similarity=0.320 Sum_probs=197.7
Q ss_pred eeeeecCCeEEEEEEEcc---CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE-eCCeEEEEEec
Q psy11194 28 KIIGTGSYATVKLARSTR---HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE-TTHRVYIIMEY 103 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~ 103 (316)
+.||+|+||.||+|.+.. .+..+++|.+..... ....+.+.+|+.+++.++|||++++++++. .++..++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC--HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998653 345789998754322 222455678999999999999999999775 45568999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 104 AENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 104 ~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
+.+++|.+++.+. ..++...+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~--~~ 156 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--SV 156 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce--ee
Confidence 9999999999763 34678888999999999999999999999999999999999999999999998643211100 00
Q ss_pred CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy11194 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 261 (316)
.......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+..+....+..+...+.+..++..+.+++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 235 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVM 235 (262)
T ss_pred cccccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 11112234668999999887766665 999999999999999 6778888888777777777666666666899999999
Q ss_pred HHhc-CCCCCCCCHHHHhh
Q psy11194 262 SNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 262 ~~~l-~~p~~Rps~~~il~ 279 (316)
..|| .+|++||++.++++
T Consensus 236 ~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 236 LSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHcCCChhhCCCHHHHHH
Confidence 9999 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=293.81 Aligned_cols=268 Identities=24% Similarity=0.456 Sum_probs=237.6
Q ss_pred ccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 13 DRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 13 ~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
......+.-.+++++..||-|+||.|-++........+|+|.+++.---+....+.+..|-.++..++.|.|+++|..|.
T Consensus 411 ~~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 411 AEEFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred HhhhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence 33445566778889999999999999999877666568999988766555555777889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
+..++|++||-|-||.||+.++..+.+++...+.++..++.|++|||++||+++||||+|.+++.+|-+||.|||+|..
T Consensus 491 d~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk- 569 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK- 569 (732)
T ss_pred cchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHH-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999976
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC-CCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF-PKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~ 251 (316)
..........+||+.|.|||++.++.++.. .|.||||+++|||++|.+||.+.++...+..+.++... ..+.
T Consensus 570 ------i~~g~KTwTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr 642 (732)
T KOG0614|consen 570 ------IGSGRKTWTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR 642 (732)
T ss_pred ------hccCCceeeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc
Confidence 334455566789999999999999999887 99999999999999999999999999999999887653 3345
Q ss_pred CCCHHHHHHHHHhcC-CCCCCCC-----HHHHhhCCCCCCCCC
Q psy11194 252 EVSTECKELISNILS-PVQTRPR-----LKTIAEDRWLKPKPK 288 (316)
Q Consensus 252 ~~~~~~~~li~~~l~-~p~~Rps-----~~~il~~~~~~~~~~ 288 (316)
.++....+||+.+++ +|.+|.. +.+|.+|.||.+++=
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 799999999999995 7999886 899999999987653
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=276.04 Aligned_cols=244 Identities=23% Similarity=0.377 Sum_probs=200.4
Q ss_pred eeeecCCeEEEEEEEccCC------ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 29 IIGTGSYATVKLARSTRHS------GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 29 ~ig~g~~g~vy~~~~~~~~------~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
.||+|++|.||+|.+.... ..+++|.+...... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 5899999999999876433 57899987543221 124456689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC-----CeEEeeccccc
Q psy11194 103 YAENGSLFDIIRGQ-------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY-----NIKLSDFGFAR 170 (316)
Q Consensus 103 ~~~~~sL~~~l~~~-------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~-----~~~l~Df~~~~ 170 (316)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++++|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999999642 3478899999999999999999999999999999999999877 89999999986
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCC
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPK 249 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (316)
....... ........++..|+|||.+.+...+.+ +||||||+++|+|++ |..||......+....+.....+..
T Consensus 160 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05044 160 DIYKSDY----YRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK 234 (269)
T ss_pred ccccccc----cccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCC
Confidence 5321111 011112234678999999987776665 999999999999998 9999988887777777766666666
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
...+|..+.++|.+|| .+|.+||+++++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6778999999999999 58999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=274.65 Aligned_cols=247 Identities=21% Similarity=0.346 Sum_probs=190.4
Q ss_pred eeeeecCCeEEEEEEEcc--CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCC
Q psy11194 28 KIIGTGSYATVKLARSTR--HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAE 105 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 105 (316)
+.||+|+||.||+|.... ....+++|.+..... ......+.+|+..++.++|+||+++++.+......++||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC--hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 358999999999996543 334678887654322 2234456689999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 106 NGSLFDIIRGQG-----YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 106 ~~sL~~~l~~~~-----~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
+++|.+++.... ..++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 999999997532 246778899999999999999999999999999999999999999999998854221100
Q ss_pred CCCCCcccccccCccCcccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccC--CC---
Q psy11194 181 DNSLSETFCGSYAYASPEILQG------IPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVT--FP--- 248 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~--~~--- 248 (316)
........++..|+|||++.. ....+.++|||||||++|+|++ |..||......+.......... .+
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 156 -YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred -eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 011122335667999998743 1233445999999999999998 8899988776665554433221 11
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCHHHHhhC
Q psy11194 249 KQPEVSTECKELISNILSPVQTRPRLKTIAED 280 (316)
Q Consensus 249 ~~~~~~~~~~~li~~~l~~p~~Rps~~~il~~ 280 (316)
....++..+.+++..|+.+|.+|||++++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 235 LDLKYSDRWYEVMQFCWLDPETRPTAEEVHEL 266 (269)
T ss_pred ccccCCHHHHHHHHHHhcCcccccCHHHHHHH
Confidence 22357899999999999899999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=322.18 Aligned_cols=266 Identities=29% Similarity=0.458 Sum_probs=229.9
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
..+|.-..+||.|.||.||.|.+..+|...|+|.+...... ......+.+|..++..++|||+|+++++=.+.+..++.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 45688889999999999999999999999999998655444 33455677999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||||+||+|.++++.++-.++.....+..|++.|++|||+.||||+||||.||+++.+|-+|++|||.|....+... .
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~--~ 1390 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ--T 1390 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh--c
Confidence 99999999999999988788888999999999999999999999999999999999999999999999987543311 1
Q ss_pred CCCCCcccccccCccCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcccCCCCCCCCCHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGI---PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN-ELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 256 (316)
-+.......||+.|||||++.+- .+... .|||||||++.||+||+.||...+.+ ++.-.+..+..++.+..+|.+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A-~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGA-ADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcc-hhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 22334456799999999999653 34444 89999999999999999999886655 666777778788888889999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
-++||..|| .||+.|.++.|+++|.|=+....+-
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence 999999999 7999999999999999987766543
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=273.83 Aligned_cols=246 Identities=20% Similarity=0.337 Sum_probs=190.6
Q ss_pred eeeeecCCeEEEEEEEcc--CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCC
Q psy11194 28 KIIGTGSYATVKLARSTR--HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAE 105 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 105 (316)
+.||+|+||.||+|.... ++..+++|.++...... ....+.+|+.+++.++||||+++++++......++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ--EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 358999999999998653 44578999876554322 23456789999999999999999999999899999999999
Q ss_pred CCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 106 NGSLFDIIRGQ-----GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 106 ~~sL~~~l~~~-----~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
+++|.+++... ..++...+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~---- 154 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED---- 154 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc----
Confidence 99999999642 235677888999999999999999999999999999999999999999999885421110
Q ss_pred CCCCCcccccccCccCcccccCCC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcc--cCCCC--
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIP------YAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNK--VTFPK-- 249 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~--~~~~~-- 249 (316)
.........++..|+|||++.+.. ..+.++|+||||+++|+|++ |..||......+........ ...+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 011122334677899999986432 12345999999999999996 99999877666554333221 11121
Q ss_pred -CCCCCHHHHHHHHHhcCCCCCCCCHHHHhh
Q psy11194 250 -QPEVSTECKELISNILSPVQTRPRLKTIAE 279 (316)
Q Consensus 250 -~~~~~~~~~~li~~~l~~p~~Rps~~~il~ 279 (316)
....+..+.++|..|+.+|.+|||+++|++
T Consensus 235 ~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 235 LKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 124678999999999978999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=283.29 Aligned_cols=249 Identities=29% Similarity=0.449 Sum_probs=192.2
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC-eEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-RVYI 99 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~l 99 (316)
.++|.-...||+|+||+||+|..... +.||||.+....... ...+.+|+.++..++|||+++++|+|.+.+ ..++
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 46788889999999999999987754 899999776655432 223789999999999999999999999988 5999
Q ss_pred EEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC---ccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 100 IMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERG---VVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~---~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
|+||++.|||.+.+.... ++++....+|+.++|+||+|||... ++|+|||++|||+|++.+.||+|||++.....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 999999999999997644 8999999999999999999999854 99999999999999999999999999944210
Q ss_pred ccCcCCCCCCCccc-ccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH----HHhcc--
Q psy11194 175 CRSNAADNSLSETF-CGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS---VNELLK----QVQNK-- 244 (316)
Q Consensus 175 ~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~----~~~~~-- 244 (316)
........ .|+.+|.|||+......+.+ +||||||+++.||++|+.+..... .....+ .+..+
T Consensus 230 ------~~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~ 302 (361)
T KOG1187|consen 230 ------GDTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL 302 (361)
T ss_pred ------cccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence 01111111 68999999999988666666 999999999999999998776432 111111 11111
Q ss_pred ---cCCCCC-CCCC--H---HHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 245 ---VTFPKQ-PEVS--T---ECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 245 ---~~~~~~-~~~~--~---~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
...... ...+ . .+..+...|+ .+|.+||++.++++.
T Consensus 303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 111111 1223 2 2456777888 579999999997543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=276.28 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=204.2
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEcc----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTR----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-- 93 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 93 (316)
...+|++.+.||+|+||.||+|.... +++.+++|++...... ...+.+.+|+.+++.+.|+|++++++++..
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 35678899999999999999998643 4778999998765443 235567899999999999999999999877
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
....+++|||+++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 568899999999999999997644 5999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------------HHHH
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS---------------VNEL 237 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---------------~~~~ 237 (316)
...... ........++..|+|||.......... +|+||||+++|+|++|..|+.... ....
T Consensus 160 ~~~~~~---~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 160 PEDKDY---YYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccCCcc---eeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 311110 001111224556999999877666655 999999999999999999886532 2223
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 238 LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
...+......+.+..++.++.+++.+|| .+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3344445555556678899999999999 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=270.45 Aligned_cols=228 Identities=24% Similarity=0.336 Sum_probs=187.5
Q ss_pred cCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCHHHH
Q psy11194 33 GSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDI 112 (316)
Q Consensus 33 g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~ 112 (316)
|.+|.||+|.+..+++.+++|.+..... ..+|...+....|||++++++++......+++|||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8899999999999999999999866432 22444455556799999999999999999999999999999999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCccccccc
Q psy11194 113 IRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192 (316)
Q Consensus 113 l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (316)
+.+...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+...... .....++.
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---------~~~~~~~~ 146 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---------CDGEAVEN 146 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---------cccCCcCc
Confidence 987777999999999999999999999999999999999999999999999999977543211 11223456
Q ss_pred CccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCC
Q psy11194 193 AYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTR 271 (316)
Q Consensus 193 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~R 271 (316)
.|+|||.......+.+ +|+||+|+++|++++|..|+...... +........+..+++.+.++|.+|| .+|++|
T Consensus 147 ~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 220 (237)
T cd05576 147 MYCAPEVGGISEETEA-CDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220 (237)
T ss_pred cccCCcccCCCCCCch-hhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHh
Confidence 7999999877666655 99999999999999999887542211 1111222334568999999999999 699999
Q ss_pred CCH-----HHHhhCCCC
Q psy11194 272 PRL-----KTIAEDRWL 283 (316)
Q Consensus 272 ps~-----~~il~~~~~ 283 (316)
|++ +++++||||
T Consensus 221 ~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 221 LGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cCCCccchHHHHcCCCC
Confidence 996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=271.62 Aligned_cols=250 Identities=26% Similarity=0.487 Sum_probs=204.2
Q ss_pred CeEEeeeeeecCCeEEEEEEEcc-CCceEEEEEeecCCC-------CchHHHhhHHHHHHHHhc-CCCCCcceeeeEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTR-HSGDVAIKIVSKVQA-------PPDYLKKFLPREIEVVKG-LKHPNLIRFLQAIET 93 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~-~~~~v~vK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~ 93 (316)
+|++.+.||+|++|.||+|.+.. .++.+++|.+..... ........+.+|+.++.. ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999887 678899998864321 112223334577877765 689999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
.+..+++|||+++++|.+++.. ...+++..++.++.|++.+|.+||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP 248 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (316)
+..... ........++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.......+......+
T Consensus 161 ~~~~~~-------~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd08528 161 AKQKQP-------ESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232 (269)
T ss_pred eeeccc-------ccccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence 865321 112233457788999999987666555 999999999999999999998887777766665544333
Q ss_pred CC-CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 249 KQ-PEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 249 ~~-~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.. ..+++++.++|.+|| .+|++||++.++.++
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 33 367899999999999 599999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=269.66 Aligned_cols=263 Identities=22% Similarity=0.363 Sum_probs=206.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCc----eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe-CC
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSG----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-TH 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 95 (316)
-..|++...||+|.+|.||+|...+++. .+|+|.+.-...... ......+|+.+++.++|||++.+..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3569999999999999999996544322 689998866544332 23445599999999999999999999977 88
Q ss_pred eEEEEEecCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC----CCeEEeec
Q psy11194 96 RVYIIMEYAENGSLFDIIRG-----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD----YNIKLSDF 166 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~----~~~~l~Df 166 (316)
.+++++||.+. +|+..++- ...++...++.|+.||+.|+.|||++=++||||||.||++..+ |.|||+|+
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999977 99999953 3459999999999999999999999999999999999999877 89999999
Q ss_pred ccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------HHH
Q psy11194 167 GFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV---------NEL 237 (316)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---------~~~ 237 (316)
|+++.+.+.- ..-......+.|.+|+|||.+.+..+++++.|||+.|||+.||++-.+.|.+... .+.
T Consensus 181 GlaR~~~~pl---kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 181 GLARLFNNPL---KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred cHHHHhhccc---cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999874221 1111234456789999999999999999999999999999999998888754221 122
Q ss_pred HHHHhcccCCCC------------C------------------------CCCCHHHHHHHHHhcC-CCCCCCCHHHHhhC
Q psy11194 238 LKQVQNKVTFPK------------Q------------------------PEVSTECKELISNILS-PVQTRPRLKTIAED 280 (316)
Q Consensus 238 ~~~~~~~~~~~~------------~------------------------~~~~~~~~~li~~~l~-~p~~Rps~~~il~~ 280 (316)
.+.+.+....|. . ..-++...+|+..||. ||-+|.|++++++|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 222222111111 0 1234457789999995 99999999999999
Q ss_pred CCCCCCCC
Q psy11194 281 RWLKPKPK 288 (316)
Q Consensus 281 ~~~~~~~~ 288 (316)
+||...+-
T Consensus 338 ~yF~~d~l 345 (438)
T KOG0666|consen 338 PYFTEDPL 345 (438)
T ss_pred cccccCCC
Confidence 99987644
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=278.39 Aligned_cols=253 Identities=23% Similarity=0.418 Sum_probs=195.4
Q ss_pred CCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCHHHHH
Q psy11194 34 SYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDII 113 (316)
Q Consensus 34 ~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l 113 (316)
+++.||.++...+++.+|+|++........ ..+.+.+|+.+++.++|+||+++++++......+++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKE-DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchh-HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 456667777777899999999976533332 3456889999999999999999999999999999999999999999999
Q ss_pred Hh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC-CCCCCCccccc
Q psy11194 114 RG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA-ADNSLSETFCG 190 (316)
Q Consensus 114 ~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~-~~~~~~~~~~~ 190 (316)
.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++++||+.+.......... ..........+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 75 3458999999999999999999999999999999999999999999999999886543211110 00111122345
Q ss_pred ccCccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhcccC---------------------
Q psy11194 191 SYAYASPEILQGI--PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL-KQVQNKVT--------------------- 246 (316)
Q Consensus 191 ~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-~~~~~~~~--------------------- 246 (316)
+..|+|||.+... .++.+ +|+||||+++|+|++|..||......... +.+.....
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~-~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEK-SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred cccccCHHHhcCCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 6789999998653 34444 99999999999999999999876543322 22211100
Q ss_pred -----------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 247 -----------FPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 247 -----------~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
......++.++.++|..|| .+|++|||++++++||||+...+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~ 303 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR 303 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence 0001123568889999999 59999999999999999987763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=271.60 Aligned_cols=238 Identities=18% Similarity=0.283 Sum_probs=187.8
Q ss_pred eeeeecCCeEEEEEEEccC------------CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 28 KIIGTGSYATVKLARSTRH------------SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~------------~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
+.||+|++|.||+|..... ...+++|+..... ......+..|+.++..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4689999999999985422 2257888765432 222445668899999999999999999999989
Q ss_pred eEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC-------eEEeecc
Q psy11194 96 RVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN-------IKLSDFG 167 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~-------~~l~Df~ 167 (316)
..+++|||+++++|..++.. ...+++..+..++.||+.||+|||+.+++|+||+|+||+++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999998875 456999999999999999999999999999999999999976654 8999999
Q ss_pred cccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcccC
Q psy11194 168 FARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVT 246 (316)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 246 (316)
.+.... ......++..|+|||++......+.++||||||+++|+|+ +|..||......+.........
T Consensus 158 ~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~- 226 (262)
T cd05077 158 IPITVL----------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC- 226 (262)
T ss_pred CCcccc----------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCc-
Confidence 875421 1112346678999999874444444599999999999998 5899988766555443333222
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 247 FPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 247 ~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
......+.++.++|.+|| .+|.+||++.+|+++
T Consensus 227 -~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 227 -MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 222345789999999999 599999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=272.50 Aligned_cols=237 Identities=22% Similarity=0.302 Sum_probs=187.2
Q ss_pred eeeecCCeEEEEEEEccC------------------------CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCc
Q psy11194 29 IIGTGSYATVKLARSTRH------------------------SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84 (316)
Q Consensus 29 ~ig~g~~g~vy~~~~~~~------------------------~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 84 (316)
.||+|+||.||+|....+ ...+++|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 599999999999975322 1247788774422 1223446688899999999999
Q ss_pred ceeeeEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC----
Q psy11194 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY---- 159 (316)
Q Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~---- 159 (316)
+++++++......++||||+++++|..++.+ .+.+++..+..++.|++.||+|||+.|++|+||+|+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 45689999999999999999999999999999999999997543
Q ss_pred ---CeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCHH
Q psy11194 160 ---NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVN 235 (316)
Q Consensus 160 ---~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~p~~~~~~~ 235 (316)
.++++|||.+..... .....++..|+|||.+.+....+.++||||||+++|+++ +|..||......
T Consensus 159 ~~~~~kl~d~g~~~~~~~----------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS----------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred ccceeeecCCcccccccc----------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 379999998743211 011235677999998876444444599999999999985 699999877666
Q ss_pred HHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 236 ELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+...........+ ...++.+.++|.+|| .+|.+|||+++++++
T Consensus 229 ~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 229 EKERFYEKKHRLP--EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHHhccCCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 5544444433333 335678999999999 599999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.53 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=224.2
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.|+++..+...-.+||.|-||.||.|.+++..-.||||.++..... .+.|..|+.+++.++|||+|+++++|..+.
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 3677777778888999999999999999999999999998765543 344559999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
.+||++|||..|+|.+++++.. .++.-....++.||..|++||..+++||+||..+|+|+.++..||+.|||+++.+.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999999998743 47777889999999999999999999999999999999999999999999998764
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
...... .....-+.-|.|||.+....++.+ +|||+||++|||+.| |-.||++.+..+++..+.+++++..+.+
T Consensus 417 gDTYTA-----HAGAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeG 490 (1157)
T KOG4278|consen 417 GDTYTA-----HAGAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEG 490 (1157)
T ss_pred CCceec-----ccCccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCC
Confidence 332211 112234567999999988888887 999999999999998 9999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcC-CCCCCCCHHHHh
Q psy11194 253 VSTECKELISNILS-PVQTRPRLKTIA 278 (316)
Q Consensus 253 ~~~~~~~li~~~l~-~p~~Rps~~~il 278 (316)
|++.+.+||++||+ .|.+||++.++-
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 99999999999997 999999999985
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=274.17 Aligned_cols=238 Identities=20% Similarity=0.313 Sum_probs=190.2
Q ss_pred eeeeecCCeEEEEEEEccCCc-------eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 28 KIIGTGSYATVKLARSTRHSG-------DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~-------~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
+.||.|+||.||+|.+...+. .+++|...... ....+.+..|+.+++.++|||++++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999998765443 37778764322 22345567899999999999999999999998999999
Q ss_pred EecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC--------eEEeecccccc
Q psy11194 101 MEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN--------IKLSDFGFARA 171 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~--------~~l~Df~~~~~ 171 (316)
|||+++++|..++...+ .+++..+..++.||+.||+|||+.|++|+||+|+||+++.++. ++++|||.+..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997644 5899999999999999999999999999999999999987655 68999998754
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcccCCCCC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFG-RLPFDDSSVNELLKQVQNKVTFPKQ 250 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
... .....++..|+|||++.+....+.++||||||+++|++++| ..||...+............. .+
T Consensus 158 ~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~ 225 (258)
T cd05078 158 VLP----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQ--LP 225 (258)
T ss_pred cCC----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcccc--CC
Confidence 211 11234677899999997754444459999999999999998 577776666555444443332 33
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
...+.++.++|.+|| .+|++|||++++++.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 456789999999999 599999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=290.30 Aligned_cols=272 Identities=24% Similarity=0.421 Sum_probs=229.7
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.......-|..++.||-|+||.|.+++..++...||+|.+++............+.|..+|.....+.||+++..|.+.+
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 44556666999999999999999999998888899999998765544444566888999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc-
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR- 174 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~- 174 (316)
.+|+||+|++||.+-.++-+.+-+.+..++.++..+..|+++.|+.|+||+||||+|||||.+|.+||+|||+++-+-.
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999999999998888899999999999999999999999999999999999999999999999999853310
Q ss_pred -------ccCcC----------------------------CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHH
Q psy11194 175 -------CRSNA----------------------------ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVL 219 (316)
Q Consensus 175 -------~~~~~----------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll 219 (316)
.+... ......-..+||+.|+|||++....++.. +|+||.|+||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil 861 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVIL 861 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHH
Confidence 00000 00112233478999999999998888776 9999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHH---HhcccCCCCCCCCCHHHHHHHHHhcCCCCCCC---CHHHHhhCCCCCCCCC
Q psy11194 220 FAMVFGRLPFDDSSVNELLKQ---VQNKVTFPKQPEVSTECKELISNILSPVQTRP---RLKTIAEDRWLKPKPK 288 (316)
Q Consensus 220 ~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~p~~Rp---s~~~il~~~~~~~~~~ 288 (316)
|+|+.|+.||-...+.+.... +.....++....++.++.+||.++++.++.|. .++++..||||++.+=
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccch
Confidence 999999999987666555433 45677888889999999999999998777766 5788999999988764
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=270.60 Aligned_cols=251 Identities=18% Similarity=0.376 Sum_probs=202.1
Q ss_pred eEEeeeeeecCCeEEEEEEEcc---CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC-----
Q psy11194 24 YTVGKIIGTGSYATVKLARSTR---HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 95 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 95 (316)
|.+.+.||+|++|.||+|.+.. ++..+++|++......... .+.+.+|+.+++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHH-HHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 5678899999999999998653 5678999998654433332 455678999999999999999999886432
Q ss_pred -eEEEEEecCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 96 -RVYIIMEYAENGSLFDIIRGQ------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 96 -~~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
..+++++|+.+++|..++... ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347889999999998887421 2478899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCC
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTF 247 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 247 (316)
++...... .........++..|++||.+.....+.+ +||||||+++|+|++ |..||......+....+......
T Consensus 160 ~~~~~~~~----~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (273)
T cd05074 160 SKKIYSGD----YYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL 234 (273)
T ss_pred cccccCCc----ceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 86532110 0001112234567999999887766665 999999999999999 89999888887777777666555
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 248 PKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 248 ~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
......+..+.+++.+|| .+|.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 555678899999999999 589999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=304.40 Aligned_cols=267 Identities=27% Similarity=0.475 Sum_probs=205.3
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-------
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------- 94 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------- 94 (316)
.+|+.++.||+||||.||+|+.+=+|+.||||.+.... .... ...+.+|+..+.+|+|||||+++..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~-~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKL-YSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHH-HHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 46788999999999999999999999999999997655 2333 33456999999999999999987543110
Q ss_pred --------------------------------------------------------------------------------
Q psy11194 95 -------------------------------------------------------------------------------- 94 (316)
Q Consensus 95 -------------------------------------------------------------------------------- 94 (316)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeEEEEEecCCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHc
Q psy11194 95 --------------------------------HRVYIIMEYAENGSLFDIIRGQGYI-DEIRARRWFGQLLEALQYCHER 141 (316)
Q Consensus 95 --------------------------------~~~~lv~e~~~~~sL~~~l~~~~~l-~~~~~~~i~~~i~~~l~~Lh~~ 141 (316)
...|+-||||+..+|.+++.++... .....++++.+|+.||+|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0157889999986777777665543 4778999999999999999999
Q ss_pred CccccCCCCCCeeeCCCCCeEEeecccccccc------c-----c-cCcCCCCCCCcccccccCccCcccccCCC--CCC
Q psy11194 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHM------R-----C-RSNAADNSLSETFCGSYAYASPEILQGIP--YAP 207 (316)
Q Consensus 142 ~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~------~-----~-~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~ 207 (316)
|+|||||||.|||+++++.|||+|||+++... . . ..............||..|+|||++.+.. .++
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999998722 0 0 11112222445567999999999997765 444
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcccCCCCCC----CCCHHHHHHHHHhc-CCCCCCCCHHHHhhCC
Q psy11194 208 HLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNKVTFPKQP----EVSTECKELISNIL-SPVQTRPRLKTIAEDR 281 (316)
Q Consensus 208 ~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l-~~p~~Rps~~~il~~~ 281 (316)
.++|+||||++++||+. ||.. +..-.++..++++ ..|.+. .--+.-..+|++|| .||++|||+.|+|.+.
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g-~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKG-SIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccC-CCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 55999999999999995 4643 4444555666643 334332 23356778999999 5999999999999999
Q ss_pred CCCCCCCCCChhhHH
Q psy11194 282 WLKPKPKSRGVDKAE 296 (316)
Q Consensus 282 ~~~~~~~~~~~~~~~ 296 (316)
||.+ ++.++....
T Consensus 873 llpp--e~~el~~~~ 885 (1351)
T KOG1035|consen 873 LLPP--EESELLVFL 885 (1351)
T ss_pred CCCc--cchHHHHHH
Confidence 9998 555554433
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=281.63 Aligned_cols=269 Identities=28% Similarity=0.449 Sum_probs=222.8
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHH----HhhHHHHHHHHhcCCCCCcceeeeEEE-e
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYL----KKFLPREIEVVKGLKHPNLIRFLQAIE-T 93 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~-~ 93 (316)
+.+++|-++.+||+|||+.||+|.|....+.||+|+-.....|.+.- .....+|..+-+.|.||.||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 35788999999999999999999999999999999988776665433 234668999999999999999999995 5
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--CccccCCCCCCeeeCC---CCCeEEeeccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER--GVVHRDIKCENLLLDS---DYNIKLSDFGF 168 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--~~~H~dl~p~nil~~~---~~~~~l~Df~~ 168 (316)
.+.+|-|.|||+|..|+-+++....+++.+++.|+.||+.||.||... .|+|.||+|.|||+.. -|.+||+|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 667899999999999999999999999999999999999999999976 4999999999999954 37899999999
Q ss_pred ccccccccCc-CCCCCCCcccccccCccCcccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH--H
Q psy11194 169 ARAHMRCRSN-AADNSLSETFCGSYAYASPEILQG---IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE-LLKQ--V 241 (316)
Q Consensus 169 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~--~ 241 (316)
+.++...... ..+-.+..-..||.+|.+||++.- .+..+.+.||||.|+|+|.++.|+.||......+ +++. +
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 9987654433 222333344568999999999842 3334445999999999999999999998754333 2221 1
Q ss_pred --hcccCCCCCCCCCHHHHHHHHHhcC-CCCCCCCHHHHhhCCCCCCCC
Q psy11194 242 --QNKVTFPKQPEVSTECKELISNILS-PVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 242 --~~~~~~~~~~~~~~~~~~li~~~l~-~p~~Rps~~~il~~~~~~~~~ 287 (316)
.....+|..+.++.+..+||++||. --++|....++..||||.+.-
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 2345778888999999999999995 688899999999999998843
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=277.53 Aligned_cols=259 Identities=22% Similarity=0.363 Sum_probs=207.2
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC--CC----Ccceee
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK--HP----NLIRFL 88 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~----~i~~~~ 88 (316)
.......++|.++..+|+|.||.|..+.+..++..||||+++....- .+...-|+.++.+++ .| -++.+.
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY----reAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY----REAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH----hhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 44555688999999999999999999999999999999999775432 334457899999984 22 367788
Q ss_pred eEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC---------
Q psy11194 89 QAIETTHRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS--------- 157 (316)
Q Consensus 89 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~--------- 157 (316)
++|...++.++|+|.+ |-|+.+++++++ +++...++.++.|++.++++||+.+++|.||||+||++..
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence 8899999999999999 779999998755 5899999999999999999999999999999999999942
Q ss_pred -----------CCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCC
Q psy11194 158 -----------DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGR 226 (316)
Q Consensus 158 -----------~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~ 226 (316)
+-.++++|||.|+... ........|..|+|||++.+..|+.. +||||+||||.||++|.
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~---------e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDH---------EHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGE 306 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceec---------cCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccc
Confidence 2348999999886421 12244567899999999999999998 99999999999999999
Q ss_pred CCCCCCCHHHHHHHHhccc-CCC---------------------C---------------C--------CCCCHHHHHHH
Q psy11194 227 LPFDDSSVNELLKQVQNKV-TFP---------------------K---------------Q--------PEVSTECKELI 261 (316)
Q Consensus 227 ~p~~~~~~~~~~~~~~~~~-~~~---------------------~---------------~--------~~~~~~~~~li 261 (316)
..|...+..+-...+.... ++| + + ...-.++.+||
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 9998655444222221100 111 0 0 01123678999
Q ss_pred HHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 262 SNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 262 ~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+.|| -||.+|+|+.|+|.||||+....
T Consensus 387 ~~mL~fDP~~RiTl~EAL~HpFF~~~~~ 414 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALSHPFFARLTP 414 (415)
T ss_pred HHHHccCccccccHHHHhcCHHhhcCCC
Confidence 9999 59999999999999999987654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=267.87 Aligned_cols=235 Identities=20% Similarity=0.281 Sum_probs=188.3
Q ss_pred eeeeecCCeEEEEEEEccCC----------ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 28 KIIGTGSYATVKLARSTRHS----------GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~----------~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
+.||+|+||.||+|.+..++ ..+++|........ ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998766 24677766443221 3456689999999999999999999988 778
Q ss_pred EEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC-------CeEEeecccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY-------NIKLSDFGFA 169 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~-------~~~l~Df~~~ 169 (316)
++||||+++++|.+++.... .++...+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998755 699999999999999999999999999999999999998877 7999999988
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCC-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCC
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGI-PYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTF 247 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 247 (316)
..... .....+...|+|||++... ...+.++|+||||+++|+|++ |..||..................
T Consensus 156 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 225 (259)
T cd05037 156 ITVLS----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL 225 (259)
T ss_pred ccccc----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCC
Confidence 65321 1123355679999998775 233444999999999999999 68888776554444443332222
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 248 PKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 248 ~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+. .....+.++|.+|| .+|.+|||+.++++
T Consensus 226 ~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 226 PM--PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CC--CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22 23489999999999 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=269.50 Aligned_cols=260 Identities=16% Similarity=0.247 Sum_probs=193.1
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccC---CceEEEEEeecCCCCchHHH--------hhHHHHHHHHhcCCCCCc
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRH---SGDVAIKIVSKVQAPPDYLK--------KFLPREIEVVKGLKHPNL 84 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~--------~~~~~e~~~l~~l~~~~i 84 (316)
+.++.+++|.+.+.||+|+||.||+|.+..+ +..+++|+............ .....+...+..+.|+++
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 4556778999999999999999999998776 66777776543322110000 011133345566789999
Q ss_pred ceeeeEEEeCC----eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC
Q psy11194 85 IRFLQAIETTH----RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN 160 (316)
Q Consensus 85 ~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~ 160 (316)
+++++++.... ..+++++++. .++.+.+......++..+..++.|++.||.|||+.+++||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 99998775543 4578888884 478888776655788899999999999999999999999999999999999999
Q ss_pred eEEeecccccccccccCcCC-CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHH-
Q psy11194 161 IKLSDFGFARAHMRCRSNAA-DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV-NEL- 237 (316)
Q Consensus 161 ~~l~Df~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~- 237 (316)
++|+|||+++.+........ .........|++.|+|||+..+..++.+ +|||||||++|+|++|..||..... ...
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999976532111111 0111223458999999999988777665 9999999999999999999987632 221
Q ss_pred -------HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 238 -------LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 238 -------~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
...+.... ...+..+.++.+++..|+ .+|++||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22222221 123457899999999999 59999999999975
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=265.88 Aligned_cols=247 Identities=18% Similarity=0.294 Sum_probs=189.2
Q ss_pred eeeeecCCeEEEEEEEccCC--ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCC
Q psy11194 28 KIIGTGSYATVKLARSTRHS--GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAE 105 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~--~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 105 (316)
+.||+|+||.||++.....+ ..+++|.+..... ....+.+.+|+.+++.++||||+++++.+......++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 35999999999999755432 2456666544332 2224567789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 106 NGSLFDIIRGQ----GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 106 ~~sL~~~l~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
+++|.+++.+. ...+...++.++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~----~~~ 154 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK----EDY 154 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCc----chh
Confidence 99999999753 2366778899999999999999999999999999999999999999999998743110 000
Q ss_pred CCCCcccccccCccCcccccCCC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccc-----CCCC
Q psy11194 182 NSLSETFCGSYAYASPEILQGIP------YAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKV-----TFPK 249 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-----~~~~ 249 (316)
........++..|+|||++.... ..+.++||||||+++|+|++ |..||......+....+.... ....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 11122345678899999875321 12344999999999999997 678998777666655543321 1222
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCHHHHhhC
Q psy11194 250 QPEVSTECKELISNILSPVQTRPRLKTIAED 280 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l~~p~~Rps~~~il~~ 280 (316)
...+++.+.+++..|+.+|.+||+++++++.
T Consensus 235 ~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~~ 265 (268)
T cd05086 235 ELPYSERWYEVLQFCWLSPEKRATAEEVHRL 265 (268)
T ss_pred CCCCcHHHHHHHHHHhhCcccCCCHHHHHHH
Confidence 3457889999999999779999999999763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=293.60 Aligned_cols=258 Identities=25% Similarity=0.427 Sum_probs=224.8
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCc---eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
..++......|.+.||.|.||.|++|+.+..|+ .||||.++.-. .+.....|..|+.++-++.||||+++-|+..
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 456777888999999999999999999887665 69999985433 2333455669999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
..+...+++|||+.|+|+.+++. .+.++..++..++..|+.|++||.+.|+|||||..+|||++.+-.+|++|||+++.
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 99999999999999999999976 45699999999999999999999999999999999999999999999999999987
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQ 250 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
..+.. ........+ .-+.+|.|||.+...++++. +||||+|++|||.++ |..||-++...++++.+.++.+.|.+
T Consensus 781 ledd~-~~~ytt~GG--KIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP 856 (996)
T KOG0196|consen 781 LEDDP-EAAYTTLGG--KIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP 856 (996)
T ss_pred cccCC-CccccccCC--ccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC
Confidence 54322 111111111 13578999999999999988 999999999999876 99999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..+|..+.+||.+|| +|=.+||.+.+|+.
T Consensus 857 mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 857 MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 999999999999999 68999999998874
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=271.34 Aligned_cols=260 Identities=28% Similarity=0.485 Sum_probs=223.3
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 96 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 96 (316)
.+-..+|..+..||.|+||.|.+|..+.+.+.+|||++++.-.-.+...+--..|-++|... +-|.+++++.+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45677899999999999999999999989999999999764332222222223566667666 47889999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.|+||||++||.|--.++.-+.+.+..+.-++..|+.||-+||++||++|||+.+||+++.+|.+||.|||++..
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE----- 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE----- 499 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc-----
Confidence 999999999999999999988899999999999999999999999999999999999999999999999999754
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
+..........+||+.|+|||++...++... .|+||+|++||||+.|+.||.+.+.+++...+.+. ....+..+|.+
T Consensus 500 -ni~~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-nvsyPKslSkE 576 (683)
T KOG0696|consen 500 -NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-NVSYPKSLSKE 576 (683)
T ss_pred -cccCCcceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-cCcCcccccHH
Confidence 3333444556789999999999999888776 99999999999999999999999999998888764 34455679999
Q ss_pred HHHHHHHhc-CCCCCCCCH-----HHHhhCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRL-----KTIAEDRWLKP 285 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~-----~~il~~~~~~~ 285 (316)
...++..+| +.|.+|... ++|-+||||..
T Consensus 577 Av~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 577 AVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 999999999 789999854 78999999954
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=284.62 Aligned_cols=261 Identities=27% Similarity=0.423 Sum_probs=225.7
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCc---eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
...+-.++..+.++||+|.||.|++|.+...+. .||||.++...... ....|.+|+.++.+|+|+|++++||+..
T Consensus 104 kclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 104 KCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred ceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 445566778889999999999999999885433 58999987766554 3556779999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
+ ....+|||.+++|||.+.+.. ...|.......++.||+.|+.||.++++||+||-.+|+++-....|||+|||+.+
T Consensus 182 ~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 182 D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence 8 677899999999999999976 4458888999999999999999999999999999999999989999999999987
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCC
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPK 249 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (316)
.+.. +...-.+.....-...|+|||.+....++.. +|||++|+++|||++ |..||.+-...++++.+.++...+.
T Consensus 261 aLg~---ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR 336 (1039)
T KOG0199|consen 261 ALGE---NEDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR 336 (1039)
T ss_pred ccCC---CCcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC
Confidence 6432 1222233344445778999999999999887 999999999999998 9999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
++.+|+.+.+++..|| ..|.+||++..|.+.-++
T Consensus 337 Pk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred CCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 9999999999999999 589999999999765554
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=280.89 Aligned_cols=247 Identities=31% Similarity=0.522 Sum_probs=204.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 99 (316)
.+.|.+...+|.|+|+.|-.+.+..++...++|++...... ..+|..++... +|||++++.+.+.+....++
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 56788889999999999999999999999999999776322 23667566665 69999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee-CCCCCeEEeecccccccccccCc
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL-DSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~-~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
|||.+.|+-|.+.+....... .++..|+.+|+.|+.+||.+|++||||+|+|||+ +..|+++|+|||++......
T Consensus 394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 999999988877777655444 7788899999999999999999999999999999 58899999999998653221
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcccCCCCCCCCCHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN-ELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
....+-|..|.|||+.....++.. +||||||++||+|++|+.||...... ++...+..+ +....+|++.
T Consensus 470 ------~~tp~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~---~~s~~vS~~A 539 (612)
T KOG0603|consen 470 ------CDTPALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP---KFSECVSDEA 539 (612)
T ss_pred ------hcccchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC---ccccccCHHH
Confidence 223346788999999997667666 99999999999999999999865444 444444322 2336799999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
++||.+|| -+|.+||++.++..||||-..+.
T Consensus 540 KdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t 571 (612)
T KOG0603|consen 540 KDLLQQLLQVDPALRLGADEIGAHPWFLSHPT 571 (612)
T ss_pred HHHHHHhccCChhhCcChhhhccCcchhcCCC
Confidence 99999999 59999999999999999944443
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=262.49 Aligned_cols=266 Identities=24% Similarity=0.322 Sum_probs=214.0
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEe
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET 93 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 93 (316)
...++...+.+-+..||.|.||+|++..++.+|+..|||.++......+ ..++..|.....+. ++||||+++|....
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke--q~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE--QKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH--HHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 3567788888889999999999999999999999999999988776333 44455777655555 79999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeecc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG-----QGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFG 167 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~ 167 (316)
++..|+.||.++ .||+.+.+. +..+++..+-.|....+.||.||-. ..++|||+||+|||++..|.+||||||
T Consensus 135 EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 135 EGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred CCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeeccc
Confidence 999999999995 499888753 4569999999999999999999985 589999999999999999999999999
Q ss_pred cccccccccCcCCCCCCCcccccccCccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcc
Q psy11194 168 FARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI--PYAPHLSDIWSMGVVLFAMVFGRLPFDDS-SVNELLKQVQNK 244 (316)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~ 244 (316)
++-.+. .+.......|-..|+|||-+... .+.-+ +||||||++|||+.||+.||..- +.-+...++..+
T Consensus 214 IcGqLv-------~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g 285 (361)
T KOG1006|consen 214 ICGQLV-------DSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG 285 (361)
T ss_pred chHhHH-------HHHHhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence 985432 33334455677889999998543 34555 99999999999999999999763 333444444443
Q ss_pred cCCCC-----CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 245 VTFPK-----QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 245 ~~~~~-----~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
-.+.. ....+..+..+|.-|| ++-+.||...+++++||+.--..+.+
T Consensus 286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~ 338 (361)
T KOG1006|consen 286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGP 338 (361)
T ss_pred CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCC
Confidence 22211 1348899999999999 89999999999999999976655444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=257.33 Aligned_cols=240 Identities=37% Similarity=0.667 Sum_probs=204.8
Q ss_pred CCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCHHHHH
Q psy11194 34 SYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDII 113 (316)
Q Consensus 34 ~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l 113 (316)
++|.||+|.+..+++.+++|+......... .+.+.+|+..++.++|++++++++.+......++++|++++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998899999999876554332 456779999999999999999999999999999999999999999999
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccC
Q psy11194 114 RGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193 (316)
Q Consensus 114 ~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (316)
.....++...+..++.+++.++.+||+.+++|+||+|.||+++.++.++++|||.+...... .......++..
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-------~~~~~~~~~~~ 151 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG-------GLLTTFVGTPE 151 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc-------cccccccCCcC
Confidence 87666899999999999999999999999999999999999999999999999998654221 12233446778
Q ss_pred ccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcccCCCCCCC--CCHHHHHHHHHhc-CCCC
Q psy11194 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNKVTFPKQPE--VSTECKELISNIL-SPVQ 269 (316)
Q Consensus 194 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l-~~p~ 269 (316)
|++||.......+.+ +|+|+||++++++++|..||.. .+.....+.+........... ++.++.+++.+|| .+|+
T Consensus 152 ~~~pE~~~~~~~~~~-~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 230 (244)
T smart00220 152 YMAPEVLLGKGYGKA-VDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPE 230 (244)
T ss_pred CCCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCch
Confidence 999999987667664 9999999999999999999987 666666666655444333322 8899999999999 5999
Q ss_pred CCCCHHHHhhCCCC
Q psy11194 270 TRPRLKTIAEDRWL 283 (316)
Q Consensus 270 ~Rps~~~il~~~~~ 283 (316)
+||++.++++||||
T Consensus 231 ~Rp~~~~~~~~~~~ 244 (244)
T smart00220 231 KRLTAEEALQHPFF 244 (244)
T ss_pred hccCHHHHhhCCCC
Confidence 99999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=283.24 Aligned_cols=269 Identities=24% Similarity=0.404 Sum_probs=225.4
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEE-----
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIE----- 92 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~----- 92 (316)
.-...|++.+.||.|.+|.||+++...+++..|+|+.......+ +.++.|+.+++.+ .|||++.++++|.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 34567999999999999999999999999999999987766553 3466788899888 5999999999985
Q ss_pred eCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
.++..|+|||||.|||..+++++ +..+.+..+..|+..++.|+.+||++.++|+|++=.|||++.+|.|||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 35579999999999999999976 5569999999999999999999999999999999999999999999999999886
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGI-----PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV 245 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (316)
... ..-.......|++.|+|||++.-. .++.. +|+||||++..||.-|.+|+.++.+...+-.+....
T Consensus 172 Qld------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP 244 (953)
T KOG0587|consen 172 QLD------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 244 (953)
T ss_pred eee------cccccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhhhhccCCCCC
Confidence 542 233444556799999999998532 34444 899999999999999999999998887776665543
Q ss_pred CCCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHhHHHHH
Q psy11194 246 TFPK--QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDM 305 (316)
Q Consensus 246 ~~~~--~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (316)
++.. +...+.++.++|..|| ++-++||+..++++|||+...+ +++++...|+-
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~-------~e~qir~~ik~ 300 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP-------NERQVRIQIKD 300 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc-------cHHHHHHHHHH
Confidence 3222 3457899999999999 8999999999999999999555 55566555543
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=277.91 Aligned_cols=250 Identities=23% Similarity=0.391 Sum_probs=212.6
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccC--Cc--eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRH--SG--DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~--~~--~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
.+...+.++||.|-||.||.|..... |+ .||||+.+.....+. .+.|.+|+.++++++||||++++|++.+ ..
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 33444567899999999999986533 33 588888865444333 6667799999999999999999999976 46
Q ss_pred EEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
.|+|||.++.|-|..+++.+ ..++......++.||..||+|||+..+|||||..+|||+.....|||+|||+++.....
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 89999999999999999764 45999999999999999999999999999999999999999999999999999865422
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
.. ........+.-|+|||.+.-..+++. +|||.||+-+||++. |..||.+....+++-.+..+.+.|.++.+|
T Consensus 545 ~y-----YkaS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCP 618 (974)
T KOG4257|consen 545 AY-----YKASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCP 618 (974)
T ss_pred ch-----hhccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCC
Confidence 21 11222234667999999988888877 999999999999987 999999999999999999999999999999
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhh
Q psy11194 255 TECKELISNILS-PVQTRPRLKTIAE 279 (316)
Q Consensus 255 ~~~~~li~~~l~-~p~~Rps~~~il~ 279 (316)
+.+..|+.+||. +|.+||.+.++..
T Consensus 619 p~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 619 PALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred hHHHHHHHHHhccCcccCCcHHHHHH
Confidence 999999999995 9999999988753
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=258.37 Aligned_cols=270 Identities=23% Similarity=0.351 Sum_probs=215.1
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-- 93 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 93 (316)
..-.+...|.-+.+||+|.||.||+|+...+|+.|++|.+-..+.....-...+ +|++++..++|+|++.++++|..
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpital-reikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITAL-REIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHH-HHHHHHHHhcchhHHHHHHHHhhcc
Confidence 445667789999999999999999999999999999987755333322223444 89999999999999999888742
Q ss_pred ------CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeec
Q psy11194 94 ------THRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDF 166 (316)
Q Consensus 94 ------~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df 166 (316)
...+++||++|+. .|.-++... ..++...+++++.+++.||.|+|.+.++|||+|+.|++++.+|.++|+||
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 3358999999976 899998764 56999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---
Q psy11194 167 GFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN--- 243 (316)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--- 243 (316)
|+++.+.-... ...........|.+|++||.+.+...+.++.|||+-||++.+|+++.+.+.+....+.+..+..
T Consensus 169 Glar~fs~~~n--~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 169 GLARAFSTSKN--VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccceecccc--cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 99977643222 1222244455689999999998876666669999999999999999999987766655544432
Q ss_pred ccC---CC---------------CC-------------CCCCHHHHHHHHHhcC-CCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 244 KVT---FP---------------KQ-------------PEVSTECKELISNILS-PVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 244 ~~~---~~---------------~~-------------~~~~~~~~~li~~~l~-~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
... +| .+ -.-+++..+|+..||. ||.+|+++++++.|.||...+-.
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 000 01 00 0134578899999995 99999999999999999877665
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=259.04 Aligned_cols=284 Identities=28% Similarity=0.486 Sum_probs=239.7
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT 94 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 94 (316)
-+-+.-++|.++..||+|++..|..++..++.+.+|+|++++...+++...+..+.|-.+..+. +||.+|.++.+|+.+
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 4567788999999999999999999999999999999999988777777788898999998887 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
+..++|.||.+||.|--.++++..++++.++.+...|..||.|||+.||+++|||.+|++++..|.+||+|+|+++.
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--- 400 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--- 400 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc---
Confidence 99999999999999988888888899999999999999999999999999999999999999999999999998754
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC-------CCCHHHHHHHHhcccCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD-------DSSVNELLKQVQNKVTF 247 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~-------~~~~~~~~~~~~~~~~~ 247 (316)
...........+||+.|.|||++.+..+.-. .|+|+||+++++|+.|+.||. ..+.++..-++.-..+.
T Consensus 401 ---~l~~gd~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 401 ---GLGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred ---CCCCCcccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 2333444556789999999999999888776 999999999999999999995 33445554444333345
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCC------CHHHHhhCCCCCCCCCCCChhhHHHhHhHHHHHhhccccC
Q psy11194 248 PKQPEVSTECKELISNIL-SPVQTRP------RLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMIQTSASS 312 (316)
Q Consensus 248 ~~~~~~~~~~~~li~~~l-~~p~~Rp------s~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (316)
..+..+|.....++...| +||.+|. .+.++..|+||. .++|-.-|-+...-+.++..++
T Consensus 477 riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr------~idwd~leqk~v~ppf~p~i~~ 542 (593)
T KOG0695|consen 477 RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR------SIDWDLLEQKQVLPPFQPQITD 542 (593)
T ss_pred cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh------hCCHHHHhhcccCCCCCCcccc
Confidence 555678888999999999 6999986 468999999996 3455555555555444444443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=281.36 Aligned_cols=258 Identities=20% Similarity=0.301 Sum_probs=175.8
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccC----CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeE---
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRH----SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQA--- 90 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~--- 90 (316)
.+..++|.+.+.||+|+||.||+|.+..+ +..+|+|.+........ ...+ .+....+.++..+...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~-----~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI-----WMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH-----HHHH--HHHhhchhhHHHHHHhhhc
Confidence 44678899999999999999999999988 89999998754322111 1011 1111111222221111
Q ss_pred ---EEeCCeEEEEEecCCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCccccC
Q psy11194 91 ---IETTHRVYIIMEYAENGSLFDIIRGQGY--------------------IDEIRARRWFGQLLEALQYCHERGVVHRD 147 (316)
Q Consensus 91 ---~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------l~~~~~~~i~~~i~~~l~~Lh~~~~~H~d 147 (316)
.......++|+||+++++|.+++..... .....+..++.|++.||.|||+.+++|+|
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2456678999999999999999875321 12334678999999999999999999999
Q ss_pred CCCCCeeeCC-CCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCC---------------------
Q psy11194 148 IKCENLLLDS-DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY--------------------- 205 (316)
Q Consensus 148 l~p~nil~~~-~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--------------------- 205 (316)
|||+|||++. ++.++|+|||++.... ...........+++.|+|||.+.....
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~-----~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLR-----VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccc-----cccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 9999999985 5789999999986432 111222334567889999996532211
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-c---------C----------CCCCCCCCHHHHHHHHHhc
Q psy11194 206 APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK-V---------T----------FPKQPEVSTECKELISNIL 265 (316)
Q Consensus 206 ~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~---------~----------~~~~~~~~~~~~~li~~~l 265 (316)
.+.++|||||||++|+|+++..++... .......+... . . +......+....+||.+||
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 112369999999999999977665431 12222221110 0 0 0000112345568999999
Q ss_pred -CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 266 -SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 266 -~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.||++|||++++++||||++...
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCCc
Confidence 69999999999999999987655
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=273.08 Aligned_cols=259 Identities=20% Similarity=0.353 Sum_probs=218.1
Q ss_pred cccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 14 RKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 14 ~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
.+..++-.+...+.++||+|-||.|..+.... +..||+|.++....... .+.|.+|+++|.+|+||||+.++++|..
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~--r~~F~kEIkiLsqLkhPNIveLvGVC~~ 606 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNA--RNDFLKEIKILSRLKHPNIVELLGVCVQ 606 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhH--HHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence 44667778889999999999999999997553 58999999877665443 5678899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQGY--IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
++.+++++||++.|.|..++..... +......+|+.||+.|++||.+.++|||||.++|+|+++++++||+|||+++.
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccc
Confidence 9999999999999999999987532 35566788999999999999999999999999999999999999999999975
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhcccCC--
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF--GRLPFDDSSVNELLKQVQNKVTF-- 247 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~~~~~~~~~~~~~-- 247 (316)
+- ....-...+....+.+|+|||.+....++++ +|+|+||+++||+++ ...||.....+++.+.....+.-
T Consensus 687 ly----sg~yy~vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 687 LY----SGDYYRVQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG 761 (807)
T ss_pred cc----cCCceeeecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence 32 1222233344556789999999998888887 999999999999876 77899999888888777554332
Q ss_pred -----CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 248 -----PKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 248 -----~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+.++-++.++.++|..|+ .+-++||+++++..+
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 234568999999999999 589999999998643
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=275.66 Aligned_cols=203 Identities=33% Similarity=0.515 Sum_probs=173.4
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe------
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------ 93 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 93 (316)
++.-|...+.||+|+||.||+++++.+|+.||||.++....... .+...+|+.++++++|+|||+++++=++
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~--~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP--RERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccch--HHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 44557788899999999999999999999999999987553332 4455699999999999999999887654
Q ss_pred CCeEEEEEecCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC--C--CeEEeec
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG---QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD--Y--NIKLSDF 166 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~--~--~~~l~Df 166 (316)
.+...+|||||.||+|...+++ ..+|++.+++.++.++..|+.|||++||+||||||.||++..+ | ..||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 3467999999999999999965 4469999999999999999999999999999999999999433 3 3999999
Q ss_pred ccccccccccCcCCCCCCCcccccccCccCcccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy11194 167 GFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG-IPYAPHLSDIWSMGVVLFAMVFGRLPFDDS 232 (316)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~ll~~l~~g~~p~~~~ 232 (316)
|.|+. ...+......+||..|.+||.... ..++.. +|.|||||++|++.||..||...
T Consensus 169 G~Are-------l~d~s~~~S~vGT~~YLhPel~E~q~~y~~t-VDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 169 GAARE-------LDDNSLFTSLVGTEEYLHPELYERQKKYTAT-VDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccccc-------CCCCCeeeeecCchhhcChHHHhhccCcCce-eehhhhhhHHHHHhccCCCCCcC
Confidence 99965 444556778889999999999986 445544 99999999999999999999653
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=258.02 Aligned_cols=133 Identities=26% Similarity=0.428 Sum_probs=115.4
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC--------CCCcceeee
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK--------HPNLIRFLQ 89 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~ 89 (316)
.+.+.+|.+.++||+|-|++||+|.|....+.||+|+.+...- ..+....|+++|++++ ..+||++++
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 4456899999999999999999999999999999999866332 3455558999999984 247999999
Q ss_pred EEE----eCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeee
Q psy11194 90 AIE----TTHRVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLL 155 (316)
Q Consensus 90 ~~~----~~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~ 155 (316)
.|. .+.++|||+|++ |.+|..+|.. ...++...+++|+.|++.||.|||. +||+|.||||+|||+
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 995 456899999999 7799999976 3469999999999999999999995 699999999999999
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=243.33 Aligned_cols=254 Identities=26% Similarity=0.469 Sum_probs=202.6
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEe--CC
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIET--TH 95 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~ 95 (316)
-..++|++.+++|+|.++.||.|....+++.+++|++++.. ...+++|+++|+.+. +|||++++++..+ ..
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 36778999999999999999999998999999999997654 456889999999996 9999999999865 45
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-CCeEEeeccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHMR 174 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~-~~~~l~Df~~~~~~~~ 174 (316)
.+.+++||.+......+.. .++...++.++.++++||.|+|+.||.|+|+||.|++++.. -+.+|+|+|+|..+-+
T Consensus 109 tpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred CchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 7889999998866665544 38888999999999999999999999999999999999854 5699999999976532
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-C-CHHHHHHHH-----------
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-S-SVNELLKQV----------- 241 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~-~~~~~~~~~----------- 241 (316)
. ..-.....+..|.-||.+...+..+..-|+|||||++..|+..+.||.. . +..+..+..
T Consensus 186 ~-------~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 186 G-------KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred C-------ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 1 1122334566788999997777777768999999999999999888853 2 222222111
Q ss_pred -hc-----------------------ccCCCCCCCCCHHHHHHHHHhcC-CCCCCCCHHHHhhCCCCCCCCC
Q psy11194 242 -QN-----------------------KVTFPKQPEVSTECKELISNILS-PVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 242 -~~-----------------------~~~~~~~~~~~~~~~~li~~~l~-~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+ ........-.+++..+|+..+|. |-.+|+|+.|++.||||.+..+
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 10 00000112367999999999995 8999999999999999987655
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=267.90 Aligned_cols=261 Identities=26% Similarity=0.453 Sum_probs=214.3
Q ss_pred cccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC------CCcc
Q psy11194 12 IDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH------PNLI 85 (316)
Q Consensus 12 ~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~ 85 (316)
|...+.++...+|.+....|+|=||+|.+|.+...|..||||+++.... ....=..|+.+|++|+. -|++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 3445788899999999999999999999999999999999999976432 22223389999999962 4899
Q ss_pred eeeeEEEeCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-CCe
Q psy11194 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQG---YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-YNI 161 (316)
Q Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~-~~~ 161 (316)
+++..|...+++|+|||-+.. +|.++++..+ .|....+..++.|+..||..|-.+|++|.||+|.|||+.+. ..+
T Consensus 498 rl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence 999999999999999999954 9999998743 58899999999999999999999999999999999999876 559
Q ss_pred EEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy11194 162 KLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV 241 (316)
Q Consensus 162 ~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~ 241 (316)
||||||.|.. ...+...+ +..+..|.|||++.+.++... .|+||.||.||||+||...|++...++++...
T Consensus 577 KLCDfGSA~~-------~~eneitP-YLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 577 KLCDFGSASF-------ASENEITP-YLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred eeccCccccc-------cccccccH-HHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 9999998843 33333332 335667999999999999887 99999999999999999999998888877655
Q ss_pred hcc-cCCCC----------------------------------------C-----------CCC-------CHHHHHHHH
Q psy11194 242 QNK-VTFPK----------------------------------------Q-----------PEV-------STECKELIS 262 (316)
Q Consensus 242 ~~~-~~~~~----------------------------------------~-----------~~~-------~~~~~~li~ 262 (316)
... .++|. + +.+ -..+++|+.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 431 11110 0 112 236789999
Q ss_pred Hhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 263 NIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 263 ~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
.|+ -||++|.|.+++|.||||+.+
T Consensus 728 kml~LdP~KRit~nqAL~HpFi~~k 752 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALKHPFITEK 752 (752)
T ss_pred HHhccChhhcCCHHHHhcCCcccCC
Confidence 999 599999999999999999863
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=266.63 Aligned_cols=262 Identities=21% Similarity=0.229 Sum_probs=185.0
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEc----------------cCCceEEEEEeecCCCCchH-----------HHhhHHH
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARST----------------RHSGDVAIKIVSKVQAPPDY-----------LKKFLPR 71 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~----------------~~~~~v~vK~~~~~~~~~~~-----------~~~~~~~ 71 (316)
...++|.+.++||+|+||.||+|.+. ..++.||||.+......... ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 46889999999999999999999742 34567999998653321100 0111224
Q ss_pred HHHHHhcCCCCC-----cceeeeEEEe--------CCeEEEEEecCCCCCHHHHHHhC----------------------
Q psy11194 72 EIEVVKGLKHPN-----LIRFLQAIET--------THRVYIIMEYAENGSLFDIIRGQ---------------------- 116 (316)
Q Consensus 72 e~~~l~~l~~~~-----i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~---------------------- 116 (316)
|+.++..++|.+ ++++++++.. ....++|+||+++++|.+++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 566666665543 3566666542 35689999999999999988631
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCc
Q psy11194 117 --GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194 (316)
Q Consensus 117 --~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (316)
..++...++.++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++...... .........+++.|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-----~~~~~~~g~~tp~Y 376 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-----INFNPLYGMLDPRY 376 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC-----CccCccccCCCcce
Confidence 12356678899999999999999999999999999999999999999999998543211 11111112246889
Q ss_pred cCcccccCCCC---------------------CCCchhHHHHHHHHHHHHhCCC-CCCCCCHH------------HHHHH
Q psy11194 195 ASPEILQGIPY---------------------APHLSDIWSMGVVLFAMVFGRL-PFDDSSVN------------ELLKQ 240 (316)
Q Consensus 195 ~aPE~~~~~~~---------------------~~~~~Di~slG~ll~~l~~g~~-p~~~~~~~------------~~~~~ 240 (316)
+|||.+..... .....|+||+||++|+|++|.. ||...... .....
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 99998754221 1112699999999999999875 66432111 11111
Q ss_pred HhcccCCCCCCCCCHHHHHHHHHhc-CCC---CCCCCHHHHhhCCCCCC
Q psy11194 241 VQNKVTFPKQPEVSTECKELISNIL-SPV---QTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l-~~p---~~Rps~~~il~~~~~~~ 285 (316)
......++.....++..++|+.+|| .+| .+|+|++++|+||||.+
T Consensus 457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 1123345555678999999999999 443 68999999999999975
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=274.00 Aligned_cols=260 Identities=26% Similarity=0.430 Sum_probs=220.4
Q ss_pred hcccccceeeccCeEEeeeeeecCCeEEEEEEEcc---C----CceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCC
Q psy11194 11 DIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTR---H----SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHP 82 (316)
Q Consensus 11 ~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~---~----~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~ 82 (316)
.++. .+++..++..+.+.||.|.||.|++|.... . ...||||........ ...+.+..|+.+++.+ .|+
T Consensus 286 ~~~~-~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~ 362 (609)
T KOG0200|consen 286 PEDP-KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHP 362 (609)
T ss_pred CcCC-ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCc
Confidence 3455 788888888899999999999999998442 1 346899998665554 3366788999999999 599
Q ss_pred CcceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy11194 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG----------------YIDEIRARRWFGQLLEALQYCHERGVVHR 146 (316)
Q Consensus 83 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~ 146 (316)
||+.+++++......++|+||+..|+|.++++..+ .++......++.||+.|++||++.+++||
T Consensus 363 niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHR 442 (609)
T KOG0200|consen 363 NIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHR 442 (609)
T ss_pred chhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccch
Confidence 99999999999999999999999999999997644 48999999999999999999999999999
Q ss_pred CCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccc--cccCccCcccccCCCCCCCchhHHHHHHHHHHHHh
Q psy11194 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC--GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF 224 (316)
Q Consensus 147 dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~ 224 (316)
||-.+|||+..+..+|++|||+++....... ....... .+..|+|||.+....++.+ +||||+|++|||+++
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~-----y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~Eifs 516 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDY-----YRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFT 516 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCc-----eEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhh
Confidence 9999999999999999999999975322111 1111111 3556999999999777776 999999999999998
Q ss_pred -CCCCCCCCC-HHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 225 -GRLPFDDSS-VNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 225 -g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
|..||++.. ..++.+.+.++.++..+..++.++.++|..|| .+|++||++.++.+
T Consensus 517 LG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 517 LGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 999999865 77778889999999999999999999999999 59999999998874
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=277.39 Aligned_cols=251 Identities=28% Similarity=0.410 Sum_probs=194.1
Q ss_pred eEEeeeeeecCCeE-EEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEEEE
Q psy11194 24 YTVGKIIGTGSYAT-VKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 24 y~~~~~ig~g~~g~-vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
|.-.+.+|.|+.|+ ||+|... |+.||||.+-... ....++|+..++.. +||||+++++.-.+++..|+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 44456688998887 8888654 7899999874322 34577999999999 5999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC---C--CCeEEeeccccccc
Q psy11194 102 EYAENGSLFDIIRGQG----YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS---D--YNIKLSDFGFARAH 172 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~----~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~---~--~~~~l~Df~~~~~~ 172 (316)
|.|.. +|.++++... .......+.++.|++.||++||+.++|||||+|.||||+. + ..++|+|||++..+
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 99966 9999998631 1111345788999999999999999999999999999975 3 45999999999887
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcc-cC-CCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNK-VT-FPK 249 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~-~~~ 249 (316)
........ ......|+.+|+|||.+........ +|||||||++|+.++ |..||.+....+.. |..+ .. ...
T Consensus 662 ~~~~sS~~---r~s~~sGt~GW~APE~L~~~~~~~a-vDiFslGCvfyYvltgG~HpFGd~~~R~~N--Il~~~~~L~~L 735 (903)
T KOG1027|consen 662 AGGKSSFS---RLSGGSGTSGWQAPEQLREDRKTQA-VDIFSLGCVFYYVLTGGSHPFGDSLERQAN--ILTGNYTLVHL 735 (903)
T ss_pred CCCcchhh---cccCCCCcccccCHHHHhccccCcc-cchhhcCceEEEEecCCccCCCchHHhhhh--hhcCccceeee
Confidence 54433332 2455669999999999987666554 999999999999998 59999875443321 2211 11 111
Q ss_pred CCCCCHHHHHHHHHhcC-CCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 250 QPEVSTECKELISNILS-PVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l~-~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
.+....+..+||.+|++ +|..||++.++|.||+|.+.+.+
T Consensus 736 ~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekr 776 (903)
T KOG1027|consen 736 EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKR 776 (903)
T ss_pred ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHH
Confidence 11122299999999994 89999999999999999887653
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=244.61 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=208.6
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
..+....+|.-++.+|.|.. .|..|.|.-.+++|++|.......... ......+|..++..++|+|+++++.+|.-..
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~-~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQT-HAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCc-cchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 35567889999999999998 888898999999999998866543322 2445669999999999999999999995433
Q ss_pred ------eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 96 ------RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 96 ------~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
..++|||++.. +|..++.. .++=..+..++.|++.|+++||+.||+||||||+||++..+..+|+.|||++
T Consensus 89 ~l~~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred cHHHHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence 57999999955 99988873 3777889999999999999999999999999999999999999999999999
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK 249 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (316)
+. ............+..|+|||++.+..+... +||||+||++.||++|+..|++.+.-+.+-++.+....|.
T Consensus 166 r~-------e~~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 166 RT-------EDTDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred cc-------cCcccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence 64 222234555668889999999998886666 9999999999999999999987765555444322111110
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCC
Q psy11194 250 -----------------------------------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 250 -----------------------------------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~ 284 (316)
.+.-+..+++++.+|| -+|++|.|++++|+|||++
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1234567889999999 5999999999999999996
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=267.39 Aligned_cols=248 Identities=23% Similarity=0.409 Sum_probs=214.1
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCc----eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSG----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
.+..+.||+|+||+||+|.+-..|+ +||+|++........ ...+..|+.++..++|||++++++++.... ..+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~--s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA--SIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh--hHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 4556789999999999999876665 688888866555433 344558999999999999999999998765 789
Q ss_pred EEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 100 IMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
|++|+++|+|.++++. .+.+-....+.|+.||++|+.|||...++||||-.+|||+..-..+|+.|||++.......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~-- 852 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE-- 852 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc--
Confidence 9999999999999976 4468888999999999999999999999999999999999999999999999997754322
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
.+.........+-|+|-|.+....++.. +||||+|+++|||+| |..|+.+...+++-+.++.+.+.+.++.++..+
T Consensus 853 --~ey~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDV 929 (1177)
T KOG1025|consen 853 --KEYSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDV 929 (1177)
T ss_pred --ccccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHH
Confidence 2222233334667999999999888887 999999999999998 999999999999999999999999999999999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..++.+|| -|+..||+++++..
T Consensus 930 y~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 930 YMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHhccCcccCccHHHHHH
Confidence 99999999 69999999988753
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=263.72 Aligned_cols=261 Identities=25% Similarity=0.413 Sum_probs=223.0
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
-.++|.+++.+|.|.+|.||+|++..+++..|+|+++...... ...+++|+.+++.++||||+.+++.+......|+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 3678999999999999999999999999999999998766544 4456799999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
+||||.||+|.+...-.+++++.++...+...+++++|||+.|=+|||||=.||++++.|.+++.|||.+..+.
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit------ 163 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT------ 163 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh------
Confidence 99999999999998888899999999999999999999999999999999999999999999999999875431
Q ss_pred CCCCCCcccccccCccCcccc---cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcccCCCCC---CC
Q psy11194 180 ADNSLSETFCGSYAYASPEIL---QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQ---PE 252 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~---~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~---~~ 252 (316)
..-.......|++.|+|||+. ....+... +|||++|++..++---+.|..+..+....... +++++.|.. ..
T Consensus 164 ati~KrksfiGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~k 242 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTK 242 (829)
T ss_pred hhhhhhhcccCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCcc
Confidence 111223345699999999986 33445544 99999999999999888888888777776655 344444433 35
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
.++.+.+|++.+| ++|.+||+++.+|.|||....-+.+
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~r 281 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRR 281 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhH
Confidence 8899999999999 7999999999999999998774433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=280.08 Aligned_cols=236 Identities=19% Similarity=0.313 Sum_probs=182.3
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
.+...+.||+|+||.||+|.+..++..||+|.+...... ...|+..+++++||||+++++++......++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 456677899999999999999889999999988653322 1256888999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH---ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh---~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|+++++|.++++. +++..+..++.+++.|++||| +.+++|+||+|+||+++.++..++. ++......
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------ 833 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------ 833 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------
Confidence 9999999999974 889999999999999999999 6699999999999999988887765 55432210
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcc------cCC-
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-----VNELLKQVQNK------VTF- 247 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~~~------~~~- 247 (316)
......++..|+|||++.+..++.+ +|||||||++|||++|+.||.... ..+........ ...
T Consensus 834 ----~~~~~~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 834 ----TDTKCFISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred ----cCCCccccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 0112246789999999988777666 999999999999999999985321 11111111000 000
Q ss_pred -----CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 248 -----PKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 248 -----~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+.......++.+++.+|+ .+|++||+++++++.
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000112236778999999 599999999999754
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=239.49 Aligned_cols=258 Identities=24% Similarity=0.413 Sum_probs=205.8
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC-----
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 95 (316)
..+.+..+.||.|+||.||.++|..+|+.+++|.+......-...++.+ +|++++..++|.|++..+++..-..
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvF-re~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVF-REIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHH-HHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 3344556789999999999999999999999999866554444334444 8999999999999999988876544
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..|+++|.+. .+|.+.+-....++...++-++.||+.||+|||+.+|.|+||||.|.+++.+...||||||+++...
T Consensus 131 EiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-- 207 (449)
T KOG0664|consen 131 ELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD-- 207 (449)
T ss_pred HHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc--
Confidence 2456777774 3777777777789999999999999999999999999999999999999999999999999998743
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-------
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP------- 248 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 248 (316)
............|..|+|||.+.+..+++.+.||||.|||+.||+..+..|....+-+..+.+.+....|
T Consensus 208 ---~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 208 ---QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ---hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 2233334445568899999999988888888999999999999999999998777776666554322211
Q ss_pred -----------------CC---------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 249 -----------------KQ---------PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 249 -----------------~~---------~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
.. ..-..+...++..++ .+|..|.+.++++.|+++..
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 11 122346667888888 58999999999999999844
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=235.58 Aligned_cols=259 Identities=19% Similarity=0.323 Sum_probs=219.4
Q ss_pred ccccceeeccCeEEeeeeeecCCeEEEEEEEccCCc-----eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCccee
Q psy11194 13 DRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSG-----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87 (316)
Q Consensus 13 ~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~-----~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 87 (316)
+.+-..+...++++...+-+|.||.||.|.+.+..+ .+.+|.+...... -....+..|.-.+..+.|||+.++
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~--iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ--IQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH--HHHHHHHHHHHHHhcCcCCCccce
Confidence 344556778889999999999999999997764332 4677776543322 123445588888888999999999
Q ss_pred eeEEE-eCCeEEEEEecCCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC
Q psy11194 88 LQAIE-TTHRVYIIMEYAENGSLFDIIRG--------QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD 158 (316)
Q Consensus 88 ~~~~~-~~~~~~lv~e~~~~~sL~~~l~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~ 158 (316)
.+++. +...+++++.+..-|+|..++.. .+.++..+...++.|++.|++|||+.|++|.||..+|.++++.
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 99885 45578899999988999999972 2347888899999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11194 159 YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNEL 237 (316)
Q Consensus 159 ~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~ 237 (316)
-+|||+|=.+++...+.... ....+...+..|++||.+.+..+++. +|+||||+++|||+| |..|+...++.+.
T Consensus 433 LqVkltDsaLSRDLFP~DYh----cLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYH----CLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred eeEEeccchhccccCccccc----ccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 99999999999877654433 34455567889999999999888877 999999999999998 9999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHhcC-CCCCCCCHHHHh
Q psy11194 238 LKQVQNKVTFPKQPEVSTECKELISNILS-PVQTRPRLKTIA 278 (316)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~-~p~~Rps~~~il 278 (316)
...++++.+...+..+|+++..+|.-||. .|++||+++++.
T Consensus 508 ~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 508 EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 99999999999999999999999999995 899999999986
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=235.86 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=189.0
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhc--CCCCCcceeeeEEEeCC-
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKG--LKHPNLIRFLQAIETTH- 95 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~- 95 (316)
...++..+.+.||+|.||.||+|.++ |+.||||++..... +...+|.++++. |+|+||+.+++.-..++
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc--CCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 34678899999999999999999777 78999999965432 123367777766 49999999988875433
Q ss_pred ---eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCCeeeCCCCCeEEe
Q psy11194 96 ---RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER--------GVVHRDIKCENLLLDSDYNIKLS 164 (316)
Q Consensus 96 ---~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------~~~H~dl~p~nil~~~~~~~~l~ 164 (316)
..|+|++|.+.|||.+++++. .++.....+++..++.||++||.. .|.|||||..|||+..+|.+-|+
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 679999999999999999984 599999999999999999999952 39999999999999999999999
Q ss_pred ecccccccccccCcCCCCCCCcccccccCccCcccccCCC-----CCCCchhHHHHHHHHHHHHhC----------CCCC
Q psy11194 165 DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIP-----YAPHLSDIWSMGVVLFAMVFG----------RLPF 229 (316)
Q Consensus 165 Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~ll~~l~~g----------~~p~ 229 (316)
|+|+|..+.... ..-.......+||.+|||||++.... .+.+.+||||||.++||+... ..||
T Consensus 359 DLGLAv~h~~~t--~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 359 DLGLAVRHDSDT--DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred eceeeEEecccC--CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 999998765433 22233445567999999999985421 122338999999999998742 3676
Q ss_pred CC-----CCHHHHHHHHh-cccCCCCCCCC--C---HHHHHHHHHhc-CCCCCCCCHHHHh
Q psy11194 230 DD-----SSVNELLKQVQ-NKVTFPKQPEV--S---TECKELISNIL-SPVQTRPRLKTIA 278 (316)
Q Consensus 230 ~~-----~~~~~~~~~~~-~~~~~~~~~~~--~---~~~~~li~~~l-~~p~~Rps~~~il 278 (316)
.+ .+.++..+-+- +..++..++.. . ..+-++|+.|| .+|..|.|+-.|.
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 43 33344443331 22333333222 2 35667899999 6999999987665
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=248.79 Aligned_cols=202 Identities=33% Similarity=0.581 Sum_probs=178.6
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch-HH----HhhHHHHHHHHhcCC---CCCcceeeeEEEe
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD-YL----KKFLPREIEVVKGLK---HPNLIRFLQAIET 93 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~-~~----~~~~~~e~~~l~~l~---~~~i~~~~~~~~~ 93 (316)
.+|..++.+|.|+||.|+.|.++.+...|++|.+.+.+-..+ +. ...+-.|+.++..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458999999999999999999999999999999976433211 11 223557999999997 9999999999999
Q ss_pred CCeEEEEEecC-CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYA-ENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~-~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
+++++++||-- +|..|++++.....+++.+.+.|+.|++.|+++||+.||+|||||.+|++++.+|-++|+|||.+.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa-- 718 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA-- 718 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh--
Confidence 99999999954 567999999998889999999999999999999999999999999999999999999999999873
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD 231 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~ 231 (316)
...+.......||..|.|||++.+..+..+.-|||+||++||.++....||.+
T Consensus 719 ------~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 ------YTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ------hhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 34556677788999999999999999988889999999999999998888754
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=238.72 Aligned_cols=243 Identities=25% Similarity=0.374 Sum_probs=190.5
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC--CCCCcceeeeEEEeCC--
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL--KHPNLIRFLQAIETTH-- 95 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~~-- 95 (316)
+.....+.+.||+|.||.||+|... ++.||||++.... .+.+..|-.+++.. +|+||+++++.-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 3455778899999999999999766 5799999985432 45566777777664 7999999988765544
Q ss_pred --eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------cCccccCCCCCCeeeCCCCCeEEe
Q psy11194 96 --RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE---------RGVVHRDIKCENLLLDSDYNIKLS 164 (316)
Q Consensus 96 --~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~---------~~~~H~dl~p~nil~~~~~~~~l~ 164 (316)
.+++|++|.+.|||-+++..+- +++....+++..+++||+|||+ -.|+|||||..|||+..+++..|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 8999999999999999999765 9999999999999999999995 359999999999999999999999
Q ss_pred ecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCC-----CchhHHHHHHHHHHHHhCC------------C
Q psy11194 165 DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP-----HLSDIWSMGVVLFAMVFGR------------L 227 (316)
Q Consensus 165 Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~ll~~l~~g~------------~ 227 (316)
|||+|.++.+.. .....-+..||.+|||||++.+..-.. ++.||||+|.++||+++.. +
T Consensus 359 DFGLAl~~~p~~----~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql 434 (534)
T KOG3653|consen 359 DFGLALRLEPGK----PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL 434 (534)
T ss_pred ccceeEEecCCC----CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence 999998876322 222333478999999999986543222 3489999999999999753 2
Q ss_pred CCC-----CCCHHHHHHHHhcccCCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHH
Q psy11194 228 PFD-----DSSVNELLKQVQNKVTFPKQP------EVSTECKELISNIL-SPVQTRPRLK 275 (316)
Q Consensus 228 p~~-----~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l-~~p~~Rps~~ 275 (316)
||. +...++..+.+......|..+ .-...+++.+..|| .||+.|.|+.
T Consensus 435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 332 344556666654444444332 23467889999999 6999999984
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=215.07 Aligned_cols=217 Identities=25% Similarity=0.412 Sum_probs=174.4
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 95 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 95 (316)
.++..++......||+|++|.|-+.++..+|...|+|.++..-...+ ...+.+|+.+.... .+|++|.+++....+.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~--q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE--QKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH--HHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 34455666677889999999999999999999999999976544322 23344788777776 6999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIR----GQGYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
..++.||.+.. ||..+.+ .++.+++..+-+|+..++.||.|||++ .++|||+||+|||++..|+||+||||++-
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999955 9987764 467799999999999999999999975 89999999999999999999999999985
Q ss_pred ccccccCcCCCCCCCcccccccCccCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcc
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQ----GIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNK 244 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~ 244 (316)
.+.+ +.......|-..|+|||.+. ...++-+ +||||||+++.||.++++||.. ..+-+..+++.+.
T Consensus 198 ~L~d-------SiAkt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 198 YLVD-------SIAKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred eehh-------hhHHHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 4322 12222244677899999874 2345555 9999999999999999999975 4555666666544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-31 Score=215.91 Aligned_cols=212 Identities=42% Similarity=0.712 Sum_probs=182.1
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCH
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSL 109 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 109 (316)
||.|.+|.||++.+..+++.+++|+........ ..+.+.+|+..++.+.|++++++++++......++++|++++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987655432 235577999999999999999999999999999999999998999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC-CCCeEEeecccccccccccCcCCCCCCCcc
Q psy11194 110 FDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS-DYNIKLSDFGFARAHMRCRSNAADNSLSET 187 (316)
Q Consensus 110 ~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~-~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~ 187 (316)
.+++... ..++...+..++.+++.++.+||+.|++|+||+|.||+++. ++.++|+||+.+........ ....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~~~~ 152 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------LLKT 152 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------hhhc
Confidence 9999875 46899999999999999999999999999999999999998 89999999998865422110 1222
Q ss_pred cccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-C
Q psy11194 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-S 266 (316)
Q Consensus 188 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~ 266 (316)
..+...|.+||........+.++|+|++|++++++ ..+.+++..|+ .
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhC
Confidence 34677899999987763444449999999999999 79999999999 5
Q ss_pred CCCCCCCHHHHhhCC
Q psy11194 267 PVQTRPRLKTIAEDR 281 (316)
Q Consensus 267 ~p~~Rps~~~il~~~ 281 (316)
+|.+||+++++++++
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=233.92 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=203.8
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEcc---CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCC
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTR---HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH 95 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 95 (316)
..+.|.++++||.|.|++||++.+.. .++.||+|.+....... .+..|+.+|..+. +.||+++.+++..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~-----ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS-----RILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch-----HHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 45679999999999999999999887 77899999997766543 3679999999995 899999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-CCeEEeeccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHMR 174 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~-~~~~l~Df~~~~~~~~ 174 (316)
...+|+||++.....++... ++..+++.+++.+++||+++|.+||+|+||||.|++++.. ++..|+|||+|.....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999999888888776 6788999999999999999999999999999999999754 7799999999873211
Q ss_pred cc------C------------------c--------------CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHH
Q psy11194 175 CR------S------------------N--------------AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMG 216 (316)
Q Consensus 175 ~~------~------------------~--------------~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG 216 (316)
.. . . ...........||++|+|||++...+--+.++||||-|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 10 0 0 00001111235899999999998876666669999999
Q ss_pred HHHHHHHhCCCCCCCC--CHHHHHHHH---------------------------------hcccCC--------------
Q psy11194 217 VVLFAMVFGRLPFDDS--SVNELLKQV---------------------------------QNKVTF-------------- 247 (316)
Q Consensus 217 ~ll~~l~~g~~p~~~~--~~~~~~~~~---------------------------------~~~~~~-------------- 247 (316)
+|+..++++.+||... +...+.+.+ ......
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999998421 111111100 000000
Q ss_pred --CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 248 --PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 248 --~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
......+..+.+|+.+|| -+|.+|.|++++|+||||.+.++
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 001224568999999999 49999999999999999996655
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=213.15 Aligned_cols=214 Identities=39% Similarity=0.659 Sum_probs=179.7
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEec
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
|.+.+.||.|++|.||+|.+..+++.+++|........ ...+.+.+|+..+..++|++++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56788999999999999999988899999999765443 1355677999999999999999999999998999999999
Q ss_pred CCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 104 AENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 104 ~~~~sL~~~l~~~~~-l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
+++++|.+++..... +++..+..++.+++.++.+||+.+++|+|++|.||+++.++.++|+|||.+....... .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-----~ 153 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-----A 153 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----c
Confidence 999999999987666 8999999999999999999999999999999999999999999999999886643221 0
Q ss_pred CCCcccccccCccCcccc-cCCCCCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHhccc
Q psy11194 183 SLSETFCGSYAYASPEIL-QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD--SSVNELLKQVQNKV 245 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~-~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~--~~~~~~~~~~~~~~ 245 (316)
.......+...|++||.. ....++. ++|+|+||++++++++|+.||.. .+...+.+.+..+.
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 112233466789999998 5545555 49999999999999999999977 44446666666554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=209.06 Aligned_cols=237 Identities=25% Similarity=0.429 Sum_probs=181.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeE-EEeCCeEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQA-IETTHRVY 98 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~-~~~~~~~~ 98 (316)
.+.|.|.+.||+|.||.+-+++++.+++.+++|.+...... .+.+.+|...--.| .|.||+..+++ |+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 45699999999999999999999999999999998664432 45577888877777 48999987765 57778899
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC--CCCeEEeeccccccccccc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS--DYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~--~~~~~l~Df~~~~~~~~~~ 176 (316)
+++||++.|+|.+.+...+ +-+...+.++.|++.||.|||++++||||||.+|||+-. .-++||||||..+...
T Consensus 99 F~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g--- 174 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG--- 174 (378)
T ss_pred EeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC---
Confidence 9999999999999887654 889999999999999999999999999999999999943 3479999999875421
Q ss_pred CcCCCCCCCcccccccCccCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HH-HHHHHHhcccCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGI----PYAPHLSDIWSMGVVLFAMVFGRLPFDDSS---VN-ELLKQVQNKVTFP 248 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~-~~~~~~~~~~~~~ 248 (316)
.........-.|.+||..... -.....+|+|.||+++|.++||+.||.... +. -...+......+.
T Consensus 175 ------~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 175 ------TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA 248 (378)
T ss_pred ------ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence 111122234467889876432 122233899999999999999999997422 11 2223333333222
Q ss_pred C---CCCCCHHHHHHHHHhc-CCCCCC
Q psy11194 249 K---QPEVSTECKELISNIL-SPVQTR 271 (316)
Q Consensus 249 ~---~~~~~~~~~~li~~~l-~~p~~R 271 (316)
. ...+++.+..+.++-| .+|++|
T Consensus 249 ~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 249 LPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred CchhhcccCHHHHHHHHHhcCCccccc
Confidence 2 2457889999999999 578888
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=250.61 Aligned_cols=201 Identities=15% Similarity=0.210 Sum_probs=142.0
Q ss_pred CCcceeeeEE-------EeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCe
Q psy11194 82 PNLIRFLQAI-------ETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENL 153 (316)
Q Consensus 82 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ni 153 (316)
+||++++++| .....++.++|++ +++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777777776 2334577888988 5599999975 34599999999999999999999999999999999999
Q ss_pred eeCCCCCeEE-------------------eecccccccccccCc---C-------CCCCCCcccccccCccCcccccCCC
Q psy11194 154 LLDSDYNIKL-------------------SDFGFARAHMRCRSN---A-------ADNSLSETFCGSYAYASPEILQGIP 204 (316)
Q Consensus 154 l~~~~~~~~l-------------------~Df~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~aPE~~~~~~ 204 (316)
|++..|.+++ +|||+++........ . ..........+++.|+|||++.+..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 9966555554 455544321100000 0 0000011234788899999998877
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 205 YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 205 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+..+ +|||||||++|||++|..|+.... .....+......+......+...+++..|| .+|.+||++.++++||||
T Consensus 192 ~~~~-sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 192 SNCA-SDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred CCch-hhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhh
Confidence 7655 999999999999999988875321 122222222112221223556778999999 589999999999999999
Q ss_pred CCC
Q psy11194 284 KPK 286 (316)
Q Consensus 284 ~~~ 286 (316)
...
T Consensus 269 ~~~ 271 (793)
T PLN00181 269 NEP 271 (793)
T ss_pred hhh
Confidence 764
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=201.64 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=194.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCC-ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC----CCCcceeeeEE-EeCCe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHS-GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK----HPNLIRFLQAI-ETTHR 96 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~ 96 (316)
+|.+.+.||+|+||.||.|.+...+ ..+|+|+......... ..+..|..++..+. .++++.+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988764 5789998876543221 14668888888886 36999999999 58888
Q ss_pred EEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-----CCeEEeecccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-----YNIKLSDFGFA 169 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~-----~~~~l~Df~~~ 169 (316)
.++||+.+ |.+|.++.+.. +.++...+..++.|++.+|++||+.|++||||||.|+++... ..++|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 88999998653 469999999999999999999999999999999999999755 35999999999
Q ss_pred c--ccccccCcC-CCCCC-CcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---h
Q psy11194 170 R--AHMRCRSNA-ADNSL-SETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV---Q 242 (316)
Q Consensus 170 ~--~~~~~~~~~-~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~---~ 242 (316)
+ .+....... ..... .....||..|.++.+..+...... .|+||++.++.+++.|..||...........+ .
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8 432222111 11111 234559999999999999888888 99999999999999999999765532222222 2
Q ss_pred cccCCC-CCCCCCHHHHHHHHHhcC-CCCCCCCHHHHhhC
Q psy11194 243 NKVTFP-KQPEVSTECKELISNILS-PVQTRPRLKTIAED 280 (316)
Q Consensus 243 ~~~~~~-~~~~~~~~~~~li~~~l~-~p~~Rps~~~il~~ 280 (316)
...... .....+.++.++...+-. +..++|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 222222 223355677777776664 78889988887654
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=187.21 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=198.1
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCC
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH 95 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 95 (316)
..+-..+|.++++||.|+||.+|.|....+|..||+|+-+.....+ ++..|.+++..++ ..+|+.+..++.+..
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-----QLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-----chhHHHHHHHHhccCCCCchhhhhccccc
Confidence 3456789999999999999999999999999999999986655432 3558999999996 678889988999999
Q ss_pred eEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC---CCeEEeecccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD---YNIKLSDFGFARA 171 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~---~~~~l~Df~~~~~ 171 (316)
+-.+||+.+ |.||+++.+- ...++...++-++.|++.-++|+|..+++|+||||+|+++.-+ .++.++|||++..
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 999999999 8999999864 3459999999999999999999999999999999999999643 5699999999988
Q ss_pred cccccCcCCCC-CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhcc-cC
Q psy11194 172 HMRCRSNAADN-SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNEL---LKQVQNK-VT 246 (316)
Q Consensus 172 ~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~---~~~~~~~-~~ 246 (316)
+-.......-+ .......||.+|.+-....+...+.. .|+-|+|.++.++.-|..||.+..+... .+.+.+. ..
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 75444333222 23335668999988777777666666 8999999999999999999998655433 3333221 12
Q ss_pred CC---CCCCCCHHHHHHHHHhcC-CCCCCCCH
Q psy11194 247 FP---KQPEVSTECKELISNILS-PVQTRPRL 274 (316)
Q Consensus 247 ~~---~~~~~~~~~~~li~~~l~-~p~~Rps~ 274 (316)
.+ ...+.|.++.-.+.-|-. --++-|..
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 22 235788899888888862 33344443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=191.62 Aligned_cols=159 Identities=23% Similarity=0.235 Sum_probs=125.0
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCC
Q psy11194 107 GSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS 185 (316)
Q Consensus 107 ~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~ 185 (316)
|||.+++.. +.++++.+++.++.|++.||.|||+.+ ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 589999976 456999999999999999999999998 999999999999999 9988653211
Q ss_pred cccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcccCCC------CCCCCCH--H
Q psy11194 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV-NELLKQVQNKVTFP------KQPEVST--E 256 (316)
Q Consensus 186 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~------~~~~~~~--~ 256 (316)
...+++.|+|||++.+..++.+ +|||||||++|+|++|..||..... ......+....... ....++. +
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARS 140 (176)
T ss_pred -cCCCcccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhh
Confidence 1147889999999988777665 9999999999999999999975432 22333332221111 1122333 6
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
+.++|..|| .+|.+||++.++++|+|+..
T Consensus 141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 141 FADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 999999999 69999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=186.79 Aligned_cols=212 Identities=21% Similarity=0.297 Sum_probs=179.7
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETT 94 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 94 (316)
-..+.+-.|.+.++||+|+||.++.|...-++.+||||.-..... .-+++.|...++.|. .++|+.++.+..++
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 445678899999999999999999999999999999998754443 345788999999995 79999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-----CCeEEeeccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-----YNIKLSDFGF 168 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~-----~~~~l~Df~~ 168 (316)
.+-.+|+|.+ |.||+++..- +..++...+..++.|++.-++++|++.+|+|||||+|+||... ..+.++|||+
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 9999999999 8999999975 4569999999999999999999999999999999999999644 3489999999
Q ss_pred ccccccccCcC-CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy11194 169 ARAHMRCRSNA-ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV 234 (316)
Q Consensus 169 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~ 234 (316)
|..+-...... -.-.......||.+||+=.-..+...+.. .|+-|||-++++.+-|.+||.+...
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccC
Confidence 98875433221 22223345679999999888888888887 9999999999999999999987543
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=218.83 Aligned_cols=263 Identities=25% Similarity=0.458 Sum_probs=204.2
Q ss_pred EEeeeeeecCCeEEEEEEEccCCceEEEEEeecC--CCCch-HHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKV--QAPPD-YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 25 ~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~--~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
.....+|.|.+|.|+.+......+.+..|..+.. ....+ .....+..|+.+-..+.|++++..+..........-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567799999998888877766666666655421 11111 11122556777777889999988777776655555559
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
|||++ .|..++...+.++..++..++.|++.|+.|+|..|+.|+|+|++|+++..+|.++++|||.+..+... ....
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~--~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP--WEKN 477 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC--cchh
Confidence 99999 99999998878999999999999999999999999999999999999999999999999988664311 1111
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhc-------ccCCCCCCCC
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL-KQVQN-------KVTFPKQPEV 253 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-~~~~~-------~~~~~~~~~~ 253 (316)
........|+..|.|||++....+.+...||||.|+++..|.+|+.||......+.. ..... .........+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 245566778999999999999999999999999999999999999999765544332 11111 1111223458
Q ss_pred CHHHHHHHHHhcC-CCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 254 STECKELISNILS-PVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 254 ~~~~~~li~~~l~-~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
+...+.+|.+||. +|.+|.|+++|++.+||+..+.+.
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH 595 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence 8999999999995 999999999999999999887654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=191.80 Aligned_cols=170 Identities=18% Similarity=0.222 Sum_probs=129.1
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEcc-CCceEEEEEeecCCC--CchHHHhhHHHHHHHHhcCCCCCcce-eeeEEEeC
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTR-HSGDVAIKIVSKVQA--PPDYLKKFLPREIEVVKGLKHPNLIR-FLQAIETT 94 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~ 94 (316)
.-..+|.+.+.||+|+||.||+|.+.. ++..+|+|+...... ........+.+|+.+++.++|+++++ +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 346789999999999999999999876 677789998753311 12333556889999999999999885 4432
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCC-CCCCeeeCCCCCeEEeecccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDI-KCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl-~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
...++||||++|++|... .. .. ...++.+++.+|.+||+.|++|||| ||+||+++.++.++|+|||++..+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 457999999999999632 11 11 1467889999999999999999999 9999999989999999999998754
Q ss_pred cccCcCCCCC----CCcccccccCccCccccc
Q psy11194 174 RCRSNAADNS----LSETFCGSYAYASPEILQ 201 (316)
Q Consensus 174 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~ 201 (316)
... ..... ......+++.|+|||.+.
T Consensus 164 ~~~--~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 164 RRG--ALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cCc--chhhhhhhhhhhhhhccCccCCcccCC
Confidence 321 11110 012445777899999874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-23 Score=182.28 Aligned_cols=262 Identities=32% Similarity=0.519 Sum_probs=206.2
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC-CcceeeeEEEeCCeEEEEEe
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP-NLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 102 (316)
|.+.+.||.|+|+.||.+.+. ..+++|.+.............+.+|...+..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788899999999999999887 68899998776555443456677999999999887 79999999987777899999
Q ss_pred cCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC-CeEEeecccccccccccCc
Q psy11194 103 YAENGSLFDIIRGQG---YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY-NIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~---~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~-~~~l~Df~~~~~~~~~~~~ 178 (316)
++.++++.+++.... .++......++.|++.++.++|..+++|+|++|+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887654 699999999999999999999999999999999999999988 6999999998643221111
Q ss_pred CCCCCCCcccccccCccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcccCC--CCC
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGI--PYAPHLSDIWSMGVVLFAMVFGRLPFDDSS----VNELLKQVQNKVTF--PKQ 250 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~--~~~ 250 (316)
...........++..|++||.+... .......|+|++|++++++++|..||.... .....+.+...... ...
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1000134556789999999999874 344444999999999999999999987765 34555555443322 111
Q ss_pred CC--C----CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 251 PE--V----STECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 251 ~~--~----~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.. . ...+.+++..++ .+|..|.+..+...+++......
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~ 283 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL 283 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence 11 1 258899999999 68999999999998866654433
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=179.00 Aligned_cols=242 Identities=21% Similarity=0.326 Sum_probs=196.1
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
-.+..+..+|.....|..|+|++++ ..++.|++... .......+.+..|.-.++.+.||||+++++.|....++.++
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr-~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVR-EVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccC--cchhhhhhhhh-hcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 3445567788899999999998874 47788887543 33455567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeCCCCCeEEe--eccccccccc
Q psy11194 101 MEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERG--VVHRDIKCENLLLDSDYNIKLS--DFGFARAHMR 174 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~--~~H~dl~p~nil~~~~~~~~l~--Df~~~~~~~~ 174 (316)
..|++.|||..++.++. .++..++.+++.+++.|++|||+.. +.-..|....++++++-+.+|+ |--++
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs----- 340 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS----- 340 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee-----
Confidence 99999999999998754 3778899999999999999999875 4445688999999998776665 22211
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhcccCCCCCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPY--APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL-KQVQNKVTFPKQP 251 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~ 251 (316)
.. ..+....+.|++||.++..+. +..++|+|||++++|||.|...||.+..+.+.- +...++.+...++
T Consensus 341 ----fq----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ipp 412 (448)
T KOG0195|consen 341 ----FQ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP 412 (448)
T ss_pred ----ee----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC
Confidence 11 111224678999999977653 334589999999999999999999998877764 4447888899999
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIA 278 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il 278 (316)
++++.+.+||.-|+ .||-+||.++.+.
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999 5999999998765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=181.02 Aligned_cols=234 Identities=22% Similarity=0.284 Sum_probs=153.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC----------CCcceeeeEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH----------PNLIRFLQAIE 92 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~----------~~i~~~~~~~~ 92 (316)
.+...+.||.|+++.||.|++..+|+++++|+............+.+++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778889999999999999999999999999987775555455666666655555422 12222233321
Q ss_pred ------------eCC-----eEEEEEecCCCCCHHHHHHh----CC---CCCHHHHHHHHHHHHHHHHHHHHcCccccCC
Q psy11194 93 ------------TTH-----RVYIIMEYAENGSLFDIIRG----QG---YIDEIRARRWFGQLLEALQYCHERGVVHRDI 148 (316)
Q Consensus 93 ------------~~~-----~~~lv~e~~~~~sL~~~l~~----~~---~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl 148 (316)
... +.+++|+.+.+ +|.+++.. .. .+.......+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 23678888854 88888642 11 1333445666789999999999999999999
Q ss_pred CCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCC-------CCCCCchhHHHHHHHHHH
Q psy11194 149 KCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI-------PYAPHLSDIWSMGVVLFA 221 (316)
Q Consensus 149 ~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~ll~~ 221 (316)
+|+|++++.+|.++|+||+.......... ....+..|.|||..... ...+.+.|.|+||+++|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR---------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE---------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee---------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 99999999999999999987754321111 01234678899876332 123334899999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCC
Q psy11194 222 MVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTR 271 (316)
Q Consensus 222 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~R 271 (316)
|++|..||........... .+.....+|+.++.||..+| .+|.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc-----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999985433221111 34444578999999999999 588887
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=198.60 Aligned_cols=240 Identities=27% Similarity=0.487 Sum_probs=196.9
Q ss_pred eeecCCeEEEEEEE---ccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEEEEecCC
Q psy11194 30 IGTGSYATVKLARS---TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIMEYAE 105 (316)
Q Consensus 30 ig~g~~g~vy~~~~---~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 105 (316)
+|+|.+|.|+.++. .+.|.-+++|+..+......... .-..|..++..++ ||.++++...++.+...+++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 68999999998753 24566788888866444332222 3446778888886 9999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCC
Q psy11194 106 NGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS 185 (316)
Q Consensus 106 ~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~ 185 (316)
|+.|...+.....+++...+.+...++.+++++|+.+++|+|+|++||+++.+|.+++.|||.++........
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~------- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA------- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-------
Confidence 9999999888777899999999999999999999999999999999999999999999999998764322211
Q ss_pred cccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc
Q psy11194 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL 265 (316)
Q Consensus 186 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 265 (316)
+|+..|+|||++. .+... .|.||+|+++++|++|..||.. +....+... .++.+..++.++++++..++
T Consensus 154 ---cgt~eymApEI~~--gh~~a-~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-~~~~p~~l~~~a~~~~~~l~ 222 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSA-ADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-ELEMPRELSAEARSLFRQLF 222 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCc-ccchhhhhhHHHHhhCCCCCch----HHHHHHhhh-ccCCchhhhHHHHHHHHHHH
Confidence 6899999999998 34444 8999999999999999999988 444444432 24445679999999999999
Q ss_pred -CCCCCCCCH-----HHHhhCCCCCCCCC
Q psy11194 266 -SPVQTRPRL-----KTIAEDRWLKPKPK 288 (316)
Q Consensus 266 -~~p~~Rps~-----~~il~~~~~~~~~~ 288 (316)
.+|.+|.-. .++++|++|+....
T Consensus 223 ~r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 223 KRNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred hhCHHHHhccCcchhHHHhccchheeeeH
Confidence 699999855 79999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-24 Score=169.41 Aligned_cols=141 Identities=19% Similarity=0.210 Sum_probs=110.6
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchH-----------------------HHhhHHHHHHHHhcCCCCC
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDY-----------------------LKKFLPREIEVVKGLKHPN 83 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~~~~ 83 (316)
...||+|++|.||+|.+. +|+.||+|+++........ ......+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 8999999999764321110 0123345999999998777
Q ss_pred cceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHcCccccCCCCCCeeeCCCCCeE
Q psy11194 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC-HERGVVHRDIKCENLLLDSDYNIK 162 (316)
Q Consensus 84 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~H~dl~p~nil~~~~~~~~ 162 (316)
+......... ..++||||++|+++.........++...+..++.|++.+|.++ |+.|++|+||||+||+++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6443333222 2389999999887766544456799999999999999999999 799999999999999998 57899
Q ss_pred Eeecccccc
Q psy11194 163 LSDFGFARA 171 (316)
Q Consensus 163 l~Df~~~~~ 171 (316)
|+|||++..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-24 Score=171.66 Aligned_cols=178 Identities=17% Similarity=0.185 Sum_probs=134.6
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhh------HHHHHHHHhcCCCCCcceeee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKF------LPREIEVVKGLKHPNLIRFLQ 89 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~------~~~e~~~l~~l~~~~i~~~~~ 89 (316)
.-.+...+|++.+.||.|+||.||.+.+ +++.+++|+++......+..... +++|+..+..+.|++++.+.+
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d 102 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLND 102 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceE
Confidence 4445688999999999999999999755 46689999998765554443333 578999999999999999988
Q ss_pred EEEeC--------CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCe
Q psy11194 90 AIETT--------HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNI 161 (316)
Q Consensus 90 ~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~ 161 (316)
++... ...+++|||++|.+|.++.. +++ ....+++.++..+|+.|++|+|++|+||+++++| +
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence 86533 35789999999999988732 333 2456899999999999999999999999999888 9
Q ss_pred EEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHH
Q psy11194 162 KLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV 223 (316)
Q Consensus 162 ~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~ 223 (316)
+|+|||........ . ..........+.. ++|+|+||+++..+.
T Consensus 174 ~liDfg~~~~~~e~-------~-----------a~d~~vler~y~~-~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQR-------K-----------AKDRIDLERHYGI-KNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccch-------h-----------hHHHHHHHhHhcc-cccccceeEeehHHH
Confidence 99999977432100 0 0001222333443 499999999876654
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-24 Score=201.82 Aligned_cols=242 Identities=25% Similarity=0.363 Sum_probs=179.4
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC--chHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP--PDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.|...+-||.+.|=.|.+|++. .+.|++|++-+.... -....+.+ .|++ ...+++||++++..+-..++..|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGLVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--CceEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 6888899999999999999766 346999998665422 12223333 3444 5566899999998888888888999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc-cccccCcC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA-HMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~-~~~~~~~~ 179 (316)
-+|... +|.+.+.....+..-+.+.|+.|++.||..+|..|++|||||.+|||++.-+=+.|+||..-+. +.+.....
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 999954 9999999888899999999999999999999999999999999999999888899999975421 11111111
Q ss_pred CCCCCCcccccccCccCcccccCC----------CCCCCchhHHHHHHHHHHHHh-CCCCCCCC-----------CHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGI----------PYAPHLSDIWSMGVVLFAMVF-GRLPFDDS-----------SVNEL 237 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~-g~~p~~~~-----------~~~~~ 237 (316)
...........-..|.|||-+... ....++.||||+||++.||++ |+++|.-. +++..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 111112222234469999987431 113345899999999999998 89998521 12222
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 238 LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.+++ -+..+++||..|+ .||++|.|+++.|+.
T Consensus 259 Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 2211 2448899999999 699999999999976
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=162.71 Aligned_cols=141 Identities=20% Similarity=0.198 Sum_probs=111.6
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch-----------------------HHHhhHHHHHHHHhcCCCCC
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD-----------------------YLKKFLPREIEVVKGLKHPN 83 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~~~~ 83 (316)
...||+|++|.||+|.+. +|+.||+|+.+....... .....++.|...+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 899999999986532110 01223467889999998888
Q ss_pred cceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeE
Q psy11194 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIK 162 (316)
Q Consensus 84 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~ 162 (316)
+.....+.... .++||||++|+++.........++...+..++.+++.++.++|+ .|++|+||+|+||+++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 75444433332 48999999987654433334568889999999999999999999 9999999999999998 88999
Q ss_pred Eeecccccc
Q psy11194 163 LSDFGFARA 171 (316)
Q Consensus 163 l~Df~~~~~ 171 (316)
|+|||++..
T Consensus 158 liDFG~a~~ 166 (190)
T cd05145 158 IIDVSQAVE 166 (190)
T ss_pred EEEccccee
Confidence 999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-23 Score=190.53 Aligned_cols=228 Identities=25% Similarity=0.473 Sum_probs=172.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
..+|..+++|..|++|-||.++++.+..++|+|+- +.+. .+++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l-------ilRn---ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL-------ILRN---ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccc-ccch-------hhhc---cccccCCccee---------------
Confidence 56799999999999999999999999999999542 2111 1111 22223344333
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc--
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN-- 178 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~-- 178 (316)
|+=.++++.-++++..- +.+++|||+.|++|+|++|+|.+|+.-|.+|+.|||+.+.-......
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 23334455545555433 88999999999999999999999999999999999988654322111
Q ss_pred -------CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-cCCCC-
Q psy11194 179 -------AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK-VTFPK- 249 (316)
Q Consensus 179 -------~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~- 249 (316)
..........++++.|.|||++....|... +|+|++|+|+|+.+-|..||.+..++++..++... ..+++
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 122223344579999999999998888777 99999999999999999999999999998887542 33333
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCC---CHHHHhhCCCCCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRP---RLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rp---s~~~il~~~~~~~~~~~ 289 (316)
...++++++++|.++| .+|..|. .+-++.+|+||+..+-.
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 3458899999999999 6888875 67899999999887654
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=191.80 Aligned_cols=203 Identities=22% Similarity=0.337 Sum_probs=169.8
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
...+.+..|.|-+.||+|++|.||+|.... |+.||||+-.+...+.-++-.+++..++ ..--+.|..+.......+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK---PQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc---hhhhcchHHHHHHHccCC
Confidence 467889999999999999999999999887 9999999999999998877666544333 112356777777777788
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC-------CCCeEEeeccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS-------DYNIKLSDFGF 168 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~-------~~~~~l~Df~~ 168 (316)
..++|++|.+.|||.++++..+..++..+..++.|++..+++||..+||||||||+|+++.. .--++|+|||.
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 88999999999999999998888999999999999999999999999999999999999942 23499999998
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRL 227 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~ 227 (316)
+-.+.- ...........++-.+-.+|...++.|+.. .|.|+|+.+++-|+.|++
T Consensus 848 siDm~l----fp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 848 SIDMKL----FPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceeeeE----cCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 854321 112234455567888999999999999988 999999999999999974
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=153.55 Aligned_cols=193 Identities=17% Similarity=0.118 Sum_probs=135.1
Q ss_pred EEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHH-HhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEEEEe
Q psy11194 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYL-KKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 25 ~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~-~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 102 (316)
.+...|++|+||+||.+.. .+.+++.+.+.....+.... ...+++|+.+++++. ++++++++++ ...+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3567899999999997744 57788877776555433322 224789999999995 5889999886 44699999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCC-CCCCeeeCCCCCeEEeecccccccccccCcC--
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDI-KCENLLLDSDYNIKLSDFGFARAHMRCRSNA-- 179 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl-~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~-- 179 (316)
|+.|.+|....... ...++.+++.+|.++|+.|++|+|| +|+||+++.+|.++|+|||++....+.....
T Consensus 79 yI~G~~L~~~~~~~-------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 79 YLAGAAMYQRPPRG-------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eecCccHHhhhhhh-------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 99999987543221 2357789999999999999999999 7999999999999999999996432111000
Q ss_pred -CCCCC----CcccccccCccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy11194 180 -ADNSL----SETFCGSYAYASPEILQGI-PYAPHLSDIWSMGVVLFAMVFGRLPFD 230 (316)
Q Consensus 180 -~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~ 230 (316)
..... ......++.+..|+...-. ..+-...++++.|+-+|.++|+..+.-
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 00000 0011134555566544322 122123699999999999999888764
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=164.36 Aligned_cols=196 Identities=24% Similarity=0.355 Sum_probs=140.8
Q ss_pred CCCCcceeeeEEEe---------------------------CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q psy11194 80 KHPNLIRFLQAIET---------------------------THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL 132 (316)
Q Consensus 80 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~ 132 (316)
+||||+++...|.+ ....|+||...+. +|..++-.+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence 59999999877632 2247999999966 9999997654 56667788899999
Q ss_pred HHHHHHHHcCccccCCCCCCeeeC--CCCC--eEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCC----
Q psy11194 133 EALQYCHERGVVHRDIKCENLLLD--SDYN--IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIP---- 204 (316)
Q Consensus 133 ~~l~~Lh~~~~~H~dl~p~nil~~--~~~~--~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---- 204 (316)
.|+.|||.+|+.|+|+|.+||++. +++. .+++|||++-.-...+.........-...|+..-+|||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999994 3333 77889998754222111112222222345777889999986543
Q ss_pred -CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHH
Q psy11194 205 -YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNEL-LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTI 277 (316)
Q Consensus 205 -~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~i 277 (316)
.+..++|.|+.|.+.||+++...||........ ....++...++.+..+++.+++++..+| .+|++|++.+-+
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 233348999999999999999999865111100 0112233345556679999999999999 599999997544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=155.63 Aligned_cols=143 Identities=19% Similarity=0.192 Sum_probs=114.1
Q ss_pred CeEEeeeeeecCCeEEEEEE-EccCCceEEEEEeecCCCCch---------------------HHHhhHHHHHHHHhcCC
Q psy11194 23 GYTVGKIIGTGSYATVKLAR-STRHSGDVAIKIVSKVQAPPD---------------------YLKKFLPREIEVVKGLK 80 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~-~~~~~~~v~vK~~~~~~~~~~---------------------~~~~~~~~e~~~l~~l~ 80 (316)
-|.+.+.||.|++|.||+|. +..+|+.||+|+++....... .....+++|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38899999999999999998 667899999999976432110 01234568999999996
Q ss_pred C--CCcceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccCCCCCCeeeCC
Q psy11194 81 H--PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG-VVHRDIKCENLLLDS 157 (316)
Q Consensus 81 ~--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-~~H~dl~p~nil~~~ 157 (316)
+ ..++++++. ...++||||++|.+|.........+....+..++.|++.++++||+.| ++|+||+|+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 4 334555543 234899999999888776544455677778899999999999999999 99999999999998
Q ss_pred CCCeEEeeccccc
Q psy11194 158 DYNIKLSDFGFAR 170 (316)
Q Consensus 158 ~~~~~l~Df~~~~ 170 (316)
+++++|+|||.+.
T Consensus 184 ~~~i~LiDFg~a~ 196 (237)
T smart00090 184 DGKVVIIDVSQSV 196 (237)
T ss_pred CCCEEEEEChhhh
Confidence 8899999999874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.5e-20 Score=147.60 Aligned_cols=133 Identities=20% Similarity=0.199 Sum_probs=104.9
Q ss_pred EeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-----CCCCcceeeeEEEeCC---e-
Q psy11194 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-----KHPNLIRFLQAIETTH---R- 96 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~- 96 (316)
-.+.||+|++|.||. +..++.. +||++...... ..+.+.+|+.+++.+ .||||+++++++.++. .
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 346799999999995 6666555 79988664322 234578999999999 5799999999998874 3
Q ss_pred EEEEEec--CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHcCccccCCCCCCeeeCCC----CCeEEeecc
Q psy11194 97 VYIIMEY--AENGSLFDIIRGQGYIDEIRARRWFGQLLEAL-QYCHERGVVHRDIKCENLLLDSD----YNIKLSDFG 167 (316)
Q Consensus 97 ~~lv~e~--~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l-~~Lh~~~~~H~dl~p~nil~~~~----~~~~l~Df~ 167 (316)
+.+|+|| +.+++|.+++++. .+++. ..++.+++.++ +|||+.+++|+||+|+||+++.. +.++|+|++
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3478999 4478999999764 36665 35677888777 99999999999999999999743 479999954
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-21 Score=170.19 Aligned_cols=181 Identities=24% Similarity=0.424 Sum_probs=134.4
Q ss_pred EEEEEecCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQ---GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~---~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
+++.|++|...+|.+|+.+. ...+....+.++.|++.++.| ++.+|+|++|.||++..++.++|.|||+.....
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~ 407 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQD 407 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecc
Confidence 57888999999999999643 246777889999999999999 999999999999999999999999999987654
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
.+..............|+..|++||.+.+..+..+ +|||+||.+++||+. -.-++ ........++.+.-+|....
T Consensus 408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip~~~~~ 483 (516)
T KOG1033|consen 408 KDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIPPEFLQ 483 (516)
T ss_pred cCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCChHHhh
Confidence 33311111223334568999999999999888877 999999999999997 22222 12222333333332222222
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~ 284 (316)
-.++-..|+.+|| ..|.+||++-+..-|+|.+
T Consensus 484 d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 484 DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 3345568999999 5899999888888888764
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-19 Score=161.20 Aligned_cols=227 Identities=25% Similarity=0.417 Sum_probs=172.1
Q ss_pred HhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCc-cccCCCCCCe
Q psy11194 76 VKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGV-VHRDIKCENL 153 (316)
Q Consensus 76 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~-~H~dl~p~ni 153 (316)
++.+.|.|+.++++.+..+...+.|.+||..|+|.+.+.. ...++......++.+|+.|++|+|+..+ +||.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3567899999999999999999999999999999999977 4468999999999999999999999876 9999999999
Q ss_pred eeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCC------CCCCchhHHHHHHHHHHHHhCCC
Q psy11194 154 LLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIP------YAPHLSDIWSMGVVLFAMVFGRL 227 (316)
Q Consensus 154 l~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~ll~~l~~g~~ 227 (316)
+++..-.+|++|||+...... ...............|.|||.+.... ..+++.|+||+|++++++++...
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~----~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE----TAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred eeeeeEEEEechhhhcccccc----cccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999865432 11111122223456799999986631 13455899999999999999999
Q ss_pred CCCC----CCHHHHHHHHhcccCCCCC------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCC-CCCCCC--CCCChh
Q psy11194 228 PFDD----SSVNELLKQVQNKVTFPKQ------PEVSTECKELISNIL-SPVQTRPRLKTIAEDR-WLKPKP--KSRGVD 293 (316)
Q Consensus 228 p~~~----~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~-~~~~~~--~~~~~~ 293 (316)
||.. .++.++...+.++...+.. ...++++..++.+|+ .+|..||+++++-..- .+.... ...-++
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~~~nl~D 236 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSSKGNLMD 236 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccccchhHH
Confidence 9964 3445666666662222211 145568999999999 6899999999987432 222221 224577
Q ss_pred hHHHhHhHHHHHh
Q psy11194 294 KAEAELDHYIDMI 306 (316)
Q Consensus 294 ~~~~~~~~~~~~~ 306 (316)
.....+..|-+..
T Consensus 237 ~m~~~le~Y~~nL 249 (484)
T KOG1023|consen 237 SLFRMLESYADNL 249 (484)
T ss_pred HHHHHHHHHHhhh
Confidence 7777777776554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.6e-19 Score=144.46 Aligned_cols=136 Identities=22% Similarity=0.275 Sum_probs=113.0
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch-----HHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD-----YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
+.||+|++|.||+|.+ .|..+++|+......... .....+.+|+.++..+.+++++....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999976 577899998654332211 112346689999999999888777777777778899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
|++|++|.+++..... ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 9999999999876432 7889999999999999999999999999999998 7899999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=140.57 Aligned_cols=133 Identities=20% Similarity=0.243 Sum_probs=105.9
Q ss_pred eeeecCCeEEEEEEEccCCceEEEEEeecCCCCch-----HHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEec
Q psy11194 29 IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD-----YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 29 ~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
.||+|++|.||+|.. .|..+++|.......... .....+.+|+.++..+.++++.....++......+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999974 567899998654322111 1124567899999999887765555555566677899999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 104 AENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 104 ~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 7899999999999999999999999999998 88999999998743
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=140.53 Aligned_cols=137 Identities=21% Similarity=0.289 Sum_probs=107.6
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch-------------------HHHhhHHHHHHHHhcCCCC--
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD-------------------YLKKFLPREIEVVKGLKHP-- 82 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~-------------------~~~~~~~~e~~~l~~l~~~-- 82 (316)
|.+.+.||+|++|.||++... +|+.+++|+++....... ........|+.++..+.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999875 789999999865431110 0112356788888888766
Q ss_pred CcceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeE
Q psy11194 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIK 162 (316)
Q Consensus 83 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~ 162 (316)
.++..++ ....++||||++|++|..+... .....++.+++.++.++|+.|++|+||+|.||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4555443 2345899999999998765431 34567889999999999999999999999999999999999
Q ss_pred Eeecccccc
Q psy11194 163 LSDFGFARA 171 (316)
Q Consensus 163 l~Df~~~~~ 171 (316)
|+|||.+..
T Consensus 166 liDfg~~~~ 174 (198)
T cd05144 166 IIDWPQMVS 174 (198)
T ss_pred EEECCcccc
Confidence 999998844
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-17 Score=153.74 Aligned_cols=138 Identities=20% Similarity=0.245 Sum_probs=110.1
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC-----chHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP-----PDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
.|...+.||+|+||.||++.+... .+++|+....... .....+.+.+|+.++..++|++++....++......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 345678999999999999976543 4455443222111 111234577999999999999998877777777778
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
++||||++|++|.+++. ....++.+++.+|.+||+.|++|+||+|+||++ .++.++|+|||++..
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999876 356789999999999999999999999999999 678999999998853
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.1e-20 Score=169.42 Aligned_cols=261 Identities=30% Similarity=0.489 Sum_probs=207.4
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCC-ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHS-GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 98 (316)
...|.+.+.||.|.++.|-.+....+. ..++.|.+.... ........+..|..+-..+. |+|++.+++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 567889999999999999988765443 345666554443 23333445556788888886 999999999999999999
Q ss_pred EEEecCCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCCeeeCCCC-CeEEeeccccccccc
Q psy11194 99 IIMEYAENGSLFDII-RGQG-YIDEIRARRWFGQLLEALQYCH-ERGVVHRDIKCENLLLDSDY-NIKLSDFGFARAHMR 174 (316)
Q Consensus 99 lv~e~~~~~sL~~~l-~~~~-~l~~~~~~~i~~~i~~~l~~Lh-~~~~~H~dl~p~nil~~~~~-~~~l~Df~~~~~~~~ 174 (316)
+.+++..|+++.+-+ .... ..+......++.|+..++.|+| ..++.|+|++|+|.+++..+ ..++.|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999998 5544 5777888999999999999999 99999999999999999999 999999999987654
Q ss_pred ccCcCCCCCCCccccc-ccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHhc--ccCCCC
Q psy11194 175 CRSNAADNSLSETFCG-SYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL--KQVQN--KVTFPK 249 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~-~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~--~~~~~--~~~~~~ 249 (316)
. ...........| ++.|.|||...+..+.....|+||.|+++..+++|..|+......... ..... ......
T Consensus 178 ~---~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 178 K---NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred c---CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 1 122233334456 899999999988766666699999999999999999998754433321 11111 123445
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
+..++....+++.+++ .+|+.|.+.+++..++|+..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccccccccc
Confidence 5678999999999999 58999999999999999988
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=132.27 Aligned_cols=137 Identities=24% Similarity=0.309 Sum_probs=97.6
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhh---------------------HHHHHHHHhcCCCC--C
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKF---------------------LPREIEVVKGLKHP--N 83 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~---------------------~~~e~~~l~~l~~~--~ 83 (316)
.+.||+|++|.||+|.+. +++.|++|+.+............ ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 78899999987643322111111 13455555555433 3
Q ss_pred cceeeeEEEeCCeEEEEEecCCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCe
Q psy11194 84 LIRFLQAIETTHRVYIIMEYAENGSLFD-IIRGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNI 161 (316)
Q Consensus 84 i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~ 161 (316)
+++.++. ...++||||++++++.. .+.... .. ..+..++.+++.++.++|. .|++|+||+|+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4454443 23589999999854321 111111 11 5688999999999999999 9999999999999999 8899
Q ss_pred EEeecccccc
Q psy11194 162 KLSDFGFARA 171 (316)
Q Consensus 162 ~l~Df~~~~~ 171 (316)
+++|||.+..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999998854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=4e-16 Score=129.69 Aligned_cols=136 Identities=20% Similarity=0.268 Sum_probs=102.6
Q ss_pred eee-ecCCeEEEEEEEccCCceEEEEEeecCCC----------CchHHHhhHHHHHHHHhcCCCCCc--ceeeeEEEeCC
Q psy11194 29 IIG-TGSYATVKLARSTRHSGDVAIKIVSKVQA----------PPDYLKKFLPREIEVVKGLKHPNL--IRFLQAIETTH 95 (316)
Q Consensus 29 ~ig-~g~~g~vy~~~~~~~~~~v~vK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~~ 95 (316)
.|| .|+.|+||.+... +..++||....... ........+.+|+.++..+.++++ ++.+++.....
T Consensus 38 ~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred eeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 466 7888888888654 67899988753211 111223456789999999987774 66776654322
Q ss_pred ----eEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 96 ----RVYIIMEYAEN-GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 96 ----~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
..++|+|+++| .+|.+++... .+++.. +.+++.+|.+||+.|++|+||+|.|||++.++.++|+|||.+.
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 23599999997 6899888753 455543 5689999999999999999999999999998999999999874
Q ss_pred c
Q psy11194 171 A 171 (316)
Q Consensus 171 ~ 171 (316)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 3
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.9e-15 Score=135.13 Aligned_cols=171 Identities=16% Similarity=0.318 Sum_probs=135.0
Q ss_pred EE-EEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecCCCCCHHHHHHhC
Q psy11194 38 VK-LARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ 116 (316)
Q Consensus 38 vy-~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~ 116 (316)
+| .|..+.++.++.+.+...... ...+...+.++.++.++||+|+++++.+..+...|+|+|.+ ..|..++++.
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l 101 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL 101 (690)
T ss_pred cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh
Confidence 44 466677888999998866554 22455678899999999999999999999999999999999 3899999874
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCcc
Q psy11194 117 GYIDEIRARRWFGQLLEALQYCH-ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195 (316)
Q Consensus 117 ~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (316)
....+...+.||+.||.||| +++++|++|+-..|+++..|.++|.+|..+..... ...........-.|.
T Consensus 102 ---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~------~~~~~~~~~~~~s~~ 172 (690)
T KOG1243|consen 102 ---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG------FNAPAKSLYLIESFD 172 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc------CCcccccchhhhccc
Confidence 47788888999999999997 67899999999999999999999999988744211 111222333344567
Q ss_pred CcccccCCCCCCCchhHHHHHHHHHHHHhC
Q psy11194 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFG 225 (316)
Q Consensus 196 aPE~~~~~~~~~~~~Di~slG~ll~~l~~g 225 (316)
.|+.+....+ ..|.|.|||++++++.|
T Consensus 173 ~P~~~~~s~~---s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 173 DPEEIDPSEW---SIDSWGLGCLIEELFNG 199 (690)
T ss_pred ChhhcCcccc---chhhhhHHHHHHHHhCc
Confidence 7776544332 26999999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.5e-16 Score=119.89 Aligned_cols=131 Identities=23% Similarity=0.280 Sum_probs=109.8
Q ss_pred EeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC--CCcceeeeEEEeCCeEEEEEec
Q psy11194 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH--PNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
+++.||.|.++.||++.... ..+++|....... ...+.+|...++.+.+ ..+++++.+....+..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999998754 6899998755432 2346688999999965 5889999888888889999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc---CccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 104 AENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER---GVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 104 ~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
++|.++..+ +......++.+++.+++.||.. +++|+|++|+||+++..+.++++||+.+.
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 998777544 5566778899999999999985 69999999999999998999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.4e-14 Score=113.22 Aligned_cols=139 Identities=15% Similarity=0.222 Sum_probs=101.7
Q ss_pred eeeeeecCCeEEEEEEEcc------CCceEEEEEeecCCC-----------C------------chHHHhhHHHHHHHHh
Q psy11194 27 GKIIGTGSYATVKLARSTR------HSGDVAIKIVSKVQA-----------P------------PDYLKKFLPREIEVVK 77 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~------~~~~v~vK~~~~~~~-----------~------------~~~~~~~~~~e~~~l~ 77 (316)
...||.|.-+.||.|.... .+..+|||+.+.... . ........++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997654 357999999863211 0 0011123448999999
Q ss_pred cCC--CCCcceeeeEEEeCCeEEEEEecCCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHH-HHcCccccCCCCCCe
Q psy11194 78 GLK--HPNLIRFLQAIETTHRVYIIMEYAENGSLFD-IIRGQGYIDEIRARRWFGQLLEALQYC-HERGVVHRDIKCENL 153 (316)
Q Consensus 78 ~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~H~dl~p~ni 153 (316)
.+. .-.+++++++ ...++||||+.+..+.. .++ ...++......+..+++.++..| |+.|++||||++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 985 3566777764 45689999997643322 222 22356667788899999999988 899999999999999
Q ss_pred eeCCCCCeEEeecccccc
Q psy11194 154 LLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 154 l~~~~~~~~l~Df~~~~~ 171 (316)
++. ++.++++|||.+..
T Consensus 157 L~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EEE-CCcEEEEECCCcee
Confidence 996 57899999998854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.8e-15 Score=133.80 Aligned_cols=263 Identities=22% Similarity=0.262 Sum_probs=190.7
Q ss_pred eeeccCeEEeeeeee--cCCeEEEEEEE--ccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEE
Q psy11194 18 VLESHGYTVGKIIGT--GSYATVKLARS--TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIE 92 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~--g~~g~vy~~~~--~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 92 (316)
....+.+.+.+.+|. |.+|.+|.+.. ..++..+++|.-......+....... +|+...+.++ |++.++.+..+.
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~-~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKL-REFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccccccc-chhhcccccCccccccccCcccc
Confidence 344566778888999 99999999987 77888899987433222111112222 6677777775 899999889999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHH----HHHHHHHcCccccCCCCCCeeeCCC-CCeEEeec
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLE----ALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDF 166 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~----~l~~Lh~~~~~H~dl~p~nil~~~~-~~~~l~Df 166 (316)
..+..++-+|.+ +.+|..+...-. .++...++..+.+... ||.++|..+++|-|++|.||+...+ ...+++||
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 999999999999 568888886644 4889999999999999 9999999999999999999999988 78999999
Q ss_pred ccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-
Q psy11194 167 GFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV- 245 (316)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~- 245 (316)
|+.............. ......+...|++||...+.... ..|+|+||.++.+..++-.+....... .+.++....
T Consensus 268 ~~v~~i~~~~~~~~~~-~~~r~~~~~~Y~~ke~~~~l~~~--~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~i 343 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFK-VSKRPEGDCIYAAKELLNGLATF--ASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGYI 343 (524)
T ss_pred ceeEEccCCcccccee-eeecCCCCceEeChhhhccccch--HhhhcchhhhhHhhHhhcccccCCCCC-CccccccccC
Confidence 9887654332211111 11223467789999998774333 389999999999988765544322111 111122211
Q ss_pred CCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 246 TFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 246 ~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
+.......+.++...+..|+ .+|..|++.+.+..++++..+
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 12223456677777999999 589999999999999999743
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.54 E-value=3e-15 Score=140.61 Aligned_cols=274 Identities=20% Similarity=0.277 Sum_probs=201.7
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
...+++.+.+-+..|.++.++.+.-..+|.....|+............+.+..+-.++-.-.+|-++...-.+.......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 35677888889999999999988766666555555544322211111111112222222223455554444455677889
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+|++|+.+++|...+...+..+.+-.+.....+.+++++||...+.|+|++|.|.+...+|...+.||+......-....
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999999998887888888888899999999999999999999999999999999999999843222111000
Q ss_pred C-------------------------CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy11194 179 A-------------------------ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS 233 (316)
Q Consensus 179 ~-------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~ 233 (316)
. ..........+++.|.+||...+..+.+. .|+|+.|+.+++.++|..||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 00011233468899999999999888887 899999999999999999999999
Q ss_pred HHHHHHHHhccc-CCCC-CCCCCHHHHHHHHHhc-CCCCCCCCHH---HHhhCCCCCCCCCCCChh
Q psy11194 234 VNELLKQVQNKV-TFPK-QPEVSTECKELISNIL-SPVQTRPRLK---TIAEDRWLKPKPKSRGVD 293 (316)
Q Consensus 234 ~~~~~~~~~~~~-~~~~-~~~~~~~~~~li~~~l-~~p~~Rps~~---~il~~~~~~~~~~~~~~~ 293 (316)
+.++.+.+.... .++. +...+.+.++++..++ .+|.+|..+. ++..|+||++..-..-..
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccc
Confidence 999887776543 2232 2357899999999999 5899999998 999999999887755443
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.3e-14 Score=120.44 Aligned_cols=212 Identities=19% Similarity=0.280 Sum_probs=144.8
Q ss_pred HHHHhcCCCCCcceeeeEEEe-----CCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcC-
Q psy11194 73 IEVVKGLKHPNLIRFLQAIET-----THRVYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERG- 142 (316)
Q Consensus 73 ~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~- 142 (316)
+..+-++-|.|+++++.++.+ .....+.+||+..|+|..++++ +..+.....++|+-||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 455666678899999888754 3457899999999999999975 345888899999999999999999985
Q ss_pred -ccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHH
Q psy11194 143 -VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFA 221 (316)
Q Consensus 143 -~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~ 221 (316)
++|+++..+.|++..+|-+++.--.........+ ...........+.++|.+||.-..-+.+.. +|||++|+-..+
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~--~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAle 274 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVN--STREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALE 274 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhh--hhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHH
Confidence 8999999999999988878775322111100000 001111122335678999997655455554 999999988888
Q ss_pred HHhCCCCC-CCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 222 MVFGRLPF-DDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 222 l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
+..+..-- .+...-.....+... ....-...-+++|..|+ ..|..||+++.++.||.+-+.+....
T Consensus 275 mailEiq~tnseS~~~~ee~ia~~----i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslkl 342 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIANV----IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLKL 342 (458)
T ss_pred HHHheeccCCCcceeehhhhhhhh----eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecchHHH
Confidence 87765432 111111111111110 00112234456899999 58999999999999999987776544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.4e-13 Score=122.67 Aligned_cols=139 Identities=23% Similarity=0.236 Sum_probs=96.4
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch---------------------------HH----H------hhHH
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD---------------------------YL----K------KFLP 70 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~---------------------------~~----~------~~~~ 70 (316)
+.||.|+.|.||+|+.. +|+.||||+.++.....- .. . -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999875 689999999865321100 00 0 0233
Q ss_pred HHHHHHhcCC-----CCC--cceeeeEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHHc
Q psy11194 71 REIEVVKGLK-----HPN--LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLE-ALQYCHER 141 (316)
Q Consensus 71 ~e~~~l~~l~-----~~~--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~-~l~~Lh~~ 141 (316)
+|+..+..+. +++ +++++. ......++||||++|++|.++.... ...+ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555555542 233 233332 2234569999999999998876532 1222 3456666665 47889999
Q ss_pred CccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 142 ~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
|++|+|++|.||+++.+|.++++|||++...
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-13 Score=107.44 Aligned_cols=126 Identities=17% Similarity=0.121 Sum_probs=94.4
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCC-cceeeeEEEeCCeEEEEEecCC
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN-LIRFLQAIETTHRVYIIMEYAE 105 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~ 105 (316)
++.|+.|.++.||+++.. ++.+++|+....... ...+.+|+.+++.+...+ +++++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999765 778999987554321 223568888888885444 455555443 33579999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCc-----cccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 106 NGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV-----VHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 106 ~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~-----~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
|.++... . .....++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++||+.+
T Consensus 75 G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a 134 (170)
T cd05151 75 GSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA 134 (170)
T ss_pred CCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence 9887643 0 1123456789999999999885 9999999999998 678999999977
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.9e-13 Score=122.19 Aligned_cols=144 Identities=21% Similarity=0.306 Sum_probs=92.0
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC---------------------------ch----HHHhh---
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP---------------------------PD----YLKKF--- 68 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~---------------------------~~----~~~~~--- 68 (316)
.|.. +.||.|+.|.||+|+.+.+|+.||||+.++.... .. ...+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 6799999999999999888999999999754210 00 01111
Q ss_pred ---HHHHHHHHhcCC----CCCcceeeeEE-EeCCeEEEEEecCCCCCHHHHH--HhCCCCCHHHHHHHHHHHHH-HHHH
Q psy11194 69 ---LPREIEVVKGLK----HPNLIRFLQAI-ETTHRVYIIMEYAENGSLFDII--RGQGYIDEIRARRWFGQLLE-ALQY 137 (316)
Q Consensus 69 ---~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l--~~~~~l~~~~~~~i~~~i~~-~l~~ 137 (316)
+.+|+..+.++. +...+.+=.++ ......++||||++|+++.++- ...+ .+... ++...+. -+..
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~---la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKL---LAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHH---HHHHHHHHHHHH
Confidence 334444444442 22222221222 2244568999999999998753 3222 22222 2222222 2344
Q ss_pred HHHcCccccCCCCCCeeeCCCC----CeEEeecccccc
Q psy11194 138 CHERGVVHRDIKCENLLLDSDY----NIKLSDFGFARA 171 (316)
Q Consensus 138 Lh~~~~~H~dl~p~nil~~~~~----~~~l~Df~~~~~ 171 (316)
+...|++|+|++|.||+++.+| .++++|||++..
T Consensus 276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 5679999999999999999887 899999998743
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.1e-12 Score=99.65 Aligned_cols=133 Identities=20% Similarity=0.236 Sum_probs=99.7
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHH-----hhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLK-----KFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~-----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
..+.+|+-+.+|.+.+. |.++++|.-.+......... ..-.+|+.++..+..-+|....-+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999553 55677776544333333222 234478899999876566555556667777789999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
|++|..|.+++... ...++..+-..+.-||..|++||||.++||++... .+.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccc
Confidence 99999999888875 14566677777888999999999999999999655 49999999984
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.4e-13 Score=119.31 Aligned_cols=247 Identities=20% Similarity=0.194 Sum_probs=176.3
Q ss_pred cCeEEeeeeeecCCeEEEEEEEc-cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARST-RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 99 (316)
.+|..+..||.|.|+.++.+... .++..|++|...............+ .|+-+...+. |.+++++...+..-+..++
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCccccccccC
Confidence 46889999999999999988755 5677889988766544443333333 5566666664 8888888888877777789
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-CCeEEeecccccccccccCc
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~-~~~~l~Df~~~~~~~~~~~~ 178 (316)
--|||+++++...+.-...+++..++.+..|++.++-++|+..++|+|++|.||++..+ +..++.||++...+.
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~----- 418 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA----- 418 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc-----
Confidence 99999998887766544558888999999999999999999999999999999999775 678888998774311
Q ss_pred CCCCCCCcccccccCcc--CcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 179 AADNSLSETFCGSYAYA--SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~--aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
.........-++. +|.......+..+ .|+++||..+.+..++...-..... ...+..+ ..+..+....+
T Consensus 419 ----~~~~~~~~~~r~~p~~~~~~e~~~~~~~-~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~-~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 ----FSSGVFHHIDRLYPIAEILLEDYPHLSK-ADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSG-DTPNLPGLKLQ 489 (524)
T ss_pred ----eecccccccccccccchhhccccccccc-cccccccccccccccCcccCccccc---ceeeecc-cccCCCchHHh
Confidence 1111111233344 3444445556666 9999999999999998644322111 1122222 23444455578
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+..+..-++ .++..||++.++..|.=|
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchh
Confidence 888888888 588889999998877644
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.6e-11 Score=94.51 Aligned_cols=144 Identities=19% Similarity=0.180 Sum_probs=105.1
Q ss_pred EeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch-----HHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD-----YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.+..|-+|+-+.|+++.+. |+..+||.-........ -......+|++.+.++.--+|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 6778999999999999655 77777775432222211 1233456899999998754554444456666677899
Q ss_pred EecCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC---eEEeecccccc
Q psy11194 101 MEYAEN-GSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN---IKLSDFGFARA 171 (316)
Q Consensus 101 ~e~~~~-~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~---~~l~Df~~~~~ 171 (316)
|||++| .++.+++... ..........++.+|-..+.-||.++++||||..+||++.++|. +.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 4788888652 22333334788899999999999999999999999999976654 58999998743
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.7e-11 Score=105.26 Aligned_cols=211 Identities=18% Similarity=0.235 Sum_probs=153.5
Q ss_pred CCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE----eCCeEEEEEecCCC-CC
Q psy11194 34 SYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE----TTHRVYIIMEYAEN-GS 108 (316)
Q Consensus 34 ~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~lv~e~~~~-~s 108 (316)
-..+.|++....+|..|++|+++-...... .....-++.++++.|.|||++.++|. .+...++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 567899999999999999999944333221 12235588899999999999999886 34568999999987 57
Q ss_pred HHHHHH---------------hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 109 LFDIIR---------------GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 109 L~~~l~---------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
|.++.- ++...++..+|.++.|+..||.++|+.|+...-|.|.+|+++..-+++|+..|+.....
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 776652 12357889999999999999999999999999999999999988889998777664422
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHHhcccCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF--DDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
... . +-+.. .++-|.=.||.++..|.+|..-- .........+.+. .
T Consensus 445 ~d~------------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~--------~ 492 (655)
T KOG3741|consen 445 EDP------------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT--------T 492 (655)
T ss_pred CCC------------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh--------h
Confidence 111 0 11111 12279999999999999996441 2222222123322 3
Q ss_pred CCCHHHHHHHHHhcC-CCCCCCCHHHHhhC
Q psy11194 252 EVSTECKELISNILS-PVQTRPRLKTIAED 280 (316)
Q Consensus 252 ~~~~~~~~li~~~l~-~p~~Rps~~~il~~ 280 (316)
..+.+++++|.-+-. .+++ .++.+++.+
T Consensus 493 ~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 493 TYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 578889999988884 5666 788888755
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-11 Score=100.83 Aligned_cols=139 Identities=17% Similarity=0.198 Sum_probs=103.7
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC--CCcceeeeEEEeCC---eEEEEEe
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH--PNLIRFLQAIETTH---RVYIIME 102 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~---~~~lv~e 102 (316)
+.|+.|..+.+|++.... |+.+++|........ .....+.+|+.+++.+.+ ..+++++.+..... ..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998653 578999997554321 123457799999999965 34577777766532 5689999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE------------------------------------------ 140 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~------------------------------------------ 140 (316)
+++|.++...+.. ..++..+...++.+++++|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 346666777777777777777773
Q ss_pred --------------cCccccCCCCCCeeeCC--CCCeEEeeccccc
Q psy11194 141 --------------RGVVHRDIKCENLLLDS--DYNIKLSDFGFAR 170 (316)
Q Consensus 141 --------------~~~~H~dl~p~nil~~~--~~~~~l~Df~~~~ 170 (316)
..++|+|++|.||+++. ++.+.++||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999988 5668999999763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.2e-11 Score=98.69 Aligned_cols=137 Identities=24% Similarity=0.305 Sum_probs=104.4
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCC-------------------CCchHHHhhHHHHHHHHhcCCCC--
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQ-------------------APPDYLKKFLPREIEVVKGLKHP-- 82 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~-------------------~~~~~~~~~~~~e~~~l~~l~~~-- 82 (316)
+.+...||-|.-|.||.|.+. .|.++++|.-+... .+-.......++|..+|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 347788999999999999877 67899999875321 11122234567899999999643
Q ss_pred CcceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeE
Q psy11194 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIK 162 (316)
Q Consensus 83 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~ 162 (316)
.|++.++ .+...+|||+++|..|..+- ++......++..|+.-+..+-..|++|||+++-||+++++|.++
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 6666543 45668999999997665432 23556667777788777777799999999999999999999999
Q ss_pred Eeeccccc
Q psy11194 163 LSDFGFAR 170 (316)
Q Consensus 163 l~Df~~~~ 170 (316)
++||-.+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998763
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.7e-11 Score=94.00 Aligned_cols=127 Identities=23% Similarity=0.308 Sum_probs=83.5
Q ss_pred EEEEEEEccCCceEEEEEeecCC-----------------------CCchHHHhhHHHHHHHHhcCCCC--CcceeeeEE
Q psy11194 37 TVKLARSTRHSGDVAIKIVSKVQ-----------------------APPDYLKKFLPREIEVVKGLKHP--NLIRFLQAI 91 (316)
Q Consensus 37 ~vy~~~~~~~~~~v~vK~~~~~~-----------------------~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~ 91 (316)
.||.|... +|..+|+|+.+... .+........++|+..|..+... ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48888764 56799999986421 11122234577999999999754 567776543
Q ss_pred EeCCeEEEEEecCC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHcCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 92 ETTHRVYIIMEYAE--NGSLFDIIRGQGYIDEIRARRWFGQLLEALQY-CHERGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 92 ~~~~~~~lv~e~~~--~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~-Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
..++||||++ |..+..+.... ++......++.+++..+.. +|..|++||||++.||+++++ .+.++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2379999998 76666554432 2234567777888885444 689999999999999999877 999999998
Q ss_pred ccc
Q psy11194 169 ARA 171 (316)
Q Consensus 169 ~~~ 171 (316)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=7e-10 Score=93.42 Aligned_cols=138 Identities=17% Similarity=0.079 Sum_probs=96.8
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCchHH---------HhhHHHHHHHHhcCCCCC--cceeeeEEEe-----
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYL---------KKFLPREIEVVKGLKHPN--LIRFLQAIET----- 93 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~---------~~~~~~e~~~l~~l~~~~--i~~~~~~~~~----- 93 (316)
+.......|+++.. .|+.+.||........ ... .....+|+..+..|...+ +++++.++..
T Consensus 30 v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 30 FRELEGRRTLRFEL--AGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EecCCCceEEEEEE--CCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33444445666543 4678999966332211 000 112568888888885333 3445555543
Q ss_pred CCeEEEEEecCCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC-------CCCeEE
Q psy11194 94 THRVYIIMEYAENG-SLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS-------DYNIKL 163 (316)
Q Consensus 94 ~~~~~lv~e~~~~~-sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~-------~~~~~l 163 (316)
....++|+|++++. +|.+++.. ....+......++.+++..+..||+.|++|+|+++.|||++. ++.+.+
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 23578999999885 89999864 334667778899999999999999999999999999999974 467999
Q ss_pred eeccccc
Q psy11194 164 SDFGFAR 170 (316)
Q Consensus 164 ~Df~~~~ 170 (316)
+||+.+.
T Consensus 187 IDl~r~~ 193 (268)
T PRK15123 187 IDLHRAQ 193 (268)
T ss_pred EECCccc
Confidence 9999763
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.3e-12 Score=114.73 Aligned_cols=156 Identities=19% Similarity=0.291 Sum_probs=111.7
Q ss_pred HHHHHHHHHHHc-CccccCCCCCCeeeCCCCCeEEeecccccccccccC-cC-CC-CCCCcccccccCccCcccccCCCC
Q psy11194 130 QLLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS-NA-AD-NSLSETFCGSYAYASPEILQGIPY 205 (316)
Q Consensus 130 ~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~-~~-~~-~~~~~~~~~~~~~~aPE~~~~~~~ 205 (316)
+.+.|+.++|.. ++||++|.|++|+++.+|.+||+.|+++....+... .. .. ............|.|||++.. ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 344899999965 799999999999999999999999998865432111 00 11 111222234667999999988 44
Q ss_pred CCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHH---hcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 206 APHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQV---QNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 206 ~~~~~Di~slG~ll~~l~-~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
...++|+||||+++|.+. .|...+............ .....+-....+|.++++=+.++| .++.-||++..++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 444599999999999999 466555443322222222 222233344679999999999999 589999999999999
Q ss_pred CCCCCC
Q psy11194 281 RWLKPK 286 (316)
Q Consensus 281 ~~~~~~ 286 (316)
|||++-
T Consensus 266 ~ff~D~ 271 (700)
T KOG2137|consen 266 PFFSDP 271 (700)
T ss_pred cccCCc
Confidence 999764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.6e-09 Score=93.67 Aligned_cols=234 Identities=18% Similarity=0.248 Sum_probs=148.9
Q ss_pred EeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeee------EEEeCC-eE
Q psy11194 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQ------AIETTH-RV 97 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~------~~~~~~-~~ 97 (316)
....||+|+.+.+|..-.-. .-+.|+.+....... . +....+... .||-+-.-+. +...++ ..
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 45669999999999763221 235577655443211 1 223333333 3543322011 112222 36
Q ss_pred EEEEecCCCC-CHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 98 YIIMEYAENG-SLFDIIR------GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 98 ~lv~e~~~~~-sL~~~l~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
-++|..++|. ....+.+ ......+....+.+..++.+.+.||+.|-+-||+.++|+|+++++.|.|+|-+.-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 6788888765 2333332 23358888999999999999999999999999999999999999999999765432
Q ss_pred ccccccCcCCCCCCCcccccccCccCccccc-----CCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCC-------HHH-
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQ-----GIPYAPHLSDIWSMGVVLFAMVFG-RLPFDDSS-------VNE- 236 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~-------~~~- 236 (316)
. +......-...|...|.+||.-. +..-... .|.|.||+++++++.| +.||.+.. +.+
T Consensus 166 i-------~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 166 I-------NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred e-------ccCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 2 12233344556888999999753 3333334 8999999999999885 99997532 111
Q ss_pred -HH-------HHHhcccCCC----CCCCCCHHHHHHHHHhcC---CCCCCCCHHH
Q psy11194 237 -LL-------KQVQNKVTFP----KQPEVSTECKELISNILS---PVQTRPRLKT 276 (316)
Q Consensus 237 -~~-------~~~~~~~~~~----~~~~~~~~~~~li~~~l~---~p~~Rps~~~ 276 (316)
+. .+-..+...+ ...-+++.+..|..+|.. .+.-|||++.
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 10 0011111111 112478999999999984 3668999865
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.8e-09 Score=83.11 Aligned_cols=139 Identities=12% Similarity=0.110 Sum_probs=99.9
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCc---hHHHhhHHHHHHHHhcCCC--CCcceeeeEEEe----CCeEEEE
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP---DYLKKFLPREIEVVKGLKH--PNLIRFLQAIET----THRVYII 100 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~----~~~~~lv 100 (316)
-|+||-|.|++.... |..+-+|.-....... ..-...+.+|+..+..+.. -.++++...... .-.-++|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 356888999987554 3468888765211111 1113457799999998852 235555522222 1246899
Q ss_pred EecCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC--eEEeeccccc
Q psy11194 101 MEYAEN-GSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN--IKLSDFGFAR 170 (316)
Q Consensus 101 ~e~~~~-~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~--~~l~Df~~~~ 170 (316)
+|-++| .+|.+++.+. .+.+......++.+++.++..||+.|+.|+|+.+.||+++.+|. +.++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997854 5899998663 34678888999999999999999999999999999999987777 9999997553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=8e-09 Score=84.13 Aligned_cols=104 Identities=23% Similarity=0.283 Sum_probs=83.3
Q ss_pred hHHHHHHHHhcCCC--CCcceeeeEEEeCC----eEEEEEecCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11194 68 FLPREIEVVKGLKH--PNLIRFLQAIETTH----RVYIIMEYAENG-SLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140 (316)
Q Consensus 68 ~~~~e~~~l~~l~~--~~i~~~~~~~~~~~----~~~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~ 140 (316)
...+|...+..|.. =.+++.+.+..... ..++++|++++. +|.+++......+......++.+++..+..||.
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~ 136 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD 136 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence 35578887777743 33455666665432 458999999884 899999875447777889999999999999999
Q ss_pred cCccccCCCCCCeeeCCCC---CeEEeecccccc
Q psy11194 141 RGVVHRDIKCENLLLDSDY---NIKLSDFGFARA 171 (316)
Q Consensus 141 ~~~~H~dl~p~nil~~~~~---~~~l~Df~~~~~ 171 (316)
.|++|+|+++.|||++.++ .+.++||+-+..
T Consensus 137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999998887 799999997643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.9e-09 Score=84.82 Aligned_cols=142 Identities=22% Similarity=0.243 Sum_probs=93.3
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHh------hHHHHHHHHhcCCCC---Cccee
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKK------FLPREIEVVKGLKHP---NLIRF 87 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~------~~~~e~~~l~~l~~~---~i~~~ 87 (316)
-.+...+|.+.+.+-......|.+. ..+|+.+++|..+......+.... ...+++.....+... ....+
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 3456788999999988877666665 556889999998765443322111 112333333333221 22222
Q ss_pred eeE-----EEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeE
Q psy11194 88 LQA-----IETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIK 162 (316)
Q Consensus 88 ~~~-----~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~ 162 (316)
+.+ +......+++|||++|..|.+... +++ .+...+++++..||+.|++|||.+|.|++++.+ .++
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEE
Confidence 222 223345679999999988866532 222 244567788999999999999999999999854 599
Q ss_pred Eeecccc
Q psy11194 163 LSDFGFA 169 (316)
Q Consensus 163 l~Df~~~ 169 (316)
++|++..
T Consensus 175 iID~~~k 181 (229)
T PF06176_consen 175 IIDTQGK 181 (229)
T ss_pred EEECccc
Confidence 9999854
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.2e-08 Score=81.47 Aligned_cols=138 Identities=20% Similarity=0.194 Sum_probs=94.9
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchH---------------------HHhhHHHHHHHHhcCC--CCC
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDY---------------------LKKFLPREIEVVKGLK--HPN 83 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~---------------------~~~~~~~e~~~l~~l~--~~~ 83 (316)
...|+.|.-+.||+|.. .++..+|+|+.+........ ...+..+|+..|+.+. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34688899999999965 45789999999653322111 1234567888888874 334
Q ss_pred cceeeeEEEeCCeEEEEEecCCCCCH-HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCe
Q psy11194 84 LIRFLQAIETTHRVYIIMEYAENGSL-FDIIRGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNI 161 (316)
Q Consensus 84 i~~~~~~~~~~~~~~lv~e~~~~~sL-~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~ 161 (316)
+++.+.+.. -.+|||++....+ .-.++. -++...+...+..++++.+.-|-. .++||+||+.-|||+. ++.+
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 455544433 3789999954311 001111 123333677888888888888876 8999999999999998 8899
Q ss_pred EEeecccccc
Q psy11194 162 KLSDFGFARA 171 (316)
Q Consensus 162 ~l~Df~~~~~ 171 (316)
.++|++.+..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999998854
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.9e-08 Score=80.57 Aligned_cols=132 Identities=17% Similarity=0.133 Sum_probs=83.0
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC--CcceeeeEEEeCCeEEEEEecCC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP--NLIRFLQAIETTHRVYIIMEYAE 105 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~lv~e~~~ 105 (316)
..|++|..+.||+. .+..+++|..+.... ...+.+|.++++.+..- .+++.+++....+...+||++++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~-----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD-----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCC-----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999974 255788898754321 23357899999888633 35778888888788889999999
Q ss_pred CCC-HHHHHH--------------h------C---CCCCHHH-HHHHHHH----------HHH-HHHHHHH----cCccc
Q psy11194 106 NGS-LFDIIR--------------G------Q---GYIDEIR-ARRWFGQ----------LLE-ALQYCHE----RGVVH 145 (316)
Q Consensus 106 ~~s-L~~~l~--------------~------~---~~l~~~~-~~~i~~~----------i~~-~l~~Lh~----~~~~H 145 (316)
|.+ +...+. + . ...+... ...+-.+ +.. ...+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 221110 0 0 0111111 0111000 111 1122221 23789
Q ss_pred cCCCCCCeeeCCCCCeEEeecccc
Q psy11194 146 RDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 146 ~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
||++|.||++++++ +.++||+.+
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a 180 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDF 180 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhc
Confidence 99999999999887 999999976
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=7.5e-08 Score=87.91 Aligned_cols=137 Identities=26% Similarity=0.278 Sum_probs=93.4
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCC---------------------------chHH----Hh------hHH
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP---------------------------PDYL----KK------FLP 70 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~---------------------------~~~~----~~------~~~ 70 (316)
+.|+.++-|.||+|+.+. |+.||||+.++.-.. .... .+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 568899999999999875 999999999753110 0000 01 144
Q ss_pred HHHHHHhcCC-----CCC--cceeeeEEEeCCeEEEEEecCCCCCHHHHH--HhCCCCCHHHHHHHHHHHHHH-HHHHHH
Q psy11194 71 REIEVVKGLK-----HPN--LIRFLQAIETTHRVYIIMEYAENGSLFDII--RGQGYIDEIRARRWFGQLLEA-LQYCHE 140 (316)
Q Consensus 71 ~e~~~l~~l~-----~~~--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l--~~~~~l~~~~~~~i~~~i~~~-l~~Lh~ 140 (316)
+|+..+..++ .+. |+++ +++......++|||++|..+.+.. +. ...+... ++..++.+ +..+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V--~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKV--YWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEecee--ehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHh
Confidence 5665555552 233 2333 233345668999999999998884 44 3366444 33344433 444556
Q ss_pred cCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 141 ~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
.|++|+|.+|.||++..+|++.+.|||+...
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceec
Confidence 8999999999999999999999999998744
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.1e-07 Score=70.79 Aligned_cols=142 Identities=22% Similarity=0.253 Sum_probs=99.1
Q ss_pred hcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCc-ceeee
Q psy11194 11 DIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL-IRFLQ 89 (316)
Q Consensus 11 ~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~ 89 (316)
++...........-...+.|+.|.+|.||++.+. |..+++|+-+.... ...+..|++++..++..++ ++++.
T Consensus 11 ~~~i~~~~~~~~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~ 83 (201)
T COG2112 11 DIEILNVEEGKYELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYF 83 (201)
T ss_pred CeeeeeeeccchhhhhhhhhhcccccEEEEeecc--CceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEE
Confidence 3334334444445567788999999999999665 66999998765544 4557899999999986665 44555
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC-CCCeeeCCCCCeEEeeccc
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIK-CENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~-p~nil~~~~~~~~l~Df~~ 168 (316)
+..+ ++.|||+.|.+|.++.... +... ...++....-|...||-|+.|+ |..+++..++.+.|+||..
T Consensus 84 yg~~----~i~me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~ 152 (201)
T COG2112 84 YGED----FIRMEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDS 152 (201)
T ss_pred echh----hhhhhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccc
Confidence 4443 3459999998988776542 2223 3345555556778899999986 4445555556999999998
Q ss_pred cc
Q psy11194 169 AR 170 (316)
Q Consensus 169 ~~ 170 (316)
|+
T Consensus 153 At 154 (201)
T COG2112 153 AT 154 (201)
T ss_pred hh
Confidence 74
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.2e-07 Score=74.88 Aligned_cols=78 Identities=23% Similarity=0.215 Sum_probs=56.0
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC--CcceeeeEE---EeCCeEEEEE
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP--NLIRFLQAI---ETTHRVYIIM 101 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~---~~~~~~~lv~ 101 (316)
++.|+.|..+.||++.... +.+++|..... .....+.+|..+++.+... .+++++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4679999999999997664 59999996553 2345677888888888522 356666643 3344579999
Q ss_pred ecCCCCCHHH
Q psy11194 102 EYAENGSLFD 111 (316)
Q Consensus 102 e~~~~~sL~~ 111 (316)
++++|.++..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.4e-07 Score=74.35 Aligned_cols=76 Identities=16% Similarity=0.113 Sum_probs=53.5
Q ss_pred eeeecCC-eEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 29 IIGTGSY-ATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 29 ~ig~g~~-g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
.|..|.+ ..||++... +..+++|...... ...+.+|+.+++.+. +--+++++++....+..++||++++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 4555555 778988543 4688888875432 223557888888874 34467788887776778999999999
Q ss_pred CCHHHH
Q psy11194 107 GSLFDI 112 (316)
Q Consensus 107 ~sL~~~ 112 (316)
.+|...
T Consensus 77 ~~l~~~ 82 (244)
T cd05150 77 VPAAAL 82 (244)
T ss_pred ccHhHh
Confidence 887644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.3e-06 Score=84.74 Aligned_cols=205 Identities=17% Similarity=0.174 Sum_probs=141.5
Q ss_pred HHHHHHHHhcCCCCCcceeeeEEEeCCeEE----EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q psy11194 69 LPREIEVVKGLKHPNLIRFLQAIETTHRVY----IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVV 144 (316)
Q Consensus 69 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~----lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~ 144 (316)
...|...+....|+|++.++.+.......- +..++++..++...++.-+.++....+.+..++..|+.++|+..+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 446777788889999999998886544333 3457888889999999888899999999999999999999999776
Q ss_pred ccCCCCC---CeeeCCCCCeEEe--ecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCC-chhHHHHHHH
Q psy11194 145 HRDIKCE---NLLLDSDYNIKLS--DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPH-LSDIWSMGVV 218 (316)
Q Consensus 145 H~dl~p~---nil~~~~~~~~l~--Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Di~slG~l 218 (316)
|.-|..+ +.-.+..+.+... ||+....+.... ..........+.+||.......... .+|+|++|.+
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~-------~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE-------KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcc-------cchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 6666555 4444555666666 787765432211 1112223445677777654333222 2799999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCC-CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 219 LFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE-VSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 219 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
...+..|..+-.... . ....... ...+..++...|+ .++++|+++.+++.|+|.........
T Consensus 382 ~~~~~~~~~i~~~~~------~-----~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~ 445 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA------V-----PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES 445 (1351)
T ss_pred HhhhhhcCccccccc------c-----hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence 999988764422100 0 0111111 2227888999999 68999999999999999977655433
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.1e-06 Score=82.18 Aligned_cols=82 Identities=16% Similarity=0.193 Sum_probs=56.9
Q ss_pred EeeeeeecCCeEEEEEEEccCC--ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCc--ceeeeEEEeC---CeE
Q psy11194 26 VGKIIGTGSYATVKLARSTRHS--GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNL--IRFLQAIETT---HRV 97 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~~--~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~ 97 (316)
.++.++.|.+..+|+......+ ..+++|+......... ...+.+|+.+++.+. |.++ ++++.++.+. ...
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~--~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS--AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc--HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 4577899999999998765432 4678887543222111 235779999999995 5654 7777777654 467
Q ss_pred EEEEecCCCCCH
Q psy11194 98 YIIMEYAENGSL 109 (316)
Q Consensus 98 ~lv~e~~~~~sL 109 (316)
|+||||++|..+
T Consensus 120 flVME~v~G~~~ 131 (822)
T PLN02876 120 FYIMEYLEGRIF 131 (822)
T ss_pred eEEEEecCCccc
Confidence 899999988653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.2e-05 Score=64.49 Aligned_cols=131 Identities=21% Similarity=0.308 Sum_probs=91.7
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC-------------chHHHhhHHHHHHHHhcCC------CCCccee
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP-------------PDYLKKFLPREIEVVKGLK------HPNLIRF 87 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~-------------~~~~~~~~~~e~~~l~~l~------~~~i~~~ 87 (316)
...||+|+.-.||.- . .....+||+....... .........+|+..+..+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356999999999943 3 3446799999776600 0011233446666666555 7899999
Q ss_pred eeEEEeCCeEEEEEecCCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC--C
Q psy11194 88 LQAIETTHRVYIIMEYAEN------GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD--Y 159 (316)
Q Consensus 88 ~~~~~~~~~~~lv~e~~~~------~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~--~ 159 (316)
+|+.++....-+|+|.+.. .||.++++++. ++. ...+. +-.-..+|-+.+|+.+|++|.||++... +
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999987742 37999997654 655 33333 3344566789999999999999999643 2
Q ss_pred --CeEEee
Q psy11194 160 --NIKLSD 165 (316)
Q Consensus 160 --~~~l~D 165 (316)
.++|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.4e-06 Score=71.11 Aligned_cols=73 Identities=11% Similarity=0.079 Sum_probs=46.5
Q ss_pred eeeeecCCeE-EEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC---CcceeeeEEEeC---CeEEEE
Q psy11194 28 KIIGTGSYAT-VKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP---NLIRFLQAIETT---HRVYII 100 (316)
Q Consensus 28 ~~ig~g~~g~-vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv 100 (316)
+.|+.|+... ||+. +..+++|+.+.... ...+.+|..++..+... .++++++..... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~-----~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGY-----AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccch-----HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 4577666664 8876 23578887543211 33577899999887532 355555554332 245889
Q ss_pred EecCCCCCHH
Q psy11194 101 MEYAENGSLF 110 (316)
Q Consensus 101 ~e~~~~~sL~ 110 (316)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.34 E-value=4e-06 Score=76.60 Aligned_cols=137 Identities=25% Similarity=0.309 Sum_probs=89.4
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc----------------------------hHHHh------hHHHHH
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP----------------------------DYLKK------FLPREI 73 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~----------------------------~~~~~------~~~~e~ 73 (316)
+.|+..+.|.|++|+.+. |+.||||+-++.-... +...+ .+.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 568999999999999886 9999999986532110 00001 122444
Q ss_pred HHHhcC----CCCC------cceeeeEEEeCCeEEEEEecCCCCCHHHHH--HhCCCCCHHHHHHHHHHHHHH-HHHHHH
Q psy11194 74 EVVKGL----KHPN------LIRFLQAIETTHRVYIIMEYAENGSLFDII--RGQGYIDEIRARRWFGQLLEA-LQYCHE 140 (316)
Q Consensus 74 ~~l~~l----~~~~------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l--~~~~~l~~~~~~~i~~~i~~~-l~~Lh~ 140 (316)
+....+ +|-+ |++++..+. ....++|||++|..+.++- ++.+ ++... ++..+..+ +..+=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~---i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG-ISPHD---ILNKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC-CCHHH---HHHHHHHHHHHHHHh
Confidence 433333 2333 555544443 4568999999998776653 4433 66554 44444444 233456
Q ss_pred cCccccCCCCCCeeeCC----CCCeEEeecccccc
Q psy11194 141 RGVVHRDIKCENLLLDS----DYNIKLSDFGFARA 171 (316)
Q Consensus 141 ~~~~H~dl~p~nil~~~----~~~~~l~Df~~~~~ 171 (316)
.|++|+|-+|.||++.. ++.+.+-|+|+...
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 78999999999999984 56789999998754
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=8.8e-06 Score=70.15 Aligned_cols=82 Identities=10% Similarity=0.058 Sum_probs=58.8
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC---CCcceeeeEEEe---C
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH---PNLIRFLQAIET---T 94 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~ 94 (316)
+..-.-.+.||.|..+.||..... +..+++|..+.... ...+..|+..++.+.. -.++++++++.. .
T Consensus 13 ~~~~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 13 GEKLSRVECISEQPYAALWALYDS--QGNPMPLMARSFST-----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred chhhheeeecCCccceeEEEEEcC--CCCEEEEEeccccc-----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 335556678999999999998543 23577787533111 3457789999988852 468888888754 3
Q ss_pred CeEEEEEecCCCCCH
Q psy11194 95 HRVYIIMEYAENGSL 109 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL 109 (316)
+..++|||+++|.++
T Consensus 86 g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 86 GPDVLLLERLRGVSV 100 (297)
T ss_pred CCeEEEEeccCCEec
Confidence 568999999998765
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.9e-06 Score=72.87 Aligned_cols=135 Identities=16% Similarity=0.222 Sum_probs=96.0
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCC-------------------CchHHHhhHHHHHHHHhcCCC--C
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA-------------------PPDYLKKFLPREIEVVKGLKH--P 82 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~-------------------~~~~~~~~~~~e~~~l~~l~~--~ 82 (316)
+.+...||-|.-+.||.+.+. .|++.++|.-+.-.. |-....-...+|+..++.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567888999999999999755 578889987643211 111111224478888888742 2
Q ss_pred CcceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeE
Q psy11194 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIK 162 (316)
Q Consensus 83 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~ 162 (316)
-|++.+++ +..++|||++.|-+|..+-.- ..+..+...++.-+--|-+.|+||||+.--||++++++.++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 34444433 456899999988777654322 12445666777777788999999999999999999999999
Q ss_pred Eeecccc
Q psy11194 163 LSDFGFA 169 (316)
Q Consensus 163 l~Df~~~ 169 (316)
++||-..
T Consensus 243 vIDFPQm 249 (465)
T KOG2268|consen 243 VIDFPQM 249 (465)
T ss_pred EeechHh
Confidence 9999754
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.4e-05 Score=67.54 Aligned_cols=141 Identities=20% Similarity=0.252 Sum_probs=97.1
Q ss_pred EeeeeeecCCeEEEEEEEccCCceEEEEEeecCC-----------------------CCchHHHhhHHHHHHHHhcCCCC
Q psy11194 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQ-----------------------APPDYLKKFLPREIEVVKGLKHP 82 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~-----------------------~~~~~~~~~~~~e~~~l~~l~~~ 82 (316)
+-.+|+-|.-+.||.|. ..+|..+|||+..-.- .+..-..-+...|+..|.+++..
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 45668999999999986 4467789999884310 01111234566888888888766
Q ss_pred CcceeeeEEEeCCeEEEEEecCCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHH-HHcCccccCCCCCCeeeCCCCC
Q psy11194 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDI-IRGQGYIDEIRARRWFGQLLEALQYC-HERGVVHRDIKCENLLLDSDYN 160 (316)
Q Consensus 83 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~H~dl~p~nil~~~~~~ 160 (316)
+|+..--+.. ....+||+++.+ .=+.. .-+.-.++...+..+-.+++.-+.-| +.+++||.||+--|+|+ -+|.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred CCCCCCceee--ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 6544333333 234799999953 22211 11233477778888888888887776 46799999999999999 4678
Q ss_pred eEEeecccccc
Q psy11194 161 IKLSDFGFARA 171 (316)
Q Consensus 161 ~~l~Df~~~~~ 171 (316)
++++|.+.+..
T Consensus 303 lyiIDVSQSVE 313 (520)
T KOG2270|consen 303 LYIIDVSQSVE 313 (520)
T ss_pred EEEEEcccccc
Confidence 99999997743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.2e-05 Score=69.38 Aligned_cols=136 Identities=24% Similarity=0.228 Sum_probs=80.5
Q ss_pred EeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC--CcceeeeE------EEeCCeE
Q psy11194 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP--NLIRFLQA------IETTHRV 97 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~------~~~~~~~ 97 (316)
-.+.|..|....+|++.. .+..+++|+... .. ...+..|+.++..+... .+++++.. ....+..
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK--VS----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC--CC----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 356788888889998854 345789998754 11 23355677777777422 24444332 2334567
Q ss_pred EEEEecCCCCCHHH----HHH----------h--CC-CC--------CHHH--HH--------HHHHHHHHHHHHHHH--
Q psy11194 98 YIIMEYAENGSLFD----IIR----------G--QG-YI--------DEIR--AR--------RWFGQLLEALQYCHE-- 140 (316)
Q Consensus 98 ~lv~e~~~~~sL~~----~l~----------~--~~-~l--------~~~~--~~--------~i~~~i~~~l~~Lh~-- 140 (316)
++|+++++|.++.. ... . .+ .. .... .. .....+..++..+.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999876522 110 0 00 00 0000 00 011112233444443
Q ss_pred -----cCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 141 -----RGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 141 -----~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
.+++|+|++|.||++++++.+.|+||+.+
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 46999999999999998776789999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.15 E-value=6.6e-05 Score=66.85 Aligned_cols=82 Identities=16% Similarity=0.046 Sum_probs=54.6
Q ss_pred EEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCC---Cc-hHHHhhHHHHHHHHhcCC---CCCcceeeeEEEeCCeE
Q psy11194 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA---PP-DYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHRV 97 (316)
Q Consensus 25 ~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~---~~-~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~ 97 (316)
.-.+.||.|....||++.+...++.++||....... .. ....+....|...|..+. ..++++++.+.. ...
T Consensus 29 ~~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~ 106 (401)
T PRK09550 29 LTAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELA 106 (401)
T ss_pred ceeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCC
Confidence 345679999999999998864445899998642211 00 011344557788787763 346777777633 557
Q ss_pred EEEEecCCCCC
Q psy11194 98 YIIMEYAENGS 108 (316)
Q Consensus 98 ~lv~e~~~~~s 108 (316)
++|||++++..
T Consensus 107 ~lVME~L~~~~ 117 (401)
T PRK09550 107 VTVMEDLSDHK 117 (401)
T ss_pred EEEEecCCCcc
Confidence 89999997643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.13 E-value=5e-05 Score=63.16 Aligned_cols=75 Identities=13% Similarity=0.115 Sum_probs=48.3
Q ss_pred eeeeeecCCeEEEEEEEcc-CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC-CcceeeeEEEeCCeEEEEEecC
Q psy11194 27 GKIIGTGSYATVKLARSTR-HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP-NLIRFLQAIETTHRVYIIMEYA 104 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e~~ 104 (316)
++.|..|-...+|++.... .++.+++|+....... .-...+|+.++..+... -.++++..+. + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4668888888999986543 3568899976543211 11234788888888533 3455544432 2 4799999
Q ss_pred CCCCH
Q psy11194 105 ENGSL 109 (316)
Q Consensus 105 ~~~sL 109 (316)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.2e-07 Score=83.53 Aligned_cols=242 Identities=19% Similarity=0.147 Sum_probs=155.5
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCC-cceeeeEEEeCCeEEEEEe
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN-LIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e 102 (316)
+......++++.+.+++.+...+.... .+++... ....-++++|.+++||| .+..++.+..+...+++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 555666788999999988766554333 5555443 22446789999999999 7788888888899999999
Q ss_pred cCCCC-CHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 103 YAENG-SLFDII-RGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 103 ~~~~~-sL~~~l-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
++.++ +-.... .....+...+...++..-.++++++|+.-=+|+| ||+.. ++..+..||+....+.+.
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~----- 384 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRT----- 384 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcc-----
Confidence 99877 221111 1111244445666666777889999988667887 66554 467899999877543211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-C---CCCCCHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP-K---QPEVSTE 256 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~ 256 (316)
.......+++.++|||+.....+... .|+|++|.-..++.-|-.|-... ......+..+..-+ . ...-+.+
T Consensus 385 --~~~~t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~ 459 (829)
T KOG0576|consen 385 --MKPRTAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVF 459 (829)
T ss_pred --cccccCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCccc
Confidence 12334457889999999888777776 89999998766666666654331 00000000000000 0 0001111
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
-+++...|+ .-|..|+....++-|.+|+..+-.
T Consensus 460 ~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~ 493 (829)
T KOG0576|consen 460 HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLR 493 (829)
T ss_pred ccCCcccccCCCCCCCcchhhHHHHHHhccCccc
Confidence 123666777 468889999999999999877653
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.3e-05 Score=66.18 Aligned_cols=132 Identities=15% Similarity=0.151 Sum_probs=76.4
Q ss_pred eeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCC-cceeeeEEEeCCeEEEEEecCCCC
Q psy11194 29 IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN-LIRFLQAIETTHRVYIIMEYAENG 107 (316)
Q Consensus 29 ~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~~ 107 (316)
.+..|-.+.+|++. .+++.+++|......... .-...+|..+++.+...+ .++++.... .++|++|++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL---GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc---cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45678888899886 456688898754322111 012457888888885333 345554432 36899999987
Q ss_pred CHHH-----------HH---H---h----CCCCCHH-HHHHHHHHH---------HHHHHHHHH--------cCccccCC
Q psy11194 108 SLFD-----------II---R---G----QGYIDEI-RARRWFGQL---------LEALQYCHE--------RGVVHRDI 148 (316)
Q Consensus 108 sL~~-----------~l---~---~----~~~l~~~-~~~~i~~~i---------~~~l~~Lh~--------~~~~H~dl 148 (316)
++.. +. . . ..+++.. .+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6532 11 1 0 0111211 112221111 111222221 24899999
Q ss_pred CCCCeeeCCCCCeEEeeccccc
Q psy11194 149 KCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 149 ~p~nil~~~~~~~~l~Df~~~~ 170 (316)
.|.||++++++ +.++||..+.
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccC
Confidence 99999998876 7899998773
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.2e-05 Score=64.25 Aligned_cols=97 Identities=21% Similarity=0.185 Sum_probs=77.3
Q ss_pred HHHHHHhcCCC-CCcceeeeEEEeCCeEEEEEecCCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH---cCc
Q psy11194 71 REIEVVKGLKH-PNLIRFLQAIETTHRVYIIMEYAENGSLFDI---IRGQGYIDEIRARRWFGQLLEALQYCHE---RGV 143 (316)
Q Consensus 71 ~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~---l~~~~~l~~~~~~~i~~~i~~~l~~Lh~---~~~ 143 (316)
.|.-+++.+.+ +++++++|+|-. ++|.||...+++... +..--..++..+.+|+.+++..+.+|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 67888888864 699999999843 678899976665421 1111236889999999999999999997 347
Q ss_pred cccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 144 VHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 144 ~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
.-.|++|+|+-++.+|+++++|.+.+..
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 7799999999999999999999986643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00022 Score=56.98 Aligned_cols=129 Identities=19% Similarity=0.176 Sum_probs=88.1
Q ss_pred ccCeEEeeeeeecCC-eEEEEEEEccCCceEEEEEeecCCC-----------Cch-------HHHhhHHHHHHHHhcC--
Q psy11194 21 SHGYTVGKIIGTGSY-ATVKLARSTRHSGDVAIKIVSKVQA-----------PPD-------YLKKFLPREIEVVKGL-- 79 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~-g~vy~~~~~~~~~~v~vK~~~~~~~-----------~~~-------~~~~~~~~e~~~l~~l-- 79 (316)
+.+++.++.||.|.. |.||++... |+.+|+|+++.-.. ..+ ....-+..|.+..-.|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 378999999999999 999999665 67999999432100 000 1223355666665555
Q ss_pred -CCCCc--ceeeeEEEeC------------------CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q psy11194 80 -KHPNL--IRFLQAIETT------------------HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138 (316)
Q Consensus 80 -~~~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~L 138 (316)
.+.++ ++++|+..-. ....||.||.+... .++...+ .+|..-+..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~----~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDI----PQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHH----HHHHHHHHHH
Confidence 45566 8898887321 12467888876643 2344443 4555667779
Q ss_pred HHcCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 139 h~~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
|..||+-+|+++.|.. + -+|+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc---C--CEEEecccC
Confidence 9999999999999985 2 388999854
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00012 Score=63.47 Aligned_cols=139 Identities=19% Similarity=0.173 Sum_probs=79.7
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCC--cceeeeE------EEeCC
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN--LIRFLQA------IETTH 95 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~ 95 (316)
....+.++.|....+|++.. +++.+++|+.+.... .+.+..|..++..|...+ +++++.. ....+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~-----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVK-----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEe--CCCcEEEEEecCCCC-----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 44567788888889998853 344788998755322 122345566666663222 3444332 12345
Q ss_pred eEEEEEecCCCCCHH----HH-------HH---h--CC---C----CCHHHH----H-----------HHHHHHHHHHHH
Q psy11194 96 RVYIIMEYAENGSLF----DI-------IR---G--QG---Y----IDEIRA----R-----------RWFGQLLEALQY 137 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~----~~-------l~---~--~~---~----l~~~~~----~-----------~i~~~i~~~l~~ 137 (316)
..+++++|++|.++. .. +. . .+ . .....- . .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999885431 11 10 0 11 0 001100 0 001112234444
Q ss_pred HHH-------cCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 138 CHE-------RGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 138 Lh~-------~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
+.. .+++|+|+++.||+++.++.+.++||+.+
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 432 57999999999999998877789999976
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00012 Score=62.88 Aligned_cols=141 Identities=18% Similarity=0.172 Sum_probs=88.2
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC--CCcceeeeEEEeCC--eE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH--PNLIRFLQAIETTH--RV 97 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~--~~ 97 (316)
....+++.+..|....+|...+. +++++++ . +.............+|+.++..+.. --++..++.+..+. .+
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~-P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-K-PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEe-c-CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 34455566656655566666444 7788888 3 2222222224446688888888853 34555667776655 77
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHH-HHHHHHHHHHHH------------------------------------
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWF-GQLLEALQYCHE------------------------------------ 140 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~-~~i~~~l~~Lh~------------------------------------ 140 (316)
|.||+|++|..+.+-... .+.. .+.+ ..++..|+.||+
T Consensus 101 f~v~~~veGe~~~~~~~~---~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~ 175 (321)
T COG3173 101 FYVMEWVEGEVVWSALPP---ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGG 175 (321)
T ss_pred eEEEEEecceeccCcCCc---ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccC
Confidence 999999988533322211 0001 1222 245555555553
Q ss_pred ----------------------cCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 141 ----------------------RGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 141 ----------------------~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
-.++|||+++.|+++++++.+-++||+.+..
T Consensus 176 ~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 176 RIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 2489999999999999988899999998854
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00024 Score=61.99 Aligned_cols=29 Identities=41% Similarity=0.654 Sum_probs=24.9
Q ss_pred cCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 141 ~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
.+++|+|+.|.||+++.+...-++||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccc
Confidence 37999999999999986655689999976
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0003 Score=62.55 Aligned_cols=76 Identities=21% Similarity=0.113 Sum_probs=50.5
Q ss_pred EeeeeeecCCeEEEEEEEccCCceEEEEEeecCCC-----CchHHHhhHHHHHHHHhcCC---CCCcceeeeEEEeCCeE
Q psy11194 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA-----PPDYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHRV 97 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~ 97 (316)
..+.||.|....||++.+. ++.++||....... ++- ....-..|+..|+.+. ...+++++.++. ...
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl-~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPM-TKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccC-CccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence 4677999999999999763 45799998752111 111 1222335566666653 347888888877 445
Q ss_pred EEEEecCCC
Q psy11194 98 YIIMEYAEN 106 (316)
Q Consensus 98 ~lv~e~~~~ 106 (316)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 788999976
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00052 Score=59.39 Aligned_cols=76 Identities=14% Similarity=0.039 Sum_probs=48.3
Q ss_pred eeeeeecCCeEEEEEEEcc------CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC-CcceeeeEEEeCCeEEE
Q psy11194 27 GKIIGTGSYATVKLARSTR------HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP-NLIRFLQAIETTHRVYI 99 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~l 99 (316)
++.+..|-...+|++.... .++.+++|+....... .....+|..++..+... -.+++++++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL----LIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc----eechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3456677777899886543 2578999996553221 12345788888887532 24556665542 35
Q ss_pred EEecCCCCCHH
Q psy11194 100 IMEYAENGSLF 110 (316)
Q Consensus 100 v~e~~~~~sL~ 110 (316)
|++|++|.++.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00076 Score=59.00 Aligned_cols=75 Identities=15% Similarity=0.043 Sum_probs=47.5
Q ss_pred eeeecCCeEEEEEEEccCCceEEEEEeecC----C-CCchHHHhhHHHHHHHHhcCC--CC-CcceeeeEEEeCCeEEEE
Q psy11194 29 IIGTGSYATVKLARSTRHSGDVAIKIVSKV----Q-APPDYLKKFLPREIEVVKGLK--HP-NLIRFLQAIETTHRVYII 100 (316)
Q Consensus 29 ~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~----~-~~~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv 100 (316)
.||.|....||++.+...++.++||..... . .++- ..+....|...|+... .| ++++++. .++....+|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl-~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPL-TLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCC-CccHHHHHHHHHHHhhccCccccCeEEE--Eccccceeh
Confidence 579999999999997644468999986431 1 1111 1233446777777764 34 4555543 344556799
Q ss_pred EecCCC
Q psy11194 101 MEYAEN 106 (316)
Q Consensus 101 ~e~~~~ 106 (316)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00061 Score=60.32 Aligned_cols=77 Identities=16% Similarity=0.073 Sum_probs=50.0
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecC----CCCchHHHhhHHHHHHHHhcCC--CC-CcceeeeEEEeCCeEEE
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKV----QAPPDYLKKFLPREIEVVKGLK--HP-NLIRFLQAIETTHRVYI 99 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~----~~~~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~l 99 (316)
++.||.|.-..||++.+...++.++||..... ..++- ..+....|...|+... .| ++++++.+ ++....+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL-~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKL-STNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCC-ChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhH
Confidence 67899999999999987544568999876431 11111 1334456778887764 34 45556443 4455678
Q ss_pred EEecCCC
Q psy11194 100 IMEYAEN 106 (316)
Q Consensus 100 v~e~~~~ 106 (316)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 8988853
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00063 Score=61.43 Aligned_cols=157 Identities=22% Similarity=0.333 Sum_probs=104.0
Q ss_pred HHHHHHhcCCCCCcceeeeEEEeC-CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q psy11194 71 REIEVVKGLKHPNLIRFLQAIETT-HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIK 149 (316)
Q Consensus 71 ~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~ 149 (316)
-.+.+++.+.|++...++++.... ....+|+|++ +.||++.+..+. +-..... .|+-+.
T Consensus 31 gr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~~~~~~ 90 (725)
T KOG1093|consen 31 GRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------AHGVLH 90 (725)
T ss_pred hhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------ccccce
Confidence 567889999999999998887542 3478999999 559999987654 3222211 233221
Q ss_pred CCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy11194 150 CENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF 229 (316)
Q Consensus 150 p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~ 229 (316)
. |+ .+.+| .++.. | |-.+. + ++|||++|.++.++.-|...+
T Consensus 91 ~-~~-------~~~td-~~~t~----------------------~--~~~~~-----p-KsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 91 L-NI-------IYITD-HFLTK----------------------Y--PSPIG-----P-KSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred e-hh-------hhccc-ccccc----------------------C--CCCCC-----c-chhhhhHHHHHHHHHHhhHHH
Confidence 1 12 12222 11100 0 11111 1 499999999999999998888
Q ss_pred CCCCHHHHHHHHhcccCCCCC-----------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 230 DDSSVNELLKQVQNKVTFPKQ-----------PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
......+....+.+....+.. -.++....++...|+ -.|..||...++.+++-|...
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 776666666666554333321 236777888999999 589999999999999998654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0014 Score=57.83 Aligned_cols=138 Identities=16% Similarity=0.198 Sum_probs=80.0
Q ss_pred eEEeeeeeecCCeEEEEEEEcc----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCc-ceeeeEEEeCCeEE
Q psy11194 24 YTVGKIIGTGSYATVKLARSTR----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL-IRFLQAIETTHRVY 98 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~ 98 (316)
..-.+.|..|-...+|++.... .++.+++|+...... ...+ ..+|..+++.+...++ +++++.+...
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~---~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g---- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE---LFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG---- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC---eeec-hHHHHHHHHHHHHcCCCCceEEEECCc----
Confidence 3344556678888899986432 246789998755321 1122 2478888888853333 4566666432
Q ss_pred EEEecCCCCCHHHH-------H-------H---hCC------CCCHHHHHHHHHHH-----------------HHHHHHH
Q psy11194 99 IIMEYAENGSLFDI-------I-------R---GQG------YIDEIRARRWFGQL-----------------LEALQYC 138 (316)
Q Consensus 99 lv~e~~~~~sL~~~-------l-------~---~~~------~l~~~~~~~i~~~i-----------------~~~l~~L 138 (316)
.|.+|+++.+|... + . ... +.....+..+..++ ...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 47888887766421 1 0 000 11122233332211 1111122
Q ss_pred ----H----HcCccccCCCCCCeeeCC-CCCeEEeecccc
Q psy11194 139 ----H----ERGVVHRDIKCENLLLDS-DYNIKLSDFGFA 169 (316)
Q Consensus 139 ----h----~~~~~H~dl~p~nil~~~-~~~~~l~Df~~~ 169 (316)
. ...++|+|+++.||++++ ++.+.++||..+
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya 229 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYA 229 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence 1 125899999999999976 467999999876
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.001 Score=56.78 Aligned_cols=30 Identities=30% Similarity=0.430 Sum_probs=24.8
Q ss_pred CccccCCCCCCeeeCCCCC-eEEeecccccc
Q psy11194 142 GVVHRDIKCENLLLDSDYN-IKLSDFGFARA 171 (316)
Q Consensus 142 ~~~H~dl~p~nil~~~~~~-~~l~Df~~~~~ 171 (316)
.++|||++|.||+++++++ .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999987555 56999998743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0032 Score=55.21 Aligned_cols=136 Identities=15% Similarity=0.205 Sum_probs=77.2
Q ss_pred EeeeeeecCCeEEEEEEEccC---CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCc-ceeeeEEEeCCeEEEEE
Q psy11194 26 VGKIIGTGSYATVKLARSTRH---SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL-IRFLQAIETTHRVYIIM 101 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~ 101 (316)
.++.|..|-...+|++..... +..+++|+...... ...+ ..+|..+++.+..-++ +++++++.. . ++.
T Consensus 18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~ 89 (330)
T PLN02421 18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFGN--G--MIQ 89 (330)
T ss_pred EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeCC--c--Eee
Confidence 344565677778998865432 33788998754322 1112 3478888888864444 456666532 2 488
Q ss_pred ecCCCCCHHH-------HH-------Hh--CCC------C-CHHHHHHHHHHH----------------------HHHHH
Q psy11194 102 EYAENGSLFD-------II-------RG--QGY------I-DEIRARRWFGQL----------------------LEALQ 136 (316)
Q Consensus 102 e~~~~~sL~~-------~l-------~~--~~~------l-~~~~~~~i~~~i----------------------~~~l~ 136 (316)
+|++|.+|.. .+ ++ ... . ....+.++..++ ..-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 9988776522 11 10 100 1 122222222221 11111
Q ss_pred HHH----Hc----CccccCCCCCCeeeCC-CCCeEEeecccc
Q psy11194 137 YCH----ER----GVVHRDIKCENLLLDS-DYNIKLSDFGFA 169 (316)
Q Consensus 137 ~Lh----~~----~~~H~dl~p~nil~~~-~~~~~l~Df~~~ 169 (316)
.+. .. -++|+|+.+.||++++ ++.++++||..+
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 211 11 2799999999999975 578999999976
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0014 Score=55.96 Aligned_cols=76 Identities=17% Similarity=0.230 Sum_probs=49.2
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC---CCCcceeeeEEEeCCeEEEE
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv 100 (316)
-+-.+.++.|....+|+.. .+++.+.||+-.... ...+..|+.-|+.|. .-.+++++.+....+..+++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3455678999999999885 667899999976321 345778888888873 45688899999887888999
Q ss_pred EecCCCC
Q psy11194 101 MEYAENG 107 (316)
Q Consensus 101 ~e~~~~~ 107 (316)
+||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0062 Score=52.91 Aligned_cols=29 Identities=21% Similarity=0.238 Sum_probs=26.7
Q ss_pred CccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 142 GVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 142 ~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
+++|+|+.+.|+++++++.+.++||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.98 E-value=8.1e-05 Score=74.77 Aligned_cols=211 Identities=18% Similarity=0.100 Sum_probs=130.2
Q ss_pred HHHHHHhcCCCCCcceeeeEEE--eCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHc---
Q psy11194 71 REIEVVKGLKHPNLIRFLQAIE--TTHRVYIIMEYAENGSLFDIIRGQ----GYIDEIRARRWFGQLLEALQYCHER--- 141 (316)
Q Consensus 71 ~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~--- 141 (316)
.|..-++...|+++.....-.. ....-+.+++++.+|.+.+.+-++ .+++...+.....+.+....-+|+.
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 4444455566776665433332 222457788999999999998542 3344444443333335555555532
Q ss_pred C--ccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHH
Q psy11194 142 G--VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVL 219 (316)
Q Consensus 142 ~--~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll 219 (316)
| .+|.+|++.|.++..+.++++.++|+.++.. ......+...+++.|+.|+......++.+ +|+|.+|+.+
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn------p~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~l 1430 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN------PVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSL 1430 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccC------chHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHH
Confidence 2 6899999999999999999999999987322 22223344556778888998887777776 9999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 220 FAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 220 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
|.+..|..+|...........+..+..+..+...|.+.......+| -.-..||.-..++.-+.|.....
T Consensus 1431 y~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~~~ 1500 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVGLR 1500 (2724)
T ss_pred HHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccccccc
Confidence 9999998877543333322223222222222222222222233333 23445888888887777755443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0021 Score=52.46 Aligned_cols=29 Identities=34% Similarity=0.583 Sum_probs=20.6
Q ss_pred CccccCCCCCCeee-CCCCCeEEeeccccc
Q psy11194 142 GVVHRDIKCENLLL-DSDYNIKLSDFGFAR 170 (316)
Q Consensus 142 ~~~H~dl~p~nil~-~~~~~~~l~Df~~~~ 170 (316)
.++|+|+.|.||++ ..++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 888999999999773
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.011 Score=52.85 Aligned_cols=78 Identities=18% Similarity=0.122 Sum_probs=45.9
Q ss_pred EEeeeeeecCCeEEEEEEEccC-Cce-----EEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCc-ceeeeEEEeCCeE
Q psy11194 25 TVGKIIGTGSYATVKLARSTRH-SGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL-IRFLQAIETTHRV 97 (316)
Q Consensus 25 ~~~~~ig~g~~g~vy~~~~~~~-~~~-----v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~ 97 (316)
...+.|..|-...+|++..... +.. |.+++.. ...+... ...+|+.+++.+...++ +++++.+..
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g---~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~---- 124 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS---TYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD---- 124 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEecc---CCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence 3445676788889999975433 122 3333321 1111111 13478889999864444 566666643
Q ss_pred EEEEecCCCCCHH
Q psy11194 98 YIIMEYAENGSLF 110 (316)
Q Consensus 98 ~lv~e~~~~~sL~ 110 (316)
+++.||++|.+|.
T Consensus 125 g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 FTIQEWVEGNTMG 137 (383)
T ss_pred EEEEEEeccccCC
Confidence 5899999987664
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.012 Score=47.95 Aligned_cols=76 Identities=14% Similarity=0.205 Sum_probs=54.0
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC---CCCcceeeeEEEeCCeEEEEEec
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
.+.+..|.--..|.+.+. ..++.+|+-.... ...+..|+.-|+.+. .-.|++++.+.....+.++|++|
T Consensus 21 r~~v~gG~inea~~v~dg--~~~~FvK~n~~~~------~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~ 92 (286)
T COG3001 21 REEVSGGDINEAWRLRDG--TDPFFVKCNQREQ------LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY 92 (286)
T ss_pred ccccCCccccceeEeecC--CcceEEEecchhh------HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence 344666666667777544 3378888753321 345667777777663 46788999999999999999999
Q ss_pred CCCCCHH
Q psy11194 104 AENGSLF 110 (316)
Q Consensus 104 ~~~~sL~ 110 (316)
++.+++.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9987665
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.028 Score=49.04 Aligned_cols=133 Identities=21% Similarity=0.252 Sum_probs=75.4
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCC------cceeee----EEEeCCeEEE
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN------LIRFLQ----AIETTHRVYI 99 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~----~~~~~~~~~l 99 (316)
|.. .-..+|++... ++.+++|+.+.. .. ...+..|...+..+.... ++..-| ......+.+.
T Consensus 34 l~s-~eN~~f~~~~~--~g~~iLki~~~~-~~----~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 34 LNS-EENSNFRVQTE--DGRYILKIYRPG-WT----RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred ccc-ccCceEEEEec--CCCeEEEEecCC-CC----HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 444 45568888544 335599998775 22 334556777777763111 222222 1122247889
Q ss_pred EEecCCCCCHHH-----HHH--------------hCC--------CCCHH----H---------HHHHHHHHHHHHHHHH
Q psy11194 100 IMEYAENGSLFD-----IIR--------------GQG--------YIDEI----R---------ARRWFGQLLEALQYCH 139 (316)
Q Consensus 100 v~e~~~~~sL~~-----~l~--------------~~~--------~l~~~----~---------~~~i~~~i~~~l~~Lh 139 (316)
+++|++|..+.. .+. ... ...+. . -.....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999987772 110 000 01111 0 0112223333344443
Q ss_pred --------HcC--ccccCCCCCCeeeCCCCC-eEEeeccccc
Q psy11194 140 --------ERG--VVHRDIKCENLLLDSDYN-IKLSDFGFAR 170 (316)
Q Consensus 140 --------~~~--~~H~dl~p~nil~~~~~~-~~l~Df~~~~ 170 (316)
+.+ +||+|+.|.||+++.+.. +-++||+.+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 234 899999999999998875 8899999763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.012 Score=51.28 Aligned_cols=73 Identities=21% Similarity=0.309 Sum_probs=56.6
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
+..+.|++|++- |++|.-. ..-..+++..++.+++..+.-+..+ .+=|+|+...||+++ +|++-|+||.+++.
T Consensus 297 e~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 444678888877 5565422 1245667888999988888777654 689999999999999 99999999999874
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.025 Score=48.64 Aligned_cols=74 Identities=14% Similarity=0.053 Sum_probs=43.5
Q ss_pred eecCCeEEEEEEEcc----CCc----eEEEEEeecCCCCch--HHHhhHHHHHHHHhcCC-------------CCCccee
Q psy11194 31 GTGSYATVKLARSTR----HSG----DVAIKIVSKVQAPPD--YLKKFLPREIEVVKGLK-------------HPNLIRF 87 (316)
Q Consensus 31 g~g~~g~vy~~~~~~----~~~----~v~vK~~~~~~~~~~--~~~~~~~~e~~~l~~l~-------------~~~i~~~ 87 (316)
|.|-.|.+|++.... ++. .++||.........+ .....+.+|+.+++.+- ...++++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 566778888877543 222 578888652211111 12355778887776551 1235666
Q ss_pred eeEEEeCCeEEEEEecC
Q psy11194 88 LQAIETTHRVYIIMEYA 104 (316)
Q Consensus 88 ~~~~~~~~~~~lv~e~~ 104 (316)
+.........++|||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 66665555678888766
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.66 Score=47.18 Aligned_cols=29 Identities=45% Similarity=0.608 Sum_probs=24.6
Q ss_pred cCccccCCCCCCeeeCCCC--CeE-Eeecccc
Q psy11194 141 RGVVHRDIKCENLLLDSDY--NIK-LSDFGFA 169 (316)
Q Consensus 141 ~~~~H~dl~p~nil~~~~~--~~~-l~Df~~~ 169 (316)
.++||+|+.+.||+++.++ .+. |+|||-+
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa 234 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDA 234 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccc
Confidence 4699999999999998775 454 9999976
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.016 Score=48.60 Aligned_cols=78 Identities=17% Similarity=0.141 Sum_probs=53.5
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEecC-CC
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA-EN 106 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 106 (316)
..+..|..+.|+.++ ..+|.+.++|+......... + . .....|+..+..+.+++++.-. ....+++|++ ++
T Consensus 8 ~~~~~g~~s~V~pv~-~~dG~~avLKl~~p~~~~~~---E-~-~g~~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~g 79 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVR-RADGTPAVLKLAPPHAEAEH---E-A-RGEAALRWWNGRGAVRLLAADP--ERGALLLERLDPG 79 (253)
T ss_pred CCCCCCcceEEEEEE-cCCCCeEEEEecCCcccchh---h-h-hHHhHhheeCCCCceeeecccc--ccchhhhhhccCC
Confidence 446678999999997 44688999999865433211 0 1 1225588888888999887764 3457888998 55
Q ss_pred CCHHHHH
Q psy11194 107 GSLFDII 113 (316)
Q Consensus 107 ~sL~~~l 113 (316)
.+|.++.
T Consensus 80 ~~L~~~~ 86 (253)
T PF04655_consen 80 RSLASLP 86 (253)
T ss_pred Cchhhcc
Confidence 5776554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.023 Score=50.35 Aligned_cols=61 Identities=16% Similarity=0.199 Sum_probs=46.9
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCCeeeCCC
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH-ERGVVHRDIKCENLLLDSD 158 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~H~dl~p~nil~~~~ 158 (316)
..++-+|..|.++..+++..+ .++..+++++.-.++|+-.+- --+++|.|++|.||++..+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 456777888999999998654 556677777777777765544 5689999999999999644
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.052 Score=49.48 Aligned_cols=76 Identities=18% Similarity=0.060 Sum_probs=46.4
Q ss_pred EeeeeeecCCeEEEEEEEccC--------CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCc-ceeeeEEEeCCe
Q psy11194 26 VGKIIGTGSYATVKLARSTRH--------SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL-IRFLQAIETTHR 96 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~ 96 (316)
-++.|..|-.-.+|++..... ++.|++++...... ... ...+|..+++.+...++ +++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te---~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD---ELY-NPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc---cee-CHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 566777888888998875422 45788887644221 112 23467777777754344 34555553
Q ss_pred EEEEEecCCCCCH
Q psy11194 97 VYIIMEYAENGSL 109 (316)
Q Consensus 97 ~~lv~e~~~~~sL 109 (316)
-..+.+|++|.+|
T Consensus 181 gg~I~efi~g~~l 193 (442)
T PTZ00296 181 GGRIEEWLYGDPL 193 (442)
T ss_pred CCEEEEeeCCccC
Confidence 2457889987644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 316 | ||||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-55 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-54 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-54 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-54 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-54 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-54 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-53 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-53 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-53 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-51 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-44 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-44 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-44 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-44 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-44 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-43 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-43 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-42 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-39 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-38 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-38 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-37 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-37 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-37 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-37 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-37 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-37 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-37 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-37 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-37 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-37 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-37 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-37 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-37 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-37 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-37 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-37 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-36 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-36 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-36 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-36 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-36 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-36 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-36 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-36 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-36 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-36 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-36 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-36 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-36 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-36 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-35 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-35 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-35 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-34 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-34 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-34 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-34 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-33 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-33 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-33 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-33 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-33 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-33 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-33 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-33 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-33 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-33 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-32 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-32 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-32 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-32 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-32 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-32 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-32 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-32 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-32 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-32 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-32 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-32 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-32 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-32 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-32 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-32 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-32 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-31 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-31 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-31 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-31 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-31 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-31 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-31 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-31 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-31 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-31 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-31 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-31 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-31 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-31 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-31 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-31 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-31 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-31 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-31 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-31 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-31 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-31 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-31 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-31 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-31 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-31 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-31 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-31 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-31 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-31 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-31 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-31 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-31 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-31 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-31 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-31 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-30 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-30 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-30 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-30 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-30 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-30 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-30 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-30 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-30 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-30 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-30 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-30 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-29 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-29 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-29 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-29 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-29 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-29 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-29 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-29 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-28 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-28 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-28 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-28 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-28 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-28 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-28 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-28 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-28 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-28 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-28 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-28 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-28 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-28 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-27 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-27 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-27 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-27 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-27 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-27 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-27 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-27 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-27 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-27 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-27 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-27 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-27 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-27 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-27 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-27 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-27 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-26 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-26 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-26 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-26 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-26 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-26 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-25 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-25 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-25 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-25 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-25 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-25 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-25 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-25 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-25 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-25 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-25 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-25 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-25 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-25 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-25 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-25 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-25 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-25 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-25 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-25 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-25 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-25 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-25 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-25 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-25 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-25 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-25 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-25 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-25 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-25 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-25 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-25 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-25 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-25 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-25 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-25 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-25 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-25 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-25 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-25 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-25 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-25 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-25 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-25 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-25 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-25 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-25 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-24 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-24 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-24 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-24 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-24 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-24 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-24 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-24 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-24 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-24 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-24 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-24 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-24 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-24 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-24 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-24 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-24 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-24 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-24 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-24 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-24 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-24 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-24 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-24 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-24 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-24 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-24 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-24 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-24 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-24 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-24 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-24 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-24 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-23 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-23 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-23 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-23 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-23 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-23 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-23 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-23 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-23 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-23 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-23 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-23 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-23 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-23 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-23 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-23 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-23 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-23 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-23 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-23 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-22 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-22 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-22 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-22 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-22 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-22 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-22 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-21 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-21 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-21 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-21 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-21 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-21 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-21 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-21 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-21 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-21 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-21 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-21 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-21 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-21 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-21 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-21 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-21 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-21 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-21 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-21 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-21 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-21 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-21 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-21 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-20 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-20 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-20 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-20 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-20 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-20 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-20 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-20 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-20 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-20 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-20 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-20 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-20 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-20 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-20 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-20 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-20 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-20 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-20 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-20 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-19 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-19 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-19 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-19 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-19 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-19 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-19 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-19 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-19 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-19 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-19 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-19 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-19 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-19 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-19 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-19 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-19 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-18 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-18 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-18 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-18 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-18 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-18 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-18 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-18 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-18 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-18 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-18 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-18 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-18 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-18 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-18 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-18 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-18 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-18 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-18 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-18 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-18 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-18 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-18 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-18 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-18 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-18 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-18 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-17 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-17 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-17 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-17 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-17 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-17 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-17 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-17 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-17 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-16 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-16 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-16 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-16 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-14 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-14 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-14 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-13 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-12 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-12 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-12 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 |
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = e-102
Identities = 112/295 (37%), Positives = 164/295 (55%), Gaps = 12/295 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + K IG G++A VKLAR +VAIKI+ K Q P L+K L RE+ ++K L HPN
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIMKILNHPN 75
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+++ + IET +Y+IMEYA G +FD + G + E AR F Q++ A+QYCH++ +
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRI 135
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
VHRD+K ENLLLD+D NIK++DFGF+ + FCG+ YA+PE+ QG
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFS-NEFT------VGGKLDAFCGAPPYAAPELFQGK 188
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKELIS 262
Y D+WS+GV+L+ +V G LPFD ++ EL ++V K P +ST+C+ L+
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYMSTDCENLLK 246
Query: 263 NILSP-VQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMIQTSASSTDGY 316
L R L+ I +DRW+ + + D + GY
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGY 301
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 6e-99
Identities = 96/268 (35%), Positives = 144/268 (53%), Gaps = 11/268 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y +G +G G++ VK+ VA+KI+++ + + + REI+ +K +HP+
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+I+ Q I T +++MEY G LFD I G ++E+ ARR F Q+L A+ YCH V
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
VHRD+K EN+LLD+ N K++DFG + M D T CGS YA+PE++ G
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLS-NMMS------DGEFLRTSCGSPNYAAPEVISGR 185
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKELIS 262
YA DIWS GV+L+A++ G LPFDD V L K+++ P ++ L+
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP--EYLNRSVATLLM 243
Query: 263 NILSP-VQTRPRLKTIAEDRWLKPKPKS 289
++L R +K I E W K S
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQDLPS 271
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 1e-98
Identities = 85/264 (32%), Positives = 129/264 (48%), Gaps = 9/264 (3%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + + +G G+Y V+LA + VA+KIV +A + +EI + K L H N
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHEN 66
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+++F + Y+ +EY G LFD I + E A+R+F QL+ + Y H G+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
HRDIK ENLLLD N+K+SDFG A R + L CG+ Y +PE+L+
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLA-TVFRYNNR---ERLLNKMCGTLPYVAPELLKRR 182
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN--ELLKQVQNKVTFPKQPEVSTECKELI 261
+ D+WS G+VL AM+ G LP+D S + E + K ++ + L+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 262 SNILSP-VQTRPRLKTIAEDRWLK 284
IL R + I +DRW
Sbjct: 243 HKILVENPSARITIPDIKKDRWYN 266
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 7e-98
Identities = 85/264 (32%), Positives = 128/264 (48%), Gaps = 9/264 (3%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + + +G G+Y V+LA + VA+KIV +A + +EI + K L H N
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHEN 66
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+++F + Y+ +EY G LFD I + E A+R+F QL+ + Y H G+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
HRDIK ENLLLD N+K+SDFG A R + L CG+ Y +PE+L+
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLA-TVFRYNNR---ERLLNKMCGTLPYVAPELLKRR 182
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSS--VNELLKQVQNKVTFPKQPEVSTECKELI 261
+ D+WS G+VL AM+ G LP+D S E + K ++ + L+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 262 SNILSP-VQTRPRLKTIAEDRWLK 284
IL R + I +DRW
Sbjct: 243 HKILVENPSARITIPDIKKDRWYN 266
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 1e-97
Identities = 77/275 (28%), Positives = 136/275 (49%), Gaps = 12/275 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ VG ++G GS+A V A S +VAIK++ K + + + E+++ LKHP+
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERG 142
++ E ++ VY+++E NG + ++ + E AR + Q++ + Y H G
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
++HRD+ NLLL + NIK++DFG A ++ + T CG+ Y SPEI
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLA-TQLK-----MPHEKHYTLCGTPNYISPEIATR 186
Query: 203 IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKELI 261
+ SD+WS+G + + ++ GR PFD +V L +V P +S E K+LI
Sbjct: 187 SAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP--SFLSIEAKDLI 243
Query: 262 SNILSPV-QTRPRLKTIAEDRWLKPKPKSRGVDKA 295
+L R L ++ + ++ ++ D+
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 2e-97
Identities = 65/263 (24%), Positives = 121/263 (46%), Gaps = 11/263 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y G+ +G G +A A KIV K + ++ + EI + + L H +
Sbjct: 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ F E V++++E SL ++ + + + E AR + Q++ QY H V
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 162
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRD+K NL L+ D +K+ DFG A D + CG+ Y +PE+L
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVE------YDGERKKVLCGTPNYIAPEVLSKK 216
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKELIS 262
++ D+WS+G +++ ++ G+ PF+ S + E ++ +N+ + P ++ LI
Sbjct: 217 GHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--KHINPVAASLIQ 273
Query: 263 NILSPV-QTRPRLKTIAEDRWLK 284
+L RP + + D +
Sbjct: 274 KMLQTDPTARPTINELLNDEFFT 296
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 2e-97
Identities = 65/263 (24%), Positives = 121/263 (46%), Gaps = 11/263 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y G+ +G G +A A KIV K + ++ + EI + + L H +
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ F E V++++E SL ++ + + + E AR + Q++ QY H V
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 136
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRD+K NL L+ D +K+ DFG A D + CG+ Y +PE+L
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEY------DGERKKVLCGTPNYIAPEVLSKK 190
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKELIS 262
++ D+WS+G +++ ++ G+ PF+ S + E ++ +N+ + P ++ LI
Sbjct: 191 GHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--KHINPVAASLIQ 247
Query: 263 NILSPV-QTRPRLKTIAEDRWLK 284
+L RP + + D +
Sbjct: 248 KMLQTDPTARPTINELLNDEFFT 270
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 5e-96
Identities = 86/269 (31%), Positives = 131/269 (48%), Gaps = 19/269 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y K IG+G++ +L R VA+K + + A + ++ REI + L+HPN
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ----REIINHRSLRHPN 77
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++RF + I T + IIMEYA G L++ I G E AR +F QLL + YCH +
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 144 VHRDIKCENLLLDSDY--NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
HRD+K EN LLD +K+ DFG++ +S ++ G+ AY +PE+L
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYS-KSSV------LHSQPKSTVGTPAYIAPEVLL 190
Query: 202 GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-----TFPKQPEVSTE 256
Y ++D+WS GV L+ M+ G PF+D ++ ++ + P +S E
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250
Query: 257 CKELISNILSP-VQTRPRLKTIAEDRWLK 284
C LIS I TR + I W
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 2e-95
Identities = 93/263 (35%), Positives = 144/263 (54%), Gaps = 12/263 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + + +G GS+ VKLA + VA+K +S+ + + REI +K L+HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+I+ I T + +++EYA G LFD I + + E RR+F Q++ A++YCH +
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
VHRD+K ENLLLD + N+K++DFG + M D + +T CGS YA+PE++ G
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLS-NIMT------DGNFLKTSCGSPNYAAPEVINGK 182
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKELIS 262
YA D+WS G+VL+ M+ GRLPFDD + L K+V + P +S + LI
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP--DFLSPGAQSLIR 240
Query: 263 NILSP-VQTRPRLKTIAEDRWLK 284
++ R ++ I D W
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFN 263
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 3e-95
Identities = 96/283 (33%), Positives = 147/283 (51%), Gaps = 11/283 (3%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y +G +G G++ VK+ + VA+KI+++ + + + REI+ +K +HP+
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+I+ Q I T ++++MEY G LFD I G +DE +RR F Q+L + YCH V
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
VHRD+K EN+LLD+ N K++DFG + M D T CGS YA+PE++ G
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLS-NMMS------DGEFLRTSCGSPNYAAPEVISGR 190
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKELIS 262
YA DIWS GV+L+A++ G LPFDD V L K++ + P ++ L+
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP--QYLNPSVISLLK 248
Query: 263 NILSP-VQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYID 304
++L R +K I E W K + + ID
Sbjct: 249 HMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMID 291
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 2e-94
Identities = 78/290 (26%), Positives = 145/290 (50%), Gaps = 36/290 (12%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSK----------VQAPPDYLKKFLP--- 70
YT+ IG GSY VKLA + + A+K++SK + PP +
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 71 ----------REIEVVKGLKHPNLIRFLQAIE--TTHRVYIIMEYAENGSLFDIIRGQGY 118
+EI ++K L HPN+++ ++ ++ +Y++ E G + ++
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKP 133
Query: 119 IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178
+ E +AR +F L++ ++Y H + ++HRDIK NLL+ D +IK++DFG +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG---- 189
Query: 179 AADNSLSETFCGSYAYASPEILQGI--PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE 236
++L G+ A+ +PE L ++ D+W+MGV L+ VFG+ PF D +
Sbjct: 190 --SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 237 LLKQVQN-KVTFPKQPEVSTECKELISNILSP-VQTRPRLKTIAEDRWLK 284
L ++++ + FP QP+++ + K+LI+ +L ++R + I W+
Sbjct: 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 2e-93
Identities = 74/274 (27%), Positives = 133/274 (48%), Gaps = 17/274 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSK--VQAPPDYLKKFLPREIEVVKGLKH 81
Y +G ++G GSY VK + A+KI+ K ++ P+ + +EI++++ L+H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRH 65
Query: 82 PNLIRFLQAI--ETTHRVYIIMEYAENGS--LFDIIRGQGYIDEIRARRWFGQLLEALQY 137
N+I+ + + E ++Y++MEY G + D + + +A +F QL++ L+Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEY 124
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H +G+VH+DIK NLLL + +K+S G A A + T GS A+ P
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA----ADDTCRTSQGSPAFQPP 180
Query: 198 EILQGI-PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVST 255
EI G+ ++ DIWS GV L+ + G PF+ ++ +L + + P +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP--GDCGP 238
Query: 256 ECKELISNILSP-VQTRPRLKTIAEDRWLKPKPK 288
+L+ +L R ++ I + W + K
Sbjct: 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 3e-93
Identities = 81/271 (29%), Positives = 134/271 (49%), Gaps = 25/271 (9%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQ----APPDYLKKFLPREIEVVKGL 79
Y VG ++G+G + +V + VAIK V K + + +P E+ ++K +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKV 103
Query: 80 KH--PNLIRFLQAIETTHRVYIIMEYAEN-GSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
+IR L E +I+E E LFD I +G + E AR +F Q+LEA++
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 137 YCHERGVVHRDIKCENLLLDSDY-NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
+CH GV+HRDIK EN+L+D + +KL DFG +++ F G+ Y+
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGS--------GALLKDTVYTDFDGTRVYS 215
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255
PE ++ Y + +WS+G++L+ MV G +PF+ + ++ +V F VS+
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQVFFR--QRVSS 268
Query: 256 ECKELISNILSP-VQTRPRLKTIAEDRWLKP 285
EC+ LI L+ RP + I W++
Sbjct: 269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 1e-92
Identities = 86/301 (28%), Positives = 141/301 (46%), Gaps = 21/301 (6%)
Query: 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKF-----LPREIEV 75
S Y+ +G+G++ V A + +V +K + K + D + + EI +
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 76 VKGLKHPNLIRFLQAIETTHRVYIIMEYAENGS-LFDIIRGQGYIDEIRARRWFGQLLEA 134
+ ++H N+I+ L E ++ME +G LF I +DE A F QL+ A
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194
+ Y + ++HRDIK EN+++ D+ IKL DFG A A++ L TFCG+ Y
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLE------RGKLFYTFCGTIEY 195
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254
+PE+L G PY ++WS+GV L+ +VF PF + L + V+ + P VS
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE-----LEETVEAAIHPP--YLVS 248
Query: 255 TECKELISNILSP-VQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMIQTSASST 313
E L+S +L P + R L+ + D W+ E + + SA+S
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASL 308
Query: 314 D 314
+
Sbjct: 309 E 309
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 4e-92
Identities = 88/263 (33%), Positives = 143/263 (54%), Gaps = 13/263 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ +G+ +G G + V LAR ++ +A+K++ K Q + ++ L REIE+ L+HPN
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++R R+Y+++E+A G L+ ++ G DE R+ + +L +AL YCHER V
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKV 135
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRDIK ENLL+ +K++DFG+ S A + T CG+ Y PE+++G
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGW--------SVHAPSLRRRTMCGTLDYLPPEMIEGK 187
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKELIS 262
+ D+W GV+ + + G PFD S E +++ N + FP P +S K+LIS
Sbjct: 188 THDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDGSKDLIS 244
Query: 263 NILSP-VQTRPRLKTIAEDRWLK 284
+L R LK + E W+K
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWVK 267
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 6e-92
Identities = 84/271 (30%), Positives = 132/271 (48%), Gaps = 25/271 (9%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSK---VQAPPDYLKKFLPREIEVVK--- 77
Y +G ++G G + TV VAIK++ + + P P E+ ++
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 78 -GLKHPNLIRFLQAIETTHRVYIIMEYAENGS-LFDIIRGQGYIDEIRARRWFGQLLEAL 135
G HP +IR L ET +++E LFD I +G + E +R +FGQ++ A+
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 136 QYCHERGVVHRDIKCENLLLDSDY-NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194
Q+CH RGVVHRDIK EN+L+D KL DFG + F G+ Y
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS--------GALLHDEPYTDFDGTRVY 204
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254
+ PE + Y + +WS+G++L+ MV G +PF+ + ++ ++ FP VS
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILEAELHFPAH--VS 257
Query: 255 TECKELISNILSP-VQTRPRLKTIAEDRWLK 284
+C LI L+P +RP L+ I D W++
Sbjct: 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 1e-91
Identities = 85/263 (32%), Positives = 142/263 (53%), Gaps = 13/263 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ +G+ +G G + V LAR + +A+K++ K Q ++ L RE+E+ L+HPN
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++R RVY+I+EYA G+++ ++ DE R + +L AL YCH + V
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRDIK ENLLL S +K++DFG+ S A +S CG+ Y PE+++G
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKELIS 262
+ D+WS+GV+ + + G+ PF+ ++ E K++ + TFP V+ ++LIS
Sbjct: 183 MHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 239
Query: 263 NILSP-VQTRPRLKTIAEDRWLK 284
+L RP L+ + E W+
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWIT 262
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 6e-88
Identities = 61/305 (20%), Positives = 106/305 (34%), Gaps = 54/305 (17%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLP------------- 70
Y + + + G + + L A+K K
Sbjct: 33 YRIIRTLNQGKFNKIILCEKDNKF--YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 71 -REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIR------ 123
E++++ +K+ + I VYII EY EN S+ +D+
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 124 --ARRWFGQLLEALQYCH-ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180
+ +L + Y H E+ + HRD+K N+L+D + +KLSDFG S
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE--------SEYM 202
Query: 181 DNSLSETFCGSYAYASPEILQG-IPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELL 238
+ + G+Y + PE Y DIWS+G+ L+ M + +PF S+ EL
Sbjct: 203 VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 239 KQVQN-KVTFPKQ-----------------PEVSTECKELISNILSP-VQTRPRLKTIAE 279
++ + +P +S E + + L R + +
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
Query: 280 DRWLK 284
WL
Sbjct: 323 HEWLA 327
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 7e-87
Identities = 61/297 (20%), Positives = 125/297 (42%), Gaps = 25/297 (8%)
Query: 9 QDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKF 68
+++ + ++ Y++ K IG+G + V + AIK V+ +A L +
Sbjct: 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSY 73
Query: 69 LPREIEVVKGLKHPNL--IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARR 126
EI + L+ + IR T +Y++ME N L ++ + ID +
Sbjct: 74 R-NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKS 131
Query: 127 WFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186
++ +LEA+ H+ G+VH D+K N L+ +KL DFG A + + +
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQM----QPDTTSVVKD 186
Query: 187 TFCGSYAYASPEILQGIPYAPHL----------SDIWSMGVVLFAMVFGRLPFDD--SSV 234
+ G+ Y PE ++ + + SD+WS+G +L+ M +G+ PF + +
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 235 NELLKQVQNKVTFPKQPEVSTECKELISNIL--SPVQTRPRLKTIAEDRWLKPKPKS 289
++L + + ++++ L P Q R + + +++ +
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ-RISIPELLAHPYVQIQTHP 302
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 2e-85
Identities = 70/302 (23%), Positives = 133/302 (44%), Gaps = 32/302 (10%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ ++G G++ V AR+ S AIK + + + E+ ++ L H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL----SEVMLLASLNHQY 63
Query: 84 LIRF-------------LQAIETTHRVYIIMEYAENGSLFD-IIRGQGYIDEIRARRWFG 129
++R+ + A++ ++I MEY ENG+L+D I R F
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR--------AHMRCRSNAAD 181
Q+LEAL Y H +G++HRD+K N+ +D N+K+ DFG A+ + ++
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV 241
+ + G+ Y + E+L G + D++S+G++ F M++ +LK++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKL 241
Query: 242 QN-KVTFPKQ--PEVSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKPKSRGVDKAEA 297
++ + FP K++I ++ RP +T+ WL K + + +A
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALK 301
Query: 298 EL 299
L
Sbjct: 302 SL 303
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 4e-85
Identities = 61/282 (21%), Positives = 119/282 (42%), Gaps = 25/282 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y++ K IG+G + V + AIK V+ +A L + EI + L+ +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR-NEIAYLNKLQQHS 68
Query: 84 L--IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
IR T +Y++ME N L ++ + ID + ++ +LEA+ H+
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
G+VH D+K N L+ +KL DFG A + + ++ G+ Y PE ++
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQM----QPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 202 GIPYAPHL----------SDIWSMGVVLFAMVFGRLPFDD--SSVNELLKQVQNKVTFPK 249
+ + SD+WS+G +L+ M +G+ PF + +++L +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 250 QPEVSTECKELISNIL--SPVQTRPRLKTIAEDRWLKPKPKS 289
+ ++++ L P Q R + + +++ +
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQ-RISIPELLAHPYVQIQTHP 283
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 4e-85
Identities = 61/292 (20%), Positives = 122/292 (41%), Gaps = 25/292 (8%)
Query: 14 RKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREI 73
+ ++ Y++ K IG+G + V + AIK V+ +A L + EI
Sbjct: 48 NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR-NEI 105
Query: 74 EVVKGLKHPNL--IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQL 131
+ L+ + IR T +Y++ME N L ++ + ID + ++ +
Sbjct: 106 AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNM 164
Query: 132 LEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGS 191
LEA+ H+ G+VH D+K N L+ +KL DFG A + + ++ G+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQM----QPDTTSVVKDSQVGA 219
Query: 192 YAYASPEILQGIPYAPHL----------SDIWSMGVVLFAMVFGRLPFDD--SSVNELLK 239
Y PE ++ + + SD+WS+G +L+ M +G+ PF + +++L
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
Query: 240 QVQNKVTFPKQPEVSTECKELISNIL--SPVQTRPRLKTIAEDRWLKPKPKS 289
+ + ++++ L P Q R + + +++ +
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ-RISIPELLAHPYVQIQTHP 330
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 5e-83
Identities = 57/289 (19%), Positives = 121/289 (41%), Gaps = 19/289 (6%)
Query: 15 KVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIE 74
+ ++++ Y + +G G ++ V L A+K + D ++ RE +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQQD--REEAQREAD 78
Query: 75 VVKGLKHPNLIRFLQAI----ETTHRVYIIMEYAENGSLFDII----RGQGYIDEIRARR 126
+ + HPN++R + H ++++ + + G+L++ I ++ E +
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 127 WFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186
+ L+ H +G HRD+K N+LL + L D G + +
Sbjct: 139 LLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 187 ---TFCGSYAYASPEILQGIPYAP--HLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ- 240
+ +Y +PE+ + +D+WS+G VL+AM+FG P+D
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
Query: 241 -VQNKVTFPKQPEVSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKP 287
VQN+++ P+ P S+ +L++++++ RP + + P
Sbjct: 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 2e-79
Identities = 77/266 (28%), Positives = 134/266 (50%), Gaps = 11/266 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + IG GS+ L +ST IK ++ + ++ RE+ V+ +KHPN
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR-REVAVLANMKHPN 84
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHER 141
++++ ++ E +YI+M+Y E G LF I Q E + WF Q+ AL++ H+R
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
++HRDIK +N+ L D ++L DFG AR + L+ G+ Y SPEI +
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN------STVELARACIGTPYYLSPEICE 198
Query: 202 GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261
PY + SDIW++G VL+ + + F+ S+ L+ ++ + P S + + L+
Sbjct: 199 NKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257
Query: 262 SNILSPV-QTRPRLKTIAEDRWLKPK 286
S + + RP + +I E ++ +
Sbjct: 258 SQLFKRNPRDRPSVNSILEKGFIAKR 283
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-77
Identities = 86/274 (31%), Positives = 129/274 (47%), Gaps = 20/274 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y V IGTGSY + R + K + + + E+ +++ LKHPN
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNLLRELKHPN 66
Query: 84 LIRFLQAI--ETTHRVYIIMEYAENGSLFDII----RGQGYIDEIRARRWFGQLLEALQY 137
++R+ I T +YI+MEY E G L +I + + Y+DE R QL AL+
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 138 CHERG-----VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
CH R V+HRD+K N+ LD N+KL DFG AR D S ++TF G+
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN------HDTSFAKTFVGTP 180
Query: 193 AYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE 252
Y SPE + + Y SDIWS+G +L+ + PF S EL +++
Sbjct: 181 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 253 VSTECKELISNILSP-VQTRPRLKTIAEDRWLKP 285
S E E+I+ +L+ RP ++ I E+ +
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 5e-77
Identities = 62/268 (23%), Positives = 106/268 (39%), Gaps = 25/268 (9%)
Query: 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
+H + + I+G G+ A V R + AIK+ + + RE EV+K L
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLN 65
Query: 81 HPNLIRFLQAIE--TTHRVYIIMEYAENGSLFDIIRGQGY---IDEIRARRWFGQLLEAL 135
H N+++ E TT +IME+ GSL+ ++ + E ++ +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 136 QYCHERGVVHRDIKCENLLL----DSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGS 191
+ E G+VHR+IK N++ D KL+DFG AR D+ + G+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-------DDEQFVSLYGT 178
Query: 192 YAYASPEILQGIPYAPHLS-------DIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK 244
Y P++ + D+WS+GV + G LPF K+V K
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238
Query: 245 VTFPKQPEVSTECKELISNILSPVQTRP 272
+ K + ++ + + P
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMP 266
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 4e-76
Identities = 93/292 (31%), Positives = 146/292 (50%), Gaps = 27/292 (9%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKF-----LPREIEVV 76
Y + K +G+G+ VKLA R T VAIKI+SK + ++ + EIE++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCK--KVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
K L HP +I+ + YI++E E G LFD + G + E + +F Q+L A+Q
Sbjct: 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 137 YCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193
Y HE G++HRD+K EN+LL S D IK++DFG ++ + + SL T CG+
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILG------ETSLMRTLCGTPT 181
Query: 194 YASPEILQGIPYAPHLS--DIWSMGVVLFAMVFGRLPFDDSSV-NELLKQVQN-KVTFPK 249
Y +PE+L + A + D WS+GV+LF + G PF + L Q+ + K F
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 250 QP--EVSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKPKSRGVDKAEAE 298
+ EVS + +L+ +L + R + WL+ + R +E
Sbjct: 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 293
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-75
Identities = 62/256 (24%), Positives = 105/256 (41%), Gaps = 27/256 (10%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
+ + I+G G+ A V R + +GD AIK+ + + RE EV+K L H
Sbjct: 11 WLLSDILGQGATANVFRGRH-KKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHK 67
Query: 83 NLIRFLQAIE--TTHRVYIIMEYAENGSLFDIIRGQGY---IDEIRARRWFGQLLEALQY 137
N+++ E TT +IME+ GSL+ ++ + E ++ + +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 138 CHERGVVHRDIKCENLLL----DSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193
E G+VHR+IK N++ D KL+DFG AR D+ + G+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-------DDEQFVSLYGTEE 180
Query: 194 YASPEILQGIPYAPHLS-------DIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT 246
Y P++ + D+WS+GV + G LPF K+V K+
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 247 FPKQPEVSTECKELIS 262
K + ++ +
Sbjct: 241 TGKPSGAISGVQKAEN 256
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-74
Identities = 91/284 (32%), Positives = 144/284 (50%), Gaps = 27/284 (9%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKF-----LPREIEVV 76
Y + K +G+G+ VKLA R T VAI+I+SK + ++ + EIE++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKK--VAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
K L HP +I+ + YI++E E G LFD + G + E + +F Q+L A+Q
Sbjct: 195 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 137 YCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193
Y HE G++HRD+K EN+LL S D IK++DFG ++ + SL T CG+
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-------LGETSLMRTLCGTPT 306
Query: 194 YASPEILQGIPYAPHLS--DIWSMGVVLFAMVFGRLPF-DDSSVNELLKQVQN-KVTFPK 249
Y +PE+L + A + D WS+GV+LF + G PF + + L Q+ + K F
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366
Query: 250 QP--EVSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKPKSR 290
+ EVS + +L+ +L + R + WL+ + R
Sbjct: 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 8e-73
Identities = 82/277 (29%), Positives = 131/277 (47%), Gaps = 19/277 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT+ IG GS+ VK+A A K + K +EIE++K L HPN
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPN 67
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+IR + E +Y++ME G LF+ + + E A R +L A+ YCH+ V
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 144 VHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
HRD+K EN L + D +KL DFG A + + T G+ Y SP++L
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFK------PGKMMRTKVGTPYYVSPQVL 180
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--EVSTEC 257
+G Y P D WS GV+++ ++ G PF + +E++ +++ TFP++ VS +
Sbjct: 181 EG-LYGPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 258 KELISNILSP-VQTRPRLKTIAEDRWLKPKPKSRGVD 293
+ LI +L+ + R E W + + S +
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRN 275
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 1e-72
Identities = 63/274 (22%), Positives = 108/274 (39%), Gaps = 23/274 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + + +GTG + V VAIK + +P + ++ EI+++K L HPN
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPN 73
Query: 84 LIRFLQAIET------THRVYIIMEYAENGSLFDIIRGQG---YIDEIRARRWFGQLLEA 134
++ + + + MEY E G L + + E R + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 135 LQYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGS 191
L+Y HE ++HRD+K EN++L K+ D G+A+ L F G+
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-------QGELCTEFVGT 186
Query: 192 YAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL-KQVQNKVTFPKQ 250
Y +PE+L+ Y + D WS G + F + G PF + +V+ K
Sbjct: 187 LQYLAPELLEQKKYTVTV-DYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 251 PEVSTECKELISNILSPVQTRPRLKTIAEDRWLK 284
S++L + +RWL+
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 3e-72
Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 17/282 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + K IG G ++ V A VA+K V + +EI+++K L HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG----YIDEIRARRWFGQLLEALQYCH 139
+I++ + + + I++E A+ G L +I+ I E ++F QL AL++ H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
R V+HRDIK N+ + + +KL D G R + + + + G+ Y SPE
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS------SKTTAAHSLVGTPYYMSPER 207
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPF--DDSSVNELLKQVQNKVTFPKQPE--VST 255
+ Y SDIWS+G +L+ M + PF D ++ L K+++ +P P S
Sbjct: 208 IHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPPLPSDHYSE 265
Query: 256 ECKELISNILSPV-QTRPRLKTIAEDRWLKPKPKSRGVDKAE 296
E ++L++ ++P + RP + + + + ++
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 3e-72
Identities = 73/281 (25%), Positives = 130/281 (46%), Gaps = 31/281 (11%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDY------LKKFLPREIEV 75
Y +I+G G + V+ + T + A+KI+ L++ +E+++
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCK--EYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 76 VKGLK-HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEA 134
++ + HPN+I+ ET +++ + + G LFD + + + E R+ LLE
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194
+ H+ +VHRD+K EN+LLD D NIKL+DFGF+ + CG+ +Y
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLD------PGEKLREVCGTPSY 189
Query: 195 ASPEILQGIPYAPHLS-----DIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFP 248
+PEI++ H D+WS GV+++ ++ G PF +L+ + + F
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249
Query: 249 KQP--EVSTECKELISNILSPVQTRPRLKTIAE---DRWLK 284
+ S K+L+S L VQ + R T E + +
Sbjct: 250 SPEWDDYSDTVKDLVSRFLV-VQPQKRY-TAEEALAHPFFQ 288
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-72
Identities = 81/277 (29%), Positives = 140/277 (50%), Gaps = 24/277 (8%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
Y V + +G G+++ V+ ++T + A KI++ + +K RE + + L+H
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGL--EFAAKIINTKKLSARDFQKLE-REARICRKLQH 64
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
PN++R +I+ Y++ + G LF+ I + + E A Q+LE++ YCH
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 142 GVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
G+VHR++K ENLLL S +KL+DFG A + D+ F G+ Y SPE
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVN------DSEAWHGFAGTPGYLSPE 177
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--EVST 255
+L+ PY+ DIW+ GV+L+ ++ G PF D + L Q++ +P V+
Sbjct: 178 VLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236
Query: 256 ECKELISNILSPVQTRPRLKTIAE---DRWLKPKPKS 289
E K LI ++L+ V + R+ T + W+ + +
Sbjct: 237 EAKSLIDSMLT-VNPKKRI-TADQALKVPWICNRERV 271
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-72
Identities = 71/258 (27%), Positives = 125/258 (48%), Gaps = 25/258 (9%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSK-----VQAPPDYLKKFLPREIEVV 76
Y +IG G + V+ R+T H + A+KI+ + +++ RE ++
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGH--EFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 77 KGLK-HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEAL 135
+ + HP++I + + E++ ++++ + G LFD + + + E R LLEA+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 136 QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
+ H +VHRD+K EN+LLD + I+LSDFGF+ H+ CG+ Y
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC-HLE------PGEKLRELCGTPGYL 266
Query: 196 SPEILQGIPYAPHLS-----DIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPK 249
+PEIL+ H D+W+ GV+LF ++ G PF +L+ + + F
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326
Query: 250 QP--EVSTECKELISNIL 265
+ S+ K+LIS +L
Sbjct: 327 PEWDDRSSTVKDLISRLL 344
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 6e-72
Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 21/271 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + +G+G++ V L + IK ++K ++ + + EIEV+K L HPN
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPN 81
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDII----RGQGYIDEIRARRWFGQLLEALQYCH 139
+I+ + E H +YI+ME E G L + I + E Q++ AL Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 140 ERGVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYAS 196
+ VVH+D+K EN+L IK+ DFG A + S G+ Y +
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-------KSDEHSTNAAGTALYMA 194
Query: 197 PEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPE-VS 254
PE+ + DIWS GVV++ ++ G LPF +S+ E+ ++ + + + ++
Sbjct: 195 PEVFKR-DVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252
Query: 255 TECKELISNILSP-VQTRPRLKTIAEDRWLK 284
+ +L+ +L+ + RP + W K
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-71
Identities = 67/291 (23%), Positives = 121/291 (41%), Gaps = 30/291 (10%)
Query: 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
V +++ G +A V A+ + A+K + + + +E+ +K L
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL-SNEEEK--NRAIIQEVCFMKKLS 83
Query: 81 -HPNLIRFLQA-------IETTHRVYIIMEYAENGSLFDII---RGQGYIDEIRARRWFG 129
HPN+++F A +T ++++ G L + + +G + + F
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 130 QLLEALQYCHERG--VVHRDIKCENLLLDSDYNIKLSDFGFARA---HMRCRSNAADNSL 184
Q A+Q+ H + ++HRD+K ENLLL + IKL DFG A + +A +L
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 185 SE---TFCGSYAYASPEIL---QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL 238
E T + Y +PEI+ P DIW++G +L+ + F + PF+D + L
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEK-QDIWALGCILYLLCFRQHPFEDGAK---L 259
Query: 239 KQVQNKVTFPKQPEVSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKPK 288
+ V K + P T LI +L + R + + +
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-71
Identities = 81/270 (30%), Positives = 134/270 (49%), Gaps = 21/270 (7%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
Y + ++G GS+ V R T+ A+K+++K A L RE+E++K L H
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQE--YAVKVINKASAKNKDTSTIL-REVELLKKLDH 80
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
PN+++ + +E + YI+ E G LFD I + E A R Q+ + Y H+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 142 GVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
+VHRD+K EN+LL+S D +IK+ DFG + N+ + G+ Y +PE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST-------CFQQNTKMKDRIGTAYYIAPE 193
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--EVST 255
+L+G Y D+WS GV+L+ ++ G PF + ++LK+V+ K F +S
Sbjct: 194 VLRG-TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251
Query: 256 ECKELISNILSP-VQTRPRLKTIAEDRWLK 284
+ K+LI +L+ R E W++
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 8e-71
Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 23/275 (8%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
+ +++G+G+++ V L R T A+K + K A L EI V+K +KH
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGK--LFALKCIKKSPAFR---DSSLENEIAVLKKIKH 65
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
N++ E+T Y++M+ G LFD I +G E A Q+L A++Y HE
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 142 GVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
G+VHRD+K ENLL + + I ++DFG ++ N + T CG+ Y +PE
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--------QNGIMSTACGTPGYVAPE 177
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--EVST 255
+L PY+ D WS+GV+ + ++ G PF + + ++L ++++ F ++S
Sbjct: 178 VLAQKPYSKA-VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236
Query: 256 ECKELISNILSP-VQTRPRLKTIAEDRWLKPKPKS 289
K+ I ++L R + W+
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-70
Identities = 54/284 (19%), Positives = 112/284 (39%), Gaps = 39/284 (13%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ ++IG+G + V A+ IK V Y + RE++ + L H N
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHVN 65
Query: 84 LIRFLQAIE----------------TTHRVYIIMEYAENGSLFDII--RGQGYIDEIRAR 125
++ + + T ++I ME+ + G+L I R +D++ A
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 126 RWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS 185
F Q+ + + Y H + +++RD+K N+ L +K+ DFG + ++
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-------LKNDGKR 178
Query: 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV 245
G+ Y SPE + Y D++++G++L ++ + ++ +++ +
Sbjct: 179 TRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDGI 235
Query: 246 TFPKQPEVSTECKELISNILSPV-QTRPRLKTIAEDRWLKPKPK 288
+ K L+ +LS + RP I + K
Sbjct: 236 -IS--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-70
Identities = 80/313 (25%), Positives = 126/313 (40%), Gaps = 57/313 (18%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKF--LPREIEVVKGL 79
Y + IG GSY V++A TR AIKI++K + K + E+ ++K L
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRA--IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYID------------------- 120
HPN+ R + E + ++ME G L D +
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 121 ---------------------EIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD- 158
E Q+ AL Y H +G+ HRDIK EN L ++
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 159 -YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI--PYAPHLSDIWSM 215
+ IKL DFG ++ + N + T G+ + +PE+L Y P D WS
Sbjct: 206 SFEIKLVDFGLSKEFY--KLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK-CDAWSA 262
Query: 216 GVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--EVSTECKELISNILSP-VQTR 271
GV+L ++ G +PF + + + QV N K+ F +S ++L+SN+L+ V R
Sbjct: 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322
Query: 272 PRLKTIAEDRWLK 284
+ W+
Sbjct: 323 FDAMRALQHPWIS 335
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 8e-70
Identities = 77/250 (30%), Positives = 129/250 (51%), Gaps = 19/250 (7%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
Y V + +G G+++ V+ ++T + A KI++ + +K RE + + L+H
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGL--EFAAKIINTKKLSARDFQKLE-REARICRKLQH 87
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
PN++R +I+ Y++ + G LF+ I + + E A Q+LE++ YCH
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 142 GVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
G+VHR++K ENLLL S +KL+DFG A + D+ F G+ Y SPE
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVN------DSEAWHGFAGTPGYLSPE 200
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--EVST 255
+L+ PY+ DIW+ GV+L+ ++ G PF D + L Q++ +P V+
Sbjct: 201 VLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259
Query: 256 ECKELISNIL 265
E K LI ++L
Sbjct: 260 EAKSLIDSML 269
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 2e-69
Identities = 82/292 (28%), Positives = 139/292 (47%), Gaps = 19/292 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y + ++G GS+ V + R + A+K+++K A L RE+E++K L HP
Sbjct: 24 YNIVCMLGKGSFGEVLKCKD-RITQQEYAVKVINKASAKNKDTSTIL-REVELLKKLDHP 81
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
N+++ + +E + YI+ E G LFD I + E A R Q+ + Y H+
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 143 VVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+VHRD+K EN+LL+S D +IK+ DFG + N+ + G+ Y +PE+
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-------QQNTKMKDRIGTAYYIAPEV 194
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--EVSTE 256
L+G Y D+WS GV+L+ ++ G PF + ++LK+V+ K F +S +
Sbjct: 195 LRG-TYDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252
Query: 257 CKELISNILSP-VQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMIQ 307
K+LI +L+ R E W++ L+ + I+
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIR 304
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-68
Identities = 82/268 (30%), Positives = 138/268 (51%), Gaps = 16/268 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y +++G GS+ V L + + A+K++SK Q K+ L RE++++K L HPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+++ + E Y++ E G LFD I + E+ A R Q+L + Y H+ +
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 147
Query: 144 VHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
VHRD+K ENLLL+S D NI++ DFG + + + G+ Y +PE+L
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHF-------EASKKMKDKIGTAYYIAPEVL 200
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--EVSTEC 257
G Y D+WS GV+L+ ++ G PF+ ++ ++LK+V+ K TF +VS
Sbjct: 201 HG-TYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258
Query: 258 KELISNILSP-VQTRPRLKTIAEDRWLK 284
K+LI +L+ R + + W++
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQ 286
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 7e-68
Identities = 89/291 (30%), Positives = 138/291 (47%), Gaps = 17/291 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y K +G+G+Y V L R + AIKI+ K K L E+ V+K L HPN
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL-EEVAVLKLLDHPN 97
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+++ E Y++ME + G LFD I + +E+ A Q+L + Y H+ +
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157
Query: 144 VHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
VHRD+K ENLLL+S D IK+ DFG + + + G+ Y +PE+L
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVF-------ENQKKMKERLGTAYYIAPEVL 210
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--EVSTEC 257
+ Y D+WS+GV+LF ++ G PF + E+L++V+ K TF VS
Sbjct: 211 RK-KYDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 258 KELISNILSP-VQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMIQ 307
K+LI +L Q R + E W+K + L + I+ ++
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMR 319
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-67
Identities = 82/275 (29%), Positives = 136/275 (49%), Gaps = 19/275 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + + +G G+++ V+ + A I++ + +K RE + + LKHPN
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE-REARICRLLKHPN 71
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++R +I Y+I + G LF+ I + Y E A Q+LEA+ +CH+ GV
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131
Query: 144 VHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
VHR++K ENLLL S +KL+DFG A + + F G+ Y SPE+L
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAI-EVE-----GEQQAWFGFAGTPGYLSPEVL 185
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--EVSTEC 257
+ PY D+W+ GV+L+ ++ G PF D + L +Q++ FP V+ E
Sbjct: 186 RKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244
Query: 258 KELISNILSPVQTRPRLKTIAE---DRWLKPKPKS 289
K+LI+ +L+ ++ R+ T AE W+ +
Sbjct: 245 KDLINKMLTINPSK-RI-TAAEALKHPWISHRSTV 277
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-67
Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 31/285 (10%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + +G G + V A++ + AIK + ++ + RE++ + L+HP
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEHPG 64
Query: 84 LIRFLQAIETTHR------------VYIIMEYAENGSLFDII---RGQGYIDEIRARRWF 128
++R+ A + +YI M+ +L D + + F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 129 GQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA------HMRCRSNAADN 182
Q+ EA+++ H +G++HRD+K N+ D +K+ DFG A +
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLKQV 241
+ G+ Y SPE + G Y+ H DI+S+G++LF +++ PF L V
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240
Query: 242 QNKVTFPKQPE-VSTECKELISNILSPV-QTRPRLKTIAEDRWLK 284
+N + FP ++ ++LSP RP I E+ +
Sbjct: 241 RN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-66
Identities = 86/293 (29%), Positives = 141/293 (48%), Gaps = 26/293 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ V +G G+ + V + A+K++ K KK + EI V+ L HPN
Sbjct: 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPN 109
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+I+ + ET + +++E G LFD I +GY E A Q+LEA+ Y HE G+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 144 VHRDIKCENLLL---DSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
VHRD+K ENLL D +K++DFG ++ L +T CG+ Y +PEIL
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIV-------EHQVLMKTVCGTPGYCAPEIL 222
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLKQVQN-KVTFPKQP--EVSTE 256
+G Y P D+WS+G++ + ++ G PF D+ + +++ N + F EVS
Sbjct: 223 RGCAYGP-EVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281
Query: 257 CKELISNILSPVQTRPRLKTIAE---DRWLKPK-PKSRGVDKAEAELDHYIDM 305
K+L+ ++ + RL T + W+ K +D A+ +L +
Sbjct: 282 AKDLVRKLIVLDPKK-RL-TTFQALQHPWVTGKAANFVHMDTAQKKLQEFNAR 332
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 1e-66
Identities = 78/278 (28%), Positives = 130/278 (46%), Gaps = 26/278 (9%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSK----------VQAPPDYLKKFLPREI 73
Y + +G+G+Y V L + + AIK++ K + + + EI
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 74 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLE 133
++K L HPN+I+ E Y++ E+ E G LF+ I + DE A Q+L
Sbjct: 98 SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS 157
Query: 134 ALQYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCG 190
+ Y H+ +VHRDIK EN+LL++ NIK+ DFG + + + G
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-------SKDYKLRDRLG 210
Query: 191 SYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPK 249
+ Y +PE+L+ Y D+WS GV+++ ++ G PF + +++K+V+ K F
Sbjct: 211 TAYYIAPEVLKK-KYNE-KCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 250 QP--EVSTECKELISNILSP-VQTRPRLKTIAEDRWLK 284
+S E KELI +L+ R + RW+K
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-65
Identities = 75/288 (26%), Positives = 132/288 (45%), Gaps = 27/288 (9%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSK---VQAPPDYLKKFLPREIEVVKG 78
Y +G+ +G+G +A VK +ST + A K + K + ++ + RE+ +++
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGL--EYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+ H N+I E V +I+E G LFD + + + E A + Q+L+ + Y
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 139 HERGVVHRDIKCENLLLDS----DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194
H + + H D+K EN++L +IKL DFG A D + G+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-------EIEDGVEFKNIFGTPEF 184
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP-- 251
+PEI+ P +D+WS+GV+ + ++ G PF + E L + + F ++
Sbjct: 185 VAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 252 EVSTECKELISNILSPVQTRPRLKTIAE---DRWLKPKPKSRGVDKAE 296
S K+ I +L +TR RL TI E W+ P + + + E
Sbjct: 244 HTSELAKDFIRKLLV-KETRKRL-TIQEALRHPWITPVDNQQAMVRRE 289
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 4e-65
Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 29/283 (10%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSK--VQAPPDYLKKFLPREIEVVKGL 79
Y + ++IG G ++ V+ R T A+KIV + P + L RE + L
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQ--QFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDII--RGQGYID--EIRARRWFGQLLEAL 135
KHP+++ L+ + +Y++ E+ + L I R E A + Q+LEAL
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 136 QYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
+YCH+ ++HRD+K +LL S +KL FG A ++ G+
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE------SGLVAGGRVGTP 197
Query: 193 AYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP 251
+ +PE+++ PY D+W GV+LF ++ G LPF + L + + K +
Sbjct: 198 HFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQ 255
Query: 252 --EVSTECKELISNILSPVQTRPRLKTIAE---DRWLKPKPKS 289
+S K+L+ +L + R+ T+ E WLK + +
Sbjct: 256 WSHISESAKDLVRRMLM-LDPAERI-TVYEALNHPWLKERDRY 296
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 5e-65
Identities = 73/288 (25%), Positives = 134/288 (46%), Gaps = 27/288 (9%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSG-DVAIKIVSK---VQAPPDYLKKFLPREIEVVKGL 79
Y +G+ +G+G +A V+ R + +G + A K + K + ++ + RE+ +++ +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQ-KGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
+HPN+I E V +I+E G LFD + + + E A ++ Q+L+ + Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 140 ERGVVHRDIKCENLLLDS----DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
+ + H D+K EN++L + IKL DFG A + + G+ +
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-------KIEAGNEFKNIFGTPEFV 178
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--E 252
+PEI+ P +D+WS+GV+ + ++ G PF + E L + F ++
Sbjct: 179 APEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237
Query: 253 VSTECKELISNILSPVQTRPRLKTIAE---DRWLKPKPKS--RGVDKA 295
S K+ I +L + R+ TIA+ W+K + RG D
Sbjct: 238 TSELAKDFIRRLLV-KDPKRRM-TIAQSLEHSWIKAIRRRNVRGEDSG 283
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-64
Identities = 76/288 (26%), Positives = 133/288 (46%), Gaps = 27/288 (9%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSK---VQAPPDYLKKFLPREIEVVKG 78
Y +G+ +G+G +A VK +ST + A K + K + ++ + RE+ +++
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGL--EYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+ HPN+I E V +I+E G LFD + + + E A + Q+L+ + Y
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 139 HERGVVHRDIKCENLLLDS----DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194
H + + H D+K EN++L +IKL DFG A D + G+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-------EIEDGVEFKNIFGTPEF 184
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP-- 251
+PEI+ P +D+WS+GV+ + ++ G PF + E L + F ++
Sbjct: 185 VAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243
Query: 252 EVSTECKELISNILSPVQTRPRLKTIAE---DRWLKPKPKSRGVDKAE 296
+ S K+ I +L +TR RL TI E W+ P + + + E
Sbjct: 244 QTSELAKDFIRKLLV-KETRKRL-TIQEALRHPWITPVDTQQAMVRRE 289
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-64
Identities = 64/269 (23%), Positives = 106/269 (39%), Gaps = 21/269 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KH 81
+ +G GSY V RS + G A+K P + L E+ + + +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRS-KEDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQH 116
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHE 140
P +R QA E +Y+ E SL G + E + + L AL + H
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
+G+VH D+K N+ L KL DFG E G Y +PE+L
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLV-------ELGTAGAGEVQEGDPRYMAPELL 228
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGR-LPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259
QG Y +D++S+G+ + + LP +L + F +S+E +
Sbjct: 229 QG-SYGTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL-PPEFT--AGLSSELRS 283
Query: 260 LISNILSP-VQTRPRLKTIAEDRWLKPKP 287
++ +L P + R + + L+ +P
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVLR-QP 311
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-64
Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 27/286 (9%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSK---VQAPPDYLKKFLPREIEVVKG 78
Y G+ +G+G +A VK +ST A K + K + ++ + RE+ ++K
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGL--QYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
++HPN+I + E V +I+E G LFD + + + E A + Q+L + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 139 HERGVVHRDIKCENLLLDS----DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194
H + H D+K EN++L IK+ DFG A + + G+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-------KIDFGNEFKNIFGTPEF 183
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP-- 251
+PEI+ P +D+WS+GV+ + ++ G PF + E L V F +
Sbjct: 184 VAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 252 EVSTECKELISNILSPVQTRPRLKTIAE---DRWLKPKPKSRGVDK 294
S K+ I +L + R+ TI + W+KPK + + +
Sbjct: 243 NTSALAKDFIRRLLV-KDPKKRM-TIQDSLQHPWIKPKDTQQALSR 286
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 3e-64
Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 31/291 (10%)
Query: 8 VQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYL 65
+ + R Y V + IG GSY+ K ++T + A+KI+ K
Sbjct: 9 IVQQLHRNSIQFTDG-YEVKEDIGVGSYSVCKRCIHKATNM--EFAVKIIDKS------- 58
Query: 66 KKFLPREIEVV-KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRA 124
K+ EIE++ + +HPN+I + VY++ E + G L D I Q + E A
Sbjct: 59 KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA 118
Query: 125 RRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD----YNIKLSDFGFARAHMRCRSNAA 180
+ + ++Y H +GVVHRD+K N+L + +I++ DFGFA+ +R A
Sbjct: 119 SAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK-QLR-----A 172
Query: 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD---DSSVNEL 237
+N L T C + + +PE+L+ Y DIWS+GV+L+ M+ G PF D + E+
Sbjct: 173 ENGLLMTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
Query: 238 LKQVQN-KVTFPKQP--EVSTECKELISNILSP-VQTRPRLKTIAEDRWLK 284
L ++ + K + VS K+L+S +L R + W+
Sbjct: 232 LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-63
Identities = 36/305 (11%), Positives = 81/305 (26%), Gaps = 59/305 (19%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREI---------- 73
G ++G A + + + PP K + E+
Sbjct: 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134
Query: 74 ---------------EVVKGLKHPNLIRFLQAIETTH--RVYIIMEYAEN------GSLF 110
++VK + +IR + + ++ L
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194
Query: 111 DIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170
+ + Q++ L H G+VH ++ +++LD + L+ F
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHL----------SDIWSMGVVLF 220
+ S + PE+ + D W++G+V++
Sbjct: 255 R----------DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 221 AMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILSP-VQTRPRLKTIAE 279
+ LP + + + F + + L+ L + R E
Sbjct: 305 WIWCADLPITKDAALGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359
Query: 280 DRWLK 284
+
Sbjct: 360 TPEYE 364
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-61
Identities = 79/278 (28%), Positives = 138/278 (49%), Gaps = 32/278 (11%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK- 80
K +G GS++ + + + A+KI+SK + +EI +K +
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQ--AFAVKIISKRM------EANTQKEITALKLCEG 64
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
HPN+++ + +++ME G LF+ I+ + + E A +L+ A+ + H+
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 141 RGVVHRDIKCENLLL---DSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
GVVHRD+K ENLL + + IK+ DFGFAR DN +T C + YA+P
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK------PPDNQPLKTPCFTLHYAAP 178
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-------SSVNELLKQVQN-KVTFPK 249
E+L Y D+WS+GV+L+ M+ G++PF +S E++K+++ +F
Sbjct: 179 ELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 250 QP--EVSTECKELISNILSP-VQTRPRLKTIAEDRWLK 284
+ VS E K+LI +L+ R ++ + + WL+
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-60
Identities = 69/276 (25%), Positives = 125/276 (45%), Gaps = 22/276 (7%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
Y + + +GTG++ V R+T + + A K V D K+ + +EI+ + L+H
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGN--NFAAKFVMT-PHESD--KETVRKEIQTMSVLRH 213
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFD-IIRGQGYIDEIRARRWFGQLLEALQYCHE 140
P L+ A E + + +I E+ G LF+ + + E A + Q+ + L + HE
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 141 RGVVHRDIKCENLLLDS--DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
VH D+K EN++ + +KL DFG + + G+ +A+PE
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-------HLDPKQSVKVTTGTAEFAAPE 326
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQ--PEVST 255
+ +G P + +D+WS+GV+ + ++ G PF + +E L+ V++ +S
Sbjct: 327 VAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385
Query: 256 ECKELISNILSP-VQTRPRLKTIAEDRWLKPKPKSR 290
+ K+ I +L TR + E WL P
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-60
Identities = 43/303 (14%), Positives = 75/303 (24%), Gaps = 51/303 (16%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + + G + V L R D A+K+ + + L L +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 84 LIRFLQAI--------------------------ETTHRVYIIMEYA-----ENGSLFDI 112
++M A S D
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 113 IRGQGYIDEIRARRWFG-QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171
+ + I A QL+ +G+VH +NL + D + L D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW- 242
Query: 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP-HLSDIWSMGVVLFAMVFGRLPFD 230
+ YA E L H + W +G+ ++ + LPF
Sbjct: 243 --------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 231 DSS--------VNELLKQVQNKVTFPKQPEVSTECKELISNILSP-VQTRPRLKTIAEDR 281
+ L + + F + K LI L+ + R E
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354
Query: 282 WLK 284
Sbjct: 355 EFL 357
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-60
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 26/277 (9%)
Query: 24 YTV-GKIIGTGSYATVKLARSTRHSG-DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
Y + K +G G +A V+ S + +G + A K + K + D + L EI V++ K
Sbjct: 30 YILTSKELGRGKFAVVRQCIS-KSTGQEYAAKFLKKRRRGQDCRAEIL-HEIAVLELAKS 87
Query: 82 -PNLIRFLQAIETTHRVYIIMEYAENGSLFDII--RGQGYIDEIRARRWFGQLLEALQYC 138
P +I + E T + +I+EYA G +F + + E R Q+LE + Y
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 139 HERGVVHRDIKCENLLL---DSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
H+ +VH D+K +N+LL +IK+ DFG +R G+ Y
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-------KIGHACELREIMGTPEYL 200
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--E 252
+PEIL P +D+W++G++ + ++ PF E + V + ++
Sbjct: 201 APEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259
Query: 253 VSTECKELISNILSPVQTRPRLKTIAE---DRWLKPK 286
VS + I ++L R T WL+
Sbjct: 260 VSQLATDFIQSLLV-KNPEKRP-TAEICLSHSWLQQW 294
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-60
Identities = 74/290 (25%), Positives = 131/290 (45%), Gaps = 26/290 (8%)
Query: 24 YTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
Y + + +G+G++ V ++T K ++ P D K + EI ++ L H
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGR--VFVAKFINT-PYPLD--KYTVKNEISIMNQLHH 107
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYI-DEIRARRWFGQLLEALQYCHE 140
P LI A E + + +I+E+ G LFD I + Y E + Q E L++ HE
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 141 RGVVHRDIKCENLLLDS--DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
+VH DIK EN++ ++ ++K+ DFG A + + + + +A+PE
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLAT-------KLNPDEIVKVTTATAEFAAPE 220
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQ--PEVST 255
I+ P + +D+W++GV+ + ++ G PF E L+ V+ F + VS
Sbjct: 221 IVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279
Query: 256 ECKELISNILSPVQTRPRLKTIAE---DRWLKPKPKSRGVDKAEAELDHY 302
E K+ I N+L + R RL T+ + WLK + + +
Sbjct: 280 EAKDFIKNLLQ-KEPRKRL-TVHDALEHPWLKGDHSNLTSRIPSSRYNKI 327
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 4e-60
Identities = 60/280 (21%), Positives = 121/280 (43%), Gaps = 23/280 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + + +G G + V T K V +K +EI ++ +H N
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK----KEISILNIARHRN 62
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFD-IIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
++ ++ E+ + +I E+ +F+ I ++E + Q+ EALQ+ H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 143 VVHRDIKCENLLLDS--DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
+ H DI+ EN++ + IK+ +FG AR + Y +PE+
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQAR-------QLKPGDNFRLLFTAPEYYAPEVH 175
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQP--EVSTEC 257
Q + +D+WS+G +++ ++ G PF + ++++ + N + TF ++ E+S E
Sbjct: 176 QHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 258 KELISNILSPVQTRPRLKTIAE---DRWLKPKPKSRGVDK 294
+ + +L + + R+ T +E WLK K +
Sbjct: 235 MDFVDRLLV-KERKSRM-TASEALQHPWLKQKIERVSTKV 272
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 8e-60
Identities = 75/253 (29%), Positives = 136/253 (53%), Gaps = 11/253 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
+ GKI+G GS++TV LAR + AIKI+ K + ++ RE +V+ L HP
Sbjct: 32 FKFGKILGEGSFSTVVLARE-LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
++ + ++Y + YA+NG L IR G DE R + +++ AL+Y H +G
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
++HRD+K EN+LL+ D +I+++DFG A+ + + + +F G+ Y SPE+L
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLS----PESKQARANSFVGTAQYVSPELLTE 206
Query: 203 IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVSTECKELI 261
SD+W++G +++ +V G PF + + ++ ++ + FP + + ++L+
Sbjct: 207 KSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP--EKFFPKARDLV 263
Query: 262 SNILSPVQTRPRL 274
+L T+ RL
Sbjct: 264 EKLLVLDATK-RL 275
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-59
Identities = 74/284 (26%), Positives = 131/284 (46%), Gaps = 28/284 (9%)
Query: 24 YTVGK--IIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
YTV K I+G G + V +T +A KI+ + D K+ + EI V+ L
Sbjct: 89 YTVSKTEILGGGRFGQVHKCEETATGLK--LAAKIIKT-RGMKD--KEEVKNEISVMNQL 143
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYI-DEIRARRWFGQLLEALQYC 138
H NLI+ A E+ + + ++MEY + G LFD I + Y E+ + Q+ E +++
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 139 HERGVVHRDIKCENLLLDS--DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYAS 196
H+ ++H D+K EN+L + IK+ DFG AR + + G+ + +
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-------PREKLKVNFGTPEFLA 256
Query: 197 PEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQ--PEV 253
PE++ + +D+WS+GV+ + ++ G PF + E L + + + ++
Sbjct: 257 PEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDI 315
Query: 254 STECKELISNILSPVQTRPRLKTIAE---DRWLKPKPKSRGVDK 294
S E KE IS +L + R+ + +E WL +
Sbjct: 316 SEEAKEFISKLLI-KEKSWRI-SASEALKHPWLSDHKLHSRLSA 357
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 3e-59
Identities = 66/300 (22%), Positives = 117/300 (39%), Gaps = 47/300 (15%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSG-DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-H 81
KI+G GS TV G VA+K + D+ L EI+++ H
Sbjct: 17 VVSEKILGYGSSGTVVFQ--GSFQGRPVAVKRMLI-----DFCDIAL-MEIKLLTESDDH 68
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYID-------EIRARRWFGQLLEA 134
PN+IR+ + T +YI +E +L D++ + D E Q+
Sbjct: 69 PNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 135 LQYCHERGVVHRDIKCENLLLDS-------------DYNIKLSDFGFARAHMRCRSNAAD 181
+ + H ++HRD+K +N+L+ + + I +SDFG + +S+
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR- 186
Query: 182 NSLSETFCGSYAYASPEILQGIPYAPHLS------DIWSMGVVLFAMV-FGRLPFDDSSV 234
+ G+ + +PE+L+ DI+SMG V + ++ G+ PF D
Sbjct: 187 -TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 235 NELLKQVQNKVTFPKQ-----PEVSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKPK 288
E ++ + + + E +LIS ++ RP + PK K
Sbjct: 246 RE-SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-59
Identities = 67/270 (24%), Positives = 126/270 (46%), Gaps = 31/270 (11%)
Query: 24 YTVGK-IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-H 81
Y + + ++G G++A V+ + S + A+KI+ K P +++ + RE+E++ + H
Sbjct: 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGH 70
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
N++ ++ E R Y++ E GS+ I + + +E+ A + AL + H +
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 142 GVVHRDIKCENLLL---DSDYNIKLSDFGFARA-HMRCRSNAADNSLSETFCGSYAYASP 197
G+ HRD+K EN+L + +K+ DF + + T CGS Y +P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 198 EILQGIPYAPHL----SDIWSMGVVLFAMVFGRLPFDD---------------SSVNELL 238
E+++ + D+WS+GV+L+ ++ G PF + N L
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 239 KQVQN-KVTFPKQP--EVSTECKELISNIL 265
+ +Q K FP + +S K+LIS +L
Sbjct: 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLL 280
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-58
Identities = 61/299 (20%), Positives = 111/299 (37%), Gaps = 26/299 (8%)
Query: 4 STVQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSG-DVAIKIVSKVQAPP 62
S Q D + V ++ + ++G G+ T+ DVA+K +
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYR--GMFDNRDVAVKRILPECF-- 61
Query: 63 DYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYID- 120
F RE+++++ +HPN+IR+ + YI +E +L + + + +
Sbjct: 62 ----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHL 116
Query: 121 EIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL-----DSDYNIKLSDFGFARAHMRC 175
+ Q L + H +VHRD+K N+L+ +SDFG + +
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK---KL 173
Query: 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPH--LSDIWSMGVVLFAM-VFGRLPFDDS 232
S G+ + +PE+L DI+S G V + + G PF S
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233
Query: 233 SVNELLKQVQNKVTFPKQPE--VSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKPK 288
+ + PE +ELI +++ Q RP K + + + K
Sbjct: 234 LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 190 bits (483), Expect = 1e-57
Identities = 37/299 (12%), Positives = 84/299 (28%), Gaps = 48/299 (16%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL---- 79
G ++G A + + + PP K + E+ ++ L
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 80 ------------------KHPNLIRFLQAIETTHRVYIIMEYAEN-----------GSLF 110
K P + ++ ++++ + L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 111 DIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170
+ + Q++ L H G+VH ++ +++LD + L+ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP----HLSDIWSMGVVLFAMVFGR 226
R A+ S + +L + P D W++G+ ++ +
Sbjct: 260 -----RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 227 LPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNILSP-VQTRPRLKTIAEDRWLK 284
LP D + + + F + + L+ L + R E +
Sbjct: 315 LPNTDDAALGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-57
Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 44/284 (15%)
Query: 24 YTVGK-IIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL- 79
Y + K ++G G V R T A+K++ +E++
Sbjct: 30 YQLSKQVLGLGVNGKVLECFHRRTGQ--KCALKLLYD--------SPKARQEVDHHWQAS 79
Query: 80 KHPNLIRFLQAIETTHR----VYIIMEYAENGSLFDII--RGQGYIDEIRARRWFGQLLE 133
P+++ L E H + IIME E G LF I RG E A +
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 134 ALQYCHERGVVHRDIKCENLLL---DSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCG 190
A+Q+ H + HRD+K ENLL + D +KL+DFGFA+ + +T C
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--------ETTQNALQTPCY 191
Query: 191 SYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF----DDSSVNELLKQVQN-KV 245
+ Y +PE+L Y D+WS+GV+++ ++ G PF + + ++++ +
Sbjct: 192 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250
Query: 246 TFPKQP--EVSTECKELISNILSPVQTRPRLKTIAE---DRWLK 284
FP EVS + K+LI +L T RL TI + W+
Sbjct: 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTE-RL-TITQFMNHPWIN 292
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-57
Identities = 45/288 (15%), Positives = 105/288 (36%), Gaps = 28/288 (9%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVS-KVQAPPDYLKKF-LPREIEVVKGLKH 81
V ++G G++A V A + + KVQ P + + + + +E +K
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-----GQGYIDEIRARRWFGQLLEALQ 136
++F A + ++ E G+L + I + + + + ++L ++
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 137 YCHERGVVHRDIKCENLLL-----------DSDYNIKLSDFGFARAHMRCRSNAADNSLS 185
H+ ++H DIK +N +L D + L D G + M+ ++
Sbjct: 187 QVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI-DMKLFP---KGTIF 242
Query: 186 ETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV 245
C + + E+L P+ + D + + ++ M+FG + E + +
Sbjct: 243 TAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR- 300
Query: 246 TFPKQPEVSTECKELISNILSPVQTRPRLKTIAE--DRWLKPKPKSRG 291
++ E ++ NI P L + + + + ++
Sbjct: 301 -RLPHLDMWNEFFHVMLNI-PDCHHLPSLDLLRQKLKKVFQQHYTNKI 346
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-56
Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 42/303 (13%)
Query: 4 STVQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAP 61
V+ + K + +++G G V + T+ A+K++
Sbjct: 44 PQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQE--KFALKMLQDCPK- 100
Query: 62 PDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT----HRVYIIMEYAENGSLFDII--R 114
RE+E+ + P+++R + E + I+ME + G LF I R
Sbjct: 101 -------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 153
Query: 115 GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFARA 171
G E A + EA+QY H + HRD+K ENLL S + +KL+DFGFA+
Sbjct: 154 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213
Query: 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
+ NSL+ T C + Y +PE+L Y D+WS+GV+++ ++ G PF
Sbjct: 214 T------TSHNSLT-TPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYS 265
Query: 232 SSVN----ELLKQVQN-KVTFPKQP--EVSTECKELISNILSPVQTRPRLKTIAE---DR 281
+ + +++ + FP EVS E K LI N+L T+ R+ TI E
Sbjct: 266 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ-RM-TITEFMNHP 323
Query: 282 WLK 284
W+
Sbjct: 324 WIM 326
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-54
Identities = 61/245 (24%), Positives = 123/245 (50%), Gaps = 13/245 (5%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
TVG+ IG+GS+ TV + GDVA+K+++ P L+ F E+ V++ +H N+
Sbjct: 27 TVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRHVNI 82
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGV 143
+ F+ T ++ I+ ++ E SL+ + + + Q + Y H + +
Sbjct: 83 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRD+K N+ L D +K+ DFG A R + E GS + +PE+++
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS----GSHQFEQLSGSILWMAPEVIRMQ 197
Query: 204 PYAP--HLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNKVTFPKQPEVSTECKEL 260
P SD+++ G+VL+ ++ G+LP+ + ++ +++++ V P +V + C +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 261 ISNIL 265
+ ++
Sbjct: 258 MKRLM 262
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 4e-54
Identities = 59/283 (20%), Positives = 104/283 (36%), Gaps = 25/283 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KH 81
+ + IG+G + +V R G AIK K A + L RE+ L +H
Sbjct: 13 FHELEKIGSGEFGSVFKCVK-RLDGCIYAIKRSKKPLAGSVDEQNAL-REVYAHAVLGQH 70
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDII----RGQGYIDEIRARRWFGQLLEALQY 137
+++R+ A + I EY GSL D I R Y E + Q+ L+Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN---------AADNSLSETF 188
H +VH DIK N+ + + S +
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190
Query: 189 CGSYAYASPEILQG-IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF 247
G + + E+LQ + P +DI+++ + + + ++ + Q +
Sbjct: 191 EGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNG--DQWHEIRQGR--L 245
Query: 248 PKQPEV-STECKELISNILSPV-QTRPRLKTIAEDRWLKPKPK 288
P+ P+V S E EL+ ++ P + RP + + L +
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-54
Identities = 68/249 (27%), Positives = 103/249 (41%), Gaps = 13/249 (5%)
Query: 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
E H T +G GS+ V + + A+K V L+ F E+ GL
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGL 107
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
P ++ A+ V I ME E GSL +I+ G + E RA + GQ LE L+Y H
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH 167
Query: 140 ERGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
R ++H D+K +N+LL SD L DFG A ++ + G+ + +PE
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLKQVQNKVTFPKQPE-VSTE 256
++ G P DIWS ++ M+ G P+ LK + P +
Sbjct: 227 VVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285
Query: 257 CKELISNIL 265
+ I L
Sbjct: 286 TAQAIQEGL 294
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-53
Identities = 58/244 (23%), Positives = 103/244 (42%), Gaps = 14/244 (5%)
Query: 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIV-SKVQAPPDYLKKFLPREIEVVKGLKH 81
Y + +++G G V A T VA+K++ + + P + + RE L+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQ-REARTAGRLQE 93
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER 141
P+++ E ++Y+ M L ++R QG + RA Q+ AL H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET--FCGSYAYASPEI 199
G HRD+K EN+L+ +D L DFG A A D L++ G+ Y +PE
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASA-------TTDEKLTQLGNTVGTLYYMAPER 206
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ--PEVSTEC 257
A + +DI+++ VL+ + G P+ ++ + + + P P +
Sbjct: 207 FSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265
Query: 258 KELI 261
+I
Sbjct: 266 DAVI 269
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 3e-52
Identities = 72/251 (28%), Positives = 125/251 (49%), Gaps = 14/251 (5%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
K+IG G++ V+L R + + V A+K++SK + F E +++ P +++
Sbjct: 75 KVIGRGAFGEVQLVRH-KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
A + +Y++MEY G L +++ + E AR + +++ AL H G +HR
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHR 192
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K +N+LLD ++KL+DFG + N +T G+ Y SPE+L+
Sbjct: 193 DVKPDNMLLDKSGHLKLADFGTCM-----KMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 207 PHLS---DIWSMGVVLFAMVFGRLPFDDSSVNELLKQV---QNKVTFPKQPEVSTECKEL 260
+ D WS+GV L+ M+ G PF S+ ++ +N +TFP ++S E K L
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 261 ISNILSPVQTR 271
I L+ + R
Sbjct: 308 ICAFLTDREVR 318
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-52
Identities = 73/245 (29%), Positives = 129/245 (52%), Gaps = 16/245 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIV-SKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y + +G G +TV LA T + VAIK + + + LK+F RE+ L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE-REVHNSSQLSHQ 71
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
N++ + E Y++MEY E +L + I G + A + Q+L+ +++ H+
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET--FCGSYAYASPEIL 200
+VHRDIK +N+L+DS+ +K+ DFG A+A ++ SL++T G+ Y SPE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKA-------LSETSLTQTNHVLGTVQYFSPEQA 184
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLKQVQNKVTFP---KQPEVSTE 256
+G +DI+S+G+VL+ M+ G PF+ +++V+ +K +Q+ V + ++
Sbjct: 185 KGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 257 CKELI 261
+I
Sbjct: 244 LSNVI 248
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 8e-52
Identities = 69/298 (23%), Positives = 114/298 (38%), Gaps = 59/298 (19%)
Query: 7 QVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDY 64
V+ + K + +++G G V + T+ A+K++
Sbjct: 3 HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQE--KFALKMLQDCPK---- 56
Query: 65 LKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR----VYIIMEYAENGSLFDII--RGQG 117
RE+E+ + P+++R + E + + I+ME + G LF I RG
Sbjct: 57 ----ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 118 YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMR 174
E A + EA+QY H + HRD+K ENLL S + +KL+DFGFA
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 167
Query: 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV 234
E Y D+WS+GV+++ ++ G PF +
Sbjct: 168 ----------------------KETTGE-KYDKS-CDMWSLGVIMYILLCGYPPFYSNHG 203
Query: 235 ----NELLKQVQN-KVTFPKQP--EVSTECKELISNILSP-VQTRPRLKTIAEDRWLK 284
+ +++ + FP EVS E K LI N+L R + W+
Sbjct: 204 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-51
Identities = 53/250 (21%), Positives = 116/250 (46%), Gaps = 18/250 (7%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+G++IG G + V R G+VAI+++ + D LK F RE+ + +H N+
Sbjct: 36 EIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFK-REVMAYRQTRHENV 91
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGV 143
+ F+ A + + II + +L+ ++R +D + R+ ++++ + Y H +G+
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+H+D+K +N+ D + + ++DFG ++ ++ L G + +PEI++ +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLR-IQNGWLCHLAPEIIRQL 209
Query: 204 PYAP--------HLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255
SD++++G + + + PF ++ Q+ + K
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM---KPNLSQI 266
Query: 256 ECKELISNIL 265
+ IS+IL
Sbjct: 267 GMGKEISDIL 276
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-51
Identities = 69/246 (28%), Positives = 127/246 (51%), Gaps = 18/246 (7%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+ + IG GS+ TV R+ H DVA+KI+ + + + +FL RE+ ++K L+HPN+
Sbjct: 40 NIKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFL-REVAIMKRLRHPNI 96
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG---YIDEIRARRWFGQLLEALQYCHER 141
+ F+ A+ + I+ EY GSL+ ++ G +DE R + + + Y H R
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 142 G--VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+VHR++K NLL+D Y +K+ DFG +R S++ G+ + +PE+
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST------FLSSKSAAGTPEWMAPEV 210
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259
L+ P SD++S GV+L+ + + P+ + + +++ V K K+ E+
Sbjct: 211 LRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK---CKRLEIPRNLNP 266
Query: 260 LISNIL 265
++ I+
Sbjct: 267 QVAAII 272
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-51
Identities = 73/260 (28%), Positives = 129/260 (49%), Gaps = 30/260 (11%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIE-------V 75
+ K +GTGS+ V L + + SG+ A+KI+ K +K ++IE +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKH-KESGNHYAMKILDK----QKVVKL---KQIEHTLNEKRI 94
Query: 76 VKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEAL 135
++ + P L++ + + +Y++MEY G +F +R G E AR + Q++
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 136 QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
+Y H +++RD+K ENLL+D I+++DFGFA+ + T CG+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLCGTPEAL 205
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVS 254
+PEI+ Y D W++GV+++ M G PF ++ ++ V KV FP S
Sbjct: 206 APEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFS 262
Query: 255 TECKELISNILSPVQTRPRL 274
++ K+L+ N+L T+ R
Sbjct: 263 SDLKDLLRNLLQVDLTK-RF 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 8e-51
Identities = 59/270 (21%), Positives = 121/270 (44%), Gaps = 21/270 (7%)
Query: 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
IG GS+ TV T + +VA + + ++F E E++KGL+HPN++R
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-EEAEMLKGLQHPNIVR 89
Query: 87 FL----QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
F ++ + ++ E +G+L ++ + R W Q+L+ LQ+ H R
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 143 --VVHRDIKCENLLLDSDY-NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
++HRD+KC+N+ + ++K+ D G A S ++ G+ + +PE+
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--------RASFAKAVIGTPEFMAPEM 201
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNKVTFPKQPEV-STEC 257
+ Y D+++ G+ + M P+ + + ++ ++V + V +V E
Sbjct: 202 YEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
Query: 258 KELISNILSP-VQTRPRLKTIAEDRWLKPK 286
KE+I + R +K + + + +
Sbjct: 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 1e-50
Identities = 72/248 (29%), Positives = 123/248 (49%), Gaps = 17/248 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIV-SKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y +G+I+G G + V LAR R DVA+K++ + + P + +F RE + L HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHP 72
Query: 83 NLIRFL----QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
++ YI+MEY + +L DI+ +G + RA +AL +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET--FCGSYAYAS 196
H+ G++HRD+K N+++ + +K+ DFG ARA + NS+++T G+ Y S
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARA-----IADSGNSVTQTAAVIGTAQYLS 187
Query: 197 PEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLKQVQNKVTFPKQ--PEV 253
PE +G SD++S+G VL+ ++ G PF DS V+ + V+ P +
Sbjct: 188 PEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
Query: 254 STECKELI 261
S + ++
Sbjct: 247 SADLDAVV 254
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 6e-50
Identities = 64/249 (25%), Positives = 134/249 (53%), Gaps = 26/249 (10%)
Query: 28 KIIGTGSYATVKLAR--STRHSGDV-AIKIVSKVQAPPDYLKKFLPREIE-------VVK 77
+++G G Y V R + ++G + A+K++ K ++ ++ +++
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK----AMIVRN--AKDTAHTKAERNILE 76
Query: 78 GLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
+KHP ++ + A +T ++Y+I+EY G LF + +G E A + ++ AL +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H++G+++RD+K EN++L+ ++KL+DFG C+ + D +++ TFCG+ Y +P
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGL------CKESIHDGTVTHTFCGTIEYMAP 190
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVSTE 256
EIL + D WS+G +++ M+ G PF + + + + ++ K+ P P ++ E
Sbjct: 191 EILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--PYLTQE 247
Query: 257 CKELISNIL 265
++L+ +L
Sbjct: 248 ARDLLKKLL 256
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 7e-50
Identities = 73/260 (28%), Positives = 142/260 (54%), Gaps = 30/260 (11%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIE-------V 75
+ + + +GTGS+ V L RS RH+G A+K++ K ++ +++E +
Sbjct: 8 FQILRTLGTGSFGRVHLIRS-RHNGRYYAMKVLKK----EIVVRL---KQVEHTNDERLM 59
Query: 76 VKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEAL 135
+ + HP +IR + ++++IM+Y E G LF ++R A+ + ++ AL
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 136 QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
+Y H + +++RD+K EN+LLD + +IK++DFGFA+ ++ T CG+ Y
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTYTLCGTPDYI 170
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVS 254
+PE++ PY D WS G++++ M+ G PF DS+ + ++ + ++ FP P +
Sbjct: 171 APEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFN 227
Query: 255 TECKELISNILSPVQTRPRL 274
+ K+L+S +++ ++ RL
Sbjct: 228 EDVKDLLSRLITRDLSQ-RL 246
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-49
Identities = 82/248 (33%), Positives = 133/248 (53%), Gaps = 28/248 (11%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPR-EIE-------VVKG 78
K++G G++ V L R + +G A+KI+ K + + + E+ V++
Sbjct: 11 KLLGKGTFGKVILVRE-KATGRYYAMKILRK--------EVIIAKDEVAHTVTESRVLQN 61
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+HP L A +T R+ +MEYA G LF + + E RAR + +++ AL+Y
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H R VV+RDIK ENL+LD D +IK++DFG C+ +D + +TFCG+ Y +PE
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGL------CKEGISDGATMKTFCGTPEYLAPE 175
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVSTEC 257
+L+ Y D W +GVV++ M+ GRLPF + L + + ++ FP +S E
Sbjct: 176 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEA 232
Query: 258 KELISNIL 265
K L++ +L
Sbjct: 233 KSLLAGLL 240
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-49
Identities = 64/248 (25%), Positives = 115/248 (46%), Gaps = 28/248 (11%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
V +++G G++ V A + DVAIK + K F+ E+ + + HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKA--KWRAKDVAIKQIE----SESERKAFI-VELRQLSRVNHPNI 63
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG---YIDEIRARRWFGQLLEALQYCHER 141
++ A + V ++MEYAE GSL++++ G Y A W Q + + Y H
Sbjct: 64 VKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 142 ---GVVHRDIKCENLLLDSDYN-IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
++HRD+K NLLL + +K+ DFG A + GS A+ +P
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---------QTHMTNNKGSAAWMAP 172
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257
E+ +G Y D++S G++L+ ++ R PFD+ + ++ V +P +
Sbjct: 173 EVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 258 KELISNIL 265
+ I +++
Sbjct: 230 PKPIESLM 237
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-49
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 17/231 (7%)
Query: 66 KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYI---DEI 122
+I + N + LQ +YI M+ +L D + + + +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164
Query: 123 RARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182
F Q+ EA+++ H +G++HRD+K N+ D +K+ DFG A +
Sbjct: 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 183 SLSE------TFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVN 235
+ G+ Y SPE + G Y+ H DI+S+G++LF +++ F
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLY---SFSTQMERV 280
Query: 236 ELLKQVQNKVTFPKQPEV-STECKELISNILSPV-QTRPRLKTIAEDRWLK 284
++ V+N FP + ++ ++LSP RP I E+ +
Sbjct: 281 RIITDVRNLK-FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 6e-49
Identities = 67/254 (26%), Positives = 123/254 (48%), Gaps = 16/254 (6%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
K+IG G++ V + + +++ V A+KI++K + E +V+ +
Sbjct: 80 KVIGRGAFGEVAVVKL-KNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
A + + +Y++M+Y G L ++ + + + E AR + +++ A+ H+ VH
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RDIK +N+L+D + +I+L+DFG M S G+ Y SPEILQ +
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKLME-----DGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 206 APHL----SDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV---QNKVTFPKQ-PEVSTEC 257
D WS+GV ++ M++G PF S+ E ++ + + FP Q +VS
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
Query: 258 KELISNILSPVQTR 271
K+LI ++ + R
Sbjct: 314 KDLIRRLICSREHR 327
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-49
Identities = 64/248 (25%), Positives = 122/248 (49%), Gaps = 26/248 (10%)
Query: 28 KIIGTGSYATVKLAR--STRHSGDV-AIKIVSKVQAPPDYLKKFLPREIE------VVKG 78
K++G GS+ V L + S + + A+K++ K LK + ++
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-----ATLKV--RDRVRTKMERDILVE 82
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+ HP +++ A +T ++Y+I+++ G LF + + E + + +L AL +
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H G+++RD+K EN+LLD + +IKL+DFG + + + +FCG+ Y +PE
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGL------SKESIDHEKKAYSFCGTVEYMAPE 196
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVSTEC 257
++ + +D WS GV++F M+ G LPF E + ++ K+ P +S E
Sbjct: 197 VVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP--QFLSPEA 253
Query: 258 KELISNIL 265
+ L+ +
Sbjct: 254 QSLLRMLF 261
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-48
Identities = 74/248 (29%), Positives = 120/248 (48%), Gaps = 27/248 (10%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIE--------VVKG 78
K++G GS+ V LA + + AIK + K D + ++E +
Sbjct: 23 KMLGKGSFGKVFLAEF-KKTNQFFAIKALKK-----DVVLM--DDDVECTMVEKRVLSLA 74
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+HP L +T ++ +MEY G L I+ D RA + +++ LQ+
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H +G+V+RD+K +N+LLD D +IK++DFG C+ N ++ + TFCG+ Y +PE
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGM------CKENMLGDAKTNTFCGTPDYIAPE 188
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVSTEC 257
IL G Y H D WS GV+L+ M+ G+ PF EL + +P + E
Sbjct: 189 ILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--RWLEKEA 245
Query: 258 KELISNIL 265
K+L+ +
Sbjct: 246 KDLLVKLF 253
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-48
Identities = 79/272 (29%), Positives = 126/272 (46%), Gaps = 17/272 (6%)
Query: 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
++G G+Y V R + +AIK + + + Y + L EI + K LKH N+++
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQP-LHEEIALHKHLKHKNIVQ 83
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIR---GQGYIDEIRARRWFGQLLEALQYCHERGV 143
+L + + I ME GSL ++R G +E + Q+LE L+Y H+ +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 144 VHRDIKCENLLLDS-DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE-ILQ 201
VHRDIK +N+L+++ +K+SDFG + + A N +ETF G+ Y +PE I +
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTS------KRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 202 GIPYAPHLSDIWSMGVVLFAMVFGRLPFDD--SSVNELLKQVQNKVTFPKQPEVSTECKE 259
G +DIWS+G + M G+ PF + + K KV +S E K
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257
Query: 260 LISNILSP-VQTRPRLKTIAEDRWLKPKPKSR 290
I P R + D +LK K +
Sbjct: 258 FILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-48
Identities = 71/256 (27%), Positives = 120/256 (46%), Gaps = 18/256 (7%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
K+IG G+++ V + + + +G V A+KI++K E +V+ + +
Sbjct: 67 KVIGRGAFSEVAVVKM-KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCHERGVVH 145
A + + +Y++MEY G L ++ G I AR + +++ A+ H G VH
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RDIK +N+LLD +I+L+DFG + A S G+ Y SPEILQ +
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCL-----KLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 206 APHLS------DIWSMGVVLFAMVFGRLPFDDSSVNELLKQV---QNKVTFPKQP-EVST 255
P D W++GV + M +G+ PF S E ++ + ++ P V
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPE 300
Query: 256 ECKELISNILSPVQTR 271
E ++ I +L P +TR
Sbjct: 301 EARDFIQRLLCPPETR 316
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-48
Identities = 77/248 (31%), Positives = 126/248 (50%), Gaps = 27/248 (10%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIE--------VVKG 78
K+IG GS+ V LAR + A+K++ K LKK +E + ++K
Sbjct: 44 KVIGKGSFGKVLLARH-KAEEVFYAVKVLQK----KAILKK---KEEKHIMSERNVLLKN 95
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+KHP L+ + +T ++Y +++Y G LF ++ + E RAR + ++ AL Y
Sbjct: 96 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYL 155
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H +V+RD+K EN+LLDS +I L+DFG C+ N NS + TFCG+ Y +PE
Sbjct: 156 HSLNIVYRDLKPENILLDSQGHIVLTDFGL------CKENIEHNSTTSTFCGTPEYLAPE 209
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVSTEC 257
+L PY D W +G VL+ M++G PF + E+ + + P ++
Sbjct: 210 VLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSA 266
Query: 258 KELISNIL 265
+ L+ +L
Sbjct: 267 RHLLEGLL 274
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-48
Identities = 55/245 (22%), Positives = 117/245 (47%), Gaps = 17/245 (6%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86
+ IG GS+ V + + + + A+K ++K + + + +E+++++GL+HP L+
Sbjct: 21 RAIGKGSFGKVCIVQK-NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHR 146
+ + ++++++ G L ++ + E + + +L+ AL Y + ++HR
Sbjct: 80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHR 139
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA 206
D+K +N+LLD ++ ++DF A + T G+ Y +PE+ A
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAA-------MLPRETQITTMAGTKPYMAPEMFSSRKGA 192
Query: 207 PHLS--DIWSMGVVLFAMVFGRLPF---DDSSVNELLKQVQN-KVTFPKQPEVSTECKEL 260
+ D WS+GV + ++ GR P+ +S E++ + VT+P S E L
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP--SAWSQEMVSL 250
Query: 261 ISNIL 265
+ +L
Sbjct: 251 LKKLL 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-47
Identities = 71/249 (28%), Positives = 133/249 (53%), Gaps = 29/249 (11%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPR-EIE--------VVK 77
+++G GS+ V LAR + +GD+ A+K++ K L ++E +
Sbjct: 29 RVLGKGSFGKVMLARV-KETGDLYAVKVLKK--------DVILQDDDVECTMTEKRILSL 79
Query: 78 GLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
HP L + +T R++ +ME+ G L I+ DE RAR + +++ AL +
Sbjct: 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H++G+++RD+K +N+LLD + + KL+DFG C+ + + TFCG+ Y +P
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFG------MCKEGICNGVTTATFCGTPDYIAP 193
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVSTE 256
EILQ + Y P + D W+MGV+L+ M+ G PF+ + ++L + + ++V +P + +
Sbjct: 194 EILQEMLYGPAV-DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TWLHED 250
Query: 257 CKELISNIL 265
++ + +
Sbjct: 251 ATGILKSFM 259
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-47
Identities = 67/250 (26%), Positives = 125/250 (50%), Gaps = 31/250 (12%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEV----------V 76
++G GS+ V L+ + + ++ A+KI+ K + ++ +V
Sbjct: 26 MVLGKGSFGKVMLSER-KGTDELYAVKILKK---------DVVIQDDDVECTMVEKRVLA 75
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
K P L + +T R+Y +MEY G L I+ G E A + ++ L
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYAS 196
+ +G+++RD+K +N++LDS+ +IK++DFG C+ N D ++TFCG+ Y +
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM------CKENIWDGVTTKTFCGTPDYIA 189
Query: 197 PEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVST 255
PEI+ PY + D W+ GV+L+ M+ G+ PF+ +EL + +++ V +P +S
Sbjct: 190 PEIIAYQPYGKSV-DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSK 246
Query: 256 ECKELISNIL 265
E + ++
Sbjct: 247 EAVAICKGLM 256
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-46
Identities = 59/254 (23%), Positives = 113/254 (44%), Gaps = 29/254 (11%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIV--SKVQAPPDYLKKFLPREIEVVKGLKHP 82
T+ +IIG G + V R+ +VA+K + ++ +E ++ LKHP
Sbjct: 10 TLEEIIGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVR-QEAKLFAMLKHP 66
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
N+I + ++ME+A G L ++ G+ I W Q+ + Y H+
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 143 ---VVHRDIKCENLLLD--------SDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGS 191
++HRD+K N+L+ S+ +K++DFG AR + + G+
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--------EWHRTTKMSAAGA 177
Query: 192 YAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQP 251
YA+ +PE+++ ++ SD+WS GV+L+ ++ G +PF + V
Sbjct: 178 YAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN---KLAL 233
Query: 252 EVSTECKELISNIL 265
+ + C E + ++
Sbjct: 234 PIPSTCPEPFAKLM 247
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-46
Identities = 41/249 (16%), Positives = 95/249 (38%), Gaps = 25/249 (10%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+ + + D+ +K++ + F E ++ HPN+
Sbjct: 13 NFLTKLNENHSGELW--KGRWQGNDIVVKVLKVRDWSTRKSRDFN-EECPRLRIFSHPNV 69
Query: 85 IRFLQAIET--THRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCH- 139
+ L A ++ +I + GSL++++ +D+ +A ++ + + + H
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 140 -ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
E + + ++++D D ++S + S + A+ +PE
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----------SPGRMYAPAWVAPE 178
Query: 199 ILQGIPYAP--HLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256
LQ P +D+WS V+L+ +V +PF D S E+ +V + +P +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE---GLRPTIPPG 235
Query: 257 CKELISNIL 265
+S ++
Sbjct: 236 ISPHVSKLM 244
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 79/249 (31%), Positives = 133/249 (53%), Gaps = 29/249 (11%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPR-EIE-------VVKG 78
K++G G++ V L + + +G A+KI+ K + + + E+ V++
Sbjct: 154 KLLGKGTFGKVILVKE-KATGRYYAMKILKK--------EVIVAKDEVAHTLTENRVLQN 204
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+HP L + +T R+ +MEYA G LF + + E RAR + +++ AL Y
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 139 H-ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H E+ VV+RD+K ENL+LD D +IK++DFG C+ D + +TFCG+ Y +P
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGL------CKEGIKDGATMKTFCGTPEYLAP 318
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVSTE 256
E+L+ Y + D W +GVV++ M+ GRLPF + +L + + ++ FP + E
Sbjct: 319 EVLEDNDYGRAV-DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLGPE 375
Query: 257 CKELISNIL 265
K L+S +L
Sbjct: 376 AKSLLSGLL 384
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-46
Identities = 74/258 (28%), Positives = 130/258 (50%), Gaps = 38/258 (14%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPR-EIE--------VVK 77
++IG GSYA V L R + + + A+K+V K + +I+ +
Sbjct: 15 RVIGRGSYAKVLLVRL-KKTDRIYAMKVVKK--------ELVNDDEDIDWVQTEKHVFEQ 65
Query: 78 GLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
HP L+ +T R++ ++EY G L ++ Q + E AR + ++ AL Y
Sbjct: 66 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
HERG+++RD+K +N+LLDS+ +IKL+D+G C+ + TFCG+ Y +P
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAP 179
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF---------DDSSVNELLKQ-VQNKVTF 247
EIL+G Y D W++GV++F M+ GR PF D ++ + L + ++ ++
Sbjct: 180 EILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 238
Query: 248 PKQPEVSTECKELISNIL 265
P +S + ++ + L
Sbjct: 239 P--RSLSVKAASVLKSFL 254
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 9e-46
Identities = 66/258 (25%), Positives = 135/258 (52%), Gaps = 36/258 (13%)
Query: 28 KIIGTGSYATVKLAR--STRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEVV-------- 76
K++GTG+Y V L R S +G + A+K++ K + ++ +
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK---------ATIVQKAKTTEHTRTERQ 110
Query: 77 ---KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLE 133
+ P L+ A +T ++++I++Y G LF + + E + + G+++
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 134 ALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193
AL++ H+ G+++RDIK EN+LLDS+ ++ L+DFG ++ + + + FCG+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-----DETERAYDFCGTIE 225
Query: 194 YASPEILQGIPYAPHLS-DIWSMGVVLFAMVFGRLPF----DDSSVNELLKQ-VQNKVTF 247
Y +P+I++G + D WS+GV+++ ++ G PF + +S E+ ++ ++++ +
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
Query: 248 PKQPEVSTECKELISNIL 265
P E+S K+LI +L
Sbjct: 286 P--QEMSALAKDLIQRLL 301
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-45
Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 12/266 (4%)
Query: 10 DDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFL 69
+KV L+ + +G G+ V +A K++ P + +
Sbjct: 21 LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQI 78
Query: 70 PREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG 129
RE++V+ P ++ F A + + I ME+ + GSL +++ G I E +
Sbjct: 79 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 138
Query: 130 QLLEALQYCH-ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETF 188
+++ L Y + ++HRD+K N+L++S IKL DFG S +S++ +F
Sbjct: 139 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--------SGQLIDSMANSF 190
Query: 189 CGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP 248
G+ +Y SPE LQG Y+ SDIWSMG+ L M GR P EL +V
Sbjct: 191 VGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249
Query: 249 KQPEVSTECKELISNILSPVQTRPRL 274
+ +RP +
Sbjct: 250 AAETPPRPRTPGRPLNKFGMDSRPPM 275
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 67/249 (26%), Positives = 123/249 (49%), Gaps = 29/249 (11%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPR-EIEVVK-------- 77
++G GS+ V L+ + + ++ A+KI+ K + ++E
Sbjct: 347 MVLGKGSFGKVMLSER-KGTDELYAVKILKK--------DVVIQDDDVECTMVEKRVLAL 397
Query: 78 GLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
K P L + +T R+Y +MEY G L I+ G E A + ++ L +
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
+G+++RD+K +N++LDS+ +IK++DFG C+ N D ++TFCG+ Y +P
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGM------CKENIWDGVTTKTFCGTPDYIAP 511
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQ-VQNKVTFPKQPEVSTE 256
EI+ PY D W+ GV+L+ M+ G+ PF+ +EL + +++ V +P +S E
Sbjct: 512 EIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKE 568
Query: 257 CKELISNIL 265
+ ++
Sbjct: 569 AVAICKGLM 577
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-45
Identities = 51/257 (19%), Positives = 106/257 (41%), Gaps = 31/257 (12%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD-----YLKKFLPREIEVVKGL 79
K IG G + V R + VAIK + + + ++F RE+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ-REVFIMSNL 80
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYC 138
HPN+++ + ++ME+ G L+ + + + I R + ++Y
Sbjct: 81 NHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 139 HERG--VVHRDIKCENLLLDS-----DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGS 191
+ +VHRD++ N+ L S K++DFG ++ G+
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---------QSVHSVSGLLGN 189
Query: 192 YAYASPEILQG--IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK 249
+ + +PE + Y +D +S ++L+ ++ G PFD+ S ++ + N +
Sbjct: 190 FQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMIREEG 246
Query: 250 Q-PEVSTECKELISNIL 265
P + +C + N++
Sbjct: 247 LRPTIPEDCPPRLRNVI 263
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-45
Identities = 47/216 (21%), Positives = 94/216 (43%), Gaps = 13/216 (6%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
G+++G G + + +K + + + + FL +E++V++ L+HPN+
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFL-KEVKVMRCLEHPNV 69
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGV 143
++F+ + R+ I EY + G+L II+ + + + + Y H +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFAR--------AHMRCRSNAADNSLSETFCGSYAYA 195
+HRD+ N L+ + N+ ++DFG AR D T G+ +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
+PE++ G Y D++S G+VL ++ D
Sbjct: 190 APEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPD 224
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-45
Identities = 75/250 (30%), Positives = 132/250 (52%), Gaps = 22/250 (8%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIEV-VKGLKHPNLI 85
++IG GSYA V L R + + + A+++V K D ++ E V + HP L+
Sbjct: 58 RVIGRGSYAKVLLVRL-KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
+T R++ ++EY G L ++ Q + E AR + ++ AL Y HERG+++
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 176
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+K +N+LLDS+ +IKL+D+G C+ + TFCG+ Y +PEIL+G Y
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 206 APHLSDIWSMGVVLFAMVFGRLPF---------DDSSVNELLKQ-VQNKVTFPKQPEVST 255
+ D W++GV++F M+ GR PF D ++ + L + ++ ++ P +S
Sbjct: 231 GFSV-DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSV 287
Query: 256 ECKELISNIL 265
+ ++ + L
Sbjct: 288 KAASVLKSFL 297
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 61/252 (24%), Positives = 110/252 (43%), Gaps = 31/252 (12%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKK-------FLPREI-EVVKG 78
+IIG G + V R +G + A+K + K +K R + +V
Sbjct: 195 RIIGRGGFGEVYGCRK-ADTGKMYAMKCLDK-----KRIKMKQGETLALNERIMLSLVST 248
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
P ++ A T ++ I++ G L + G E R + +++ L++
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H R VV+RD+K N+LLD ++++SD G A + + + G++ Y +PE
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--------ASVGTHGYMAPE 360
Query: 199 ILQ-GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS---VNELLKQVQN-KVTFPKQPEV 253
+LQ G+ Y +D +S+G +LF ++ G PF +E+ + V P
Sbjct: 361 VLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSF 417
Query: 254 STECKELISNIL 265
S E + L+ +L
Sbjct: 418 SPELRSLLEGLL 429
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-43
Identities = 57/255 (22%), Positives = 116/255 (45%), Gaps = 34/255 (13%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKKFLPREIE-------VVKGL 79
+++G G + V + + +G + A K ++K LKK + + ++ +
Sbjct: 191 RVLGRGGFGEVFACQM-KATGKLYACKKLNK-----KRLKK--RKGYQGAMVEKKILAKV 242
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLF----DIIRGQGYIDEIRARRWFGQLLEAL 135
++ A ET + ++M G + ++ E RA + Q++ L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 136 QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
++ H+R +++RD+K EN+LLD D N+++SD G A + ++ + G+ +
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA------GQTKTKGYAGTPGFM 356
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK-----VTFPKQ 250
+PE+L G Y + D +++GV L+ M+ R PF K+++ + VT+P +
Sbjct: 357 APELLLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415
Query: 251 PEVSTECKELISNIL 265
S K+ +L
Sbjct: 416 --FSPASKDFCEALL 428
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-42
Identities = 63/295 (21%), Positives = 115/295 (38%), Gaps = 47/295 (15%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
T+ + +G G Y V + +VA+KI S D F E+ L+H N+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFS----SRDEKSWFRETELYNTVMLRHENI 64
Query: 85 IRFLQAIETTH----RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
+ F+ + T+ ++++I Y E GSL+D ++ +D + R + L + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHI 123
Query: 141 R--------GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
+ HRD+K +N+L+ + ++D G A H + + + G+
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR--VGTK 181
Query: 193 AYASPEILQGIPYAPHL-----SDIWSMGVVLFAMVFG----------RLPFDD-SSVNE 236
Y +PE+L DIW+ G+VL+ + + PF D +
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 237 LLKQVQNKVTFPKQ-PEVSTECKELISNILSPVQTRPRLKTIAEDRWLKPKPKSR 290
+ ++ V +Q P I N T L + ++ W P +R
Sbjct: 242 SFEDMRKVVCVDQQRPN--------IPNRWFSDPTLTSLAKLMKECW-YQNPSAR 287
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 5e-42
Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 27/222 (12%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSG-DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y V I G + LA +G V +K + + + E + + + HP
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAM-AERQFLAEVVHP 139
Query: 83 NLIRFLQAIETTHR-----VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
++++ +E T R YI+MEY SL + + E A + ++L AL Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAE--AIAYLLEILPALSY 197
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSET--FCGSYAYA 195
H G+V+ D+K EN++L + +KL D G ++ G+ +
Sbjct: 198 LHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR------------INSFGYLYGTPGFQ 244
Query: 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNEL 237
+PEI++ P +DI+++G L A+ + V+ L
Sbjct: 245 APEIVRTGPTVA--TDIYTVGRTLAALTLDLPTRNGRYVDGL 284
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 56/251 (22%), Positives = 108/251 (43%), Gaps = 29/251 (11%)
Query: 28 KIIGTGSYATVKLARSTRHSGDV-AIKIVSKVQAPPDYLKK-----FLPREIEVVKGLKH 81
+++G G + V + R +G + A K + K +KK E ++++ +
Sbjct: 190 RVLGKGGFGEVCACQV-RATGKMYACKKLEK-----KRIKKRKGEAMALNEKQILEKVNS 243
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR--GQGYIDEIRARRWFGQLLEALQYCH 139
++ A ET + +++ G L I GQ E RA + ++ L+ H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+V+RD+K EN+LLD +I++SD G A + + + G+ Y +PE+
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAV-------HVPEGQTIKGRVGTVGYMAPEV 356
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-----QNKVTFPKQPEVS 254
++ Y D W++G +L+ M+ G+ PF ++V + + S
Sbjct: 357 VKNERYTFSP-DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFS 413
Query: 255 TECKELISNIL 265
+ + L S +L
Sbjct: 414 PQARSLCSQLL 424
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-40
Identities = 66/208 (31%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT + IG G+ TV A +VAI+ + +Q P K+ + EI V++ K+PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPK--KELIINEILVMRENKNPN 78
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ +L + ++++MEY GSL D++ + +DE + + L+AL++ H V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRDIK +N+LL D ++KL+DFGF C + S T G+ + +PE++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGF------CAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
Y P DIWS+G++ M+ G P+ +
Sbjct: 192 AYGP-KVDIWSLGIMAIEMIEGEPPYLN 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-40
Identities = 61/208 (29%), Positives = 109/208 (52%), Gaps = 11/208 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
IG GS V LAR VA+K++ ++ ++ L E+ +++ +H N
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQR--RELLFNEVVIMRDYQHFN 103
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ ++ ++++ME+ + G+L DI+ Q ++E + +L+AL Y H +GV
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRDIK +++LL D +KLSDFGF C + D ++ G+ + +PE++
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGF------CAQISKDVPKRKSLVGTPYWMAPEVISRS 216
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
YA DIWS+G+++ MV G P+
Sbjct: 217 LYAT-EVDIWSLGIMVIEMVDGEPPYFS 243
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 13/217 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + ++IG+G+ A V+ A VAIK ++ + L +EI+ + HPN
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHHPN 74
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRG--------QGYIDEIRARRWFGQLLEAL 135
++ + + ++++M+ GS+ DII+ G +DE ++LE L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 136 QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
+Y H+ G +HRD+K N+LL D +++++DFG + A + + N + +TF G+ +
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITRNKVRKTFVGTPCWM 193
Query: 196 SPE-ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
+PE + Q Y +DIWS G+ + G P+
Sbjct: 194 APEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHK 229
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 59/295 (20%), Positives = 112/295 (37%), Gaps = 47/295 (15%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+ K IG G Y V + + VA+K+ + F EI ++H N+
Sbjct: 40 QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFF----TTEEASWFRETEIYQTVLMRHENI 93
Query: 85 IRFLQAIETTH----RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
+ F+ A ++Y+I +Y ENGSL+D ++ +D + + L + H
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 141 R--------GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
+ HRD+K +N+L+ + ++D G A + + + G+
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR--VGTK 210
Query: 193 AYASPEILQGIPYAPHL-----SDIWSMGVVLFAMVFG----------RLPFDD-SSVNE 236
Y PE+L H +D++S G++L+ + +LP+ D +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270
Query: 237 LLKQVQNKVTFPKQ-PEVSTECKELISNILSPVQTRPRLKTIAEDRWLKPKPKSR 290
+ ++ V K P N S + ++ + + W P SR
Sbjct: 271 SYEDMREIVCIKKLRPS--------FPNRWSSDECLRQMGKLMTECW-AHNPASR 316
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-39
Identities = 69/301 (22%), Positives = 128/301 (42%), Gaps = 26/301 (8%)
Query: 9 QDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKF 68
I + E + +G+G+ V R + +A+K + + + K+
Sbjct: 12 YLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRI 70
Query: 69 LPREIEVV-KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRW 127
L +++VV K P +++ T V+I ME + R QG I E +
Sbjct: 71 L-MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM 129
Query: 128 FGQLLEALQYCH-ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186
+++AL Y + GV+HRD+K N+LLD IKL DFG + + + ++
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS-GRL-------VDDKAK 181
Query: 187 -TFCGSYAYASPEILQ-----GIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLK 239
G AY +PE + Y +D+WS+G+ L + G+ P+ + + E+L
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLT 240
Query: 240 QVQNKV--TFPKQPEVSTECKELISNIL--SPVQTRPRLKTIAEDRWLKPKPKSRGVDKA 295
+V + P S + + + + L + RP+ + E ++K + ++ VD A
Sbjct: 241 KVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDH-RKRPKYNKLLEHSFIK-RYETLEVDVA 298
Query: 296 E 296
Sbjct: 299 S 299
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-39
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+T + IG GS+ V R VAIKI+ +A + + + +EI V+ P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPY 81
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+ ++ + +++IIMEY GS D++ G +DE + ++L+ L Y H
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKK 140
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRDIK N+LL +KL+DFG A + TF G+ + +PE+++
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVA-GQL-----TDTQIKRNTFVGTPFWMAPEVIKQS 194
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
Y +DIWS+G+ + G P +
Sbjct: 195 AYD-SKADIWSLGITAIELARGEPPHSE 221
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-38
Identities = 71/223 (31%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y IG GSY V R+ R +G VAIK +KK REI ++K LKHP
Sbjct: 5 YEKIGKIGEGSYGVVFKCRN-RDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHP 62
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
NL+ L+ R++++ EY ++ L ++ R Q + E + Q L+A+ +CH+
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA----YASPE 198
+HRD+K EN+L+ IKL DFGFAR + + Y SPE
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLL-----TGPSDYYDD-----EVATRWYRSPE 172
Query: 199 ILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLK 239
+L G Y P + D+W++G V ++ G + S V++L
Sbjct: 173 LLVGDTQYGPPV-DVWAIGCVFAELLSGVPLWPGKSDVDQLYL 214
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ V + +G GSY +V A VAIK V + +K EI +++ P+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK-----EISIMQQCDSPH 85
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERG 142
++++ + ++I+MEY GS+ DIIR + E L+ L+Y H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
+HRDIK N+LL+++ + KL+DFG + T G+ + +PE++Q
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGV------AGQLTDTMAKRNTVIGTPFWMAPEVIQE 199
Query: 203 IPYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
I Y ++DIWS+G+ M G+ P+ D
Sbjct: 200 IGYN-CVADIWSLGITAIEMAEGKPPYAD 227
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 51/231 (22%), Positives = 94/231 (40%), Gaps = 29/231 (12%)
Query: 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
+S + ++ G + V ++ + VA+KI D E+ +
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVW--KAQLLNEYVAVKIFP----IQDKQSWQNEYEVYSLP 73
Query: 78 GLKHPNLIRFLQAIETTHRV----YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLE 133
G+KH N+++F+ A + V ++I + E GSL D ++ + +
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMAR 132
Query: 134 ALQYCHER----------GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNS 183
L Y HE + HRDIK +N+LL ++ ++DFG A +S +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 184 LSETFCGSYAYASPEILQGIPYAPHL----SDIWSMGVVLFAMVFGRLPFD 230
G+ Y +PE+L+G D+++MG+VL+ + D
Sbjct: 193 Q----VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 25 TVGKIIGTGSYATVKLAR----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
K++G+G++ TV + VAIK + + P K+ L E V+ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DEAYVMASVD 75
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCH 139
+P++ R L I T V +I + G L D +R + I W Q+ + + Y
Sbjct: 76 NPHVCR-LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+R +VHRD+ N+L+ + ++K++DFG A+ L Y +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL------------LGA---EEKEYHAEGG 179
Query: 200 LQGIP---YAP---------HLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQN 243
+P A H SD+WS GV ++ M FG P+D +E+ ++
Sbjct: 180 K--VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 26/212 (12%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+ + IG G + V +VA+KI S + F EI L+H N+
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENI 98
Query: 85 IRFLQAIETTH----RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
+ F+ A + +++++ +Y E+GSLFD + + + + L + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 141 R--------GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
+ HRD+K +N+L+ + ++D G A H G+
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR--VGTK 215
Query: 193 AYASPEILQGIPYAPHL-----SDIWSMGVVL 219
Y +PE+L H +DI++MG+V
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 39/251 (15%), Positives = 74/251 (29%), Gaps = 44/251 (17%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIV-SKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y + G A T VA+ V + P D L++ L + + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKP 91
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
+ R L + T ++ E+ GSL ++ + A R L A H G
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG 149
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
V + + D ++ L+ A+P+
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMPD-----------------------ANPQ---- 182
Query: 203 IPYAPHLSDIWSMGVVLFAMVFGRLPFD----DSSVNELLKQVQNKVTFPKQ--PEVSTE 256
DI +G L+A++ R P S + + + P ++ +
Sbjct: 183 -------DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235
Query: 257 CKELISNILSP 267
+ + +
Sbjct: 236 ISAVAARSVQG 246
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 51/216 (23%), Positives = 93/216 (43%), Gaps = 11/216 (5%)
Query: 24 YTVGKIIGTG--SYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
Y + +IG G TV LAR V ++ ++ + + FL E+ V K H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNH 85
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCH 139
PN++ + + ++++ + GS D+I ++E+ +L+AL Y H
Sbjct: 86 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFAR---AHMRCRSNAADNSLSETFCGSYAYAS 196
G VHR +K ++L+ D + LS +H + + + + + S
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV--HDFPKYSVKVLPWLS 203
Query: 197 PE-ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
PE + Q + SDI+S+G+ + G +PF D
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 18/222 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y ++G GSY V R+ + +G VAIK +KK REI+++K L+H
Sbjct: 27 YENLGLVGEGSYGMVMKCRN-KDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
NL+ L+ + R Y++ E+ ++ L D+ +D +++ Q++ + +CH
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE---TFCGSYAYASPEI 199
++HRDIK EN+L+ +KL DFGFAR A + T Y +PE+
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTL-----AAPGEVYDDEVATR----WYRAPEL 195
Query: 200 LQG-IPYAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLK 239
L G + Y + D+W++G ++ M G F DS +++L
Sbjct: 196 LVGDVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDSDIDQLYH 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-36
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 16/212 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
++ + IG GS+ V AR R+S VAIK +S + + + +E+ ++ L+HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERG 142
I++ H +++MEY GS D++ + + E+ L+ L Y H
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI--- 199
++HRD+K N+LL +KL DFG A + M + +F G+ + +PE+
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSA-SIMAPAN---------SFVGTPYWMAPEVILA 224
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
+ Y D+WS+G+ + + P +
Sbjct: 225 MDEGQYD-GKVDVWSLGITCIELAERKPPLFN 255
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 61/280 (21%), Positives = 120/280 (42%), Gaps = 25/280 (8%)
Query: 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV-KGLKHPNLIRFL 88
+G G+Y V+ R +A+K + K+ L ++++ + + P + F
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLL-MDLDISMRTVDCPFTVTFY 72
Query: 89 QAIETTHRVYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCH-ERGV 143
A+ V+I ME + SL + I E + +++AL++ H + V
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS-ETFCGSYAYASPEILQG 202
+HRD+K N+L+++ +K+ DFG + ++ + ++ + G Y +PE +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGIS-GYL-------VDDVAKDIDAGCKPYMAPERINP 183
Query: 203 IPYAP---HLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNKVTFPKQPEV-STEC 257
SDIWS+G+ + + R P+D + + LKQV + + + S E
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEF 243
Query: 258 KELISNILS-PVQTRPRLKTIAEDRWLKPKPKSRGVDKAE 296
+ S L + RP + + + +S+G D A
Sbjct: 244 VDFTSQCLKKNSKERPTYPELMQHPFFT-LHESKGTDVAS 282
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 47/219 (21%), Positives = 84/219 (38%), Gaps = 33/219 (15%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK--GLKHP 82
+ ++IG G Y V VA+K+ + F+ E + + ++H
Sbjct: 16 KLLELIGRGRYGAVYKGSL--DERPVAVKVF-----SFANRQNFI-NEKNIYRVPLMEHD 67
Query: 83 NLIRFLQAIETTHRV-----YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
N+ RF+ E ++MEY NGSL + D + + R + L Y
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAY 126
Query: 138 CHE---------RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETF 188
H + HRD+ N+L+ +D +SDFG + R +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 189 --CGSYAYASPEILQG------IPYAPHLSDIWSMGVVL 219
G+ Y +PE+L+G A D++++G++
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 50/214 (23%), Positives = 105/214 (49%), Gaps = 16/214 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + +G G++ V A++ A K++ ++ + + EIE++ HP
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEE--LEDYIVEIEILATCDHPY 77
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERG 142
+++ L A +++I++E+ G++ I+ + E + + Q+LEAL + H +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI--- 199
++HRD+K N+L+ + +I+L+DFG N ++F G+ + +PE+
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGV------SAKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 200 --LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD 231
++ PY + +DIWS+G+ L M P +
Sbjct: 192 ETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHE 224
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 57/237 (24%), Positives = 98/237 (41%), Gaps = 38/237 (16%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSG----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
K++G+G++ TV VAIK + + P K+ L E V+ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DEAYVMASVD 75
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCH 139
+P++ R L I T V +I + G L D +R + I W Q+ + + Y
Sbjct: 76 NPHVCR-LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+R +VHRD+ N+L+ + ++K++DFG A+ Y +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL---------------LGAEEKEYHAEGG 179
Query: 200 LQGIP---YAP---------HLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQN 243
+P A H SD+WS GV ++ M FG P+D +E+ ++
Sbjct: 180 K--VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-35
Identities = 69/313 (22%), Positives = 127/313 (40%), Gaps = 32/313 (10%)
Query: 2 IDSTVQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP 61
I+S+ +++ ++ + IG G+Y +V +A+K +
Sbjct: 3 IESSGKLKISPEQHWDF-TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 62 PDYLKKFLPREIEVV-KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-----G 115
+ +K L +++VV + P +++F A+ +I ME + S +
Sbjct: 62 KE--QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVL 118
Query: 116 QGYIDEIRARRWFGQLLEALQYCH-ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174
I E + ++AL + ++HRDIK N+LLD NIKL DFG + +
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS-GQL- 176
Query: 175 CRSNAADNSLSET-FCGSYAYASPEILQGIPYAP---HLSDIWSMGVVLFAMVFGRLPFD 230
+S+++T G Y +PE + SD+WS+G+ L+ + GR P+
Sbjct: 177 ------VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230
Query: 231 D-SSVNELLKQVQNKV--TFPKQPEV--STECKELISNIL--SPVQTRPRLKTIAEDRWL 283
+SV + L QV E S ++ L RP+ K + + ++
Sbjct: 231 KWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDE-SKRPKYKELLKHPFI 289
Query: 284 KPKPKSRGVDKAE 296
+ R V+ A
Sbjct: 290 L-MYEERAVEVAC 301
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 33/230 (14%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLP----REIEVVKGL 79
Y + IG G+Y TV A++ VA+K +V+ D + +P REI ++K L
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVR--LDDDDEGVPSSALREICLLKEL 58
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAEN--GSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
KH N++R + + ++ ++ E+ + FD G +D + + QLL+ L +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA---HMRCRSNAADNSLSE--TFCGSY 192
CH R V+HRD+K +NLL++ + +KL++FG ARA +RC S E T
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-------EVVTLW--- 166
Query: 193 AYASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPF--DDSSVNELLK 239
Y P++L G Y+ + D+WS G + + P + ++L +
Sbjct: 167 -YRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 36/237 (15%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD---VAIKIVSK-VQAPPDYLKKFLPREIEVVKGLK 80
+ + +G GS+ V+ SG VA+K + V + P+ + F+ RE+ + L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLD 79
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCH 139
H NLIR L + T + ++ E A GSL D +R QG+ R+ Q+ E + Y
Sbjct: 80 HRNLIR-LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+ +HRD+ NLLL + +K+ DFG RA D+ +
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA-----LPQNDD---------HYVMQEHR 184
Query: 200 LQGIP---YAP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
+P AP H SD W GV L+ M +G+ P+ + +++L ++
Sbjct: 185 K--VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 61/249 (24%), Positives = 106/249 (42%), Gaps = 43/249 (17%)
Query: 12 IDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSG--DVAIKIVSKVQAPPDYLKKFL 69
+DRK+ LE K +G+G++ TVK VA+KI+ P + L
Sbjct: 13 LDRKLLTLE------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 66
Query: 70 PREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG 129
E V++ L +P ++R + I ++ME AE G L ++ ++ +
Sbjct: 67 -AEANVMQQLDNPYIVR-MIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 124
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Q+ ++Y E VHRD+ N+LL + + K+SDFG ++A +
Sbjct: 125 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-------LRADE------ 171
Query: 190 GSYAYASPEILQG--IP---YAP---------HLSDIWSMGVVLF-AMVFGRLPFDDSSV 234
+Y A P YAP SD+WS GV+++ A +G+ P+
Sbjct: 172 -NYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226
Query: 235 NELLKQVQN 243
+E+ ++
Sbjct: 227 SEVTAMLEK 235
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-34
Identities = 56/238 (23%), Positives = 99/238 (41%), Gaps = 42/238 (17%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
+ +I+G G + V T H G +VA+K K D +KF+ E ++K L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFM-SEAVIMKNLDH 72
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHE 140
P++++ L I +IIME G L + + + + + Q+ +A+ Y
Sbjct: 73 PHIVK-LIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
VHRDI N+L+ S +KL DFG +R + + Y Y +
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRY------------IEDE---DY-YKA---- 171
Query: 201 QG--IP---YAP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
+P +P SD+W V ++ ++ FG+ PF +++ ++
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 49/237 (20%), Positives = 93/237 (39%), Gaps = 38/237 (16%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSG----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
K++G+G + TV V IK++ + ++ + + + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT-DHMLAIGSLD 73
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCH 139
H +++R L + + ++ +Y GSL D +R +G + W Q+ + + Y
Sbjct: 74 HAHIVR-LLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
E G+VHR++ N+LL S ++++DFG A E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADL---------------LPPDDKQLLYSEA 177
Query: 200 LQGIP---YAP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
P A H SD+WS GV ++ ++ FG P+ + E+ ++
Sbjct: 178 K--TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 69/230 (30%), Positives = 121/230 (52%), Gaps = 35/230 (15%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLP----REIEVVKG 78
Y + IG G+Y V A++ G+ A+K K++ + + +P REI ++K
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN--YGETFALK---KIR--LEKEDEGIPSTTIREISILKE 56
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAEN--GSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
LKH N+++ I T R+ ++ E+ + L D +G ++ + A+ + QLL +
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIA 114
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA---HMRCRSNAADNSLSE--TFCGS 191
YCH+R V+HRD+K +NLL++ + +K++DFG ARA +R ++ E T
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-------EIVTLW-- 165
Query: 192 YAYASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLK 239
Y +P++L G Y+ + DIWS+G + MV G F S ++L++
Sbjct: 166 --YRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 68/235 (28%), Positives = 115/235 (48%), Gaps = 42/235 (17%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT K+IG GS+ V A+ S +VAIK KV K+F RE+++++ +KHPN
Sbjct: 42 YTNCKVIGNGSFGVVFQAKL-VESDEVAIK---KVLQD----KRFKNRELQIMRIVKHPN 93
Query: 84 LIRFLQAIETTHR------VYIIMEYAENGSLFDIIR----GQGYIDEIRARRWFGQLLE 133
++ + + +++EY +++ R + + + + + QLL
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 134 ALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
+L Y H G+ HRDIK +NLLLD +KL DFG A+ + N SY
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV-----------SY 201
Query: 193 A----YASPEILQGIPYAPHLS---DIWSMGVVLFAMVFGRLPFD-DSSVNELLK 239
Y +PE++ G A + + DIWS G V+ ++ G+ F +S +++L++
Sbjct: 202 ICSRYYRAPELIFG---ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 48/239 (20%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQ------APPDYLKKFLPREIEVVK 77
+ + +G G+YATV + VA+K +V+ P + REI ++K
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALK---EVKLDSEEGTPSTAI-----REISLMK 58
Query: 78 GLKHPNLIRFLQAIETTHRVYIIMEYAEN--GSLFD---IIRGQGYIDEIRARRWFGQLL 132
LKH N++R I T +++ ++ E+ +N D + ++ + + QLL
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 133 EALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA---HMRCRSNAADNSLSETFC 189
+ L +CHE ++HRD+K +NLL++ +KL DFG ARA +
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--------------- 163
Query: 190 GSYA-------YASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLK 239
+++ Y +P++L G Y+ + DIWS G +L M+ G+ F + +L
Sbjct: 164 -TFSSEVVTLWYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKL 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 42/238 (17%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
+G+ IG G + V VAIK K +KFL +E ++ H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFL-QEALTMRQFDH 75
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHE 140
P++++ L + T + V+IIME G L ++ + +D + QL AL Y
Sbjct: 76 PHIVK-LIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
+ VHRDI N+L+ S+ +KL DFG +R + ++ +Y Y +
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY------------MEDS---TY-YKA---- 174
Query: 201 QG--IP---YAP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
+P AP SD+W GV ++ ++ G PF N+++ +++N
Sbjct: 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 33/233 (14%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+G+ IG G++ V R + VA+K + PPD KFL +E ++K HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFL-QEARILKQYSHPNI 174
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCHERGV 143
+R + +YI+ME + G +R +G + + G ++Y +
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRD+ N L+ +K+SDFG +R AD YA+ L+ +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSRE-------EADGV----------YAASGGLRQV 277
Query: 204 PY---AP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
P AP SD+WS G++L+ G P+ + S + + V+
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 67/265 (25%), Positives = 113/265 (42%), Gaps = 60/265 (22%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQ-APPDYLKKFLP----REIEVVKG 78
Y +G G +ATV AR + VAIK K++ K + REI++++
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIK---KIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAEN--GSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
L HPN+I L A + ++ ++ E + I+A + L+ L+
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA--YMLMTLQGLE 126
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA---HMRCRSNAADNSLSETFCGSYA 193
Y H+ ++HRD+K NLLLD + +KL+DFG A++ R +Y
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR----------------AYT 170
Query: 194 -------YASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPF--DDSSVNELLK---- 239
Y +PE+L G Y + D+W++G +L ++ PF DS +++L +
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFET 228
Query: 240 -------------QVQNKVTFPKQP 251
+ + VTF P
Sbjct: 229 LGTPTEEQWPDMCSLPDYVTFKSFP 253
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 67/240 (27%), Positives = 104/240 (43%), Gaps = 50/240 (20%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQ-------APPDYLKKFLPREIEVV 76
Y +G G+Y V A T + VAIK +++ P + RE+ ++
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGTAI-----REVSLL 87
Query: 77 KGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
K L+H N+I I HR+++I EYAEN L + + + + QL+ +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 137 YCHERGVVHRDIKCENLLLDSDY-----NIKLSDFGFARA---HMRCRSNAADNSLSETF 188
+CH R +HRD+K +NLLL +K+ DFG ARA +R
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-------------- 192
Query: 189 CGSYA-------YASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLK 239
+ Y PEIL G Y+ + DIWS+ + M+ F DS +++L K
Sbjct: 193 --QFTHEIITLWYRPPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 64/236 (27%), Positives = 103/236 (43%), Gaps = 47/236 (19%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQ------APPDYLKKFLPREIEVVK 77
Y +G G+YATV +S VA+K +++ AP + RE+ ++K
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALK---EIRLEHEEGAPCTAI-----REVSLLK 55
Query: 78 GLKHPNLIRFLQAIETTHRVYIIMEYAEN--GSLFDIIRGQGYIDEIRARRWFGQLLEAL 135
LKH N++ I T + ++ EY + D I+ + + QLL L
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD--DCGNIINMHNVKLFLFQLLRGL 113
Query: 136 QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA---HMRCRSNAADNSLSETFCGSY 192
YCH + V+HRD+K +NLL++ +KL+DFG ARA + +Y
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK----------------TY 157
Query: 193 A-------YASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLK 239
Y P+IL G Y+ + D+W +G + + M GR F + +L
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHF 212
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 64/242 (26%), Positives = 105/242 (43%), Gaps = 50/242 (20%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLP----REIEVVKG 78
Y IG G+Y V AR ++ G VA+K +V+ ++ +P RE+ V++
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRV--QTGEEGMPLSTIREVAVLRH 67
Query: 79 LK---HPNLIRFL-----QAIETTHRVYIIMEYAEN--GSLFDIIRGQGYIDEIRARRWF 128
L+ HPN++R + ++ ++ E+ + + D + G + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMM 126
Query: 129 GQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA---HMRCRSNAADNSLS 185
QLL L + H VVHRD+K +N+L+ S IKL+DFG AR M
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----------- 175
Query: 186 ETFCGSYA-------YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNEL 237
Y +PE+L YA + D+WS+G + M + F S V++L
Sbjct: 176 ------LTSVVVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQL 228
Query: 238 LK 239
K
Sbjct: 229 GK 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 64/235 (27%), Positives = 116/235 (49%), Gaps = 45/235 (19%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-VAIKIVSKVQAPPDYLKKFLP----REIEVVKG 78
Y + +G G+Y V A+ + G VA+K +++ D + +P REI ++K
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDS--QGRIVALK---RIRL--DAEDEGIPSTAIREISLLKE 75
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAEN--GSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
L HPN++ + I + + ++ E+ E + D + + + + + + QLL +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG--LQDSQIKIYLYQLLRGVA 133
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA---HMRCRSNAADNSLSETFCGSYA 193
+CH+ ++HRD+K +NLL++SD +KL+DFG ARA +R SY
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR----------------SYT 177
Query: 194 -------YASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVNELLK 239
Y +P++L G Y+ + DIWS+G + M+ G+ F + ++L K
Sbjct: 178 HEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 53/230 (23%), Positives = 99/230 (43%), Gaps = 35/230 (15%)
Query: 30 IGTGSYATVKLARSTRHSG--DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
+G G++ +V+ DVAIK++ K ++ + RE +++ L +P ++R
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMM-REAQIMHQLDNPYIVR- 74
Query: 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHR 146
L + + ++ME A G L + G+ I Q+ ++Y E+ VHR
Sbjct: 75 LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIP-- 204
D+ N+LL + + K+SDFG ++A Y + + P
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGA---------------DDSYYTARSAGK-WPLK 178
Query: 205 -YAP---------HLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQN 243
YAP SD+WS GV ++ A+ +G+ P+ E++ ++
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 64/238 (26%), Positives = 102/238 (42%), Gaps = 39/238 (16%)
Query: 25 TVGKIIGTGSYATV---KLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
+ KIIG+G V +L + VAIK + K + FL E ++ H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFL-SEASIMGQFDH 109
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHE 140
PN+IR + I+ EY ENGSL +R G ++ + ++Y +
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
G VHRD+ N+L+DS+ K+SDFG +R D+ AY +
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV-------LEDDP-------DAAYTT---- 211
Query: 201 QG--IP---YAP---------HLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQN 243
G IP AP SD+WS GVV++ + +G P+ + + +++ V+
Sbjct: 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-32
Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
+G+ IG G + V VAIK K +KFL +E ++ H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFL-QEALTMRQFDH 450
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHE 140
P++++ L + T + V+IIME G L ++ + +D + QL AL Y
Sbjct: 451 PHIVK-LIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY--AYASPE 198
+ VHRDI N+L+ S+ +KL DFG +R D++ + G + +PE
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKGKLPIKWMAPE 562
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
+ + SD+W GV ++ ++ G PF N+++ +++N
Sbjct: 563 SINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 63/244 (25%), Positives = 101/244 (41%), Gaps = 52/244 (21%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLP----REIEVVKGL 79
Y IG G+Y TV AR VA+K V +V P RE+ +++ L
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGL-PISTVREVALLRRL 68
Query: 80 K---HPNLIRFLQAIETTH-----RVYIIMEYAEN--GSLFDIIRGQGYIDEIRARRWFG 129
+ HPN++R + T+ +V ++ E+ + + D G + +
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMR 127
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Q L L + H +VHRD+K EN+L+ S +KL+DFG AR
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI------------------ 169
Query: 190 GSYA-------------YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD-DSSVN 235
Y+ Y +PE+L YA + D+WS+G + M + F +S +
Sbjct: 170 --YSYQMALTPVVVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEAD 226
Query: 236 ELLK 239
+L K
Sbjct: 227 QLGK 230
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 52/224 (23%), Positives = 107/224 (47%), Gaps = 17/224 (7%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
T+ +G G Y V ++S VA+K + K +++FL +E V+K +KHPNL
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME--VEEFL-KEAAVMKEIKHPNL 278
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERG 142
++ L YII E+ G+L D +R + + Q+ A++Y ++
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY--ASPEIL 200
+HR++ N L+ ++ +K++DFG +R ++ + + +PE L
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLM-------TGDTYTAHAGAKFPIKWTAPESL 391
Query: 201 QGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
++ SD+W+ GV+L+ + +G P+ ++++ + ++
Sbjct: 392 AYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 70/235 (29%), Positives = 114/235 (48%), Gaps = 41/235 (17%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT K+IG GS+ V A+ VAIK KV K+F RE+++++ L H N
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KVLQD----KRFKNRELQIMRKLDHCN 108
Query: 84 LIRFLQAIETTHR------VYIIMEYAENGSLFDIIR----GQGYIDEIRARRWFGQLLE 133
++R ++ + ++++Y +++ + R + + I + + QL
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 134 ALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
+L Y H G+ HRDIK +NLLLD D +KL DFG A+ +R N SY
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-----------SY 216
Query: 193 A----YASPEILQGIPYAPHLS---DIWSMGVVLFAMVFGRLPFD-DSSVNELLK 239
Y +PE++ G A + D+WS G VL ++ G+ F DS V++L++
Sbjct: 217 ICSRYYRAPELIFG---ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 39/229 (17%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHP 82
+ + +++G G+Y V R + AIK++ ++ + +EI ++K H
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHR 81
Query: 83 NLIRFL------QAIETTHRVYIIMEYAENGSLFDIIRG--QGYIDE------IRARRWF 128
N+ + +++++ME+ GS+ D+I+ + E R
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR----- 136
Query: 129 GQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR--AHMRCRSNAADNSLSE 186
++L L + H+ V+HRDIK +N+LL + +KL DFG + R N
Sbjct: 137 -EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN-------- 187
Query: 187 TFCGSYAYASPEILQGIPYAP----HLSDIWSMGVVLFAMVFGRLPFDD 231
TF G+ + +PE++ SD+WS+G+ M G P D
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-31
Identities = 63/239 (26%), Positives = 99/239 (41%), Gaps = 40/239 (16%)
Query: 25 TVGKIIGTGSYATVKLAR----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
T K+IG G + V S + VAIK + K FL E ++
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFL-GEAGIMGQFS 104
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCH 139
H N+IR I + II EY ENG+L +R G ++ + ++Y
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
VHRD+ N+L++S+ K+SDFG +R D+ Y +
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV-------LEDDP-------EATYTT--- 207
Query: 200 LQG--IP---YAP---------HLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQN 243
G IP AP SD+WS G+V++ M +G P+ + S +E++K + +
Sbjct: 208 -SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 57/247 (23%), Positives = 109/247 (44%), Gaps = 35/247 (14%)
Query: 13 DRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSG--DVAIKIVSKVQAPPDYLKKFLP 70
D+K+ + + +G G++ +V+ DVAIK++ K ++ +
Sbjct: 327 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMM- 384
Query: 71 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFG 129
RE +++ L +P ++R L + + ++ME A G L + G + I
Sbjct: 385 REAQIMHQLDNPYIVR-LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Q+ ++Y E+ VHR++ N+LL + + K+SDFG ++A AD+S
Sbjct: 444 QVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL------GADDS------ 491
Query: 190 GSYAYASPEILQGIP---YAP---------HLSDIWSMGVVLF-AMVFGRLPFDDSSVNE 236
Y + + P YAP SD+WS GV ++ A+ +G+ P+ E
Sbjct: 492 ---YYTARSAGK-WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
Query: 237 LLKQVQN 243
++ ++
Sbjct: 548 VMAFIEQ 554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 39/238 (16%)
Query: 25 TVGKIIGTGSYATV---KLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
++ K++G G + V +L ++ VAIK + KV + FL E ++ H
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFL-GEASIMGQFDH 105
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHE 140
PN+IR + + V I+ EY ENGSL +R I+ + ++Y +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
G VHRD+ N+L++S+ K+SDFG R D+ AY +
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRV-------LEDDP-------EAAYTT---- 207
Query: 201 QG--IP---YAP---------HLSDIWSMGVVLF-AMVFGRLPFDDSSVNELLKQVQN 243
+G IP +P SD+WS G+VL+ M +G P+ + S +++K V
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 64/256 (25%), Positives = 118/256 (46%), Gaps = 18/256 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y +G+G+Y +V A T+ VA+K +S+ + K+ RE+ ++K +KH N
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 89
Query: 84 LIRFL------QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
+I L +++E + VY++ L +I++ Q D+ + Q+L L+Y
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDD-HVQFLIYQILRGLKY 147
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H ++HRD+K NL ++ D +K+ DFG AR + ++ + Y +P
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTADEMTGYVATRW-YRAP 198
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257
EI+ + DIWS+G ++ ++ GR F + + LK + V P +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 258 KELISNILSPVQTRPR 273
E N + + P+
Sbjct: 259 SESARNYIQSLTQMPK 274
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 38/220 (17%)
Query: 30 IGTGSYATVKLARS--TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87
+G G+Y V A+ + D A+K + REI +++ LKHPN+I
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLRELKHPNVIS- 82
Query: 88 LQAIETTH---RVYIIMEYAE--------NGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
LQ + +H +V+++ +YAE + + + Q+L+ +
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 137 YCHERGVVHRDIKCENLLLDSDYN----IKLSDFGFARA---HMRCRSNAADNSLSETFC 189
Y H V+HRD+K N+L+ + +K++D GFAR ++ ++ + TF
Sbjct: 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFW 200
Query: 190 GSYAYASPEILQGIPYAPHLS---DIWSMGVVLFAMVFGR 226
Y +PE+L G A H + DIW++G + ++
Sbjct: 201 ----YRAPELLLG---ARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 65/267 (24%), Positives = 120/267 (44%), Gaps = 31/267 (11%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y K IG+G+ V A +VAIK +S+ + K+ RE+ ++K + H N
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 85
Query: 84 LIRFLQAI------ETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
+I L E VYI+ME + +L +I+ + +D R Q+L +++
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKH 142
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA---- 193
H G++HRD+K N+++ SD +K+ DFG A R+ ++ Y
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTP-----YVVTRY 191
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE- 252
Y +PE++ G+ Y ++ DIWS+G ++ M+ G + F + + +V ++ P
Sbjct: 192 YRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250
Query: 253 --VSTECKELISNILSPVQTRPRLKTI 277
+ + + N P + +
Sbjct: 251 KKLQPTVRTYVENR--PKYAGYSFEKL 275
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 19/256 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y +G+G+Y +V A R VAIK +S+ + K+ RE+ ++K ++H N
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHEN 84
Query: 84 LIRFLQAIETTHR------VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
+I L Y++M + + L I+ + E + + Q+L+ L+Y
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H GVVHRD+K NL ++ D +K+ DFG AR AD ++ + Y +P
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTRW-YRAP 192
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257
E++ + DIWS+G ++ M+ G+ F + L Q+ P V
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252
Query: 258 KELISNILSPVQTRPR 273
+ + + + PR
Sbjct: 253 DKAAKSYIQSLPQTPR 268
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 54/275 (19%), Positives = 110/275 (40%), Gaps = 52/275 (18%)
Query: 3 DSTVQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLAR----STRHSGDVAIKIVSKV 58
D + + + T E + +G G + V+L R VA+K + K
Sbjct: 2 DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KP 60
Query: 59 QAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR--VYIIMEYAENGSLFDIIRG- 115
++ +++ +EIE+++ L H N++++ + +IME+ +GSL + +
Sbjct: 61 ESGGNHIADLK-KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN 119
Query: 116 QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175
+ I+ + ++ Q+ + + Y R VHRD+ N+L++S++ +K+ DFG +A
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA---- 175
Query: 176 RSNAADNSLSETFCGSYAYASPEILQGIP---YAP---------HLSDIWSMGVVLFAMV 223
+ Y + + P YAP SD+WS GV L ++
Sbjct: 176 ---IETDK-------EYYTVKDD--RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
Query: 224 -FGR--------------LPFDDSSVNELLKQVQN 243
+ +V L+ ++
Sbjct: 224 TYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 57/256 (22%), Positives = 109/256 (42%), Gaps = 58/256 (22%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD----VAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
+ +G G++ +V++ R + VA+K + + L+ F REIE++K L+
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEH-LRDFE-REIEILKSLQ 69
Query: 81 HPNLIRFLQAIETTHR--VYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQY 137
H N++++ + R + +IMEY GSL D ++ + ID I+ ++ Q+ + ++Y
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
+ +HRD+ N+L++++ +K+ DFG + + +
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKV-------LPQDK-------EFFKVK- 174
Query: 198 EILQG--IP---YAP---------HLSDIWSMGVVL----------------FAMVFGRL 227
+ P YAP SD+WS GVVL F + G
Sbjct: 175 ---EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 228 PFDDSSVNELLKQVQN 243
V L++ ++N
Sbjct: 232 KQGQMIVFHLIELLKN 247
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 62/256 (24%), Positives = 117/256 (45%), Gaps = 18/256 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + +G+G+Y V A R VAIK + + + K+ RE+ ++K ++H N
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHEN 85
Query: 84 LIRFL------QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
+I L + ++ Y++M + L +++ + + E R + Q+L+ L+Y
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 143
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H G++HRD+K NL ++ D +K+ DFG AR AD+ ++ + Y +P
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMTGYVVTRW-YRAP 194
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257
E++ DIWS+G ++ M+ G+ F S + LK++ P V
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254
Query: 258 KELISNILSPVQTRPR 273
+ N + + +
Sbjct: 255 SDEAKNYMKGLPELEK 270
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 59/274 (21%), Positives = 106/274 (38%), Gaps = 52/274 (18%)
Query: 3 DSTVQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGD----VAIKIVSKV 58
++V TV + +G G + V L + VA+K + K
Sbjct: 12 HGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KA 70
Query: 59 QAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR--VYIIMEYAENGSLFDIIRGQ 116
A P + + +EI++++ L H ++I++ E + ++MEY GSL D +
Sbjct: 71 DAGPQHRSGWK-QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH 129
Query: 117 GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176
I + + Q+ E + Y H + +HRD+ N+LLD+D +K+ DFG A+A
Sbjct: 130 S-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA----- 183
Query: 177 SNAADNSLSETFCGSYAYASPEILQGIP---YAP---------HLSDIWSMGVVLFAMV- 223
+ Y + P YAP + SD+WS GV L+ ++
Sbjct: 184 --VPEGH-------EYYRVRED--GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
Query: 224 FGR--------------LPFDDSSVNELLKQVQN 243
+ +V L + ++
Sbjct: 233 HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 15/222 (6%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+ +G G + V + + VAIK + P+ FL +E +V+K L+H L
Sbjct: 187 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE---AFL-QEAQVMKKLRHEKL 241
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERG 142
++ + + +YI+ EY GSL D ++G+ Y+ + Q+ + Y
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
VHRD++ N+L+ + K++DFG AR A + + +PE
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAALY 355
Query: 203 IPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
+ SD+WS G++L + GR+P+ E+L QV+
Sbjct: 356 GRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 26/216 (12%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y K IG+G+ V A +VAIK +S+ + K+ RE+ ++K + H N
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 122
Query: 84 LIRFL------QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
+I L + +E VY++ME + +L +I+ + +D R Q+L +++
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKH 179
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA---- 193
H G++HRD+K N+++ SD +K+ DFG A R+ ++ Y
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTP-----YVVTRY 228
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF 229
Y +PE++ G+ Y ++ DIWS+G ++ MV ++ F
Sbjct: 229 YRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILF 263
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 58/256 (22%), Positives = 109/256 (42%), Gaps = 58/256 (22%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD----VAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
+ +G G++ +V++ R + VA+K + + L+ F REIE++K L+
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEH-LRDFE-REIEILKSLQ 100
Query: 81 HPNLIRFLQAIETTHR--VYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQY 137
H N++++ + R + +IMEY GSL D ++ + ID I+ ++ Q+ + ++Y
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
+ +HRD+ N+L++++ +K+ DFG + + Y
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKV-------LPQDK-------EYYKVK- 205
Query: 198 EILQG--IP---YAP---------HLSDIWSMGVVL----------------FAMVFGRL 227
+ P YAP SD+WS GVVL F + G
Sbjct: 206 ---EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262
Query: 228 PFDDSSVNELLKQVQN 243
V L++ ++N
Sbjct: 263 KQGQMIVFHLIELLKN 278
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 49/239 (20%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+ + +G G + V + VA+K + + PD FL E ++K L+H L
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPD---AFL-AEANLMKQLQHQRL 70
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL-------EALQY 137
+R L A+ T +YII EY ENGSL D ++ + +LL E + +
Sbjct: 71 VR-LYAVVTQEPIYIITEYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAF 124
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
ER +HRD++ N+L+ + K++DFG AR A + +
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK------------- 171
Query: 198 EILQGIPY---AP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
P AP SD+WS G++L +V GR+P+ + E+++ ++
Sbjct: 172 -----FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 55/223 (24%), Positives = 109/223 (48%), Gaps = 24/223 (10%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HP 82
Y + + +G G Y+ V A + ++ V +KI+ V+ KK REI++++ L+ P
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIK-REIKILENLRGGP 91
Query: 83 NLIRFLQAI--ETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
N+I + + ++ E+ N + + + + R + ++L+AL YCH
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS 148
Query: 141 RGVVHRDIKCENLLLDSDY-NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
G++HRD+K N+++D ++ ++L D+G A + Y + PE+
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE------FYHPGQEYNVRVASRY-FKGPEL 201
Query: 200 LQGIP-YAPHLSDIWSMGVVLFAMVFGRLPF--DDSSVNELLK 239
L Y L D+WS+G +L +M+F + PF + ++L++
Sbjct: 202 LVDYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 15/222 (6%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+ +G G + V + + VAIK + P+ FL +E +V+K L+H L
Sbjct: 270 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE---AFL-QEAQVMKKLRHEKL 324
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERG 142
++ + + +YI+ EY GSL D ++G+ Y+ + Q+ + Y
Sbjct: 325 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
VHRD++ N+L+ + K++DFG AR A + + +PE
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAALY 438
Query: 203 IPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
+ SD+WS G++L + GR+P+ E+L QV+
Sbjct: 439 GRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 33/222 (14%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y IG G++ V AR + VA+K V ++ + REI++++ LKH N
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHEN 77
Query: 84 LIRFLQAIETTHR---------VYIIMEYAEN--GSLFDIIRGQGYIDEIRARRWFGQLL 132
++ L I T +Y++ ++ E+ L + + + EI+ LL
Sbjct: 78 VVN-LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLL 134
Query: 133 EALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
L Y H ++HRD+K N+L+ D +KL+DFG ARA + + Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF---------SLAKNSQPNRY 185
Query: 193 A-------YASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGR 226
Y PE+L G Y P + D+W G ++ M
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRS 226
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-29
Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 47/239 (19%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
T+ +G G Y V ++S VA+K + K ++FL +E V+K +KHPNL
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEV--EEFL-KEAAVMKEIKHPNL 71
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL-------EALQY 137
++ L YII E+ G+L D +R R LL A++Y
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEY 126
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
++ +HRD+ N L+ ++ +K++DFG +R A +
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK------------- 173
Query: 198 EILQGIPY---AP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
P AP SD+W+ GV+L+ + +G P+ ++++ + ++
Sbjct: 174 -----FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-29
Identities = 61/241 (25%), Positives = 101/241 (41%), Gaps = 57/241 (23%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+ + IG G + V L + VA+K + K A + FL E V+ L+H NL
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGN--KVAVKCI-KNDATA---QAFL-AEASVMTQLRHSNL 76
Query: 85 IRFLQAIETTHR--VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL-------EAL 135
++ L + + +YI+ EY GSL D +R +G R+ LL EA+
Sbjct: 77 VQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAM 130
Query: 136 QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
+Y VHRD+ N+L+ D K+SDFG + +
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--------------- 175
Query: 196 SPEILQGIPY---AP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQ 242
+P AP SD+WS G++L+ + FGR+P+ + +++ +V+
Sbjct: 176 -------LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
Query: 243 N 243
Sbjct: 229 K 229
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 56/253 (22%), Positives = 108/253 (42%), Gaps = 53/253 (20%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD----VAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
+G G++ +V+L R + VA+K + + P D + F REI+++K L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGP-DQQRDFQ-REIQILKALH 82
Query: 81 HPNLIRFLQAIETTHR--VYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQY 137
++++ R + ++MEY +G L D ++ + +D R + Q+ + ++Y
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
R VHRD+ N+L++S+ ++K++DFG A+ + + Y
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKL-LPLDKD-------------YYVVRE 188
Query: 198 EILQGIP---YAP---------HLSDIWSMGVVLFAMV-FGRLPF--------------D 230
P YAP SD+WS GVVL+ + + D
Sbjct: 189 P--GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246
Query: 231 DSSVNELLKQVQN 243
+++ LL+ ++
Sbjct: 247 VPALSRLLELLEE 259
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + ++G G+Y V A VAIK + P L+ REI+++K KH N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 84 LIRFLQAIETTHR-----VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+I VYII E + L +I Q + + + + Q L A++
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVL 128
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA----Y 194
H V+HRD+K NLL++S+ ++K+ DFG AR ++ ++ + ++ + Y
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 195 ASPEIL-------QGIPYAPHLSDIWSMGVVLFAMVFGR 226
+PE++ + + D+WS G +L + R
Sbjct: 189 RAPEVMLTSAKYSRAM-------DVWSCGCILAELFLRR 220
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 57/248 (22%), Positives = 97/248 (39%), Gaps = 49/248 (19%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
T+ + +G GS+ V + D VAIK V A +FL E V+K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL-NEASVMKEF 85
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRG---QGYIDEIRARRWFGQLLE-AL 135
+++R L + +IME G L +R + + A ++++ A
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 136 Q------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
+ Y + VHRD+ N ++ D+ +K+ DFG R + +
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR---------------DIYE 190
Query: 190 GSYAYA------------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVN 235
Y Y SPE + G+ + + SD+WS GVVL+ + P+ S
Sbjct: 191 TDY-YRKGGKGLLPVRWMSPESLKDGV-FTTY-SDVWSFGVVLWEIATLAEQPYQGLSNE 247
Query: 236 ELLKQVQN 243
++L+ V
Sbjct: 248 QVLRFVME 255
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 55/221 (24%), Positives = 86/221 (38%), Gaps = 31/221 (14%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLP--------REIEV 75
YTV + I +GSY V + VAIK V + + REI +
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGI-PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 76 VKGLKHPNLIRFLQAIETTHR-----VYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFG 129
+ HPN++ +Y++ E L +I + I + +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
+L L HE GVVHRD+ N+LL + +I + DF A R + AD + +
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA------REDTADANKTH--- 192
Query: 190 GSYA----YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGR 226
Y Y +PE++ L D+WS G V+ M +
Sbjct: 193 --YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 42/226 (18%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + +IGTGSY V A VAIK + +V K+ L REI ++ L H +
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDH 113
Query: 84 LIRFLQAIETTHR-----VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+++ L + +Y+++E A++ + R Y+ E+ + LL ++Y
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA----- 193
H G++HRD+K N L++ D ++K+ DFG AR + + +S
Sbjct: 173 HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 194 ----------------YASPEIL-------QGIPYAPHLSDIWSMG 216
Y +PE++ + I D+WS+G
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-------DVWSIG 271
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 44/211 (20%)
Query: 49 DVAIKIVSKVQAPPDY--LKKFLPREIEVVKGLKHPNLIRFL-QAIETTHR--VYIIMEY 103
VA+K ++ + ++F +EI+V+ +H NL+ L + + VY Y
Sbjct: 56 TVAVKKLAAMVDITTEELKQQFD-QEIKVMAKCQHENLVELLGFSSDGDDLCLVY---VY 111
Query: 104 AENGS----LFDIIRGQGYID-EIR-------ARRWFGQLLEALQYCHERGVVHRDIKCE 151
NGS L + G + +R A + + HE +HRDIK
Sbjct: 112 MPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAAN--------GINFLHENHHIHRDIKSA 162
Query: 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNS-LSETFCGSYAYASPEILQGIPYAPHL- 209
N+LLD + K+SDFG ARA S + ++ G+ AY +PE L+G +
Sbjct: 163 NILLDEAFTAKISDFGLARA-----SEKFAQTVMTSRIVGTTAYMAPEALRG-----EIT 212
Query: 210 --SDIWSMGVVLFAMVFGRLPFDDSSVNELL 238
SDI+S GVVL ++ G D+ +LL
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 47/248 (18%), Positives = 99/248 (39%), Gaps = 48/248 (19%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD---VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
T+G+++G G + +V+ A+ + G VA+K++ +++FL RE +K H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL-REAACMKEFDH 84
Query: 82 PNLIRFL------QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLE-A 134
P++ + + +A +I+ + ++G L + + L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP-LQTLVRFM 143
Query: 135 LQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETF 188
+ Y R +HRD+ N +L D + ++DFG +R + +
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR---------------KIY 188
Query: 189 CGSYAYA-----------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVN 235
G Y + E + + Y H SD+W+ GV ++ ++ G+ P+
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLADNL-YTVH-SDVWAFGVTMWEIMTRGQTPYAGIENA 246
Query: 236 ELLKQVQN 243
E+ +
Sbjct: 247 EIYNYLIG 254
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 57/235 (24%), Positives = 107/235 (45%), Gaps = 41/235 (17%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
T+ K +G+G + VKL + + DVA+K++ + D +F +E + + L HP L
Sbjct: 11 TLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSED---EFF-QEAQTMMKLSHPKL 65
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGV 143
++F + +YI+ EY NG L + +R G ++ + + E + +
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG- 202
+HRD+ N L+D D +K+SDFG R + + Y +S G
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTR------------YVLDD---QY-VSS----VGT 165
Query: 203 -IP---YAP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
P AP SD+W+ G++++ + G++P+D + +E++ +V
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 37/240 (15%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + +IG GSY V LA +VAIK V+++ K+ L REI ++ LK
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDY 86
Query: 84 LIRFLQAIETTHR-----VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+IR I +YI++E A++ L + + ++ E + LL +
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA----- 193
HE G++HRD+K N LL+ D ++K+ DFG AR + N L E
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 194 -----------YASPEIL-------QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN 235
Y +PE++ + I DIWS G + ++ + N
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTKSI-------DIWSTGCIFAELLNMLQSHINDPTN 258
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-28
Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 49/239 (20%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
T + IG+G + V L + VAIK + + + F+ E EV+ L HP L
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEE---DFI-EEAEVMMKLSHPKL 65
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL-------EALQY 137
++ + ++ E+ E+G L D +R Q R LL E + Y
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ------RGLFAAETLLGMCLDVCEGMAY 119
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
E V+HRD+ N L+ + IK+SDFG R + + ++ +
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK------------- 166
Query: 198 EILQGIP---YAP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
P +P SD+WS GV+++ + G++P+++ S +E+++ +
Sbjct: 167 -----FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-28
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT IG G+Y V A + VAIK +S + + REI+++ +H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 84 LIRFL-----QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+I IE VYI+ + E L+ +++ Q ++ + Q+L L+Y
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 144
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA----Y 194
H V+HRD+K NLLL++ ++K+ DFG AR A + F Y Y
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-------ADPDHDHTGFLTEYVATRWY 197
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMVFGR 226
+PEI+ DIWS+G +L M+ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-28
Identities = 57/224 (25%), Positives = 105/224 (46%), Gaps = 19/224 (8%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+ K +G G + V +A VA+K + + FL E V+K L+H L
Sbjct: 191 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVE---AFL-AEANVMKTLQHDKL 245
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRAR--RWFGQLLEALQYCHERG 142
++ L A+ T +YII E+ GSL D ++ + + + Q+ E + + +R
Sbjct: 246 VK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY--ASPEIL 200
+HRD++ N+L+ + K++DFG AR DN + + +PE +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARV-------IEDNEYTAREGAKFPIKWTAPEAI 357
Query: 201 QGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
+ SD+WS G++L +V +GR+P+ S E+++ ++
Sbjct: 358 NFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 48/247 (19%), Positives = 95/247 (38%), Gaps = 47/247 (19%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD---VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
+GKI+G G + +V + G VA+K + + +++FL E +K H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL-SEAACMKDFSH 95
Query: 82 PNLIRFL-----QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLE-AL 135
PN+IR L + + + +I+ + + G L + + LL+ +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP-LQTLLKFMV 154
Query: 136 Q------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Y R +HRD+ N +L D + ++DFG ++ + +
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK---------------KIYS 199
Query: 190 GSYAYA-----------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNE 236
G Y + E + + Y SD+W+ GV ++ + G P+ +E
Sbjct: 200 GDYYRQGRIAKMPVKWIAIESLADRV-YTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHE 257
Query: 237 LLKQVQN 243
+ + +
Sbjct: 258 MYDYLLH 264
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 61/241 (25%), Positives = 101/241 (41%), Gaps = 57/241 (23%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
+ + IG G + V L + VA+K + K A + FL E V+ L+H NL
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGN--KVAVKCI-KNDATA---QAFL-AEASVMTQLRHSNL 248
Query: 85 IRFLQAIETTHR--VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL-------EAL 135
++ L + + +YI+ EY GSL D +R +G R+ LL EA+
Sbjct: 249 VQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAM 302
Query: 136 QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYA 195
+Y VHRD+ N+L+ D K+SDFG + +
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--------------- 347
Query: 196 SPEILQGIPY---AP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQ 242
+P AP SD+WS G++L+ + FGR+P+ + +++ +V+
Sbjct: 348 -------LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
Query: 243 N 243
Sbjct: 401 K 401
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 31/230 (13%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL 84
T K +GTG + VK + R DVAIK++ + D +F+ E +V+ L H L
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSED---EFI-EEAKVMMNLSHEKL 81
Query: 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL-------EALQY 137
++ ++II EY NG L + +R R R QLL EA++Y
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREM------RHRFQTQQLLEMCKDVCEAMEY 135
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY--A 195
+ +HRD+ N L++ +K+SDFG +R D+ + + + +
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-------YVLDDEYTSSVGSKFPVRWS 188
Query: 196 SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
PE ++ ++ SDIW+ GV+++ + G++P++ + +E + +
Sbjct: 189 PPEVLMYSK-FS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-27
Identities = 49/238 (20%), Positives = 96/238 (40%), Gaps = 37/238 (15%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD---VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
++IG G + V + G A+K + + +FL E ++K H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSH 85
Query: 82 PNLIRFLQAI-ETTHRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCH 139
PN++ L + +++ Y ++G L + IR + + + Q+ + ++Y
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+ VHRD+ N +LD + +K++DFG AR + + Y Y+
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---------------DMYDKEY-YSVHNK 189
Query: 200 LQG-IP---YAP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
+P A SD+WS GV+L+ ++ G P+ D + ++ +
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 66/255 (25%), Positives = 110/255 (43%), Gaps = 33/255 (12%)
Query: 1 MIDSTVQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA 60
M + D+ RK + V ++ G G++ TV+L + VAIK KV
Sbjct: 6 MSLNAAAAADERSRKEMD----RFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQ 58
Query: 61 PPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR-------VYIIMEYAENGSLFDII 113
P + + L + ++ + L HPN+++ T + ++MEY + +L
Sbjct: 59 DPRFRNREL-QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC 116
Query: 114 RGQGY----IDEIRARRWFGQLLEALQYCHER--GVVHRDIKCENLLLD-SDYNIKLSDF 166
R I + + QL+ ++ H V HRDIK N+L++ +D +KL DF
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 167 GFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG-IPYAPHLSDIWSMGVVLFAMVFG 225
G A+ N C Y Y +PE++ G Y + DIWS+G + M+ G
Sbjct: 177 GSAKKLSPSEPN------VAYICSRY-YRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG 228
Query: 226 RLPFD-DSSVNELLK 239
F D+S +L +
Sbjct: 229 EPIFRGDNSAGQLHE 243
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 35/228 (15%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HP 82
Y + K +G G+Y V + R VA+K + ++ REI ++ L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHE 69
Query: 83 NLIRFLQAI--ETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
N++ L + + VY++ +Y E L +IR ++ + + QL++ ++Y H
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHS 127
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA------- 193
G++HRD+K N+LL+++ ++K++DFG +R+ + R + LS
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 194 --------YASPEIL-------QGIPYAPHLSDIWSMGVVLFAMVFGR 226
Y +PEIL +GI D+WS+G +L ++ G+
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGI-------DMWSLGCILGEILCGK 228
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 52/253 (20%), Positives = 96/253 (37%), Gaps = 53/253 (20%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
+ +G + V + VAIK + K +A ++F E + L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFR-HEAMLRARL 69
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRW---------FGQ 130
+HPN++ L + + +I Y +G L + + + ++ +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 131 LLE-ALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNS 183
+ Q Y VVH+D+ N+L+ N+K+SD G R
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR------------- 176
Query: 184 LSETFCGSYAYA-----------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFD 230
E + Y +PE I+ G ++ SDIWS GVVL+ + +G P+
Sbjct: 177 --EVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FS-IDSDIWSYGVVLWEVFSYGLQPYC 232
Query: 231 DSSVNELLKQVQN 243
S ++++ ++N
Sbjct: 233 GYSNQDVVEMIRN 245
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 42/242 (17%), Positives = 84/242 (34%), Gaps = 42/242 (17%)
Query: 25 TVGKIIGTGSYATVKLAR-------STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
+ +G G++ + H +V +K++ K A +Y + F ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFF-EAASMMS 67
Query: 78 GLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQ 136
L H +L+ ++ E+ + GSL ++ + I+ + QL A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 137 YCHERGVVHRDIKCENLLLDSDYN--------IKLSDFGFARAHMRCRSNAADNSLSETF 188
+ E ++H ++ +N+LL + + IKLSD G + +
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPK- 174
Query: 189 CGSYAYA-----SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQV 241
PE I +D WS G L+ + G P L+
Sbjct: 175 --DILQERIPWVPPECIENPKNLN-LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
Query: 242 QN 243
++
Sbjct: 232 ED 233
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 64/265 (24%), Positives = 113/265 (42%), Gaps = 69/265 (26%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y++GK +GTGS+ V A+K KV P ++ RE++++K L H N
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALK---KVLQDP----RYKNRELDIMKVLDHVN 61
Query: 84 LIRFLQAIETTHR--------------------------------------VYIIMEYAE 105
+I+ + TT + +IMEY
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 106 NGSLFDIIRGQGY------IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS-D 158
+ +L +++ ++ I + QL A+ + H G+ HRDIK +NLL++S D
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIY--QLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 159 YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLS---DIWSM 215
+KL DFG A+ C + Y +PE++ G A + D+WS+
Sbjct: 179 NTLKLCDFGSAKK------LIPSEPSVAYICSRF-YRAPELMLG---ATEYTPSIDLWSI 228
Query: 216 GVVLFAMVFGRLPFD-DSSVNELLK 239
G V ++ G+ F ++S+++L++
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLVR 253
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 64/251 (25%), Positives = 103/251 (41%), Gaps = 54/251 (21%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSG--DVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KH 81
+IG G++ V AR + D AIK + K A D + F E+EV+ L H
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFA-GELEVLCKLGHH 85
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRW---------FGQLL 132
PN+I L A E +Y+ +EYA +G+L D +R ++ A QLL
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 133 E-ALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLS 185
A Y ++ +HRD+ N+L+ +Y K++DFG +R
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-------------- 191
Query: 186 ETFCGSYAYA-----------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDS 232
+ E + + Y SD+WS GV+L+ +V G P+
Sbjct: 192 ----QEVYVKKTMGRLPVRWMAIESLNYSV-YT-TNSDVWSYGVLLWEIVSLGGTPYCGM 245
Query: 233 SVNELLKQVQN 243
+ EL +++
Sbjct: 246 TCAELYEKLPQ 256
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 60/253 (23%), Positives = 98/253 (38%), Gaps = 55/253 (21%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
+ +G G++ V LA + VA+K + + A + F RE E++ L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQ-REAELLTML 100
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRW--------FGQL 131
+H +++RF + ++ EY +G L +R G ++ A GQL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 132 LE-ALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSL 184
L A Q Y VHRD+ N L+ +K+ DFG +R
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-------------- 206
Query: 185 SETFCGSYAYA------------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFD 230
+ + Y Y PE IL + SD+WS GVVL+ + +G+ P+
Sbjct: 207 -DIYSTDY-YRVGGRTMLPIRWMPPESILYRK-FTTE-SDVWSFGVVLWEIFTYGKQPWY 262
Query: 231 DSSVNELLKQVQN 243
S E + +
Sbjct: 263 QLSNTEAIDCITQ 275
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 47/231 (20%), Positives = 97/231 (41%), Gaps = 23/231 (9%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD---VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
++IG G + V + G A+K + + +FL E ++K H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSH 149
Query: 82 PNLIRFLQAI-ETTHRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCH 139
PN++ L + +++ Y ++G L + IR + + + Q+ + +++
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA-----Y 194
+ VHRD+ N +LD + +K++DFG AR + D + A +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR-------DMYDKEFDSVHNKTGAKLPVKW 262
Query: 195 ASPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
+ E + + SD+WS GV+L+ ++ G P+ D + ++ +
Sbjct: 263 MALESLQTQK-FT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-26
Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 61/261 (23%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
+GK +G G + V A + G VA+K++ K A P L+ L E V+K +
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLL-SEFNVLKQV 83
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-----GQGYIDEIRARRWFG----- 129
HP++I+ A + +I+EYA+ GSL +R G GY+ +R
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 130 -------QLLE-ALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175
L+ A Q Y E +VHRD+ N+L+ +K+SDFG +R
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR----- 198
Query: 176 RSNAADNSLSETFCGSYAYA-----------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV 223
+ + + E + I Y SD+WS GV+L+ +V
Sbjct: 199 ----------DVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQ-SDVWSFGVLLWEIV 246
Query: 224 -FGRLPFDDSSVNELLKQVQN 243
G P+ L ++
Sbjct: 247 TLGGNPYPGIPPERLFNLLKT 267
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-26
Identities = 51/238 (21%), Positives = 95/238 (39%), Gaps = 37/238 (15%)
Query: 25 TVGKIIGTGSYATV---KLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH 81
++IG G + V + ++ AIK + ++ FL RE +++GL H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFL-REGLLMRGLNH 81
Query: 82 PNLIRFLQA-IETTHRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCH 139
PN++ + + ++++ Y +G L IR + Q+ ++Y
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
E+ VHRD+ N +LD + +K++DFG AR + Y Y+ +
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLAR---------------DILDREY-YSVQQH 185
Query: 200 LQG-IP---YAP---------HLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQN 243
+P A SD+WS GV+L+ ++ G P+ +L +
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-26
Identities = 63/234 (26%), Positives = 97/234 (41%), Gaps = 57/234 (24%)
Query: 29 IIGTGSYATV---KLARSTRHSGDVAIKIVSK--VQAPPDYLKKFLPREIEVVKGLKHPN 83
+IG G + V L + VA+K + Q +++F EIE + +HP+
Sbjct: 46 LIGHGVFGKVYKGVLRDGAK----VALKRRTPESSQG----IEEFE-TEIETLSFCRHPH 96
Query: 84 LIRFL-QAIETTHR--VYIIMEYAENGS----LFDIIRGQGYID-EIR-------ARRWF 128
L+ + E +Y +Y ENG+ L+ + E R AR
Sbjct: 97 LVSLIGFCDERNEMILIY---KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR--- 150
Query: 129 GQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNS-LSET 187
L Y H R ++HRD+K N+LLD ++ K++DFG ++ D + LS
Sbjct: 151 -----GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK-----GTELDQTHLSTV 200
Query: 188 FCGSYAYASPEILQGIPYAP--HL---SDIWSMGVVLFAMVFGRLPFDDSSVNE 236
G+ Y PE Y L SD++S GVVLF ++ R S E
Sbjct: 201 VKGTLGYIDPE------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 56/248 (22%), Positives = 90/248 (36%), Gaps = 49/248 (19%)
Query: 25 TVGKIIGTGSY-----ATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
T+ + +G G++ V + VA+K + FL E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIISKF 90
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLE-ALQ-- 136
H N++R + + +I+ME G L +R + LL A
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 137 ----YCHERGVVHRDIKCENLLLD---SDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Y E +HRDI N LL K+ DFG AR + +
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---------------DIYR 195
Query: 190 GSYAYA------------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVN 235
SY Y PE ++GI + +D WS GV+L+ + G +P+ S
Sbjct: 196 ASY-YRKGGCAMLPVKWMPPEAFMEGI-FTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQ 252
Query: 236 ELLKQVQN 243
E+L+ V +
Sbjct: 253 EVLEFVTS 260
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 57/224 (25%), Positives = 91/224 (40%), Gaps = 35/224 (15%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKV--QAPPDYLKKFLPREIEVVKGLKH 81
Y K +G G V A VAIK K+ P REI++++ L H
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHAL--REIKIIRRLDH 67
Query: 82 PNLIRFLQAIETTHR--------------VYIIMEYAENGSLFDIIRGQGYIDEIRARRW 127
N+++ + + + VYI+ EY E L +++ + E AR +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP-LLEEHARLF 125
Query: 128 FGQLLEALQYCHERGVVHRDIKCENLLLDS-DYNIKLSDFGFARAHMRCRSNAADNSLSE 186
QLL L+Y H V+HRD+K NL +++ D +K+ DFG AR + +
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI-------MDPHYSHK 178
Query: 187 TFCGSYA----YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGR 226
Y SP +L D+W+ G + M+ G+
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-25
Identities = 55/248 (22%), Positives = 91/248 (36%), Gaps = 49/248 (19%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
T+ + +G G++ V + + D VA+K + FL E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIISKF 131
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLE-ALQ-- 136
H N++R + + +I++E G L +R + LL A
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 137 ----YCHERGVVHRDIKCENLLLD---SDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Y E +HRDI N LL K+ DFG AR + +
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---------------DIYR 236
Query: 190 GSYAYA------------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVN 235
Y Y PE ++GI + +D WS GV+L+ + G +P+ S
Sbjct: 237 AGY-YRKGGCAMLPVKWMPPEAFMEGI-FTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQ 293
Query: 236 ELLKQVQN 243
E+L+ V +
Sbjct: 294 EVLEFVTS 301
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 57/262 (21%), Positives = 96/262 (36%), Gaps = 63/262 (24%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
+ IG G++ V AR+ VA+K++ K +A D F RE ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQ-REAALMAEF 107
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR--------GQGYIDEIRARRWFGQL 131
+PN+++ L + ++ EY G L + +R + D R
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 132 LEAL----------------QYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175
L Y ER VHRD+ N L+ + +K++DFG +R
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR----- 222
Query: 176 RSNAADNSLSETFCGSYAYA------------SPE-ILQGIPYAPHLSDIWSMGVVLFAM 222
+ Y Y PE I Y SD+W+ GVVL+ +
Sbjct: 223 ----------NIYSADY-YKADGNDAIPIRWMPPESIFYNR-YTTE-SDVWAYGVVLWEI 269
Query: 223 V-FGRLPFDDSSVNELLKQVQN 243
+G P+ + E++ V++
Sbjct: 270 FSYGLQPYYGMAHEEVIYYVRD 291
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 56/256 (21%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-------VAIKIVSKVQAPPDYLKKFLPREIEVVK 77
T+GK +G G++ V +A + D VA+K++ K A L + E+E++K
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 95
Query: 78 GL-KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRW--------- 127
+ KH N+I L A +Y+I+EYA G+L + +R + +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 128 FGQLLE-ALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180
F L+ Q Y + +HRD+ N+L+ + +K++DFG AR
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR---------- 205
Query: 181 DNSLSETFCGSYAYA-----------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRL 227
+ Y +PE + + Y SD+WS GV+++ + G
Sbjct: 206 -----DINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQ-SDVWSFGVLMWEIFTLGGS 258
Query: 228 PFDDSSVNELLKQVQN 243
P+ V EL K ++
Sbjct: 259 PYPGIPVEELFKLLKE 274
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 56/254 (22%), Positives = 100/254 (39%), Gaps = 56/254 (22%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
+ + +G G++ V LA S VA+K + K F RE E++ L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--DPTLAARKDFQ-REAELLTNL 74
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRW---------FGQ 130
+H ++++F + ++ EY ++G L +R G I Q
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 131 LLE-ALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNS 183
+L A Q Y + VHRD+ N L+ ++ +K+ DFG +R
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR------------- 181
Query: 184 LSETFCGSYAYA------------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPF 229
+ + Y Y PE I+ + SD+WS GV+L+ + +G+ P+
Sbjct: 182 --DVYSTDY-YRVGGHTMLPIRWMPPESIMYRK-FTTE-SDVWSFGVILWEIFTYGKQPW 236
Query: 230 DDSSVNELLKQVQN 243
S E+++ +
Sbjct: 237 FQLSNTEVIECITQ 250
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-24
Identities = 54/258 (20%), Positives = 93/258 (36%), Gaps = 59/258 (22%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
+ GK +G G++ V A + VA+K++ K A + + E++V+ L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALM-SELKVLSYL 83
Query: 80 -KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR-----------GQGYIDEIRARRW 127
H N++ L A +I EY G L + +R +++
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 128 FGQLLE-ALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180
LL + Q + + +HRD+ N+LL K+ DFG AR
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN------ 197
Query: 181 DNSLSETFCGSYAYA------------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGR 226
Y +PE I + Y SD+WS G+ L+ + G
Sbjct: 198 ----------DSNYVVKGNARLPVKWMAPESIFNCV-YT-FESDVWSYGIFLWELFSLGS 245
Query: 227 LPFDDSSVN-ELLKQVQN 243
P+ V+ + K ++
Sbjct: 246 SPYPGMPVDSKFYKMIKE 263
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-24
Identities = 62/256 (24%), Positives = 106/256 (41%), Gaps = 56/256 (21%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-------VAIKIVSKVQAPPDYLKKFLPREIEVVK 77
T+GK +G G + V +A + D VA+K++ K A L + E+E++K
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 141
Query: 78 GL-KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRW--------- 127
+ KH N+I L A +Y+I+EYA G+L + +R + +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 128 FGQLLE-ALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180
F L+ Q Y + +HRD+ N+L+ + +K++DFG AR
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR---------- 251
Query: 181 DNSLSETFCGSYAYA-----------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRL 227
+ Y +PE + + Y SD+WS GV+++ + G
Sbjct: 252 -----DINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQ-SDVWSFGVLMWEIFTLGGS 304
Query: 228 PFDDSSVNELLKQVQN 243
P+ V EL K ++
Sbjct: 305 PYPGIPVEELFKLLKE 320
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-24
Identities = 64/256 (25%), Positives = 105/256 (41%), Gaps = 56/256 (21%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-------VAIKIVSKVQAPPDYLKKFLPREIEVVK 77
+GK +G G++ V LA + D VA+K++ K A L + E+E++K
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI-SEMEMMK 129
Query: 78 GL-KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRG---------QGYIDEIRARRW 127
+ KH N+I L A +Y+I+EYA G+L + ++ +
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 128 FGQLLE-ALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180
L+ A Q Y + +HRD+ N+L+ D +K++DFG AR
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR---------- 239
Query: 181 DNSLSETFCGSYAYA-----------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRL 227
+ Y +PE + I Y SD+WS GV+L+ + G
Sbjct: 240 -----DIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQ-SDVWSFGVLLWEIFTLGGS 292
Query: 228 PFDDSSVNELLKQVQN 243
P+ V EL K ++
Sbjct: 293 PYPGVPVEELFKLLKE 308
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-23
Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 47/185 (25%)
Query: 72 EIEVVKGLKHPNLIRFLQA--IETTHR--VYIIMEYAENGS----LFDIIRGQGYID-EI 122
E+E++ H NL+R L+ + T R VY Y NGS L + Q +D
Sbjct: 77 EVEMISMAVHRNLLR-LRGFCMTPTERLLVY---PYMANGSVASCLRERPESQPPLDWPK 132
Query: 123 R-------ARRWFGQLLEALQYCHERG---VVHRDIKCENLLLDSDYNIKLSDFGFARAH 172
R AR L Y H+ ++HRD+K N+LLD ++ + DFG A+
Sbjct: 133 RQRIALGSAR--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL- 183
Query: 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP--HL---SDIWSMGVVLFAMVFGRL 227
+ D ++ G+ + +PE Y +D++ GV+L ++ G+
Sbjct: 184 ----MDYKDTHVTTAVRGTIGHIAPE------YLSTGKSSEKTDVFGYGVMLLELITGQR 233
Query: 228 PFDDS 232
FD +
Sbjct: 234 AFDLA 238
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-23
Identities = 59/254 (23%), Positives = 101/254 (39%), Gaps = 55/254 (21%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
GK +G G++ V A + + VA+K++ K A D + + E++++ L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM-SELKIMSHL 106
Query: 80 -KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRW-------FGQL 131
+H N++ L A V +I EY G L + +R + + E L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 132 LE-ALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSL 184
L + Q + + +HRD+ N+LL + + K+ DFG AR M
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN---------- 216
Query: 185 SETFCGSYAYA------------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFD 230
Y +PE I + Y SD+WS G++L+ + G P+
Sbjct: 217 ------DSNYIVKGNARLPVKWMAPESIFDCV-YTVQ-SDVWSYGILLWEIFSLGLNPYP 268
Query: 231 DSSVN-ELLKQVQN 243
VN + K V++
Sbjct: 269 GILVNSKFYKLVKD 282
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-23
Identities = 50/256 (19%), Positives = 101/256 (39%), Gaps = 56/256 (21%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
+GK +G G++ V A + VA+K++ K A + + E++++ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALM-SELKILIHI 87
Query: 80 -KHPNLIRFLQA-IETTHRVYIIMEYAENGSLFDIIR---GQGYIDEIRARRWFGQLLE- 133
H N++ L A + + +I+E+ + G+L +R + ++ + L
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 134 ------ALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181
+ Q + R +HRD+ N+LL +K+ DFG AR
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR----------- 196
Query: 182 NSLSETFCGSYAYA-----------SPE-ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLP 228
+ + +PE I + Y SD+WS GV+L+ + G P
Sbjct: 197 ----DIYKDPDYVRKGDARLPLKWMAPETIFDRV-YT-IQSDVWSFGVLLWEIFSLGASP 250
Query: 229 FDDSSVN-ELLKQVQN 243
+ ++ E ++++
Sbjct: 251 YPGVKIDEEFCRRLKE 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-22
Identities = 63/263 (23%), Positives = 107/263 (40%), Gaps = 64/263 (24%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
GK++G+G++ V A + S VA+K++ K +A + + E++++ L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALM-SELKMMTQL 105
Query: 80 -KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIR------GQGYIDEIRARRW----- 127
H N++ L A + +Y+I EY G L + +R + I+ +R
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 128 -----FGQLLE-ALQ------YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175
F LL A Q + + VHRD+ N+L+ +K+ DFG AR M
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS- 224
Query: 176 RSNAADNSLSETFCGSYAYA------------SPE-ILQGIPYAPHLSDIWSMGVVLFAM 222
Y +PE + +GI Y SD+WS G++L+ +
Sbjct: 225 ---------------DSNYVVRGNARLPVKWMAPESLFEGI-YT-IKSDVWSYGILLWEI 267
Query: 223 V-FGRLPFDDSSVN-ELLKQVQN 243
G P+ V+ K +QN
Sbjct: 268 FSLGVNPYPGIPVDANFYKLIQN 290
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 54/230 (23%), Positives = 102/230 (44%), Gaps = 33/230 (14%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-- 81
Y V K+IG GS+ V A + VA+K+V + ++ EI +++ L+
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAA-EEIRILEHLRKQD 154
Query: 82 ----PNLIRFLQAIETTHR--VYIIMEYAENGSLFDIIRGQGY----IDEIRARRWFGQL 131
N+I L+ R + + E +L+++I+ + + +R ++ +
Sbjct: 155 KDNTMNVIHMLENFT--FRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVR--KFAHSI 209
Query: 132 LEALQYCHERGVVHRDIKCENLLL--DSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
L+ L H+ ++H D+K EN+LL IK+ DFG + C + + T+
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-----CYEH---QRVY-TYI 260
Query: 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK 239
S Y +PE++ G Y + D+WS+G +L ++ G + L
Sbjct: 261 QSRFYRAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLA 309
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 47/235 (20%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK--- 80
Y + + +G G ++TV LA+ ++ VA+KI V+ Y + EI++++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKI---VRGDKVYTEAAE-DEIKLLQRVNDAD 76
Query: 81 -----HPNLIRFLQAIET-THR------VYIIME-YAENGSLFDIIRGQGY--IDEIRAR 125
L+ ++ H+ V ++ E EN L +I+ + I I +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALIKKYEHRGIPLIYVK 134
Query: 126 RWFGQLLEALQYCH-ERGVVHRDIKCENLLLD------SDYNIKLSDFGFARAHMRCRSN 178
+ QLL L Y H G++H DIK EN+L++ + IK++D G A C +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-----CWYD 189
Query: 179 AADNSLSETFCG---SYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD 230
E + + Y SPE+L G P+ DIWS ++F ++ G F+
Sbjct: 190 -------EHYTNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFE 236
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 35/232 (15%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP- 82
Y + +IG GS+ V A VAIKI+ +L + E+ +++ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQ-IEVRLLELMNKHD 111
Query: 83 -----NLIRFLQAIETTHR--VYIIMEYAENGSLFDIIRGQGY----IDEIRARRWFGQL 131
++ + R + ++ E +L+D++R + ++ R++ Q+
Sbjct: 112 TEMKYYIVHLKRHFM--FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLT--RKFAQQM 166
Query: 132 LEALQYCHER--GVVHRDIKCENLLL--DSDYNIKLSDFGFARAHMRCRSNAADNSLSET 187
AL + ++H D+K EN+LL IK+ DFG S+
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---------SSCQLGQRIYQ 217
Query: 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK 239
+ S Y SPE+L G+PY D+WS+G +L M G F ++ + +
Sbjct: 218 YIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 268
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 51/242 (21%), Positives = 100/242 (41%), Gaps = 35/242 (14%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-- 81
+ V + +G G++ V L + + A+K+V ++ Y + E +++K +++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK---YTRSAK-IEADILKKIQNDD 92
Query: 82 PNLIRFLQAIET-THR--VYIIMEYAENGSLFDIIRGQGY----IDEIRARRWFG-QLLE 133
N ++ + + +I E SL++II Y I++I+ + ++L+
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKL---YCIEILK 148
Query: 134 ALQYCHERGVVHRDIKCENLLL-DSDYNIKLSDFGFARAHMRCRSNAADNSL-------S 185
AL Y + + H D+K EN+LL D + L + + ++
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 186 ETFCGSYAYA--------SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNEL 237
TF Y + +PE++ + + SD+WS G VL + G L F E
Sbjct: 209 ATFKSDYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267
Query: 238 LK 239
L
Sbjct: 268 LA 269
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 9e-18
Identities = 52/221 (23%), Positives = 87/221 (39%), Gaps = 33/221 (14%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-- 81
Y +G+ IG+GS+ + L +VAIK+ P L E ++ K ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 65
Query: 82 --PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG-QLLEALQYC 138
P + E + ++ME SL D+ ++ Q++ ++Y
Sbjct: 66 GIPTIRWCGA--EGDYN-VMVMEL-LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 139 HERGVVHRDIKCENLLLDSDYN---IKLSDFGFARA--------HMRCRSNAADNSLSET 187
H + +HRD+K +N L+ + + DFG A+ H+ R N
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN------- 174
Query: 188 FCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLP 228
G+ YAS GI + D+ S+G VL G LP
Sbjct: 175 LTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLP 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 54/264 (20%), Positives = 90/264 (34%), Gaps = 65/264 (24%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK--- 80
Y V + +G G ++TV L+ + VA+K+V + + EI ++K ++
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL----DEIRLLKSVRNSD 94
Query: 81 --HPNLIRFLQAIET--------THRVYIIMEYAENG-SLFDIIRGQGY--IDEIRARRW 127
PN +Q ++ TH ++ E G L I Y + ++
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHIC-MVFEVL--GHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 128 FGQLLEALQYCH-ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSE 186
Q+L+ L Y H + ++H DIK EN+LL + A R + S
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 187 TFCGSY----------------------------------------AYASPEILQGIPYA 206
T + Y S E+L G Y
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYN 271
Query: 207 PHLSDIWSMGVVLFAMVFGRLPFD 230
+DIWS + F + G F+
Sbjct: 272 TP-ADIWSTACMAFELATGDYLFE 294
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 56/257 (21%), Positives = 95/257 (36%), Gaps = 69/257 (26%)
Query: 24 YTVGKIIGTGSYATVKLAR-STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y + +G G++ V VA+KIV V Y + EI+V++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAAR-SEIQVLEHLNTT 71
Query: 83 ------NLIRFLQAIETTHR--VYIIMEYAENGSLFDIIRGQGY----IDEIRARRWFG- 129
++ L+ E H + I+ E S +D I+ G+ +D IR
Sbjct: 72 DPNSTFRCVQMLEWFE--HHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRK---MAY 125
Query: 130 QLLEALQYCHERGVVHRDIKCEN-LLLDSDY------------------NIKLSDFGFAR 170
Q+ +++ + H + H D+K EN L + SDY +IK+ DFG
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG--- 182
Query: 171 AHMRCRSNAADNSLSETFCGSYAYA--------SPEILQGIPYAPHLSDIWSMGVVLFAM 222
S T+ + +PE++ + ++ D+WS+G +L
Sbjct: 183 --------------SATYDDEHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEY 227
Query: 223 VFGRLPFDDSSVNELLK 239
G F E L
Sbjct: 228 YLGFTVFPTHDSKEHLA 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 4e-17
Identities = 53/229 (23%), Positives = 93/229 (40%), Gaps = 49/229 (21%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-- 81
+ +G+ IG+GS+ + L + + + +VAIK+ + P L E ++ + L+
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LLYESKIYRILQGGT 63
Query: 82 --PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG---------Q 130
PN+ F E + ++M+ SL D+ R Q
Sbjct: 64 GIPNVRWFGV--EGDYN-VLVMDL-LGPSLEDLFNFCS--------RKLSLKTVLMLADQ 111
Query: 131 LLEALQYCHERGVVHRDIKCENLLLDSDYN---IKLSDFGFARA--------HMRCRSNA 179
++ +++ H + +HRDIK +N L+ + + DFG A+ H+ R N
Sbjct: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLP 228
G+ YAS GI + D+ S+G VL + G LP
Sbjct: 172 N-------LTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLP 212
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-17
Identities = 53/257 (20%), Positives = 91/257 (35%), Gaps = 69/257 (26%)
Query: 24 YTVGKIIGTGSYATVKLAR-STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP 82
Y + +G G++ V R VA+KI+ V Y + EI V+K +K
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK---YREAAR-LEINVLKKIKEK 76
Query: 83 ------NLIRFLQAIETTHR--VYIIMEYAENGSLFDIIRGQGY----IDEIRARRWFG- 129
+ + I E + F+ ++ + + +R
Sbjct: 77 DKENKFLCVLMSDWFN--FHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRH---MAY 130
Query: 130 QLLEALQYCHERGVVHRDIKCEN-LLLDSDY------------------NIKLSDFGFAR 170
QL AL++ HE + H D+K EN L ++S++ +I+++DFG
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--- 187
Query: 171 AHMRCRSNAADNSLSETFCGSYAYA--------SPEILQGIPYAPHLSDIWSMGVVLFAM 222
S TF + PE++ + +A D+WS+G +LF
Sbjct: 188 --------------SATFDHEHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEY 232
Query: 223 VFGRLPFDDSSVNELLK 239
G F E L
Sbjct: 233 YRGFTLFQTHENREHLV 249
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 51/232 (21%), Positives = 87/232 (37%), Gaps = 53/232 (22%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-- 81
+ VGK IG G++ ++L ++ + VAIK+ P L E K L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-----LHLEYRFYKQLGSGD 65
Query: 82 --PNLIRFLQAIETTHRVYIIMEYAENG-SLFDIIRGQGYIDEIRARRWFG--------- 129
P + F + +++E G SL D+ R F
Sbjct: 66 GIPQVYYFGP--CGKYN-AMVLELL--GPSLEDLFDLCD--------RTFSLKTVLMIAI 112
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYN-----IKLSDFGFAR--------AHMRCR 176
QL+ ++Y H + +++RD+K EN L+ N I + DF A+ H+ R
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLP 228
+ + G+ Y S G + D+ ++G + + G LP
Sbjct: 173 EHKS-------LTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLP 216
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 57/232 (24%), Positives = 88/232 (37%), Gaps = 53/232 (22%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-- 81
Y VG+ IG GS+ + + ++ VAIK + P L E K L
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-----LRDEYRTYKLLAGCT 66
Query: 82 --PNLIRFLQAIETTHRVYIIMEYAENG-SLFDIIRGQGYIDEIRARRWFG--------- 129
PN+ F Q E H ++++ G SL D++ G R F
Sbjct: 67 GIPNVYYFGQ--EGLHN-VLVIDLL--GPSLEDLLDLCG--------RKFSVKTVAMAAK 113
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYN-----IKLSDFGFAR--------AHMRCR 176
Q+L +Q HE+ +V+RDIK +N L+ + I + DFG + H+ R
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLP 228
G+ Y S G + D+ ++G V + G LP
Sbjct: 174 EKKN-------LSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLP 217
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 37/241 (15%), Positives = 83/241 (34%), Gaps = 53/241 (21%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSG--------DVAIKIVSK----VQAPPDYLKKFLPR 71
+ + + + A T ++K+ +K + + P
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 72 EIEV---VKGLKH---PNLIRFLQAIETTHRVYIIMEYAENG-SLFDIIRGQGYIDEIRA 124
++ + P + F + +R ++++ G SL +
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGF-GVHQDKYR-FLVLPSL--GRSLQSALDVSP------- 152
Query: 125 RRWFG---------QLLEALQYCHERGVVHRDIKCENLLLDSDY--NIKLSDFGFAR--- 170
+ +LL+AL++ HE VH ++ EN+ +D + + L+ +GFA
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 171 ---AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRL 227
H+ + G + S ++ +G + SD+ S+G + ++G L
Sbjct: 213 PSGKHVAYVEGSRS-----PHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFL 266
Query: 228 P 228
P
Sbjct: 267 P 267
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 48/243 (19%), Positives = 79/243 (32%), Gaps = 57/243 (23%)
Query: 24 YTVGKIIGTGSYATVKLAR-----STRHSGDVAIKIVSKVQAPPDYLKKFL-----PREI 73
+ VG IG G + + LA S +K+ P KF P +I
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 74 EVVKGLKH------PNLIRF--LQAIETTHRVYIIMEYAENG-SLFDIIRGQGYIDEIRA 124
+ + P ++R +IM+ G L I
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRF-MIMDRF--GSDLQKIYEANA------- 146
Query: 125 RRWFG---------QLLEALQYCHERGVVHRDIKCENLLLD-SDYN-IKLSDFGFAR--- 170
+ F ++L+ L+Y HE VH DIK NLLL+ + + + L D+G A
Sbjct: 147 -KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205
Query: 171 -----AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFG 225
G+ + S + G+ + D+ +G + + G
Sbjct: 206 PEGVHKAYAADPKRC-------HDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLTG 257
Query: 226 RLP 228
LP
Sbjct: 258 HLP 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 47/238 (19%), Positives = 85/238 (35%), Gaps = 50/238 (21%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVS--KVQAPPDYLKKFLPREIEVVKGLKH 81
+ +GK IG+G + + LA T A +V + P L E++ + +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP------LFSELKFYQRVAK 92
Query: 82 PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY------------IDEIRARRWFG 129
+ I+ + + I + Y GS +G+ Y F
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFY---GSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFK 149
Query: 130 ---------QLLEALQYCHERGVVHRDIKCENLLLDSDYN--IKLSDFGFAR-------- 170
++L+ L+Y HE VH DIK NLLL + L+D+G +
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLP 228
+ G+ + S + +G+ + SD+ +G + + G+LP
Sbjct: 210 KQYQENPRKG-------HNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLP 259
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 2e-11
Identities = 33/208 (15%), Positives = 57/208 (27%), Gaps = 48/208 (23%)
Query: 9 QDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIV-----SKVQAPPD 63
Q L + + IG G + V + VAIKI+ V
Sbjct: 7 QKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADH--TPVAIKIIAIEGPDLVNGSHQ 64
Query: 64 YLKKFLPREIEVVKGL---------KHPNLIRFLQA------------------------ 90
+ + EI + K L + I
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 91 ------IETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER-GV 143
+++I++E+ G + +R + A+ QL +L
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRF 183
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARA 171
HRD+ N+LL KL ++
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKS 211
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 27/127 (21%), Positives = 51/127 (40%), Gaps = 29/127 (22%)
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Q+ + +++ R +HRD+ N+LL +K+ DFG AR +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--------------- 245
Query: 190 GSYAYA-----------SPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVN-E 236
+PE + Y SD+WS GV+L+ + G P+ ++ E
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304
Query: 237 LLKQVQN 243
++++
Sbjct: 305 FCRRLKE 311
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 21/97 (21%), Positives = 46/97 (47%), Gaps = 9/97 (9%)
Query: 25 TVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
+GK +G G++ V A + VA+K++ K A + + E++++ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALM-SELKILIHI 82
Query: 80 -KHPNLIRFLQA-IETTHRVYIIMEYAENGSLFDIIR 114
H N++ L A + + +I+E+ + G+L +R
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 7e-05
Identities = 50/329 (15%), Positives = 93/329 (28%), Gaps = 93/329 (28%)
Query: 38 VKLARSTRHSGDVAI------KIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAI 91
+ L + + +I + D+ + I ++ L R L+
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN-IKLRIHSIQ----AELRRLLK-- 239
Query: 92 ETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCE 151
+ Y L ++ + + + A ++ C+
Sbjct: 240 ---SKPY-------ENCL--LV-----LLNV----QNAKAWNAF-----------NLSCK 267
Query: 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNSL----SETFCGSYAYAS-----PEILQG 202
LL + +DF A + +L ++ Y E+L
Sbjct: 268 ILLTTRFKQV--TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT 325
Query: 203 IPYAPHLSDIWSMGVVLFAMV--FGRLPFD------DSSVNEL----LKQV-QNKVTFPK 249
P LS I A + + D +SS+N L +++ FP
Sbjct: 326 NPRR--LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPP 383
Query: 250 Q---P---------EVSTECKELISNIL---SPVQTRPRLKTIA-EDRWLKPKPKSRGVD 293
P +V ++ N L S V+ +P+ TI+ +L+ K K
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEY 443
Query: 294 KAEAEL-DHY-----IDMIQTSASSTDGY 316
+ DHY D D Y
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQY 472
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 316 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.14 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.96 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.93 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.81 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.7 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.65 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.38 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.33 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.17 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.16 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.1 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.06 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.96 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.73 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.7 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.7 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.57 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.36 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.35 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.01 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.75 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.49 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.84 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.03 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-63 Score=415.65 Aligned_cols=255 Identities=37% Similarity=0.671 Sum_probs=214.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
.+|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999998765544444566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||+ +|+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+|||++.+|.+||+|||+|+... .
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~-------~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-------D 164 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC-------C
Confidence 999 66999999888889999999999999999999999999999999999999999999999999996532 1
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 261 (316)
........||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+..+..+.+..+. .+.+..+|+++++||
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 243 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLI 243 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHH
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHH
Confidence 2223346799999999999988887767999999999999999999999998888888876653 344567999999999
Q ss_pred HHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 262 SNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 262 ~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
.+|| .||++|||++|+++||||+.
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHccCChhHCcCHHHHHcCccccc
Confidence 9999 69999999999999999963
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-63 Score=423.63 Aligned_cols=262 Identities=27% Similarity=0.541 Sum_probs=230.1
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45689999999999999999999999999999999975432222224567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||++||+|.+++++.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... .
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~----~ 185 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP----E 185 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT----T
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC----C
Confidence 999999999999999888899999999999999999999999999999999999999999999999999976431 1
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
.........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..++...+.... +..+..+|+++++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~d 263 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-YDFPEKFFPKARD 263 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTCCHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCcccCHHHHH
Confidence 12233455679999999999988777665 999999999999999999999999998888886653 3445679999999
Q ss_pred HHHHhc-CCCCCCCCHHH------HhhCCCCCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKT------IAEDRWLKPKP 287 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~------il~~~~~~~~~ 287 (316)
||.+|| .||++|||++| |++||||++..
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 999999 69999999988 58999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-62 Score=422.20 Aligned_cols=260 Identities=25% Similarity=0.436 Sum_probs=228.8
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.+.|++++.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356999999999999999999999999999999997654432 45577999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||||+||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... .
T Consensus 150 mEy~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~------~ 222 (346)
T 4fih_A 150 MEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS------K 222 (346)
T ss_dssp ECCCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC------S
T ss_pred EeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecC------C
Confidence 9999999999999874 59999999999999999999999999999999999999999999999999997642 1
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--CCCCCCCCHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--FPKQPEVSTECK 258 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 258 (316)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+..... .+.+..+|++++
T Consensus 223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 301 (346)
T 4fih_A 223 EVPRRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK 301 (346)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHH
T ss_pred CCCcccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 2223345679999999999988777665 9999999999999999999999999888888876543 333457899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
+||.+|| .||++|||++|+++||||+.......
T Consensus 302 dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p~~ 335 (346)
T 4fih_A 302 GFLDRLLVRDPAQRATAAELLKHPFLAKAGPPAS 335 (346)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHhhcCCCCCcc
Confidence 9999999 69999999999999999987655443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-62 Score=424.90 Aligned_cols=259 Identities=30% Similarity=0.528 Sum_probs=224.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
-++|++++.||+|+||.||+|++..+|+.||||++........ ..+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH-HHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999987655433 356678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 101 MEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--- 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--- 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH---
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC---
Confidence 9999999999999653 35799999999999999999999999999999999999999999999999999764211
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+..+...+.+..+|++++
T Consensus 179 ---~~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~ 254 (350)
T 4b9d_A 179 ---VELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLR 254 (350)
T ss_dssp ---HHHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred ---cccccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 111234569999999999998777665 9999999999999999999999999999888887766666778999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
+||.+|| .||++|||++++++||||+..-
T Consensus 255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 9999999 6999999999999999997543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=423.34 Aligned_cols=261 Identities=25% Similarity=0.438 Sum_probs=230.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.+.|++++.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.+++.++||||++++++|.+++..|+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 356999999999999999999999999999999997654433 45678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||||+||+|.++++.. .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.... .
T Consensus 227 mEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~------~ 299 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS------K 299 (423)
T ss_dssp EECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECC------S
T ss_pred EeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECC------C
Confidence 9999999999999764 59999999999999999999999999999999999999999999999999997642 1
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--CCCCCCCCHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--FPKQPEVSTECK 258 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 258 (316)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+..... .+.+..+|++++
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 378 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK 378 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHH
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHH
Confidence 2223445679999999999988887665 9999999999999999999999999888888876543 334567999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCCh
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGV 292 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~ 292 (316)
+||.+|| .||++|||++|+|+||||+.......+
T Consensus 379 dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~~l 413 (423)
T 4fie_A 379 GFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASI 413 (423)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGT
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHHhcCCCCCccc
Confidence 9999999 699999999999999999876554433
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-61 Score=413.47 Aligned_cols=263 Identities=24% Similarity=0.450 Sum_probs=222.0
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEc---cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARST---RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~---~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
......++|++++.||+|+||.||+|++. .+++.||+|++......... ...+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 18 HEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp CCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEE
T ss_pred cccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 33445678999999999999999999874 46778999999754322211 234668999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
+++..++|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||+|+..
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999999753
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
. .........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+.+.. .+.+..
T Consensus 177 ~------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~ 248 (304)
T 3ubd_A 177 I------DHEKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGMPQF 248 (304)
T ss_dssp ----------CCCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTT
T ss_pred c------CCCccccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCc
Confidence 2 12233345679999999999988777765 999999999999999999999999999888886653 444567
Q ss_pred CCHHHHHHHHHhc-CCCCCCCC-----HHHHhhCCCCCCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRPR-----LKTIAEDRWLKPKP 287 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps-----~~~il~~~~~~~~~ 287 (316)
+|+++++||.+|| .||++||| ++++++||||++.+
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 9999999999999 69999998 58999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-59 Score=400.45 Aligned_cols=255 Identities=23% Similarity=0.460 Sum_probs=216.2
Q ss_pred ccCe-EEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe----CC
Q psy11194 21 SHGY-TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----TH 95 (316)
Q Consensus 21 ~~~y-~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~ 95 (316)
..+| ++.+.||+|+||.||+|.+..++..||+|++........ ..+.+.+|+.+++.++||||+++++++.. +.
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 3455 778889999999999999999999999999976554433 35668899999999999999999999865 35
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeC-CCCCeEEeeccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG--VVHRDIKCENLLLD-SDYNIKLSDFGFARAH 172 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~H~dl~p~nil~~-~~~~~~l~Df~~~~~~ 172 (316)
..++|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 68999999999999999998888999999999999999999999998 99999999999997 4799999999999642
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcccCCC-CC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS-SVNELLKQVQNKVTFP-KQ 250 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~ 250 (316)
.........||+.|+|||++.+ .++ .++|||||||++|+|++|+.||.+. ....+...+..+..++ .+
T Consensus 183 --------~~~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 183 --------RASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp --------CTTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred --------CCCccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC
Confidence 1123345679999999999876 454 4599999999999999999999764 5566666776654433 33
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
..+++++++||.+|| .+|++|||++++++||||++.
T Consensus 253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 568899999999999 699999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-60 Score=407.57 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=221.1
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.+.|++.++||+|+||.||+|++..+|+.||||+++.... ..+|+.+++.++|||||++++++.+++..++|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4568999999999999999999999999999999976432 23799999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC-CeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY-NIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~-~~~l~Df~~~~~~~~~~~~~ 179 (316)
|||++||+|.+++++.+.+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||+|||+++........
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~- 207 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG- 207 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc-
Confidence 99999999999999888899999999999999999999999999999999999999887 5999999999764321111
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC--CCCCCCCHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF--PKQPEVSTEC 257 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 257 (316)
.........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+....+....+...... ..++.+|+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 11112234569999999999998777665 99999999999999999999887666666666544321 2356799999
Q ss_pred HHHHHHhc-CCCCCCCCHHHH-------------hhCCCCCCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRPRLKTI-------------AEDRWLKPKPKSRG 291 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~i-------------l~~~~~~~~~~~~~ 291 (316)
.+||.+|| .||.+|||+.|+ ++|||++..++.++
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~ 334 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG 334 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence 99999999 699999999997 57999998877654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=402.87 Aligned_cols=264 Identities=25% Similarity=0.397 Sum_probs=222.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe------C
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------T 94 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 94 (316)
+++|++++.||+|+||.||+|++..+|+.||||++........ ..+.+.+|+.+++.++||||+++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVT-NAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHH-HHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchH-HHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 4689999999999999999999999999999999976554333 34456699999999999999999998754 3
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
+..|+||||++ |+|.+++...+++++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||+++.+..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 67899999996 58999999888899999999999999999999999999999999999999999999999999976432
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-----
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK----- 249 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 249 (316)
.. ..........+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+..+....+......+.
T Consensus 211 ~~--~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 211 SP--AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred Cc--cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 11 12223344567999999999998877766669999999999999999999999888877776643221111
Q ss_pred -------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 250 -------------------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 250 -------------------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+.+++++.+||.+|| .||++|||++++|+||||+....
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 1357899999999999 59999999999999999987643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-58 Score=391.50 Aligned_cols=259 Identities=22% Similarity=0.389 Sum_probs=222.4
Q ss_pred cccccceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcce
Q psy11194 12 IDRKVTVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86 (316)
Q Consensus 12 ~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 86 (316)
+++....+..++|.+.+.||+|+||.||+|++. .++..||||+++.. .....+.+.+|+.++++++||||++
T Consensus 3 ~d~~~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~ 79 (299)
T 4asz_A 3 MDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVK 79 (299)
T ss_dssp GGGSCCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred chhhhcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCcc
Confidence 344556677889999999999999999999865 35778999998643 2334566889999999999999999
Q ss_pred eeeEEEeCCeEEEEEecCCCCCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCe
Q psy11194 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQ-------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENL 153 (316)
Q Consensus 87 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ni 153 (316)
+++++.+++..++||||+++|+|.+++... ..+++.++..++.||+.||.|||+++++||||||+||
T Consensus 80 l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NI 159 (299)
T 4asz_A 80 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 159 (299)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhE
Confidence 999999999999999999999999999753 3599999999999999999999999999999999999
Q ss_pred eeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy11194 154 LLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDS 232 (316)
Q Consensus 154 l~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~ 232 (316)
|++.++.+||+|||+++....... ........||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.
T Consensus 160 Ll~~~~~~Ki~DFGla~~~~~~~~----~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 160 LVGENLLVKIGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGC----EEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred EECCCCcEEECCcccceecCCCCc----eeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999975432111 111223458899999999988777765 999999999999998 99999999
Q ss_pred CHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy11194 233 SVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIA 278 (316)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il 278 (316)
+..++...+..+...+.+..+|+++.+||.+|| .+|++|||++++.
T Consensus 235 ~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 235 SNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 999999999888877788889999999999999 6999999999985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-57 Score=388.76 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=224.1
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeee
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 89 (316)
+..++...++++.+.||+|+||.||+|... .+++.||||+++...... ..+.+.+|+.++.+++||||+++++
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~--~~~~f~~E~~il~~l~HpNIV~l~g 96 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP--LREEFRHEAMLRARLQHPNVVCLLG 96 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH--HHHHHHHHHHHHHhCCCCCCCCcce
Confidence 345677888999999999999999999863 456789999986543322 2456889999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCe
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQ----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENL 153 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ni 153 (316)
++..++..++|||||++|+|.+++... ..+++..+..++.||+.||.|||+.+++||||||+||
T Consensus 97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NI 176 (308)
T 4gt4_A 97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 176 (308)
T ss_dssp EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccce
Confidence 999999999999999999999999642 3589999999999999999999999999999999999
Q ss_pred eeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy11194 154 LLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDS 232 (316)
Q Consensus 154 l~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~ 232 (316)
|++.++.+||+|||+++...... .........||+.|+|||++.+..++.+ +|||||||++|||+| |..||.+.
T Consensus 177 Ll~~~~~~Ki~DFGlar~~~~~~----~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 177 LVYDKLNVKISDLGLFREVYAAD----YYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp EECGGGCEEECCSCCBCGGGGGG----CBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred EECCCCCEEECCcccceeccCCC----ceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997643221 1222344568999999999988777665 999999999999998 89999999
Q ss_pred CHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 233 SVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+..++...+..+...+.+..+|+++.+||.+|| .+|++|||+.+|+++
T Consensus 252 ~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 252 SNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999988888888899999999999999 699999999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=388.25 Aligned_cols=257 Identities=21% Similarity=0.347 Sum_probs=217.0
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQA 90 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 90 (316)
...+..+++.+.+.||+|+||.||+|++. .+++.||||+++.. .....+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34566788999999999999999999865 35788999998643 23345668899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee
Q psy11194 91 IETTHRVYIIMEYAENGSLFDIIRGQ---------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL 155 (316)
Q Consensus 91 ~~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~ 155 (316)
+.+.+..++||||+++|+|.++++.. +++++.++..++.||+.||.|||+.+++||||||+|||+
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 99999999999999999999999653 358999999999999999999999999999999999999
Q ss_pred CCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11194 156 DSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSV 234 (316)
Q Consensus 156 ~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~ 234 (316)
+.++.+||+|||+++..... ..........||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+.
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~----~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYST----DYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp ETTTEEEECCCC--------------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred CCCCcEEEcccccceeccCC----CcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999754221 11122334568999999999998877765 999999999999999 9999999999
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 235 NELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.+....+..+..++.+..+|+++.+||..|| .+|++|||+++|+++
T Consensus 267 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 267 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999888888888889999999999999 699999999999753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-57 Score=388.05 Aligned_cols=261 Identities=23% Similarity=0.391 Sum_probs=200.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC------
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH------ 95 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 95 (316)
++|++++.||+|+||.||+|++..+|+.||+|++..... +...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 369999999999999999999999999999999976542 333566789999999999999999999997654
Q ss_pred ------eEEEEEecCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeec
Q psy11194 96 ------RVYIIMEYAENGSLFDIIRGQGY---IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDF 166 (316)
Q Consensus 96 ------~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df 166 (316)
..++|||||+||+|.+++..... .+...++.++.||+.||+|||++|++||||||+|||++.+|.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 36899999999999999987553 455678999999999999999999999999999999999999999999
Q ss_pred ccccccccccCcCC------CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHH
Q psy11194 167 GFARAHMRCRSNAA------DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-VNELLK 239 (316)
Q Consensus 167 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~ 239 (316)
|+|+.......... ........+||+.|+|||++.+..++.+ +|||||||++|+|++ ||.+.. ......
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 99976543221111 1112234569999999999998777665 999999999999996 776432 222233
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 240 QVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+.....++.....++.+.+||.+|| .+|.+|||+.++++||||++.+-
T Consensus 239 ~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 33333222233346678899999999 69999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=386.53 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=206.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEc---cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCe
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARST---RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 96 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~---~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 96 (316)
.++|++.+.||+|+||.||+|+++ .+++.||+|.+..... ...+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 578999999999999999999875 3567899999865432 23466899999988 69999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-CCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~-~~~~l~Df~~~~~~~~~ 175 (316)
.++||||++|++|.++++ .+++..++.++.||+.||+|||++|++||||||+|||++.+ +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999999985 39999999999999999999999999999999999999876 89999999999754322
Q ss_pred cCcC----------------------CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-C
Q psy11194 176 RSNA----------------------ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-S 232 (316)
Q Consensus 176 ~~~~----------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~ 232 (316)
.... .........+||+.|+|||++.+....+.++||||+||++|+|++|+.||.. .
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1100 0111223456999999999998876566669999999999999999999954 3
Q ss_pred CHHHHHHHHhc-----------------------------------------------------ccCCCCCCCCCHHHHH
Q psy11194 233 SVNELLKQVQN-----------------------------------------------------KVTFPKQPEVSTECKE 259 (316)
Q Consensus 233 ~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~~~~ 259 (316)
+..+....+.. ....+.+..+|+++.+
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 33333222211 0011123468999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
||.+|| .||++|||++|+|+||||++.
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999 599999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-55 Score=374.42 Aligned_cols=255 Identities=24% Similarity=0.428 Sum_probs=206.6
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.|++..+++++.+.||+|+||.||+|++. ..||||+++...... ...+.+.+|+.+++.++||||+++++++.. +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTP-EQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 46788899999999999999999999754 369999987655433 345668899999999999999999998765 5
Q ss_pred eEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
..++|||||+||+|.+++.. ...+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 67999999999999999975 45699999999999999999999999999999999999999999999999999975421
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcccCCCC--
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIP--YAPHLSDIWSMGVVLFAMVFGRLPFDDSSV-NELLKQVQNKVTFPK-- 249 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~-- 249 (316)
. ..........||+.|+|||++.+.. ..+.++|||||||++|||+||+.||.+.+. ......+..+...|.
T Consensus 185 ~----~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 185 W----SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp -------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST
T ss_pred C----CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 1 1122234457999999999986432 234459999999999999999999987654 444555555544432
Q ss_pred --CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 250 --QPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 250 --~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+..+|+++.+||.+|| .+|++|||+.++++
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 3568999999999999 69999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-55 Score=404.95 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=217.1
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCC---CchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA---PPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
.+.-++|++++.||+|+||.||+|++..+|+.||+|++.+... .........+.++.+++.++||||++++++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 4457889999999999999999999999999999999975321 1111112223446677788999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
+..|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999975421
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcccCCCCCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS---SVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~ 251 (316)
......+||+.|+|||++......+.++|||||||++|+|++|..||.+. +..++...+... ....+.
T Consensus 345 --------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~~~~p~ 415 (689)
T 3v5w_A 345 --------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELPD 415 (689)
T ss_dssp --------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-CCCCCT
T ss_pred --------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-CCCCCc
Confidence 22334579999999999975444444599999999999999999999753 334444444332 344556
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCC-----HHHHhhCCCCCCC
Q psy11194 252 EVSTECKELISNIL-SPVQTRPR-----LKTIAEDRWLKPK 286 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps-----~~~il~~~~~~~~ 286 (316)
.+|+++++||..|| .||.+|++ +++|++||||++.
T Consensus 416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 79999999999999 69999998 7999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-55 Score=381.50 Aligned_cols=261 Identities=20% Similarity=0.354 Sum_probs=219.1
Q ss_pred ccccceeeccCeEEeeeeeecCCeEEEEEEEccCC-----ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC-CCcce
Q psy11194 13 DRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHS-----GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-PNLIR 86 (316)
Q Consensus 13 ~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~ 86 (316)
+...+++..++|++.+.||+|+||.||+|.+...+ +.||+|.+...... ...+.+.+|+.++..+.| |||++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEE
Confidence 33456788899999999999999999999976543 57999998654432 224567799999999965 89999
Q ss_pred eeeEEEeC-CeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q psy11194 87 FLQAIETT-HRVYIIMEYAENGSLFDIIRGQ----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIK 149 (316)
Q Consensus 87 ~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~ 149 (316)
++++|... ...++|||||++|+|.++++.. ..+++..+..++.||+.||.|||+++++|||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK 212 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 212 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccC
Confidence 99999664 5689999999999999999642 348999999999999999999999999999999
Q ss_pred CCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q psy11194 150 CENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLP 228 (316)
Q Consensus 150 p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p 228 (316)
|+|||++.++.+||+|||+|+..... ..........||+.|+|||++.+..++.+ +|||||||++|||+| |..|
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~----~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKD----PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTC----TTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCS
T ss_pred ccceeeCCCCCEEECcchhhhhcccC----CCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCC
Confidence 99999999999999999999754211 11112334568899999999988777665 999999999999998 9999
Q ss_pred CCCCC-HHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 229 FDDSS-VNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
|.+.. ...+...+..+..++.+..+++++.++|..|| .+|++|||+.+|++|
T Consensus 288 f~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 288 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp STTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 98865 45566777788778888889999999999999 699999999999976
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=400.53 Aligned_cols=257 Identities=26% Similarity=0.467 Sum_probs=225.3
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||++++++|.+....++||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999986643 223566789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC--CCeEEeecccccccccccCc
Q psy11194 102 EYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD--YNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 102 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~--~~~~l~Df~~~~~~~~~~~~ 178 (316)
|||+||+|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+|||++.+ +.+||+|||+++...
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~----- 308 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD----- 308 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC-----
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc-----
Confidence 99999999999964 4579999999999999999999999999999999999999754 899999999997642
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CCC--CCCCCCH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TFP--KQPEVST 255 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~ 255 (316)
........+||+.|+|||++.+..++.. +|||||||++|+|++|..||.+.+..+....+.... .++ ....+|+
T Consensus 309 --~~~~~~~~~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 309 --PKQSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp --TTSEEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred --CCCceeeeEECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 1222334569999999999998877665 999999999999999999999999999888886643 222 3357999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
++++||.+|| .||.+|||+.++|+||||++....
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 9999999999 699999999999999999876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=366.54 Aligned_cols=261 Identities=40% Similarity=0.724 Sum_probs=230.1
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
...+|++.+.||+|+||.||+|.+..+|+.||+|++........ ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 35689999999999999999999999999999999977654433 34556799999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~------ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT------ 165 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS------
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC------
Confidence 99999999999999887889999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
.........|++.|+|||++.+..+...++|||||||++|+|++|..||.+.+..+....+..+. ...+..+++++.+
T Consensus 166 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 243 (328)
T 3fe3_A 166 -VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK-YRIPFYMSTDCEN 243 (328)
T ss_dssp -SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHH
T ss_pred -CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHH
Confidence 11223445689999999999888777666999999999999999999999999888888876653 3444568999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
||.+|| .+|.+|||++++++||||+.....
T Consensus 244 li~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred HHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence 999999 599999999999999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=360.03 Aligned_cols=260 Identities=32% Similarity=0.528 Sum_probs=225.1
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
+..++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++...+..+
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 35678999999999999999999999999999999997532111111345668999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+||||++|++|..++.+.+.+++..++.++.||+.||.|||+.|++||||||+||+++.+|.++|+|||++....
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~----- 156 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI----- 156 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC-----
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc-----
Confidence 999999999999999888889999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
..........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+.......+... ....+..+++++.
T Consensus 157 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 233 (337)
T 1o6l_A 157 -SDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPRTLSPEAK 233 (337)
T ss_dssp -CTTCCBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTTSCHHHH
T ss_pred -cCCCcccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHH
Confidence 11222344568999999999988777666 99999999999999999999998888887777553 2334457999999
Q ss_pred HHHHHhc-CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 259 ELISNIL-SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 259 ~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
++|.+|| .+|.+|| +++++++||||++.
T Consensus 234 ~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 9999999 6999999 99999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=351.38 Aligned_cols=262 Identities=28% Similarity=0.478 Sum_probs=225.7
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 4678999999999999999999999999999999997654433 3456799999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----- 168 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----- 168 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-----
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC-----
Confidence 99999999999999875 499999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCCCCHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV--TFPKQPEVSTEC 257 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 257 (316)
.........|++.|+|||++.+..++.+ +||||||+++|+|++|..||...+.......+.... ....+..++..+
T Consensus 169 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T 3fxz_A 169 -EQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (297)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHH
T ss_pred -cccccCCccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHH
Confidence 1122334568999999999988777665 999999999999999999999888776665554332 333445789999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCCh
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGV 292 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~ 292 (316)
.++|.+|| .+|.+|||++++++||||+..+.....
T Consensus 247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~ 282 (297)
T 3fxz_A 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSL 282 (297)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhhChhhcccCccccc
Confidence 99999999 599999999999999999877665443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=358.94 Aligned_cols=261 Identities=26% Similarity=0.479 Sum_probs=225.9
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch---HHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..++|.+.+.||+|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 35679999999999999999999999999999999976543221 123557799999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC----CeEEeeccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY----NIKLSDFGFARAH 172 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~----~~~l~Df~~~~~~ 172 (316)
.++||||++|++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999998888899999999999999999999999999999999999998776 7999999998753
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-CC--C
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-FP--K 249 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~--~ 249 (316)
.. ........|++.|+|||++.+..++.+ +||||||+++|+|++|..||.+.+..+....+..... ++ .
T Consensus 170 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (361)
T 2yab_A 170 ED-------GVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241 (361)
T ss_dssp CT-------TCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred CC-------CCccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence 21 122334568999999999988766655 9999999999999999999999888888887765432 22 1
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+..+++++.+||..|| .+|.+|||++++++||||++...
T Consensus 242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 2578999999999999 59999999999999999987653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-52 Score=363.85 Aligned_cols=261 Identities=27% Similarity=0.509 Sum_probs=220.5
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 96 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 96 (316)
.+..++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|..++..+ +||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999764222222244566899999988 69999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++||||++|++|..++...+.+++..++.++.||+.||+|||+.|++||||||+||+++.+|.++|+|||++....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~--- 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI--- 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC---
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc---
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999986421
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
..........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+.... ...+..++.+
T Consensus 176 ---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~ 250 (353)
T 3txo_A 176 ---CNGVTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLHED 250 (353)
T ss_dssp ---C---------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHH
T ss_pred ---cCCccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHH
Confidence 12223344568999999999987666655 999999999999999999999999988888886653 3334569999
Q ss_pred HHHHHHHhc-CCCCCCCCH------HHHhhCCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRL------KTIAEDRWLKPK 286 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~------~~il~~~~~~~~ 286 (316)
+.++|.+|| .+|.+||++ +++++||||++.
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 999999999 699999999 899999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=354.88 Aligned_cols=257 Identities=27% Similarity=0.518 Sum_probs=224.6
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
+..++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|..+++.++||||+++++++.+....+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 35678999999999999999999999999999999997532211112345678999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+||||++|++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||++....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~----- 157 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 157 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-----
Confidence 999999999999999988889999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
.......|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+.... ...+..+++++.
T Consensus 158 ----~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~ 231 (318)
T 1fot_A 158 ----DVTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVK 231 (318)
T ss_dssp ----SCBCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHH
T ss_pred ----CccccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHH
Confidence 11234468999999999988777766 999999999999999999999988888777776542 334467899999
Q ss_pred HHHHHhc-CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 259 ELISNIL-SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 259 ~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
++|.+|| .+|.+|| +++++++||||++.
T Consensus 232 ~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 9999999 6999999 99999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=361.85 Aligned_cols=262 Identities=29% Similarity=0.519 Sum_probs=220.2
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 95 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 95 (316)
..+..++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|..++..+ +||||+++++++...+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 455678999999999999999999999999999999999876554444455677899998876 8999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++||||++|++|..++.+.+.+++..++.++.||+.||.|||+.|++||||||+||+++.+|.++|+|||++....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~-- 204 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-- 204 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc--
Confidence 999999999999999999888889999999999999999999999999999999999999999999999999986421
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhcccC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS---------SVNELLKQVQNKVT 246 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---------~~~~~~~~~~~~~~ 246 (316)
..........|++.|+|||++.+..++.. +|||||||++|+|++|..||... ........+... .
T Consensus 205 ----~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~ 278 (396)
T 4dc2_A 205 ----RPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-Q 278 (396)
T ss_dssp ----CTTCCBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-C
T ss_pred ----cCCCccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-c
Confidence 12223445678999999999988777655 99999999999999999999632 222333333332 3
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCH------HHHhhCCCCCCC
Q psy11194 247 FPKQPEVSTECKELISNIL-SPVQTRPRL------KTIAEDRWLKPK 286 (316)
Q Consensus 247 ~~~~~~~~~~~~~li~~~l-~~p~~Rps~------~~il~~~~~~~~ 286 (316)
...+..++.++.+||.+|| .+|.+||++ +++++||||++.
T Consensus 279 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 279 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 4445679999999999999 699999985 899999999765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=353.70 Aligned_cols=263 Identities=30% Similarity=0.517 Sum_probs=223.8
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 95 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 95 (316)
..+..++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|..++..+ +||||+++++++....
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 345678999999999999999999999999999999999876655555566678999999988 8999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++||||++|++|.+++.+.+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||++....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~-- 161 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-- 161 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC--
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc--
Confidence 999999999999999999887789999999999999999999999999999999999999999999999999986421
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHhcccC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD---------SSVNELLKQVQNKVT 246 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~---------~~~~~~~~~~~~~~~ 246 (316)
..........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.. .........+... .
T Consensus 162 ----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~ 235 (345)
T 3a8x_A 162 ----RPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-Q 235 (345)
T ss_dssp ----CTTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-C
T ss_pred ----CCCCcccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-C
Confidence 11122344568999999999988777655 9999999999999999999965 2233334444332 3
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCH------HHHhhCCCCCCCC
Q psy11194 247 FPKQPEVSTECKELISNIL-SPVQTRPRL------KTIAEDRWLKPKP 287 (316)
Q Consensus 247 ~~~~~~~~~~~~~li~~~l-~~p~~Rps~------~~il~~~~~~~~~ 287 (316)
...+..++.++.+||.+|| .+|.+||++ +++++||||++..
T Consensus 236 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 236 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 3444679999999999999 599999995 8999999998653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=358.41 Aligned_cols=263 Identities=29% Similarity=0.478 Sum_probs=223.8
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 95 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 95 (316)
..+..++|.+.+.||+|+||.||+|++..+|+.||+|++...........+.+..|..++..+ +||||+++++++.+..
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 345678999999999999999999999999999999999763211111134456788888876 8999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++||||++|++|.+++...+.+++..++.++.||+.||+|||+.|++||||+|+||+++.+|.++|+|||++....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 169 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM-- 169 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc--
Confidence 999999999999999999887789999999999999999999999999999999999999999999999999986421
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCH
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (316)
..........|++.|+|||++.+..++.. +|||||||++|+|++|..||.+.+..+....+.... ...+..+++
T Consensus 170 ----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 243 (345)
T 1xjd_A 170 ----LGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEK 243 (345)
T ss_dssp ----CTTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCH
T ss_pred ----cCCCcccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccCH
Confidence 11222345568999999999988777655 999999999999999999999999888888776543 333456899
Q ss_pred HHHHHHHHhc-CCCCCCCCHH-HHhhCCCCCCCC
Q psy11194 256 ECKELISNIL-SPVQTRPRLK-TIAEDRWLKPKP 287 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~-~il~~~~~~~~~ 287 (316)
++.+||.+|| .+|.+||++. ++++||||++..
T Consensus 244 ~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 244 EAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 9999999999 5999999998 999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=356.78 Aligned_cols=259 Identities=25% Similarity=0.460 Sum_probs=226.6
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
.....++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34567899999999999999999999999999999999965322111123456789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++||||++|++|.+++.+.+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||++.....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence 999999999999999998878899999999999999999999999999999999999999999999999999865321
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
......|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+..+. ...+..++.+
T Consensus 194 -------~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~ 264 (350)
T 1rdq_E 194 -------RTWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSD 264 (350)
T ss_dssp -------CBCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHH
T ss_pred -------CcccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHH
Confidence 1234568999999999988776655 999999999999999999999998888888876653 3445679999
Q ss_pred HHHHHHHhc-CCCCCCCC-----HHHHhhCCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPR-----LKTIAEDRWLKPK 286 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps-----~~~il~~~~~~~~ 286 (316)
+.++|.+|| .+|.+||+ ++++++||||++.
T Consensus 265 ~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 999999999 59999998 9999999999764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=353.98 Aligned_cols=260 Identities=32% Similarity=0.532 Sum_probs=218.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999999999999999986544322 245678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 159 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---- 159 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC----
Confidence 9999999999999887789999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcccCCCCCCCCCHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN--ELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
.........|++.|+|||++.+..+.+.++|||||||++|+|++|..||...... ............+....++.++.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 1122334568999999999988777665699999999999999999999765432 22233333333444467899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
+||.+|| .+|.+|||++++++||||+..
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 9999999 599999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=366.20 Aligned_cols=265 Identities=28% Similarity=0.460 Sum_probs=225.8
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|..++..++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 34567899999999999999999999999999999999975221111113457789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++||||++||+|.++++.. .+++..++.++.||+.||.|||+.|++||||||+||+++.+|.++|+|||++......
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~- 221 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE- 221 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC-
Confidence 99999999999999999864 5999999999999999999999999999999999999999999999999998653211
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---cCCCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPY---APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK---VTFPKQ 250 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~ 250 (316)
.........|++.|+|||++.+... .+.++|||||||++|+|++|..||.+.+..+....+... ..+|..
T Consensus 222 ----~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 222 ----GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp ----SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred ----CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 1112234568999999999976542 334599999999999999999999999988888887653 456666
Q ss_pred CCCCHHHHHHHHHhc-CCCCC--CCCHHHHhhCCCCCCCC
Q psy11194 251 PEVSTECKELISNIL-SPVQT--RPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~--Rps~~~il~~~~~~~~~ 287 (316)
..++.++++||.+|| .+|.+ ||++++|++||||++..
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 789999999999999 47877 99999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=344.56 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=213.9
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|.+..+++.||+|++........ ..+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT-HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCC-cchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 589999999999999999999999999999999976654333 3455669999999999999999999999999999999
Q ss_pred ecCCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||+++ +|.+.+ ...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~------~ 153 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG------I 153 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------S
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC------C
Confidence 99976 555555 446679999999999999999999999999999999999999999999999999986532 1
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhcccCCC-----------
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLP-FDDSSVNELLKQVQNKVTFP----------- 248 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~----------- 248 (316)
.........+++.|+|||++.+....+.++|||||||++|+|++|..| |.+.+..+....+......+
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 112233445789999999998776555569999999999999987766 66666666666553321111
Q ss_pred -----------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 249 -----------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 249 -----------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
..+.+++++++||.+|| .+|++|||++++++||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 11357899999999999 5999999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=361.01 Aligned_cols=259 Identities=30% Similarity=0.511 Sum_probs=223.9
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
-.++|++.+.||+|+||.||+|.+..+|+.+|+|++...... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 357899999999999999999999999999999999765543 3335567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC---CCCCeEEeeccccccccccc
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD---SDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~---~~~~~~l~Df~~~~~~~~~~ 176 (316)
||||++|++|.+.+...+.+++..+..++.||+.||.|||+.|++|+||||+||+++ .++.++|+|||++.....
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~-- 165 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-- 165 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT--
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC--
Confidence 999999999999998888899999999999999999999999999999999999998 467899999999965321
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC---CCCCCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT---FPKQPEV 253 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 253 (316)
.........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+..+.. .+....+
T Consensus 166 ----~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 166 ----EQQAWFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp ----TCCBCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred ----CCceeecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence 1122234568999999999988777665 9999999999999999999999998888888766432 2333578
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
++++.+||..|| .+|.+|||+.++++||||+..
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999999 599999999999999999643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=350.17 Aligned_cols=261 Identities=27% Similarity=0.471 Sum_probs=224.3
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch---HHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 35679999999999999999999999999999999976543221 124557799999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC----CeEEeeccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY----NIKLSDFGFARAH 172 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~----~~~l~Df~~~~~~ 172 (316)
.++||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999998888899999999999999999999999999999999999998877 7999999998754
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-CC--C
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-FP--K 249 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~--~ 249 (316)
.. ........+++.|+|||++.+..++.+ +||||||+++|+|++|..||.+....+....+..... ++ .
T Consensus 169 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (326)
T 2y0a_A 169 DF-------GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240 (326)
T ss_dssp CT-------TSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CC-------CCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc
Confidence 21 112234468999999999987766655 9999999999999999999998888777776654322 22 1
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
...++..+.+||..|| .+|.+|||++++++||||++...
T Consensus 241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 2568999999999999 59999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=360.82 Aligned_cols=257 Identities=35% Similarity=0.653 Sum_probs=217.5
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
...+|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++......++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45789999999999999999999999999999999865322111123457799999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||+ +++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~------ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT------ 159 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT------
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc------
Confidence 99999 67999999887889999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
.........|++.|+|||++.+..+.+.++||||||+++|+|++|..||.+.........+... ....+..+|+++.+
T Consensus 160 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 160 -DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQS 237 (336)
T ss_dssp -TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHH
T ss_pred -CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHH
Confidence 1222334568999999999988777666699999999999999999999875544433333222 23344568999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
||.+|| .+|.+|||++++++||||+.
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 999999 59999999999999999965
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=355.49 Aligned_cols=262 Identities=26% Similarity=0.457 Sum_probs=223.2
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 95 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 95 (316)
..+..++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+..|..++..+ +||+|+++++++...+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 445678999999999999999999999999999999999763221111234566899999888 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++||||++|++|.+++...+.+++..++.++.||+.||.|||+.|++||||+|+||+++.+|.++|+|||++....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 172 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-- 172 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc--
Confidence 999999999999999999887789999999999999999999999999999999999999999999999999986421
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCH
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (316)
..........|++.|+|||++.+..++.. +|||||||++|+|++|..||.+.+..+....+.... ...+..++.
T Consensus 173 ----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 246 (353)
T 2i0e_A 173 ----WDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSK 246 (353)
T ss_dssp ----CTTCCBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCH
T ss_pred ----cCCcccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCH
Confidence 11222344568999999999988777655 999999999999999999999998888887776542 334457999
Q ss_pred HHHHHHHHhc-CCCCCCCC-----HHHHhhCCCCCCC
Q psy11194 256 ECKELISNIL-SPVQTRPR-----LKTIAEDRWLKPK 286 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps-----~~~il~~~~~~~~ 286 (316)
++.+||.+|| .+|.+||+ ++++++||||++.
T Consensus 247 ~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 247 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 9999999999 59999994 6999999999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=346.12 Aligned_cols=265 Identities=27% Similarity=0.408 Sum_probs=216.4
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 3689999999999999999999999999999999866544 333455677999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|||+++++|..++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------ 154 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG------ 154 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC------
Confidence 99999999999998888899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc---------------
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV--------------- 245 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------- 245 (316)
.........++..|+|||++.+....+.++||||||+++|+|++|..||.+....+....+....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 11222334578899999999775554556999999999999999999999888776655543211
Q ss_pred -----CCCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCCh
Q psy11194 246 -----TFPK----------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGV 292 (316)
Q Consensus 246 -----~~~~----------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~ 292 (316)
..+. .+.++..+.+||..|| .+|.+|||++++++||||++..+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 297 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-----
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHHH
Confidence 1111 1458899999999999 599999999999999999987765443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=350.52 Aligned_cols=273 Identities=31% Similarity=0.538 Sum_probs=216.3
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.+++.++||||+++++++......+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 345779999999999999999999999999999999976432 345778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC---CCCeEEeecccccccccc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~---~~~~~l~Df~~~~~~~~~ 175 (316)
+||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~-- 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-- 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC--
Confidence 99999999999999988888999999999999999999999999999999999999975 7899999999986532
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcccC---CCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE-LLKQVQNKVT---FPKQP 251 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~~---~~~~~ 251 (316)
.........|++.|+|||++.+..++.+ +|||||||++|+|++|..||......+ ....+..... .+...
T Consensus 203 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 276 (349)
T 2w4o_A 203 -----HQVLMKTVCGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWD 276 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTT
T ss_pred -----cccccccccCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhh
Confidence 1122234568999999999988766655 999999999999999999997655443 4455544322 22335
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC-hhhHHHhHhHHHH
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG-VDKAEAELDHYID 304 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~-~~~~~~~~~~~~~ 304 (316)
.++.++.+||.+|| .+|++|||+.++++||||++...... ++...+++++|..
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 331 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNA 331 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSCCHHHHHHHHHHHH
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchhhhcchHHHHHHHHH
Confidence 78999999999999 59999999999999999998776544 5556666666643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=352.50 Aligned_cols=257 Identities=31% Similarity=0.562 Sum_probs=223.6
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++........ ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 5679999999999999999999999999999999976655433 345677999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC---CCeEEeecccccccccccC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD---YNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~---~~~~l~Df~~~~~~~~~~~ 177 (316)
|||++|++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~---- 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---- 182 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT----
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec----
Confidence 9999999999999888889999999999999999999999999999999999999765 459999999986532
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CCC--CCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TFP--KQPEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~ 254 (316)
.........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+..+. .++ .+..++
T Consensus 183 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (362)
T 2bdw_A 183 ---DSEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258 (362)
T ss_dssp ---TCCSCCCSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred ---CCcccccCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 1122334568999999999988766655 999999999999999999999988888887776543 222 224689
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
+++.+||.+|| .+|.+|||+.++++||||+..
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 99999999999 599999999999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=349.56 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=190.6
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC----e
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----R 96 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 96 (316)
.++|.+.+.||+|+||.||+|++ +|+.||||++.... ......+.|+..+..++||||+++++++..++ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 46799999999999999999986 48899999986532 11223345666667889999999999997654 5
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER--------GVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
.++||||+++|+|.++++.. .+++..+.+++.|++.||+|||+. +++||||||+|||++.++++||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 79999999999999999875 489999999999999999999987 899999999999999999999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCC-----CCCchhHHHHHHHHHHHHhCCCCCC----------C--
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY-----APHLSDIWSMGVVLFAMVFGRLPFD----------D-- 231 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~l~~g~~p~~----------~-- 231 (316)
++....... ..........||+.|+|||++.+... .+.++|||||||++|||+||..||. .
T Consensus 155 a~~~~~~~~--~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 155 AVRHDSATD--TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp CEEEETTTT--EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccCCCC--ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 976432211 11122334569999999999876421 2334999999999999999976553 1
Q ss_pred ---CCHHHHHHHHhcc-cCCCCCC-----CCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 232 ---SSVNELLKQVQNK-VTFPKQP-----EVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 232 ---~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
....+....+... .+++.+. ..+..+.+||.+|| .+|++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1233444444332 2222221 13357899999999 69999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=355.13 Aligned_cols=257 Identities=34% Similarity=0.611 Sum_probs=211.8
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
....++|++.+.||+|+||.||+|++..+++.||+|++...... .+.+.+|+.+++.++||||+++++++......
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 34578899999999999999999999999999999999765443 24467999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC--eEEeecccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN--IKLSDFGFARAHMRC 175 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~--~~l~Df~~~~~~~~~ 175 (316)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~-- 169 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-- 169 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc--
Confidence 999999999999999988778999999999999999999999999999999999999987665 9999999986321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHh-cccCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV----NELLKQVQ-NKVTFPKQ 250 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~~ 250 (316)
.........|++.|+|||++.+..+..+++|||||||++|+|++|..||.+... ......+. .....+..
T Consensus 170 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (361)
T 3uc3_A 170 -----LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT
T ss_pred -----ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc
Confidence 112223345899999999998877777668999999999999999999986432 33333333 33445555
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
..+++++.+||.+|| .+|.+|||++++++||||..
T Consensus 245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 678999999999999 59999999999999999944
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=354.58 Aligned_cols=262 Identities=21% Similarity=0.389 Sum_probs=221.5
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
...+..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 35567789999999999999999999999999999999987533211122345678999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++||||+.|++|..++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||++....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-- 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc--
Confidence 999999999999999999988889999999999999999999999999999999999999999999999999996532
Q ss_pred cCcCCCCCCCcccccccCccCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcccCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGI---PYAPHLSDIWSMGVVLFAMVFGRLPFDD---SSVNELLKQVQNKVTFPK 249 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~p~~~---~~~~~~~~~~~~~~~~~~ 249 (316)
.........|++.|+|||++... .++.. +|||||||++|+|++|..||.. ....+....+... ....
T Consensus 167 -----~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~ 239 (384)
T 4fr4_A 167 -----RETQITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVTY 239 (384)
T ss_dssp -----TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-CCCC
T ss_pred -----CCCceeccCCCccccCCeeeccCCCCCCCcc-ceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-ccCC
Confidence 22233455689999999998643 34444 9999999999999999999974 3344444444332 3444
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCC-HHHHhhCCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPR-LKTIAEDRWLKPK 286 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps-~~~il~~~~~~~~ 286 (316)
+..++.++.+||..|| .+|.+||+ ++++++||||++.
T Consensus 240 p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 240 PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 5679999999999999 59999998 9999999999764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=346.32 Aligned_cols=262 Identities=25% Similarity=0.398 Sum_probs=212.0
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
..-.++|++.+.||+|+||.||+|.+. +|+.||+|++....... .....+.+|+.+++.++||||+++++++..+...
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDE-GIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccc-hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 344678999999999999999999985 58899999996554322 2245567999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
++||||+++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~-- 171 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-- 171 (311)
T ss_dssp EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS--
T ss_pred EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC--
Confidence 999999976 888887654 4599999999999999999999999999999999999999999999999999865321
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-------
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK------- 249 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 249 (316)
.........+++.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+......+.
T Consensus 172 ----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 172 ----PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ----CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred ----CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 112223345789999999987755555569999999999999999999987665555544432111110
Q ss_pred ----------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 250 ----------------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 250 ----------------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+.+++++.+||.+|| .+|++|||++++++||||++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 1347889999999999 59999999999999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=347.17 Aligned_cols=264 Identities=23% Similarity=0.472 Sum_probs=216.4
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEc---cCCceEEEEEeecCCCC-chHHHhhHHHHHHHHhcCCCCCcceeeeE
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARST---RHSGDVAIKIVSKVQAP-PDYLKKFLPREIEVVKGLKHPNLIRFLQA 90 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~---~~~~~v~vK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 90 (316)
....+..++|++.+.||+|+||.||+|++. .+|+.+|+|++...... .......+.+|+.+++.++||||++++++
T Consensus 10 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 10 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp ---CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 345567889999999999999999999985 57889999999764321 11224456789999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 91 IETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 91 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
+...+..++||||++|++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||++.
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999999999887889999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ 250 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
.... .........|++.|+|||++.+..++.+ +||||||+++|+|++|..||.+.+..+....+.... ...+
T Consensus 170 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p 241 (327)
T 3a62_A 170 ESIH------DGTVTHTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLP 241 (327)
T ss_dssp ---------------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCC
T ss_pred cccc------CCccccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCC
Confidence 4321 1122234468999999999987766554 999999999999999999999988888777776542 3444
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 251 PEVSTECKELISNIL-SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
..++.++.++|.+|| .+|.+|| +++++++||||++.
T Consensus 242 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 242 PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 678999999999999 5999999 89999999999865
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=344.44 Aligned_cols=263 Identities=31% Similarity=0.594 Sum_probs=225.4
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
....++|++.+.||+|++|.||+|.+..++..+|+|++.............+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45678999999999999999999999999999999998654322222245677999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
++||||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~---- 160 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 160 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC----
Confidence 9999999999999999887789999999999999999999999999999999999999999999999999874421
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHH
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
........+++.|+|||.+.+...+.+ +||||||+++|+|++|..||......+....+... ....+..++..+
T Consensus 161 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (279)
T 3fdn_A 161 ----SSRRTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFVTEGA 234 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCCCTTSCHHH
T ss_pred ----cccccccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC-CCCCCCcCCHHH
Confidence 112233457899999999988776665 99999999999999999999998888877776554 334445689999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
.+||..|| .+|.+|||++++++||||++.....
T Consensus 235 ~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 235 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred HHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence 99999999 5999999999999999998766544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=350.88 Aligned_cols=256 Identities=21% Similarity=0.367 Sum_probs=221.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 578999999999999999999999999999999986432 2245677999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC--CCCeEEeecccccccccccC
Q psy11194 101 MEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS--DYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~--~~~~~l~Df~~~~~~~~~~~ 177 (316)
|||++|++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~--- 156 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--- 156 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC---
Confidence 9999999999999765 36999999999999999999999999999999999999987 78999999999865421
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC---CCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK---QPEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 254 (316)
........+++.|+|||++.+..++.+ +||||||+++|+|++|..||......+....+........ .+.+|
T Consensus 157 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T 1tki_A 157 ----GDNFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp ----TCEEEEEESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ----CCccccccCChhhcCcHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCC
Confidence 112233457899999999987665554 9999999999999999999999888888877765432222 24789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.++.+||..|| .+|.+|||+.++++||||+...+
T Consensus 232 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 99999999999 59999999999999999987643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=366.92 Aligned_cols=262 Identities=35% Similarity=0.643 Sum_probs=228.3
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
...+...+|.+.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34556789999999999999999999999999999999997542211122456789999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++||||++|++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~- 168 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 168 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc-
Confidence 9999999999999999998888899999999999999999999999999999999999999999999999999865321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCH
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (316)
........|++.|+|||++.+..+.+.++|||||||++|+|++|..||.+.........+..+. ...+..+++
T Consensus 169 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 241 (476)
T 2y94_A 169 ------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-FYTPQYLNP 241 (476)
T ss_dssp ------TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-CCCCTTCCH
T ss_pred ------cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-cCCCccCCH
Confidence 1223345689999999999887776666999999999999999999999888888777776653 344457899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
++.+||.+|| .+|.+|||++++++||||+.
T Consensus 242 ~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 9999999999 59999999999999999965
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=353.21 Aligned_cols=261 Identities=30% Similarity=0.530 Sum_probs=218.1
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHH-HhcCCCCCcceeeeEEEeCCe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV-VKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~ 96 (316)
.+..++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|..+ ++.++||||+++++++...+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4567889999999999999999999999999999999977544333233444566665 466899999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++||||++|++|.+++.+.+.+++..++.++.||+.||.|||+.|++||||||+||+++.+|.++|+|||++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~--- 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--- 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB---
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc---
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999986422
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
..........|++.|+|||++.+..++.. +|||||||++|+|++|..||.+.+..+....+.... ...+..++.+
T Consensus 191 ---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 265 (373)
T 2r5t_A 191 ---EHNSTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNS 265 (373)
T ss_dssp ---CCCCCCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-CCCCSSSCHH
T ss_pred ---cCCCccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHH
Confidence 11223345568999999999988776655 999999999999999999999998888887776542 3344679999
Q ss_pred HHHHHHHhc-CCCCCCCCH----HHHhhCCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRL----KTIAEDRWLKPK 286 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~----~~il~~~~~~~~ 286 (316)
+.+||.+|| .+|.+||++ +++++||||++.
T Consensus 266 ~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 999999999 599999987 699999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=361.97 Aligned_cols=264 Identities=26% Similarity=0.448 Sum_probs=222.7
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
.+..++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|..++..++||||+++++++.+.+..
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999753221111234477999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
++||||++||+|.+++.+ .+.+++..++.++.||+.||.|||+.|++||||||+|||++.+|.++|+|||++.....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~-- 227 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-- 227 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc--
Confidence 999999999999999987 56799999999999999999999999999999999999999999999999999865321
Q ss_pred CcCCCCCCCcccccccCccCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---cCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQ-----GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK---VTFP 248 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~ 248 (316)
..........|++.|+|||++. ...++ .++|||||||++|+|++|..||.+.+..+....+... ..+|
T Consensus 228 ---~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 228 ---DGTVQSSVAVGTPDYISPEILQAMEGGKGRYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp ---TSCEECCSCCSCGGGCCHHHHHHHHTSCCEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred ---CCCcccccccCCcCeeChHHHhhcccCCCCCC-CcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 1112223456899999999986 33344 4599999999999999999999999888888777542 3333
Q ss_pred CC-CCCCHHHHHHHHHhc-CCCCC--CCCHHHHhhCCCCCCCC
Q psy11194 249 KQ-PEVSTECKELISNIL-SPVQT--RPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 249 ~~-~~~~~~~~~li~~~l-~~p~~--Rps~~~il~~~~~~~~~ 287 (316)
.. ..+++++++||.+|| .+|+. ||+++++++||||++..
T Consensus 304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 33 468999999999999 46666 99999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=337.81 Aligned_cols=262 Identities=30% Similarity=0.544 Sum_probs=226.9
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|+||.||+|.+..+++.|++|++........ ..+.+.+|+.+++.++||||+++++++......++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHH-HHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 6789999999999999999999999999999999976654333 345677999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC---eEEeecccccccccccC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN---IKLSDFGFARAHMRCRS 177 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~---~~l~Df~~~~~~~~~~~ 177 (316)
|||+++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~---- 159 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---- 159 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc----
Confidence 999999999999988788999999999999999999999999999999999999986655 9999999986532
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc---CCCCCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV---TFPKQPEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 254 (316)
.........+++.|+|||++.+..++.+ +||||||+++|+|++|..||.+.........+.... ..+....++
T Consensus 160 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T 3kk8_A 160 ---DSEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235 (284)
T ss_dssp ---SSCBCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred ---cCccccCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccC
Confidence 1122233568899999999988777655 999999999999999999999988888887776543 223335789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
+++.++|..|| .+|.+|||++++++||||+..++...
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 273 (284)
T 3kk8_A 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS 273 (284)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence 99999999999 59999999999999999988766443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=360.04 Aligned_cols=265 Identities=26% Similarity=0.406 Sum_probs=222.4
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..++..++||+|+++++++.+.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 34567899999999999999999999999999999999975332222224557899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
.++||||++|++|.+++.+. ..+++..++.++.||+.||.|||+.|++||||||+||+++.+|.++|+|||++.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~- 214 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA- 214 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC-
Confidence 99999999999999999764 4799999999999999999999999999999999999999999999999999865321
Q ss_pred cCcCCCCCCCcccccccCccCcccccC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---c
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQG-------IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK---V 245 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~ 245 (316)
..........|++.|+|||++.. ..++ .++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 215 ----~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 215 ----DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYG-PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289 (412)
T ss_dssp ----TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred ----CCccccceeccccCcCCHHHHhhcccCcCCCCCC-hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc
Confidence 11112234568999999999862 3344 4599999999999999999999998888887777542 2
Q ss_pred CCCC-CCCCCHHHHHHHHHhcCCCCCC---CCHHHHhhCCCCCCCC
Q psy11194 246 TFPK-QPEVSTECKELISNILSPVQTR---PRLKTIAEDRWLKPKP 287 (316)
Q Consensus 246 ~~~~-~~~~~~~~~~li~~~l~~p~~R---ps~~~il~~~~~~~~~ 287 (316)
.++. ...+|+++++||.+||.+|.+| |+++++++||||++..
T Consensus 290 ~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 290 SLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp CCC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred CCCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCC
Confidence 3332 3579999999999999888887 6999999999997753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=341.45 Aligned_cols=265 Identities=25% Similarity=0.428 Sum_probs=224.8
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
.|...+.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.+++.++||||+++++++......++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888899999999999999999999999999997654432 3456799999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCC
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADN 182 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~ 182 (316)
|+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 123 ~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~------~~ 195 (321)
T 2c30_A 123 FLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK------DV 195 (321)
T ss_dssp CCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS------SS
T ss_pred cCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc------Cc
Confidence 99999999998754 599999999999999999999999999999999999999999999999999865321 11
Q ss_pred CCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC--CCCCCCCHHHHHH
Q psy11194 183 SLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF--PKQPEVSTECKEL 260 (316)
Q Consensus 183 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 260 (316)
.......|++.|+|||++.+..++.+ +||||||+++|+|++|..||......+....+...... .....+++++.++
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 274 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDF 274 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHH
T ss_pred cccccccCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHH
Confidence 12234568999999999988766665 99999999999999999999988888877777655432 2234589999999
Q ss_pred HHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHh
Q psy11194 261 ISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAE 298 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~ 298 (316)
|.+|| .+|++|||++++++||||+..........+.+.
T Consensus 275 i~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~~~ 313 (321)
T 2c30_A 275 LERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQL 313 (321)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGGGCCCGGGGHHHHHH
T ss_pred HHHHccCChhhCcCHHHHhcChhhccCCCcccchHHHHH
Confidence 99999 599999999999999999876654444333333
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=343.43 Aligned_cols=264 Identities=25% Similarity=0.450 Sum_probs=226.7
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch---HHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 35679999999999999999999999999999999976543321 124557799999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC----CeEEeeccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY----NIKLSDFGFARAH 172 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~----~~~l~Df~~~~~~ 172 (316)
.++||||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999999999888899999999999999999999999999999999999999887 7999999998653
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC---
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK--- 249 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 249 (316)
.. ........+++.|+|||++.+..++.+ +||||||+++|+|++|..||.+....+....+........
T Consensus 170 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (321)
T 2a2a_A 170 ED-------GVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241 (321)
T ss_dssp CT-------TCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred Cc-------cccccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh
Confidence 21 122234458899999999987766655 9999999999999999999999888888777765432211
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
...++..+.++|..|| .+|.+|||++++++||||++......
T Consensus 242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~~ 284 (321)
T 2a2a_A 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284 (321)
T ss_dssp HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHHH
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcccc
Confidence 2568999999999999 59999999999999999998765443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=351.50 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=221.2
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|+||.||+|.+..+|+.+|+|++..... .....+.+|+.+++.++||||+++++++......++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4679999999999999999999999999999999865432 2244677999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC--CCCeEEeecccccccccccC
Q psy11194 101 MEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS--DYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~--~~~~~l~Df~~~~~~~~~~~ 177 (316)
|||++|++|.+++.... .+++..++.++.||+.||.|||+.|++|+||+|+||+++. .+.++|+|||++.....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~--- 203 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--- 203 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC---
Confidence 99999999999997643 6999999999999999999999999999999999999974 47799999999875321
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc---CCCCCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV---TFPKQPEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 254 (316)
........+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+.... .......++
T Consensus 204 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 204 ----DEIVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp ----TSCEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred ----CcceeeeccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence 122233468999999999988766655 999999999999999999999988887777765532 222335689
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
+++.+||..|| .+|.+|||++++++||||++....
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCccc
Confidence 99999999999 599999999999999999876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=343.21 Aligned_cols=260 Identities=29% Similarity=0.558 Sum_probs=215.1
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc-----------------------hHHHhhHHHHHH
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP-----------------------DYLKKFLPREIE 74 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~-----------------------~~~~~~~~~e~~ 74 (316)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 345689999999999999999999999999999999997643211 111355779999
Q ss_pred HHhcCCCCCcceeeeEEEe--CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCC
Q psy11194 75 VVKGLKHPNLIRFLQAIET--THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCEN 152 (316)
Q Consensus 75 ~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~n 152 (316)
+++.++||||+++++++.. ....++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.|++|+||+|+|
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 9999999999999999986 6689999999999999886543 469999999999999999999999999999999999
Q ss_pred eeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCC
Q psy11194 153 LLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY--APHLSDIWSMGVVLFAMVFGRLPFD 230 (316)
Q Consensus 153 il~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~p~~ 230 (316)
|+++.++.++|+|||++...... ........+++.|+|||++.+... .+.++||||||+++|+|++|..||.
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGS------DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSS------SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEECCCCCEEEecCCCccccccc------cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999998754211 112234468999999999876543 3455899999999999999999999
Q ss_pred CCCHHHHHHHHhcc-cCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCC
Q psy11194 231 DSSVNELLKQVQNK-VTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 231 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~ 284 (316)
..........+... ..++....+++++.++|.+|| .+|++|||+.++++||||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp CSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred CccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 88887776666543 345555679999999999999 5999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=362.59 Aligned_cols=262 Identities=30% Similarity=0.503 Sum_probs=217.4
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 34556789999999999999999999999999999999975422222223445689999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
.++||||+++++|..++...+.+++..++.++.||+.||+|||+ .|++|+||+|+||+++.++.++|+|||++....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~-- 300 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-- 300 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC--
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc--
Confidence 99999999999999999888889999999999999999999998 999999999999999999999999999986421
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCH
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (316)
..........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+.... ...+..+++
T Consensus 301 ----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~ 374 (446)
T 4ejn_A 301 ----KDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGP 374 (446)
T ss_dssp ----C-----CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCH
T ss_pred ----CCCcccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCH
Confidence 11222334568999999999988777655 999999999999999999999988888877775542 334457999
Q ss_pred HHHHHHHHhc-CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 256 ECKELISNIL-SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
++.+||..|| .+|.+|| +++++++||||++.
T Consensus 375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 9999999999 5999999 99999999999876
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=345.09 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=203.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
..+|++.+.||+|+||.||+|.+..+|+.||+|++........ .+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--PSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS--CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc--HHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 5689999999999999999999999999999999976543221 34566899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 101 MEYAENGSLFDIIRGQ------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
|||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999975 999998642 3599999999999999999999999999999999999999999999999999865321
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC------
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP------ 248 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 248 (316)
.........+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 161 ------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 161 ------PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp ------CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred ------CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence 11122344578999999999775544556999999999999999999999988777766653311100
Q ss_pred ---------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 249 ---------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 249 ---------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
....++.++.+||.+|| .+|++|||++++++||||++......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 305 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS 305 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence 11257889999999999 59999999999999999988766544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=354.22 Aligned_cols=271 Identities=23% Similarity=0.385 Sum_probs=217.8
Q ss_pred ceeeccCeEEeeeeeec--CCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 17 TVLESHGYTVGKIIGTG--SYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g--~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
......+|++.+.||+| +||.||+|++..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 34467889999999999 99999999999999999999997755433 3456688999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999999999764 66999999999999999999999999999999999999999999999999988654
Q ss_pred ccccCc-CCCCCCCcccccccCccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc----
Q psy11194 173 MRCRSN-AADNSLSETFCGSYAYASPEILQG--IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV---- 245 (316)
Q Consensus 173 ~~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---- 245 (316)
...... ...........+++.|+|||++.+ ..++. ++|||||||++|+|++|..||.+....+....+..+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCc-HhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 322111 111122233468889999999977 34444 4999999999999999999998654433332221110
Q ss_pred -----------------------------------------CCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 246 -----------------------------------------TFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 246 -----------------------------------------~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
..+....+++++.+||.+|| .+|++|||++++++||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 11123457899999999999 599999999999999999
Q ss_pred CCCCCC
Q psy11194 284 KPKPKS 289 (316)
Q Consensus 284 ~~~~~~ 289 (316)
+.....
T Consensus 338 ~~~~~~ 343 (389)
T 3gni_B 338 KQIKRR 343 (389)
T ss_dssp GGC---
T ss_pred HHHhhc
Confidence 887653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=346.66 Aligned_cols=263 Identities=26% Similarity=0.366 Sum_probs=211.5
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
.....++|++.+.||+|+||.||+|.+..+++.||+|++........ ..+.+.+|+.+++.++||||+++++++.....
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG-VPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc-cchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 34456789999999999999999999999999999999976543322 23445689999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC-----CCCCeEEeecccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD-----SDYNIKLSDFGFARA 171 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~-----~~~~~~l~Df~~~~~ 171 (316)
.++||||+++ +|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++ ..+.++|+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999975 9999999888899999999999999999999999999999999999994 445599999999865
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC-
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ- 250 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 250 (316)
... .........+++.|+|||++.+....+.++|||||||++|+|++|..||......+....+......+..
T Consensus 187 ~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 187 FGI------PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HC-----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cCC------cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 421 1112233457889999999987665555699999999999999999999988877766665443222211
Q ss_pred ----------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 251 ----------------------------PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 251 ----------------------------~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
..+++++.+||.+|| .+|.+|||++++++||||++..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 116899999999999 5999999999999999998764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=353.77 Aligned_cols=266 Identities=24% Similarity=0.450 Sum_probs=209.3
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCC--e
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH--R 96 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~ 96 (316)
..++|++.+.||+|+||.||+|.+..+|+.||+|++......... .+.+.+|+.++..+. ||||+++++++..++ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD-AQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHH-HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHH-HHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 357899999999999999999999999999999998655443333 444568999999997 999999999997544 7
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++||||+++ +|..+++.. .+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||+++......
T Consensus 86 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 86 VYLVFDYMET-DLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEEEECCSE-EHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEecccCc-CHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 8999999975 999999874 59999999999999999999999999999999999999999999999999997643211
Q ss_pred Cc---------------CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy11194 177 SN---------------AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV 241 (316)
Q Consensus 177 ~~---------------~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~ 241 (316)
.. ...........+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 10 011122334578999999999987555555699999999999999999999998887777666
Q ss_pred hcccCCCC----------------------------------------------CCCCCHHHHHHHHHhc-CCCCCCCCH
Q psy11194 242 QNKVTFPK----------------------------------------------QPEVSTECKELISNIL-SPVQTRPRL 274 (316)
Q Consensus 242 ~~~~~~~~----------------------------------------------~~~~~~~~~~li~~~l-~~p~~Rps~ 274 (316)
......|. ...+++++.+||.+|| .+|.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 44322221 1267899999999999 599999999
Q ss_pred HHHhhCCCCCCCCC
Q psy11194 275 KTIAEDRWLKPKPK 288 (316)
Q Consensus 275 ~~il~~~~~~~~~~ 288 (316)
+++++||||+....
T Consensus 324 ~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 324 NDALKHPFVSIFHN 337 (388)
T ss_dssp HHHTTSTTTTTTCC
T ss_pred HHHhCCHHHHHhcC
Confidence 99999999977654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=339.42 Aligned_cols=277 Identities=25% Similarity=0.399 Sum_probs=236.3
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
...+.|++.+.||+|+||.||+|.+..+++.|++|++........ .+.+.+|+.+++.++||||+++++++......+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH--HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 346779999999999999999999999999999999976544322 456779999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+||||+++++|.+++.. +.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 172 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--- 172 (303)
T ss_dssp EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT---
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc---
Confidence 99999999999999976 45999999999999999999999999999999999999999999999999998654221
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
........+++.|+|||++.+..++.+ +||||||+++|+|++|..||...........+...........++..+.
T Consensus 173 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 248 (303)
T 3a7i_A 173 ---QIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLK 248 (303)
T ss_dssp ---BCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHH
T ss_pred ---ccccCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHH
Confidence 112233457889999999988776665 9999999999999999999999888887777766665566678999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC-ChhhHHHhHhHHHHH
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR-GVDKAEAELDHYIDM 305 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 305 (316)
++|..|| .+|.+|||++++++||||....... ......+++++|...
T Consensus 249 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (303)
T 3a7i_A 249 EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAE 297 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCGGGGHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHhhChhhhcCCCccHHHHHHHHHHHHhhhh
Confidence 9999999 5999999999999999996554433 366666666666543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=341.16 Aligned_cols=263 Identities=25% Similarity=0.376 Sum_probs=209.8
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc--hHHHhhHHHHHHHHhcC---CCCCcceeeeEE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP--DYLKKFLPREIEVVKGL---KHPNLIRFLQAI 91 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~ 91 (316)
..+..++|++.+.||+|+||.||+|++..+++.||+|++....... ......+.+|+.+++.+ +||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 3456789999999999999999999999999999999997543211 11122344677766666 499999999999
Q ss_pred EeCC-----eEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEe
Q psy11194 92 ETTH-----RVYIIMEYAENGSLFDIIRGQGY--IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLS 164 (316)
Q Consensus 92 ~~~~-----~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~ 164 (316)
.... ..++|||++.+ +|.+++..... +++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 7755 58999999965 99999987543 9999999999999999999999999999999999999999999999
Q ss_pred ecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Q psy11194 165 DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK 244 (316)
Q Consensus 165 Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (316)
|||++.... .........+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+....+....+...
T Consensus 163 Dfg~a~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 163 DFGLARIYS-------YQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp SCSCTTTST-------TCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred eCccccccC-------CCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999986532 2222344568999999999988777666 99999999999999999999998888777666442
Q ss_pred cCCCC--------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 245 VTFPK--------------------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 245 ~~~~~--------------------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
...+. .+.+++++.+||.+|| .+|.+|||+.++++||||+...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 21111 1357899999999999 59999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=339.00 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=209.7
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|.+ .+|+.+|+|++...... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 5899999999999999999998 67889999998654322 212345668999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||+++ +|.+++... +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------ 152 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI------ 152 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc------
Confidence 99976 999998763 5699999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC------------
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP------------ 248 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 248 (316)
.........+++.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+......+
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 11112234578999999999765545556999999999999999999999887766655543211000
Q ss_pred ----------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 249 ----------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 249 ----------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
....+++++.+||.+|| .+|++|||++++++||||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 11357899999999999 599999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=338.61 Aligned_cols=263 Identities=36% Similarity=0.645 Sum_probs=219.1
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..++|.+.+.||+|++|.||+|.+..+|+.|++|++...........+.+.+|+.+++.++||||+++++++.....
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 44567899999999999999999999999999999999865322111223457799999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++||||+++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~-- 163 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-- 163 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC--
Confidence 999999999999999998877899999999999999999999999999999999999999999999999999865321
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
........+++.|+|||.+.+....+.++||||||+++|+|++|..||.........+.+.... ...+..++.+
T Consensus 164 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (276)
T 2h6d_A 164 -----GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRS 237 (276)
T ss_dssp ------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHH
T ss_pred -----CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHH
Confidence 1122334578899999999887665556999999999999999999999988888877776553 3344568999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
+.++|.+|| .+|.+|||++++++||||+..-
T Consensus 238 l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 999999999 5999999999999999997543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=336.42 Aligned_cols=258 Identities=31% Similarity=0.538 Sum_probs=223.0
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|+||.||+|.+..++..+++|.+....... .+.+.+|+.+++.++||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 567999999999999999999999999999999997654433 44577999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee---CCCCCeEEeecccccccccccC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL---DSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~---~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
|||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~---- 160 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK---- 160 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc----
Confidence 9999999999999888889999999999999999999999999999999999999 778899999999986532
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC---CCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ---PEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 254 (316)
.........+++.|+|||++.+. ++.+ +||||||+++|+|++|..||......+....+..+...... ..++
T Consensus 161 ---~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T 3f3z_A 161 ---PGKMMRTKVGTPYYVSPQVLEGL-YGPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVS 235 (277)
T ss_dssp ---TTSCBCCCCSCTTTCCHHHHTTC-BCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred ---CccchhccCCCCCccChHHhccc-CCch-hhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCC
Confidence 12223344588999999998764 4444 99999999999999999999998888887777665332221 3689
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
+++.++|.+|| .+|.+|||+.++++||||++.....
T Consensus 236 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~ 272 (277)
T 3f3z_A 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence 99999999999 5999999999999999997655443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=366.29 Aligned_cols=262 Identities=31% Similarity=0.548 Sum_probs=226.6
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
..-.++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34567899999999999999999999999999999999766544333356678999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee---CCCCCeEEeeccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL---DSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~---~~~~~~~l~Df~~~~~~~~ 174 (316)
++||||+.+++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999999999888889999999999999999999999999999999999999 4678899999999865321
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC---CCCCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT---FPKQP 251 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 251 (316)
........|++.|+|||++.+ .++. ++|||||||++|+|++|..||.+.+..+....+..+.. .+.+.
T Consensus 182 -------~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 252 (484)
T 3nyv_A 182 -------SKKMKDKIGTAYYIAPEVLHG-TYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK 252 (484)
T ss_dssp -------CCSHHHHTTGGGTCCHHHHHT-CCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGG
T ss_pred -------ccccccCCCCccccCceeecC-CCCC-cceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence 122233458999999999876 4444 59999999999999999999999999888888866532 23335
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.+|+++.+||.+|| .+|.+|||++++++||||+....
T Consensus 253 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 253 KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 68999999999999 59999999999999999976543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=350.36 Aligned_cols=276 Identities=25% Similarity=0.470 Sum_probs=221.4
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCC--CchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA--PPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
-.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35689999999999999999999999999999999864211 1111145577999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC---eEEeeccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN---IKLSDFGFAR 170 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~---~~l~Df~~~~ 170 (316)
++||||++|++|.+.+.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 999999999999888753 235899999999999999999999999999999999999986654 9999999987
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CCC-
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TFP- 248 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~- 248 (316)
.... .........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.. .+....+..+. ..+
T Consensus 182 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~ 253 (351)
T 3c0i_A 182 QLGE------SGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP 253 (351)
T ss_dssp ECCT------TSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH
T ss_pred EecC------CCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc
Confidence 5421 1122334568999999999988776655 999999999999999999998754 44444444332 222
Q ss_pred -CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC---CCChhhHHHhHhHHH
Q psy11194 249 -KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK---SRGVDKAEAELDHYI 303 (316)
Q Consensus 249 -~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~---~~~~~~~~~~~~~~~ 303 (316)
....++.++.+||.+|| .+|.+|||+.++++||||+.... ........++++++.
T Consensus 254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~ 313 (351)
T 3c0i_A 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFN 313 (351)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHH
Confidence 12568999999999999 59999999999999999986432 222334455555554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=334.95 Aligned_cols=264 Identities=32% Similarity=0.523 Sum_probs=220.6
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|++|.||+|.+..+++.|++|++....... ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 367999999999999999999999999999999997654332 245677999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---- 159 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---- 159 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc----
Confidence 9999999999999877789999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhc-ccCCCCCCCCCHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN-ELLKQVQN-KVTFPKQPEVSTECK 258 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~ 258 (316)
.........+++.|+|||.+.+..+.+.++||||||+++|+|++|..||...... .....+.. ....+....++..+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 1112234457889999999988776555699999999999999999999765432 22223322 223333456899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
++|..|| .+|.+|||++++++||||+...+..
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 272 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKG 272 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred HHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence 9999999 5999999999999999998776543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=348.43 Aligned_cols=279 Identities=25% Similarity=0.382 Sum_probs=218.1
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 57999999999999999999999999999999986543221 1223447999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~------ 152 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI------ 152 (324)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC------
Confidence 99975 898888764 4599999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-----------
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK----------- 249 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 249 (316)
.........+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 112223345789999999987755555569999999999999999999999888877766654222111
Q ss_pred ------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC---hhhHHHhHhHHHHHhh
Q psy11194 250 ------------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG---VDKAEAELDHYIDMIQ 307 (316)
Q Consensus 250 ------------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 307 (316)
.+.+++++.+||.+|| .+|.+|||++++++||||++..+... -......++.+..+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~q~~ 312 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKE 312 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTCCCCC-
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHHHhhhh
Confidence 1357889999999999 59999999999999999987765433 2333444444444443
Q ss_pred cc
Q psy11194 308 TS 309 (316)
Q Consensus 308 ~~ 309 (316)
.+
T Consensus 313 ~~ 314 (324)
T 3mtl_A 313 AS 314 (324)
T ss_dssp --
T ss_pred hh
Confidence 33
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=334.94 Aligned_cols=264 Identities=24% Similarity=0.466 Sum_probs=229.5
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
...++|.+.+.||+|+||.||+|.+..+++.+++|++...........+.+.+|+.+++.++||||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34678999999999999999999999999999999998765555555667889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+||||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~---- 167 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY---- 167 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc----
Confidence 9999999999999998877899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
.........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||......+....+... ....+..++..+.
T Consensus 168 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 243 (294)
T 2rku_A 168 --DGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSIPKHINPVAA 243 (294)
T ss_dssp --TTCCBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCCCTTSCHHHH
T ss_pred --CccccccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-cCCCccccCHHHH
Confidence 1112233457889999999987766655 99999999999999999999988877776666554 2344567899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
++|.+|| .+|++|||++++++||||+......
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 9999999 5999999999999999997765433
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=338.80 Aligned_cols=261 Identities=32% Similarity=0.611 Sum_probs=225.1
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
.+..++|.+.+.||+|++|.||+|.+..+++.|++|++...........+.+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 45678899999999999999999999999999999998653222222235577999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
++||||+++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~--- 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--- 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS---
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc---
Confidence 99999999999999998877899999999999999999999999999999999999999999999999998854221
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHH
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
.......+++.|+|||++.+..++.+ +||||||+++|+|++|..||......+....+... ....+..++.++
T Consensus 167 -----~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (284)
T 2vgo_A 167 -----LRRRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKFPPFLSDGS 239 (284)
T ss_dssp -----SCBCCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCCCTTSCHHH
T ss_pred -----cccccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-ccCCCCcCCHHH
Confidence 11233457899999999988777666 99999999999999999999988877777666543 234446789999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.++|..|| .+|.+|||++++++||||+....
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 99999999 59999999999999999975443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=345.78 Aligned_cols=258 Identities=30% Similarity=0.495 Sum_probs=218.4
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch-----HHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD-----YLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.++|++.+.||+|+||.||+|++..+++.||+|++........ ...+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4689999999999999999999999999999999987543221 12345668999999999999999999999999
Q ss_pred eEEEEEecCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 96 RVYIIMEYAENG-SLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 96 ~~~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
..++||||+.++ +|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~- 181 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE- 181 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC-
Confidence 999999998766 999999988889999999999999999999999999999999999999999999999999986532
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
.........|++.|+|||++.+..+.+.++||||||+++|+|++|..||..... ... .....+..++
T Consensus 182 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~--~~~~~~~~~~ 248 (335)
T 3dls_A 182 ------RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----TVE--AAIHPPYLVS 248 (335)
T ss_dssp ------TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----GTT--TCCCCSSCCC
T ss_pred ------CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----HHh--hccCCCcccC
Confidence 122233455899999999998877766669999999999999999999976321 111 1223344689
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCCh
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGV 292 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~ 292 (316)
+++.+||..|| .+|.+|||++++++||||+......+.
T Consensus 249 ~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~ 287 (335)
T 3dls_A 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADY 287 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCCGGGC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCccccCCcccccc
Confidence 99999999999 599999999999999999876654443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=333.66 Aligned_cols=255 Identities=28% Similarity=0.511 Sum_probs=213.0
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|.+.+.||+|+||.||+|.+..++..+++|++........ .+.+.+|+.+++.++||||+++++++......++
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 35789999999999999999999999999999999976543322 4567799999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee---CCCCCeEEeeccccccc
Q psy11194 100 IMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL---DSDYNIKLSDFGFARAH 172 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~---~~~~~~~l~Df~~~~~~ 172 (316)
||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999999853 3679999999999999999999999999999999999999 45578999999998653
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC--CCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF--PKQ 250 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 250 (316)
.. ........+++.|+|||++.+ .++ .++||||||+++|+|++|..||.+....+........... ...
T Consensus 178 ~~-------~~~~~~~~~t~~y~aPE~~~~-~~~-~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (285)
T 3is5_A 178 KS-------DEHSTNAAGTALYMAPEVFKR-DVT-FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248 (285)
T ss_dssp ----------------CTTGGGCCHHHHTT-CCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--
T ss_pred CC-------cccCcCcccccCcCChHHhcc-CCC-cccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc
Confidence 21 122334458899999999864 344 4599999999999999999999998888777666443222 122
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
..+++++.+||.+|| .+|++|||++++++||||+.
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 458999999999999 59999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=361.51 Aligned_cols=260 Identities=29% Similarity=0.546 Sum_probs=221.6
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ ....+.+|+.+++.++||||+++++++......++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 5789999999999999999999999999999999865322111 134577999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC---CCCCeEEeecccccccccccC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD---SDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~---~~~~~~l~Df~~~~~~~~~~~ 177 (316)
|||+++++|.+.+...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++ .++.++|+|||++....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 175 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---- 175 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC----
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC----
Confidence 99999999999998878899999999999999999999999999999999999995 45679999999986532
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc---CCCCCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV---TFPKQPEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 254 (316)
.........|++.|+|||++.+. ++ .++|||||||++|+|++|..||.+....+....+..+. ..+.+..+|
T Consensus 176 ---~~~~~~~~~gt~~y~aPE~~~~~-~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 176 ---QNTKMKDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp ---CC----CCTTGGGGCCGGGGGSC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred ---CCCccCCCcCCCCCCCHHHhCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 12223344689999999998763 44 45999999999999999999999999888888876653 223345689
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
+++.+||..|| .+|.+|||+.++++||||+......
T Consensus 251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~ 287 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287 (486)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence 99999999999 5999999999999999998776554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=342.90 Aligned_cols=271 Identities=23% Similarity=0.356 Sum_probs=227.8
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|.+.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999999999999999999876555555556678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|||+.| +|.+++. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 133 ~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 133 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 999975 8888875 456799999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCcccccccCccCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-CCCCCCCCH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQ---GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-FPKQPEVST 255 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 255 (316)
.....+++.|+|||++. ...++. ++|||||||++|+|++|..||.+.+.......+..... ......+++
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~-~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 280 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Confidence 12345889999999984 334444 59999999999999999999998877766655544432 333456899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHhHHH
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYI 303 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (316)
.+.++|..|| .+|++|||++++++||||........+....++.++..
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~ 329 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 329 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcchhhHHHHHHHHHH
Confidence 9999999999 59999999999999999988777666655555555443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=340.54 Aligned_cols=264 Identities=24% Similarity=0.468 Sum_probs=229.3
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|.+.+.||+|+||.||+|.+..+++.+++|++...........+.+.+|+.+++.++||||+++++++...+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 45789999999999999999999999999999999987655555556778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~----- 193 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY----- 193 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS-----
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc-----
Confidence 999999999999998877899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
.........++..|+|||++.+..++.+ +||||||+++|+|++|..||......+....+... ....+..++.++.+
T Consensus 194 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 270 (335)
T 2owb_A 194 -DGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSIPKHINPVAAS 270 (335)
T ss_dssp -TTCCBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCCCTTSCHHHHH
T ss_pred -CcccccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-CCCCCccCCHHHHH
Confidence 1122233458899999999987766555 99999999999999999999988877776666543 23344578999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
+|.+|| .+|++|||++++++||||+.......
T Consensus 271 li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~ 303 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 303 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred HHHHHccCChhHCcCHHHHhcCccccCCCcccc
Confidence 999999 59999999999999999987654433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=336.21 Aligned_cols=260 Identities=29% Similarity=0.531 Sum_probs=195.9
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|+||.||+|.+..+|+.|++|++...........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999999999999999999653222112235577999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 101 MEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~---- 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP---- 165 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC----
Confidence 9999999999999864 56999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...........+... ....+..++.++.+
T Consensus 166 --~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 241 (278)
T 3cok_A 166 --HEKHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSFLSIEAKD 241 (278)
T ss_dssp ----------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCCTTSCHHHHH
T ss_pred --CCcceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCccccCHHHHH
Confidence 111223457889999999987766665 99999999999999999999876544444333221 23344568999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+|.+|| .+|.+|||++++++||||+....
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence 999999 59999999999999999987554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=336.58 Aligned_cols=282 Identities=24% Similarity=0.353 Sum_probs=224.4
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
......++|++.+.||+|+||.||+|.+..+|+.|++|.+..... .+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 23 LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp -------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred hhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 344557889999999999999999999999999999999976443 344678999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
..++||||+++++|.+++. ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999999999999997 456799999999999999999999999999999999999999999999999999865421
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--CCCCCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--FPKQPE 252 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 252 (316)
. ........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...........+..... ...+..
T Consensus 178 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T 3com_A 178 T------MAKRNTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL 250 (314)
T ss_dssp T------BSCBCCCCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred h------ccccCccCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCccc
Confidence 1 112233457889999999988777766 9999999999999999999998877766555544322 223345
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHhHHHHHhhcc
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMIQTS 309 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (316)
++..+.++|..|| .+|.+|||+.++++||||+..+.........++.....-.-+.+
T Consensus 251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (314)
T 3com_A 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQES 308 (314)
T ss_dssp SCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGGHHHHHHHC---------
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchHHHHHhhhhhhhhhhhhhh
Confidence 7999999999999 59999999999999999999888777766666655554443333
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=356.42 Aligned_cols=264 Identities=29% Similarity=0.515 Sum_probs=222.7
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch----------HHHhhHHHHHHHHhcCCCCCcce
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD----------YLKKFLPREIEVVKGLKHPNLIR 86 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~ 86 (316)
.....++|.+.+.||+|+||.||+|.+..+++.+|+|++........ ...+.+.+|+.+++.++||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 33456889999999999999999999999999999999976543211 22456779999999999999999
Q ss_pred eeeEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC---CeEE
Q psy11194 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY---NIKL 163 (316)
Q Consensus 87 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~---~~~l 163 (316)
+++++......++||||++|++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999999999998878899999999999999999999999999999999999998776 6999
Q ss_pred eecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy11194 164 SDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN 243 (316)
Q Consensus 164 ~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~ 243 (316)
+|||++.... .........|++.|+|||++.+ .++. ++|||||||++|+|++|..||.+....+....+..
T Consensus 191 ~Dfg~a~~~~-------~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 191 VDFGLSSFFS-------KDYKLRDRLGTAYYIAPEVLKK-KYNE-KCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp CCCTTCEECC-------TTSCBCCCCSCTTTCCHHHHTT-CBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EECCCCEEcC-------CCCccccccCCcCCCCHHHhcc-CCCc-hHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 9999996532 1222334568999999999875 4444 59999999999999999999999999988888876
Q ss_pred ccCCC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 244 KVTFP---KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 244 ~~~~~---~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
+.... .+..+|+++.+||..|| .+|.+|||++++++||||+.....
T Consensus 262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence 54322 23578999999999999 599999999999999999876554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=334.54 Aligned_cols=257 Identities=29% Similarity=0.532 Sum_probs=220.9
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|.+.+.||+|+||.||+|++..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 3578999999999999999999999999999999997543322 3457799999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee---CCCCCeEEeeccccccccccc
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL---DSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~---~~~~~~~l~Df~~~~~~~~~~ 176 (316)
||||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~--- 160 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--- 160 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC---
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC---
Confidence 99999999999999887789999999999999999999999999999999999999 678899999999885421
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC---CCCCCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT---FPKQPEV 253 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 253 (316)
........+++.|+|||++.+..++.+ +||||||+++|+|++|..||...........+..+.. .+....+
T Consensus 161 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (304)
T 2jam_A 161 -----NGIMSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDI 234 (304)
T ss_dssp -----CBTTHHHHSCCCBCCTTTBSSCSCCHH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTS
T ss_pred -----CCccccccCCCCccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccC
Confidence 112233457899999999987666655 9999999999999999999999888888777766532 2233578
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
++++.++|..|| .+|++|||++++++||||++...
T Consensus 235 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 235 SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 999999999999 59999999999999999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=332.54 Aligned_cols=262 Identities=25% Similarity=0.376 Sum_probs=218.1
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++..++||||+++++++...+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 45568899999999999999999999999999999999977666666666778899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++||||++|++|.+++...+++++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 163 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-- 163 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc--
Confidence 999999999999999999888899999999999999999999999999999999999999999999999999865321
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC----CCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP----KQPE 252 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~ 252 (316)
..........|++.|+|||.+.+..++.+ +||||||+++|+|++|..||.+....+............ ....
T Consensus 164 ---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T 4eqm_A 164 ---TSLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTT
T ss_pred ---ccccccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccC
Confidence 11122233458999999999988777665 999999999999999999999887766554443332211 2356
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~ 284 (316)
+|+.+.++|.+|| .+|.+||+..+.+.+.|..
T Consensus 240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 8999999999999 6999999655555555543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=335.12 Aligned_cols=273 Identities=21% Similarity=0.363 Sum_probs=221.6
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
.....++|++.+.||+|+||.||+|.+..+++.+++|++....... .+.+.+|+.++..++||||+++++++...+.
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC---HHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH---HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 3445778999999999999999999999999999999986543322 3456689999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
.++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999999865 456999999999999999999999999999999999999999999999999987542211
Q ss_pred cCcCCCCCCCcccccccCccCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC--CC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQ----GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF--PK 249 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~ 249 (316)
. .......+++.|+|||++. .....+.++||||||+++|+|++|..||...+.......+...... ..
T Consensus 171 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T 2j7t_A 171 L------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT 244 (302)
T ss_dssp H------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS
T ss_pred c------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCC
Confidence 1 1112335788999999983 2233344599999999999999999999988877776666544322 23
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHh
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAE 298 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~ 298 (316)
+..++.++.++|..|| .+|.+|||++++++||||+.......+.+..++
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~ 294 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAE 294 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccchhHHHHHHH
Confidence 4568999999999999 599999999999999999998876554444443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=340.12 Aligned_cols=255 Identities=31% Similarity=0.546 Sum_probs=196.5
Q ss_pred cCeEEe---eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeE
Q psy11194 22 HGYTVG---KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRV 97 (316)
Q Consensus 22 ~~y~~~---~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 97 (316)
++|.+. +.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++.+. ||||+++++++.++...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 345554 77999999999999999999999999986531 345668999999997 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC---CeEEeeccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY---NIKLSDFGFARAHMR 174 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~---~~~l~Df~~~~~~~~ 174 (316)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999999999999888899999999999999999999999999999999999997765 799999999865321
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcccCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-------VNELLKQVQNKVTF 247 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~ 247 (316)
.........+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+ ..+....+..+...
T Consensus 162 ------~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 162 ------DNQPLKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234 (325)
T ss_dssp ----------------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred ------CCCcccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence 1222334457899999999988776655 999999999999999999997643 34555555544322
Q ss_pred CC---CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 248 PK---QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 248 ~~---~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
.. +..+++++.+||..|| .+|.+|||++++++||||++....
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence 11 1358999999999999 599999999999999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=361.75 Aligned_cols=260 Identities=21% Similarity=0.323 Sum_probs=220.0
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
.+..++|.+.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++.+....
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 36788899999999999999999999999999999999653221111234567899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
++||||++|++|.+++...+ .+++..++.++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||++.....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 99999999999999997644 499999999999999999999999999999999999999999999999999965321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcccCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS----VNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~ 251 (316)
........|++.|+|||++.+..++.. +|||||||++|+|++|..||.... ...+...+... ....+.
T Consensus 339 ------~~~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~~p~ 410 (576)
T 2acx_A 339 ------GQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYSE 410 (576)
T ss_dssp ------TCCEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCCCCT
T ss_pred ------CccccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cccCCc
Confidence 112233468999999999988776655 999999999999999999998643 34455444433 333446
Q ss_pred CCCHHHHHHHHHhc-CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 252 EVSTECKELISNIL-SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
.+++++.+||.+|| .+|.+|| +++++++||||++.
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 79999999999999 5999999 89999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=340.76 Aligned_cols=264 Identities=26% Similarity=0.419 Sum_probs=218.6
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
+.....++|++.+.||+|+||.||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 97 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK 97 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence 4455678999999999999999999999999999999998665443 334556779999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++||||+++++|..++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999999999998887778999999999999999999999999999999999999999999999999998653211
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----------
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK----------- 244 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------- 244 (316)
........+++.|+|||++.+....+.++||||||+++|+|++|..||......+....+...
T Consensus 178 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 178 ------GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred ------ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 122233457889999999987655555699999999999999999999987766655444211
Q ss_pred ---------cCCCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 245 ---------VTFPK----------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 245 ---------~~~~~----------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
...+. .+.+++++.+||.+|| .+|.+|||++++++||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 11111 1357999999999999 599999999999999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=339.96 Aligned_cols=259 Identities=22% Similarity=0.364 Sum_probs=217.3
Q ss_pred hcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-----CCCcc
Q psy11194 11 DIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-----HPNLI 85 (316)
Q Consensus 11 ~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~ 85 (316)
++..+...+..++|.+.+.||+|+||.||+|++..+++.||+|++... ....+....|+.+++.+. ||||+
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 344456677789999999999999999999999999999999998642 223455668999999986 99999
Q ss_pred eeeeEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC------
Q psy11194 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS------ 157 (316)
Q Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~------ 157 (316)
++++++...+..++|||++ +++|.+++.... .+++..++.++.||+.||.|||+.|++|+||||+||+++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 9999999999999999999 889999997644 5999999999999999999999999999999999999975
Q ss_pred -------------------CCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHH
Q psy11194 158 -------------------DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVV 218 (316)
Q Consensus 158 -------------------~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~l 218 (316)
++.++|+|||++.... .......+++.|+|||++.+..++.+ +|||||||+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~i 248 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS---------DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCV 248 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT---------SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecC---------CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHH
Confidence 7889999999986422 11234457899999999988877766 999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHhcccCCCC---------------------------C------------------CCC
Q psy11194 219 LFAMVFGRLPFDDSSVNELLKQVQNKVTFPK---------------------------Q------------------PEV 253 (316)
Q Consensus 219 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~------------------~~~ 253 (316)
+|+|++|..||...+..+....+........ . ...
T Consensus 249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 328 (360)
T 3llt_A 249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328 (360)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence 9999999999998887776665544221110 0 012
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~ 284 (316)
++.+.+||.+|| .+|.+|||++++++||||+
T Consensus 329 ~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 329 HELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 477889999999 5999999999999999996
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=340.65 Aligned_cols=271 Identities=22% Similarity=0.330 Sum_probs=220.1
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe------
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------ 93 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 93 (316)
...+|++.+.||+|+||.||+|++..+|+.||+|++......... ...+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-PITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS-CHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc-hHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 457899999999999999999999999999999998665443322 3345689999999999999999999976
Q ss_pred --CCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 94 --THRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 94 --~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
.+..++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4468999999976 77777765 3569999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK- 249 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 249 (316)
...... ...........+++.|+|||++.+....+.++|||||||++|+|++|..||.+.........+......+.
T Consensus 173 ~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 173 AFSLAK--NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp ECCCCS--SSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccc--cccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 643211 11222334456799999999987755545569999999999999999999999888777666644221111
Q ss_pred --CCC----------------------------CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhh
Q psy11194 250 --QPE----------------------------VSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDK 294 (316)
Q Consensus 250 --~~~----------------------------~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~ 294 (316)
.+. .++++.+||.+|| .||.+|||++++++||||+..........
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~ 326 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKG 326 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSHH
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcccccc
Confidence 111 2778999999999 59999999999999999998877766433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=335.88 Aligned_cols=267 Identities=25% Similarity=0.463 Sum_probs=207.7
Q ss_pred ccCeEEe-eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEE
Q psy11194 21 SHGYTVG-KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 21 ~~~y~~~-~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 98 (316)
.++|.+. +.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.++..+ +||||+++++++...+..+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 5689985 78999999999999999999999999997654322 34567899999885 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC---eEEeecccccccccc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN---IKLSDFGFARAHMRC 175 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~---~~l~Df~~~~~~~~~ 175 (316)
+||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999988778999999999999999999999999999999999999988766 999999998654211
Q ss_pred cCcC-CCCCCCcccccccCccCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------------H
Q psy11194 176 RSNA-ADNSLSETFCGSYAYASPEILQG-----IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS---------------V 234 (316)
Q Consensus 176 ~~~~-~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---------------~ 234 (316)
.... ..........+++.|+|||++.. ..++.+ +|||||||++|+|++|..||.... .
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTT-HHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcc-cccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 1100 01112223458999999999864 234444 999999999999999999997643 2
Q ss_pred HHHHHHHhccc-CCCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 235 NELLKQVQNKV-TFPK--QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 235 ~~~~~~~~~~~-~~~~--~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
......+.... .++. ...++.++.+||.+|| .+|.+|||++++++||||++......
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~ 307 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-------
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCccc
Confidence 33444444432 2221 1468999999999999 59999999999999999998655433
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=336.90 Aligned_cols=273 Identities=24% Similarity=0.412 Sum_probs=218.4
Q ss_pred hhhhcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcce
Q psy11194 8 VQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIR 86 (316)
Q Consensus 8 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~ 86 (316)
...+++........++|++.+.||+|+||.||+|.+..+|+.||+|++...... .+.+.+|+.+++.+ +||||++
T Consensus 10 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~ 85 (326)
T 2x7f_A 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIAT 85 (326)
T ss_dssp ------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCC
T ss_pred cchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeee
Confidence 334444555556788999999999999999999999999999999999764432 34567899999998 7999999
Q ss_pred eeeEEEe------CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC
Q psy11194 87 FLQAIET------THRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD 158 (316)
Q Consensus 87 ~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~ 158 (316)
+++++.. ....++||||+++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.+
T Consensus 86 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN 165 (326)
T ss_dssp EEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT
T ss_pred eeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC
Confidence 9999976 56889999999999999999763 469999999999999999999999999999999999999999
Q ss_pred CCeEEeecccccccccccCcCCCCCCCcccccccCccCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy11194 159 YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ-----GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS 233 (316)
Q Consensus 159 ~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~ 233 (316)
+.++|+|||++...... ........+++.|+|||++. ...++.+ +||||||+++|+|++|..||....
T Consensus 166 ~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRT------VGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp CCEEECCCTTTC-------------------CCGGGCCHHHHC--------CCTT-HHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCEEEeeCcCceecCcC------ccccccccCCccccChhhhccccccCcCCCcc-chHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999998653211 11123345789999999986 3344444 999999999999999999999887
Q ss_pred HHHHHHHHhccc-CCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 234 VNELLKQVQNKV-TFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
.......+.... .......++..+.++|.+|| .+|.+||+++++++||||++....+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~ 298 (326)
T 2x7f_A 239 PMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQ 298 (326)
T ss_dssp HHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHHH
T ss_pred HHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccccc
Confidence 776665554432 22334568999999999999 59999999999999999998776544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=342.91 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=209.1
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC----
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH---- 95 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 95 (316)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 35789999999999999999999999999999999865443 3334556779999999999999999999997653
Q ss_pred --eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 --RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 --~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
..++||||+ +++|.++++. ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||+++...
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 7799999987 459999999999999999999999999999999999999999999999999986532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-----
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP----- 248 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 248 (316)
.......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 180 ---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 180 ---------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp ---------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ---------cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 112334678999999998774444445999999999999999999999887766655543211110
Q ss_pred -------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 249 -------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 249 -------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
..+..++++.+||.+|| .||.+|||++++++||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 12457899999999999 59999999999999999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=342.23 Aligned_cols=252 Identities=30% Similarity=0.527 Sum_probs=213.0
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 98 (316)
-.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+|+.++..+ +||||+++++++.+....+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 356799999999999999999999999999999999765432 23677778777 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC----CCeEEeeccccccccc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD----YNIKLSDFGFARAHMR 174 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~----~~~~l~Df~~~~~~~~ 174 (316)
+||||++|++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||++... +.++|+|||++.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999999988889999999999999999999999999999999999998543 3499999999875421
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcccC-CC--
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD---SSVNELLKQVQNKVT-FP-- 248 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~---~~~~~~~~~~~~~~~-~~-- 248 (316)
.........+++.|+|||++.+..++.+ +|||||||++|+|++|..||.. ....++...+..+.. ++
T Consensus 173 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 173 ------ENGLLMTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp ------TTCCBCCSSCCSSCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST
T ss_pred ------CCCceeccCCCccccCHHHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc
Confidence 1122334568999999999876555554 9999999999999999999975 456666666655432 22
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 249 KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 249 ~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
.+..+++++.+||.+|| .+|++|||+.++++||||.+
T Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 23568999999999999 59999999999999999954
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=347.80 Aligned_cols=268 Identities=26% Similarity=0.363 Sum_probs=208.9
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 94 (316)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC-hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 367899999999999999999999999999999999765433 33345677999999999999999999999766
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
...++|||++++ +|.++++....+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||+++....
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 579999999964 9999999888899999999999999999999999999999999999999999999999999976532
Q ss_pred ccCcCC----------------CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhC-----------CC
Q psy11194 175 CRSNAA----------------DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFG-----------RL 227 (316)
Q Consensus 175 ~~~~~~----------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-----------~~ 227 (316)
...... .........+++.|+|||++......+.++|||||||++|+|++| .+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 211100 001234557899999999975555455569999999999999984 44
Q ss_pred CCCCCC-----------------HHHHHHHH------------------------hcccCCC------CCCCCCHHHHHH
Q psy11194 228 PFDDSS-----------------VNELLKQV------------------------QNKVTFP------KQPEVSTECKEL 260 (316)
Q Consensus 228 p~~~~~-----------------~~~~~~~~------------------------~~~~~~~------~~~~~~~~~~~l 260 (316)
+|.+.+ ..+....+ ....... ..+.+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 444432 01111111 1110000 014589999999
Q ss_pred HHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 261 ISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
|.+|| .||.+|||++++++||||++.+..
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 99999 599999999999999999887543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=332.11 Aligned_cols=262 Identities=27% Similarity=0.475 Sum_probs=212.1
Q ss_pred hhhhcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCccee
Q psy11194 8 VQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87 (316)
Q Consensus 8 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 87 (316)
.+..+......+...+|++.+.||+|+||.||+|.+ +|+.||+|++........ ..+.+.+|+.+++.++||||+++
T Consensus 23 ~~~~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~ 99 (309)
T 3p86_A 23 FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLF 99 (309)
T ss_dssp ---------CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHH-HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred eccCCCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHH-HHHHHHHHHHHHHhCCCCCEeeE
Confidence 566677777788899999999999999999999976 478999999976554433 34557799999999999999999
Q ss_pred eeEEEeCCeEEEEEecCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeCCCCCeE
Q psy11194 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQGY---IDEIRARRWFGQLLEALQYCHERG--VVHRDIKCENLLLDSDYNIK 162 (316)
Q Consensus 88 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~~i~~~l~~Lh~~~--~~H~dl~p~nil~~~~~~~~ 162 (316)
++++......++||||+++++|.+++...+. +++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~k 179 (309)
T 3p86_A 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179 (309)
T ss_dssp EEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEE
T ss_pred EEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEE
Confidence 9999999999999999999999999987543 999999999999999999999999 99999999999999999999
Q ss_pred EeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy11194 163 LSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ 242 (316)
Q Consensus 163 l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~ 242 (316)
|+|||++..... .........|++.|+|||++.+..++.+ +||||||+++|+|++|..||......+....+.
T Consensus 180 L~Dfg~a~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~ 252 (309)
T 3p86_A 180 VCDFGLSRLKAS------TFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVG 252 (309)
T ss_dssp ECCCC-----------------------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH
T ss_pred ECCCCCCccccc------cccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999864221 1112234468899999999988777666 999999999999999999999988888777664
Q ss_pred -cccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 243 -NKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 243 -~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.....+.+..+++++.++|.+|| .+|.+|||++++++
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 34445556679999999999999 59999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=328.49 Aligned_cols=254 Identities=20% Similarity=0.253 Sum_probs=209.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 99 (316)
.++|++.+.||+|+||.||+|.+..+++.||+|++......... ...+.+|+..+..+ +||||+++++++...+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH-HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 46799999999999999999999999999999999765554443 34455888888888 89999999999999999999
Q ss_pred EEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-----------------
Q psy11194 100 IMEYAENGSLFDIIRGQ----GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD----------------- 158 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~----------------- 158 (316)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999763 669999999999999999999999999999999999999844
Q ss_pred --CCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy11194 159 --YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE 236 (316)
Q Consensus 159 --~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~ 236 (316)
..++|+|||.+..... .....+++.|+|||++.+....+.++||||||+++|+|++|..++....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--- 235 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISS----------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--- 235 (289)
T ss_dssp -CCCEEECCCTTCEETTC----------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred CceEEEEcccccccccCC----------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence 4799999999865321 1123478999999999876454445999999999999999988775543
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 237 LLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
....+........+..+++++.++|..|| .+|.+|||+.++++||||++..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 288 (289)
T 1x8b_A 236 QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288 (289)
T ss_dssp HHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-----
T ss_pred HHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhcc
Confidence 23344444444555679999999999999 59999999999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=353.95 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=207.5
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 94 (316)
..++|++++.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh-HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4578999999999999999999999999999999997653333 3345567999999999999999999999654
Q ss_pred -CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 95 -HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 95 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
...++||||+++ +|.+.+.. .+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||+++...
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 467999999976 67777654 38999999999999999999999999999999999999999999999999996532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC----
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK---- 249 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 249 (316)
.........+++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+.+....+.
T Consensus 216 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 216 -------TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp --------CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred -------CCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 1223344568999999999988877765 9999999999999999999999887776666543221110
Q ss_pred ----------------CCC---------------------CCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 250 ----------------QPE---------------------VSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 250 ----------------~~~---------------------~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
... .++++.+||.+|| .||++|||++++++||||+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 000 1567999999999 59999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=351.79 Aligned_cols=265 Identities=24% Similarity=0.383 Sum_probs=197.1
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe-----CC
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-----TH 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~ 95 (316)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC-HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 47899999999999999999999999999999999654433 3334557799999999999999999999943 35
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++|||++ +++|.+++.....+++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||+++.....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 789999998 4699999998888999999999999999999999999999999999999999999999999999765321
Q ss_pred cCcCC---------------------CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh----------
Q psy11194 176 RSNAA---------------------DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF---------- 224 (316)
Q Consensus 176 ~~~~~---------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~---------- 224 (316)
..... .........||+.|+|||++......+.++|||||||++|+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 11000 00123345679999999987554545556999999999999998
Q ss_pred -CCCCCCCCCH--------------------HHHHHHHhcccC---------------------C---------CCCCCC
Q psy11194 225 -GRLPFDDSSV--------------------NELLKQVQNKVT---------------------F---------PKQPEV 253 (316)
Q Consensus 225 -g~~p~~~~~~--------------------~~~~~~~~~~~~---------------------~---------~~~~~~ 253 (316)
|..+|.+.+. .+....+..... + ...+..
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 6777765431 111111111000 0 012456
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
++++.+||.+|| .||.+|||++++++||||++..
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 999999999999 5999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=330.70 Aligned_cols=260 Identities=25% Similarity=0.472 Sum_probs=220.1
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch---HHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
.++|++.+.||+|+||.||+|.+..+++.+++|++........ ...+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 4679999999999999999999999999999999976543221 1245677999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC----CeEEeecccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY----NIKLSDFGFARAHM 173 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~----~~~l~Df~~~~~~~ 173 (316)
++||||+++++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998877899999999999999999999999999999999999998876 79999999986532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC---CC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP---KQ 250 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 250 (316)
. ........+++.|+|||++.+..++.+ +||||||+++|+|++|..||......+....+....... ..
T Consensus 164 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T 3bhy_A 164 A-------GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 235 (283)
T ss_dssp ---------------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred C-------CCcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhc
Confidence 1 111233457889999999987766655 999999999999999999999988887777765543211 12
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
..++..+.++|.+|| .+|++|||+.++++||||+....
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 568999999999999 59999999999999999976543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=340.03 Aligned_cols=255 Identities=26% Similarity=0.483 Sum_probs=218.2
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc-----hHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP-----DYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 95 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~-----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 95 (316)
++|.+.+.||.|++|.||+|.+..+|+.||||+++...... ....+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 57999999999999999999999899999999997654221 12245577899999998 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++||||++|++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||++.....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~- 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP- 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT-
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC-
Confidence 9999999999999999998877899999999999999999999999999999999999999999999999999865321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGI------PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP- 248 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 248 (316)
........|++.|+|||++.+. .++. ++|||||||++|+|++|..||...........+..+....
T Consensus 253 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 325 (365)
T 2y7j_A 253 ------GEKLRELCGTPGYLAPEILKCSMDETHPGYGK-EVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS 325 (365)
T ss_dssp ------TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred ------CcccccCCCCCCccChhhccccccccCcCCCc-hhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 1223345689999999998532 3444 4999999999999999999999888877777765543222
Q ss_pred --CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCC
Q psy11194 249 --KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 249 --~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~ 284 (316)
.+..++..+.++|..|| .+|++|||++++++||||+
T Consensus 326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 22468999999999999 5999999999999999997
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=340.07 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=206.0
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC------
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH------ 95 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 95 (316)
++|++.+.||+|+||.||+|++..+|+.||+|++....... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTT--HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 57999999999999999999999999999999997654322 3566789999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEecCCCCCHHHHHHhCC---CCCH
Q psy11194 96 ---------------------------------------------------RVYIIMEYAENGSLFDIIRGQG---YIDE 121 (316)
Q Consensus 96 ---------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~---~l~~ 121 (316)
..++||||+++++|.+++.... ..+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 3899999999999999998754 3566
Q ss_pred HHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC------CCCCCcccccccCcc
Q psy11194 122 IRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA------DNSLSETFCGSYAYA 195 (316)
Q Consensus 122 ~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 195 (316)
..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........... .........|++.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 67899999999999999999999999999999999999999999999976532211100 012233456899999
Q ss_pred CcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCH
Q psy11194 196 SPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRL 274 (316)
Q Consensus 196 aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~ 274 (316)
|||++.+..++.+ +||||||+++|+|++|..|+. ........+............++++.++|.+|| .+|.+|||+
T Consensus 244 aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 244 SPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQM--ERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp CHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHH--HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred ChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChh--HHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence 9999988776655 999999999999999876642 222233333333222222346788999999999 599999999
Q ss_pred HHHhhCCCCCCC
Q psy11194 275 KTIAEDRWLKPK 286 (316)
Q Consensus 275 ~~il~~~~~~~~ 286 (316)
+++++||||++.
T Consensus 321 ~~~l~~~~f~~~ 332 (332)
T 3qd2_B 321 TDIIENAIFENL 332 (332)
T ss_dssp HHHHHSTTCCCC
T ss_pred HHHhhchhhhcC
Confidence 999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=330.32 Aligned_cols=261 Identities=27% Similarity=0.477 Sum_probs=220.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc------hHHHhhHHHHHHHHhcCC-CCCcceeeeEEEe
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP------DYLKKFLPREIEVVKGLK-HPNLIRFLQAIET 93 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~------~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 93 (316)
.++|++.+.||+|++|.||+|.+..+|+.||+|++....... ....+.+.+|+.+++.+. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 578999999999999999999999999999999997654211 122455778999999995 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
....++||||+++++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 99999999999999999999887789999999999999999999999999999999999999999999999999986532
Q ss_pred cccCcCCCCCCCcccccccCccCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQ-----GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TF 247 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~ 247 (316)
. ........+++.|+|||++. .....+.++||||||+++|+|++|..||...........+.... ..
T Consensus 176 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 176 P-------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp T-------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred C-------CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 1 11223345788999999874 22233445999999999999999999999888877777665543 22
Q ss_pred --CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 248 --PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 248 --~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+....++..+.++|..|| .+|.+|||++++++||||++...
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 222468999999999999 59999999999999999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=367.33 Aligned_cols=261 Identities=26% Similarity=0.460 Sum_probs=224.8
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 96 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 96 (316)
.+...+|.+++.||+|+||.||+|++..+++.||||++...........+.+..|..++..+ +||+|+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34567899999999999999999999999999999999753211111234466888999988 69999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++||||++|++|..++...+.+++..++.++.||+.||+|||+.|++||||||+|||++.+|.++|+|||++....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~--- 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--- 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC---
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc---
Confidence 99999999999999999987889999999999999999999999999999999999999999999999999986421
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
..........|++.|+|||++.+..++.+ +||||||+++|+|++|..||.+.+..+....+.... ...+..++++
T Consensus 494 ---~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 568 (674)
T 3pfq_A 494 ---WDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKE 568 (674)
T ss_dssp ---CTTCCBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHH
T ss_pred ---cCCcccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHH
Confidence 11222345578999999999988777665 999999999999999999999999998888887653 3444679999
Q ss_pred HHHHHHHhc-CCCCCCCCH-----HHHhhCCCCCCC
Q psy11194 257 CKELISNIL-SPVQTRPRL-----KTIAEDRWLKPK 286 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~-----~~il~~~~~~~~ 286 (316)
+.+||..|| .+|.+||++ ++|++||||++.
T Consensus 569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 999999999 699999998 999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=328.04 Aligned_cols=256 Identities=23% Similarity=0.449 Sum_probs=214.5
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe----CC
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----TH 95 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~ 95 (316)
.+..|.+.+.||+|+||.||+|.+..++..|++|++........ ..+.+.+|+.+++.++||||+++++++.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 34459999999999999999999999999999999976554433 35567799999999999999999999865 45
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeC-CCCCeEEeeccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG--VVHRDIKCENLLLD-SDYNIKLSDFGFARAH 172 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~H~dl~p~nil~~-~~~~~~l~Df~~~~~~ 172 (316)
..++||||+++++|.+++...+.+++..++.++.||+.||.|||+.| ++|+||+|+||+++ .++.++|+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 68999999999999999998788999999999999999999999999 99999999999997 7899999999998542
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcccCCC-CC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNKVTFP-KQ 250 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~ 250 (316)
. ........+++.|+|||++.+. ++ .++||||||+++|+|++|..||.. .........+....... ..
T Consensus 183 ~--------~~~~~~~~~t~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 183 R--------ASFAKAVIGTPEFMAPEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp C--------TTSBEESCSSCCCCCGGGGGTC-CC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred c--------ccccccccCCcCcCCHHHHhcc-CC-CcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC
Confidence 1 1222334588999999988753 44 459999999999999999999987 45555556665543332 23
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
...++++.++|..|| .+|.+|||++++++||||++.
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 457899999999999 599999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=333.94 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=203.4
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHH-hcCCCCCcceeeeEEEeCCeE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV-KGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~ 97 (316)
+-.++|++.+.||+|+||+||+|.+..+|+.||||++...........+.+ .|+..+ ...+||||+++++++...+..
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHH-HHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHH-HHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 334789999999999999999999999999999999876555444444444 444444 445899999999999999999
Q ss_pred EEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~--- 208 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG--- 208 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc---
Confidence 9999999 5699988865 4469999999999999999999999999999999999999999999999999986532
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-CCCCCCCCH
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-FPKQPEVST 255 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 255 (316)
.........|++.|+|||++.+ .++. ++||||||+++|+|++|..|+.... ....+..... ......+++
T Consensus 209 ----~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 279 (311)
T 3p1a_A 209 ----TAGAGEVQEGDPRYMAPELLQG-SYGT-AADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSS 279 (311)
T ss_dssp ----------CCCCCGGGCCGGGGGT-CCST-HHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCH
T ss_pred ----cCCCCcccCCCccccCHhHhcC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCH
Confidence 1122334458999999999876 4444 5999999999999999976665432 2233333221 122356899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
++.++|..|| .+|.+|||++++++||||+.
T Consensus 280 ~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999 59999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=355.11 Aligned_cols=255 Identities=33% Similarity=0.533 Sum_probs=215.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|+||.||+|++..++..+|+|++......... ...+.+|+.+++.++||||+++++++......++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45799999999999999999999999999999999765432221 34567999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC---CCeEEeecccccccccccC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD---YNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~---~~~~l~Df~~~~~~~~~~~ 177 (316)
|||+++++|.+.+.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.. +.++|+|||++.....
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~--- 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--- 191 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT---
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC---
Confidence 9999999999999887889999999999999999999999999999999999999764 4599999999876431
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC---CCCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF---PKQPEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 254 (316)
........|++.|+|||++.+ .++. ++|||||||++|+|++|..||.+....+....+..+... +.+..+|
T Consensus 192 ----~~~~~~~~gt~~y~aPE~l~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 265 (494)
T 3lij_A 192 ----QKKMKERLGTAYYIAPEVLRK-KYDE-KCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265 (494)
T ss_dssp ----TBCBCCCCSCTTTCCHHHHTT-CBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred ----CccccccCCCcCeeCHHHHcc-cCCC-chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCC
Confidence 122334568999999999864 4444 599999999999999999999999998888888665322 2335789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
+++.+||..|| .+|.+|||++++++||||+.
T Consensus 266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 99999999999 59999999999999999965
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=332.77 Aligned_cols=262 Identities=21% Similarity=0.304 Sum_probs=203.7
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
++..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+..+...++.++||||+++++++..++..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 4567899999999999999999999999999999999965543 233344455566668888999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
++||||+++ +|.+++.. ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 88777753 56799999999999999999999998 9999999999999999999999999998653
Q ss_pred ccccCcCCCCCCCcccccccCccCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHH-HHHHhcccCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQ---GIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNEL-LKQVQNKVTF 247 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~-~~~~~~~~~~ 247 (316)
.. ........+++.|+|||++. .....+.++||||||+++|+|++|..||.. ...... ...+......
T Consensus 161 ~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 161 VD-------DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC
T ss_pred cc-------cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC
Confidence 21 12222335888999999972 223334459999999999999999999985 333333 3334444333
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 248 PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 248 ~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.....+++++.++|..|| .+|.+|||++++++||||+....
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 334578999999999999 59999999999999999976443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=343.19 Aligned_cols=265 Identities=27% Similarity=0.409 Sum_probs=222.7
Q ss_pred ccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 13 DRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 13 ~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
......+..++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 101 (360)
T 3eqc_A 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 101 (360)
T ss_dssp HHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred hhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence 34466788999999999999999999999999999999999997653 2334566789999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
..+..++||||+++++|.+++...+.+++..+..++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||++..
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred ECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999999999999998877899999999999999999999996 999999999999999999999999999865
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----------
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV---------- 241 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~---------- 241 (316)
.... ......+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+..+....+
T Consensus 182 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3eqc_A 182 LIDS--------MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252 (360)
T ss_dssp HHHH--------C----CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred cccc--------cccCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence 4221 1223457899999999988766655 99999999999999999999877665543222
Q ss_pred --------------------------------hcccCCC-CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 242 --------------------------------QNKVTFP-KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 242 --------------------------------~~~~~~~-~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
....... ....++.++.+||..|| .+|.+|||++++++||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 1111111 12347899999999999 5999999999999999997654
Q ss_pred C
Q psy11194 288 K 288 (316)
Q Consensus 288 ~ 288 (316)
.
T Consensus 333 ~ 333 (360)
T 3eqc_A 333 A 333 (360)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=342.17 Aligned_cols=266 Identities=27% Similarity=0.431 Sum_probs=215.1
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCC--CchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA--PPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
.++|++.+.||+|+||.||+|.+..+++.+|+|++..... ......+.+.+|+.+++.++||||+++++++...+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 5779999999999999999999999999999999865321 11122456779999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q psy11194 99 IIMEYAENGSLFDIIRG----------------------------------------QGYIDEIRARRWFGQLLEALQYC 138 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~----------------------------------------~~~l~~~~~~~i~~~i~~~l~~L 138 (316)
+||||++|++|.+++.. ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999852 11246778899999999999999
Q ss_pred HHcCccccCCCCCCeeeCCCC--CeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCC-CCCCCchhHHHH
Q psy11194 139 HERGVVHRDIKCENLLLDSDY--NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI-PYAPHLSDIWSM 215 (316)
Q Consensus 139 h~~~~~H~dl~p~nil~~~~~--~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~sl 215 (316)
|+.|++|+||+|+||+++.++ .++|+|||++........ ..........+++.|+|||++.+. ...+.++|||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN--GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC--C--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc--cccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 999999999999999998776 899999999976432111 111123345689999999998652 333445999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 216 GVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP---KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 216 G~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
|+++|+|++|..||.+....+....+....... ....+++++.++|.+|| .+|.+||++.++++||||++...
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 999999999999999988887777765543222 22348999999999999 59999999999999999987654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=338.89 Aligned_cols=263 Identities=24% Similarity=0.373 Sum_probs=211.4
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc--hHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP--DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
..++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+.+|+.+++.++||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999999999999999987543221 11234567899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
++||||+++ +|..++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-- 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-- 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC--
Confidence 999999976 899888764 3589999999999999999999999999999999999999999999999999865321
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-------
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK------- 249 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 249 (316)
.........+++.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+......+.
T Consensus 165 ----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 165 ----PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp ----CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ----CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 112233456789999999997655455569999999999999999999998887777666543211110
Q ss_pred --------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 250 --------------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 250 --------------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
...++.++.+||..|| .+|.+|||++++++||||++.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 1346789999999999 599999999999999999875543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=354.55 Aligned_cols=262 Identities=21% Similarity=0.309 Sum_probs=220.6
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..++|.+.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.....
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 34567899999999999999999999999999999999975332111113456789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQ----GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
.++||||++|++|..++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.+|.++|+|||++...
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999999753 36999999999999999999999999999999999999999999999999999753
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcccCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS----SVNELLKQVQNKVTFP 248 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~ 248 (316)
.. .........|++.|+|||++.+..++.+ +|||||||++|+|++|..||... ...++...+... ...
T Consensus 340 ~~------~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~~~ 411 (543)
T 3c4z_A 340 KA------GQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AVT 411 (543)
T ss_dssp CT------TCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CCC
T ss_pred cC------CCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-ccC
Confidence 21 1112234468999999999988777665 99999999999999999999764 345555555443 233
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCC-----HHHHhhCCCCCCC
Q psy11194 249 KQPEVSTECKELISNIL-SPVQTRPR-----LKTIAEDRWLKPK 286 (316)
Q Consensus 249 ~~~~~~~~~~~li~~~l-~~p~~Rps-----~~~il~~~~~~~~ 286 (316)
.+..+++++.+||..|| .+|.+||+ ++++++||||++.
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 44679999999999999 59999996 5899999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=340.15 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=214.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-----C
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----H 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 95 (316)
+.+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.++..++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 578999999999999999999999999999999986533 233345677999999999999999999999654 4
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++|||++++ +|.++++.. .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 68999999975 999999764 5999999999999999999999999999999999999999999999999999764322
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-------
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP------- 248 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 248 (316)
. ..........+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 182 ~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 182 H---DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp G---CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred C---CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 1 111223345689999999997665544556999999999999999999998876655554443211111
Q ss_pred -----------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 249 -----------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 249 -----------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
..+.+++++.+||.+|| .+|.+|||++++++||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 01457899999999999 5999999999999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=350.21 Aligned_cols=258 Identities=33% Similarity=0.535 Sum_probs=203.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC-----chHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP-----PDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.++|.+.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 57899999999999999999999999999999999764321 11223457799999999999999999999854 5
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC---CeEEeeccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY---NIKLSDFGFARAH 172 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~---~~~l~Df~~~~~~ 172 (316)
..++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5799999999999999998888899999999999999999999999999999999999997554 4999999999653
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcccCCC-
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQG--IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN-ELLKQVQNKVTFP- 248 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~- 248 (316)
. .........|++.|+|||++.+ ....+.++|||||||++|+|++|..||...... .....+..+....
T Consensus 293 ~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 293 G-------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365 (419)
T ss_dssp C------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred C-------CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence 2 1222334568999999999854 223334599999999999999999999764322 3333443332211
Q ss_pred --CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 249 --KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 249 --~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
....+++.+.+||.+|| .+|.+|||++++++||||++.
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 12468999999999999 599999999999999999764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=335.64 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=219.0
Q ss_pred eccCeEEe-eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeE
Q psy11194 20 ESHGYTVG-KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRV 97 (316)
Q Consensus 20 ~~~~y~~~-~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 97 (316)
-.++|.+. +.||+|+||.||+|.+..+++.||+|++......... ...+.+|+.++..+. ||||+++++++......
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC-HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH-HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 35668887 8899999999999999999999999999765443322 345668999999995 79999999999999999
Q ss_pred EEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC---CCCeEEeeccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFARAH 172 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~---~~~~~l~Df~~~~~~ 172 (316)
++||||+++++|.+++.. ...+++..++.++.||+.||++||+.|++|+||+|+||+++. ++.++|+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 999999999999999854 356999999999999999999999999999999999999987 789999999999754
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc---CCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV---TFPK 249 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~ 249 (316)
.. ........+++.|+|||++.+..++.+ +||||||+++|+|++|..||...+..+....+.... ..+.
T Consensus 185 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 256 (327)
T 3lm5_A 185 GH-------ACELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256 (327)
T ss_dssp ----------------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred CC-------ccccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh
Confidence 21 112233468999999999988776665 999999999999999999999988887766665432 2333
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
...+++.+.++|.+|| .+|.+|||++++++||||+...-+..
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 4578999999999999 59999999999999999987655433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=338.88 Aligned_cols=264 Identities=27% Similarity=0.427 Sum_probs=217.9
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC--
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-- 95 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 95 (316)
..-.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 345688999999999999999999999999999999998766555555667889999999999999999999987544
Q ss_pred --eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 --RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 --~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
..++||||++|++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 359999999999999999887889999999999999999999999999999999999999999999999999987543
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC---C
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK---Q 250 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 250 (316)
... ..........|++.|+|||++.+..++.+ +||||||+++|+|++|..||.+....+...........+. .
T Consensus 168 ~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 168 DSG---NSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred ccc---cccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 211 11112233458999999999988766655 9999999999999999999999888777655544433222 2
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
..++.++.++|.+|| .+|.+||++.+++.|+|++.
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 468999999999999 59999999999999999853
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=340.93 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=207.6
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe----
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET---- 93 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 93 (316)
....++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 34578899999999999999999999999999999998654322 2379999999999999999999843
Q ss_pred ----------------------------------CCeEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHH
Q psy11194 94 ----------------------------------THRVYIIMEYAENGSLFDIIR----GQGYIDEIRARRWFGQLLEAL 135 (316)
Q Consensus 94 ----------------------------------~~~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~~i~~~l 135 (316)
....++||||+++ +|.+.+. ....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 3348899999975 8777664 356799999999999999999
Q ss_pred HHHHHcCccccCCCCCCeeeC-CCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHH
Q psy11194 136 QYCHERGVVHRDIKCENLLLD-SDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWS 214 (316)
Q Consensus 136 ~~Lh~~~~~H~dl~p~nil~~-~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 214 (316)
.|||+.|++|+||+|+||+++ .++.++|+|||++..... ........+++.|+|||++.+....+.++||||
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP-------SEPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT-------TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC-------CCCCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 999999999999999999997 678999999999975321 122334457889999999887665555699999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC------------------CC----------CCCCCCHHHHHHHHHhc-
Q psy11194 215 MGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT------------------FP----------KQPEVSTECKELISNIL- 265 (316)
Q Consensus 215 lG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------~~----------~~~~~~~~~~~li~~~l- 265 (316)
|||++|+|++|..||.+.+..+....+..... ++ .+..+++++.+||.+||
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 99999999999999998887766655533111 11 12357899999999999
Q ss_pred CCCCCCCCHHHHhhCCCCCCC
Q psy11194 266 SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 266 ~~p~~Rps~~~il~~~~~~~~ 286 (316)
.+|.+|||+.++++||||+..
T Consensus 308 ~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp SSGGGSCCHHHHHTSGGGHHH
T ss_pred CChhhCCCHHHHhcCHHHHHH
Confidence 599999999999999999653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=342.70 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=211.3
Q ss_pred cCeEE--eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 22 HGYTV--GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 22 ~~y~~--~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..|.+ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 34555 6789999999999999999999999999876432 234567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee--CCCCCeEEeeccccccccccc
Q psy11194 100 IMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL--DSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~--~~~~~~~l~Df~~~~~~~~~~ 176 (316)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~-- 241 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-- 241 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT--
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC--
Confidence 99999999999988653 469999999999999999999999999999999999999 5678899999999976421
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CCC--CCCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TFP--KQPEV 253 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~ 253 (316)
........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+.... .++ ....+
T Consensus 242 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 315 (373)
T 2x4f_A 242 -----REKLKVNFGTPEFLAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDI 315 (373)
T ss_dssp -----TCBCCCCCSSCTTCCHHHHTTCBCCHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTS
T ss_pred -----ccccccccCCCcEeChhhccCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccC
Confidence 112233458999999999977665554 999999999999999999999988887777665532 222 23568
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
++++.+||.+|| .+|.+|||++++++||||++.+
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 999999999999 5999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=334.35 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=220.5
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCc---eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
...+...+|++.+.||+|+||.||+|.+..++. .||+|++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 346678899999999999999999999986555 499999865432 333556779999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
..+..++||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999999999754 5699999999999999999999999999999999999999999999999999976
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQ 250 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
...... .........++..|+|||++.+..++.+ +||||||+++|+|++ |..||......+....+......+.+
T Consensus 201 ~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (325)
T 3kul_A 201 LEDDPD---AAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP 276 (325)
T ss_dssp CC-------CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred cccCcc---ceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCC
Confidence 432111 1111222335678999999987666665 999999999999999 99999999999999999888888888
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..+++++.++|..|| .+|.+|||+.++++
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 899999999999999 59999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=335.76 Aligned_cols=272 Identities=23% Similarity=0.429 Sum_probs=195.3
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
..+.+..++|++.+.||+|++|.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++...
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcch--hHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 356678899999999999999999999998899999999986543221 244567899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeec
Q psy11194 95 HRVYIIMEYAENGSLFDIIRG--------QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDF 166 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df 166 (316)
+..++||||+++++|.+++.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999999999963 456999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC
Q psy11194 167 GFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT 246 (316)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (316)
|++........ ...........+++.|+|||++.+....+.++||||||+++|+|++|..||.................
T Consensus 166 g~~~~~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 166 GVSAFLATGGD-ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp HHHHHCC----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred cchheeccCCC-ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 98865432111 11112223445889999999986533334459999999999999999999987665554433332211
Q ss_pred C---------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 247 F---------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 247 ~---------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
. .....++.++.++|.+|| .+|.+|||++++++||||+..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 1 122467899999999999 599999999999999999987664
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=342.03 Aligned_cols=252 Identities=29% Similarity=0.511 Sum_probs=201.0
Q ss_pred ccCeEEe-eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHH-hcCCCCCcceeeeEEEe----C
Q psy11194 21 SHGYTVG-KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV-KGLKHPNLIRFLQAIET----T 94 (316)
Q Consensus 21 ~~~y~~~-~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~ 94 (316)
.++|.+. +.||+|+||.||+|.+..+|+.||+|++... ..+.+|+.++ +..+||||+++++++.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4567776 7899999999999999999999999998632 2355788776 44589999999999875 5
Q ss_pred CeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC---CCCeEEeecccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFA 169 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~---~~~~~l~Df~~~ 169 (316)
...++||||++|++|.+++...+ .+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 67899999999999999998643 5999999999999999999999999999999999999987 788999999998
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhc-c
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE----LLKQVQN-K 244 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~-~ 244 (316)
.... .........+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+..... ....+.. .
T Consensus 212 ~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 212 KETT-------SHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp EECC------------------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred cccC-------CCCccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 6532 1122234567999999999987776655 999999999999999999997644221 2222322 2
Q ss_pred cCC--CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 245 VTF--PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 245 ~~~--~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
..+ +....++.++.+||..|| .+|.+|||++++++||||.....
T Consensus 284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 222 333578999999999999 59999999999999999976543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=328.45 Aligned_cols=260 Identities=33% Similarity=0.515 Sum_probs=221.9
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE--eCCeEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE--TTHRVY 98 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~ 98 (316)
.++|++.+.||+|+||.||+|.+..+++.|++|.+....... ...+.+.+|+.+++.++||||+++++++. .....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 578999999999999999999999999999999997655433 33566789999999999999999999884 467899
Q ss_pred EEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 99 IIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERG-----VVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
+||||+++++|.+++.. ...+++..++.++.|++.||.+||+.| ++|+||+|+||+++.++.++|+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 99999999999999965 235999999999999999999999999 999999999999999999999999998
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK 249 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (316)
...... ........++..|+|||++.+..++.+ +||||||+++|+|++|..||......+....+..+...+.
T Consensus 164 ~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 236 (279)
T 2w5a_A 164 RILNHD------TSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236 (279)
T ss_dssp HHC---------CHHHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred eeeccc------cccccccCCCccccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC
Confidence 653211 111122357889999999987766654 9999999999999999999999988888888877765566
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+..++.++.++|.+|| .+|.+|||++++++|+|+.+-..
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 6679999999999999 59999999999999999986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=340.30 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=198.7
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 94 (316)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 357899999999999999999999999999999998654433 33345567999999999999999999998654
Q ss_pred -CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 95 -HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 95 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
...++|++++ +++|.++++. +.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||+++...
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5679999999 6799999876 469999999999999999999999999999999999999999999999999986532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-----
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP----- 248 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 248 (316)
. ......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 184 ~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 184 D---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred c---------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 1 12334688999999998874444455999999999999999999999888776665553321111
Q ss_pred -------------------C------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 249 -------------------K------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 249 -------------------~------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
. .+..++++.+||.+|| .+|.+|||++++++||||+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 0 1356889999999999 59999999999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=336.56 Aligned_cols=263 Identities=22% Similarity=0.360 Sum_probs=210.7
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC--CCcceeeeEEEeCC
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH--PNLIRFLQAIETTH 95 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~ 95 (316)
.+.+++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+.++..++| |||+++++++....
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccch-HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 456888999999999999999999874 58899999997655433 334567799999999976 99999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..++|||+. +++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++ ++.++|+|||++......
T Consensus 83 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEECCC-SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 999999955 779999999888899999999999999999999999999999999999996 678999999999754321
Q ss_pred cCcCCCCCCCcccccccCccCcccccC----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHH-HHHhc
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQG----------IPYAPHLSDIWSMGVVLFAMVFGRLPFDDS-SVNELL-KQVQN 243 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~----------~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~-~~~~~ 243 (316)
..........|++.|+|||++.+ ....+.++|||||||++|+|++|..||... ...... ..+..
T Consensus 161 ----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 161 ----TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp -------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred ----cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 11112234568999999999853 123344599999999999999999999864 322333 33333
Q ss_pred ccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 244 KVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 244 ~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
......+...+.++.++|..|| .+|.+|||+.++++||||+....
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 3444455567889999999999 59999999999999999975443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=323.78 Aligned_cols=254 Identities=24% Similarity=0.413 Sum_probs=220.5
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.+.+..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 35678899999999999999999999876 4678999999765443 345779999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
..++||||+++++|.+++.. .+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999999999999965 44599999999999999999999999999999999999999999999999999865422
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEV 253 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (316)
.. ........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||......+....+........+...
T Consensus 159 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T 4hcu_A 159 DQ-----YTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 232 (269)
T ss_dssp HH-----HHSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred cc-----cccccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcC
Confidence 11 111223345678999999977666655 999999999999999 99999999999999999888777777789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
++.+.++|..|| .+|++|||+.+++++
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999 599999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=341.83 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=211.0
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC------CCCCcceeeeE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL------KHPNLIRFLQA 90 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~ 90 (316)
......+|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.+ +|+||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 345567899999999999999999999999999999998653 22244566788777776 57799999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC--eEEeec
Q psy11194 91 IETTHRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN--IKLSDF 166 (316)
Q Consensus 91 ~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~--~~l~Df 166 (316)
+......++|||++. ++|.+++.... .+++..++.++.||+.||.|||+.|++|+||||+||+++.++. ++|+||
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999999999996 59999997643 4999999999999999999999999999999999999999887 999999
Q ss_pred ccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC
Q psy11194 167 GFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT 246 (316)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (316)
|++.... .......+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+.....
T Consensus 247 G~a~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~ 316 (429)
T 3kvw_A 247 GSSCYEH---------QRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316 (429)
T ss_dssp TTCEETT---------CCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccceecC---------CcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 9985421 11223467899999999988777655 9999999999999999999998887776655543211
Q ss_pred CCC----------------------------------------------------------CCCCCHHHHHHHHHhc-CC
Q psy11194 247 FPK----------------------------------------------------------QPEVSTECKELISNIL-SP 267 (316)
Q Consensus 247 ~~~----------------------------------------------------------~~~~~~~~~~li~~~l-~~ 267 (316)
.+. ....++++.+||.+|| .|
T Consensus 317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 110 0124788999999999 59
Q ss_pred CCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 268 VQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 268 p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
|++|||++++++||||+......
T Consensus 397 P~~Rpta~e~L~Hpw~~~~~~~~ 419 (429)
T 3kvw_A 397 PAVRMTPGQALRHPWLRRRLPKP 419 (429)
T ss_dssp TTTSCCHHHHHTSTTTC------
T ss_pred hhhCCCHHHHhCChhhccCCCCC
Confidence 99999999999999998765433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=329.41 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=209.6
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEe-
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIET- 93 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~- 93 (316)
......++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++..
T Consensus 30 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 103 (330)
T 3nsz_A 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDP 103 (330)
T ss_dssp CCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred hcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence 44456788999999999999999999999999999999986432 345779999999997 9999999999987
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC-CeEEeecccccc
Q psy11194 94 -THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY-NIKLSDFGFARA 171 (316)
Q Consensus 94 -~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~-~~~l~Df~~~~~ 171 (316)
....++||||+++++|.++++. +++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++..
T Consensus 104 ~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 104 VSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp TTCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 6788999999999999998864 89999999999999999999999999999999999999776 899999999965
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHh--------
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS-SVNELLKQVQ-------- 242 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~-------- 242 (316)
... ........++..|+|||++.+....+.++|||||||++|+|++|..||... ...+....+.
T Consensus 181 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~ 253 (330)
T 3nsz_A 181 YHP-------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253 (330)
T ss_dssp CCT-------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred cCC-------CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence 321 122334457889999999987555555699999999999999999999542 2222221111
Q ss_pred -----cc-----------------------cCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 243 -----NK-----------------------VTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 243 -----~~-----------------------~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.. ........+++++.+||.+|| .+|.+|||++++++||||++..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 10 001111237999999999999 59999999999999999998765
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=336.43 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=211.1
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE---
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV--- 97 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--- 97 (316)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 57899999999999999999999999999999999765443 33455677999999999999999999999876654
Q ss_pred ---EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 98 ---YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 98 ---~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
++||||+. ++|.+++.. .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~- 195 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 195 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc-
Confidence 99999997 488888753 49999999999999999999999999999999999999999999999999986532
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC------
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP------ 248 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 248 (316)
.......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 196 --------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 196 --------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred --------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 112234578999999999874444445999999999999999999999888776665553321111
Q ss_pred ------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 249 ------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 249 ------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
..+.+++++.+||.+|| .+|.+|||++++++||||++...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 01357899999999999 59999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=336.47 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=218.5
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEcc-------CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceee
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTR-------HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFL 88 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~ 88 (316)
+.+..++|++.+.||+|+||.||+|++.. ++..||+|++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 35667899999999999999999998752 34579999986543 333355677999999999 899999999
Q ss_pred eEEEeCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCC
Q psy11194 89 QAIETTHRVYIIMEYAENGSLFDIIRGQG----------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCEN 152 (316)
Q Consensus 89 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~n 152 (316)
+++...+..++||||+++++|.+++.... .++...+..++.||+.||.|||+.|++|+||+|+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999997643 47899999999999999999999999999999999
Q ss_pred eeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q psy11194 153 LLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDD 231 (316)
Q Consensus 153 il~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~ 231 (316)
|+++.++.++|+|||++....... .........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNID----YYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCC----TTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEECCCCCEEEccccCCcccCccc----ceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999987542211 1111223346778999999987766655 999999999999999 9999999
Q ss_pred CCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 232 SSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
....+....+..+...+.+..++.++.++|..|| .+|.+||++.++++
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 309 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp CCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8888888888888777777789999999999999 59999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=339.26 Aligned_cols=264 Identities=22% Similarity=0.369 Sum_probs=212.0
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC--CCCcceeeeEEEeC
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK--HPNLIRFLQAIETT 94 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~ 94 (316)
..+.+.+|++.+.||+|+||.||+|.+.. ++.||+|++...... ....+.+.+|+.++..+. ||||+++++++..+
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~ 128 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence 34456679999999999999999998765 889999999765543 334566789999999996 59999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
+..++|||+ .+++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++ ++.++|+|||++.....
T Consensus 129 ~~~~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 129 QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp SEEEEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred CEEEEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 999999994 5779999999888899999999999999999999999999999999999995 58999999999976432
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHH-h
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGI----------PYAPHLSDIWSMGVVLFAMVFGRLPFDDS-SVNELLKQV-Q 242 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~-~ 242 (316)
.. .........|++.|+|||++.+. ...+.++|||||||++|+|++|..||... ........+ .
T Consensus 207 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 207 DT----TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp -----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred CC----ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 11 11122345689999999998652 23344599999999999999999999864 333333333 3
Q ss_pred cccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 243 NKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.....+.+...+.++.+||..|| .+|.+|||+.++++||||+....
T Consensus 283 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329 (390)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence 33344445567899999999999 59999999999999999976543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=321.55 Aligned_cols=253 Identities=22% Similarity=0.415 Sum_probs=219.3
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++..++||||+++++++.....
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 3567899999999999999999999766 5668999999765443 3446799999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
.++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999999999764 35999999999999999999999999999999999999999999999999998653211
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
.........+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...........+........+...+
T Consensus 158 -----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (268)
T 3sxs_A 158 -----QYVSSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLAS 231 (268)
T ss_dssp -----CEEECCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSC
T ss_pred -----hhhcccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcCh
Confidence 1111223345678999999987777666 999999999999999 999999999998888888877777777889
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+.+.++|..|| .+|.+|||+.+++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 232 DTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 599999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=341.07 Aligned_cols=258 Identities=23% Similarity=0.384 Sum_probs=222.4
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
..+.+..++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 356778899999999999999999999999899999999986542 233345677999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
...++||||+++++|.++++.. ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999999999764 359999999999999999999999999999999999999999999999999986532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
... .........++..|+|||++....++.+ +||||||+++|+|++ |..||......+..+.+..+...+.+..
T Consensus 265 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (377)
T 3cbl_A 265 DGV----YAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPEL 339 (377)
T ss_dssp TSE----EECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred CCc----eeecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 110 0011112235678999999977666555 999999999999998 9999999999999888888888888888
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+++++.++|..|| .+|.+|||++++++
T Consensus 340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999 59999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=325.85 Aligned_cols=257 Identities=30% Similarity=0.546 Sum_probs=219.0
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|++|.||+|.+..+++.|++|++........ ..+.+.+|+.+++.++||||+++++++......++|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 5789999999999999999999999999999999976443222 134577999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC---CCeEEeecccccccccccC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD---YNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~---~~~~l~Df~~~~~~~~~~~ 177 (316)
+|++++++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~---- 175 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---- 175 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC----
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec----
Confidence 9999999999999877789999999999999999999999999999999999999764 469999999986532
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC---CCCCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT---FPKQPEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 254 (316)
.........+++.|+|||.+.+. + +.++||||||+++|+|++|..||.+....+....+..+.. .+....++
T Consensus 176 ---~~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 176 ---QNTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp ---CCSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred ---CCCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 11222334578899999998764 4 4459999999999999999999999888888777765432 22335789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
.++.++|.+|| .+|.+|||++++++||||+...
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 99999999999 5999999999999999997543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=338.33 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=205.2
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC----
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH---- 95 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 95 (316)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 457899999999999999999999999999999999765433 333455679999999999999999999997654
Q ss_pred --eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 --RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 --~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
..++||||+++ +|.+++.. .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 88888863 48999999999999999999999999999999999999999999999999986532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC---
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ--- 250 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 250 (316)
.........+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+......+.+
T Consensus 179 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 179 -------TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred -------cccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 1122234468899999999988777665 99999999999999999999998877766666443221110
Q ss_pred -----------------C---------------------CCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 251 -----------------P---------------------EVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 251 -----------------~---------------------~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
. ..+.++.+||.+|| .||.+|||++++++||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0 01568999999999 59999999999999999964
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=333.15 Aligned_cols=268 Identities=25% Similarity=0.371 Sum_probs=214.1
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC--
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-- 94 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 94 (316)
.....++|.+.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 3345689999999999999999999999999999999986432 233345566999999999999999999988654
Q ss_pred ---CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 95 ---HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 95 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
...++||||+. ++|.+++.. +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67899999996 499999987 4599999999999999999999999999999999999999999999999999976
Q ss_pred cccccCcCC----CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC
Q psy11194 172 HMRCRSNAA----DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF 247 (316)
Q Consensus 172 ~~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (316)
......... .........|++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 532211111 0111223467899999998865444455599999999999999999999988766555444221110
Q ss_pred -------------------------CC------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 248 -------------------------PK------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 248 -------------------------~~------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+. .+.+++++.+||.+|| .+|.+|||++++++||||+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 10 1368899999999999 59999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=331.77 Aligned_cols=267 Identities=19% Similarity=0.368 Sum_probs=203.9
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCc---eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
...+..++|++.+.||+|+||.||+|.+..+++ .||+|++......... .+.+.+|+.+++.++||||+++++++.
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHH-HHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHH-HHHHHHHHHHHHHCCCCceehhhceee
Confidence 355678899999999999999999999887665 7999999765443333 456779999999999999999999998
Q ss_pred eCCeE------EEEEecCCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC
Q psy11194 93 TTHRV------YIIMEYAENGSLFDIIRGQG------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN 160 (316)
Q Consensus 93 ~~~~~------~lv~e~~~~~sL~~~l~~~~------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~ 160 (316)
..... ++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 77655 99999999999999996422 5999999999999999999999999999999999999999999
Q ss_pred eEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy11194 161 IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLK 239 (316)
Q Consensus 161 ~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~ 239 (316)
++|+|||++....... .........+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+....+...
T Consensus 176 ~kl~Dfg~a~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 250 (323)
T 3qup_A 176 VCVADFGLSRKIYSGD----YYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250 (323)
T ss_dssp EEECCCCC---------------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred EEEeeccccccccccc----cccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence 9999999987543211 1111223345678999999987666655 999999999999999 999999988888888
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCC-------HHHHhhCCCCCCCCC
Q psy11194 240 QVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPR-------LKTIAEDRWLKPKPK 288 (316)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps-------~~~il~~~~~~~~~~ 288 (316)
.+......+.+..+++++.++|.+|| .+|.+||| ++++++|||+.+...
T Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 251 YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 88887777777889999999999999 59999999 899999999987655
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=334.42 Aligned_cols=259 Identities=33% Similarity=0.543 Sum_probs=206.8
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC-----chHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP-----PDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 56899999999999999999999999999999998654321 1122345779999999999999999999987665
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC---eEEeeccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN---IKLSDFGFARAH 172 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~---~~l~Df~~~~~~ 172 (316)
.++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988888999999999999999999999999999999999999987665 999999998653
Q ss_pred ccccCcCCCCCCCcccccccCccCccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcccCCC-
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQ--GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN-ELLKQVQNKVTFP- 248 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~- 248 (316)
.. ........+++.|+|||++. .....+.++||||||+++|+|++|..||...... .....+..+....
T Consensus 168 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 168 GE-------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp CC-------CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred cc-------ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 21 11112345788999999973 2233344599999999999999999999764322 2333333322111
Q ss_pred --CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 249 --KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 249 --~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
....++.++.++|.+|| .+|.+|||++++++||||++..
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 12468999999999999 5999999999999999998643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=323.19 Aligned_cols=256 Identities=22% Similarity=0.389 Sum_probs=219.0
Q ss_pred cccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 14 RKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 14 ~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
...+.+..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++..++||||+++++++..
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 3456788999999999999999999999776 5678999999765443 3446799999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
.+..++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 9999999999999999999976 456999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
.... ........+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+....+........+.
T Consensus 171 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T 3gen_A 171 LDDE-----YTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 244 (283)
T ss_dssp CCHH-----HHSTTSTTSCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred cccc-----cccccCCccCcccCCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCC
Confidence 2211 111222335678999999987666554 999999999999998 999999999999998888887777777
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
..++.+.++|..|| .+|.+|||++++++|
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 89999999999999 599999999999965
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=338.96 Aligned_cols=262 Identities=23% Similarity=0.385 Sum_probs=218.7
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchH--------------HHhhHHHHHHHHhcCCCC
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDY--------------LKKFLPREIEVVKGLKHP 82 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~--------------~~~~~~~e~~~l~~l~~~ 82 (316)
.....++|.+.+.||+|+||.||+|.+ +|+.||+|++......... ..+.+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 334567999999999999999999988 7899999999753322111 015678999999999999
Q ss_pred CcceeeeEEEeCCeEEEEEecCCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCe
Q psy11194 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDI------IRG--QGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENL 153 (316)
Q Consensus 83 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~ni 153 (316)
||+++++++...+..++||||+++++|.++ +.. ...+++..++.++.|++.||.+||+ .|++|+||+|+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 655 5679999999999999999999999 9999999999999
Q ss_pred eeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy11194 154 LLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI-PYAPHLSDIWSMGVVLFAMVFGRLPFDDS 232 (316)
Q Consensus 154 l~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~ 232 (316)
+++.++.++|+|||++...... ......++..|+|||++.+. .+...++||||||+++|+|++|..||...
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK--------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT--------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEcCCCcEEEeccccccccccc--------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999998653211 22344588999999999876 44443599999999999999999999876
Q ss_pred CH-HHHHHHHhccc-CCCCC-----------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 233 SV-NELLKQVQNKV-TFPKQ-----------------PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 233 ~~-~~~~~~~~~~~-~~~~~-----------------~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
.. .+....+.... ..+.. ..++.++.+||.+|| .+|.+|||++++++||||++...
T Consensus 256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp SCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred CcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 65 66666665442 22211 568999999999999 59999999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=336.11 Aligned_cols=264 Identities=26% Similarity=0.471 Sum_probs=215.0
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEc---cCCceEEEEEeecCCCC-chHHHhhHHHHHHHHhcC-CCCCcceeeeEE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARST---RHSGDVAIKIVSKVQAP-PDYLKKFLPREIEVVKGL-KHPNLIRFLQAI 91 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~---~~~~~v~vK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 91 (316)
..+..++|++.+.||+|+||.||+|++. .+++.||+|++...... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3445589999999999999999999984 47889999998653211 111133455789999999 699999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 92 ETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 92 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
......++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999998877899999999999999999999999999999999999999999999999999875
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcccC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGI-PYAPHLSDIWSMGVVLFAMVFGRLPFDDS----SVNELLKQVQNKVT 246 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~~~~ 246 (316)
..... ........|++.|+|||++.+. ...+.++|||||||++|+|++|..||... ....+...+... .
T Consensus 209 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~ 282 (355)
T 1vzo_A 209 FVADE-----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-E 282 (355)
T ss_dssp CCGGG-----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-C
T ss_pred cccCC-----CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-C
Confidence 42211 1122334689999999999753 23345599999999999999999999642 334444444332 3
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 247 FPKQPEVSTECKELISNIL-SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 247 ~~~~~~~~~~~~~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
.+.+..++..+.+||.+|| .+|.+|| +++++++||||+..
T Consensus 283 ~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 283 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 3445678999999999999 6999999 99999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=339.88 Aligned_cols=261 Identities=20% Similarity=0.295 Sum_probs=221.3
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEE-----EccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLAR-----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQA 90 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~-----~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 90 (316)
...+..++|++.+.||+|+||.||+|. +..++..||+|++..... ......+.+|+.+++.++||||++++++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC--hhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 456678899999999999999999999 445677899999864332 2234456789999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC---C
Q psy11194 91 IETTHRVYIIMEYAENGSLFDIIRGQ-------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY---N 160 (316)
Q Consensus 91 ~~~~~~~~lv~e~~~~~sL~~~l~~~-------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~---~ 160 (316)
+......++||||+++++|.+++... ..++...++.++.||+.||.|||+.|++||||||+||+++.+| .
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 99999999999999999999999753 3589999999999999999999999999999999999998555 4
Q ss_pred eEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy11194 161 IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLK 239 (316)
Q Consensus 161 ~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~ 239 (316)
++|+|||++....... .........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||......+...
T Consensus 223 ~kL~DFG~a~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~~~ 297 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAG----YYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297 (367)
T ss_dssp EEECCCHHHHHHHHHS----SCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred EEECCCcccccccccc----ccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999997543221 1122233456889999999977666655 999999999999998 999999999999999
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 240 QVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
.+..+...+.+..++..+.++|..|| .+|.+|||+.+++++.++
T Consensus 298 ~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 99888777777889999999999999 599999999999988765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=333.61 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=222.5
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEccC-------CceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcce
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARSTRH-------SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIR 86 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~ 86 (316)
..+++..++|.+.+.||+|+||.||+|.+... +..||+|++..... ....+.+.+|+.+++.+ +||||++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--HHHHHHHHHHHHHHHHhcCCchhhh
Confidence 34577889999999999999999999997543 34799999865432 33345677999999999 8999999
Q ss_pred eeeEEEeCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCC
Q psy11194 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQG----------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKC 150 (316)
Q Consensus 87 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p 150 (316)
+++++...+..++||||+++++|.+++.... .+++..++.++.||+.||.+||+.|++|+||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999997643 499999999999999999999999999999999
Q ss_pred CCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q psy11194 151 ENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPF 229 (316)
Q Consensus 151 ~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~ 229 (316)
+||+++.++.++|+|||++....... .........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~ 294 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHID----YYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 294 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCC----TTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSS
T ss_pred ceEEEcCCCcEEEcccCccccccccc----ccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999986542111 1122233446788999999987666655 999999999999999 99999
Q ss_pred CCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 230 DDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
......+....+........+..+++++.++|..|| .+|++|||+++++++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 295 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999888777777889999999999999 599999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=335.16 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=206.2
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.......+|++.+.||+|+||.||+|.+..++. +|+|.+...... ..+|+.+++.++||||+++++++....
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 344456789999999999999999999877665 888877553322 237999999999999999999995543
Q ss_pred ------eEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC-CCCCeEEe
Q psy11194 96 ------RVYIIMEYAENGSLFDIIR----GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD-SDYNIKLS 164 (316)
Q Consensus 96 ------~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~-~~~~~~l~ 164 (316)
..++||||+++ ++...+. ....+++..++.++.||+.||.|||+.|++|+||||+||+++ .++.++|+
T Consensus 106 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~ 184 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLI 184 (394)
T ss_dssp SSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEe
Confidence 38899999977 4444432 356799999999999999999999999999999999999998 78999999
Q ss_pred ecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Q psy11194 165 DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK 244 (316)
Q Consensus 165 Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (316)
|||++..... ........+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 185 DFG~a~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~ 257 (394)
T 4e7w_A 185 DFGSAKILIA-------GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257 (394)
T ss_dssp CCTTCEECCT-------TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred eCCCcccccC-------CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999976421 112233457889999999977665555699999999999999999999988776665544331
Q ss_pred c------------------CCC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 245 V------------------TFP----------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 245 ~------------------~~~----------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
. .++ ....+++++.+||.+|| .+|.+|||+.++++||||++...
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 1 111 12348899999999999 59999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=329.10 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=221.8
Q ss_pred cccccceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcce
Q psy11194 12 IDRKVTVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86 (316)
Q Consensus 12 ~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 86 (316)
.......+..++|.+.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.+++.++||||++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~ 90 (314)
T 2ivs_A 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSEFNVLKQVNHPHVIK 90 (314)
T ss_dssp -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCceee
Confidence 334456778999999999999999999999874 3457899999865432 333456779999999999999999
Q ss_pred eeeEEEeCCeEEEEEecCCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHcC
Q psy11194 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQG------------------------YIDEIRARRWFGQLLEALQYCHERG 142 (316)
Q Consensus 87 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------~l~~~~~~~i~~~i~~~l~~Lh~~~ 142 (316)
+++++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 170 (314)
T 2ivs_A 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK 170 (314)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999997643 2899999999999999999999999
Q ss_pred ccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHH
Q psy11194 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAM 222 (316)
Q Consensus 143 ~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l 222 (316)
++|+||+|+||+++.++.++|+|||++........ ........+++.|+|||++.+..++.+ +||||||+++|+|
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el 245 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS----YVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEI 245 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSC----EECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHH
T ss_pred CcccccchheEEEcCCCCEEEcccccccccccccc----ceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHH
Confidence 99999999999999999999999999865422111 111223345778999999977666555 9999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 223 VF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 223 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
++ |..||.+.........+......+.+..+++++.++|..|| .+|.+|||+.+++++
T Consensus 246 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 246 VTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99 99999998888888888877777777789999999999999 599999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=325.54 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=213.5
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEc-cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC---CCCCcceeeeEEE---
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARST-RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL---KHPNLIRFLQAIE--- 92 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~--- 92 (316)
..++|++.+.||+|+||.||+|.+. .+|+.||+|++........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4688999999999999999999985 6788999999975433221 123355677776665 8999999999987
Q ss_pred --eCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 93 --TTHRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 93 --~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
.....++||||++ ++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5667899999997 5999999764 3499999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP 248 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (316)
+...... .......++..|+|||++.+..++.+ +||||||+++|+|++|..||.+....+....+......+
T Consensus 167 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 167 ARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp CCCCCGG-------GGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccCC-------CCccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 8653211 12233457889999999988776655 999999999999999999999888777666554321110
Q ss_pred --------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 249 --------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 249 --------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
....++.++.+||.+|| .+|.+|||+.++++||||++.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 12458899999999999 5999999999999999999887654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=348.79 Aligned_cols=249 Identities=13% Similarity=0.170 Sum_probs=198.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHH---HHhcCCCCCcceee-------eE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIE---VVKGLKHPNLIRFL-------QA 90 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~---~l~~l~~~~i~~~~-------~~ 90 (316)
.++|++.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+. .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 577999999999999999999998899999999998654444444667889994 45555799999988 66
Q ss_pred EEeCC-----------------eEEEEEecCCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHcCcccc
Q psy11194 91 IETTH-----------------RVYIIMEYAENGSLFDIIRGQGYIDE-------IRARRWFGQLLEALQYCHERGVVHR 146 (316)
Q Consensus 91 ~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~~l~~-------~~~~~i~~~i~~~l~~Lh~~~~~H~ 146 (316)
+...+ ..++||||+ +|+|.+++...+.+++ ..++.++.||+.||+|||+.|++|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 65543 288999999 5699999986444544 7888999999999999999999999
Q ss_pred CCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCC-----------CCCCCchhHHHH
Q psy11194 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI-----------PYAPHLSDIWSM 215 (316)
Q Consensus 147 dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~~Di~sl 215 (316)
||||+|||++.++.++|+|||++.... .......| +.|+|||++.+. .++. ++|||||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~---------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~-~~DvwSl 299 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG---------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF-SFDAWAL 299 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT---------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH-HHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC---------CcccCCCC-cCccChhhhcccccccccccccccCCh-hhhHHHH
Confidence 999999999999999999999986421 11223346 899999999776 4544 4999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 216 GVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 216 G~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
||++|+|++|..||...........+. .....+++++.+||.+|| .+|.+|||+.++++||||+..
T Consensus 300 G~il~elltg~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGGSEWIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHHHSSCCC------CCSGGGG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHHCCCCCcccccccchhhhh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 999999999999997655433322222 223578999999999999 599999999999999999653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=333.81 Aligned_cols=263 Identities=25% Similarity=0.391 Sum_probs=208.0
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc--------hHHHhhHHHHHHHHhcCCCCCcceeeeEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP--------DYLKKFLPREIEVVKGLKHPNLIRFLQAI 91 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 91 (316)
..++|++.+.||+|+||.||+|.+.. |+.||+|++....... ....+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 46889999999999999999998865 8899999986543322 12235677999999999999999999998
Q ss_pred Ee-----CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEee
Q psy11194 92 ET-----THRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSD 165 (316)
Q Consensus 92 ~~-----~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~D 165 (316)
.. ....++||||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 43 3468999999975 888888654 4699999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc
Q psy11194 166 FGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV 245 (316)
Q Consensus 166 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (316)
||++.... .........+++.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+....
T Consensus 178 fg~~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 178 FNLAREDT-------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp TTC----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cCcccccc-------cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 99986421 12223344578899999998875545556999999999999999999999887776665553311
Q ss_pred CCC-------------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 246 TFP-------------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 246 ~~~-------------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
..+ ..+..++.+.+||.+|| .+|.+|||++++++||||+......+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 328 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD 328 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence 111 11356899999999999 59999999999999999988755444
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=330.84 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=209.8
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe----
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR---- 96 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 96 (316)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 5789999999999999999999999999999999966443 33345567799999999999999999999977653
Q ss_pred --EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 97 --VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 97 --~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
.++||||+.+ +|.+++.. .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 4999999974 88887753 499999999999999999999999999999999999999999999999999865321
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--------
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-------- 246 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 246 (316)
......+++.|+|||++.+....+.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 179 ---------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 179 ---------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp --------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred ---------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 122345789999999987744444559999999999999999999998876665554432110
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 247 ----------------------FPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 247 ----------------------~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
....+.+++++.+||.+|| .+|.+|||++++++||||++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 0112467999999999999 59999999999999999987643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=328.63 Aligned_cols=258 Identities=23% Similarity=0.354 Sum_probs=212.7
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEE-ccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC------Ccceee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARS-TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP------NLIRFL 88 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~ 88 (316)
...+..++|++.+.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+.+++.++|+ ++++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 4556678999999999999999999998 457889999998642 23345677899988888654 599999
Q ss_pred eEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC---------
Q psy11194 89 QAIETTHRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS--------- 157 (316)
Q Consensus 89 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~--------- 157 (316)
+++...+..++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+.|++|+||+|+||+++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 779999997754 6899999999999999999999999999999999999987
Q ss_pred ----------CCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q psy11194 158 ----------DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRL 227 (316)
Q Consensus 158 ----------~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~ 227 (316)
++.++|+|||++.... .......+++.|+|||++.+..++.+ +||||||+++|+|++|..
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDD---------EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETT---------SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccCCCceEeeCcccccCc---------cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCC
Confidence 6689999999986522 11233457899999999988776665 999999999999999999
Q ss_pred CCCCCCHHHHHHHHhcccCC-C------------------------------------------CCCCCCHHHHHHHHHh
Q psy11194 228 PFDDSSVNELLKQVQNKVTF-P------------------------------------------KQPEVSTECKELISNI 264 (316)
Q Consensus 228 p~~~~~~~~~~~~~~~~~~~-~------------------------------------------~~~~~~~~~~~li~~~ 264 (316)
||...+..+....+...... + .....++++.+||.+|
T Consensus 233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 99988777665544322110 0 1112357899999999
Q ss_pred c-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 265 L-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 265 l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
| .+|.+|||+.++++||||+..++
T Consensus 313 L~~dP~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 313 LEYDPAKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp TCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred hCcCcccccCHHHHhcCHHHHHHhc
Confidence 9 59999999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=337.34 Aligned_cols=253 Identities=28% Similarity=0.450 Sum_probs=204.5
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-----
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 94 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 94 (316)
...+|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999865432 233799999999999999999988532
Q ss_pred -CeEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-CCeEEeeccc
Q psy11194 95 -HRVYIIMEYAENGSLFDIIR----GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGF 168 (316)
Q Consensus 95 -~~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~-~~~~l~Df~~ 168 (316)
...++||||+++ +|.+++. ....+++..++.++.||+.||.|||+.|++|+||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 246799999976 6766654 35679999999999999999999999999999999999999865 5689999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc----
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK---- 244 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---- 244 (316)
++.... ........+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 204 a~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 204 AKQLVR-------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276 (420)
T ss_dssp CEECCT-------TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred hhhccc-------CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 975421 111223457899999999977644555699999999999999999999987766555444321
Q ss_pred --------------cCCC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 245 --------------VTFP----------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 245 --------------~~~~----------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
..++ ..+.+++++.+||.+|| .+|.+||++.++++||||+...
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 1111 12356899999999999 5999999999999999997543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=321.81 Aligned_cols=262 Identities=26% Similarity=0.469 Sum_probs=204.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe-------
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------- 93 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------- 93 (316)
.++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 46799999999999999999999999999999998642 2334567799999999999999999998865
Q ss_pred ------CCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeec
Q psy11194 94 ------THRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDF 166 (316)
Q Consensus 94 ------~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df 166 (316)
....++||||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 457899999999999999998543 5888999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCc--------CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHH
Q psy11194 167 GFARAHMRCRSN--------AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNEL 237 (316)
Q Consensus 167 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~ 237 (316)
|++......... ...........+++.|+|||++.+....+.++||||||+++|+|++ ||.. ......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 998754321100 0011222344588899999999865445556999999999999998 5543 233344
Q ss_pred HHHHhccc---CCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 238 LKQVQNKV---TFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 238 ~~~~~~~~---~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
...+.... +.......+..+.++|..|| .+|.+|||++++++||||+.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence 44443321 12223457788999999999 599999999999999999876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=330.29 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=219.6
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAI 91 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 91 (316)
..+..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4567889999999999999999999987 345789999986543 233456688999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccC
Q psy11194 92 ETTHRVYIIMEYAENGSLFDIIRGQ------------------------GYIDEIRARRWFGQLLEALQYCHERGVVHRD 147 (316)
Q Consensus 92 ~~~~~~~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~d 147 (316)
...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999999763 5699999999999999999999999999999
Q ss_pred CCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CC
Q psy11194 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GR 226 (316)
Q Consensus 148 l~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~ 226 (316)
|+|+||+++.++.++|+|||++........ ........+++.|+|||++.+..++.+ +||||||+++|+|++ |.
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADY----YKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC----BC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTC
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCcc----ccccCCCcccceecChhhhccCCcCcc-cccHHHHHHHHHHHhcCC
Confidence 999999999999999999999875432111 111223456888999999877666554 999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 227 LPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.||.+....+....+..+...+.+..++.++.++|..|| .+|.+|||+.++++
T Consensus 275 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 999999999988888877666667789999999999999 59999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=328.63 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=205.0
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC--
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-- 95 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 95 (316)
...+++|++.+.||+|+||.||+|.+..+++.||+|++........ .+.+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 3457889999999999999999999999999999999875433222 344668999999999999999999997655
Q ss_pred eEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee----CCCCCeEEeeccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQG---YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL----DSDYNIKLSDFGF 168 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~----~~~~~~~l~Df~~ 168 (316)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 7899999999999999997643 39999999999999999999999999999999999999 7778899999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCccccc--------CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHH
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQ--------GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS----SVNE 236 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~ 236 (316)
+..... ........+++.|+|||++. +..++.+ +|||||||++|+|++|..||... ...+
T Consensus 163 a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 163 ARELED-------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp CEECCT-------TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTT-HHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred ceecCC-------CCceeecccCCCccCHHHhhhccccccccCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 975321 12223445889999999875 3445544 99999999999999999999642 2233
Q ss_pred HHHHHhcccC--------------------CCCC----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCC
Q psy11194 237 LLKQVQNKVT--------------------FPKQ----PEVSTECKELISNIL-SPVQTRPRLKTIAEDRW 282 (316)
Q Consensus 237 ~~~~~~~~~~--------------------~~~~----~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~ 282 (316)
....+..+.. .+.. ..++..+.++|..|| .||++|||++++++||-
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 3333332221 1111 124568889999999 59999999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=325.09 Aligned_cols=262 Identities=27% Similarity=0.511 Sum_probs=215.1
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc-hHHHhhHHHHHHHHhcCCCCCcceeeeEE--EeCCeE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP-DYLKKFLPREIEVVKGLKHPNLIRFLQAI--ETTHRV 97 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~ 97 (316)
..+|.+.+.||+|+||.||+|.+..+++.+++|++....... ....+.+.+|+.+++.++||||+++++++ ......
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999999999999986532110 11245677999999999999999999998 445688
Q ss_pred EEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
++||||++++ |.+++.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999875 7777765 456999999999999999999999999999999999999999999999999998654211
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPY-APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
. .........+++.|+|||++.+... .+.++||||||+++|+|++|..||.+.+..+....+.... .+.+..++
T Consensus 163 ~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~ 237 (305)
T 2wtk_C 163 A----ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCG 237 (305)
T ss_dssp C----SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSSSC
T ss_pred c----cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCccC
Confidence 1 1112233457899999999876432 3445999999999999999999999988888877776553 34456789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+.+.++|.+|| .+|.+|||++++++||||+....
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 99999999999 59999999999999999976544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=320.46 Aligned_cols=265 Identities=29% Similarity=0.420 Sum_probs=209.3
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+.-.+|.....||+|+||.||+|.+..+++.|++|.+...... ..+.+.+|+.+++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---YSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH---HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 334444555556999999999999999999999999998765332 24557799999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC-CCCeEEeeccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQ---GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS-DYNIKLSDFGFARAH 172 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~---~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~-~~~~~l~Df~~~~~~ 172 (316)
.++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 99999999999999999764 24678999999999999999999999999999999999987 899999999998654
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HH-HHHHhcccCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN-EL-LKQVQNKVTFPK 249 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~-~~~~~~~~~~~~ 249 (316)
... ........+++.|+|||++.+.. ..+.++||||||+++|+|++|..||...... .. ............
T Consensus 174 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 2clq_A 174 AGI------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI 247 (295)
T ss_dssp CC-----------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCC
T ss_pred CCC------CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccc
Confidence 211 11123345788999999986543 2334599999999999999999999754322 22 222222333444
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
+..+++++.++|.+|| .+|++|||++++++||||+......
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 289 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-----
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccC
Confidence 5678999999999999 5999999999999999998766543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=316.44 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=218.7
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
+.+..++|++.+.||+|+||.||+|.+. +++.|++|++...... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4567889999999999999999999886 5678999999765433 3457799999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
.++||||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999999764 56899999999999999999999999999999999999999999999999998654211
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
. ........++..|+|||++.+..++.+ +||||||+++|+|++ |..||......+....+..+.....+..++
T Consensus 158 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 231 (267)
T 3t9t_A 158 Q-----YTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS 231 (267)
T ss_dssp H-----HHSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred c-----ccccccccccccccChhhhcCCCccch-hchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCc
Confidence 1 111223345778999999977666554 999999999999999 999999999998888888877777777899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
..+.++|..|| .+|.+|||+.+++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 232 THVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999 599999999999853
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=334.03 Aligned_cols=260 Identities=24% Similarity=0.411 Sum_probs=211.6
Q ss_pred cccceeeccCeEEeeeeeecCCeEEEEEEEc---cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeE
Q psy11194 14 RKVTVLESHGYTVGKIIGTGSYATVKLARST---RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQA 90 (316)
Q Consensus 14 ~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~---~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 90 (316)
.....+...+|.+.+.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.++..++||||++++++
T Consensus 37 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 37 EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp TTSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred HHHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3345677889999999999999999999876 456789999986543 23335567799999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 91 IETTHRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 91 ~~~~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
+......++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 999999999999999999999997643 6999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCC
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFP 248 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 248 (316)
........ .........++..|+|||++.+..++.+ +||||||+++|+|++ |..||......+....+..+...+
T Consensus 195 ~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~ 270 (373)
T 2qol_A 195 RVLEDDPE---AAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP 270 (373)
T ss_dssp ----------------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC
T ss_pred cccccCCc---cceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 76432111 0111112234678999999987666655 999999999999998 999999999999988888887777
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 249 KQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 249 ~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+..++.++.++|..|| .+|.+||+++++++
T Consensus 271 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 77789999999999999 59999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=333.62 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=199.8
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe--
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR-- 96 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 96 (316)
...++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+++..+..++||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34678999999999999999999999999999999986543322 234467778888899999999999965433
Q ss_pred -----EEEEEecCCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccCCCCCCeeeCC-CCCeEEe
Q psy11194 97 -----VYIIMEYAENGSLFDII----RGQGYIDEIRARRWFGQLLEALQYCH--ERGVVHRDIKCENLLLDS-DYNIKLS 164 (316)
Q Consensus 97 -----~~lv~e~~~~~sL~~~l----~~~~~l~~~~~~~i~~~i~~~l~~Lh--~~~~~H~dl~p~nil~~~-~~~~~l~ 164 (316)
.++||||+++ +|...+ .....+++..++.++.|++.||.+|| +.|++|+||+|+||+++. ++.++|+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 8899999977 555444 34567999999999999999999999 999999999999999986 8999999
Q ss_pred ecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Q psy11194 165 DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK 244 (316)
Q Consensus 165 Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (316)
|||++..... ........+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 175 Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 175 DFGSAKKLSP-------SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp CCTTCBCCCT-------TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred eCCCceecCC-------CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 9999865321 122233457889999999877665555699999999999999999999998877776666432
Q ss_pred cCCC-------------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 245 VTFP-------------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 245 ~~~~-------------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
...+ .....++++.+||.+|| .+|.+|||+.++++||||+.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 1111 11225789999999999 599999999999999999876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=324.38 Aligned_cols=259 Identities=19% Similarity=0.358 Sum_probs=208.7
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..++|++.+.||+|+||.||+|.+..+++.+|+|.+... .....+.+.+|+.+++.++||||+++++++..+..
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 81 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR 81 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence 456788999999999999999999999999999999987442 23345667899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
.++||||+++++|.++++. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999999999987 566999999999999999999999999999999999999999999999999999765322
Q ss_pred cCcCC--------CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHhccc
Q psy11194 176 RSNAA--------DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL--KQVQNKV 245 (316)
Q Consensus 176 ~~~~~--------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~--~~~~~~~ 245 (316)
..... .........|++.|+|||++.+..++.+ +||||||+++|+|++|..||......... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence 21110 0111124568999999999988776665 99999999999999999988652211000 0000001
Q ss_pred CCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 246 TFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 246 ~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
....+..+++.+.++|..|| .+|++|||++++++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11224568999999999999 59999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=320.29 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=208.2
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
...++|++.+.||+|+||.||+|.+..+++.|++|++...........+.+.+|+.+++.++||||+++++++..++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34578999999999999999999999999999999997655444445567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+||||+++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--- 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE--- 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc---
Confidence 99999999999999988788999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC--CCCCCCHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP--KQPEVSTE 256 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 256 (316)
.........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...........+......+ ..+.+|.+
T Consensus 188 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 188 --KLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred --ccccccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHH
Confidence 1112233457889999999988776665 999999999999999999999877665555555443322 34578999
Q ss_pred HHHHHHHhc-CCCCCCC-CHHHHhh
Q psy11194 257 CKELISNIL-SPVQTRP-RLKTIAE 279 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rp-s~~~il~ 279 (316)
+.++|.+|| .+|++|| +++++++
T Consensus 265 l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999 5999999 8888774
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=322.53 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=222.1
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.+++..++|++.+.||+|+||.||+|.+..++..|++|++..... ..+.+.+|+.+++.++||||+++++++..+.
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 467789999999999999999999999999999999999865332 2455779999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
..++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999999763 459999999999999999999999999999999999999999999999999986532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
. ..........+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+.......+......+.+..
T Consensus 163 ~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 3kfa_A 163 G-----DTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236 (288)
T ss_dssp S-----SSSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred C-----CccccccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCC
Confidence 1 11112223345778999999977666555 999999999999999 9999999888888888888877777788
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+++.+.++|..|| .+|.+|||++++++
T Consensus 237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 237 CPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999999999999 59999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=324.69 Aligned_cols=263 Identities=25% Similarity=0.352 Sum_probs=207.9
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE-----
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE----- 92 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 92 (316)
..-..+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 345788999999999999999999999999999999986542 233456779999999999999999999873
Q ss_pred ---------eCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC-CCCCeE
Q psy11194 93 ---------TTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD-SDYNIK 162 (316)
Q Consensus 93 ---------~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~-~~~~~~ 162 (316)
.....++||||++ ++|.+++.. +.+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++.++
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 4468899999997 499999975 4599999999999999999999999999999999999997 567899
Q ss_pred EeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy11194 163 LSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ 242 (316)
Q Consensus 163 l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~ 242 (316)
|+|||++....... ..........++..|+|||.+......+.++||||||+++|+|++|..||.+....+....+.
T Consensus 162 l~Dfg~~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHY---SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp ECCCTTCBCC-----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EccCccccccCCCc---ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999987542111 111222334468889999998764444555999999999999999999999888766655554
Q ss_pred cccCCC-----------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 243 NKVTFP-----------------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 243 ~~~~~~-----------------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
...... ..+.++.++.++|.+|| .+|.+|||++++++||||+...-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 322111 12458999999999999 59999999999999999986543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=321.21 Aligned_cols=254 Identities=23% Similarity=0.403 Sum_probs=206.6
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccC---CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRH---SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
.++..++|++.+.||+|+||.||+|.+..+ +..+++|+..... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 567789999999999999999999998654 4468999875533 3334566789999999999999999999984
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
++..++||||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 457889999999999999997644 6999999999999999999999999999999999999999999999999998764
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
.... ........+++.|+|||++....++.+ +||||||+++|+|++ |..||.+....+....+......+.+.
T Consensus 167 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 240 (281)
T 1mp8_A 167 EDST-----YYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 240 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred Cccc-----ccccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCC
Confidence 3211 111222345678999999977666554 999999999999997 999999888888888887777777778
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+++.+.++|..|| .+|.+|||+.++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 89999999999999 59999999999885
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=326.66 Aligned_cols=257 Identities=20% Similarity=0.350 Sum_probs=214.8
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCce----EEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGD----VAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAI 91 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~----v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 91 (316)
...+..++|++.+.||+|+||.||+|.+..+++. +++|.+....... ..+.+.+|+.++..++||||+++++++
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS--CBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH--HHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 3456788999999999999999999999888776 6677664433221 133456899999999999999999988
Q ss_pred EeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 92 ETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 92 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
. ....++||||+++++|.+++... +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 85 P-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp C-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred c-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 6 45688999999999999999764 469999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCC
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPK 249 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (316)
..... ..........++..|+|||++.+..++.+ +||||||+++|+|++ |..||.+....+....+......+.
T Consensus 164 ~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (325)
T 3kex_A 164 LLPPD----DKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ 238 (325)
T ss_dssp GSCCC----TTCCC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC
T ss_pred ccCcc----cccccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC
Confidence 64321 11122334457778999999987666655 999999999999999 9999999888888888888777777
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+..++.++.++|..|| .+|.+|||+.+++++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 239 PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7789999999999999 599999999999876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=325.28 Aligned_cols=255 Identities=25% Similarity=0.418 Sum_probs=216.5
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceE--EEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDV--AIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIE 92 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v--~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 92 (316)
...+..++|++.+.||+|+||.||+|++..++..+ ++|.+..... ....+.+.+|+.++..+ +||||+++++++.
T Consensus 19 ~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 19 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 34466789999999999999999999999888865 8888865332 22245677999999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQG----------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD 156 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~ 156 (316)
..+..++||||+++++|.+++.... .+++..++.++.||+.||.+||+.|++|+||+|+||+++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 9999999999999999999997643 699999999999999999999999999999999999999
Q ss_pred CCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy11194 157 SDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVN 235 (316)
Q Consensus 157 ~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~ 235 (316)
.++.++|+|||++..... ........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+....
T Consensus 177 ~~~~~kL~Dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp GGGCEEECCTTCEESSCE-------ECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CCCeEEEcccCcCccccc-------cccccCCCCCccccChhhhccccCCch-hcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 999999999999853211 111222345778999999877666554 999999999999998 99999999999
Q ss_pred HHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 236 ELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+....+..+...+.+..+++++.++|.+|| .+|.+|||+++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 249 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 988888887777777789999999999999 599999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=333.36 Aligned_cols=261 Identities=21% Similarity=0.355 Sum_probs=215.4
Q ss_pred ccccceeeccCeEEeeeeeecCCeEEEEEE-----EccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcce
Q psy11194 13 DRKVTVLESHGYTVGKIIGTGSYATVKLAR-----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIR 86 (316)
Q Consensus 13 ~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~-----~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~ 86 (316)
+...+++..++|++.+.||+|+||.||+|. +..+++.||+|++..... ....+.+.+|+.++..+ +||||++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceee
Confidence 344567788999999999999999999998 445668999999965433 22345677999999999 7999999
Q ss_pred eeeEEEeCC-eEEEEEecCCCCCHHHHHHhCCC-----------------------------------------------
Q psy11194 87 FLQAIETTH-RVYIIMEYAENGSLFDIIRGQGY----------------------------------------------- 118 (316)
Q Consensus 87 ~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~----------------------------------------------- 118 (316)
+++++...+ ..++||||+++++|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998755 48999999999999999976432
Q ss_pred -------------------CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 119 -------------------IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 119 -------------------l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~---- 246 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD---- 246 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC----
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc----
Confidence 899999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHhcccCCCCCCCCCHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSS-VNELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
..........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.. .......+......+.+..+++++
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 325 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 325 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred ccchhccccCCCceeEChhhhcCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHH
Confidence 11112234457888999999987666655 999999999999998 999998765 444555666666666677899999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.++|..|| .+|.+|||++++++|
T Consensus 326 ~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 326 YQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHHH
Confidence 99999999 599999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=320.89 Aligned_cols=257 Identities=23% Similarity=0.414 Sum_probs=207.7
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEE----EccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLAR----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAI 91 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~----~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 91 (316)
...+..++|++.+.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 356788999999999999999999998 5668889999998643 233345678999999999999999999998
Q ss_pred Ee--CCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 92 ET--THRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 92 ~~--~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
.. ....++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 54 456899999999999999997644 499999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------------
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN------------- 235 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~------------- 235 (316)
+....... ..........++..|+|||.+.+..++.+ +||||||+++|+|++|..|+......
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 161 TKVLPQDK---EFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236 (295)
T ss_dssp CC----------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred cccccCCc---ceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence 97643211 11112223346777999999987766655 99999999999999999988653221
Q ss_pred ---HHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 236 ---ELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 236 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
...+.+......+.+..+++++.++|..|| .+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 334445556667777789999999999999 59999999999984
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=322.97 Aligned_cols=259 Identities=23% Similarity=0.366 Sum_probs=214.6
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCC----ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHS----GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAI 91 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~----~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 91 (316)
..++...+|.+.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 45677899999999999999999999987553 359999986543 233345677999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 92 ETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 92 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
...+..++||||+++++|.+++... +.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999999999764 569999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCC
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPK 249 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (316)
....... .........++..|+|||++.+..++.+ +||||||+++|+|++ |..||......+....+..+...+.
T Consensus 196 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 271 (333)
T 1mqb_A 196 VLEDDPE---ATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 271 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred hhccccc---cccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC
Confidence 6432111 1111122235678999999987666655 999999999999998 9999999999888888888877777
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+..++..+.++|.+|| .+|.+||++.+++++
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7889999999999999 599999999999854
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=326.20 Aligned_cols=257 Identities=22% Similarity=0.389 Sum_probs=210.8
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceE----EEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDV----AIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAI 91 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v----~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 91 (316)
...+..++|++.+.||+|+||.||+|++..+++.+ ++|.+..... ....+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 86 (327)
T 3poz_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45567889999999999999999999988777654 6776654322 12245577999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 92 ETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 92 ~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
.... .+++++++.+++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 87 ~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred ecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 8765 7789999999999999976 4569999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCC
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPK 249 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (316)
...... .........++..|+|||++.+..++.+ +||||||+++|+|++ |..||.+....+....+......+.
T Consensus 166 ~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T 3poz_A 166 LLGAEE----KEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240 (327)
T ss_dssp HHTTTC----C-------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred EccCCc----ccccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC
Confidence 643211 1112223345778999999987766655 999999999999999 9999999888888888888877788
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+..++.++.+++..|| .+|.+||++.+++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 8889999999999999 599999999999865
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=325.40 Aligned_cols=259 Identities=25% Similarity=0.408 Sum_probs=219.1
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEc-------cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcce
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARST-------RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIR 86 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~-------~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~ 86 (316)
..+.+..++|++.+.||+|+||.||+|.+. .++..||+|++..... ....+.+.+|+.+++.+ +||||++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc--HHHHHHHHHHHHHHHHhhcCCCEee
Confidence 356778999999999999999999999975 3567899999865432 33345677999999999 8999999
Q ss_pred eeeEEEeCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCC
Q psy11194 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQG----------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKC 150 (316)
Q Consensus 87 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p 150 (316)
+++++...+..++||||+++++|.+++.... .+++..++.++.||+.||.+||+.|++|+||+|
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 9999999999999999999999999997643 389999999999999999999999999999999
Q ss_pred CCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q psy11194 151 ENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPF 229 (316)
Q Consensus 151 ~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~ 229 (316)
+||+++.++.++|+|||++........ ........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSS----EECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSS
T ss_pred ceEEEcCCCCEEEcccccccccccccc----ccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCc
Confidence 999999999999999999865422110 011222345778999999877666554 999999999999999 99999
Q ss_pred CCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 230 DDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.+....+....+......+.+..++.++.++|..|| .+|.+|||+++++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 261 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999888888887777777789999999999999 599999999999853
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=318.66 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=214.8
Q ss_pred ccccceeeccCeEEee-eeeecCCeEEEEEEE--ccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeee
Q psy11194 13 DRKVTVLESHGYTVGK-IIGTGSYATVKLARS--TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89 (316)
Q Consensus 13 ~~~~~~~~~~~y~~~~-~ig~g~~g~vy~~~~--~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 89 (316)
...-..+..++|.+.+ .||+|+||.||+|.+ ..+++.|++|++....... ...+.+.+|+.+++.++||||+++++
T Consensus 7 ~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp ----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C-HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH-HHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3344566788999999 999999999999954 4567889999997654332 33556779999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
++ .....++||||+++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 86 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 86 IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 99 56678999999999999999998888999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCC
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFP 248 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 248 (316)
......... ........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||......+....+..+...+
T Consensus 165 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 240 (291)
T 1xbb_A 165 KALRADENY---YKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 240 (291)
T ss_dssp EECCTTCSE---EEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred eeeccCCCc---ccccccCCCCceeeChHHhccCCCChh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 654221110 011112235678999999977665554 999999999999999 999999999998888888877777
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy11194 249 KQPEVSTECKELISNIL-SPVQTRPRLKTIA 278 (316)
Q Consensus 249 ~~~~~~~~~~~li~~~l-~~p~~Rps~~~il 278 (316)
.+..+++++.++|..|| .+|.+|||+.+++
T Consensus 241 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 271 (291)
T 1xbb_A 241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVE 271 (291)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 77789999999999999 5999999999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=336.47 Aligned_cols=249 Identities=25% Similarity=0.446 Sum_probs=215.9
Q ss_pred cccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 14 RKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 14 ~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
...+.+..++|++.+.||+|+||.||+|.+. |+.||||++..... .+.+.+|+.+++.++||||+++++++..
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTT-----SHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchH-----HHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 3456788899999999999999999999775 67999999975432 3457799999999999999999999876
Q ss_pred CC-eEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 94 TH-RVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 94 ~~-~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
.. ..++||||+++++|.+++...+ .++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 55 7999999999999999997644 37999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCC
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPK 249 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (316)
.... ......++..|+|||++.+..++.+ +||||||+++|+|++ |..||......+....+..+..++.
T Consensus 338 ~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 407 (450)
T 1k9a_A 338 EASS---------TQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 407 (450)
T ss_dssp ECC---------------CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCC
T ss_pred cccc---------cccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 4211 1112245778999999988776665 999999999999998 9999999888888888888888888
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+..+++++.++|..|| .+|.+|||+.++++
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8889999999999999 59999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=338.05 Aligned_cols=255 Identities=16% Similarity=0.126 Sum_probs=193.0
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC--CCCCcceee-------eEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL--KHPNLIRFL-------QAI 91 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~~ 91 (316)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +|||+++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 44599999999999999999999999999999999887665555666777885444444 699987754 455
Q ss_pred EeC-----------------CeEEEEEecCCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHHcCccccC
Q psy11194 92 ETT-----------------HRVYIIMEYAENGSLFDIIRGQ-GYIDEIRA------RRWFGQLLEALQYCHERGVVHRD 147 (316)
Q Consensus 92 ~~~-----------------~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~------~~i~~~i~~~l~~Lh~~~~~H~d 147 (316)
..+ ...++||||++ ++|.+++... ..++...+ ..++.||+.||+|||+.|++|+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 34899999998 7999999763 33455555 67789999999999999999999
Q ss_pred CCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccC--CCCCCCchhHHHHHHHHHHHHhC
Q psy11194 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG--IPYAPHLSDIWSMGVVLFAMVFG 225 (316)
Q Consensus 148 l~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g 225 (316)
|||+|||++.+|.++|+|||++..... ......+++.|+|||++.+ ..++. ++|||||||++|+|++|
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~-~~DiwSlG~il~elltg 289 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT---------RGPASSVPVTYAPREFLNASTATFTH-ALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC---------EEEGGGSCGGGCCHHHHTCSEEECCH-HHHHHHHHHHHHHHHHS
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC---------CccCccCCcCCcChhhccCCCCCcCc-cccHHHHHHHHHHHHhC
Confidence 999999999999999999999865321 1112345689999999976 44554 49999999999999999
Q ss_pred CCCCCCCCHHHHH--H------HHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 226 RLPFDDSSVNELL--K------QVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 226 ~~p~~~~~~~~~~--~------~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
..||......... . .......++....+++++.+||.+|| .+|++|||+.++++||||++.
T Consensus 290 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 9999865322110 0 00112233444578999999999999 599999999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=320.50 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=200.3
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
.....++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+..+..+++.++||||+++++++...+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 44566889999999999999999999999999999999976543 23334445555667888899999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
.++||||+ ++.+..+... ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999999 5567666654 56799999999999999999999995 999999999999999999999999999865321
Q ss_pred ccCcCCCCCCCcccccccCccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcccC--C
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQG----IPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNKVT--F 247 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~ 247 (316)
........+++.|+|||++.. ....+.++||||||+++|+|++|..||.. ....+....+..... .
T Consensus 178 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 178 -------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC
T ss_pred -------CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC
Confidence 112223457899999999852 22334459999999999999999999986 344555555544332 2
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 248 PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 248 ~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+....++.++.++|.+|| .+|.+||+++++++||||+....
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 333468999999999999 59999999999999999976443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=334.42 Aligned_cols=258 Identities=24% Similarity=0.413 Sum_probs=191.4
Q ss_pred ccCeEE-eeeeeecCCeEEEEEEEc--cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--CC
Q psy11194 21 SHGYTV-GKIIGTGSYATVKLARST--RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--TH 95 (316)
Q Consensus 21 ~~~y~~-~~~ig~g~~g~vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 95 (316)
.+.|.+ .++||+|+||.||+|++. .+++.||+|++...... ..+.+|+.+++.++||||+++++++.. ..
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 455777 447999999999999965 56889999998654432 346689999999999999999999954 77
Q ss_pred eEEEEEecCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee----CCCCCeE
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQ---------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL----DSDYNIK 162 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~---------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~----~~~~~~~ 162 (316)
..++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 89999999965 888887521 249999999999999999999999999999999999999 6778999
Q ss_pred EeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------
Q psy11194 163 LSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN------- 235 (316)
Q Consensus 163 l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~------- 235 (316)
|+|||++...... ...........+++.|+|||++.+....+.++|||||||++|+|++|..||.+....
T Consensus 173 l~Dfg~a~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 173 IADMGFARLFNSP---LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp ECCTTCCC-------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred EEECCCceecCCC---CcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999764311 111122334568999999999987665555699999999999999999999764432
Q ss_pred --HHHHHHhcccCCCCC-------------------------------------CCCCHHHHHHHHHhc-CCCCCCCCHH
Q psy11194 236 --ELLKQVQNKVTFPKQ-------------------------------------PEVSTECKELISNIL-SPVQTRPRLK 275 (316)
Q Consensus 236 --~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~li~~~l-~~p~~Rps~~ 275 (316)
+....+......+.. ...++.+.+||.+|| .||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 222222221111111 123788999999999 5999999999
Q ss_pred HHhhCCCCCCCC
Q psy11194 276 TIAEDRWLKPKP 287 (316)
Q Consensus 276 ~il~~~~~~~~~ 287 (316)
++++||||+..+
T Consensus 330 e~L~hp~f~~~~ 341 (405)
T 3rgf_A 330 QAMQDPYFLEDP 341 (405)
T ss_dssp HHHTSGGGTSSS
T ss_pred HHhcChhhccCC
Confidence 999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=322.73 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=220.5
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeee
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 89 (316)
..+.+..++|++.+.||+|+||.||+|.+. .+++.|++|.+..... ......+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 355677899999999999999999999876 3567899999865432 223445779999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQ----------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY 159 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~ 159 (316)
++...+..++||||+++++|.+++... ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999999642 3579999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11194 160 NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELL 238 (316)
Q Consensus 160 ~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~ 238 (316)
.++|+|||++........ ........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||......+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~ 250 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250 (322)
T ss_dssp CEEECCTTCCCGGGGGGC----EEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred eEEECcCccccccccccc----cccccCCCCCCCccChhhhccCCCCch-hhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence 999999999875432111 111222346778999999877666554 999999999999999 89999999999888
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 239 KQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
..+......+.+..++..+.++|..|| .+|.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 251 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 888777666677789999999999999 599999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=320.88 Aligned_cols=272 Identities=21% Similarity=0.342 Sum_probs=212.4
Q ss_pred hhcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC--CCCccee
Q psy11194 10 DDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK--HPNLIRF 87 (316)
Q Consensus 10 ~~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~ 87 (316)
.++......+.+++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+.++..++ |+||+++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~ 93 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRL 93 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccc-cchHHHHHHHHHHHhccccCCceEEE
Confidence 34455556777889999999999999999999875 48899999997655433 33556779999999996 5999999
Q ss_pred eeEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecc
Q psy11194 88 LQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFG 167 (316)
Q Consensus 88 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~ 167 (316)
++++......++|||+ .+++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++ ++.++|+|||
T Consensus 94 ~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg 171 (313)
T 3cek_A 94 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFG 171 (313)
T ss_dssp EEEEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred EEEeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecc
Confidence 9999999999999995 4779999999888899999999999999999999999999999999999996 4899999999
Q ss_pred cccccccccCcCCCCCCCcccccccCccCcccccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHH
Q psy11194 168 FARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI----------PYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-VNE 236 (316)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~ 236 (316)
++....... .........+++.|+|||++.+. ...+.++||||||+++|+|++|..||.... ...
T Consensus 172 ~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 172 IANQMQPDT----TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp SSCC------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred ccccccCcc----ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 987543211 11122334588999999998652 233445999999999999999999997643 222
Q ss_pred H-HHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 237 L-LKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
. ...+........+...+.++.++|..|| .+|.+|||++++++||||+.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 248 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 2 3333333444455567899999999999 599999999999999999876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=313.71 Aligned_cols=251 Identities=25% Similarity=0.458 Sum_probs=202.3
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc-hHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP-DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
++..++|++.+.||+|+||.||+|.+. ++.+|+|++....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 456789999999999999999999875 7899999987643322 2224567799999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccCCCCCCeeeCC--------CCCeEEee
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG---VVHRDIKCENLLLDS--------DYNIKLSD 165 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~---~~H~dl~p~nil~~~--------~~~~~l~D 165 (316)
.++||||+++++|.+++.. ..+++..++.++.|++.||.+||+.| ++|+||+|+||+++. ++.++|+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999999999875 46999999999999999999999999 899999999999985 67899999
Q ss_pred cccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-c
Q psy11194 166 FGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-K 244 (316)
Q Consensus 166 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~ 244 (316)
||++..... .......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.+.+.......+.. .
T Consensus 160 fg~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 160 FGLAREWHR--------TTKMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred CCccccccc--------ccccCCCCccceeCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 999865321 11223457899999999977666554 9999999999999999999998887776655543 4
Q ss_pred cCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 245 VTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 245 ~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
...+.+..+++++.++|.+|| .+|.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 445566779999999999999 599999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=336.71 Aligned_cols=254 Identities=22% Similarity=0.423 Sum_probs=218.4
Q ss_pred cccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 14 RKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 14 ~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
...+++..++|.+.+.||+|+||.||+|.+. .+..||||++...... .+.+.+|+.+++.++||||+++++++.
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 3456788899999999999999999999876 4678999999764322 455779999999999999999999986
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
....++||||+++++|.+++... ..++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||+++.
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 56789999999999999999753 3589999999999999999999999999999999999999999999999999976
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQ 250 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
..... ........++..|+|||++....++.+ +||||||+++|+|++ |..||.+....+....+..+...+.+
T Consensus 334 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 407 (454)
T 1qcf_A 334 IEDNE-----YTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP 407 (454)
T ss_dssp BCCHH-----HHTTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC
T ss_pred cCCCc-----eeccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 42111 011122335678999999977666655 999999999999999 99999999999999999888888888
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..+++++.++|.+|| .+|.+|||++++++
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 889999999999999 59999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=341.99 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=222.0
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.+++...+|.+.+.||+|+||.||+|.+..++..||+|++...... .+.+.+|+.+++.++||||+++++++....
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 4567788999999999999999999999988999999998764432 345779999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
..++||||+++++|.++++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999999763 459999999999999999999999999999999999999999999999999987542
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
.. .........++..|+|||++....++.+ +||||||+++|+|++ |..||.+.+..+..+.+......+.+..
T Consensus 370 ~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (495)
T 1opk_A 370 GD-----TYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 443 (495)
T ss_dssp TC-----CEECCTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred CC-----ceeecCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 11 1111223345678999999977666655 999999999999999 9999999888888888888888888888
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+++++.+||..|| .+|.+|||+.++++
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 9999999999999 59999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=325.56 Aligned_cols=262 Identities=20% Similarity=0.300 Sum_probs=217.1
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEE-----EccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeee
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLAR-----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~-----~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 89 (316)
....+..++|++.+.||+|+||.||+|. +..++..||+|++..... ......+.+|+.+++.++||||+++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc--hhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 3566788999999999999999999998 456788999999864332 233455778999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC---C
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQ-------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD---Y 159 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~-------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~---~ 159 (316)
++......++||||+++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.+ .
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 999999999999999999999999764 348999999999999999999999999999999999999844 4
Q ss_pred CeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11194 160 NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELL 238 (316)
Q Consensus 160 ~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~ 238 (316)
.++|+|||++....... .........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||......+..
T Consensus 181 ~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~ 255 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRAS----YYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255 (327)
T ss_dssp CEEECCCHHHHHHHC----------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred eEEECcccccccccccc----ccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence 59999999986532111 1112233446788999999877666554 999999999999998 99999999988888
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 239 KQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
..+..+.....+..++..+.++|..|| .+|.+||++.+++++.|+
T Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 256 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 888887777777789999999999999 599999999999998775
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=326.54 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=213.8
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQ 89 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 89 (316)
.+++..++|.+.+.||+|+||.||+|.+. .++..||+|++...... ...+.+.+|+.++..+ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 46678899999999999999999999973 35568999999754322 2245677999999999 8999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQG-----------------------YIDEIRARRWFGQLLEALQYCHERGVVHR 146 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~ 146 (316)
++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.|++|+
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997643 37999999999999999999999999999
Q ss_pred CCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-C
Q psy11194 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-G 225 (316)
Q Consensus 147 dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g 225 (316)
||+|+||+++.++.++|+|||++....... .........+++.|+|||++.+..++.+ +||||||+++|+|++ |
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDS----NYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLG 271 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT----TSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTS
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCc----cceeccCccCccCccCHHHhccCCCChh-HhHHHHHHHHHHHHcCC
Confidence 999999999999999999999987543211 1112233446778999999877666555 999999999999998 9
Q ss_pred CCCCCCCCH-HHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCC
Q psy11194 226 RLPFDDSSV-NELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDR 281 (316)
Q Consensus 226 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~ 281 (316)
..||.+... ......+......+.+..+++++.++|..|| .+|.+|||+.+++++.
T Consensus 272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999987654 3445555666666667789999999999999 5999999999999764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=323.05 Aligned_cols=258 Identities=31% Similarity=0.520 Sum_probs=203.7
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch---HHHhhHHHHHHHHhcC----CCCCcceeeeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD---YLKKFLPREIEVVKGL----KHPNLIRFLQA 90 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~---~~~~~~~~e~~~l~~l----~~~~i~~~~~~ 90 (316)
..-.++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.++..+ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3446789999999999999999999999999999999966443221 1133455788888888 89999999999
Q ss_pred EEeCCeEEEEEec-CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC-CCCCeEEeeccc
Q psy11194 91 IETTHRVYIIMEY-AENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD-SDYNIKLSDFGF 168 (316)
Q Consensus 91 ~~~~~~~~lv~e~-~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~-~~~~~~l~Df~~ 168 (316)
+...+..++|+|+ +.+++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++ .++.++|+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78899999998877899999999999999999999999999999999999998 789999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP 248 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (316)
+..... .......++..|+|||++.+....+.++||||||+++|+|++|..||.... + .... ...
T Consensus 187 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~---~~~~--~~~ 251 (312)
T 2iwi_A 187 GALLHD--------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E---ILEA--ELH 251 (312)
T ss_dssp CEECCS--------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H---HHHT--CCC
T ss_pred hhhccc--------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H---Hhhh--ccC
Confidence 865421 112334578899999998776666655999999999999999999997532 1 1122 233
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 249 KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 249 ~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
.+..++..+.++|.+|| .+|++|||++++++||||+...+.-
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~ 294 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence 44578999999999999 5999999999999999999876643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=325.57 Aligned_cols=258 Identities=31% Similarity=0.506 Sum_probs=214.9
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch---HHHhhHHHHHHHHhcCC--CCCcceeeeE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD---YLKKFLPREIEVVKGLK--HPNLIRFLQA 90 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--~~~i~~~~~~ 90 (316)
......++|++.+.||+|+||.||+|.+..+++.||+|++........ ...+.+.+|+.+++.++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 344557889999999999999999999999999999999976543221 11234558999999996 5999999999
Q ss_pred EEeCCeEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC-CCCCeEEeeccc
Q psy11194 91 IETTHRVYIIMEYAEN-GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD-SDYNIKLSDFGF 168 (316)
Q Consensus 91 ~~~~~~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~-~~~~~~l~Df~~ 168 (316)
+...+..++|+|++.+ ++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++ .++.++|+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999976 79999998878899999999999999999999999999999999999998 678999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP 248 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (316)
+..... .......+++.|+|||++.+....+.++||||||+++|+|++|..||.... . .... ...
T Consensus 197 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~---~~~~--~~~ 261 (320)
T 3a99_A 197 GALLKD--------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E---IIRG--QVF 261 (320)
T ss_dssp CEECCS--------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H---HHHC--CCC
T ss_pred cccccc--------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--h---hhcc--ccc
Confidence 865321 122334588999999999776665666899999999999999999997532 1 1122 233
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 249 KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 249 ~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
....+++++.++|.+|| .+|.+|||++++++||||++...
T Consensus 262 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 44578999999999999 59999999999999999998765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=321.78 Aligned_cols=256 Identities=22% Similarity=0.401 Sum_probs=211.6
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceE----EEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDV----AIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAI 91 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v----~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 91 (316)
...+..++|++.+.||+|+||.||+|.+..+++.+ ++|.+....... ..+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC--CHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH--HHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 44567889999999999999999999998888765 566554332222 245577999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 92 ETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 92 ~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
.... .+++++++.+++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 8765 7889999999999999976 4569999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCC
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPK 249 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (316)
...... .........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.+....+....+......+.
T Consensus 166 ~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T 3lzb_A 166 LLGAEE----KEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240 (327)
T ss_dssp ------------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred EccCcc----ccccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 643211 1112223345778999999987666655 999999999999999 9999999888888888888887888
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+..++.++.++|..|| .+|.+|||+.++++
T Consensus 241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 241 PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8889999999999999 59999999999996
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=328.32 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=208.2
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CC-----Ccceeee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HP-----NLIRFLQ 89 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~ 89 (316)
....-.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+..|+.+++.++ |+ +++++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 3444568999999999999999999999999999999998642 223455667888888774 44 4999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HcCccccCCCCCCeeeC--CCCCeEE
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCH--ERGVVHRDIKCENLLLD--SDYNIKL 163 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh--~~~~~H~dl~p~nil~~--~~~~~~l 163 (316)
++......++||||+++ +|.+++... ..+++..++.++.|++.||.||| +.|++|+||||+||+++ .++.++|
T Consensus 124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999999999999965 999999764 45999999999999999999999 57999999999999995 4678999
Q ss_pred eecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy11194 164 SDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN 243 (316)
Q Consensus 164 ~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~ 243 (316)
+|||++.... .......+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+..
T Consensus 203 ~DFG~a~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 203 VDFGSSCQLG---------QRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp CCCTTCEETT---------CCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EeccCceecc---------cccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999986532 11233457889999999988776655 9999999999999999999998887776665543
Q ss_pred ccCCCCC-----------------------------------CC----------------------------CCHHHHHH
Q psy11194 244 KVTFPKQ-----------------------------------PE----------------------------VSTECKEL 260 (316)
Q Consensus 244 ~~~~~~~-----------------------------------~~----------------------------~~~~~~~l 260 (316)
....+.. +. .++++.+|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 352 (382)
T 2vx3_A 273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 352 (382)
T ss_dssp HHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHH
T ss_pred HhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHH
Confidence 2111100 00 01378999
Q ss_pred HHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 261 ISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
|.+|| .||++|||++++++||||+...
T Consensus 353 i~~mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 353 ILRMLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred HHHhcCCChhhCCCHHHHhcCcccccCC
Confidence 99999 5999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=314.93 Aligned_cols=257 Identities=22% Similarity=0.374 Sum_probs=216.3
Q ss_pred ceeeccCeEEee-eeeecCCeEEEEEEEc--cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 17 TVLESHGYTVGK-IIGTGSYATVKLARST--RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 17 ~~~~~~~y~~~~-~ig~g~~g~vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
..+..++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 456788898888 9999999999999864 467789999987653 233356678999999999999999999999 4
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
.+..++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 5668999999999999999965 345999999999999999999999999999999999999999999999999998764
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
..... .........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||......+....+..+...+.+.
T Consensus 161 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 236 (287)
T 1u59_A 161 GADDS---YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 236 (287)
T ss_dssp TTCSC---EECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred ccCcc---eeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC
Confidence 21111 1111222345788999999976666555 999999999999998 999999988888888888777677777
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.+++++.++|..|| .+|.+||++.+++++
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999 599999999999965
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=314.37 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=204.9
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
.......+|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++...+
T Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp GTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999999999999999998755555555667889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
..++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999999864 45699999999999999999999999999999999999999999999999999865
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcccCCCC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS--SVNELLKQVQNKVTFPK 249 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~ 249 (316)
.... ........++..|+|||++.+..++.+ +||||||+++|+|++|..||.+. ........+......+.
T Consensus 186 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 258 (310)
T 2wqm_A 186 FSSK------TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 258 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC
T ss_pred ecCC------CccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC
Confidence 3211 112223457889999999987766655 99999999999999999999653 34455555544432222
Q ss_pred -CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 250 -QPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 250 -~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
...++.++.++|..|| .+|.+|||++++++
T Consensus 259 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 259 PSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 3568999999999999 59999999998875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=309.72 Aligned_cols=249 Identities=18% Similarity=0.297 Sum_probs=213.0
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC--
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-- 94 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 94 (316)
..+..++|++.+.||+|+||.||+|.+. ++.+|+|++........ ..+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHH-HHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHH-HHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 4567789999999999999999999875 78999999976554433 345677999999999999999999999876
Q ss_pred CeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERG--VVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~--~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
...++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++++||+++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78899999999999999998754 4899999999999999999999999 9999999999999999999999988764
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCC--chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cccCC
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPH--LSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ-NKVTF 247 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~--~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-~~~~~ 247 (316)
.. ......+++.|+|||.+.+...... ++||||||+++|+|++|..||......+....+. .....
T Consensus 162 ~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 162 SF-----------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230 (271)
T ss_dssp TT-----------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred ee-----------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC
Confidence 31 1223357889999999987655442 5999999999999999999999888777755554 44555
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 248 PKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 248 ~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..+..+++++.++|..|| .+|.+|||++++++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 666789999999999999 59999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=312.90 Aligned_cols=252 Identities=22% Similarity=0.400 Sum_probs=215.2
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
-+.+..++|++.+.||+|+||.||+|.+. ++..|++|.+...... .+.+.+|+.+++.++||||+++++++.. +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 46677899999999999999999999865 5668999998654432 3457799999999999999999999864 4
Q ss_pred eEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
..++||||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 5889999999999999997532 69999999999999999999999999999999999999999999999999987542
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
.. .........++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.+....+....+........+..
T Consensus 161 ~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T 1qpc_A 161 DN-----EYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234 (279)
T ss_dssp SS-----CEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred Cc-----ccccccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCccc
Confidence 11 1111223345778999999976665554 999999999999999 9999999998888888888777777778
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
++.++.++|..|| .+|++|||++++++
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999 59999999999884
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=332.56 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=203.3
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC--------CCCccee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK--------HPNLIRF 87 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~ 87 (316)
...+..++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.++ |+||+++
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 4455678999999999999999999999999999999998642 233456778999999885 7889999
Q ss_pred eeEEE----eCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeCCCC-
Q psy11194 88 LQAIE----TTHRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLDSDY- 159 (316)
Q Consensus 88 ~~~~~----~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~- 159 (316)
++++. .....++||||+ +++|.+.+... ..+++..++.++.||+.||.|||+. |++|+||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 99987 556899999999 55666666443 4699999999999999999999998 999999999999998775
Q ss_pred ------------------------------------------------CeEEeecccccccccccCcCCCCCCCcccccc
Q psy11194 160 ------------------------------------------------NIKLSDFGFARAHMRCRSNAADNSLSETFCGS 191 (316)
Q Consensus 160 ------------------------------------------------~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (316)
.++|+|||++..... ......++
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---------~~~~~~gt 256 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---------HFTEDIQT 256 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---------CSCSCCSC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---------cCccCCCC
Confidence 799999999865321 12334579
Q ss_pred cCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhccc-CC-----------------
Q psy11194 192 YAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS------VNELLKQVQNKV-TF----------------- 247 (316)
Q Consensus 192 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~----------------- 247 (316)
+.|+|||++.+..++.+ +|||||||++|+|++|..||...+ .......+.... ..
T Consensus 257 ~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTP-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp GGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CcccCChhhcCCCCCcH-HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 99999999988776665 999999999999999999997543 222222221100 00
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 248 -----------------------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 248 -----------------------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
......+..+.+||.+|| .+|.+|||++++++||||++
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 011223467889999999 59999999999999999974
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=315.80 Aligned_cols=256 Identities=25% Similarity=0.440 Sum_probs=208.5
Q ss_pred hhhhhcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcce
Q psy11194 7 QVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR 86 (316)
Q Consensus 7 ~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 86 (316)
..+++.....+.+..++|++.+.||+|++|.||+|.+. |+.|++|++..... .+.+.+|+.+++.++||||++
T Consensus 6 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~ 78 (278)
T 1byg_A 6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQ 78 (278)
T ss_dssp ---------CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCC
T ss_pred cchhhhhhccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhH-----HHHHHHHHHHHHhCCCCCEee
Confidence 34556666667788999999999999999999999764 78999999865432 445779999999999999999
Q ss_pred eeeEEEeC-CeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEE
Q psy11194 87 FLQAIETT-HRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKL 163 (316)
Q Consensus 87 ~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l 163 (316)
+++++... +..++||||+++++|.+++...+ .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l 158 (278)
T 1byg_A 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKV 158 (278)
T ss_dssp EEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred EEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEE
Confidence 99997544 47899999999999999997643 3899999999999999999999999999999999999999999999
Q ss_pred eecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q psy11194 164 SDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQ 242 (316)
Q Consensus 164 ~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~ 242 (316)
+|||++...... .....++..|+|||++.+..++.+ +||||||+++|+|++ |..||......+....+.
T Consensus 159 ~Dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 228 (278)
T 1byg_A 159 SDFGLTKEASST---------QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228 (278)
T ss_dssp CCCCC---------------------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT
T ss_pred eecccccccccc---------ccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999998643211 112246778999999977666555 999999999999998 999999888888888887
Q ss_pred cccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 243 NKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+...+.+..+++.+.++|..|| .+|.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 77777777789999999999999 59999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=312.74 Aligned_cols=256 Identities=19% Similarity=0.222 Sum_probs=210.1
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 95 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 95 (316)
..+.+++|++.+.||+|++|.||+|.+..+++.||+|++..... .+.+.+|+..++.+ +|++++++++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 45678899999999999999999999999999999999865443 34477899999999 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC-----eEEeecccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN-----IKLSDFGFA 169 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~-----~~l~Df~~~ 169 (316)
..++||||+ +++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 88999999864 35999999999999999999999999999999999999987765 999999999
Q ss_pred cccccccCcCC-CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhccc
Q psy11194 170 RAHMRCRSNAA-DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS---SVNELLKQVQNKV 245 (316)
Q Consensus 170 ~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---~~~~~~~~~~~~~ 245 (316)
........... .........|++.|+|||++.+..++.+ +||||||+++|+|++|..||... ...+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 76542221111 1122345568999999999988776555 99999999999999999999873 3444444433221
Q ss_pred C-CC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 246 T-FP---KQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 246 ~-~~---~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
. .+ ....+|+++.++|..|| .+|.+||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1 11 22468999999999999 69999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=320.74 Aligned_cols=258 Identities=21% Similarity=0.354 Sum_probs=215.0
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEE-----ccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARS-----TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQ 89 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~-----~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 89 (316)
.+++..++|++.+.||+|+||.||+|.+ ..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 4567789999999999999999999985 34677899999875433 22346678999999999 8999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQG------------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCE 151 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ 151 (316)
++...+..++||||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 9999999999999999999999997643 4899999999999999999999999999999999
Q ss_pred CeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q psy11194 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFD 230 (316)
Q Consensus 152 nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~ 230 (316)
||+++.++.++|+|||++....... .........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDS----NYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCT----TSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSST
T ss_pred eEEEcCCCCEEEccccccccccccc----cceeccCCCCcceeeChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999986543211 1111223446778999999877666555 999999999999998 999998
Q ss_pred CCCH-HHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 231 DSSV-NELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.... ......+........+..++.++.++|..|| .+|.+|||+++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 7653 3444555556566666789999999999999 599999999999853
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=311.35 Aligned_cols=253 Identities=20% Similarity=0.375 Sum_probs=208.0
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHH----hhHHHHHHHHhcCCCCCcceeeeEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLK----KFLPREIEVVKGLKHPNLIRFLQAI 91 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~ 91 (316)
...+..++|++.+.||+|+||.||+|.+..+++.||+|++........... +.+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 456778999999999999999999999999999999999876544332211 5577999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeCCCCC-----eEE
Q psy11194 92 ETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERG--VVHRDIKCENLLLDSDYN-----IKL 163 (316)
Q Consensus 92 ~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~H~dl~p~nil~~~~~~-----~~l 163 (316)
.... ++||||+++++|.+.+.. ...+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++. ++|
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7665 699999999999888865 446999999999999999999999999 999999999999988776 999
Q ss_pred eecccccccccccCcCCCCCCCcccccccCccCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Q psy11194 164 SDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI-PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE--LLKQ 240 (316)
Q Consensus 164 ~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~--~~~~ 240 (316)
+|||++.... .......+++.|+|||++... ...+.++||||||+++|+|++|..||....... ....
T Consensus 171 ~Dfg~~~~~~---------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 171 ADFGLSQQSV---------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CCCTTCBCCS---------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred CCCCcccccc---------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 9999986421 122334588999999998432 223345999999999999999999997644322 2333
Q ss_pred H-hcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 241 V-QNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 241 ~-~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+ ........+..+++++.++|..|| .+|.+|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3 344455566779999999999999 59999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=317.77 Aligned_cols=260 Identities=22% Similarity=0.356 Sum_probs=212.2
Q ss_pred cccceeeccCeEEeeeeeecCCeEEEEEE----EccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeee
Q psy11194 14 RKVTVLESHGYTVGKIIGTGSYATVKLAR----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89 (316)
Q Consensus 14 ~~~~~~~~~~y~~~~~ig~g~~g~vy~~~----~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 89 (316)
.....+..++|++.+.||+|+||.||+|+ +..+++.||+|++........ .+.+.+|+.+++.++||||+++++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~ 90 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHENIVKYKG 90 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CC--HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchh--HHHHHHHHHHHHhCCCCCeeeeee
Confidence 34566778889999999999999999998 566888999999976543222 455779999999999999999999
Q ss_pred EEEeC--CeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeec
Q psy11194 90 AIETT--HRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDF 166 (316)
Q Consensus 90 ~~~~~--~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df 166 (316)
++... ...++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus 91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcc
Confidence 99876 678999999999999999954 456999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC---------------
Q psy11194 167 GFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD--------------- 231 (316)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~--------------- 231 (316)
|++....... ..........++..|+|||++.+..++.+ +||||||+++|+|++|..|+..
T Consensus 171 g~~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (302)
T 4e5w_A 171 GLTKAIETDK---EYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246 (302)
T ss_dssp TTCEECCTTC---CEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred cccccccCCC---cceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence 9987643211 11122333457778999999977666655 9999999999999999887532
Q ss_pred CCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 232 SSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.........+......+.+..+++++.++|..|| .+|.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2233445555666677777889999999999999 59999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=317.99 Aligned_cols=258 Identities=19% Similarity=0.339 Sum_probs=208.6
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEcc---CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTR---HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
..+..++|.+.+.||+|+||.||+|.+.. ++..||+|++........ ..+.+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR-EIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHH-HHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchh-HHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 45678899999999999999999998775 445899999876554333 34557799999999999999999999976
Q ss_pred CC-----eEEEEEecCCCCCHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeE
Q psy11194 94 TH-----RVYIIMEYAENGSLFDIIR------GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIK 162 (316)
Q Consensus 94 ~~-----~~~lv~e~~~~~sL~~~l~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~ 162 (316)
.. ..++||||+++++|.+++. ....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 55 3599999999999999994 235699999999999999999999999999999999999999999999
Q ss_pred EeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11194 163 LSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQV 241 (316)
Q Consensus 163 l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~ 241 (316)
|+|||++....... .........+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......+....+
T Consensus 188 l~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 262 (313)
T 3brb_A 188 VADFGLSKKIYSGD----YYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262 (313)
T ss_dssp ECSCSCC--------------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred EeecCcceeccccc----ccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 99999986543211 1111223346778999999987666655 999999999999999 99999988888888888
Q ss_pred hcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 242 QNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
......+.+..+++++.++|..|| .+|.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 263 LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777777777789999999999999 599999999999853
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=322.38 Aligned_cols=259 Identities=21% Similarity=0.315 Sum_probs=210.5
Q ss_pred cccceeeccCeEEeeeeeecCCeEEEEEEEccCC-ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCC------cce
Q psy11194 14 RKVTVLESHGYTVGKIIGTGSYATVKLARSTRHS-GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN------LIR 86 (316)
Q Consensus 14 ~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~ 86 (316)
........++|++.+.||+|+||.||+|.+..++ +.||+|++... ....+.+.+|+.+++.++|++ ++.
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 3456667899999999999999999999998776 68999998642 223456778999998886544 899
Q ss_pred eeeEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee---------
Q psy11194 87 FLQAIETTHRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL--------- 155 (316)
Q Consensus 87 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~--------- 155 (316)
+++++......++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||++
T Consensus 87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence 999999999999999999 55777777553 369999999999999999999999999999999999999
Q ss_pred ----------CCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhC
Q psy11194 156 ----------DSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFG 225 (316)
Q Consensus 156 ----------~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g 225 (316)
+.++.++|+|||++.... .......+++.|+|||++.+..++.+ +|||||||++|+|++|
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g 235 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDH---------EHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRG 235 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETT---------SCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHS
T ss_pred cccccccccccCCCcEEEeecCcccccc---------ccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhC
Confidence 567889999999986421 11233458899999999988777665 9999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhcccCC-C------------------------------------------CCCCCCHHHHHHHH
Q psy11194 226 RLPFDDSSVNELLKQVQNKVTF-P------------------------------------------KQPEVSTECKELIS 262 (316)
Q Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~-~------------------------------------------~~~~~~~~~~~li~ 262 (316)
..||......+....+...... | .....+.++.+||.
T Consensus 236 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 315 (355)
T 2eu9_A 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315 (355)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence 9999988776655544332111 0 01112458899999
Q ss_pred Hhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 263 NIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 263 ~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
+|| .+|.+|||++++++||||++..
T Consensus 316 ~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 316 RMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp HHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred HHhcCChhhCcCHHHHhcChhhcCCC
Confidence 999 5999999999999999998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=314.27 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=213.1
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccC---CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRH---SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
...+..++|.+.+.||+|+||.||+|.+... +..|++|.+..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--HHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--chHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 3566788999999999999999999987643 33599999865432 233566789999999999999999999987
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
.+ ..++||||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 54 568999999999999999764 4599999999999999999999999999999999999999999999999999865
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQ 250 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
.... .........++..|+|||++.+..++.+ +||||||+++|+|++ |..||......+....+......+.+
T Consensus 163 ~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 163 IEDE-----DYYKASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236 (281)
T ss_dssp C--------------CCCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred cccc-----cccccccCCCCcceeCchhhccCCCCch-hccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence 4221 1111223346778999999976666554 999999999999998 99999887777777777777777777
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
..+++.+.++|.+|| .+|.+|||+.+++++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 789999999999999 599999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=333.14 Aligned_cols=260 Identities=22% Similarity=0.413 Sum_probs=217.6
Q ss_pred cccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 14 RKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 14 ~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
...+.+..++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+.+++.++||||+++++++..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34567788999999999999999999998874 457999998764432 3457799999999999999999999876
Q ss_pred CCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
...++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 678999999999999999964 35699999999999999999999999999999999999999999999999999975
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQ 250 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
.... .........++..|+|||++....++.+ +||||||+++|+|++ |..||.+....+....+..+...+.+
T Consensus 330 ~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 403 (452)
T 1fmk_A 330 IEDN-----EYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 403 (452)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred cCCC-----ceecccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 4211 1111223345778999999977666655 999999999999999 99999999999999999888888888
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC--CCCCC
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAED--RWLKP 285 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~--~~~~~ 285 (316)
..+++.+.++|..|| .+|++|||++++++. .++..
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 889999999999999 599999999999862 44443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=321.95 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=192.4
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHH-HHhcCCCCCcceeeeEEEeC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIE-VVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~ 94 (316)
.+.+..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+ +..|+. +++.++||||+++++++...
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~-~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQ-LLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHH-HHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHH-HHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 456778999999999999999999999999999999999976543 222233 334554 77778999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRG-----QGYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
+..++||||+++ +|.+++.. ...+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 999999999976 88888863 56799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhc
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQ----GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN-ELLKQVQN 243 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~ 243 (316)
+..... ........+++.|+|||++. +..++ .++||||||+++|+|++|..||...... +....+..
T Consensus 173 ~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (327)
T 3aln_A 173 SGQLVD-------SIAKTRDAGCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244 (327)
T ss_dssp SCC-------------------------------------CC-SHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC
T ss_pred ceeccc-------ccccccCCCCccccCceeeccccCcCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc
Confidence 865321 11122335888999999983 33344 4599999999999999999999864321 22222222
Q ss_pred ccCCC----CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 244 KVTFP----KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 244 ~~~~~----~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+.... ....+++.+.++|..|| .+|.+|||+.++++||||....+
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 21111 12358999999999999 59999999999999999976544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=315.81 Aligned_cols=249 Identities=18% Similarity=0.320 Sum_probs=208.4
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCC-------ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeee
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHS-------GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 89 (316)
..+..++|.+.+.||+|+||.||+|.+..++ ..|++|++..... ...+.+.+|+.+++.++||||+++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~ 79 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYG 79 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 4567889999999999999999999988776 4699999865332 22456779999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC--------
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN-------- 160 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~-------- 160 (316)
++...+..++||||+++++|.+++..... +++..++.++.||+.||.|||+.|++|+||+|+||+++.++.
T Consensus 80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 80 VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp EECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999999999987554 999999999999999999999999999999999999988877
Q ss_pred eEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy11194 161 IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLK 239 (316)
Q Consensus 161 ~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~ 239 (316)
++|+|||++..... .....++..|+|||++.+....+.++||||||+++|+|++ |..||..........
T Consensus 160 ~kl~Dfg~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~ 229 (289)
T 4fvq_A 160 IKLSDPGISITVLP----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229 (289)
T ss_dssp EEECCCCSCTTTSC----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred eeeccCcccccccC----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH
Confidence 99999998854321 1223467889999999874444555999999999999999 566777767666666
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 240 QVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
........+ ...+.++.++|..|| .+|.+|||+++++++
T Consensus 230 ~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 230 FYEDRHQLP--APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHTTCCCC--CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhccCCCC--CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555543333 457889999999999 599999999999965
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=322.78 Aligned_cols=254 Identities=27% Similarity=0.444 Sum_probs=184.0
Q ss_pred ceeeccCeEEee-eeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--
Q psy11194 17 TVLESHGYTVGK-IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-- 93 (316)
Q Consensus 17 ~~~~~~~y~~~~-~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 93 (316)
.....++|.+.+ .||+|+||.||+|.+..+|+.||+|++.... .........++.++||||+++++++..
T Consensus 23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 344578899965 5999999999999999999999999986521 112233344667799999999999976
Q ss_pred --CCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC---CCeEEeec
Q psy11194 94 --THRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD---YNIKLSDF 166 (316)
Q Consensus 94 --~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~---~~~~l~Df 166 (316)
....++||||++|++|.+++.... .+++..++.++.||+.||.|||+.|++|+||+|+||+++.+ +.++|+||
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 456899999999999999998653 69999999999999999999999999999999999999764 45999999
Q ss_pred ccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----
Q psy11194 167 GFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ---- 242 (316)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~---- 242 (316)
|++.... ........+++.|+|||++....++.+ +||||||+++|+|++|..||.............
T Consensus 176 g~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (336)
T 3fhr_A 176 GFAKETT--------QNALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246 (336)
T ss_dssp TTCEEC------------------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred ccceecc--------ccccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh
Confidence 9986532 112233457899999999877666554 999999999999999999997655444322111
Q ss_pred ---cccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 243 ---NKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 243 ---~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
.....+....++.++.+||..|| .+|.+|||++++++||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 12223334578999999999999 599999999999999999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=318.10 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=207.4
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 96 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 96 (316)
.+.+.+|++.+.||+|+||.||+|.+..+|+.||+|++..... .+.+.+|+.+++.+ +||||+++++++.....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 4557899999999999999999999999999999999876543 23577999999999 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC-----eEEeeccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN-----IKLSDFGFAR 170 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~-----~~l~Df~~~~ 170 (316)
.++||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 8899999986 467999999999999999999999999999999999999998877 9999999997
Q ss_pred ccccccCcC-CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhccc-
Q psy11194 171 AHMRCRSNA-ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS---SVNELLKQVQNKV- 245 (316)
Q Consensus 171 ~~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---~~~~~~~~~~~~~- 245 (316)
......... ..........|++.|+|||++.+..++.+ +||||||+++|+|++|..||.+. ...+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 643221111 11112345568999999999988776655 99999999999999999999873 3434444442221
Q ss_pred CCCC---CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 246 TFPK---QPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 246 ~~~~---~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..+. ...+| ++.++|..|| .+|.+||+++++++
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1111 12345 9999999999 69999999998876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=319.28 Aligned_cols=256 Identities=24% Similarity=0.403 Sum_probs=212.2
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEE----EccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLAR----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~----~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
..+..++|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 94 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSY 94 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence 44667889999999999999999998 46678899999986542 233456789999999999999999999886
Q ss_pred --eCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 93 --TTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 93 --~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
.....++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 95 GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp CSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred cCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 55678999999999999999976 456999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------------
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV--------------- 234 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~--------------- 234 (316)
....... ..........++..|+|||++.+..++.+ +||||||+++|+|++|..||.....
T Consensus 175 ~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 175 KLLPLDK---DYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp EECCTTC---SEEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred eecccCC---ccceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 7642111 11112233446778999999877666554 9999999999999999999864332
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 235 NELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
......+......+.+..+++++.++|..|| .+|.+|||++++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3444555666667777889999999999999 59999999999963
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=318.60 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=205.2
Q ss_pred hhhhhhcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcc
Q psy11194 6 VQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLI 85 (316)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 85 (316)
....+|-......+..++|++.+.||+|+||.||+|++. ++.||+|++.... .......+|+.++..++||||+
T Consensus 8 ~~~~~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv 81 (322)
T 3soc_A 8 HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENIL 81 (322)
T ss_dssp ------CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBC
T ss_pred cccccccCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCch
Confidence 345566777788899999999999999999999999765 7899999986532 1233455788889999999999
Q ss_pred eeeeEEEeCC----eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc----------CccccCCCCC
Q psy11194 86 RFLQAIETTH----RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER----------GVVHRDIKCE 151 (316)
Q Consensus 86 ~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~----------~~~H~dl~p~ 151 (316)
++++++.... ..++||||+++++|.++++... +++..++.++.|++.||.|||+. |++|+||||+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~ 160 (322)
T 3soc_A 82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160 (322)
T ss_dssp CEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGG
T ss_pred hhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChH
Confidence 9999998744 4799999999999999998754 99999999999999999999999 9999999999
Q ss_pred CeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCC----CCchhHHHHHHHHHHHHhCCC
Q psy11194 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYA----PHLSDIWSMGVVLFAMVFGRL 227 (316)
Q Consensus 152 nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~----~~~~Di~slG~ll~~l~~g~~ 227 (316)
||+++.++.++|+|||++....... .........+++.|+|||++.+.... +.++|||||||++|+|++|..
T Consensus 161 Nill~~~~~~kL~DFg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~ 236 (322)
T 3soc_A 161 NVLLKNNLTACIADFGLALKFEAGK----SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236 (322)
T ss_dssp GEEECTTCCEEECCCTTCEEECTTS----CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBT
T ss_pred hEEECCCCeEEEccCCccccccccc----CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCC
Confidence 9999999999999999997643211 11222335689999999998763222 223799999999999999999
Q ss_pred CCCCC----------------CHHHHHHHHhcccCCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 228 PFDDS----------------SVNELLKQVQNKVTFPKQP------EVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 228 p~~~~----------------~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
||.+. ........+......+... ..++++.+||.+|| .+|++|||+.++++
T Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp TSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 98643 2333444443333222221 12456999999999 59999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=319.21 Aligned_cols=258 Identities=20% Similarity=0.349 Sum_probs=213.1
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQ 89 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 89 (316)
.+.+..++|++.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.++..+ +||||+++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 45677899999999999999999999853 4667899999865433 22345677999999999 6999999999
Q ss_pred EEEeCC-eEEEEEecCCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCC
Q psy11194 90 AIETTH-RVYIIMEYAENGSLFDIIRGQGY----------------IDEIRARRWFGQLLEALQYCHERGVVHRDIKCEN 152 (316)
Q Consensus 90 ~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~----------------l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~n 152 (316)
++...+ ..++||||+++++|.+++..... +++..++.++.|++.||.+||+.|++|+||+|+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 987654 58999999999999999986543 8999999999999999999999999999999999
Q ss_pred eeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q psy11194 153 LLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDD 231 (316)
Q Consensus 153 il~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~ 231 (316)
|+++.++.++|+|||++...... ..........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||..
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKD----PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTC----TTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEECCCCCEEECCCccccccccC----ccceeccCCCcceeecCchhhccccccch-hHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999998653211 11111223446788999999977666655 999999999999998 9999987
Q ss_pred CC-HHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 232 SS-VNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.. .......+..+...+.+..+++++.++|..|| .+|.+|||+.++++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54 34455556666566666779999999999999 599999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=309.30 Aligned_cols=256 Identities=21% Similarity=0.360 Sum_probs=213.3
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCc---eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
...-.|.+.+.||+|+||.||+|.+..++. .+++|.+.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 344567888999999999999999765544 79999986533 2333556779999999999999999999997666
Q ss_pred eE-EEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 RV-YIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 ~~-~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
.. ++||||+.+++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 54 999999999999999976 4569999999999999999999999999999999999999999999999999997543
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
.... ..........++..|+|||.+.+..++.+ +||||||+++|+|++ |.+||...+..+....+......+.+..
T Consensus 176 ~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 3pls_A 176 DREY--YSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY 252 (298)
T ss_dssp TGGG--GCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTT
T ss_pred CCcc--cccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCcc
Confidence 2111 11122333457889999999988776665 999999999999999 6666777788888888888777777788
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+++.+.++|..|| .+|.+|||++++++
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999 59999999998874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=325.29 Aligned_cols=261 Identities=24% Similarity=0.404 Sum_probs=206.3
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-----------CCCcc
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-----------HPNLI 85 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~ 85 (316)
..+...+|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++ |+||+
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 445678999999999999999999999999999999998642 223455678898888875 78999
Q ss_pred eeeeEEEeCC----eEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeC--
Q psy11194 86 RFLQAIETTH----RVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHER-GVVHRDIKCENLLLD-- 156 (316)
Q Consensus 86 ~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~-~~~H~dl~p~nil~~-- 156 (316)
++++++.... ..++|||++ +++|.+++.. ...+++..++.++.||+.||.|||+. |++|+||+|+||+++
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence 9999997654 789999999 8899999976 34599999999999999999999998 999999999999994
Q ss_pred ----CCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy11194 157 ----SDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS 232 (316)
Q Consensus 157 ----~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~ 232 (316)
..+.++|+|||++..... ......+++.|+|||++.+..++.+ +|||||||++|+|++|..||...
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDE---------HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTB---------CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---
T ss_pred CCCcCcceEEEcccccccccCC---------CCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCC
Confidence 334799999999865321 1223457899999999988776655 99999999999999999999764
Q ss_pred CH------HHHHHHHhc-ccC----------------------------------------CCCCCCCCHHHHHHHHHhc
Q psy11194 233 SV------NELLKQVQN-KVT----------------------------------------FPKQPEVSTECKELISNIL 265 (316)
Q Consensus 233 ~~------~~~~~~~~~-~~~----------------------------------------~~~~~~~~~~~~~li~~~l 265 (316)
.. ......+.. ... ...+..++.++.+||..||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 32 112222111 000 1111235678999999999
Q ss_pred -CCCCCCCCHHHHhhCCCCCCCCCCCCh
Q psy11194 266 -SPVQTRPRLKTIAEDRWLKPKPKSRGV 292 (316)
Q Consensus 266 -~~p~~Rps~~~il~~~~~~~~~~~~~~ 292 (316)
.+|.+|||++++++||||++......+
T Consensus 319 ~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 346 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNHPWLKDTLGMEEI 346 (373)
T ss_dssp CSSTTTCBCHHHHHTCGGGTTCTTCTTC
T ss_pred ccCccccCCHHHHhhChhhhcccCcccc
Confidence 599999999999999999987665543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=311.45 Aligned_cols=264 Identities=19% Similarity=0.289 Sum_probs=212.9
Q ss_pred hcccccceeeccCeEEeeeeeecCCeEEEEEEEccCC---ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCccee
Q psy11194 11 DIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHS---GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRF 87 (316)
Q Consensus 11 ~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~---~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 87 (316)
.+......-...+|++.+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+.+|+.+++.++||||+++
T Consensus 14 ~~~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~ 91 (298)
T 3f66_A 14 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSL 91 (298)
T ss_dssp HHGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred hhhheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeee
Confidence 3334444445677999999999999999999876433 357888876533 23334567799999999999999999
Q ss_pred eeEE-EeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEee
Q psy11194 88 LQAI-ETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSD 165 (316)
Q Consensus 88 ~~~~-~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~D 165 (316)
++++ ..++..++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus 92 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp CEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECS
T ss_pred eeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECc
Confidence 9986 456678999999999999999976 44589999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcc
Q psy11194 166 FGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNK 244 (316)
Q Consensus 166 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~ 244 (316)
||++........ ..........+++.|+|||.+.+..++.+ +||||||+++|+|++ |.+||......+....+...
T Consensus 172 fg~a~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 3f66_A 172 FGLARDMYDKEY--YSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248 (298)
T ss_dssp CGGGCCCSCGGG--CBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT
T ss_pred ccccccccccch--hccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC
Confidence 999975432211 11122233456788999999977666655 999999999999999 77888887777777777777
Q ss_pred cCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 245 VTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 245 ~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.....+..++..+.++|..|| .+|.+|||++++++
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 766667789999999999999 59999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=319.21 Aligned_cols=257 Identities=22% Similarity=0.370 Sum_probs=213.9
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCc-----eEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSG-----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQ 89 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~-----~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 89 (316)
..++..++|.+.+.||+|+||.||+|.+..++. .|++|.+..... ....+.+.+|+.+++.+ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 466778999999999999999999999876654 799999865442 22355677999999999 8999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRG--------------QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL 155 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~--------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~ 155 (316)
++...+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 99999999999999999999999964 2358999999999999999999999999999999999999
Q ss_pred CCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11194 156 DSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSV 234 (316)
Q Consensus 156 ~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~ 234 (316)
+.++.++|+|||++....... .........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+...
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDS----NYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCT----TSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred CCCCeEEECcccccccccccc----ceeecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999999999999987543211 1112233446778999999877666554 999999999999998 9999987554
Q ss_pred H-HHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 235 N-ELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 235 ~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
. .....+......+.+..+++.+.++|..|| .+|.+|||+.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 3 344455555566666778999999999999 59999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=316.36 Aligned_cols=262 Identities=21% Similarity=0.380 Sum_probs=207.0
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE---
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE--- 92 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--- 92 (316)
...+..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred EEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 45677889999999999999999999999999999999986532 233556779999999999999999999986
Q ss_pred -eCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecc
Q psy11194 93 -TTHRVYIIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFG 167 (316)
Q Consensus 93 -~~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~ 167 (316)
.....++||||+++++|.+++.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence 34478999999999999999975 4679999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCcCCC---CCCCcccccccCccCcccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH
Q psy11194 168 FARAHMRCRSNAAD---NSLSETFCGSYAYASPEILQGIPY--APHLSDIWSMGVVLFAMVFGRLPFDDSS--VNELLKQ 240 (316)
Q Consensus 168 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~ 240 (316)
++............ ........+++.|+|||++..... .+.++||||||+++|+|++|..||.... .......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 87653211000000 000012235888999999876442 2345999999999999999999995311 1122333
Q ss_pred HhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 241 VQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+......+....++.++.++|..|| .+|.+|||+++++++
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 4445556666789999999999999 599999999999976
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=336.41 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=211.3
Q ss_pred ceeeccCeEEee-eeeecCCeEEEEEEEcc--CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 17 TVLESHGYTVGK-IIGTGSYATVKLARSTR--HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 17 ~~~~~~~y~~~~-~ig~g~~g~vy~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
..+...++.+.+ .||+|+||.||+|.+.. ++..||||+++...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST--THHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 445566777777 89999999999998763 45579999997643322 24567799999999999999999999976
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 568999999999999999965 345999999999999999999999999999999999999999999999999999754
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
..... .........++..|+|||++.+..++.+ +||||||+++|+|++ |..||.+....+....+..+...+.+.
T Consensus 487 ~~~~~---~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 562 (613)
T 2ozo_A 487 GADDS---YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 562 (613)
T ss_dssp C-----------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT
T ss_pred cCCCc---eeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 21111 0111112234678999999987666665 999999999999998 999999999889999998888888888
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIA 278 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il 278 (316)
.+++++.++|..|| .+|.+||++++++
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 89999999999999 5999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=338.36 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=212.8
Q ss_pred ceeeccCeEEee-eeeecCCeEEEEEEEc--cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 17 TVLESHGYTVGK-IIGTGSYATVKLARST--RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 17 ~~~~~~~y~~~~-~ig~g~~g~vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
..+..+.+.+.. .||+|+||.||+|.+. ..++.||||++....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 363 ~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 441 (635)
T 4fl3_A 363 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGICEA 441 (635)
T ss_dssp SBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG-GGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred ccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 344455555544 7999999999999654 566789999997643332 224567799999999999999999999965
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
...++||||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 442 -~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 442 -ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred -CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 4578999999999999999988889999999999999999999999999999999999999999999999999987643
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
.... .........++..|+|||++.+..++.+ +||||||+++|+|++ |..||.+....+....+..+...+.+..
T Consensus 521 ~~~~---~~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 596 (635)
T 4fl3_A 521 ADEN---YYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 596 (635)
T ss_dssp C----------------CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred cCcc---ccccccCCCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 2111 1111222335678999999987676665 999999999999998 9999999999999999998888888888
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
++.++.++|..|| .+|++||+++++++
T Consensus 597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 597 CPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999 59999999999973
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=306.71 Aligned_cols=254 Identities=25% Similarity=0.478 Sum_probs=197.3
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
..++...+|++.+.||+|+||.||+|.+. ..+++|++...... ....+.+.+|+.+++.++||||++++++. ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 56788999999999999999999999754 35999999765543 33456678999999999999999999965 455
Q ss_pred eEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
..++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 68999999999999999964 45699999999999999999999999999999999999999999999999999865321
Q ss_pred ccCcCCCCCCCcccccccCccCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcccCCCC-
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQ---GIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-VNELLKQVQNKVTFPK- 249 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~- 249 (316)
. ..........+++.|+|||++. ...++. ++||||||+++|+|++|..||.... .......+......+.
T Consensus 173 ~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 173 W----SGSHQFEQLSGSILWMAPEVIRMQDSNPYSF-QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCH-HHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred c----cccccccccCCCccccCchhhcccCCCCCCc-ccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 1 1122223445889999999986 333333 4999999999999999999998744 4445555544332222
Q ss_pred ---CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 250 ---QPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 250 ---~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
...+|+++.++|..|| .+|.+|||++++++
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2468899999999999 59999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=334.46 Aligned_cols=260 Identities=22% Similarity=0.410 Sum_probs=221.3
Q ss_pred cccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 14 RKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 14 ~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
...+++..++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+++.++||||+++++++..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~ 333 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 333 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34567888999999999999999999998874 457999999764432 3457799999999999999999999876
Q ss_pred CCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
...++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++..
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 678999999999999999964 35699999999999999999999999999999999999999999999999999865
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQ 250 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
..... ........++..|+|||++....++.+ +||||||+++|+|++ |..||.+....+....+..+...+.+
T Consensus 413 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~ 486 (535)
T 2h8h_A 413 IEDNE-----YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 486 (535)
T ss_dssp CCCHH-----HHTTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred cCCCc-----eecccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 42111 011122335678999999877666555 999999999999999 99999999999999999888888888
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC--CCCCC
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAED--RWLKP 285 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~--~~~~~ 285 (316)
..++.++.+||..|| .+|++|||++++++. .++..
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 889999999999999 599999999999864 45543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=307.81 Aligned_cols=248 Identities=21% Similarity=0.356 Sum_probs=206.3
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe------
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------ 93 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 93 (316)
-..+|++.+.||+|+||.||+|.+..+++.|++|.+.... +.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 4678999999999999999999999999999999987543 235689999999999999999998854
Q ss_pred ----------CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCe
Q psy11194 94 ----------THRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNI 161 (316)
Q Consensus 94 ----------~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~ 161 (316)
....++||||+++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence 44589999999999999999653 569999999999999999999999999999999999999999999
Q ss_pred EEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy11194 162 KLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV 241 (316)
Q Consensus 162 ~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~ 241 (316)
+|+|||++..... ........+++.|+|||++.+..++.+ +||||||+++|+|++|..|+.. .......+
T Consensus 162 kl~Dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~--~~~~~~~~ 231 (284)
T 2a19_B 162 KIGDFGLVTSLKN-------DGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFE--TSKFFTDL 231 (284)
T ss_dssp EECCCTTCEESSC-------CSCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHH--HHHHHHHH
T ss_pred EECcchhheeccc-------cccccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchh--HHHHHHHh
Confidence 9999999865321 112233458899999999988766655 9999999999999999988743 22233333
Q ss_pred hcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 242 QNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
... .....++..+.++|..|| .+|.+|||+.+++++.+.-...
T Consensus 232 ~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 232 RDG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HTT---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred hcc---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 332 233568999999999999 5999999999999997764443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=311.32 Aligned_cols=259 Identities=23% Similarity=0.383 Sum_probs=204.8
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEcc-CCc--eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTR-HSG--DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~-~~~--~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
...+..++|++.+.||+|+||.||+|.+.. +++ .|++|++...........+.+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 356678899999999999999999998654 333 58999987654444444566789999999999999999999998
Q ss_pred eCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
... .++|+||+++++|.+++.. .+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred cCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 765 7899999999999999976 35699999999999999999999999999999999999999999999999999865
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc-ccCCCC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQN-KVTFPK 249 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~-~~~~~~ 249 (316)
...... .........++..|+|||++.+..++.+ +||||||+++|+|++ |..||...+..+....+.. ....+.
T Consensus 171 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (291)
T 1u46_A 171 LPQNDD---HYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246 (291)
T ss_dssp CCC-CC---EEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred cccccc---chhhhccCCCCceeeCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC
Confidence 422111 1111223346778999999877665544 999999999999999 9999999888888777754 344556
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+..++.++.++|..|| .+|.+|||+.++++
T Consensus 247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 6789999999999999 59999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=308.91 Aligned_cols=244 Identities=27% Similarity=0.498 Sum_probs=200.2
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
..+..++|++.+.||+|+||.||+|.+. ++.|++|.+.... ..+.+.+|+.+++.++||||+++++++.+ .
T Consensus 3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 73 (307)
T 2eva_A 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--P 73 (307)
T ss_dssp CBCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--T
T ss_pred CcCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C
Confidence 3456789999999999999999999765 6789999985422 24557799999999999999999998874 4
Q ss_pred EEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---cCccccCCCCCCeeeCCCCC-eEEeecccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQG---YIDEIRARRWFGQLLEALQYCHE---RGVVHRDIKCENLLLDSDYN-IKLSDFGFA 169 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~~i~~~l~~Lh~---~~~~H~dl~p~nil~~~~~~-~~l~Df~~~ 169 (316)
.++||||+++++|.+++.... .++...+..++.|++.||.|||+ .|++|+||+|+||+++.++. ++|+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 789999999999999998654 47899999999999999999999 89999999999999998887 799999998
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcccCC
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS--SVNELLKQVQNKVTF 247 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~--~~~~~~~~~~~~~~~ 247 (316)
..... ......+++.|+|||++.+..++.+ +||||||+++|+|++|..||... ........+......
T Consensus 154 ~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 223 (307)
T 2eva_A 154 CDIQT---------HMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 223 (307)
T ss_dssp --------------------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC
T ss_pred ccccc---------ccccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC
Confidence 64321 1122347899999999988766655 99999999999999999999753 333444455555556
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 248 PKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 248 ~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
+....++..+.++|.+|| .+|.+|||++++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 666789999999999999 59999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=313.71 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=207.1
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEE----ccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARS----TRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~----~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
..+..+.|++.+.||+|+||.||++.. ..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 334555569999999999999988753 4578899999997543 2333566789999999999999999999998
Q ss_pred e--CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 93 T--THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 93 ~--~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
. ....++||||+++++|.+++.... +++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred cCCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 7 468899999999999999998755 9999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN--------------- 235 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~--------------- 235 (316)
...... ..........++..|+|||++.+..++.+ +||||||+++|+|++|..||......
T Consensus 183 ~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 183 AVPEGH---EYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp ECCTTC---SEEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred cccccc---cccccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 643211 11112233446778999999987666654 99999999999999999998753221
Q ss_pred HHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy11194 236 ELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIA 278 (316)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il 278 (316)
...+.+......+.+..+++++.++|..|| .+|.+|||+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 302 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLI 302 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 233444556666777789999999999999 5999999999997
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=317.86 Aligned_cols=262 Identities=20% Similarity=0.278 Sum_probs=200.2
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEcc---CCceEEEEEeecCCCCchHH--------HhhHHHHHHHHhcCCCCCcc
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTR---HSGDVAIKIVSKVQAPPDYL--------KKFLPREIEVVKGLKHPNLI 85 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~---~~~~v~vK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~ 85 (316)
..+.+++|.+.+.||+|+||.||+|.+.. ++..+++|+........... ...+.+|+..+..++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 34456889999999999999999999987 77899999987654321110 12245788889999999999
Q ss_pred eeeeEEEe----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC--
Q psy11194 86 RFLQAIET----THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY-- 159 (316)
Q Consensus 86 ~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~-- 159 (316)
++++++.. ....++||||+ +++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 99999987 77899999999 889999998777899999999999999999999999999999999999998877
Q ss_pred CeEEeecccccccccccCcCC-CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHH
Q psy11194 160 NIKLSDFGFARAHMRCRSNAA-DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD--SSVNE 236 (316)
Q Consensus 160 ~~~l~Df~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~--~~~~~ 236 (316)
.++|+|||++........... .........+++.|+|||++.+..++.+ +|||||||++|+|++|..||.. .+...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999976543221111 1112234568999999999988766555 9999999999999999999964 23322
Q ss_pred HHHHHhcc-cCCC-------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 237 LLKQVQNK-VTFP-------KQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 237 ~~~~~~~~-~~~~-------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
........ ...+ ....++.++.++|..|| .+|.+|||++++++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 22221111 0111 11268999999999999 599999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=320.62 Aligned_cols=264 Identities=22% Similarity=0.319 Sum_probs=198.5
Q ss_pred cccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeE
Q psy11194 12 IDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQA 90 (316)
Q Consensus 12 ~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 90 (316)
.......+...+|.+.+.||+|+||+||. ....+|+.||||++..... ..+.+|+.+++.+ +||||++++++
T Consensus 14 ~~~~~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~ 86 (432)
T 3p23_A 14 EETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCT 86 (432)
T ss_dssp ----CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccCCcEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEE
Confidence 33445677778899999999999999764 3456788999999865322 2355899999999 79999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-----CCeEEe
Q psy11194 91 IETTHRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-----YNIKLS 164 (316)
Q Consensus 91 ~~~~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~-----~~~~l~ 164 (316)
+......++|||++.| +|.+++.... .++...+..++.||+.||.|||+.|++|+||||+||+++.+ ..++|+
T Consensus 87 ~~~~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 87 EKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp EEETTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred EecCCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 9999999999999965 9999997644 35566778999999999999999999999999999999532 357899
Q ss_pred ecccccccccccCcCCCCCCCcccccccCccCcccccCC--CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11194 165 DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI--PYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQV 241 (316)
Q Consensus 165 Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~ 241 (316)
|||++....... ..........|++.|+|||++... ...+.++|||||||++|+|++ |..||............
T Consensus 166 DFG~a~~~~~~~---~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~ 242 (432)
T 3p23_A 166 DFGLCKKLAVGR---HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242 (432)
T ss_dssp CTTEEECC---------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT
T ss_pred cccceeeccCCC---cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh
Confidence 999987643211 111223345689999999999742 233345999999999999999 99999765544443333
Q ss_pred hcccCC--CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 242 QNKVTF--PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 242 ~~~~~~--~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
...... ......+..+.+||.+|| .+|.+|||++++++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 221111 111234567899999999 599999999999999999753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=319.40 Aligned_cols=255 Identities=19% Similarity=0.297 Sum_probs=201.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCC---ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE-eCCe
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHS---GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE-TTHR 96 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~---~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~ 96 (316)
...|.+.+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+.+|+.+++.++||||+++++++. .++.
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS--HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 345889999999999999999876443 35888988653332 23456779999999999999999999874 4567
Q ss_pred EEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
.++||||+++++|.++++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 89999999999999999764 45899999999999999999999999999999999999999999999999998754221
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVS 254 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (316)
.. ..........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||......+....+..+.....+..++
T Consensus 246 ~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~ 322 (373)
T 3c1x_A 246 EF--DSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 322 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCC
T ss_pred cc--ccccccCCCCCcccccChHHhcCCCCCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 11 11111223346778999999987666655 999999999999999 788998877766777777776666677899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
..+.++|..|| .+|.+|||+.+++++
T Consensus 323 ~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 323 DPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 599999999999853
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=317.17 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=201.9
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|.+.+.||+|+||.||+|.+. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 4578999999999999999999864 6889999988654332 24567799999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 100 IMEYAENGSLFDIIRGQG----YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 191 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE- 191 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS-
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 999999999999986532 589999999999999999999999999999999999999999999999999865321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcc----
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL-------KQVQNK---- 244 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-------~~~~~~---- 244 (316)
...........|++.|+|||++.+..++.+ +||||||+++|+|++|+.||....+.+.. ......
T Consensus 192 ---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 192 ---LDQTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ---SSCCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ---ccccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 111122334458899999999877666655 99999999999999999999754322111 111110
Q ss_pred -cCC----CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 245 -VTF----PKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 245 -~~~----~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
... ...+..+..+.+++.+|| .+|++|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 111234578899999999 599999999999965
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=311.03 Aligned_cols=257 Identities=23% Similarity=0.413 Sum_probs=207.4
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEE----EccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEE
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLAR----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAI 91 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~----~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 91 (316)
...+..++|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 455678899999999999999999998 45678899999986532 22345678999999999999999999998
Q ss_pred EeCC--eEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 92 ETTH--RVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 92 ~~~~--~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
.... ..++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 6544 789999999999999999775 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------------
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV-------------- 234 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-------------- 234 (316)
+........ .........++..|+|||.+.+..++.+ +||||||+++|+|++|..||.....
T Consensus 192 ~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 192 TKVLPQDKE---YYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267 (326)
T ss_dssp CEECCSSCS---EEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred hhhcccccc---ccccccCCCCceeEECchhhcCCCCCch-hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence 876432111 0011222346677999999877666554 9999999999999999988864211
Q ss_pred --HHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 235 --NELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
....+.+......+.+..+++++.++|..|| .+|++|||+.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1223444455556667789999999999999 59999999999984
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=317.50 Aligned_cols=259 Identities=17% Similarity=0.255 Sum_probs=198.8
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccC-----CceEEEEEeecCCCCchHHH--------hhHHHHHHHHhcCCCCCcc
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRH-----SGDVAIKIVSKVQAPPDYLK--------KFLPREIEVVKGLKHPNLI 85 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~-----~~~v~vK~~~~~~~~~~~~~--------~~~~~e~~~l~~l~~~~i~ 85 (316)
...++|++.+.||+|+||.||+|.+..+ ++.||+|++........... .....|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4466999999999999999999998764 57899999866432111001 1122455667788899999
Q ss_pred eeeeEEEeC----CeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC--CC
Q psy11194 86 RFLQAIETT----HRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD--SD 158 (316)
Q Consensus 86 ~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~--~~ 158 (316)
++++++... ...++||||+ |++|.+++... +.+++..++.++.||+.||.|||+.|++|+||||+||+++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998764 5689999999 88999999775 5799999999999999999999999999999999999998 88
Q ss_pred CCeEEeecccccccccccCcCC-CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHH
Q psy11194 159 YNIKLSDFGFARAHMRCRSNAA-DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS-VNE 236 (316)
Q Consensus 159 ~~~~l~Df~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~ 236 (316)
+.++|+|||++..+........ .........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.. ...
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 9999999999976543322111 1122234458999999999988776655 999999999999999999998532 111
Q ss_pred HHHHHhccc---------CCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 237 LLKQVQNKV---------TFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 237 ~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
......... .......++.++.++|..|| .+|.+||+++++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 111111100 00112568999999999999 59999999998875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=302.99 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=197.6
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEE-EeCCeEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAI-ETTHRVY 98 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~ 98 (316)
.+++|++.+.||+|+||.||+|++..+++.||+|++..... .+.+.+|+.+++.++|++++..+..+ ......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 46789999999999999999999999999999998765443 23467899999999877766655544 7788899
Q ss_pred EEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee---CCCCCeEEeeccccccccc
Q psy11194 99 IIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL---DSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~---~~~~~~~l~Df~~~~~~~~ 174 (316)
+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 8899999974 4569999999999999999999999999999999999999 7889999999999976543
Q ss_pred ccCcCC-CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-hcccCCC-
Q psy11194 175 CRSNAA-DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN---ELLKQV-QNKVTFP- 248 (316)
Q Consensus 175 ~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~-~~~~~~~- 248 (316)
...... .........+++.|+|||.+.+..++.+ +|||||||++|+|++|..||.+.... .....+ ......+
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCch-hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 221111 1122334568999999999988776655 99999999999999999999763321 111111 1111112
Q ss_pred --CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 249 --KQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 249 --~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
....+|+++.++|..|| .+|++|||++++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 12568999999999999 59999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=324.06 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=200.8
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC--
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-- 95 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 95 (316)
...+++|++.+.||+|+||.||+|.+..+|+.||+|++........ .+.+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 3457889999999999999999999999999999999975432221 345668999999999999999999998755
Q ss_pred eEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee----CCCCCeEEeeccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQG---YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL----DSDYNIKLSDFGF 168 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~----~~~~~~~l~Df~~ 168 (316)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 7899999999999999997533 39999999999999999999999999999999999999 6777899999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCC----CCHHH
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQG--------IPYAPHLSDIWSMGVVLFAMVFGRLPFDD----SSVNE 236 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~Di~slG~ll~~l~~g~~p~~~----~~~~~ 236 (316)
+...... .......+++.|+|||++.+ ..++ .++|||||||++|+|++|..||.. ....+
T Consensus 163 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 234 (396)
T 4eut_A 163 ARELEDD-------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (396)
T ss_dssp CEECCCG-------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHH-HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred ceEccCC-------CccccccCCccccCHHHhhccccccccccCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence 9754221 12223458999999999754 2233 348999999999999999999963 22334
Q ss_pred HHHHHhcccCC--------------------CCC----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 237 LLKQVQNKVTF--------------------PKQ----PEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 237 ~~~~~~~~~~~--------------------~~~----~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
....+..+.+. +.. ..++..+.++|..|| .||++||+++++++
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 44444333211 111 124568889999999 59999999999854
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=301.75 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=201.7
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeE-EEeCCeE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQA-IETTHRV 97 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~ 97 (316)
..+++|++.+.||+|+||.||+|++..+|+.||+|++...... +.+.+|+.+++.++|++++..+.. +......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 3468999999999999999999999999999999998765442 346789999999988776555554 4677788
Q ss_pred EEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC---CCCCeEEeecccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD---SDYNIKLSDFGFARAHM 173 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~---~~~~~~l~Df~~~~~~~ 173 (316)
++||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 8899999974 45699999999999999999999999999999999999994 78899999999997654
Q ss_pred cccCcCCC-CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhc-ccCCC
Q psy11194 174 RCRSNAAD-NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV---NELLKQVQN-KVTFP 248 (316)
Q Consensus 174 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~~-~~~~~ 248 (316)
........ ........+++.|+|||++.+..++.+ +||||||+++|+|++|..||..... .+....+.. ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 32211111 112344568999999999988776655 9999999999999999999976321 122222211 11111
Q ss_pred ---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 249 ---KQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 249 ---~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
....+|+++.++|..|| .+|.+|||++++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 22568999999999999 59999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.20 Aligned_cols=250 Identities=17% Similarity=0.269 Sum_probs=200.8
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEcc--------CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcce-----
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTR--------HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIR----- 86 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~--------~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~----- 86 (316)
.+++|++.+.||+|+||.||+|++.. .++.||+|++... +.+.+|+.+++.++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhh
Confidence 35889999999999999999999887 4789999998753 34668999999999998887
Q ss_pred ----------eeeEEEe-CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCe
Q psy11194 87 ----------FLQAIET-THRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENL 153 (316)
Q Consensus 87 ----------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ni 153 (316)
+++++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6677765 77899999999 88999999875 6799999999999999999999999999999999999
Q ss_pred eeCCCC--CeEEeecccccccccccCcCC-CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy11194 154 LLDSDY--NIKLSDFGFARAHMRCRSNAA-DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD 230 (316)
Q Consensus 154 l~~~~~--~~~l~Df~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~ 230 (316)
+++.++ .++|+|||++........... .........+++.|+|||++.+..++.+ +||||||+++|+|++|..||.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCcc
Confidence 999988 899999999976543222111 1122234468999999999988766555 999999999999999999998
Q ss_pred CC--CHHHHHHHHhccc----CCC----CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 231 DS--SVNELLKQVQNKV----TFP----KQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 231 ~~--~~~~~~~~~~~~~----~~~----~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.. ............. .+. ....++.++.++|..|| .+|.+|||++++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 65 3333333332111 111 11257999999999999 59999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=310.44 Aligned_cols=267 Identities=25% Similarity=0.394 Sum_probs=193.9
Q ss_pred hhhhcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcce
Q psy11194 8 VQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIR 86 (316)
Q Consensus 8 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~ 86 (316)
.+.+......++...+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++..+. ||||++
T Consensus 14 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~ 90 (337)
T 3ll6_A 14 DQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQ 90 (337)
T ss_dssp -CCSSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCC
T ss_pred hHHHhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhh
Confidence 3445556667788889999999999999999999999999999999985542 223455778999999995 999999
Q ss_pred eeeEEE--------eCCeEEEEEecCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCe
Q psy11194 87 FLQAIE--------TTHRVYIIMEYAENGSLFDIIRG---QGYIDEIRARRWFGQLLEALQYCHERG--VVHRDIKCENL 153 (316)
Q Consensus 87 ~~~~~~--------~~~~~~lv~e~~~~~sL~~~l~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~H~dl~p~ni 153 (316)
+++++. .....++||||++ ++|.+++.. .+.+++..++.++.||+.||.|||+.| ++|+||+|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NI 169 (337)
T 3ll6_A 91 FCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENL 169 (337)
T ss_dssp EEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGC
T ss_pred ccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccE
Confidence 999984 3446899999996 599998864 456999999999999999999999999 99999999999
Q ss_pred eeCCCCCeEEeecccccccccccCcCCC------CCCCcccccccCccCccccc---CCCCCCCchhHHHHHHHHHHHHh
Q psy11194 154 LLDSDYNIKLSDFGFARAHMRCRSNAAD------NSLSETFCGSYAYASPEILQ---GIPYAPHLSDIWSMGVVLFAMVF 224 (316)
Q Consensus 154 l~~~~~~~~l~Df~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~ 224 (316)
+++.++.++|+|||++............ ........+++.|+|||++. +..++ .++||||||+++|+|++
T Consensus 170 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~Dv~slG~il~el~~ 248 (337)
T 3ll6_A 170 LLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG-EKQDIWALGCILYLLCF 248 (337)
T ss_dssp EECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSS-HHHHHHHHHHHHHHHHH
T ss_pred EECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCC-hHHhHHHHHHHHHHHHh
Confidence 9999999999999998764322111000 01111345788999999983 33343 34999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCC
Q psy11194 225 GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRW 282 (316)
Q Consensus 225 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~ 282 (316)
|..||........ +......+.....+..+.++|..|| .+|.+|||+++++++.+
T Consensus 249 g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 249 RQHPFEDGAKLRI---VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp SSCCC---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCcchhHHHh---hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9999976544333 2333445555678899999999999 59999999999998753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=312.83 Aligned_cols=264 Identities=22% Similarity=0.319 Sum_probs=206.7
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
-..+..++|++.+.||+|+||.||+|.+. +|+.||+|++........ ...+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 34456789999999999999999999744 688999999876443221 235779999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHc---CccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQG----YIDEIRARRWFGQLLEALQYCHER---GVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~~i~~~l~~Lh~~---~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence 9999999999999999997532 499999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhc
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS-----SVNELLKQVQN 243 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~ 243 (316)
+..... ..........|++.|+|||++.+..++.+ +||||||+++|+|++|..||... ......+.+..
T Consensus 181 ~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 181 AKLMDY-----KDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CEECCS-----SSSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccccCc-----ccccccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 975421 11222333458999999999977666555 99999999999999999999521 11111111111
Q ss_pred ---ccCCC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 244 ---KVTFP----------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 244 ---~~~~~----------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
..... .....+..+.+++..|| .+|.+|||+.++++|..-....+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 10000 01123478999999999 59999999999999877655554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=304.14 Aligned_cols=231 Identities=29% Similarity=0.512 Sum_probs=186.2
Q ss_pred ccCeEEe-eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHH-hcCCCCCcceeeeEEEe----C
Q psy11194 21 SHGYTVG-KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV-KGLKHPNLIRFLQAIET----T 94 (316)
Q Consensus 21 ~~~y~~~-~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~ 94 (316)
..+|.+. +.||+|+||.||+|.+..+++.||+|++.. .....+|+.++ +.++||||+++++++.. .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4567776 789999999999999999999999999864 22355788877 66689999999999977 6
Q ss_pred CeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC---CCCeEEeecccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFA 169 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~---~~~~~l~Df~~~ 169 (316)
...++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999998743 6999999999999999999999999999999999999987 788999999988
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC---
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--- 246 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 246 (316)
.... +..++ .++|||||||++|+|++|..||.................
T Consensus 168 ~~~~----------------------------~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 218 (299)
T 3m2w_A 168 KETT----------------------------GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218 (299)
T ss_dssp EECT----------------------------TCGGG-GHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC
T ss_pred cccc----------------------------cccCC-chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc
Confidence 5421 01122 349999999999999999999987655443322222111
Q ss_pred CCCC----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 247 FPKQ----PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 247 ~~~~----~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
...+ ..+++++.++|..|| .+|.+|||++++++||||+....
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 1111 468999999999999 59999999999999999976543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=309.30 Aligned_cols=266 Identities=18% Similarity=0.341 Sum_probs=212.8
Q ss_pred hhhcccccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceee
Q psy11194 9 QDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFL 88 (316)
Q Consensus 9 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 88 (316)
+.......+.+..++|++.+.||+|+||.||+|.+.. .+++|++........ ..+.+.+|+.+++.++||||++++
T Consensus 20 ~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~ 95 (319)
T 2y4i_B 20 QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNED-QLKAFKREVMAYRQTRHENVVLFM 95 (319)
T ss_dssp --CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCC-CCCCCCTTGGGGTTCCCTTBCCCC
T ss_pred ccccccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHH-HHHHHHHHHHHHhcCCCCCEeEEE
Confidence 3445556677888999999999999999999998753 599999876543322 234466899999999999999999
Q ss_pred eEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecc
Q psy11194 89 QAIETTHRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFG 167 (316)
Q Consensus 89 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~ 167 (316)
+++......++||||+++++|.+++...+ .+++..++.++.||+.||.+||+.|++|+||+|+||+++ ++.++|+|||
T Consensus 96 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp EEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred EEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecC
Confidence 99999999999999999999999998754 699999999999999999999999999999999999997 6899999999
Q ss_pred cccccccccCcCCCCCCCcccccccCccCcccccCC--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy11194 168 FARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI--------PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK 239 (316)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~ 239 (316)
++........ ...........+++.|+|||++... ...+.++||||||+++|+|++|..||..........
T Consensus 175 ~~~~~~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 253 (319)
T 2y4i_B 175 LFSISGVLQA-GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW 253 (319)
T ss_dssp CCC-----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred Cccccccccc-cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9765321111 1112223344588999999998652 223445999999999999999999999988888887
Q ss_pred HHhcccCCCCC-CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 240 QVQNKVTFPKQ-PEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 240 ~~~~~~~~~~~-~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.+..+...... ..++.++.++|..|| .+|.+|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 254 QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 77666544333 368999999999999 599999999999963
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=305.27 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=194.4
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhc--CCCCCcceeeeEEEe-
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKG--LKHPNLIRFLQAIET- 93 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~- 93 (316)
.....++|++.+.||+|+||.||+|.+ +++.||+|++.... ...+.+|..++.. ++||||+++++++..
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 345678999999999999999999977 58899999986432 2233456666655 789999999998654
Q ss_pred ---CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HcCccccCCCCCCeeeCCCCCeE
Q psy11194 94 ---THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH--------ERGVVHRDIKCENLLLDSDYNIK 162 (316)
Q Consensus 94 ---~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~~~H~dl~p~nil~~~~~~~~ 162 (316)
....++||||+++++|.++++.. .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTTC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred cCCCceeEEehhhccCCCHHHHHhhc-ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 34689999999999999999754 5999999999999999999999 99999999999999999999999
Q ss_pred EeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCC-----CchhHHHHHHHHHHHHhC----------CC
Q psy11194 163 LSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP-----HLSDIWSMGVVLFAMVFG----------RL 227 (316)
Q Consensus 163 l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~ll~~l~~g----------~~ 227 (316)
|+|||++.......... ........|++.|+|||++.+..... .++||||||+++|+|++| ..
T Consensus 154 l~Dfg~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQL--DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp ECCCTTCEEEETTTTEE--ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EeeCCCeeecccccccc--cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 99999986543221111 11122346899999999997753322 349999999999999999 88
Q ss_pred CCCCC-----CHHHHHHHHhcccCCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 228 PFDDS-----SVNELLKQVQNKVTFPKQP------EVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 228 p~~~~-----~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
||... ........+......+..+ ..+.++.++|..|| .+|.+|||+.++++
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 88542 2233333333222222221 24578999999999 59999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=317.46 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=191.6
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 98 (316)
..+.|.+.+.||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.++..+ +||||+++++++...+..+
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 3566788899999999999875 34578999999986532 33456899999876 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-------------
Q psy11194 99 IIMEYAENGSLFDIIRGQGYI-------DEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD------------- 158 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l-------~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~------------- 158 (316)
+||||++ ++|.+++...... ++..++.++.||+.||.|||+.|++|+||+|+||+++..
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999996 5999999865432 223457899999999999999999999999999999654
Q ss_pred CCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q psy11194 159 YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG------IPYAPHLSDIWSMGVVLFAMVF-GRLPFDD 231 (316)
Q Consensus 159 ~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~-g~~p~~~ 231 (316)
+.++|+|||++......... .........|++.|+|||++.+ ....+.++|||||||++|+|++ |..||..
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSS--FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CEEEECCCTTCEECCC----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred eEEEEcccccceecCCCCcc--ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 47999999999764321111 0111234568999999999865 2334455999999999999999 9999976
Q ss_pred CCHHHHHHHHhcccCCCCCC-----CCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 232 SSVNELLKQVQNKVTFPKQP-----EVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
....+ ...+......+... .+++++.++|.+|| .+|.+|||+.++++||||++.
T Consensus 243 ~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 243 KYSRE-SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp TTTHH-HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred chhhH-HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 54433 22222222222221 24588999999999 599999999999999999754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=330.83 Aligned_cols=254 Identities=23% Similarity=0.404 Sum_probs=212.9
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccC---CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRH---SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
..+..++|++.+.||+|+||.||+|.+..+ +..+++|.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 455678899999999999999999998643 4468899875433 2334566779999999999999999999985
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
++..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 456899999999999999997644 6999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
... .........+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+....+....+..+...+.+.
T Consensus 542 ~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 615 (656)
T 2j0j_A 542 EDS-----TYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 615 (656)
T ss_dssp CC---------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT
T ss_pred CCC-----cceeccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 211 1111222345678999999977666554 999999999999997 999999999999988888877777788
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+++.+.++|.+|| .+|.+|||+.++++
T Consensus 616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 616 NCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 89999999999999 59999999999984
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=302.17 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=194.1
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC--CCCCcceeeeEEEeC--
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL--KHPNLIRFLQAIETT-- 94 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~-- 94 (316)
...++|++.+.||+|+||.||+|.+. ++.||+|++.... .....+|..++..+ +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34578999999999999999999875 8899999985432 12233555555554 899999999999877
Q ss_pred --CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCCeeeCCCCCeEEe
Q psy11194 95 --HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER--------GVVHRDIKCENLLLDSDYNIKLS 164 (316)
Q Consensus 95 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------~~~H~dl~p~nil~~~~~~~~l~ 164 (316)
...++||||+++++|.++++.. .+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999765 599999999999999999999998 99999999999999999999999
Q ss_pred ecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCC-----chhHHHHHHHHHHHHhC----------CCCC
Q psy11194 165 DFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPH-----LSDIWSMGVVLFAMVFG----------RLPF 229 (316)
Q Consensus 165 Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-----~~Di~slG~ll~~l~~g----------~~p~ 229 (316)
|||++......... .........|++.|+|||++.+...... ++|||||||++|+|++| ..||
T Consensus 185 Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 185 DLGLAVKFISDTNE--VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CCTTCEECC-----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred eCCCceeecccccc--ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99998654321111 1111224468999999999977655543 38999999999999999 7777
Q ss_pred CCC-----CHHHHHHHHhccc-CCCCC-----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 230 DDS-----SVNELLKQVQNKV-TFPKQ-----PEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 230 ~~~-----~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
... ........+.... ....+ ..+++++.++|.+|| .+|.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 542 2233333332222 11111 145678999999999 599999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=303.32 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=197.1
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCC-CchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEe
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA-PPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 102 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 102 (316)
|...+.||+|+||.||+|.+ +++.+++|++..... ......+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 55568999999999999975 578999999875432 223345668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 103 YAENGSLFDIIRG---QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 103 ~~~~~sL~~~l~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
|+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~---- 186 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF---- 186 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC----
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc----
Confidence 9999999999963 346999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcc----------c
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNE----LLKQVQNK----------V 245 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~~----------~ 245 (316)
..........+++.|+|||.+.+. ++ .++||||||+++|+|++|..||....... ....+... .
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~-~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGE-IT-PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTE-EC-THHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred cccccccccCCCcCcCChHHhcCC-CC-ccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence 111122334588999999998763 44 45999999999999999999997643221 22222111 0
Q ss_pred CCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 246 TFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 246 ~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
........+..+.++|..|| .+|.+|||+++++++
T Consensus 265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 265 MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01112234578999999999 599999999999853
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=313.89 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=204.7
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC-CCcceeeeEEEeCCeE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-PNLIRFLQAIETTHRV 97 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~ 97 (316)
...++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+.| ++++.+..++......
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 3478999999999999999999999999999999998765442 346689999999976 6666777777888899
Q ss_pred EEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee---CCCCCeEEeecccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLL---DSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~---~~~~~~~l~Df~~~~~~~ 173 (316)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+|||+ +.++.++|+|||++....
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8899999975 4569999999999999999999999999999999999999 578999999999997654
Q ss_pred cccCcCC-CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhccc----
Q psy11194 174 RCRSNAA-DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS---VNELLKQVQNKV---- 245 (316)
Q Consensus 174 ~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~~~~~~~---- 245 (316)
....... .........|+..|+|||++.+..++.+ +|||||||++|+|++|..||.+.. ..+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 3221111 1122235568999999999988777655 999999999999999999998643 233333332211
Q ss_pred CCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 246 TFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 246 ~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.......++.++.++|..|| .+|.+||++++|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11112468999999999999 59999999998765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=308.01 Aligned_cols=246 Identities=17% Similarity=0.235 Sum_probs=194.3
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEE-----EccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC---CCCcceee
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLAR-----STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK---HPNLIRFL 88 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~-----~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~ 88 (316)
..+..++|.+.+.||+|+||.||+|. +..+++.||+|++.... ...+.+|..++..++ |+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 45667889999999999999999994 67788999999986532 234567788888886 89999999
Q ss_pred eEEEeCCeEEEEEecCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC------
Q psy11194 89 QAIETTHRVYIIMEYAENGSLFDIIRG-----QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS------ 157 (316)
Q Consensus 89 ~~~~~~~~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~------ 157 (316)
+++...+..++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.|++||||||+|||++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999999973 456999999999999999999999999999999999999988
Q ss_pred -----CCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy11194 158 -----DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS 232 (316)
Q Consensus 158 -----~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~ 232 (316)
++.++|+|||++...... ..........|++.|+|||++.+..++.+ +|||||||++|+|++|..||...
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLF----PKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGS----CTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccccccCCEEEeeCchhhhhhcc----CCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccC
Confidence 899999999999654211 11222334568999999999988776655 99999999999999999999643
Q ss_pred CHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCC-HHHHh
Q psy11194 233 SVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPR-LKTIA 278 (316)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps-~~~il 278 (316)
.... ............++.+.+++..|| .+|.+|++ +.++.
T Consensus 289 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 289 EGGE-----CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp ETTE-----EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred CCCc-----eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 2211 000011111235788999999999 57888754 44443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=330.46 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=201.9
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe------
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------ 93 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 93 (316)
...+|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 3478999999999999999999999999999999986543 23335567799999999999999999998755
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC---eEEeecc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQG---YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN---IKLSDFG 167 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~---~~l~Df~ 167 (316)
.+..++||||++|++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 667899999999999999998643 5899999999999999999999999999999999999987765 8999999
Q ss_pred cccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--------
Q psy11194 168 FARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK-------- 239 (316)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~-------- 239 (316)
++.... .........+++.|+|||++.+..++.+ +||||||+++|+|++|..||.+........
T Consensus 170 ~a~~~~-------~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELD-------QGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTT-------SCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred cccccc-------cccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 986532 1222334568999999999988777766 999999999999999999997643332110
Q ss_pred -HH------hccc----CCCC----CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 240 -QV------QNKV----TFPK----QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 240 -~~------~~~~----~~~~----~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
.. .... ..+. ...+++.+.++|..|| .+|++|||+.++++||||+.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 00 0000 0111 1235689999999999 59999999999999999843
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=300.05 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=198.4
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhc--CCCCCcceeeeEEEeCC--
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKG--LKHPNLIRFLQAIETTH-- 95 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~-- 95 (316)
..++|.+.+.||+|+||.||+|.+ +|+.||+|++.... ...+.+|..++.. ++||||+++++++....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 457899999999999999999987 48899999985431 2345578888877 68999999999998776
Q ss_pred --eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HcCccccCCCCCCeeeCCCCCeEEee
Q psy11194 96 --RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH--------ERGVVHRDIKCENLLLDSDYNIKLSD 165 (316)
Q Consensus 96 --~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~~~H~dl~p~nil~~~~~~~~l~D 165 (316)
..++||||+++++|.+++.+. .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred cceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 799999999999999999864 5999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccCcCCCCCCCcccccccCccCcccccCCCCCC-----CchhHHHHHHHHHHHHhC----------CCCCC
Q psy11194 166 FGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAP-----HLSDIWSMGVVLFAMVFG----------RLPFD 230 (316)
Q Consensus 166 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~ll~~l~~g----------~~p~~ 230 (316)
||++.......... ........+++.|+|||++.+..... .++||||||+++|+|++| ..||.
T Consensus 191 fg~~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 191 LGLAVRHDSATDTI--DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CTTCEEEETTTTEE--EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCCceecccccccc--ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 99987643211110 01223446889999999987653222 348999999999999999 78886
Q ss_pred CC-----CHHHHHHHHhcccCCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 231 DS-----SVNELLKQVQNKVTFPKQP------EVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 231 ~~-----~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.. ........+......+..+ .++..+.++|.+|| .+|.+|||+++++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 53 3344444443332222211 23468999999999 599999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=302.08 Aligned_cols=264 Identities=22% Similarity=0.339 Sum_probs=190.1
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHH--HhcCCCCCcceeeeEEEe-
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV--VKGLKHPNLIRFLQAIET- 93 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~- 93 (316)
..+..++|++.+.||+|+||.||+|++ +++.||+|++.... ...+..|..+ +..++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 345678999999999999999999966 57899999986532 1222234444 445799999999986532
Q ss_pred ----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc---------CccccCCCCCCeeeCCCCC
Q psy11194 94 ----THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER---------GVVHRDIKCENLLLDSDYN 160 (316)
Q Consensus 94 ----~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---------~~~H~dl~p~nil~~~~~~ 160 (316)
...+++||||+++++|.+++.... .++..+..++.||+.||.|||+. |++|+||||+||+++.++.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 336789999999999999998755 68999999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccccccCcC--CCCCCCcccccccCccCcccccCCC------CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy11194 161 IKLSDFGFARAHMRCRSNA--ADNSLSETFCGSYAYASPEILQGIP------YAPHLSDIWSMGVVLFAMVFGRLPFDDS 232 (316)
Q Consensus 161 ~~l~Df~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~ll~~l~~g~~p~~~~ 232 (316)
++|+|||++.......... ..........|++.|+|||++.+.. ..+.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999997643221111 1122223446899999999987631 1223489999999999999997665321
Q ss_pred ------------------CHHHHHHHHhcccCCCC-CC------CCCHHHHHHHHHhc-CCCCCCCCHHHH------hhC
Q psy11194 233 ------------------SVNELLKQVQNKVTFPK-QP------EVSTECKELISNIL-SPVQTRPRLKTI------AED 280 (316)
Q Consensus 233 ------------------~~~~~~~~~~~~~~~~~-~~------~~~~~~~~li~~~l-~~p~~Rps~~~i------l~~ 280 (316)
........+......+. +. .+++++.++|.+|| .+|++|||+.++ +-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 11222222222211111 11 13458999999999 599999999999 456
Q ss_pred CCCCCCCCC
Q psy11194 281 RWLKPKPKS 289 (316)
Q Consensus 281 ~~~~~~~~~ 289 (316)
+|-++....
T Consensus 319 ~~~~~~~~~ 327 (336)
T 3g2f_A 319 IWERNKSVS 327 (336)
T ss_dssp CCCC-----
T ss_pred HHHhcccCC
Confidence 777665553
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=312.68 Aligned_cols=248 Identities=15% Similarity=0.169 Sum_probs=190.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC-CCc---------ceee---
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-PNL---------IRFL--- 88 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i---------~~~~--- 88 (316)
.+|...+.||+|+||.||+|.+..+|+.||||++...........+.+++|+.++..+.| ++. +...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458899999999999999999999999999999875555444445668899999999976 221 1111
Q ss_pred ---------eEEEe-----CCeEEEEEecCCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccC
Q psy11194 89 ---------QAIET-----THRVYIIMEYAENGSLFDIIRG-------QGYIDEIRARRWFGQLLEALQYCHERGVVHRD 147 (316)
Q Consensus 89 ---------~~~~~-----~~~~~lv~e~~~~~sL~~~l~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~d 147 (316)
.++.. ....+++|+.+ +++|.++++. ...+++..+..++.||+.||.|||+.|++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111 22467888877 5699999841 23478889999999999999999999999999
Q ss_pred CCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccc----------cCCCCCCCchhHHHHHH
Q psy11194 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL----------QGIPYAPHLSDIWSMGV 217 (316)
Q Consensus 148 l~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~~Di~slG~ 217 (316)
|||+|||++.++.++|+|||+++..... .....| +.|+|||++ ....++. ++|||||||
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~---------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~DvwSlGv 305 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS---------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF-AFDTWTLGL 305 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE---------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH-HHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc---------cccCCC-CceeCchhhhccccccccccCcCCCc-hhhHHHHHH
Confidence 9999999999999999999998653211 233446 899999998 3333444 499999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 218 VLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 218 ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
++|+|++|+.||...........+ +.....+|+++.+||..|| .+|.+||++.++++||||+..
T Consensus 306 il~elltg~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSGGG-----GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHCCCCCCCcchhhhHHHH-----HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 999999999999876543332222 2233468999999999999 599999999999999999654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=289.61 Aligned_cols=225 Identities=17% Similarity=0.174 Sum_probs=186.6
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
+.+.+|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+..+..++||||+++++++...+..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 56688999999999999999999999999999999998766655555567789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+||||++|++|.++++++ ....++..++.|++.||.|||+.|++|+||||+||+++.+|.++|++++.
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~---------- 175 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT---------- 175 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc----------
Confidence 999999999999999653 46667899999999999999999999999999999999999999985542
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhcccCC--CCCCC
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLK----QVQNKVTF--PKQPE 252 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~----~~~~~~~~--~~~~~ 252 (316)
++| .+.++|||||||++|+|++|..||.+.+..+... .+...... .....
T Consensus 176 ----------------~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 176 ----------------MPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231 (286)
T ss_dssp ----------------CTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred ----------------cCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence 222 2334999999999999999999998754322110 00111000 11256
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+++++.++|.+|| .+|.+| |+.++++.
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 8999999999999 699999 99999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=304.14 Aligned_cols=246 Identities=17% Similarity=0.202 Sum_probs=189.0
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC-----chHHHhhHHHHHHHHhcCC---------CCCc
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP-----PDYLKKFLPREIEVVKGLK---------HPNL 84 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------~~~i 84 (316)
+..++|++.+.||+|+||.||+|++ +|+.||+|++...... .....+.+.+|+.+++.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4568899999999999999999987 5789999999875432 1112345678888888875 6666
Q ss_pred ceeeeEE-----------------Ee-------------CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHH
Q psy11194 85 IRFLQAI-----------------ET-------------THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEA 134 (316)
Q Consensus 85 ~~~~~~~-----------------~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~ 134 (316)
+++.+++ .. ....++||||+++|++.+.+.+ +.+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 6666554 32 6789999999999976666644 558999999999999999
Q ss_pred HHHHH-HcCccccCCCCCCeeeCCCC--------------------CeEEeecccccccccccCcCCCCCCCcccccccC
Q psy11194 135 LQYCH-ERGVVHRDIKCENLLLDSDY--------------------NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193 (316)
Q Consensus 135 l~~Lh-~~~~~H~dl~p~nil~~~~~--------------------~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (316)
|.||| +.|++||||||+|||++.++ .+||+|||+++.... ....|++.
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----------~~~~gt~~ 242 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----------GIVVFCDV 242 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----------TEEECCCC
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----------CcEEEeec
Confidence 99999 99999999999999999887 899999999976431 12368899
Q ss_pred ccCcccccCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHhcccCCCC------CCCCCHHHHHHHHHhc
Q psy11194 194 YASPEILQGIPYAPHLSDIWSMGVV-LFAMVFGRLPFDDSSV-NELLKQVQNKVTFPK------QPEVSTECKELISNIL 265 (316)
Q Consensus 194 ~~aPE~~~~~~~~~~~~Di~slG~l-l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l 265 (316)
|+|||++.+.. +.++|||||+++ .++++.|..||.+... ....+.+........ ...+++++.+||.+||
T Consensus 243 y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 243 SMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp TTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred ccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHh
Confidence 99999998765 445999998777 6778889999854211 122223322211111 1247889999999999
Q ss_pred CCCCCCCCHHHHh-hCCCCC
Q psy11194 266 SPVQTRPRLKTIA-EDRWLK 284 (316)
Q Consensus 266 ~~p~~Rps~~~il-~~~~~~ 284 (316)
.- +|+++++ +||||+
T Consensus 321 ~~----dsa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 321 NF----SSATDLLCQHSLFK 336 (336)
T ss_dssp GS----SSHHHHHHHCGGGC
T ss_pred cc----CCHHHHHhcCCCcC
Confidence 52 2999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=319.90 Aligned_cols=239 Identities=22% Similarity=0.308 Sum_probs=194.1
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEcc-CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTR-HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
.+..++|++.+.||+|+||.||+|.+.. +|+.|+||++..... ....+.+.+|+.++..++||||+++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 4556899999999999999999999986 789999999865332 3334567799999999999999999999987665
Q ss_pred -----EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 97 -----VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 97 -----~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
.++||||++|++|.+++.. .+++..+..++.||+.||.|||+.|++|+||||+||+++.+ .++|+|||++..
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999998765 69999999999999999999999999999999999999875 999999999865
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC-
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ- 250 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 250 (316)
... .....|++.|+|||++.+.. +.++|||||||++|+|++|..||.+.... ..+..
T Consensus 231 ~~~----------~~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~ 288 (681)
T 2pzi_A 231 INS----------FGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPEDD 288 (681)
T ss_dssp TTC----------CSCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTTC
T ss_pred ccc----------CCccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccc----------cccccc
Confidence 321 13445899999999986643 44599999999999999999888652110 01111
Q ss_pred --CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 251 --PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 251 --~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
...++.+.++|.+|| .+|.+||+..+.+.|+|+
T Consensus 289 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 289 PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 124678999999999 599999998888777664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-34 Score=264.93 Aligned_cols=185 Identities=20% Similarity=0.141 Sum_probs=133.8
Q ss_pred eeecCCeEEEEEEEccCCceEEEEEeecCCCCc-------hHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCCeEEEEE
Q psy11194 30 IGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP-------DYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 30 ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~-------~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
.+.|+.|.+..++....|+.+++|++....... +...+.+.+|+.+|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 556777777777777789999999997653321 23345688999999999 6999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||++|++|.+++++.++++.. +|+.||+.||+|+|++||+||||||+|||++.+|.+||+|||+++... ..
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~------~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP------QD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--------
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCC------CC
Confidence 999999999999998888775 478999999999999999999999999999999999999999987532 11
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhC
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFG 225 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g 225 (316)
.......+||+.|+|||++.+.. .. .+|+|++|++++.+.++
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~~-~~-~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAENK-SW-NGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC-------------------CCCCTT
T ss_pred CccccCceechhhccHHHhCCCC-CC-cccccccccchhhhccc
Confidence 22334567999999999997643 23 38999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-27 Score=215.91 Aligned_cols=192 Identities=20% Similarity=0.195 Sum_probs=140.4
Q ss_pred EEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchH-----HHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDY-----LKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 25 ~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
...+.||+|+||.||+| ...++.+++|........... ..+.+.+|+.+++.++||||+++..++......++
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44678999999999999 445778999987554333221 13447899999999999999966666667777799
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||++|++|.+++.. +..++.|++.+|.|||++|++|+||||+||+++. .++|+|||+++.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999876 5689999999999999999999999999999988 99999999997643211000
Q ss_pred CC-CCCCcccccccCccCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy11194 180 AD-NSLSETFCGSYAYASPEILQG--IPYAPHLSDIWSMGVVLFAMVFGRLPF 229 (316)
Q Consensus 180 ~~-~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~ 229 (316)
.. ........||+.|+|||++.. ..+... +|+|+..+-..+-..++.+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhcccc
Confidence 00 001124568999999999875 334433 79999988887777666555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-25 Score=185.80 Aligned_cols=134 Identities=19% Similarity=0.277 Sum_probs=108.2
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch---------------HHHhhHHHHHHHHhcCCCCCcceee
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD---------------YLKKFLPREIEVVKGLKHPNLIRFL 88 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~~~~i~~~~ 88 (316)
|.+.+.||+|+||.||+|.+ .+|+.||+|+++....... .....+.+|+.+++.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 44559999999999999999 7899999999964322111 12455779999999998 4 6666
Q ss_pred eEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 89 QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 89 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
+++.. +..++||||++|++|.+ +.. .....++.|++.||.+||+.|++|+||+|+||+++ ++.++|+|||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 65544 45599999999999988 422 23567999999999999999999999999999999 99999999999
Q ss_pred cc
Q psy11194 169 AR 170 (316)
Q Consensus 169 ~~ 170 (316)
+.
T Consensus 239 a~ 240 (282)
T 1zar_A 239 SV 240 (282)
T ss_dssp CE
T ss_pred Ce
Confidence 85
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4e-21 Score=161.32 Aligned_cols=139 Identities=19% Similarity=0.268 Sum_probs=107.7
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCce--EEEEEeecCCCCc---------------------hHHHhhHHHHHHHHhcCC
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGD--VAIKIVSKVQAPP---------------------DYLKKFLPREIEVVKGLK 80 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~--v~vK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~ 80 (316)
|.+.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778888 9999975432110 111235778999999998
Q ss_pred CCCc--ceeeeEEEeCCeEEEEEecCCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCC
Q psy11194 81 HPNL--IRFLQAIETTHRVYIIMEYAEN-G----SLFDIIRGQGYIDEIRARRWFGQLLEALQYCH-ERGVVHRDIKCEN 152 (316)
Q Consensus 81 ~~~i--~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~H~dl~p~n 152 (316)
|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.+|| +.|++|+||+|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 7754 444432 245899999942 3 77776543 234567899999999999999 9999999999999
Q ss_pred eeeCCCCCeEEeecccccc
Q psy11194 153 LLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 153 il~~~~~~~~l~Df~~~~~ 171 (316)
||++. .++|+|||++..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99988 999999999854
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=8.4e-19 Score=153.23 Aligned_cols=138 Identities=14% Similarity=0.194 Sum_probs=99.2
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC--------------ch-H----HHhhHHHHHHHHhcCCCCCc
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP--------------PD-Y----LKKFLPREIEVVKGLKHPNL 84 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~--------------~~-~----~~~~~~~e~~~l~~l~~~~i 84 (316)
|.+...||.|++|.||+|.+. +|+.||||+.+..... .. . ..-...+|...+..+.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 889999999999999999875 6899999997542110 00 0 01112356667777654443
Q ss_pred ceeeeEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCC----
Q psy11194 85 IRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYN---- 160 (316)
Q Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~---- 160 (316)
....-+.... .++||||++|.+|..+.. ......++.||+.+|.+||+.|+|||||||.|||++++|.
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 2221121222 379999999988865432 2235678899999999999999999999999999987763
Q ss_pred ------eEEeeccccc
Q psy11194 161 ------IKLSDFGFAR 170 (316)
Q Consensus 161 ------~~l~Df~~~~ 170 (316)
+.|+||+.+.
T Consensus 248 ~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMV 263 (397)
T ss_dssp TSEEEEEEECCCTTCE
T ss_pred cccccceEEEEeCCcc
Confidence 8999999874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.8e-13 Score=114.85 Aligned_cols=139 Identities=15% Similarity=0.096 Sum_probs=110.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 100 (316)
.+|.+...++.|+.+.||++... ++.+++|+........ ...+.+|+.+++.+. +..++++++++...+..++|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 46888999999999999999643 6799999986532111 235779999999884 67788999999988999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE---------------------------------------- 140 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~---------------------------------------- 140 (316)
||+++|.+|.+.+. +......++.+++.++..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999887632 122345788899999999998
Q ss_pred -------------------cCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 141 -------------------RGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 141 -------------------~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
..++|||++|.||++++++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999875556799999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=1.3e-11 Score=103.02 Aligned_cols=133 Identities=15% Similarity=0.108 Sum_probs=97.6
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCC--cceeeeEEEeCCeEEEE
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN--LIRFLQAIETTHRVYII 100 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv 100 (316)
++.+....+.|..+.||++.. .+|+.+++|+..... ...+.+|+.+++.+.+.+ +++++++....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 455554444666799999954 456789999975431 245678999888885333 66788888888889999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG-------------------------------------- 142 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-------------------------------------- 142 (316)
|||++|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999998884 21 122 2356677777777787643
Q ss_pred --------------------ccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 143 --------------------VVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 143 --------------------~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
++|+|++|.||++++++.+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=3e-11 Score=105.93 Aligned_cols=142 Identities=14% Similarity=0.196 Sum_probs=105.6
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEee--cCCCCchHHHhhHHHHHHHHhcCC--CCCcceeeeEEEeC---Ce
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVS--KVQAPPDYLKKFLPREIEVVKGLK--HPNLIRFLQAIETT---HR 96 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~--~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~---~~ 96 (316)
...++.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 445677999999999998654 4688999875 32211 11345778999999986 45578888888766 35
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE------------------------------------ 140 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~------------------------------------ 140 (316)
.++|||+++|.++.+.. ...++......++.+++.+|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 89999999998774311 1237788889999999999999997
Q ss_pred ----------------------cCccccCCCCCCeeeCCCCC--eEEeecccccc
Q psy11194 141 ----------------------RGVVHRDIKCENLLLDSDYN--IKLSDFGFARA 171 (316)
Q Consensus 141 ----------------------~~~~H~dl~p~nil~~~~~~--~~l~Df~~~~~ 171 (316)
..++|||++|.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987754 68999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.8e-11 Score=104.89 Aligned_cols=188 Identities=14% Similarity=0.185 Sum_probs=120.2
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCC--cceeeeEEEeCC---eEEEE
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPN--LIRFLQAIETTH---RVYII 100 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv 100 (316)
++.++.|....||++ +..+++|+.... .....+.+|+.+++.+. +.. +++++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v-----~~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI-----NRDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEES-----TTSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEE-----CCEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 455899999999987 257899986432 23456789999998873 322 455555543333 35889
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE---------------------------------------- 140 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~---------------------------------------- 140 (316)
|++++|.+|...... .++..+...++.+++..+..||+
T Consensus 95 m~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999999988754332 36777888888899888888885
Q ss_pred ------------------cCccccCCCCCCeeeCC--CCCeEEeecccccccccccCcCC-CCC---CCcc----ccccc
Q psy11194 141 ------------------RGVVHRDIKCENLLLDS--DYNIKLSDFGFARAHMRCRSNAA-DNS---LSET----FCGSY 192 (316)
Q Consensus 141 ------------------~~~~H~dl~p~nil~~~--~~~~~l~Df~~~~~~~~~~~~~~-~~~---~~~~----~~~~~ 192 (316)
..++|+|++|.||++++ .+.+.++||+.+..-.+...-.. ... .... .....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 13699999999999987 45678999998754221100000 000 0000 00000
Q ss_pred CccC-cccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy11194 193 AYAS-PEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF 229 (316)
Q Consensus 193 ~~~a-PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~ 229 (316)
.... |+....... ..+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~---~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRM---KEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHH---HHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHH---HHHHHHHHHHHHHHHcCCHHH
Confidence 1111 222211111 158999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=7.2e-09 Score=86.96 Aligned_cols=132 Identities=16% Similarity=0.143 Sum_probs=99.3
Q ss_pred eeeecCCe-EEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEEEEecCCC
Q psy11194 29 IIGTGSYA-TVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIMEYAEN 106 (316)
Q Consensus 29 ~ig~g~~g-~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~ 106 (316)
.+..|..+ .||+......+..+++|+.... ....+.+|...++.+. +--+++++.++.+.+..++||++++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34556555 6899887777788999986432 2345778999988874 33478889999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q psy11194 107 GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE---------------------------------------------- 140 (316)
Q Consensus 107 ~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~---------------------------------------------- 140 (316)
.++.+..... ......++.+++..|..||.
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 9988776542 12334566777777777774
Q ss_pred ------------cCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 141 ------------RGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 141 ------------~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
..++|||+++.||++++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 127999999999999887777799999774
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=9.6e-08 Score=81.63 Aligned_cols=133 Identities=17% Similarity=0.137 Sum_probs=94.0
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCC---CcceeeeEEE-eCCeEEEEEe
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHP---NLIRFLQAIE-TTHRVYIIME 102 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e 102 (316)
++.++.|....||++ |+.+++|+... ......+.+|+.+++.+.+. .+++++.++. ..+..++||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456788999999988 56889998421 22345678999999998642 3667777764 4556889999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q psy11194 103 YAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER----------------------------------------- 141 (316)
Q Consensus 103 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~----------------------------------------- 141 (316)
+++|.+|.+..-. .++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9999888763221 145555555556666665555532
Q ss_pred -------------------CccccCCCCCCeeeCC---CCC-eEEeecccccc
Q psy11194 142 -------------------GVVHRDIKCENLLLDS---DYN-IKLSDFGFARA 171 (316)
Q Consensus 142 -------------------~~~H~dl~p~nil~~~---~~~-~~l~Df~~~~~ 171 (316)
.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999987 455 47999997754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=4.7e-07 Score=80.27 Aligned_cols=81 Identities=16% Similarity=0.072 Sum_probs=49.8
Q ss_pred EEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCC-Cch---HHHhhHHHHHHHHhcCCC--C-CcceeeeEEEeCCeE
Q psy11194 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA-PPD---YLKKFLPREIEVVKGLKH--P-NLIRFLQAIETTHRV 97 (316)
Q Consensus 25 ~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~-~~~---~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~ 97 (316)
...+.||.|..+.||++.....++.+++|....... ... ...+.+..|..+++.+.. + .+++++.+ +....
T Consensus 33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 346679999999999997666678899998653211 000 012345578888887632 3 44556544 34456
Q ss_pred EEEEecCCCC
Q psy11194 98 YIIMEYAENG 107 (316)
Q Consensus 98 ~lv~e~~~~~ 107 (316)
++|||++++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=3.9e-07 Score=79.50 Aligned_cols=87 Identities=15% Similarity=0.156 Sum_probs=56.7
Q ss_pred eEEeeee-eecCCeEEEEEEEc--c----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-C--CCcceeeeEEEe
Q psy11194 24 YTVGKII-GTGSYATVKLARST--R----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-H--PNLIRFLQAIET 93 (316)
Q Consensus 24 y~~~~~i-g~g~~g~vy~~~~~--~----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~ 93 (316)
....+.| +.|....+|++... . +++.+++|...............+.+|+.+++.+. + -.+++++.+...
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3456778 88888999988654 1 15678999864422000000234668888888874 2 357788887765
Q ss_pred C---CeEEEEEecCCCCCHH
Q psy11194 94 T---HRVYIIMEYAENGSLF 110 (316)
Q Consensus 94 ~---~~~~lv~e~~~~~sL~ 110 (316)
. ...++|||+++|.++.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 5 3568999999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.33 E-value=9.3e-06 Score=64.44 Aligned_cols=121 Identities=19% Similarity=0.135 Sum_probs=80.2
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCC
Q psy11194 107 GSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSL 184 (316)
Q Consensus 107 ~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~ 184 (316)
.||.+.++. +.+++++++|.++.|++.+|..+-. ..-...=+.|..|++..+|.|-+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 389999975 6689999999999999999877632 1212344567889999999888763 1110
Q ss_pred CcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHh
Q psy11194 185 SETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNI 264 (316)
Q Consensus 185 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 264 (316)
.....+.|||... ...+.+.=|||||+++|..+-=..| ...+..+|+.+.+||..|
T Consensus 98 ----~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHM 153 (229)
T ss_dssp -------------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHH
T ss_pred ----ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHH
Confidence 0123467888763 2233347899999999998852221 234467999999999999
Q ss_pred cC
Q psy11194 265 LS 266 (316)
Q Consensus 265 l~ 266 (316)
..
T Consensus 154 t~ 155 (229)
T 2yle_A 154 AN 155 (229)
T ss_dssp TT
T ss_pred Hh
Confidence 83
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.17 E-value=1.5e-05 Score=67.92 Aligned_cols=78 Identities=12% Similarity=0.129 Sum_probs=61.2
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC---CCCcceeeeEEEeCCeEEEE
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv 100 (316)
..-.+.|+.|....+|++.. +++.+++|+.... ....+..|+..++.+. ...+++++.+....+..++|
T Consensus 38 i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv 109 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL 109 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred eeeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence 34567799999999999964 4678999987542 1455778888888873 35688888888888899999
Q ss_pred EecCCCCCH
Q psy11194 101 MEYAENGSL 109 (316)
Q Consensus 101 ~e~~~~~sL 109 (316)
||+++|.++
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.16 E-value=2.8e-05 Score=67.06 Aligned_cols=29 Identities=24% Similarity=0.307 Sum_probs=26.4
Q ss_pred cCccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 141 ~~~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
..++|||+++.||+++.++.+.++||+.+
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 56999999999999988888999999976
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.10 E-value=1.6e-05 Score=70.90 Aligned_cols=78 Identities=18% Similarity=0.148 Sum_probs=45.7
Q ss_pred EEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCC---C--c-hHHHhhHHHHHHHHh-cCCCCCcceeeeEEEeCCeE
Q psy11194 25 TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQA---P--P-DYLKKFLPREIEVVK-GLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 25 ~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~---~--~-~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~ 97 (316)
.-.+.||.|..+.||++.. +++.++||....... . . ......++.|+..+. ......+++++.+. ....
T Consensus 37 ~~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~ 112 (420)
T 2pyw_A 37 LVIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMA 112 (420)
T ss_dssp CEEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTT
T ss_pred eEEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCcc
Confidence 3456789999999999953 467899994432111 0 0 000122333333222 12234567777665 4667
Q ss_pred EEEEecC-CC
Q psy11194 98 YIIMEYA-EN 106 (316)
Q Consensus 98 ~lv~e~~-~~ 106 (316)
++|||++ +|
T Consensus 113 ~lv~e~l~~g 122 (420)
T 2pyw_A 113 LIGMRYLEPP 122 (420)
T ss_dssp EEEECCCCTT
T ss_pred EEEEeecCCc
Confidence 9999999 77
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.06 E-value=3.1e-05 Score=65.29 Aligned_cols=87 Identities=10% Similarity=0.010 Sum_probs=61.1
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-C--CCcceeeeEE
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-H--PNLIRFLQAI 91 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~ 91 (316)
.+..+.+....-++.+|.|..+.||+++.. +|+.+++|+........ ...+..|+..|+.+. . --+++++...
T Consensus 8 ~~~~l~G~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~ 83 (288)
T 3f7w_A 8 RVTELTGREVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD 83 (288)
T ss_dssp HHHHHHCCCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE
T ss_pred HHHHhcCCCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc
Confidence 344566778888999999999999999754 68899999865433221 345778999888874 2 2345555542
Q ss_pred EeCCeEEEEEecCCCCCH
Q psy11194 92 ETTHRVYIIMEYAENGSL 109 (316)
Q Consensus 92 ~~~~~~~lv~e~~~~~sL 109 (316)
. .++|||+++++..
T Consensus 84 --~--~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 --D--RTLAMEWVDERPP 97 (288)
T ss_dssp --T--TEEEEECCCCCCC
T ss_pred --C--ceEEEEeecccCC
Confidence 2 3789999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.96 E-value=2.7e-05 Score=66.06 Aligned_cols=71 Identities=14% Similarity=0.061 Sum_probs=45.5
Q ss_pred eeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCc-ceeeeEEEeCCeEEEEEecC-
Q psy11194 27 GKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL-IRFLQAIETTHRVYIIMEYA- 104 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~- 104 (316)
++.|+.|....+|++ +.+++|+....... .-...+|+.+++.+...++ ++++... ....+++++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 788999999999998 57899987543111 1123467777777642222 5666543 33347899999
Q ss_pred CCCCH
Q psy11194 105 ENGSL 109 (316)
Q Consensus 105 ~~~sL 109 (316)
+|.+|
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 77555
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.73 E-value=9.1e-05 Score=63.35 Aligned_cols=140 Identities=21% Similarity=0.162 Sum_probs=78.1
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCC--cceeeeE------EEeCC
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN--LIRFLQA------IETTH 95 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~ 95 (316)
..-.+.|+.|....+|++... +..+++|+...... .+.+..|..++..+...+ +++++.. ....+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred ceEeeccCCCcccceEEEEeC--CccEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 345667888888999998654 34789998865211 233556777766663111 3333321 12346
Q ss_pred eEEEEEecCCCCCHHH----H-------H---Hh--CC---C----CCHHHHHHH---------------HHHHHHHHHH
Q psy11194 96 RVYIIMEYAENGSLFD----I-------I---RG--QG---Y----IDEIRARRW---------------FGQLLEALQY 137 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~----~-------l---~~--~~---~----l~~~~~~~i---------------~~~i~~~l~~ 137 (316)
..++++++++|.++.. . + .. .. + ......... ...+...+..
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 7899999999865311 1 1 10 00 0 111110000 0113334555
Q ss_pred HHH-------cCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 138 CHE-------RGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 138 Lh~-------~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
+.. .+++|+|+++.||++++++.+.++||+.+.
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 542 358999999999999876656899998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00019 Score=61.79 Aligned_cols=136 Identities=13% Similarity=0.127 Sum_probs=71.2
Q ss_pred eeeeeecCCeE-EEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC--CCCcceeeeEEEeCCeEEEEEec
Q psy11194 27 GKIIGTGSYAT-VKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK--HPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 27 ~~~ig~g~~g~-vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
.+.|+.|.... +|+... .+|+.+++|....... ..+..|+.+++.+. .-.+++++.+..... +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 44566665554 667643 2356788876543210 23446677666663 223566666643333 789999
Q ss_pred CCCCCHHHHHHhC--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHH
Q psy11194 104 AENGSLFDIIRGQ--------------------------GYIDEIRAR-------R-WF------------GQLLEALQY 137 (316)
Q Consensus 104 ~~~~sL~~~l~~~--------------------------~~l~~~~~~-------~-i~------------~~i~~~l~~ 137 (316)
+.+.++.+++... ..++..... . +. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776765544211 012221110 0 00 011112222
Q ss_pred HH------HcCccccCCCCCCeeeCCC----CCeEEeecccccc
Q psy11194 138 CH------ERGVVHRDIKCENLLLDSD----YNIKLSDFGFARA 171 (316)
Q Consensus 138 Lh------~~~~~H~dl~p~nil~~~~----~~~~l~Df~~~~~ 171 (316)
+. ...++|||+++.||+++.+ +.+.++||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 21 2358999999999999874 6789999997753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=7.6e-05 Score=65.35 Aligned_cols=136 Identities=15% Similarity=0.128 Sum_probs=80.0
Q ss_pred eeeeeecCCeEEEEEEEcc-------CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEE
Q psy11194 27 GKIIGTGSYATVKLARSTR-------HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 27 ~~~ig~g~~g~vy~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 98 (316)
++.|..|-...+|++.... +++.+++|+...... . ...+.+|..+++.+. +.-.+++++.+.. .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~-~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ-G---VDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C-C---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc-h---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567788888899987642 356899998533111 1 233458888888874 3334667666543 2
Q ss_pred EEEecCCCCCHHH-----------H---HH---h-----CCCCC--HHHHHHHHHHHHH-------------------HH
Q psy11194 99 IIMEYAENGSLFD-----------I---IR---G-----QGYID--EIRARRWFGQLLE-------------------AL 135 (316)
Q Consensus 99 lv~e~~~~~sL~~-----------~---l~---~-----~~~l~--~~~~~~i~~~i~~-------------------~l 135 (316)
+|+||++|.+|.. + +. . ..... ..++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999999865431 1 11 1 11122 3455555544422 12
Q ss_pred HHHH----H----cCccccCCCCCCeeeCCC----CCeEEeeccccc
Q psy11194 136 QYCH----E----RGVVHRDIKCENLLLDSD----YNIKLSDFGFAR 170 (316)
Q Consensus 136 ~~Lh----~----~~~~H~dl~p~nil~~~~----~~~~l~Df~~~~ 170 (316)
..|. . ..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3332 2 248999999999999876 789999999774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00023 Score=63.53 Aligned_cols=75 Identities=15% Similarity=0.098 Sum_probs=49.1
Q ss_pred EeeeeeecCCeEEEEEEEcc-------CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCC-cceeeeEEEeCCeE
Q psy11194 26 VGKIIGTGSYATVKLARSTR-------HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN-LIRFLQAIETTHRV 97 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~ 97 (316)
-++.|+.|....+|++.... .++.+++|+.... . . .+.+.+|..+++.+...+ .+++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-C-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence 45678899999999997653 2568999987432 1 1 122336888888774223 366776554 2
Q ss_pred EEEEecCCCCCH
Q psy11194 98 YIIMEYAENGSL 109 (316)
Q Consensus 98 ~lv~e~~~~~sL 109 (316)
.+|++|++|.+|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00079 Score=57.58 Aligned_cols=75 Identities=5% Similarity=-0.022 Sum_probs=46.6
Q ss_pred eeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC--CCcceeeeE-----EEeCCeEEEE
Q psy11194 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH--PNLIRFLQA-----IETTHRVYII 100 (316)
Q Consensus 28 ~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~-----~~~~~~~~lv 100 (316)
..++ |....||++... +|+.+++|..+..... .+.+..|..++..+.. -.+++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 788889987532 4568999998643222 2345567777776632 123444432 2235567899
Q ss_pred EecCCCCC
Q psy11194 101 MEYAENGS 108 (316)
Q Consensus 101 ~e~~~~~s 108 (316)
+++++|.+
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99998854
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0023 Score=55.11 Aligned_cols=30 Identities=23% Similarity=0.350 Sum_probs=26.5
Q ss_pred CccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 142 ~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
.++|+|+.+.||+++.++.+.++||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 589999999999998888899999987643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0015 Score=58.71 Aligned_cols=76 Identities=14% Similarity=0.103 Sum_probs=48.6
Q ss_pred EeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCc-ceeeeEEEeCCeEEEEEecC
Q psy11194 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL-IRFLQAIETTHRVYIIMEYA 104 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~ 104 (316)
-++.|+.|-...+|++.....+..+++|+....... .. ...+|..++..+...++ +++++.+. + .+|++|+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 456788999999999976644578999987432111 01 12478888888864444 66777663 3 2599999
Q ss_pred CCCCH
Q psy11194 105 ENGSL 109 (316)
Q Consensus 105 ~~~sL 109 (316)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00053 Score=59.84 Aligned_cols=76 Identities=20% Similarity=0.053 Sum_probs=44.7
Q ss_pred EeeeeeecCCeEEEEEEEcc--------CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCC-cceeeeEEEeCCe
Q psy11194 26 VGKIIGTGSYATVKLARSTR--------HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN-LIRFLQAIETTHR 96 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~--------~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~ 96 (316)
..+.|+.|....+|++.... .++.+++|+..... .. ......|..+++.+...+ ++++++.+ .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cc-eecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence 34568888888999997653 13688888864421 11 112357888888774223 45666554 22
Q ss_pred EEEEEecCCCCCH
Q psy11194 97 VYIIMEYAENGSL 109 (316)
Q Consensus 97 ~~lv~e~~~~~sL 109 (316)
++|++|++|.++
T Consensus 110 -~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 -GRIEEWLYGDPL 121 (369)
T ss_dssp -EEEEECCCSEEC
T ss_pred -cEEEEEecCCcC
Confidence 689999988543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0038 Score=55.37 Aligned_cols=76 Identities=14% Similarity=0.041 Sum_probs=48.8
Q ss_pred EeeeeeecCCeEEEEEEEccC-------CceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeE
Q psy11194 26 VGKIIGTGSYATVKLARSTRH-------SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRV 97 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 97 (316)
-++.+..|-...+|++..... ++.+++|+..... +. .-...+|..+++.+. ..-.+++++.+ .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 456678888889999976521 5789999864321 11 112347888888874 33345666533 22
Q ss_pred EEEEecCCCCCH
Q psy11194 98 YIIMEYAENGSL 109 (316)
Q Consensus 98 ~lv~e~~~~~sL 109 (316)
++|++|++|.+|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.49 E-value=0.032 Score=49.08 Aligned_cols=28 Identities=29% Similarity=0.514 Sum_probs=24.0
Q ss_pred ccccCCCCCCeee------CCCCCeEEeeccccc
Q psy11194 143 VVHRDIKCENLLL------DSDYNIKLSDFGFAR 170 (316)
Q Consensus 143 ~~H~dl~p~nil~------~~~~~~~l~Df~~~~ 170 (316)
++|+|+.+.||++ ++++.+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 345679999999874
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.84 E-value=0.68 Score=36.57 Aligned_cols=115 Identities=11% Similarity=0.110 Sum_probs=77.4
Q ss_pred CCCCcceeeeEEEeCCeEEEEEecCC-CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC
Q psy11194 80 KHPNLIRFLQAIETTHRVYIIMEYAE-NGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD 158 (316)
Q Consensus 80 ~~~~i~~~~~~~~~~~~~~lv~e~~~-~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~ 158 (316)
.+|++++. .+-..++.+.+.++.-+ +-++.. ++. .+....++++.+|+....++ ..-+|--|+|+|++++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~---~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS---FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG---SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh---cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCC
Confidence 57888876 56667777666666554 224443 332 77888999999998876433 344778899999999999
Q ss_pred CCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy11194 159 YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFD 230 (316)
Q Consensus 159 ~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~ 230 (316)
+.+++.=.|+.. -++|..+ +...=.-..=|++..+++++..|.
T Consensus 116 ~~p~i~~RGik~-----------------------~l~P~~~------~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 116 GLPIAKTRGLQN-----------------------VVDPLPV------SEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp SCEEESCCEETT-----------------------TBSCCCC------CHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCEEEEEccCcc-----------------------CCCCCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999988666431 2233311 111334467788889999988774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.03 E-value=1.2 Score=35.19 Aligned_cols=82 Identities=13% Similarity=0.103 Sum_probs=58.0
Q ss_pred CCCCcceeeeEEEeCCeEEEEEecCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC
Q psy11194 80 KHPNLIRFLQAIETTHRVYIIMEYAENG-SLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD 158 (316)
Q Consensus 80 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~ 158 (316)
.+|++ -..+-..++.+.+.++.-++. ++. .++. .+....++++.+|+..... |...-+|--|+|+|++++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~~---~~~~eKlrll~nl~~L~~~-~~~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIRK---TTLLSRIRAAIHLVSKVKH-HSARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHHT---SCHHHHHHHHHHHHHHHSS-CCSSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHHh---cCHHHHHHHHHHHHHHHHH-hhhCceeEEEeCceEEEeCC
Confidence 57888 334446677777777765443 444 4433 7888899988888876541 22455788999999999999
Q ss_pred CCeEEeeccc
Q psy11194 159 YNIKLSDFGF 168 (316)
Q Consensus 159 ~~~~l~Df~~ 168 (316)
+.+++.=.|+
T Consensus 121 ~~p~i~hRGi 130 (219)
T 4ano_A 121 LEPFFLHVGV 130 (219)
T ss_dssp CCEEESCCEE
T ss_pred CcEEEEEcCC
Confidence 9999986664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 316 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-75 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-73 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-72 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-70 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-70 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-70 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-68 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-67 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-67 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-66 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-66 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-65 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-65 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-62 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-61 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-60 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-59 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-58 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-57 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-56 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-55 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-54 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-53 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-53 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-52 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-50 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-50 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-50 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-47 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-45 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-43 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-42 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-21 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 4e-75
Identities = 83/262 (31%), Positives = 141/262 (53%), Gaps = 11/262 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ +G+ +G G + V LAR + +A+K++ K Q ++ L RE+E+ L+HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++R RVY+I+EYA G+++ ++ DE R + +L AL YCH + V
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRDIK ENLLL S +K++DFG++ +S T CG+ Y PE+++G
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHA--------PSSRRTTLCGTLDYLPPEMIEGR 179
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISN 263
+ D+WS+GV+ + + G+ PF+ ++ E K++ +V F V+ ++LIS
Sbjct: 180 MHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-RVEFTFPDFVTEGARDLISR 237
Query: 264 ILSP-VQTRPRLKTIAEDRWLK 284
+L RP L+ + E W+
Sbjct: 238 LLKHNPSQRPMLREVLEHPWIT 259
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 3e-73
Identities = 88/271 (32%), Positives = 131/271 (48%), Gaps = 10/271 (3%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + + +G G+Y V+LA + VA+KIV +A D + +EI + K L H N
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIK-KEICINKMLNHEN 64
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+++F + Y+ +EY G LFD I + E A+R+F QL+ + Y H G+
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
HRDIK ENLLLD N+K+SDFG A L CG+ Y +PE+L+
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSS--VNELLKQVQNKVTFPKQPEVSTECKELI 261
+ D+WS G+VL AM+ G LP+D S E + K ++ + L+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 262 SNILSP-VQTRPRLKTIAEDRWLKPKPKSRG 291
IL R + I +DRW KP +G
Sbjct: 241 HKILVENPSARITIPDIKKDRWYN-KPLKKG 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 1e-72
Identities = 79/272 (29%), Positives = 140/272 (51%), Gaps = 9/272 (3%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ GKI+G GS++TV LAR S + AIKI+ K + ++ RE +V+ L HP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ + ++Y + YA+NG L IR G DE R + +++ AL+Y H +G+
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRD+K EN+LL+ D +I+++DFG A+ S + + + +F G+ Y SPE+L
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVL----SPESKQARANSFVGTAQYVSPELLTEK 185
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKELIS 262
SD+W++G +++ +V G PF + + +++ + FP + + ++L+
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP--EKFFPKARDLVE 242
Query: 263 NILSP-VQTRPRLKTIAEDRWLKPKPKSRGVD 293
+L R + + LK P V
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 222 bits (568), Expect = 5e-72
Identities = 63/282 (22%), Positives = 125/282 (44%), Gaps = 15/282 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
++ + IG GS+ V AR R+S VAIK +S + + + +E+ ++ L+HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
I++ H +++MEY + + + + E+ L+ L Y H +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRD+K N+LL +KL DFG A + +F G+ + +PE++ +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAP----------ANSFVGTPYWMAPEVILAM 186
Query: 204 PYAPH--LSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTECKEL 260
+ D+WS+G+ + + P + + L + QN+ + S +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246
Query: 261 ISNILSP-VQTRPRLKTIAEDRWL-KPKPKSRGVDKAEAELD 300
+ + L Q RP + + + R++ + +P + +D + D
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKD 288
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 2e-70
Identities = 85/272 (31%), Positives = 128/272 (47%), Gaps = 20/272 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y V IGTGSY + R + K + + + E+ +++ LKHPN
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNLLRELKHPN 64
Query: 84 LIRFLQAI--ETTHRVYIIMEYAENGSLFDII----RGQGYIDEIRARRWFGQLLEALQY 137
++R+ I T +YI+MEY E G L +I + + Y+DE R QL AL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 138 CHERG-----VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSY 192
CH R V+HRD+K N+ LD N+KL DFG AR D S ++ F G+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH------DTSFAKAFVGTP 178
Query: 193 AYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPE 252
Y SPE + + Y SDIWS+G +L+ + PF S EL +++
Sbjct: 179 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 253 VSTECKELISNILSP-VQTRPRLKTIAEDRWL 283
S E E+I+ +L+ RP ++ I E+ +
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 3e-70
Identities = 70/276 (25%), Positives = 136/276 (49%), Gaps = 20/276 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
TVG+ IG+GS+ TV + GDVA+K+++ P L+ F E+ V++ +H N
Sbjct: 10 ITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRHVN 65
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERG 142
++ F+ T ++ I+ ++ E SL+ + + + I+ Q + + Y H +
Sbjct: 66 ILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
++HRD+K N+ L D +K+ DFG A +S + + E GS + +PE+++
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLA----TVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 203 IPYAPH--LSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNKVTFPKQPEVSTEC-- 257
P+ SD+++ G+VL+ ++ G+LP+ + ++ ++++ V P +V + C
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 258 --KELISNILSP-VQTRPRLKTIAE--DRWLKPKPK 288
K L++ L RP I + + PK
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 4e-70
Identities = 57/269 (21%), Positives = 124/269 (46%), Gaps = 17/269 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + +G G++ V A++ S A K++ + L+ ++ EI+++ HPN
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYM-VEIDILASCDHPN 70
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCHERG 142
+++ L A + ++I++E+ G++ ++ + + E + + Q L+AL Y H+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
++HRD+K N+L D +IKL+DFG + + R ++F G+ + +PE++
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR------TIQRRDSFIGTPYWMAPEVVMC 184
Query: 203 IPYAPHL----SDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK--VTFPKQPEVSTE 256
+D+WS+G+ L M P + + +L ++ T + S+
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 257 CKELISNILSP-VQTRPRLKTIAEDRWLK 284
K+ + L V R + + ++
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 211 bits (539), Expect = 4e-68
Identities = 69/277 (24%), Positives = 126/277 (45%), Gaps = 23/277 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP------DYLKKFLPREIEVVK 77
Y +I+G G + V+ + A+KI+ L++ +E+++++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 78 GLK-HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQ 136
+ HPN+I+ ET +++ + + G LFD + + + E R+ LLE +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYAS 196
H+ +VHRD+K EN+LLD D NIKL+DFGF+ CG+ +Y +
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ-------LDPGEKLREVCGTPSYLA 177
Query: 197 PEILQGIPYAPHL-----SDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN---KVTFP 248
PEI++ H D+WS GV+++ ++ G PF +L+ + + + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 249 KQPEVSTECKELISNILSP-VQTRPRLKTIAEDRWLK 284
+ + S K+L+S L Q R + + +
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 5e-68
Identities = 76/270 (28%), Positives = 135/270 (50%), Gaps = 15/270 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT + IG G+ TV A +VAI+ ++ Q P K+ + EI V++ K+PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPN 78
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ +L + ++++MEY GSL D++ + +DE + + L+AL++ H V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRDIK +N+LL D ++KL+DFGF + S T G+ + +PE++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN--KVTFPKQPEVSTECKELI 261
Y P DIWS+G++ M+ G P+ + + L + ++S ++ +
Sbjct: 192 AYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250
Query: 262 SNILSP-VQTRPRLKTIAEDRWLK-PKPKS 289
+ L V+ R K + + ++LK KP S
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 213 bits (543), Expect = 1e-67
Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 18/273 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + + +G+G++ V K ++ P K + EI ++ L HP
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINT---PYPLDKYTVKNEISIMNQLHHPK 87
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCHERG 142
LI A E + + +I+E+ G LFD I + Y + E + Q E L++ HE
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 143 VVHRDIKCENLLLDSDYN--IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
+VH DIK EN++ ++ +K+ DFG A + + + + +A+PEI+
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKL-------NPDEIVKVTTATAEFAAPEIV 200
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQ--PEVSTEC 257
P + +D+W++GV+ + ++ G PF E L+ V+ F + VS E
Sbjct: 201 DREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 258 KELISNILSP-VQTRPRLKTIAEDRWLKPKPKS 289
K+ I N+L + R + E WLK +
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 213 bits (542), Expect = 1e-67
Identities = 67/272 (24%), Positives = 125/272 (45%), Gaps = 18/272 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + + +GTG++ V + A K V P + K+ + +EI+ + L+HP
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPT 84
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERG 142
L+ A E + + +I E+ G LF+ + + + E A + Q+ + L + HE
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 143 VVHRDIKCENLLLDSDYN--IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
VH D+K EN++ + + +KL DFG + + G+ +A+PE+
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTA-------HLDPKQSVKVTTGTAEFAAPEVA 197
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN---KVTFPKQPEVSTEC 257
+G P + +D+WS+GV+ + ++ G PF + +E L+ V++ + +S +
Sbjct: 198 EGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 258 KELISNILSP-VQTRPRLKTIAEDRWLKPKPK 288
K+ I +L TR + E WL P
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (531), Expect = 2e-66
Identities = 82/268 (30%), Positives = 136/268 (50%), Gaps = 17/268 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y ++GTG+++ V LA R VAIK ++K + + EI V+ +KHPN
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPN 68
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++ E+ +Y+IM+ G LFD I +G+ E A R Q+L+A++Y H+ G+
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 144 VHRDIKCENLLL---DSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
VHRD+K ENLL D D I +SDFG ++ S+ T CG+ Y +PE+L
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-------PGSVLSTACGTPGYVAPEVL 181
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN---KVTFPKQPEVSTEC 257
PY+ D WS+GV+ + ++ G PF D + +L +Q+ + P ++S
Sbjct: 182 AQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 258 KELISNILSP-VQTRPRLKTIAEDRWLK 284
K+ I +++ + R + + W+
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQHPWIA 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-66
Identities = 66/268 (24%), Positives = 115/268 (42%), Gaps = 12/268 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ +G G+ V +A K++ + P + + RE++V+ P
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQII-RELQVLHECNSPY 65
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHER-G 142
++ F A + + I ME+ + GSL +++ G I E + +++ L Y E+
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
++HRD+K N+L++S IKL DFG + +S++ +F G+ +Y SPE LQG
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSG--------QLIDSMANSFVGTRSYMSPERLQG 177
Query: 203 IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELIS 262
Y+ SDIWSMG+ L M GR P EL +V
Sbjct: 178 THYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 263 NILSPVQTRPRLKTIAEDRWLKPKPKSR 290
+ +RP + ++ +P +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPK 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 4e-66
Identities = 60/271 (22%), Positives = 121/271 (44%), Gaps = 21/271 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
IG GS+ TV T + +VA + + ++F E E++KGL+HPN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-EEAEMLKGLQHPN 69
Query: 84 LIRFLQAIETT----HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
++RF + E+T + ++ E +G+L ++ + R W Q+L+ LQ+ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 140 ERG--VVHRDIKCENLLLDS-DYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYAS 196
R ++HRD+KC+N+ + ++K+ D G A S ++ G+ + +
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--------RASFAKAVIGTPEFMA 181
Query: 197 PEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS-SVNELLKQVQNKVTFPKQPE-VS 254
PE+ + Y D+++ G+ + M P+ + + ++ ++V + V +
Sbjct: 182 PEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 255 TECKELISNILSP-VQTRPRLKTIAEDRWLK 284
E KE+I + R +K + + +
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 5e-65
Identities = 58/272 (21%), Positives = 119/272 (43%), Gaps = 19/272 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + + +G G + V T K V +K +EI ++ +H N
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK----KEISILNIARHRN 62
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCHERG 142
++ ++ E+ + +I E+ +F+ I + ++E + Q+ EALQ+ H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 143 VVHRDIKCENLLLDSD--YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
+ H DI+ EN++ + IK+ +FG AR + Y +PE+
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-------GDNFRLLFTAPEYYAPEVH 175
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQ--PEVSTEC 257
Q + +D+WS+G +++ ++ G PF + ++++ + N + TF ++ E+S E
Sbjct: 176 QHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 258 KELISNILSP-VQTRPRLKTIAEDRWLKPKPK 288
+ + +L ++R + WLK K +
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 7e-65
Identities = 75/265 (28%), Positives = 129/265 (48%), Gaps = 13/265 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV-KGLKHP 82
+ + K++G GS+ V LA + + AIK + K D + E V+ +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 83 NLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
L +T ++ +MEY G L I+ D RA + +++ LQ+ H +G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
+V+RD+K +N+LLD D +IK++DFG + +M ++ + TFCG+ Y +PEIL G
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENM------LGDAKTNTFCGTPDYIAPEILLG 177
Query: 203 IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKELI 261
Y D WS GV+L+ M+ G+ PF EL ++ +P+ + E K+L+
Sbjct: 178 QKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW--LEKEAKDLL 234
Query: 262 SNILSP-VQTRPRLKT-IAEDRWLK 284
+ + R ++ I + +
Sbjct: 235 VKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-62
Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 27/302 (8%)
Query: 5 TVQVQDDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD- 63
TV Q+++D Y G+ +G+G +A VK R A K + K +
Sbjct: 1 TVFRQENVDDY--------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR 52
Query: 64 --YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDE 121
++ + RE+ ++K ++HPN+I + E V +I+E G LFD + + + E
Sbjct: 53 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE 112
Query: 122 IRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD----YNIKLSDFGFARAHMRCRS 177
A + Q+L + Y H + H D+K EN++L IK+ DFG A
Sbjct: 113 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI----- 167
Query: 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNEL 237
+ + G+ + +PEI+ P +D+WS+GV+ + ++ G PF + E
Sbjct: 168 --DFGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQET 224
Query: 238 LKQVQN-KVTFPKQ--PEVSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKPKSRGVD 293
L V F + S K+ I +L + R ++ + W+KPK + +
Sbjct: 225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS 284
Query: 294 KA 295
A
Sbjct: 285 SA 286
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (492), Expect = 5e-61
Identities = 71/263 (26%), Positives = 119/263 (45%), Gaps = 12/263 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y +G+I+G G + V LAR R DVA+K++ A RE + L HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 84 LIRFLQAIETTH----RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
++ E YI+MEY + +L DI+ +G + RA +AL + H
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+ G++HRD+K N+++ + +K+ DFG AR + + + G+ Y SPE
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIAR---AIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP---KQPEVSTE 256
+G SD++S+G VL+ ++ G PF S + Q + P + +S +
Sbjct: 186 ARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 257 CKELISNILSPVQTRPRLKTIAE 279
++ L+ R +T AE
Sbjct: 245 LDAVVLKALAKNPEN-RYQTAAE 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-61
Identities = 62/272 (22%), Positives = 120/272 (44%), Gaps = 16/272 (5%)
Query: 12 IDRKVTVLESHGYTVGKIIGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKFL 69
+DRK+ LE K +G+G++ TVK + + VA+KI+ P + L
Sbjct: 3 LDRKLLTLED------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 56
Query: 70 PREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFG 129
E V++ L +P ++R + E ++ME AE G L ++ ++ +
Sbjct: 57 -AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 114
Query: 130 QLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
Q+ ++Y E VHRD+ N+LL + + K+SDFG ++A R++
Sbjct: 115 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA---LRADENYYKAQTHGK 171
Query: 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFP 248
+ +PE + ++ SD+WS GV+++ +G+ P+ +E+ ++
Sbjct: 172 WPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 230
Query: 249 KQPEVSTECKELISNILSP-VQTRPRLKTIAE 279
E +L++ + V+ RP +
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 194 bits (493), Expect = 1e-60
Identities = 71/268 (26%), Positives = 137/268 (51%), Gaps = 19/268 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + + +GTGS+ V L RS + A+K++ K + E ++ + HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+IR + ++++IM+Y E G LF ++R A+ + ++ AL+Y H + +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
++RD+K EN+LLD + +IK++DFGFA+ ++ T CG+ Y +PE++
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYV---------PDVTYTLCGTPDYIAPEVVSTK 176
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKELIS 262
PY D WS G++++ M+ G PF DS+ + +++ N ++ FP P + + K+L+S
Sbjct: 177 PYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDLLS 233
Query: 263 NILS------PVQTRPRLKTIAEDRWLK 284
+++ + + + W K
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-60
Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 22/261 (8%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + IG G + V L VA+K + + FL E V+ L+H N
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN----DATAQAFL-AEASVMTQLRHSN 61
Query: 84 LIRFLQA-IETTHRVYIIMEYAENGSLFDIIRGQGY--IDEIRARRWFGQLLEALQYCHE 140
L++ L +E +YI+ EY GSL D +R +G + ++ + EA++Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
VHRD+ N+L+ D K+SDFG + +S +T + +PE L
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---------SSTQDTGKLPVKWTAPEAL 172
Query: 201 QGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259
+ ++ SD+WS G++L+ + FGR+P+ + +++ +V+ E
Sbjct: 173 REKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 260 LISNILSP-VQTRPRLKTIAE 279
++ N RP + E
Sbjct: 232 VMKNCWHLDAAMRPSFLQLRE 252
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-60
Identities = 58/268 (21%), Positives = 121/268 (45%), Gaps = 13/268 (4%)
Query: 18 VLESHGYTVGKI-IGTGSYATVKLA--RSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIE 74
L+ + I +G G++ +V+ R + DVAIK++ + ++ + RE +
Sbjct: 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ-GTEKADTEEMM-REAQ 61
Query: 75 VVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLE 133
++ L +P ++R + + + ++ME A G L + G+ I Q+
Sbjct: 62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 134 ALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193
++Y E+ VHRD+ N+LL + + K+SDFG ++A ++ + +
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA---LGADDSYYTARSAGKWPLK 177
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPE 252
+ +PE + ++ SD+WS GV ++ + +G+ P+ E++ ++ PE
Sbjct: 178 WYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236
Query: 253 VSTECKELISNILSP-VQTRPRLKTIAE 279
E L+S+ + RP T+ +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQ 264
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-59
Identities = 84/274 (30%), Positives = 136/274 (49%), Gaps = 24/274 (8%)
Query: 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD---YLKKFLPREIEV 75
LES Y VG ++G+G + +V + VAIK V K + +P E+ +
Sbjct: 2 LESQ-YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 76 VKGLK--HPNLIRFLQAIETTHRVYIIMEYAENGS-LFDIIRGQGYIDEIRARRWFGQLL 132
+K + +IR L E +I+E E LFD I +G + E AR +F Q+L
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 133 EALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHMRCRSNAADNSLSETFCGS 191
EA+++CH GV+HRDIK EN+L+D + +KL DFG +++ F G+
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA--------LLKDTVYTDFDGT 172
Query: 192 YAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQP 251
Y+ PE ++ Y + +WS+G++L+ MV G +PF+ + ++ +V F
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQVFFR--Q 225
Query: 252 EVSTECKELISNILSP-VQTRPRLKTIAEDRWLK 284
VS+EC+ LI L+ RP + I W++
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 192 bits (488), Expect = 2e-59
Identities = 56/249 (22%), Positives = 107/249 (42%), Gaps = 13/249 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPRE---IEVVKGLK 80
++V +IIG G + V R A+K + K + + E + +V
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
P ++ A T ++ I++ G L + G E R + +++ L++ H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 141 RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEIL 200
R VV+RD+K N+LLD ++++SD G A + + + G++ Y +PE+L
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--------ASVGTHGYMAPEVL 177
Query: 201 QGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ--PEVSTECK 258
Q +D +S+G +LF ++ G PF + + + +T + S E +
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237
Query: 259 ELISNILSP 267
L+ +L
Sbjct: 238 SLLEGLLQR 246
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 3e-58
Identities = 58/262 (22%), Positives = 112/262 (42%), Gaps = 10/262 (3%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD---VAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
+ ++IG G + V VAIK + + FL E ++
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS-GYTEKQRRDFL-SEASIMGQFD 85
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCH 139
HPN+I + + V II E+ ENGSL +R G I+ + ++Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+ VHRD+ N+L++S+ K+SDFG +R + ++ + + + +PE
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258
+Q + SD+WS G+V++ ++ +G P+ D + +++ ++ P + +
Sbjct: 205 IQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263
Query: 259 ELISNILSP-VQTRPRLKTIAE 279
+L+ + RP+ I
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-57
Identities = 80/245 (32%), Positives = 127/245 (51%), Gaps = 10/245 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ K++G G++ V L R A+KI+ K E V++ +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
L A +T R+ +MEYA G LF + + E RAR + +++ AL+Y H R V
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
V+RDIK ENL+LD D +IK++DFG + + D + +TFCG+ Y +PE+L+
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGIS------DGATMKTFCGTPEYLAPEVLEDN 180
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQPEVSTECKELIS 262
Y D W +GVV++ M+ GRLPF + L + + ++ FP+ +S E K L++
Sbjct: 181 DYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLA 237
Query: 263 NILSP 267
+L
Sbjct: 238 GLLKK 242
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-57
Identities = 72/283 (25%), Positives = 120/283 (42%), Gaps = 34/283 (12%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV-VKGLKHP 82
+++G G V + R A+K++ RE+E+ + + P
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 65
Query: 83 NLIRFLQAIETTHR----VYIIMEYAENGSLFDII--RGQGYIDEIRARRWFGQLLEALQ 136
+++R + E + + I+ME + G LF I RG E A + EA+Q
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 137 YCHERGVVHRDIKCENLLLDSDYN---IKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193
Y H + HRD+K ENLL S +KL+DFGFA+ ++ T C +
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------SHNSLTTPCYTPY 178
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-------T 246
Y +PE+L Y D+WS+GV+++ ++ G PF + + ++ ++
Sbjct: 179 YVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 247 FPKQPEVSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKPK 288
P+ EVS E K LI N+L R + W+ K
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-56
Identities = 62/263 (23%), Positives = 114/263 (43%), Gaps = 12/263 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD---VAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
+ + +G GS+ V+ SG VA+K + RE+ + L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCH 139
H NLIR + T + ++ E A GSL D + + QG+ R+ Q+ E + Y
Sbjct: 70 HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+ +HRD+ NLLL + +K+ DFG RA N + E +A+ +PE
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA---LPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQV-QNKVTFPKQPEVSTEC 257
L+ ++ SD W GV L+ M +G+ P+ + +++L ++ + P+ + +
Sbjct: 186 LKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 258 KELISNILSP-VQTRPRLKTIAE 279
++ + + RP + +
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-56
Identities = 58/260 (22%), Positives = 113/260 (43%), Gaps = 14/260 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
T K +GTG + VK + R DVAIK++ + D E +V+ L H
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI----EEAKVMMNLSHEK 60
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERG 142
L++ ++II EY NG L + +R + + + EA++Y +
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
+HRD+ N L++ +K+SDFG +R + + S ++ PE+L
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSR-----YVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 203 IPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELI 261
++ SDIW+ GV+++ + G++P++ + +E + + + + S + ++
Sbjct: 176 SKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234
Query: 262 SNILSP-VQTRPRLKTIAED 280
+ RP K + +
Sbjct: 235 YSCWHEKADERPTFKILLSN 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-56
Identities = 60/291 (20%), Positives = 112/291 (38%), Gaps = 36/291 (12%)
Query: 28 KIIGTGSYATVKLARSTRHSGDVAIKIVSK--VQAPPDYLKKFLPREIEVVKGLKHPNLI 85
+G G +ATV AR + VAIK + D + + REI++++ L HPN+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 86 RFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVH 145
L A + ++ ++ E I + + + L+ L+Y H+ ++H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 146 RDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY 205
RD+K NLLLD + +KL+DFG A++ + N + Y +PE+L G
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFG------SPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 206 APHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ--------------- 250
D+W++G +L ++ S + L ++ + P +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 251 ------------PEVSTECKELISNILSP-VQTRPRLKTIAEDRWLKPKPK 288
+ +LI + R + ++ +P
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-56
Identities = 61/274 (22%), Positives = 116/274 (42%), Gaps = 19/274 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ +G G + V + + VAIK + P+ +E +V+K L+H
Sbjct: 19 LRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEK 73
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQG--YIDEIRARRWFGQLLEALQYCHER 141
L++ A+ + +YI+ EY GSL D ++G+ Y+ + Q+ + Y
Sbjct: 74 LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
VHRD++ N+L+ + K++DFG AR + + + + +PE
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLAR-----LIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 202 GIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260
+ SD+WS G++L + GR+P+ E+L QV+ P PE +L
Sbjct: 188 YGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 246
Query: 261 ISNILSP-VQTRPRLKTIAE--DRWLK-PKPKSR 290
+ + RP + + + + +P+ +
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-55
Identities = 61/260 (23%), Positives = 114/260 (43%), Gaps = 16/260 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + +G G + V + H+ VA+K + + PD E ++K L+H
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFL----AEANLMKQLQHQR 69
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY--IDEIRARRWFGQLLEALQYCHER 141
L+R A+ T +YII EY ENGSL D ++ + + Q+ E + + ER
Sbjct: 70 LVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
+HRD++ N+L+ + K++DFG AR + + E + +PE +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLAR-----LIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 202 GIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260
+ SD+WS G++L +V GR+P+ + E+++ ++ + E +L
Sbjct: 184 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 261 ISNILSP-VQTRPRLKTIAE 279
+ + RP +
Sbjct: 243 MRLCWKERPEDRPTFDYLRS 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-55
Identities = 68/320 (21%), Positives = 125/320 (39%), Gaps = 43/320 (13%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT IG G+Y V A + VAIK +S + Y ++ L REI+++ +H N
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTL-REIKILLRFRHEN 67
Query: 84 LIRFLQAIET----THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
+I I + ++ + L+ +++ ++ + Q+L L+Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYIH 126
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
V+HRD+K NLLL++ ++K+ DFG AR + + + Y +PEI
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ--------- 250
+ DIWS+G +L M+ R F + L + + P Q
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 251 ---------------------PEVSTECKELISNILSP-VQTRPRLKTIAEDRWLK--PK 286
P ++ +L+ +L+ R ++ +L+
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 287 PKSRGVDKAEAELDHYIDMI 306
P + +A + D +D +
Sbjct: 304 PSDEPIAEAPFKFDMELDDL 323
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 5e-55
Identities = 57/288 (19%), Positives = 117/288 (40%), Gaps = 39/288 (13%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKG 78
GK++G+G++ V A + S VA+K++ + +A + + E++++
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALM-SELKMMTQ 96
Query: 79 L-KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ--------------------- 116
L H N++ L A + +Y+I EY G L + +R +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 117 --GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174
+ + Q+ + +++ + VHRD+ N+L+ +K+ DFG AR M
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM- 215
Query: 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSS 233
+ ++ + + +PE L Y SD+WS G++L+ + G P+
Sbjct: 216 ---SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 234 VNELL-KQVQNKVTFPKQPEVSTECKELISNILSP-VQTRPRLKTIAE 279
V+ K +QN + + E ++ + + + RP +
Sbjct: 272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-54
Identities = 63/265 (23%), Positives = 118/265 (44%), Gaps = 14/265 (5%)
Query: 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK 77
V++ T + IG+G + V L + VAIK + + + F+ E EV+
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE---EDFI-EEAEVMM 55
Query: 78 GLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYI-DEIRARRWFGQLLEALQ 136
L HP L++ + ++ E+ E+G L D +R Q + + E +
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 137 YCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYAS 196
Y E V+HRD+ N L+ + IK+SDFG R + + + S +AS
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-----TSSTGTKFPVKWAS 170
Query: 197 PEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVST 255
PE+ Y+ SD+WS GV+++ + G++P+++ S +E+++ + K ST
Sbjct: 171 PEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 229
Query: 256 ECKELISNILSP-VQTRPRLKTIAE 279
+++++ + RP +
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (449), Expect = 2e-54
Identities = 59/277 (21%), Positives = 120/277 (43%), Gaps = 16/277 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
T+ +G G Y V ++S VA+K + + +++FL +E V+K +KHPN
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFL-KEAAVMKEIKHPN 74
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDII--RGQGYIDEIRARRWFGQLLEALQYCHER 141
L++ L YII E+ G+L D + + + + Q+ A++Y ++
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
+HRD+ N L+ ++ +K++DFG +R + + +PE L
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPESLA 189
Query: 202 GIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260
++ SD+W+ GV+L+ + +G P+ ++++ + ++ + + EL
Sbjct: 190 YNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248
Query: 261 ISNILSP-VQTRPRLKTIAE--DRWLKPKPKSRGVDK 294
+ RP I + + + S V+K
Sbjct: 249 MRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-54
Identities = 62/263 (23%), Positives = 108/263 (41%), Gaps = 15/263 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD---VAIKIVSKVQAPPDYLKKFLPREIEVVKGLK 80
+G+ IG G + V VAIK + +KFL +E ++
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFL-QEALTMRQFD 66
Query: 81 HPNLIRFLQAIETTHRVYIIMEYAENGSLFDII-RGQGYIDEIRARRWFGQLLEALQYCH 139
HP++++ + I T + V+IIME G L + + +D + QL AL Y
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 140 ERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
+ VHRDI N+L+ S+ +KL DFG +R + + + +PE
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-----YMEDSTYYKASKGKLPIKWMAPES 180
Query: 200 LQGIPYAPHLSDIWSMGVVLFAM-VFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258
+ + SD+W GV ++ + + G PF N+++ +++N P P
Sbjct: 181 INFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239
Query: 259 ELISNILSP-VQTRPRLKTIAED 280
L++ + RPR +
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (446), Expect = 8e-54
Identities = 58/287 (20%), Positives = 104/287 (36%), Gaps = 38/287 (13%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKG 78
+ IG G++ V AR+ VA+K++ + +A D F RE ++
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQ-REAALMAE 72
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY-------------------- 118
+PN+++ L + ++ EY G L + +R
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 119 ----IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174
+ Q+ + Y ER VHRD+ N L+ + +K++DFG + R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS----R 188
Query: 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSS 233
+A + PE + Y SD+W+ GVVL+ + +G P+ +
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 234 VNELLKQVQNKVTFPKQPEVSTECKELISNILSP-VQTRPRLKTIAE 279
E++ V++ E L+ S RP +I
Sbjct: 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (449), Expect = 1e-53
Identities = 64/267 (23%), Positives = 120/267 (44%), Gaps = 17/267 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ K +GTGS+ V L + A+KI+ K + + E +++ + P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
L++ + + +Y++MEY G +F +R G E AR + Q++ +Y H +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
++RD+K ENLL+D I+++DFGFA+ T CG+ +PEI+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---------TLCGTPEALAPEIILSK 213
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISN 263
Y D W++GV+++ M G PF ++ +++ + S++ K+L+ N
Sbjct: 214 GYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRFPSHFSSDLKDLLRN 271
Query: 264 ILS------PVQTRPRLKTIAEDRWLK 284
+L + + I +W
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 175 bits (443), Expect = 1e-53
Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 37/290 (12%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + IG G+Y V A++ + A+K + + + REI ++K LKH N
Sbjct: 4 YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTI-REISILKELKHSN 61
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
+++ I T R+ ++ E+ + + +G ++ + A+ + QLL + YCH+R V
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRD+K +NLL++ + +K++DFG ARA + Y +P++L G
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAF------GIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ------------- 250
DIWS+G + MV G F S + L ++ + P
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 251 ---------------PEVSTECKELISNILSP-VQTRPRLKTIAEDRWLK 284
+ +L+S +L R K E + K
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-53
Identities = 54/268 (20%), Positives = 110/268 (41%), Gaps = 11/268 (4%)
Query: 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKV---QAPPDYLKKFLPREIE 74
+L+ + K++G+G++ TV V I + K P K+ L E
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAY 63
Query: 75 VVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEA 134
V+ + +P++ R L T+ I L + + I W Q+ +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 135 LQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAY 194
+ Y +R +VHRD+ N+L+ + ++K++DFG A + +E +
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA----KLLGAEEKEYHAEGGKVPIKW 179
Query: 195 ASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEV 253
+ E + Y SD+WS GV ++ ++ FG P+D +E+ ++ P+ P
Sbjct: 180 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 238
Query: 254 STECKELISNILSP-VQTRPRLKTIAED 280
+ + ++ +RP+ + + +
Sbjct: 239 TIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-53
Identities = 68/295 (23%), Positives = 118/295 (40%), Gaps = 33/295 (11%)
Query: 18 VLESHGYTVGKIIGTGSYATVKLAR--STRHSGDVAIKIVSKVQAPPDYLKKFLPREIEV 75
VL+ + +IG G++ V AR D AIK + + + D + F E+EV
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFA-GELEV 63
Query: 76 VKGL-KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ----------------GY 118
+ L HPN+I L A E +Y+ +EYA +G+L D +R
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 119 IDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178
+ + + + + Y ++ +HRD+ N+L+ +Y K++DFG +R
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE----- 178
Query: 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNEL 237
+ + E L Y + SD+WS GV+L+ +V G P+ + EL
Sbjct: 179 --VYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 238 LKQVQNKVTFPKQPEVSTECKELISNILSP-VQTRPRLKTIAE--DRWLKPKPKS 289
+++ K E +L+ RP I +R L+ +
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-52
Identities = 77/301 (25%), Positives = 122/301 (40%), Gaps = 41/301 (13%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + IG G+Y V AR+ VA+K + + REI ++K L HPN
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPN 62
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSL-FDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
+++ L I T +++Y++ E+ F I + + QLL+ L +CH
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 143 VVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQG 202
V+HRD+K +NLL++++ IKL+DFG ARA + Y +PEIL G
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAPEILLG 176
Query: 203 IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ------------ 250
Y DIWS+G + MV R F S + L ++ + P +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 251 ----------------PEVSTECKELISNILSP-VQTRPRLKTIAEDRWL----KPKPKS 289
P + + + L+S +L R K + KP P
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 296
Query: 290 R 290
R
Sbjct: 297 R 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 6e-52
Identities = 58/285 (20%), Positives = 110/285 (38%), Gaps = 21/285 (7%)
Query: 10 DDIDRKVTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFL 69
D++ + Y IG G++ V AR + VA+K V + L
Sbjct: 7 DEVSK---------YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 57
Query: 70 PREIEVVKGLKHPNLIRFLQAIETT--------HRVYIIMEYAENGSLFDIIRGQGYIDE 121
REI++++ LKH N++ ++ T +Y++ ++ E+ +
Sbjct: 58 -REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL 116
Query: 122 IRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181
+R LL L Y H ++HRD+K N+L+ D +KL+DFG ARA +++ +
Sbjct: 117 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176
Query: 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV 241
+ Y PE+L G D+W G ++ M ++ L +
Sbjct: 177 R--YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 242 QN-KVTFPKQPEVSTECKELISNILSPVQTRPRLKTIAEDRWLKP 285
+ + + + EL + + ++K + P
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDP 279
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-51
Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 33/283 (11%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-------VAIKIVSKVQAPPDYLKKFLPREIEVV 76
+GK +G G++ V LA + D VA+K++ A L + E+E++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLI-SEMEMM 72
Query: 77 KGL-KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY----------------I 119
K + KH N+I L A +Y+I+EYA G+L + ++ + +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 120 DEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179
Q+ ++Y + +HRD+ N+L+ D +K++DFG A R +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHHI 188
Query: 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELL 238
+ + +PE L Y SD+WS GV+L+ + G P+ V EL
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 239 KQVQNKVTFPKQPEVSTECKELISNILSPV-QTRPRLKTIAED 280
K ++ K + E ++ + V RP K + ED
Sbjct: 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 5e-51
Identities = 65/253 (25%), Positives = 128/253 (50%), Gaps = 14/253 (5%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD---VAIKIVSKVQAPPDY-LKKFLPREIEVVKGL 79
+ + K++GTG+Y V L R A+K++ K + E +V++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 80 KH-PNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+ P L+ A +T ++++I++Y G LF + + E + + G+++ AL++
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 145
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H+ G+++RDIK EN+LLDS+ ++ L+DFG ++ + + A + FCG+ Y +P+
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-----FCGTIEYMAPD 200
Query: 199 ILQGIPYAP-HLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV---TFPKQPEVS 254
I++G D WS+GV+++ ++ G PF ++ ++ P E+S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 255 TECKELISNILSP 267
K+LI +L
Sbjct: 261 ALAKDLIQRLLMK 273
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 6e-51
Identities = 51/269 (18%), Positives = 99/269 (36%), Gaps = 19/269 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y +G+ IG+GS+ + L +VAIK+ P L E ++ K ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 63
Query: 84 LIRFLQAIETT-HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
I ++ ++ME Q++ ++Y H +
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 143 VVHRDIKCENLL---LDSDYNIKLSDFGFARAHMRCRSNAADNS-LSETFCGSYAYASPE 198
+HRD+K +N L + + DFG A+ + R++ ++ G+ YAS
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN----KVTFPKQ---P 251
GI + D+ S+G VL G LP+ ++ + K++ P +
Sbjct: 184 THLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 252 EVSTECKELISNILSP-VQTRPRLKTIAE 279
+E ++ S +P + +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 9e-51
Identities = 51/260 (19%), Positives = 107/260 (41%), Gaps = 12/260 (4%)
Query: 27 GKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
++IG G + V + G A+K ++++ + +FL E ++K HPN
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFL-TEGIIMKDFSHPN 89
Query: 84 LIRFLQA-IETTHRVYIIMEYAENGSLFDIIRGQGY-IDEIRARRWFGQLLEALQYCHER 141
++ L + + +++ Y ++G L + IR + + + Q+ + +++ +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 142 GVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQ 201
VHRD+ N +LD + +K++DFG AR + + E LQ
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 202 GIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260
+ SD+WS GV+L+ ++ G P+ D + ++ + + E+
Sbjct: 208 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266
Query: 261 ISNILSP-VQTRPRLKTIAE 279
+ P + RP +
Sbjct: 267 MLKCWHPKAEMRPSFSELVS 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-50
Identities = 62/263 (23%), Positives = 109/263 (41%), Gaps = 13/263 (4%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD----VAIKIVSKVQAPPDYLKKFLPREIEVVKGL 79
T K+IG G + V SG VAIK + FL E ++
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-GYTEKQRVDFL-GEAGIMGQF 66
Query: 80 KHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYC 138
H N+IR I + II EY ENG+L +R + G ++ + ++Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
VHRD+ N+L++S+ K+SDFG +R + + + +PE
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR---VLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257
+ + SD+WS G+V++ ++ +G P+ + S +E++K + + P + +
Sbjct: 184 AISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242
Query: 258 KELISNILSP-VQTRPRLKTIAE 279
+L+ RP+ I
Sbjct: 243 YQLMMQCWQQERARRPKFADIVS 265
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-50
Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 34/287 (11%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
YT K+IG GS+ V A+ VAIK V + K+F RE+++++ L H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCN 74
Query: 84 LIRFLQAIETTHR------VYIIMEYAENGSLFDI---IRGQGYIDEIRARRWFGQLLEA 134
++R ++ + ++++Y R + + I + + QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 135 LQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193
L Y H G+ HRDIK +NLLLD D +KL DFG A+ + ++ S
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-------VRGEPNVSYICSRY 187
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEV 253
Y +PE++ G D+WS G VL ++ G+ F S + L ++ + P + ++
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 254 STECKELISNILSPVQTRPRLKTIAED----------RWLKPKPKSR 290
++ P K R L+ P +R
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-50
Identities = 66/291 (22%), Positives = 120/291 (41%), Gaps = 37/291 (12%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + IG G+Y TV A++ VA+K V L REI ++K LKH N
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKHKN 62
Query: 84 LIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGV 143
++R + + ++ ++ E+ + G +D + + QLL+ L +CH R V
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 144 VHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGI 203
+HRD+K +NLL++ + +KL++FG ARA + Y P++L G
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFG------IPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 204 PYAPHLSDIWSMGVVLFAMVFGRLP-FDDSSVNELLKQVQNKVTFPKQ------------ 250
D+WS G + + P F + V++ LK++ + P +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 251 ----------------PEVSTECKELISNILSP-VQTRPRLKTIAEDRWLK 284
P+++ ++L+ N+L R + + +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-50
Identities = 64/304 (21%), Positives = 118/304 (38%), Gaps = 46/304 (15%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSG-DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-- 80
Y IG G+Y V AR ++ G VA+K V + RE+ V++ L+
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLETF 67
Query: 81 -HPNLIRFLQAIETTH-----RVYIIMEYAENGSL-FDIIRGQGYIDEIRARRWFGQLLE 133
HPN++R + ++ ++ E+ + + + + + QLL
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 134 ALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYA 193
L + H VVHRD+K +N+L+ S IKL+DFG AR + + + +
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-------TSVVVTLW 180
Query: 194 YASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ--- 250
Y +PE+L YA D+WS+G + M + F SS + L ++ + + P +
Sbjct: 181 YRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 251 -----------------------PEVSTECKELISNILSP-VQTRPRLKTIAEDRWLKPK 286
++ K+L+ L+ R + + +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299
Query: 287 PKSR 290
+ +
Sbjct: 300 ERCK 303
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-48
Identities = 61/284 (21%), Positives = 105/284 (36%), Gaps = 26/284 (9%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKG 78
T+ + +G GS+ V + D VAIK V++ A +FL E V+K
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIEFL-NEASVMKE 79
Query: 79 LKHPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY----------IDEIRARRWF 128
+++R L + +IME G L +R + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 129 GQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETF 188
G++ + + Y + VHRD+ N ++ D+ +K+ DFG R
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIYETDYYRKGGKG 195
Query: 189 CGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMV-FGRLPFDDSSVNELLKQVQNKVTF 247
+ SPE L+ + + SD+WS GVVL+ + P+ S ++L+ V
Sbjct: 196 LLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254
Query: 248 PKQPEVSTECKELISNILSP-VQTRPRLKTIAE--DRWLKPKPK 288
K EL+ + RP I ++P +
Sbjct: 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-47
Identities = 53/283 (18%), Positives = 101/283 (35%), Gaps = 34/283 (12%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKG 78
+ GK +G G++ V A + VA+K++ A + + E++V+
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALM-SELKVLSY 82
Query: 79 LK-HPNLIRFLQAIETTHRVYIIMEYAENGSLFDIIRGQGY------------------I 119
L H N++ L A +I EY G L + +R + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 120 DEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179
D + Q+ + + + + +HRD+ N+LL K+ DFG A R N
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA----RDIKND 198
Query: 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD--SSVNEL 237
++ + + +PE + Y SD+WS G+ L+ + ++
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 238 LKQVQNKVTFPKQPEVSTECKELISNILSP-VQTRPRLKTIAE 279
K ++ E +++ RP K I +
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-47
Identities = 67/322 (20%), Positives = 124/322 (38%), Gaps = 49/322 (15%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y + +G+G+Y V A R VAIK + + + K+ RE+ ++K ++H N
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHEN 78
Query: 84 LIRFLQAIETTHR------VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
+I L Y++M + G+ + + E R + Q+L+ L+Y
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H G++HRD+K NL ++ D +K+ DFG AR +S + + Y +P
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------QADSEMTGYVVTRWYRAP 187
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQN-KVTFPKQ------ 250
E++ DIWS+G ++ M+ G+ F S + LK++ T P +
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 251 -----------------------PEVSTECKELISNILSP-VQTRPRLKTIAEDRWLKPK 286
S L+ +L + R + +
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307
Query: 287 PKSRGVDKAEAELDHYIDMIQT 308
+ + + D + D+ +T
Sbjct: 308 HDTEDEPQVQKYDDSFDDVDRT 329
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 156 bits (395), Expect = 2e-46
Identities = 46/271 (16%), Positives = 88/271 (32%), Gaps = 21/271 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y VG+ IG GS+ + + ++ VAIK + P E K L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR-----DEYRTYKLLAGCT 61
Query: 84 LIRFLQAI-ETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG 142
I + + ++++ + Q+L +Q HE+
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 143 VVHRDIKCENLLLDSDY-----NIKLSDFGFARAHMRCRSNA-ADNSLSETFCGSYAYAS 196
+V+RDIK +N L+ I + DFG + + + + G+ Y S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 197 PEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ----NKVTFPKQ-- 250
G + D+ ++G V + G LP+ ++ + K + P +
Sbjct: 182 INTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 251 -PEVSTECKELISNILSP-VQTRPRLKTIAE 279
E + + + P +
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 1e-45
Identities = 59/295 (20%), Positives = 105/295 (35%), Gaps = 48/295 (16%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
+ + IG G + V + +VA+KI S + F EI L+H N
Sbjct: 5 IVLQESIGKGRFGEVWRGKWRGE--EVAVKIFSSREER----SWFREAEIYQTVMLRHEN 58
Query: 84 LIRFLQAIE----TTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCH 139
++ F+ A T +++++ +Y E+GSLFD + + + L + H
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLH 117
Query: 140 E--------RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGS 191
+ HRD+K +N+L+ + ++D G A H + G+
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI--DIAPNHRVGT 175
Query: 192 YAYASPEILQGIPYAPHL-----SDIWSMGVVLFAMVFGRLPFD---------------D 231
Y +PE+L H +DI++MG+V + + D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 232 SSVNELLKQVQNKVTFPKQP------EVSTECKELISNILSP-VQTRPRLKTIAE 279
SV E+ K V + P P E +++ R I +
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-45
Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 16/257 (6%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y +G+G+Y +V A T+ VA+K +S+ + K+ RE+ ++K +KH N
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 78
Query: 84 LIRFLQAIETTHRV-----YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYC 138
+I L + ++ + L +I++ Q + + Q+L L+Y
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL-TDDHVQFLIYQILRGLKYI 137
Query: 139 HERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPE 198
H ++HRD+K NL ++ D +K+ DFG AR + + + Y +PE
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---------GYVATRWYRAPE 188
Query: 199 ILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258
I+ + DIWS+G ++ ++ GR F + + LK + V P +
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 259 ELISNILSPVQTRPRLK 275
E N + + P++
Sbjct: 249 ESARNYIQSLTQMPKMN 265
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 153 bits (386), Expect = 1e-44
Identities = 59/289 (20%), Positives = 122/289 (42%), Gaps = 30/289 (10%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HP 82
Y + + +G G Y+ V A + ++ V +KI+ V+ KK + REI++++ L+ P
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGP 90
Query: 83 NLIRFLQAIE--TTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE 140
N+I ++ + ++ E+ N + + + + R + ++L+AL YCH
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHS 147
Query: 141 RGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEI 199
G++HRD+K N+++D + ++L D+G A + S + PE+
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-------PGQEYNVRVASRYFKGPEL 200
Query: 200 LQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN-ELLKQVQNKVTFPKQPEVSTECK 258
L + D+WS+G +L +M+F + PF N + L ++ + + +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 259 ELISNILSPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMIQ 307
++ PR I K + + +D +
Sbjct: 261 ---------IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 300
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-43
Identities = 51/282 (18%), Positives = 109/282 (38%), Gaps = 33/282 (11%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGD-----VAIKIVSKVQAPPDYLKKFLPREIEVVKG 78
+GK +G G++ V A + VA+K++ + + + L E++++
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIH 72
Query: 79 LKHPNLIRFLQAI--ETTHRVYIIMEYAENGSLFDIIRGQG----------------YID 120
+ H + L + + +I+E+ + G+L +R + ++
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 121 EIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180
+ Q+ + +++ R +HRD+ N+LL +K+ DFG A R
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA----RDIYKDP 188
Query: 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFG-RLPFDDSSVNELLK 239
D + +PE + Y SD+WS GV+L+ + P+ ++E
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 240 QVQNKVTFPKQPE-VSTECKELISNILSP-VQTRPRLKTIAE 279
+ + T + P+ + E + + + RP + E
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-42
Identities = 68/290 (23%), Positives = 127/290 (43%), Gaps = 22/290 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN 83
Y K IG+G+ V A +VAIK +S+ + K+ RE+ ++K + H N
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 77
Query: 84 LIRFLQA------IETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQY 137
+I L +E VY++ME + I Q +D R Q+L +++
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKH 134
Query: 138 CHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASP 197
H G++HRD+K N+++ SD +K+ DFG AR + + + + Y +P
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-------TSFMMTPYVVTRYYRAP 187
Query: 198 EILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257
E++ G+ Y + DIWS+G ++ MV ++ F + +V ++ P PE +
Sbjct: 188 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP-CPEFMKKL 245
Query: 258 KELISNILSPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYIDMIQ 307
+ + N V+ RP+ + + + + + D++
Sbjct: 246 QPTVRNY---VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 1e-31
Identities = 59/300 (19%), Positives = 108/300 (36%), Gaps = 21/300 (7%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD-------YLKKFLPREIEVV 76
Y + + +G G ++TV LA+ ++ VA+KIV + + L++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 77 KGLKHPNLIRFLQAIET-----THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQL 131
+ ++++ L H V + EN I I ++ QL
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 132 LEALQYC-HERGVVHRDIKCENLLLDS-DYNIKLSDFGFARAHMRCRSNAADNSLSETFC 189
L L Y G++H DIK EN+L++ D L A C +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT----NSI 190
Query: 190 GSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQV-QNKVTFP 248
+ Y SPE+L G P+ +DIWS ++F ++ G F+ + K
Sbjct: 191 QTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 249 KQPEVSTECKELISNILSPVQTRPRLKTIAE-DRWLKPKPKSRGVDKAEAELDHYIDMIQ 307
E+ + + +R L+ I++ W + ++ E D +
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 3e-21
Identities = 27/160 (16%), Positives = 51/160 (31%), Gaps = 20/160 (12%)
Query: 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIV-------SKVQAPPDYLKKFLPREIEVV 76
+GK++G G + V S + G+ +K KV+ DY
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKF-GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 77 KGLKHPNLIRFLQAIETTH----RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLL 132
+ L + ++ME + + +L
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMIL 113
Query: 133 EALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172
E + + RG+VH D+ N+L+ + I + DF +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 316 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.38 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.36 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.54 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.45 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.34 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-61 Score=405.33 Aligned_cols=255 Identities=32% Similarity=0.615 Sum_probs=225.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
-++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999998754322222345677999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|||+++|+|.+++.+.+.+++..++.++.||+.||+|||+.|++||||||+|||++.+|.+||+|||++....
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~------- 157 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP------- 157 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC-------
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC-------
Confidence 9999999999999988889999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (316)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+.... ++.+..+|+++++|
T Consensus 158 -~~~~~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 234 (263)
T d2j4za1 158 -SSRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDL 234 (263)
T ss_dssp -CCCCEETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHH
T ss_pred -CCcccccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHH
Confidence 122334569999999999998777665 999999999999999999999999888888876643 34456799999999
Q ss_pred HHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 261 ISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
|.+|| .+|++|||++++++||||+.
T Consensus 235 i~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999 59999999999999999963
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-61 Score=405.54 Aligned_cols=258 Identities=32% Similarity=0.538 Sum_probs=218.1
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|++..+|+.||+|++....... ..+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 57999999999999999999999999999999997654322 2456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
||++||+|.+++...+.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...... .
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~----~ 158 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN----R 158 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT----E
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC----c
Confidence 999999999999888889999999999999999999999999999999999999999999999999997643211 1
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH-hcccCCCCCCCCCHHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN-ELLKQV-QNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~ 259 (316)
........||+.|+|||++.+..+.+.++|||||||++|+|++|+.||...... ...... ......+....+|+++.+
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence 122344579999999999988887766699999999999999999999764332 222223 333333344578999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
||.+|| .+|++|||++++++||||+.
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 999999 59999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-60 Score=400.72 Aligned_cols=256 Identities=29% Similarity=0.491 Sum_probs=223.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.++|++.+.||+|+||.||+|++..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 457999999999999999999999999999999997654433 35577999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|||++||+|.+++.+. .+++..++.++.||+.||+|||++|++||||||+|||++.+|.+||+|||++.....
T Consensus 96 mEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~------ 168 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 168 (293)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS------
T ss_pred EEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc------
Confidence 9999999999988764 599999999999999999999999999999999999999999999999999975421
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCCCCHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV--TFPKQPEVSTECK 258 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 258 (316)
.........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+.... ..+.+..+|++++
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 247 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHH
T ss_pred ccccccccccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHH
Confidence 2223345569999999999998777665 999999999999999999999888777666554432 3344567899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
+||.+|| .+|.+|||++|+++||||+..+
T Consensus 248 ~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 9999999 5999999999999999997544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-59 Score=400.60 Aligned_cols=272 Identities=21% Similarity=0.324 Sum_probs=231.3
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
+.|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999999999999999998776666655667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
|||.+++|..++...+++++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-------
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-------
Confidence 9999999988887778899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCcccccccCccCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-CCCCCCCCHHHH
Q psy11194 182 NSLSETFCGSYAYASPEILQGI--PYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-FPKQPEVSTECK 258 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 258 (316)
.....||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+....+....+..... ......+|+++.
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~ 244 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHH
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 2234689999999998643 2234459999999999999999999998888777766655433 334456899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHHHhHhHHH
Q psy11194 259 ELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAEAELDHYI 303 (316)
Q Consensus 259 ~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (316)
+||.+|| .+|++|||++++++||||.............++.++.+
T Consensus 245 ~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~~~~~~~~~~~~~~ 290 (309)
T d1u5ra_ 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 290 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHHHHHHHHHH
T ss_pred HHHHHHCcCChhHCcCHHHHHhCHHhcCCCCchhhHHHHHHHHHHH
Confidence 9999999 59999999999999999986555444444444444433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-60 Score=401.23 Aligned_cols=262 Identities=27% Similarity=0.538 Sum_probs=224.9
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|++.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 34689999999999999999999999999999999975332222224567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||++||+|.+++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.+|.++|+|||+++.....
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~---- 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---- 161 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC----
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999764311
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
..........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+.... ...+..+++++++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARD 239 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCCccCCHHHHH
Confidence 11222334568999999999988777665 999999999999999999999999888888876653 3444679999999
Q ss_pred HHHHhc-CCCCCCCCHHH------HhhCCCCCCCC
Q psy11194 260 LISNIL-SPVQTRPRLKT------IAEDRWLKPKP 287 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~------il~~~~~~~~~ 287 (316)
||.+|| .+|++|||++| +++||||++..
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 999999 59999999988 58999998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-59 Score=397.72 Aligned_cols=258 Identities=31% Similarity=0.554 Sum_probs=211.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
.+.|++.+.||+|+||.||+|++..+|+.||||++........ ...+.+|+.+++.++||||+++++++.+++..++|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 5679999999999999999999999999999999976544322 34567999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC---CCCCeEEeecccccccccccC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD---SDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~---~~~~~~l~Df~~~~~~~~~~~ 177 (316)
|||++|++|.+++.+.+.+++..+..++.||+.||.|||+.|++||||||+||++. .++.+||+|||++....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~---- 161 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---- 161 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc----
Confidence 99999999999999888899999999999999999999999999999999999995 47889999999996532
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC---CCCCCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT---FPKQPEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 254 (316)
.........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+....+....+..... .+..+.+|
T Consensus 162 ---~~~~~~~~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 162 ---PGSVLSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ---CCCeeeeeeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC
Confidence 1222334568999999999988777665 9999999999999999999999988888887765432 23345799
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
+++.+||.+|| .+|++|||++|+++||||++...
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 272 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA 272 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCc
Confidence 99999999999 59999999999999999986443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-59 Score=393.33 Aligned_cols=255 Identities=34% Similarity=0.536 Sum_probs=214.2
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe--CCeEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVY 98 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 98 (316)
.++|++.+.||+|+||.||+|++..+|+.||+|++........ ..+.+.+|+.+++.++||||+++++++.+ .+..+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHH-HHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHH-HHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4689999999999999999999999999999999977655433 35667899999999999999999999864 45689
Q ss_pred EEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCCCCCeeeCCCCCeEEeecccc
Q psy11194 99 IIMEYAENGSLFDIIRG----QGYIDEIRARRWFGQLLEALQYCHERG-----VVHRDIKCENLLLDSDYNIKLSDFGFA 169 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~H~dl~p~nil~~~~~~~~l~Df~~~ 169 (316)
+||||++||+|.+++.+ ...+++..++.++.||+.||.|||+.| ++||||||+|||++.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999853 467999999999999999999999876 999999999999999999999999999
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK 249 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (316)
..... .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+..+...+.
T Consensus 162 ~~~~~------~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~ 234 (269)
T d2java1 162 RILNH------DTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 234 (269)
T ss_dssp HHC-----------------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred eeccc------CCCccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 76421 1122334568999999999988777655 9999999999999999999999999999888877765566
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWL 283 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~ 283 (316)
+..+|+++.+||.+|| .+|.+|||++++++|||+
T Consensus 235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 6789999999999999 599999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-59 Score=397.78 Aligned_cols=265 Identities=21% Similarity=0.364 Sum_probs=222.5
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
+.|++++.||+|+||.||+|++..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4699999999999999999999999999999999765332 2455779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||++||+|.+++.+ .+++++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||++.......
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---- 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 164 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence 99999999999764 5679999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCcccccccCccCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--CCCCCCCC
Q psy11194 181 DNSLSETFCGSYAYASPEILQG----IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT--FPKQPEVS 254 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 254 (316)
.......|++.|+|||++.. ....+.++|||||||++|+|++|..||.+.+..+....+..... .+.+..+|
T Consensus 165 --~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 242 (288)
T d2jfla1 165 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242 (288)
T ss_dssp --HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSC
T ss_pred --ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCC
Confidence 11223468999999999842 22234459999999999999999999998888777777665432 33345789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCChhhHH
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGVDKAE 296 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~ 296 (316)
+++++||.+|| .+|++|||++|+++||||+.... .++.++.
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~-~p~~~li 284 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN-KPIRELI 284 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCC-HHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC-CCcHHHH
Confidence 99999999999 59999999999999999985433 3344433
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=392.30 Aligned_cols=264 Identities=26% Similarity=0.453 Sum_probs=224.4
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch---HHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
.++|++.+.||+|+||.||+|++..+|+.||||++........ ...+.+.+|+.+++.++||||+++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999999999999999999976443221 1245678999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC----CeEEeecccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY----NIKLSDFGFARAHM 173 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~----~~~l~Df~~~~~~~ 173 (316)
++||||++||+|.+++.+.+.+++..++.++.||+.||+|||+.|++||||||+||+++.++ .++++|||++....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999998888899999999999999999999999999999999999998776 49999999986532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC---CC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP---KQ 250 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 250 (316)
.........+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+....... .+
T Consensus 169 -------~~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 169 -------FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp -------TSCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred -------CCccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 1122334568899999999988777655 999999999999999999999999888888876653222 22
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCCh
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGV 292 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~ 292 (316)
+.+|+++++||.+|| .+|.+|||++++++||||++.......
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-------
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHhh
Confidence 578999999999999 599999999999999999987665443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=397.92 Aligned_cols=259 Identities=32% Similarity=0.525 Sum_probs=228.3
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
.-++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 45789999999999999999999999999999999975422111124556799999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 100 IMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||||++||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+|||++.+|.+||+|||+++...
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~------ 156 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI------ 156 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC------
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc------
Confidence 99999999999999998889999999999999999999999999999999999999999999999999996532
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
.........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+.... ...+..+|+++++
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~d 234 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKS 234 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHH
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHH
Confidence 12233445679999999999999888776 999999999999999999999999988888776653 4455679999999
Q ss_pred HHHHhc-CCCCCCCC-----HHHHhhCCCCCCC
Q psy11194 260 LISNIL-SPVQTRPR-----LKTIAEDRWLKPK 286 (316)
Q Consensus 260 li~~~l-~~p~~Rps-----~~~il~~~~~~~~ 286 (316)
||.+|| .+|.+|++ ++++++||||++.
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 999999 69999995 9999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-58 Score=384.65 Aligned_cols=253 Identities=23% Similarity=0.463 Sum_probs=215.0
Q ss_pred ccCe-EEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe----CC
Q psy11194 21 SHGY-TVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----TH 95 (316)
Q Consensus 21 ~~~y-~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~ 95 (316)
..+| ++.+.||+|+||.||+|++..+++.||+|++........ ..+.+.+|+.+++.++||||+++++++.. +.
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 4455 677889999999999999999999999999977654433 35567899999999999999999999865 34
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeC-CCCCeEEeeccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERG--VVHRDIKCENLLLD-SDYNIKLSDFGFARAH 172 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~H~dl~p~nil~~-~~~~~~l~Df~~~~~~ 172 (316)
..++||||+++++|.+++.+...+++..++.++.||+.||.|||+++ ++||||||+|||++ +++.+||+|||+++..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 68999999999999999988888999999999999999999999998 99999999999996 5789999999999642
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcccCCC-CC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDS-SVNELLKQVQNKVTFP-KQ 250 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~ 250 (316)
.........||+.|+|||++.+ .++ .++|||||||++|+|++|+.||... +..+....+..+...+ .+
T Consensus 166 --------~~~~~~~~~GT~~Y~aPE~~~~-~~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 166 --------RASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235 (270)
T ss_dssp --------CTTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred --------cCCccCCcccCccccCHHHhCC-CCC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccC
Confidence 1122334568999999999876 344 4599999999999999999999764 5666667776654433 23
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCC
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLK 284 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~ 284 (316)
...++++.+||.+|| .+|++|||++|+++||||+
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 468899999999999 5999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-58 Score=394.40 Aligned_cols=255 Identities=27% Similarity=0.521 Sum_probs=226.4
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
-++|++.+.||+|+||.||+|++..+|+.||||+++..........+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46899999999999999999999999999999999753322222245677999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|||++|++|..++.....+++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||++.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~------ 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------ 156 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS------
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc------
Confidence 99999999999999988899999999999999999999999999999999999999999999999999976321
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (316)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+..+. .+.++.+|+++.++
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 231 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDL 231 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHH
T ss_pred ---ccccccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCCCCHHHHHH
Confidence 1234569999999999988877765 999999999999999999999999998888876653 34456799999999
Q ss_pred HHHhc-CCCCCCC-----CHHHHhhCCCCCCC
Q psy11194 261 ISNIL-SPVQTRP-----RLKTIAEDRWLKPK 286 (316)
Q Consensus 261 i~~~l-~~p~~Rp-----s~~~il~~~~~~~~ 286 (316)
|.+|| .+|.+|+ |++++++||||++.
T Consensus 232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 99999 6999996 99999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-57 Score=397.55 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=223.2
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++++.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999876432 22456779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC--CCCCeEEeecccccccccccCc
Q psy11194 102 EYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD--SDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 102 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~--~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
||++||+|.+++... .++++..++.++.||+.||.|||++|++||||||+|||++ .++.++|+|||++....
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~----- 180 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN----- 180 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC-----
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC-----
Confidence 999999999887654 4699999999999999999999999999999999999997 56899999999997642
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CCC--CCCCCCH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TFP--KQPEVST 255 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~ 255 (316)
.........+++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+.... .++ ....+|+
T Consensus 181 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 181 --PDEIVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp --TTSCEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred --CCCceeeccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2223344568999999999988777665 999999999999999999999999888888776543 222 3357999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
++.+||.+|| .+|.+|||++++++||||++...
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 9999999999 59999999999999999987543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-57 Score=397.58 Aligned_cols=256 Identities=26% Similarity=0.459 Sum_probs=222.6
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999986543 233566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeC--CCCCeEEeecccccccccccCc
Q psy11194 102 EYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLD--SDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 102 e~~~~~sL~~~l~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~--~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
||++||+|.+++. ..+.+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++....
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~----- 177 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD----- 177 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC-----
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc-----
Confidence 9999999999995 456799999999999999999999999999999999999995 45789999999996532
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-CC--CCCCCCH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-FP--KQPEVST 255 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 255 (316)
.........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+..... ++ ....+|+
T Consensus 178 --~~~~~~~~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 178 --PKQSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp --TTSCEEEECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred --cccccceecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2222334568999999999988777655 9999999999999999999999988888887765432 22 2246899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 256 ECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 256 ~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
++++||.+|| .||++|||++++++||||+....
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 9999999999 59999999999999999986543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-58 Score=397.25 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=216.3
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeE
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 97 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 97 (316)
++..++|++++.||+|+||.||+|++..+|+.||+|+++...... ..+.+.+|+.+++.++||||++++++|.++...
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT--HHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 456789999999999999999999999999999999997654322 245677999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
++||||++||+|.+++.+.+.+++..++.++.|++.||.|||+ +|++||||||+|||++.+|.+||+|||+|......
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999999888889999999999999999999997 59999999999999999999999999999765321
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH------------------
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELL------------------ 238 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~------------------ 238 (316)
......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+..+..
T Consensus 159 -------~~~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 159 -------MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp -------TC---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred -------ccccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 1234579999999999998887776 99999999999999999999764432211
Q ss_pred ------------------------HHHhcccCCCC-CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 239 ------------------------KQVQNKVTFPK-QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 239 ------------------------~~~~~~~~~~~-~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
..+........ ...+|.++++||.+|| .||.+|||++|+++||||+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 11111111111 1236899999999999 59999999999999999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.9e-57 Score=380.48 Aligned_cols=259 Identities=27% Similarity=0.482 Sum_probs=223.0
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc------hHHHhhHHHHHHHHhcCC-CCCcceeeeEEEe
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP------DYLKKFLPREIEVVKGLK-HPNLIRFLQAIET 93 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~------~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 93 (316)
.++|++.+.||+|+||+||+|++..+|+.||||++....... ....+.+.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999997755432 122345778999999996 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
++..++||||++|++|.++++..+++++..++.++.||+.||+|||++|++||||+|+||+++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999997632
Q ss_pred cccCcCCCCCCCcccccccCccCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-CC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQG-----IPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKV-TF 247 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~ 247 (316)
. ........|++.|+|||.+.+ ....+.++||||+||++|+|++|+.||.+.+.......+..+. .+
T Consensus 162 ~-------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 162 P-------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp T-------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred C-------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 1 222334568999999999852 2223445999999999999999999999999888887776543 22
Q ss_pred --CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 248 --PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 248 --~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
+....+|+++++||.+|| .+|++|||++++++||||+..
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 233479999999999999 599999999999999999753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-57 Score=393.82 Aligned_cols=258 Identities=25% Similarity=0.464 Sum_probs=226.5
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
..-++|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++......+
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 34578999999999999999999999999999999986532222222345679999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||+++....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999976421
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECK 258 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+.... ...+..+|+++.
T Consensus 194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 266 (350)
T d1rdqe_ 194 -----RTWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLK 266 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHH
T ss_pred -----ccccccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHH
Confidence 1234568999999999998777665 999999999999999999999999888888886653 344567999999
Q ss_pred HHHHHhc-CCCCCC-----CCHHHHhhCCCCCCCC
Q psy11194 259 ELISNIL-SPVQTR-----PRLKTIAEDRWLKPKP 287 (316)
Q Consensus 259 ~li~~~l-~~p~~R-----ps~~~il~~~~~~~~~ 287 (316)
+||.+|| .||.+| ||++++++||||++..
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 9999999 699998 4999999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-57 Score=388.39 Aligned_cols=257 Identities=29% Similarity=0.493 Sum_probs=221.9
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHH-hcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVV-KGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
++|++.+.||+|+||.||+|++..+|+.||||++++.........+.+..|..++ +.++||||+++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999999999999999999753211111123344566655 468999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
|||++||+|.+++...+.+++..++.++.||+.||.|||++|++||||||+|||++.+|.++|+|||++.... .
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~------~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM------L 155 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC------C
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcc------c
Confidence 9999999999999988889999999999999999999999999999999999999999999999999996532 1
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEVSTECKEL 260 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (316)
.........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..++...+.... +..+..+|+++.+|
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dl 233 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDL 233 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHH
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHH
Confidence 2233344568999999999999888765 999999999999999999999999999888886553 44556799999999
Q ss_pred HHHhc-CCCCCCCCHH-HHhhCCCCCCC
Q psy11194 261 ISNIL-SPVQTRPRLK-TIAEDRWLKPK 286 (316)
Q Consensus 261 i~~~l-~~p~~Rps~~-~il~~~~~~~~ 286 (316)
|.+|| .+|.+|||+. ++++||||++.
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 99999 6999999996 89999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.6e-57 Score=394.34 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=215.0
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHH---HHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLP---REIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
.-++|++.+.||+|+||.||+|++..+|+.||+|++.............+. .++.+++.++||||+++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 457899999999999999999999999999999998653221111112222 44677788899999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
.++||||++|++|.+++.+...+++..++.++.||+.||.|||+.|++||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence 999999999999999999888899999999999999999999999999999999999999999999999999975421
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cccCCCCCCCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ--NKVTFPKQPEVS 254 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~ 254 (316)
.......||+.|+|||++......+.++|||||||++|+|++|+.||.+........... .......+..+|
T Consensus 160 ------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 233 (364)
T d1omwa3 160 ------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233 (364)
T ss_dssp ------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSC
T ss_pred ------CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Confidence 223345699999999999765544555999999999999999999998654333322222 223344456799
Q ss_pred HHHHHHHHHhc-CCCCCCCC-----HHHHhhCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPR-----LKTIAEDRWLKPK 286 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps-----~~~il~~~~~~~~ 286 (316)
+++++||.+|| .+|++||| ++++++||||++.
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 99999999999 69999999 7999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-56 Score=382.10 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=213.8
Q ss_pred EeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCc--hHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEEec
Q psy11194 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPP--DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 103 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 103 (316)
.++.||+|+||+||+|++..+|+.||||++....... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4688999999999999999999999999986543322 22234577999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCCCC
Q psy11194 104 AENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNS 183 (316)
Q Consensus 104 ~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~ 183 (316)
+.++++..+......+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++.... ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~------~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG------SPNR 155 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT------SCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccC------CCcc
Confidence 9988777777767779999999999999999999999999999999999999999999999999986532 1122
Q ss_pred CCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC--------------
Q psy11194 184 LSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK-------------- 249 (316)
Q Consensus 184 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 249 (316)
......+|+.|+|||++......+.++|||||||++|+|++|..||.+....+....+.+....+.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 233456899999999987766555569999999999999999999998888777666543211110
Q ss_pred -------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCC
Q psy11194 250 -------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRG 291 (316)
Q Consensus 250 -------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~ 291 (316)
.+.+++++.+||.+|| .||++|||++|+|+||||++.+...+
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~ 291 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCC
Confidence 1346889999999999 59999999999999999998765443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=384.64 Aligned_cols=254 Identities=22% Similarity=0.399 Sum_probs=220.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 100 (316)
-++|++.+.||+|+||.||+|++..+|+.||+|++..... ....+.+|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3679999999999999999999999999999999966432 234577999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC--CCeEEeecccccccccccC
Q psy11194 101 MEYAENGSLFDIIRGQG-YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD--YNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~--~~~~l~Df~~~~~~~~~~~ 177 (316)
||||+|++|.+++...+ .+++.+++.++.||+.||.|||+.|++||||||+||+++.+ +.++|+|||++....
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~---- 155 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---- 155 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc----
Confidence 99999999999998654 69999999999999999999999999999999999999854 579999999986532
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-CCC--CCCCC
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVT-FPK--QPEVS 254 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~ 254 (316)
.........+++.|+|||...+..++.+ +|||||||++|+|++|..||.+.+..+....+..... ++. .+.+|
T Consensus 156 ---~~~~~~~~~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T d1tkia_ 156 ---PGDNFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp ---TTCEEEEEESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ---cCCcccccccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCC
Confidence 1222334567899999999988777665 9999999999999999999999999888888866432 222 24689
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 255 TECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 255 ~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
+++++||..|| .||++|||++|+++||||+..
T Consensus 232 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999 699999999999999999643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-56 Score=377.01 Aligned_cols=264 Identities=21% Similarity=0.338 Sum_probs=225.9
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
+++..++|++.+.||+|+||.||+|++..+|+.||||++...... .+.+.+|+.+++.++||||+++++++.+++.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 678889999999999999999999999999999999998654433 3457799999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999999653 4699999999999999999999999999999999999999999999999999975321
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcccCCCCCCCC
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFG-RLPFDDSSVNELLKQVQNKVTFPKQPEV 253 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (316)
..........+++.|+|||++.+..++.+ +|||||||++|+|++| .+||...+..+..+.+..+..++.+..+
T Consensus 168 -----~~~~~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 241 (287)
T d1opja_ 168 -----DTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 241 (287)
T ss_dssp -----SSSEEETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred -----CCceeeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccc
Confidence 11112223457889999999988777655 9999999999999995 4556777888888888888888888889
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCCCh
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSRGV 292 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~~~ 292 (316)
|+++.+||..|| .+|++|||++++++ +|+...++..+
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~~~~~~~ 279 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQ--AFETMFQESSI 279 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHTTSSSCH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHHHHhCCC
Confidence 999999999999 59999999999976 34444444443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-55 Score=372.85 Aligned_cols=260 Identities=28% Similarity=0.450 Sum_probs=214.7
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++++.||+|+||.||+|.+..+|+.||+|++...... +...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 5899999999999999999999999999999999654432 222456779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHH-Hh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcC
Q psy11194 102 EYAENGSLFDII-RG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNA 179 (316)
Q Consensus 102 e~~~~~sL~~~l-~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~ 179 (316)
||+.+ ++..++ .. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~------ 153 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG------ 153 (298)
T ss_dssp ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC------
T ss_pred eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc------
Confidence 99976 554444 33 4569999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC----------
Q psy11194 180 ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPK---------- 249 (316)
Q Consensus 180 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 249 (316)
..........|++.|+|||++....+.+.++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 154 ~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 1223334456899999999988877777779999999999999999999998877766555432110000
Q ss_pred ------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCC
Q psy11194 250 ------------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKS 289 (316)
Q Consensus 250 ------------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~ 289 (316)
.+.++.++.+||.+|| .+|.+|||++|+++||||++...+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 1357889999999999 599999999999999999987653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-55 Score=372.09 Aligned_cols=259 Identities=22% Similarity=0.385 Sum_probs=210.3
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccCCc---eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRHSG---DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
++...+|++.+.||+|+||.||+|++..+++ .||+|.+..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4567889999999999999999999886665 477787654332 33345677999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
+..++||||+++|+|.+++.. .+.+++.++..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999999999998876 4569999999999999999999999999999999999999999999999999997653
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
...... .........+++.|+|||.+.+..++.+ +|||||||++|||+| |..||.+....++...+..+...+.+..
T Consensus 180 ~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (299)
T d1jpaa_ 180 DDTSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred CCCCcc-eeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 221111 1111222347889999999988776665 999999999999998 8999999999999999998888888888
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+|+++.+||.+|| .+|++|||+.+++++
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999 599999999998753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-55 Score=365.41 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=210.7
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
+..++|++.+.||+|+||.||+|.+. +++.||||+++..... .+.+.+|+.+++.++||||+++++++..++..+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 35678999999999999999999876 5678999998764433 345779999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccC
Q psy11194 99 IIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRS 177 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~ 177 (316)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~-- 154 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-- 154 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC--
Confidence 999999999999998654 56899999999999999999999999999999999999999999999999999764321
Q ss_pred cCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHH
Q psy11194 178 NAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTE 256 (316)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (316)
.........|++.|+|||++.+..++.+ +|||||||++|+|+| |.+||......+....+..+...+.+..++++
T Consensus 155 ---~~~~~~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~ 230 (263)
T d1sm2a_ 155 ---QYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230 (263)
T ss_dssp -------------CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred ---CceeecceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHH
Confidence 1122233457899999999988777665 999999999999999 67888888888888999888887777889999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 257 CKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 257 ~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+.++|.+|| .+|++|||++++++|
T Consensus 231 l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999999 599999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=372.67 Aligned_cols=253 Identities=32% Similarity=0.526 Sum_probs=212.9
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCch---HHHhhHHHHHHHHhcCC--CCCcceeeeEEEeCC
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPD---YLKKFLPREIEVVKGLK--HPNLIRFLQAIETTH 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 95 (316)
.++|++.+.||+|+||.||+|++..+|+.||||++........ .....+.+|+.+++.++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4679999999999999999999999999999999976433221 11233558999999986 899999999999999
Q ss_pred eEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCC-CCeEEeecccccccc
Q psy11194 96 RVYIIMEYAEN-GSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSD-YNIKLSDFGFARAHM 173 (316)
Q Consensus 96 ~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~-~~~~l~Df~~~~~~~ 173 (316)
..++||||+.+ +++.+++.+...+++..++.++.||+.||.|||+.|++||||||+||+++.+ +.++|+|||++....
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 5888888888889999999999999999999999999999999999999854 789999999986532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQPEV 253 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (316)
........||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+ + +... ....+..+
T Consensus 163 --------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i~~~-~~~~~~~~ 227 (273)
T d1xwsa_ 163 --------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIRG-QVFFRQRV 227 (273)
T ss_dssp --------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHC-CCCCSSCC
T ss_pred --------cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----Hhhc-ccCCCCCC
Confidence 1223345689999999999877776666899999999999999999997632 1 2222 23344579
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 254 STECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
|+++++||.+|| .+|++|||++|+++||||++...
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 999999999999 59999999999999999987653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=370.01 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=212.3
Q ss_pred cCeEEe-eeeeecCCeEEEEEEEcc--CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEE
Q psy11194 22 HGYTVG-KIIGTGSYATVKLARSTR--HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 98 (316)
Q Consensus 22 ~~y~~~-~~ig~g~~g~vy~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 98 (316)
+.+.+. +.||+|+||.||+|.+.. +++.||||+++...... ...+.+.+|+.++++++||||+++++++..+ ..+
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~ 83 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWM 83 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C-HHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEE
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCH-HHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEE
Confidence 334444 369999999999998653 45689999996544333 3345677999999999999999999999654 568
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 99 IIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 99 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
+||||+++|+|.+++.+...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||+++......
T Consensus 84 lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~-- 161 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-- 161 (277)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC--
T ss_pred EEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc--
Confidence 999999999999999988889999999999999999999999999999999999999999999999999997643211
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
..........|++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.+..++...+..+..++.+..+|+++
T Consensus 162 -~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~ 239 (277)
T d1xbba_ 162 -NYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 239 (277)
T ss_dssp -SEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred -cccccccccCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 11122233457889999999987776655 999999999999998 999999999999999998888888888899999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHh---hCCCC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIA---EDRWL 283 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il---~~~~~ 283 (316)
.+||.+|| .+|++|||+++|+ +|+|+
T Consensus 240 ~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 99999999 5999999999984 45443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=362.49 Aligned_cols=250 Identities=22% Similarity=0.414 Sum_probs=220.7
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEE
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 99 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 99 (316)
..++|++.+.||+|+||+||+|+++ +++.||||+++..... .+.+.+|+.++..++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 4578999999999999999999975 6778999999875543 3457799999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCc
Q psy11194 100 IMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSN 178 (316)
Q Consensus 100 v~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~ 178 (316)
||||+++|+|..++.. ...+++..+.+++.|++.||+|||++|++|+||+|+||+++.++.+||+|||+++....
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~---- 152 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---- 152 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS----
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC----
Confidence 9999999999999754 45699999999999999999999999999999999999999999999999999965321
Q ss_pred CCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCCCCHHH
Q psy11194 179 AADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPEVSTEC 257 (316)
Q Consensus 179 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (316)
..........+++.|+|||.+....++.+ +|||||||++|+|+| |+.||......++...+.++...+.+..+++++
T Consensus 153 -~~~~~~~~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 230 (258)
T d1k2pa_ 153 -DEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 230 (258)
T ss_dssp -SSCCCCCCSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred -CCceeecccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHH
Confidence 12222334568899999999987777655 999999999999998 899999999999999999988888888899999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 258 KELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 258 ~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.+||.+|| .+|++|||++++++|
T Consensus 231 ~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 231 YTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999 589999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-55 Score=367.31 Aligned_cols=256 Identities=22% Similarity=0.399 Sum_probs=218.7
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
-+++..++|++.+.||+|+||.||+|++. +++.||||++...... .+.+.+|+.++.+++||||+++++++.. +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 35677889999999999999999999875 5678999998754433 3457799999999999999999998755 5
Q ss_pred eEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 67899999999999998754 2359999999999999999999999999999999999999999999999999997643
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
. ..........+++.|+|||++.+..++.+ +|||||||++|+|+| |.+|+......+....+..+...+.+..
T Consensus 161 ~-----~~~~~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~ 234 (272)
T d1qpca_ 161 D-----NEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234 (272)
T ss_dssp S-----SCEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred C-----CccccccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCccc
Confidence 1 11122334457889999999987666654 999999999999999 5667778888888999988888888888
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhh--CCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAE--DRWL 283 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~--~~~~ 283 (316)
+|+++.+||.+|| .+|++|||++++++ ++||
T Consensus 235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 9999999999999 58999999999987 5555
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-54 Score=367.25 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=213.0
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++++.||+|+||+||+|++. +|+.||||++...... +...+.+.+|+.+++.++||||+++++++..++..++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 58999999999999999999886 7789999999665432 222455779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
+++.++.+..+....+.+++..++.++.||+.||+|||+.|++||||||+||+++.++.++++|||.+..... .
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~------~ 153 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI------P 153 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc------C
Confidence 9998877777777778899999999999999999999999999999999999999999999999999865321 1
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC--------------
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF-------------- 247 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 247 (316)
........+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 122333457889999999987766666799999999999999999999988777766554321100
Q ss_pred --------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCC
Q psy11194 248 --------------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKP 285 (316)
Q Consensus 248 --------------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~ 285 (316)
.....+++++.+||.+|| .||++|||++|+++||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 012457899999999999 59999999999999999974
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=366.30 Aligned_cols=260 Identities=22% Similarity=0.374 Sum_probs=219.0
Q ss_pred ceeeccCeEEeee-eeecCCeEEEEEEEcc--CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 17 TVLESHGYTVGKI-IGTGSYATVKLARSTR--HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 17 ~~~~~~~y~~~~~-ig~g~~g~vy~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
..+..++|.+.+. ||+|+||.||+|.+.. ++..||||++..... ....+.+.+|+.++++++||||+++++++..
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC--HHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 3466788999985 9999999999998764 344799999865432 3335567799999999999999999999875
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
+ ..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 81 ~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 81 E-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp S-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred C-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 4 57899999999999999865 456999999999999999999999999999999999999999999999999999764
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
.... ..........+++.|+|||++....++.+ +|||||||++|||+| |..||.+....++...+..+..++.++
T Consensus 160 ~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 235 (285)
T d1u59a_ 160 GADD---SYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 235 (285)
T ss_dssp TTCS---CEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred cccc---cccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 3211 11122233457889999999987766665 999999999999998 999999988889999998888888888
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHh---hCCCC
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIA---EDRWL 283 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il---~~~~~ 283 (316)
.+|+++.+||.+|| .+|++|||+.+|+ +|+|+
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999 5999999999884 45554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=375.17 Aligned_cols=251 Identities=29% Similarity=0.483 Sum_probs=204.4
Q ss_pred ccCeEEee-eeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHh-cCCCCCcceeeeEEEe----C
Q psy11194 21 SHGYTVGK-IIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVK-GLKHPNLIRFLQAIET----T 94 (316)
Q Consensus 21 ~~~y~~~~-~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~----~ 94 (316)
-++|.+.+ .||+|+||.||+|++..+++.||||+++. ...+.+|+.++. .++||||++++++|.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 35799875 59999999999999999999999999864 234668998865 4589999999999875 4
Q ss_pred CeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC---CCCeEEeecccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFA 169 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~---~~~~~l~Df~~~ 169 (316)
..+++|||||+||+|.+++.+. ..+++..++.++.||+.||+|||+.|++||||||+||+++. .+.++|+|||++
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 6789999999999999999763 46999999999999999999999999999999999999975 467999999999
Q ss_pred cccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----
Q psy11194 170 RAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK----- 244 (316)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----- 244 (316)
+... .........|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..+....+...
T Consensus 162 ~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 162 KETT-------SHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233 (335)
T ss_dssp EECC-------CCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred eecc-------CCCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence 7532 1222344568999999999988777665 99999999999999999999776544433333221
Q ss_pred cCCCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 245 VTFPK--QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 245 ~~~~~--~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
..++. ...+|+++.+||.+|| .+|++|||++++++||||+...
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 12222 1358999999999999 5999999999999999996543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=367.53 Aligned_cols=261 Identities=24% Similarity=0.338 Sum_probs=211.3
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccC-CceEEEEEeecCCCCchHHHhhHHHHHHHHhcC---CCCCcceeeeEEEe---
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRH-SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL---KHPNLIRFLQAIET--- 93 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~--- 93 (316)
.++|++++.||+|+||.||+|++..+ ++.||||+++........ ...+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-HHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 57899999999999999999999765 567999999764332221 22344677776655 79999999999853
Q ss_pred --CCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 94 --THRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 94 --~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
....+++||+++++.+...... ...+++..++.++.|++.||+|||++|++||||||+|||++..+.++|+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3478999999988766544433 4569999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC---
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF--- 247 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 247 (316)
... .........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+......
T Consensus 165 ~~~-------~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 165 IYS-------FQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCC-------GGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhc-------ccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 532 2223344568999999999988777765 99999999999999999999998887776665331110
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCCCC
Q psy11194 248 -----------------------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPKSR 290 (316)
Q Consensus 248 -----------------------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~~~ 290 (316)
.....+++++.+||.+|| .||++|||++|+++||||++.+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k 303 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 303 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence 012457899999999999 5999999999999999999887643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-53 Score=360.73 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=210.1
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC----e
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----R 96 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 96 (316)
.++|++.+.||+|+||.||+|++..+|+.||+|+++..........+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 578999999999999999999999999999999998776666655667889999999999999999999997654 4
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCR 176 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~ 176 (316)
+++||||++|++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.++..+++|||.+......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~- 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS- 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc-
Confidence 8999999999999999988888999999999999999999999999999999999999999999999999987653211
Q ss_pred CcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC---CCCCC
Q psy11194 177 SNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP---KQPEV 253 (316)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 253 (316)
...........|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+....+......+ ....+
T Consensus 165 --~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 165 --GNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred --cccccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 112223344568999999999988776665 999999999999999999999988877766554433222 23578
Q ss_pred CHHHHHHHHHhc-CCCCCCC-CHHHHh
Q psy11194 254 STECKELISNIL-SPVQTRP-RLKTIA 278 (316)
Q Consensus 254 ~~~~~~li~~~l-~~p~~Rp-s~~~il 278 (316)
|+++.++|.+|| .+|.+|| |+++++
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHH
Confidence 999999999999 6999999 666654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=372.07 Aligned_cols=258 Identities=22% Similarity=0.368 Sum_probs=214.5
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCc-----eEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSG-----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQ 89 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~-----~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 89 (316)
.+++..++|++.+.||+|+||.||+|++...++ .||+|.+....... ....+.+|+.++..+ +||||+++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH--HHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 356777899999999999999999999876544 58899886543322 244567899999988 8999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQ-----------------------GYIDEIRARRWFGQLLEALQYCHERGVVHR 146 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~-----------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~ 146 (316)
++.+.+..++||||+++|+|.++++.. ..+++..++.++.||+.||.|||++|++||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 999999999999999999999999653 248999999999999999999999999999
Q ss_pred CCCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-C
Q psy11194 147 DIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-G 225 (316)
Q Consensus 147 dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g 225 (316)
||||+||+++.++.+||+|||+++...... .........+|+.|+|||++.+..++.+ +|||||||++|+|++ |
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDS----NYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLG 263 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT----TSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTS
T ss_pred cCchhccccccCCeEEEeeccccccccCCC----ceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCC
Confidence 999999999999999999999997643211 1112234457899999999987777665 999999999999997 8
Q ss_pred CCCCCCCCH-HHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 226 RLPFDDSSV-NELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 226 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
..||.+... ....+.+..+..++.+..+|+++.+||.+|| .+|++|||+++|++|
T Consensus 264 ~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999987654 4455566777777777889999999999999 599999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-54 Score=361.96 Aligned_cols=255 Identities=24% Similarity=0.454 Sum_probs=206.0
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 96 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 96 (316)
+++..++|++.+.||+|+||.||+|+.. ..||||+++....... ..+.+.+|+.++..++||||+++++++.. ..
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTT-HHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE
Confidence 4667889999999999999999999643 3699999976554433 34567799999999999999999998754 56
Q ss_pred EEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 7999999999999999965 456999999999999999999999999999999999999999999999999999764321
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcccCCC----
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIP--YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN-ELLKQVQNKVTFP---- 248 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~---- 248 (316)
..........||+.|+|||++.+.. ..+.++|||||||++|+|+||+.||.+.... .....+..+...|
T Consensus 158 ----~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 158 ----SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred ----CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh
Confidence 1112234456899999999986533 2344599999999999999999999876544 4455555554433
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 249 KQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 249 ~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.+..+|+++.+||.+|| .+|.+|||+++++++
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 23568999999999999 599999999999865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=360.84 Aligned_cols=261 Identities=22% Similarity=0.415 Sum_probs=219.4
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 95 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 95 (316)
-+++..++|++.+.||+|+||.||+|++..+ +.||||++...... .+.+.+|+.+++.++||||+++++++.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 4667789999999999999999999988654 57999999755443 3457799999999999999999999855 5
Q ss_pred eEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRG--QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
..++||||+++|+|..++.. .+.+++.++..++.||+.||+|||++|++||||||+|||++.++++||+|||+++...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 57899999999999999854 4569999999999999999999999999999999999999999999999999996542
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
. ..........+++.|+|||++....++.+ +|||||||++|+|++ |.+|+......+....+..+...+.+..
T Consensus 165 ~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (285)
T d1fmka3 165 D-----NEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238 (285)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred C-----CCceeeccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc
Confidence 1 11122233458899999999988777665 999999999999999 5666777888888999988888888889
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhh--CCCCCCCCC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAE--DRWLKPKPK 288 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~--~~~~~~~~~ 288 (316)
+|+++.++|.+|| .+|++|||+++|++ ++||...+.
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 9999999999999 59999999999998 889976554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=370.43 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=209.1
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC-----
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 95 (316)
.++|++++.||+|+||+||+|.+..+|+.||||+++.... .....+.+.+|+.+++.++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 6789999999999999999999999999999999976544 3334556779999999999999999999997654
Q ss_pred -eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 96 -RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 96 -~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
.+++||||+ +.+|..+++. +.+++..++.++.||+.||.|||++|++|+||||+|||++.++.++++|||++....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 6688887765 459999999999999999999999999999999999999999999999999996532
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC-------
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTF------- 247 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 247 (316)
.......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 173 --------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 173 --------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp --------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred --------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 12234568999999999987666666699999999999999999999987766655443321110
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 248 -----------------------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 248 -----------------------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
.....+++++.+||.+|| .+|.+|||++++|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 012457899999999999 5999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-53 Score=357.06 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=212.2
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCC----ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHS----GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 92 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~----~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 92 (316)
.++...+|++.+.||+|+||.||+|.+..++ ..||||.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 3566788999999999999999999987654 3699999865433 223445779999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccc
Q psy11194 93 TTHRVYIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARA 171 (316)
Q Consensus 93 ~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~ 171 (316)
.....++||||+.+++|.+++... +.+++.++..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999999988654 5699999999999999999999999999999999999999999999999999976
Q ss_pred cccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCC
Q psy11194 172 HMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQ 250 (316)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
..... ..........|++.|+|||++.+..++.+ +|||||||++|+|++ |.+|+......++...+..+...+.+
T Consensus 160 ~~~~~---~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~ 235 (283)
T d1mqba_ 160 LEDDP---EATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred ccCCC---ccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc
Confidence 43211 11122233457889999999988777665 999999999999999 56667777888889999988888888
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 251 PEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 251 ~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..++.++.+||.+|| .+|++|||+.+|++
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 236 MDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 889999999999999 59999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=355.38 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=218.3
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCCeEEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 101 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 101 (316)
++|++++.||+|+||+||+|++..+|+.||||+++...... .....+.+|+.+++.++||||+++++++......++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh-HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 58999999999999999999999999999999997665433 33556779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCCC
Q psy11194 102 EYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAAD 181 (316)
Q Consensus 102 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~ 181 (316)
+++.+++|..++...+.+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+..... .
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~------~ 154 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI------P 154 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS------C
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC------C
Confidence 9999999999888888899999999999999999999999999999999999999999999999999976421 1
Q ss_pred CCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhcccCC-------------
Q psy11194 182 NSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPF-DDSSVNELLKQVQNKVTF------------- 247 (316)
Q Consensus 182 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~-~~~~~~~~~~~~~~~~~~------------- 247 (316)
........++..|+|||++......+.++|||||||++|+|++|+.|| .+.+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 222333456788999999887766666699999999999999999885 455555555544321110
Q ss_pred ---------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 248 ---------------PKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 248 ---------------~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
.....+++++.+||.+|| .||.+|||++|+|+||||++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 112457899999999999 5999999999999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-53 Score=356.22 Aligned_cols=255 Identities=23% Similarity=0.399 Sum_probs=208.7
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCC---ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHS---GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 93 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~---~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 93 (316)
+++..++|++.+.||+|+||.||+|++..++ ..||+|.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4567789999999999999999999987543 357778764433 3334566789999999999999999999986
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
++..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+++||||||+||+++.++.+||+|||+++..
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 4678999999999999998765 456999999999999999999999999999999999999999999999999999754
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQP 251 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
.. ..........+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+....++...+..+...+.++
T Consensus 159 ~~-----~~~~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 232 (273)
T d1mp8a_ 159 ED-----STYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 232 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred cC-----CcceeccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 21 11222334457889999999987776665 999999999999998 899999999999999998888888888
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.+|+++.+||.+|| .+|++|||+++|+++
T Consensus 233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999 599999999999854
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=360.47 Aligned_cols=264 Identities=22% Similarity=0.290 Sum_probs=211.2
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe-------
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------- 93 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------- 93 (316)
..+|++++.||+|+||+||+|++..+|+.||||++........ ....+.+|+.+++.++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS-SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH-HHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4789999999999999999999999999999999866544322 23446699999999999999999999854
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccc
Q psy11194 94 -THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAH 172 (316)
Q Consensus 94 -~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~ 172 (316)
+...++|||++.++.+.........+++..++.++.|++.||.|||+.|++||||||+||+++.++.++++|||++...
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999987666655566667999999999999999999999999999999999999999999999999999764
Q ss_pred ccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC--
Q psy11194 173 MRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFPKQ-- 250 (316)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 250 (316)
..... ..........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+......+..
T Consensus 168 ~~~~~--~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 168 SLAKN--SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp CC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccc--cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 32211 12223334568999999999987655555699999999999999999999988877776665432211110
Q ss_pred -----------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 251 -----------------------------PEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 251 -----------------------------~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
...++++.+||.+|| .||++|||++|+++||||+..+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 013678899999999 5999999999999999998643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=363.38 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=210.6
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC-----
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 95 (316)
+.+|++++.||+|+||+||+|.+..+|+.||||++..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC--hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 4579999999999999999999999999999999976442 333456779999999999999999999996543
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..+++ +++.+++|.++++.. .+++..++.++.|++.||+|||++|++||||||+|||++.++.++|+|||++......
T Consensus 85 ~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 85 DVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 34555 456688999999865 5999999999999999999999999999999999999999999999999999764332
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-------
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP------- 248 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 248 (316)
. ..........+++.|+|||++......+.++||||+||++|+|++|+.||.+.+..+...........+
T Consensus 163 ~---~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 H---DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp G---CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred C---ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 2 222334456689999999998776666666999999999999999999998877655544432211111
Q ss_pred -----------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 249 -----------------------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 249 -----------------------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
..+.+++++++||.+|| .||.+|||++++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 12457889999999999 59999999999999999985544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-53 Score=353.49 Aligned_cols=247 Identities=24% Similarity=0.435 Sum_probs=210.1
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe-CC
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-TH 95 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 95 (316)
|++..++|++.+.||+|+||.||+|++. |+.||||+++.... .+.+.+|+.++++++||||+++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 6778899999999999999999999874 77999999865432 4557799999999999999999999854 45
Q ss_pred eEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQ--GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
.+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++++|||++....
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 689999999999999999653 348999999999999999999999999999999999999999999999999986532
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
. ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||......++...+..+..++.+..
T Consensus 155 ~---------~~~~~~~~~~y~aPE~l~~~~~t~~-sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~ 224 (262)
T d1byga_ 155 S---------TQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 224 (262)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT
T ss_pred C---------CCccccccccCCChHHHhCCCCChH-HHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 1 1222346789999999987776655 999999999999998 7999999999999999988888888888
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+++++.+||.+|| .+|.+|||+.+++++
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999 599999999999753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=363.31 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=206.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe------C
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------T 94 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 94 (316)
.-+|..++.||+|+||+||+|++..+|+.||||++..... ...+|+.+++.++||||+++++++.. .
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 3479999999999999999999999999999999976432 23379999999999999999999853 3
Q ss_pred CeEEEEEecCCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC-CeEEeeccccc
Q psy11194 95 HRVYIIMEYAENGSLFDII---RGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY-NIKLSDFGFAR 170 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l---~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~-~~~l~Df~~~~ 170 (316)
.+.++||||++++.+..+. .....+++..++.++.||+.||+|||++|++||||||+|||++.++ .+||+|||++.
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 3579999999775433332 3455799999999999999999999999999999999999998775 89999999986
Q ss_pred ccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc------
Q psy11194 171 AHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNK------ 244 (316)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------ 244 (316)
... .........|++.|+|||.+.+....+.++|||||||++|+|++|..||...+..+....+.+.
T Consensus 172 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 172 QLV-------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp ECC-------TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred hcc-------CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 532 1222334568999999999876655556699999999999999999999887776665544321
Q ss_pred ------------cCCC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 245 ------------VTFP----------KQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 245 ------------~~~~----------~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
..++ ..+.+++++.+||.+|| .||++|||+.|+++||||++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0111 12357899999999999 59999999999999999987644
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=360.99 Aligned_cols=264 Identities=26% Similarity=0.463 Sum_probs=215.7
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEc---cCCceEEEEEeecCCCC-chHHHhhHHHHHHHHhcCCC-CCcceeeeEEEe
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARST---RHSGDVAIKIVSKVQAP-PDYLKKFLPREIEVVKGLKH-PNLIRFLQAIET 93 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~---~~~~~v~vK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~ 93 (316)
+.-++|++++.||+|+||.||+|.+. .+|+.||||++...... .....+.+.+|+.++++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 34588999999999999999999874 46889999998653321 11124556689999999966 899999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 94 THRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
....+++|||+.+++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||++..+.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999987643
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cccCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIP-YAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ---NKVTFPK 249 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~ 249 (316)
.. .........+++.|+|||.+.+.. ..+.++|||||||++|+|++|..||.+....+....+. .....+.
T Consensus 181 ~~-----~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~ 255 (322)
T d1vzoa_ 181 AD-----ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255 (322)
T ss_dssp GG-----GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred cc-----ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCC
Confidence 21 122233456889999999987543 34555999999999999999999997654333322222 1234455
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCC-----CHHHHhhCCCCCCCC
Q psy11194 250 QPEVSTECKELISNIL-SPVQTRP-----RLKTIAEDRWLKPKP 287 (316)
Q Consensus 250 ~~~~~~~~~~li~~~l-~~p~~Rp-----s~~~il~~~~~~~~~ 287 (316)
+..+|+++.+||.+|| .+|.+|| +++|+++||||++..
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 5679999999999999 5999999 589999999998653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=362.07 Aligned_cols=256 Identities=24% Similarity=0.340 Sum_probs=210.9
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC-----C
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----H 95 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 95 (316)
.++|++++.||+|+||+||+|++..+|+.||||++........ ..+.+.+|+.+++.++|||++++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHH-HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChH-HHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 5789999999999999999999999999999999976554433 344567999999999999999999998633 3
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccc
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~ 175 (316)
..+++++++.|++|.+++..+ .+++..++.++.||+.||+|||++|++||||||+||+++.+|.++++|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred ceEEEEEeecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence 345666777799999999754 59999999999999999999999999999999999999999999999999985432
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-------
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP------- 248 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 248 (316)
.......|++.|+|||+..+....+.++|||||||++|+|++|..||.+.+.......+......+
T Consensus 173 -------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 173 -------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred -------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 222344588999999998877766666999999999999999999999887776665553321111
Q ss_pred -----------------C------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCC
Q psy11194 249 -----------------K------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKP 287 (316)
Q Consensus 249 -----------------~------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~ 287 (316)
. ...+++++++||.+|| .||++|||++|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0 1357899999999999 5999999999999999998654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-51 Score=356.73 Aligned_cols=253 Identities=25% Similarity=0.435 Sum_probs=206.0
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEe--CCe
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIET--THR 96 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~ 96 (316)
..++|++++.||+|+||+||+|++..+|+.||+|++.... .+.+.+|+.+++.++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 4678999999999999999999999999999999986432 345679999999995 9999999999974 456
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC-CeEEeecccccccccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY-NIKLSDFGFARAHMRC 175 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~-~~~l~Df~~~~~~~~~ 175 (316)
.++||||+++++|..+. +.+++..++.++.||+.||.|||++|++|+||||+|||++.++ .++|+|||++....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~-- 181 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-- 181 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC--
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc--
Confidence 89999999999987763 3599999999999999999999999999999999999998655 59999999986532
Q ss_pred cCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhc-----------
Q psy11194 176 RSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSV-NELLKQVQN----------- 243 (316)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~----------- 243 (316)
.........+|+.|+|||.+.+....+.++||||+||++|++++|..||..... .+....+..
T Consensus 182 -----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 182 -----PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp -----TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred -----CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 112234456889999999988776656669999999999999999999975432 221111100
Q ss_pred -------------------------ccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCCCC
Q psy11194 244 -------------------------KVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPKPK 288 (316)
Q Consensus 244 -------------------------~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~~~ 288 (316)
....+....+++++.+||.+|| .+|++|||++|+|+||||++...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0001111347899999999999 59999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=354.82 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=214.6
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCce--EEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeeeEEEeCC
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGD--VAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 95 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~--v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 95 (316)
+.-++|++.+.||+|+||.||+|++..+|.. |+||.+...... ...+.+.+|+.++..+ +||||+++++++...+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4568899999999999999999999888775 566766543322 2245678999999998 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC
Q psy11194 96 RVYIIMEYAENGSLFDIIRGQ----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY 159 (316)
Q Consensus 96 ~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~ 159 (316)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+++||||+|+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999643 5699999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Q psy11194 160 NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFG-RLPFDDSSVNELL 238 (316)
Q Consensus 160 ~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~ 238 (316)
.+||+|||+++.... ........++..|+|||.+....++.+ +|||||||++|+|++| ..||.+.+..++.
T Consensus 165 ~~kl~DfG~a~~~~~-------~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~~~~ 236 (309)
T d1fvra_ 165 VAKIADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236 (309)
T ss_dssp CEEECCTTCEESSCE-------ECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred ceEEccccccccccc-------cccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999865321 111223457889999999988777655 9999999999999995 5689999999999
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 239 KQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
..+.++..++.+..+++++.+||.+|| .+|++|||+++|+++
T Consensus 237 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999888888888889999999999999 599999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=356.12 Aligned_cols=254 Identities=22% Similarity=0.398 Sum_probs=209.7
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCc----eEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSG----DVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
+...+|++++.||+|+||.||+|.+..+|+ +||+|.+....... ..+.+.+|+.+++.++||||+++++++.++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C--THHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 445679999999999999999999987776 47777775433222 245677999999999999999999999875
Q ss_pred CeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
..+++++++.+++|.+.+.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 45677888889999888765 4579999999999999999999999999999999999999999999999999997643
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQNKVTFPKQPE 252 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
.. ..........|++.|+|||++.+..++.+ +|||||||++|+|+| |..||.+....++...+..+...+.+..
T Consensus 163 ~~----~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~ 237 (317)
T d1xkka_ 163 AE----EKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 237 (317)
T ss_dssp TT----CC--------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTT
T ss_pred cc----cccccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 11 11122233457899999999987776655 999999999999998 8999999888888888888888888888
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 253 VSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 253 ~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
+++++.+||.+|| .+|++|||+.++++|
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999 599999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=350.22 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=204.6
Q ss_pred eeeccCeEEeeeeeecCCeEEEEEEEccC-C--ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeC
Q psy11194 18 VLESHGYTVGKIIGTGSYATVKLARSTRH-S--GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 94 (316)
Q Consensus 18 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~-~--~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 94 (316)
.+..++|++.+.||+|+||.||+|+.... + ..||||++...........+.+.+|+.+++.++||||+++++++.++
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~ 83 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 83 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec
Confidence 35568899999999999999999986543 3 36899998766554555556688999999999999999999999764
Q ss_pred CeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRG-QGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHM 173 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~ 173 (316)
..++||||+++++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus 84 -~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred -chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 66899999999999988754 4569999999999999999999999999999999999999999999999999997643
Q ss_pred cccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh-cccCCCCCC
Q psy11194 174 RCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDDSSVNELLKQVQ-NKVTFPKQP 251 (316)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 251 (316)
... ..........++..|+|||++.+..++.+ +||||||+++|||++ |..||.+.+..+....+. .+..++.+.
T Consensus 163 ~~~---~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (273)
T d1u46a_ 163 QND---DHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 238 (273)
T ss_dssp C-C---CEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT
T ss_pred cCC---CcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcc
Confidence 221 11122333456788999999988766655 999999999999998 899999999998877774 445666677
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 252 EVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 252 ~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.+|+++.+||..|| .+|++|||+++|++
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 89999999999999 59999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-51 Score=351.19 Aligned_cols=256 Identities=20% Similarity=0.312 Sum_probs=218.4
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEE
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAI 91 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 91 (316)
.++..++|++.+.||+|+||.||+|+.. .+++.||||++..... ....+.+.+|+.+++.++||||+++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3445678999999999999999999875 3457899999865432 33355678999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccC
Q psy11194 92 ETTHRVYIIMEYAENGSLFDIIRGQ------------------------GYIDEIRARRWFGQLLEALQYCHERGVVHRD 147 (316)
Q Consensus 92 ~~~~~~~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~d 147 (316)
......+++|||+++++|.+++... ..++...+..++.|++.||+|||+.+++|||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 9999999999999999999999642 2488999999999999999999999999999
Q ss_pred CCCCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCC-
Q psy11194 148 IKCENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGR- 226 (316)
Q Consensus 148 l~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~- 226 (316)
|||+||+++.++.+||+|||+++...... .........+++.|+|||.+.+..++.+ +|||||||++|+|++|.
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSAD----YYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGG----CBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTC
T ss_pred EcccceEECCCCcEEEccchhheeccCCc----cccccCCCCcCcCcCCHHHHccCCCChh-hhhccchhhHHHHHccCC
Confidence 99999999999999999999997543221 1122334557889999999988777755 99999999999999974
Q ss_pred CCCCCCCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 227 LPFDDSSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.||.+.+..+....+.++..++.+..+|+++.+||..|| .+|.+|||+.+|++
T Consensus 241 ~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 689999999999999888777777889999999999999 59999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=350.14 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=216.3
Q ss_pred ceeeccCeEEeeeeeecCCeEEEEEEEccCC-------ceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceee
Q psy11194 17 TVLESHGYTVGKIIGTGSYATVKLARSTRHS-------GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFL 88 (316)
Q Consensus 17 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~ 88 (316)
+++..++|++.+.||+|+||.||+|++..++ ..||||+++.... ......+.+|...+..+ +||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 7788999999999999999999999876543 3699999865443 22344566888888777 799999999
Q ss_pred eEEEeCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCC
Q psy11194 89 QAIETTHRVYIIMEYAENGSLFDIIRGQ----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCEN 152 (316)
Q Consensus 89 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~n 152 (316)
+++.++...++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+++||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 9999999999999999999999999643 348999999999999999999999999999999999
Q ss_pred eeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q psy11194 153 LLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFDD 231 (316)
Q Consensus 153 il~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~ 231 (316)
||++.++.+||+|||++...... ..........+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHI----DYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGC----CTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eeecCCCCeEeccchhhcccccc----ccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCC
Confidence 99999999999999999765322 22223344567889999999988777655 999999999999998 7999999
Q ss_pred CCHHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 232 SSVNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
....+....+..+..++.+..+++++.+||.+|| .+|++|||+.+|++
T Consensus 241 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 9999999999888888888889999999999999 69999999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=351.46 Aligned_cols=261 Identities=20% Similarity=0.348 Sum_probs=205.3
Q ss_pred ccccceeeccCeEEeeeeeecCCeEEEEEEEccC-----CceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcce
Q psy11194 13 DRKVTVLESHGYTVGKIIGTGSYATVKLARSTRH-----SGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIR 86 (316)
Q Consensus 13 ~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~ 86 (316)
+...+++..++|++.+.||+|+||.||+|++... ++.||+|++....... ..+.+.+|...+.++ +|+||+.
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH--HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH--HHHHHHHHHHHHHhhcCCCeEEE
Confidence 4445678889999999999999999999997643 4579999986544322 234455677766666 6899999
Q ss_pred eeeEEEeC-CeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q psy11194 87 FLQAIETT-HRVYIIMEYAENGSLFDIIRGQ----------------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIK 149 (316)
Q Consensus 87 ~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~ 149 (316)
+++++... ...++||||+++|+|.+++... ..+++..+..++.||+.||.|||++|++|||||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlK 161 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 161 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCC
Confidence 99988654 4689999999999999999642 248999999999999999999999999999999
Q ss_pred CCCeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCC
Q psy11194 150 CENLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFG-RLP 228 (316)
Q Consensus 150 p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p 228 (316)
|+|||++.++.+||+|||+++.... ...........||+.|+|||++.+..++.+ +|||||||++|+|++| ..|
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~----~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYK----DPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp GGGEEECGGGCEEECC------CCS----CTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCS
T ss_pred ccceeECCCCcEEEccCcchhhccc----cccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHHHhCCCCC
Confidence 9999999999999999999975321 112223344568999999999988766655 9999999999999986 567
Q ss_pred CCCCC-HHHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 229 FDDSS-VNELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
|.+.. .......+..+..++.+..+++++.++|.+|| .+|++|||++++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 237 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp STTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 87654 44556667777777777789999999999999 599999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=358.74 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=201.0
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe------C
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------T 94 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 94 (316)
.++|++++.||+|+||+||+|++..+|+.||||++........ ....+.+|+.+++.++||||++++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~-~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT-HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHH-HHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHH-HHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4789999999999999999999999999999999977655433 34557799999999999999999999953 4
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccccccccc
Q psy11194 95 HRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMR 174 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~ 174 (316)
...|+||||+.++ +.+.+. ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++++|||++....
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~- 170 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 170 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc-
Confidence 6889999999764 444443 458999999999999999999999999999999999999999999999999886532
Q ss_pred ccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC------
Q psy11194 175 CRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQNKVTFP------ 248 (316)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 248 (316)
.........+|+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+.......+......+
T Consensus 171 ------~~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 171 ------TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ------cccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 2233344568899999999988777766 999999999999999999998877666555443211100
Q ss_pred -----------------C------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhhCCCCCCC
Q psy11194 249 -----------------K------------------QPEVSTECKELISNIL-SPVQTRPRLKTIAEDRWLKPK 286 (316)
Q Consensus 249 -----------------~------------------~~~~~~~~~~li~~~l-~~p~~Rps~~~il~~~~~~~~ 286 (316)
. ....++++.+||.+|| .||++|||++|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0 0114568899999999 599999999999999999763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=347.29 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=223.0
Q ss_pred ccceeeccCeEEeeeeeecCCeEEEEEEEcc-----CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeee
Q psy11194 15 KVTVLESHGYTVGKIIGTGSYATVKLARSTR-----HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQ 89 (316)
Q Consensus 15 ~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 89 (316)
.-+++..++|++.+.||+|+||.||+|.+.. +++.||||+++.... ......+.+|+.+++.++||||+++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC--hHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 3578889999999999999999999998753 356899999865432 233456779999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCC
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQ----------GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDY 159 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~ 159 (316)
++..+...++||||+++|+|.+++... ..++...+..++.|++.||.|||+++++||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 999999999999999999999998531 2478999999999999999999999999999999999999999
Q ss_pred CeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Q psy11194 160 NIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFG-RLPFDDSSVNELL 238 (316)
Q Consensus 160 ~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~ 238 (316)
++||+|||+++....... ........+++.|+|||.+.+..++.+ +||||||+++|+|+|| ..||.+.+..+..
T Consensus 171 ~~Kl~DFGla~~~~~~~~----~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp CEEECCTTCCCGGGGGGC----EEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred eEEEeecccceeccCCcc----eeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999976532211 122233457899999999988777655 9999999999999997 6889999999999
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 239 KQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
..+.++..++.+..+|+.+.++|.+|| .+|++|||++++++
T Consensus 246 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 246 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999888888888889999999999999 59999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=343.41 Aligned_cols=257 Identities=21% Similarity=0.360 Sum_probs=216.5
Q ss_pred cceeeccCeEEeeeeeecCCeEEEEEEEc-----cCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcC-CCCCcceeee
Q psy11194 16 VTVLESHGYTVGKIIGTGSYATVKLARST-----RHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGL-KHPNLIRFLQ 89 (316)
Q Consensus 16 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 89 (316)
.+++..++|++.+.||+|+||.||+|++. .+++.||||+++..... .....+.+|+.++..+ +||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--HHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 56788899999999999999999999863 45668999999765432 2244577999999998 6999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q psy11194 90 AIETTHRVYIIMEYAENGSLFDIIRGQG------------------YIDEIRARRWFGQLLEALQYCHERGVVHRDIKCE 151 (316)
Q Consensus 90 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~ 151 (316)
++...+..++||||+++++|.+++.+.. .+++..+..++.||+.||+|||+.|++||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999996532 5899999999999999999999999999999999
Q ss_pred CeeeCCCCCeEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q psy11194 152 NLLLDSDYNIKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVF-GRLPFD 230 (316)
Q Consensus 152 nil~~~~~~~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~ 230 (316)
||+++.++.++++|||.++..... ..........+++.|+|||++....++.+ +|||||||++|+|+| |.+||.
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKND----SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSC----TTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccccCcccccccchheeccCC----CcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCC
Confidence 999999999999999998754221 11222344568999999999987666665 999999999999998 677776
Q ss_pred CCCH-HHHHHHHhcccCCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhh
Q psy11194 231 DSSV-NELLKQVQNKVTFPKQPEVSTECKELISNIL-SPVQTRPRLKTIAE 279 (316)
Q Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il~ 279 (316)
.... ..+.+.+..+.....+..+|.++.+||.+|| .+|++|||+++|++
T Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6554 4455666777777777789999999999999 58999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=337.63 Aligned_cols=250 Identities=18% Similarity=0.275 Sum_probs=203.4
Q ss_pred EeeeeeecCCeEEEEEEEccCC---ceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEe-CCeEEEEE
Q psy11194 26 VGKIIGTGSYATVKLARSTRHS---GDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-THRVYIIM 101 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~~---~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 101 (316)
..+.||+|+||+||+|++..++ ..||||.+.... .....+.+.+|+.++.+++||||+++++++.. +...++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3678999999999999986543 258899886433 33335667899999999999999999999865 56899999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeecccccccccccCcCC
Q psy11194 102 EYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGFARAHMRCRSNAA 180 (316)
Q Consensus 102 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~~~~~~~~~~~ 180 (316)
||+++++|.+++... ..++...+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++....... .
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~--~ 186 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF--D 186 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC--C
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc--c
Confidence 999999999998754 4588889999999999999999999999999999999999999999999999976432211 1
Q ss_pred CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy11194 181 DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDD-SSVNELLKQVQNKVTFPKQPEVSTECKE 259 (316)
Q Consensus 181 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (316)
.........|++.|+|||.+.+..++.+ +||||||+++|+|++|..||.. .+..+....+..+..++.+..+++++.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHH
Confidence 1222334468899999999987776655 9999999999999997666654 4555667777777777777889999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhhC
Q psy11194 260 LISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 260 li~~~l-~~p~~Rps~~~il~~ 280 (316)
||.+|| .+|++|||+.+|++|
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 999999 699999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-47 Score=324.82 Aligned_cols=267 Identities=19% Similarity=0.267 Sum_probs=204.7
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCC-cceeeeEEEeCCeEEE
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPN-LIRFLQAIETTHRVYI 99 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~l 99 (316)
+++|++.+.||+|+||.||+|++..+|+.||||++...... +.+.+|+.+++.++|++ |+.+.+++......++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 57899999999999999999999999999999998765432 34678999999997665 5556666788889999
Q ss_pred EEecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC---CCCeEEeecccccccccc
Q psy11194 100 IMEYAENGSLFDIIR-GQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS---DYNIKLSDFGFARAHMRC 175 (316)
Q Consensus 100 v~e~~~~~sL~~~l~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~---~~~~~l~Df~~~~~~~~~ 175 (316)
||||+. ++|...+. ....+++..+..++.|++.||+|||++|++||||||+||+++. +..++++|||+++.....
T Consensus 81 vme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999995 46666664 4567999999999999999999999999999999999999864 456999999999876533
Q ss_pred cCcCC-CCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----cccCCC--
Q psy11194 176 RSNAA-DNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVNELLKQVQ----NKVTFP-- 248 (316)
Q Consensus 176 ~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~-- 248 (316)
..... .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........+. .....+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 32221 1223345579999999999998777665 999999999999999999998755544332221 111111
Q ss_pred -CCCCCCHHHHHHHHHhc-CCCCCCCCHHH---HhhCCCCCC-CCCCCChhh
Q psy11194 249 -KQPEVSTECKELISNIL-SPVQTRPRLKT---IAEDRWLKP-KPKSRGVDK 294 (316)
Q Consensus 249 -~~~~~~~~~~~li~~~l-~~p~~Rps~~~---il~~~~~~~-~~~~~~~~~ 294 (316)
....+|+++.++|..|| .+|++||++.+ +++|+|... ......++|
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw 290 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 290 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCc
Confidence 23568999999999999 69999999874 567877643 233333544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-46 Score=320.72 Aligned_cols=253 Identities=19% Similarity=0.213 Sum_probs=205.5
Q ss_pred eeccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeE
Q psy11194 19 LESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRV 97 (316)
Q Consensus 19 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 97 (316)
+.+++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|++.++.+. ++|++.+++++......
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 347899999999999999999999999999999999865443 234678999999996 48999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCC-----CCCeEEeecccccc
Q psy11194 98 YIIMEYAENGSLFDIIRGQ-GYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDS-----DYNIKLSDFGFARA 171 (316)
Q Consensus 98 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~-----~~~~~l~Df~~~~~ 171 (316)
++|||++ +++|.+++... ..++...+..++.|++.||.+||+.|++||||||+||+++. .+.++|+|||+++.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 67999998764 46999999999999999999999999999999999999964 57899999999987
Q ss_pred cccccCcC-CCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcccC-
Q psy11194 172 HMRCRSNA-ADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSS---VNELLKQVQNKVT- 246 (316)
Q Consensus 172 ~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~~~~~~~~- 246 (316)
+....... ..........||+.|+|||++.+..++.+ +||||||+++|+|++|..||.+.. .......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 64332211 12223345579999999999998777665 999999999999999999997533 3333333322111
Q ss_pred C---CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy11194 247 F---PKQPEVSTECKELISNIL-SPVQTRPRLKTIA 278 (316)
Q Consensus 247 ~---~~~~~~~~~~~~li~~~l-~~p~~Rps~~~il 278 (316)
. ...+.+|+++.+++..|+ .+|++||+++.+.
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 1 123568999999999999 6999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=321.49 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=190.5
Q ss_pred ccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCcceeeeEEEeCC----e
Q psy11194 21 SHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----R 96 (316)
Q Consensus 21 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 96 (316)
+++|.+.+.||+|+||.||+|+. +|+.||||++..... .....+.|+..+..++||||+++++++..++ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 46899999999999999999975 578999999864321 1222334555666789999999999997654 6
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------cCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 97 VYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE--------RGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 97 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~--------~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
.++||||+++|+|.+++++. .+++..+..++.+++.||.|||+ +|++|+||||+|||++.++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 89999999999999999875 49999999999999999999996 5899999999999999999999999999
Q ss_pred ccccccccCcCCCCCCCcccccccCccCcccccCCCC-----CCCchhHHHHHHHHHHHHhCCCCCCC------------
Q psy11194 169 ARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPY-----APHLSDIWSMGVVLFAMVFGRLPFDD------------ 231 (316)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~l~~g~~p~~~------------ 231 (316)
+........ ..........||+.|+|||++..... .+.++|||||||++|+|+||..||..
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 155 AVRHDSATD--TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp CEEEETTTT--EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred cccccCCCc--ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 976532221 11223345678999999999876432 22348999999999999999877632
Q ss_pred ---CCHHHHHHHHhcc-cCCCCCC-----CCCHHHHHHHHHhc-CCCCCCCCHHHHhhC
Q psy11194 232 ---SSVNELLKQVQNK-VTFPKQP-----EVSTECKELISNIL-SPVQTRPRLKTIAED 280 (316)
Q Consensus 232 ---~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~li~~~l-~~p~~Rps~~~il~~ 280 (316)
.........+... .+++.+. ..+..+.+|+.+|| .+|++|||+.||+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1233333333322 2222211 12346899999999 589999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-44 Score=317.51 Aligned_cols=264 Identities=24% Similarity=0.394 Sum_probs=196.1
Q ss_pred eccCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-----------CCCcceee
Q psy11194 20 ESHGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-----------HPNLIRFL 88 (316)
Q Consensus 20 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~ 88 (316)
.+.+|++++.||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.+++.++ |+||++++
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 4467999999999999999999999999999999987532 22345668888887774 57899999
Q ss_pred eEEEe--CCeEEEEEecCCCCC-HHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeCCCCC--
Q psy11194 89 QAIET--THRVYIIMEYAENGS-LFDII--RGQGYIDEIRARRWFGQLLEALQYCHE-RGVVHRDIKCENLLLDSDYN-- 160 (316)
Q Consensus 89 ~~~~~--~~~~~lv~e~~~~~s-L~~~l--~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~H~dl~p~nil~~~~~~-- 160 (316)
+++.. ....++++.++.... ..... .....+++..++.++.||+.||.|||+ .|++||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 88854 456666666665443 22222 234569999999999999999999998 89999999999999976553
Q ss_pred ----eEEeecccccccccccCcCCCCCCCcccccccCccCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-
Q psy11194 161 ----IKLSDFGFARAHMRCRSNAADNSLSETFCGSYAYASPEILQGIPYAPHLSDIWSMGVVLFAMVFGRLPFDDSSVN- 235 (316)
Q Consensus 161 ----~~l~Df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~- 235 (316)
++++|||.+.... .......+++.|+|||++....++.+ +|+||+||++++|++|+.||......
T Consensus 167 ~~~~~kl~dfg~s~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYD---------EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp TEEEEEECCCTTCEETT---------BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC-------
T ss_pred ccceeeEeecccccccc---------cccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCcccc
Confidence 9999999986432 22234568999999999988777665 99999999999999999999753321
Q ss_pred -----HHHHHHhcc-------------------------c----------------CCCCCCCCCHHHHHHHHHhc-CCC
Q psy11194 236 -----ELLKQVQNK-------------------------V----------------TFPKQPEVSTECKELISNIL-SPV 268 (316)
Q Consensus 236 -----~~~~~~~~~-------------------------~----------------~~~~~~~~~~~~~~li~~~l-~~p 268 (316)
......... . ........++++.+||.+|| .||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 111110000 0 00011224678999999999 599
Q ss_pred CCCCCHHHHhhCCCCCCCCCCCChhhHHH
Q psy11194 269 QTRPRLKTIAEDRWLKPKPKSRGVDKAEA 297 (316)
Q Consensus 269 ~~Rps~~~il~~~~~~~~~~~~~~~~~~~ 297 (316)
.+|||++|+|+||||++......+..-.+
T Consensus 317 ~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~ 345 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDTLGMEEIRVPDR 345 (362)
T ss_dssp TTCBCHHHHHTCGGGTTCTTCTTCCCTTS
T ss_pred hHCcCHHHHhcCcccCCCCCcccCCCCCc
Confidence 99999999999999997766555433333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.3e-24 Score=172.50 Aligned_cols=135 Identities=19% Similarity=0.258 Sum_probs=105.4
Q ss_pred eEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCC---------------chHHHhhHHHHHHHHhcCCCCCcceee
Q psy11194 24 YTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAP---------------PDYLKKFLPREIEVVKGLKHPNLIRFL 88 (316)
Q Consensus 24 y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 88 (316)
+.+.+.||+|+||+||+|++. +|+.||||+++..... ..........|...+..+.+.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999875 6889999987642111 001122345688899999999998877
Q ss_pred eEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeCCCCCeEEeeccc
Q psy11194 89 QAIETTHRVYIIMEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHERGVVHRDIKCENLLLDSDYNIKLSDFGF 168 (316)
Q Consensus 89 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~H~dl~p~nil~~~~~~~~l~Df~~ 168 (316)
++.. .+++||++++..+.. ++...+..++.|++.++.+||+.|++|+||||+|||++++ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 6532 279999998865432 4555678899999999999999999999999999999865 489999998
Q ss_pred ccc
Q psy11194 169 ARA 171 (316)
Q Consensus 169 ~~~ 171 (316)
+..
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred ccc
Confidence 854
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.90 E-value=7.5e-09 Score=84.40 Aligned_cols=139 Identities=14% Similarity=0.079 Sum_probs=96.7
Q ss_pred cCeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEeCCeEEEE
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYII 100 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 100 (316)
..|+..+..+.++.+.||++. .+++.+++|......... ...+.+|...+..+. +--+++++.+...++..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 456666665555667899884 456678888875443222 334668888887774 43467888888888999999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q psy11194 101 MEYAENGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE---------------------------------------- 140 (316)
Q Consensus 101 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~---------------------------------------- 140 (316)
|++++|.++.+..... .....++.+++..+..||+
T Consensus 89 ~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9999998886654321 1223345555566666663
Q ss_pred -------------------cCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 141 -------------------RGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 141 -------------------~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127999999999999877666799999763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.38 E-value=6.5e-07 Score=72.13 Aligned_cols=127 Identities=14% Similarity=0.078 Sum_probs=82.4
Q ss_pred eeeecCC-eEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC--CCCcceeeeEEEeCCeEEEEEecCC
Q psy11194 29 IIGTGSY-ATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK--HPNLIRFLQAIETTHRVYIIMEYAE 105 (316)
Q Consensus 29 ~ig~g~~-g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~ 105 (316)
.+..|.. +.||++... .+..+++|...... ...+..|...++.+. .-.+++++.+..+++..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4455554 678988643 45568889765433 234667888887774 2336778888888889999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q psy11194 106 NGSLFDIIRGQGYIDEIRARRWFGQLLEALQYCHE--------------------------------------------- 140 (316)
Q Consensus 106 ~~sL~~~l~~~~~l~~~~~~~i~~~i~~~l~~Lh~--------------------------------------------- 140 (316)
|.++.+. ..+.. ..+.++...|..||.
T Consensus 90 G~~~~~~-----~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 90 GQDLLSS-----HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp SEETTTS-----CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccccccc-----cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 8765321 01111 111223333333331
Q ss_pred -------------cCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 141 -------------RGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 141 -------------~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 137999999999999877667799999763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.36 E-value=5.7e-07 Score=77.41 Aligned_cols=81 Identities=16% Similarity=0.044 Sum_probs=49.5
Q ss_pred EeeeeeecCCeEEEEEEEccCCceEEEEEeecC----C-CCchHHHhhHHHHHHHHhcCC--C-CCcceeeeEEEeCCeE
Q psy11194 26 VGKIIGTGSYATVKLARSTRHSGDVAIKIVSKV----Q-APPDYLKKFLPREIEVVKGLK--H-PNLIRFLQAIETTHRV 97 (316)
Q Consensus 26 ~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~----~-~~~~~~~~~~~~e~~~l~~l~--~-~~i~~~~~~~~~~~~~ 97 (316)
..+.||.|....||++.+...++.+++|..... . ..+. .......|...+..+. . ..+++++.+ ++...
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~-~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~ 106 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPL-TIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 106 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCC-CTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCC-CHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCC
Confidence 356799999999999988877889999976431 1 1110 1223446777777663 2 345666554 34455
Q ss_pred EEEEecCCCCCH
Q psy11194 98 YIIMEYAENGSL 109 (316)
Q Consensus 98 ~lv~e~~~~~sL 109 (316)
++|||++++.++
T Consensus 107 ~lvmE~L~~~~~ 118 (392)
T d2pula1 107 VTVMEDLSHLKI 118 (392)
T ss_dssp EEEECCCTTSEE
T ss_pred EEEEeccCCccc
Confidence 789999977543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.54 E-value=0.00015 Score=61.83 Aligned_cols=78 Identities=14% Similarity=0.117 Sum_probs=50.9
Q ss_pred cCeEEeeeeeecCCeEEEEEEEcc-------CCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCC-CCCcceeeeEEEe
Q psy11194 22 HGYTVGKIIGTGSYATVKLARSTR-------HSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLK-HPNLIRFLQAIET 93 (316)
Q Consensus 22 ~~y~~~~~ig~g~~g~vy~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 93 (316)
+..++ +.|+.|-.-.+|++.... .+..+++++.... ... . ...+|..+++.+. +.-.+++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~--i-dr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETE--S-HLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCH--H-HHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chh--h-HHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 34444 678889999999998653 2346777776422 121 2 2457888888874 4344677777643
Q ss_pred CCeEEEEEecCCCCCH
Q psy11194 94 THRVYIIMEYAENGSL 109 (316)
Q Consensus 94 ~~~~~lv~e~~~~~sL 109 (316)
.+|++|++|.+|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 578999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.45 E-value=0.00027 Score=58.61 Aligned_cols=68 Identities=6% Similarity=0.001 Sum_probs=42.6
Q ss_pred CeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCCCCc--ceee-----eEEEeCCeEEEEEecCCCC
Q psy11194 35 YATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKHPNL--IRFL-----QAIETTHRVYIIMEYAENG 107 (316)
Q Consensus 35 ~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~-----~~~~~~~~~~lv~e~~~~~ 107 (316)
.-.||++.. .+|..+++|+.+..... .+.+..|...+..|...++ +..+ ..+......+.++++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 457999965 46788999998654332 3445677777766632111 1111 1234567789999999764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.34 E-value=0.0002 Score=59.02 Aligned_cols=141 Identities=21% Similarity=0.133 Sum_probs=73.1
Q ss_pred CeEEeeeeeecCCeEEEEEEEccCCceEEEEEeecCCCCchHHHhhHHHHHHHHhcCCC-----CCccee---eeEEEeC
Q psy11194 23 GYTVGKIIGTGSYATVKLARSTRHSGDVAIKIVSKVQAPPDYLKKFLPREIEVVKGLKH-----PNLIRF---LQAIETT 94 (316)
Q Consensus 23 ~y~~~~~ig~g~~g~vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-----~~i~~~---~~~~~~~ 94 (316)
+..-.+.|..|---+.|++... ++.+++|+...... .+.+..|..++..+.. |..+.. ..+....
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~ 91 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 91 (316)
T ss_dssp CEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred CceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCCC-----HHHHHHHHHHHHhhhhccccccccceecCCCcceeee
Confidence 4455566777877889998644 44699999865322 2334456666666532 222221 0112334
Q ss_pred CeEEEEEecCCCCCHH-----HHH------H------h------CCCCCHH------------------HHHHHHHHHHH
Q psy11194 95 HRVYIIMEYAENGSLF-----DII------R------G------QGYIDEI------------------RARRWFGQLLE 133 (316)
Q Consensus 95 ~~~~lv~e~~~~~sL~-----~~l------~------~------~~~l~~~------------------~~~~i~~~i~~ 133 (316)
.....++.+..|.... ... . . ....... .....+..+..
T Consensus 92 ~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 171 (316)
T d2ppqa1 92 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 171 (316)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred cccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHH
Confidence 5666777766654221 000 0 0 0000000 11122222222
Q ss_pred HHHHHH----HcCccccCCCCCCeeeCCCCCeEEeeccccc
Q psy11194 134 ALQYCH----ERGVVHRDIKCENLLLDSDYNIKLSDFGFAR 170 (316)
Q Consensus 134 ~l~~Lh----~~~~~H~dl~p~nil~~~~~~~~l~Df~~~~ 170 (316)
.+.... ..|+||+|+.+.||+++.+...-++||+.+.
T Consensus 172 ~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 172 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 222222 2479999999999999988777899999874
|